data_1bvh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bvh _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.304 0.573 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.547 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -84.95 71.0 10.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.877 . . . . 0.0 109.442 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 9.3 ttmt -41.93 162.94 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.157 -0.964 . . . . 0.0 109.573 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 m -139.16 135.96 34.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 0.0 109.912 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.579 HG13 ' CZ ' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -141.7 155.53 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 108.927 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.603 ' CD1' ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -150.11 115.98 5.61 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 109.064 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.0 m-85 -86.8 151.56 23.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.512 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.518 ' HB ' ' CD1' ' A' ' 99' ' ' LEU . 5.4 t -143.82 157.92 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.59 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER 173.08 128.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -44.91 150.09 0.4 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.181 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.03 88.27 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 15' ' ' ASN . 25.6 t-20 -85.5 15.19 4.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -1.14 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 2.0 pp -119.22 131.79 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.613 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.78 ' SG ' ' CZ ' ' A' ' 138' ' ' PHE . 34.8 t 66.8 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.71 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.529 ' CG ' HG12 ' A' ' 141' ' ' VAL . 0.3 OUTLIER 43.11 78.63 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.681 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER 163.63 -61.48 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 0.0 109.94 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 19' ' ' SER . 52.1 Cg_endo -71.16 -1.25 9.28 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.85 1.7 . . . . 0.0 110.848 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.682 ' HB ' ' SG ' ' A' ' 145' ' ' CYS . 3.8 mm -74.6 -48.12 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.985 -1.072 . . . . 0.0 109.575 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.632 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -57.35 -27.85 62.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.551 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -73.27 -71.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -0.954 . . . . 0.0 109.318 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 68' ' ' ILE . . . -44.89 -26.97 0.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 108.887 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.822 ' CG1' ' SG ' ' A' ' 149' ' ' CYS . 72.2 t -70.23 -54.36 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.404 -0.81 . . . . 0.0 109.214 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.682 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 2.1 t80 -45.57 -35.78 4.21 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.461 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.3 OUTLIER -63.8 -57.66 9.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.425 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -55.97 -21.15 19.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.857 . . . . 0.0 109.652 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.768 HD13 ' SG ' ' A' ' 149' ' ' CYS . 39.7 mt -85.62 -30.79 22.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.212 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 36' ' ' SER . 2.9 p -90.67 -6.23 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.407 -0.808 . . . . 0.0 109.348 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -105.14 5.91 32.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.033 -1.042 . . . . 0.0 109.848 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 4.4 t0 -128.02 59.74 1.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 109.133 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HB3' HG23 ' A' ' 35' ' ' ILE . 1.0 OUTLIER 171.28 31.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.831 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.4 t-20 45.11 32.01 0.84 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 33' ' ' GLN . 2.7 tt -112.79 -7.31 11.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.687 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -73.11 -25.06 60.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.658 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -84.47 16.26 3.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 0.0 109.778 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.547 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 8.6 m-80 -144.46 36.13 1.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.481 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.623 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 22.1 m95 -150.18 150.39 31.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.986 -1.071 . . . . 0.0 111.029 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.5 t -128.31 70.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.582 HG12 ' CE1' ' A' ' 26' ' ' PHE . 2.4 mp -89.56 140.22 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.398 -0.814 . . . . 0.0 110.626 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -146.25 171.58 14.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.507 -0.745 . . . . 0.0 109.268 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.8 p -105.1 162.38 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.975 . . . . 0.0 109.614 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.559 ' CA ' ' CG2' ' A' ' 77' ' ' VAL . . . -143.05 122.76 1.97 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.531 ' O ' ' CG1' ' A' ' 46' ' ' VAL . . . -87.08 -41.26 13.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.142 -1.21 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER 80.25 -5.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.795 . . . . 0.0 109.436 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 76' ' ' GLN . 0.4 OUTLIER -126.49 179.61 5.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 109.371 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.507 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 19.3 t70 -120.38 7.87 10.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -91.55 -32.98 15.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.327 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -101.85 31.16 3.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 73.9 t -76.31 96.79 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.19 57.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -79.37 86.64 5.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -1.161 . . . . 0.0 109.555 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 53' ' ' ARG . 4.0 m -45.42 159.6 0.28 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.873 . . . . 0.0 109.369 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.45 152.41 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.98 1.787 . . . . 0.0 110.255 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.19 152.36 96.55 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.531 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 51.6 Cg_exo -51.22 -19.97 7.16 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.021 1.814 . . . . 0.0 110.475 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.409 ' O ' ' SG ' ' A' ' 62' ' ' CYS . 2.7 mtp180 -81.89 -47.78 12.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -0.961 . . . . 0.0 109.796 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.86 4.58 49.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.946 . . . . 0.0 109.807 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 6.8 p -89.93 -43.92 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.043 -1.036 . . . . 0.0 109.628 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.509 ' N ' HG12 ' A' ' 60' ' ' VAL . 3.8 p -76.82 -17.85 58.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.95 . . . . 0.0 109.521 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 58' ' ' ARG . 79.7 m -78.26 -62.29 1.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.523 ' CG ' HG23 ' A' ' 68' ' ' ILE . 1.0 OUTLIER -60.69 -27.99 68.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.567 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.2 ttp85 -96.94 33.37 1.91 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.649 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 61' ' ' SER . 9.1 t-20 -131.5 -43.07 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.345 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.86 -22.15 34.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.36 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 28' ' ' LYS . . . 113.16 83.33 1.22 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.523 HG23 ' CG ' ' A' ' 63' ' ' LEU . 1.3 tp -122.22 -24.5 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -1.16 . . . . 0.0 109.656 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 9.3 m-80 63.52 98.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.557 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.404 ' HB ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -124.23 91.39 3.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.77 53.55 1.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.58 ' CD2' ' N ' ' A' ' 73' ' ' LYS . 20.6 t60 -143.94 155.87 44.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.447 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.58 ' N ' ' CD2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -104.75 130.75 52.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 75' ' ' ARG . . . -43.99 -69.9 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.601 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 61.06 158.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.373 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 47' ' ' SER . 22.6 tt0 -88.39 123.78 33.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.442 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.559 ' CG2' ' CA ' ' A' ' 44' ' ' GLY . 21.3 t -47.56 151.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.86 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.477 ' N ' HG11 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -141.09 165.17 28.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.663 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' CG ' HG11 ' A' ' 106' ' ' VAL . 3.2 tmtt? -43.18 -41.67 3.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 109.495 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 84' ' ' THR . 24.4 tp10 -56.08 -48.37 76.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 109.553 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.487 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 1.2 m-20 -62.32 -34.02 75.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.77 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.688 ' HB3' ' SG ' ' A' ' 109' ' ' CYS . 79.3 m-85 -65.65 -79.07 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 110.163 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 84' ' ' THR . 7.3 p -48.13 -46.94 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.07 -1.019 . . . . 0.0 109.256 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.521 ' N ' ' CG1' ' A' ' 83' ' ' VAL . 16.4 m -45.85 -82.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.335 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.603 ' CE2' ' CD1' ' A' ' 9' ' ' LEU . 21.0 m-85 -57.13 166.5 1.07 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.317 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.33 -25.62 5.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.58 ' CE2' ' HG2' ' A' ' 6' ' ' LYS . 6.3 m-30 -109.38 72.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.107 -0.996 . . . . 0.0 109.852 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 1.3 mt -82.82 96.57 3.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.428 -0.795 . . . . 0.0 109.62 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.472 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -109.85 179.97 3.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.019 -1.051 . . . . 0.0 108.91 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -147.58 172.49 13.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.13 -0.982 . . . . 0.0 109.689 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.433 ' HE3' ' CD1' ' A' ' 116' ' ' LEU . 31.5 mmt -85.46 46.59 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.362 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' SER . 10.1 t70 56.93 -93.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.568 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 94' ' ' SER . 27.4 tt0 43.53 -94.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.305 -0.872 . . . . 0.0 109.338 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.6 ' O ' ' N ' ' A' ' 96' ' ' LEU . 4.6 p -85.67 88.2 7.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.09 -1.006 . . . . 0.0 108.71 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 96' ' ' LEU . 25.5 p-10 -31.94 85.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.091 0.472 . . . . 0.0 111.195 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' SER . 4.1 mt 29.48 56.98 0.15 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.244 0.545 . . . . 0.0 110.747 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -91.35 -50.96 5.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.082 -1.011 . . . . 0.0 109.65 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -92.77 -64.13 1.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.928 . . . . 0.0 109.653 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.518 ' CD1' ' HB ' ' A' ' 11' ' ' VAL . 17.3 mt -44.02 -40.11 4.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.217 -0.927 . . . . 0.0 109.668 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.504 ' OD1' ' CD1' ' A' ' 96' ' ' LEU . 3.2 t30 -61.59 -49.31 77.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -0.98 . . . . 0.0 109.182 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.83 14.6 11.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 108.918 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -86.25 -40.41 15.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.479 -0.763 . . . . 0.0 109.356 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.593 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 1.3 p -65.86 -11.79 49.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.42 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.4 -36.82 68.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -99.19 8.6 44.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.663 HG22 ' SG ' ' A' ' 109' ' ' CYS . 46.7 t -83.54 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.367 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 108' ' ' ASN . 12.1 tptp -62.53 88.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 108.832 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 107' ' ' LYS . 9.2 t30 73.99 71.06 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 108.932 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -85.01 143.72 28.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.315 -0.866 . . . . 0.0 109.901 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.476 ' O ' ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -143.82 13.58 1.7 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 108.985 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.539 ' CB ' HG13 ' A' ' 88' ' ' ILE . . . -89.85 97.22 11.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.965 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' ALA . 15.0 mttt -46.66 123.63 5.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 1.1 mm -99.36 139.59 20.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.875 -1.141 . . . . 0.0 110.372 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -167.11 -177.43 3.73 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.441 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -134.0 145.73 49.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.009 -1.057 . . . . 0.0 109.642 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.634 HD23 ' SG ' ' A' ' 148' ' ' CYS . 0.0 OUTLIER -43.24 152.54 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.328 -0.858 . . . . 0.0 109.448 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -158.43 -143.76 3.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 123' ' ' LYS . 2.0 p -87.24 109.19 19.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.166 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 151' ' ' ALA . 15.9 m-85 -112.27 -81.96 0.59 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.41 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.582 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -61.56 -61.47 7.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.654 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 52.3 Cg_endo -71.78 -161.68 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.77 1.647 . . . . 0.0 110.209 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -144.35 36.61 1.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 118' ' ' SER . 12.2 ptpt -111.49 159.07 18.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.242 -0.911 . . . . 0.0 109.566 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.7 81.87 7.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.49 112.79 25.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 109.386 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.5 ' CG2' ' CG ' ' A' ' 92' ' ' ASP . 6.6 mm -124.8 152.35 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.314 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.425 ' C ' ' OD2' ' A' ' 92' ' ' ASP . 2.9 mm -92.25 64.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.155 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.474 ' HG3' HG23 ' A' ' 126' ' ' ILE . 3.0 mt-10 -85.55 46.75 1.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.668 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -127.24 144.79 51.89 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.68 -42.9 1.52 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.876 1.717 . . . . 0.0 110.218 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.96 178.4 4.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.379 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -124.98 12.65 8.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 109.458 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 96.51 -115.7 5.27 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.74 -48.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -1.154 . . . . 0.0 109.335 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 135' ' ' ASP . 0.9 OUTLIER -102.26 159.71 15.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 135' ' ' ASP . . . 74.18 5.92 4.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.534 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -177.42 120.88 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.78 ' CZ ' ' SG ' ' A' ' 17' ' ' CYS . 2.0 t80 -170.85 -50.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.323 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 140' ' ' THR . 2.5 pt-20 -66.66 -28.61 68.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.411 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.417 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 32.4 m -62.18 -43.93 97.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.387 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.529 HG12 ' CG ' ' A' ' 18' ' ' ARG . 39.2 t -61.59 -57.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.234 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.591 ' CD2' HG22 ' A' ' 21' ' ' ILE . 1.4 t80 -46.52 -38.22 9.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 0.0 109.131 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.86 -39.27 79.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.737 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -68.66 -13.13 62.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.682 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.3 m -88.15 -12.56 43.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.476 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 95.8 t -58.54 -60.41 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.299 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.442 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -74.4 -18.49 60.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.897 . . . . 0.0 109.377 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.634 ' SG ' HD23 ' A' ' 116' ' ' LEU . 1.2 m -46.72 -32.21 3.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.151 -0.968 . . . . 0.0 109.184 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.822 ' SG ' ' CG1' ' A' ' 25' ' ' VAL . 1.0 OUTLIER -114.07 -30.01 6.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 109.175 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.53 ' CA ' HD11 ' A' ' 29' ' ' LEU . 18.2 ttt180 -75.22 -57.72 3.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 0.0 109.109 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 147' ' ' ARG . . . -51.77 -31.53 27.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.349 -0.844 . . . . 0.0 109.199 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.583 ' CE1' HG22 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -83.39 -29.36 28.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.813 . . . . 0.0 109.343 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.98 -18.11 65.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.067 -1.021 . . . . 0.0 108.666 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 3.7 mm-40 -70.09 -45.43 66.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.024 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -46.38 81.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.284 -0.885 . . . . 0.0 108.953 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.583 HG22 ' CE1' ' A' ' 152' ' ' PHE . 6.4 m -95.3 25.17 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.084 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 1.1 tmm_? . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.557 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 5' ' ' THR . 14.5 t . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -149.43 71.94 1.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.605 ' HB3' ' CH2' ' A' ' 39' ' ' TRP . 0.3 OUTLIER -42.28 166.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.151 -0.968 . . . . 0.0 110.304 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 85' ' ' PHE . 33.4 t -143.75 127.22 16.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.512 -0.742 . . . . 0.0 109.147 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.608 ' CG1' ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -131.09 153.25 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 108.904 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.582 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -146.21 123.52 11.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.445 -0.784 . . . . 0.0 108.997 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.2 m-85 -95.2 165.99 12.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.995 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 46' ' ' VAL . 2.0 t -147.38 149.11 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.349 -0.844 . . . . 0.0 109.644 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER 177.13 114.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 tp -46.74 156.94 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.0 109.405 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.35 49.55 75.14 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.461 ' OD1' ' HG3' ' A' ' 20' ' ' PRO . 43.4 t30 -74.29 82.09 1.86 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.133 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.446 HD11 ' HB3' ' A' ' 17' ' ' CYS . 1.2 pp -152.55 -52.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.712 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.692 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -134.61 34.73 3.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.641 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -171.37 60.07 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 109.372 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.737 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 163.59 -51.68 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 109.599 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 19' ' ' SER . 54.1 Cg_exo -49.29 -21.27 4.41 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.839 1.692 . . . . 0.0 110.455 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.579 HG22 ' CD2' ' A' ' 142' ' ' TYR . 18.5 mm -58.97 -51.28 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.165 -0.96 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.757 ' HB3' ' SG ' ' A' ' 145' ' ' CYS . . . -59.99 -16.97 34.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.136 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.51 ' OE1' ' CA ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -81.92 -72.81 0.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.221 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.525 ' HB3' ' CG2' ' A' ' 70' ' ' THR . . . -43.49 -39.18 3.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.001 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.759 HG13 ' SG ' ' A' ' 149' ' ' CYS . 47.2 t -60.83 -58.34 7.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.448 -0.782 . . . . 0.0 108.97 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.581 ' CD1' HG12 ' A' ' 41' ' ' ILE . 2.6 t80 -43.3 -29.12 0.38 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.928 . . . . 0.0 108.615 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.482 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -65.93 -62.2 1.63 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.331 -0.855 . . . . 0.0 109.226 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.08 -43.33 63.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 0.0 109.71 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.762 HD13 ' SG ' ' A' ' 149' ' ' CYS . 25.3 mt -60.39 -36.8 78.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.4 p -90.03 -4.52 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.504 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 1.4 m -107.21 12.51 28.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.848 -1.158 . . . . 0.0 109.689 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 6.9 t0 -131.84 56.14 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.132 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.526 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.7 OUTLIER 173.56 31.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 109.627 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.1 t30 45.71 36.88 2.93 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.553 HG12 ' CG2' ' A' ' 30' ' ' VAL . 2.1 tt -119.54 -7.37 11.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.959 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -74.64 -37.2 62.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 109.992 -179.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.02 1.01 11.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 110.027 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.532 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 6.8 m-20 -127.18 42.14 3.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.096 -1.003 . . . . 0.0 109.838 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.608 ' CZ3' ' CG1' ' A' ' 8' ' ' VAL . 9.4 m95 -150.23 157.3 42.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.899 -1.126 . . . . 0.0 110.819 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG13 ' CE1' ' A' ' 85' ' ' PHE . 96.5 t -133.06 71.9 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.581 HG12 ' CD1' ' A' ' 26' ' ' PHE . 2.7 mp -89.65 137.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.413 -0.804 . . . . 0.0 110.13 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 3.7 t70 -143.33 -177.21 5.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.449 -0.782 . . . . 0.0 109.312 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.469 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 95.6 p -119.54 163.6 17.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.164 -0.96 . . . . 0.0 109.688 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -142.15 134.43 6.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.42 -12.41 11.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -1.227 . . . . 0.0 109.557 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.587 ' CG2' ' CG1' ' A' ' 11' ' ' VAL . 1.8 t 56.24 17.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.53 ' HB2' ' CE2' ' A' ' 49' ' ' TRP . 1.1 p -151.24 169.82 20.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.529 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 4.5 m-20 -116.8 22.19 12.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.437 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.589 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -95.23 -24.97 16.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 109.24 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -108.88 9.62 26.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.838 . . . . 0.0 109.516 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.529 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 74.3 t -65.17 90.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.76 29.08 4.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -105.32 95.13 5.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -1.158 . . . . 0.0 109.472 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -43.99 162.49 0.19 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.462 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.64 148.86 54.08 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.958 1.772 . . . . 0.0 110.134 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 5.9 t70 -50.75 139.56 21.36 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.272 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.481 ' O ' HG11 ' A' ' 60' ' ' VAL . 50.4 Cg_exo -51.93 -18.86 7.42 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.845 1.696 . . . . 0.0 110.439 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.478 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . 8.9 mtm180 -81.96 -39.25 23.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.097 -1.002 . . . . 0.0 109.675 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.38 -1.62 57.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.94 . . . . 0.0 109.842 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.517 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 5.7 p -89.6 -39.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.05 -1.032 . . . . 0.0 109.651 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.449 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -88.46 -8.87 54.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -89.24 -64.44 1.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.646 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.553 ' HA ' ' CE2' ' A' ' 142' ' ' TYR . 1.6 pt? -43.34 -30.64 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.671 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 60' ' ' VAL . 3.5 ptp180 -93.16 41.84 1.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.852 . . . . 0.0 109.468 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -133.48 -43.95 0.83 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.382 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -83.17 -34.17 26.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.18 95.29 0.2 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.456 HG22 ' HB2' ' A' ' 24' ' ' ALA . 17.3 mm -146.08 -75.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -1.152 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 10.5 m-80 65.53 99.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.525 ' CG2' ' HB3' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -130.05 166.48 20.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.484 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -155.04 54.05 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.49 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.561 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.5 p-80 -122.71 170.61 9.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.02 154.48 37.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.554 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.99 122.7 28.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.405 ' HD2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -129.74 172.36 11.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.417 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 47' ' ' SER . 1.1 tt0 -92.13 122.32 34.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.407 HG21 ' CB ' ' A' ' 81' ' ' ASP . 8.9 p -48.9 145.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.407 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 p -132.83 168.3 18.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.215 -0.928 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HG2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -51.03 -41.37 59.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 109.255 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -59.41 -38.28 80.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.56 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.407 ' CB ' HG21 ' A' ' 77' ' ' VAL . 1.9 m-20 -59.08 -41.09 87.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -0.919 . . . . 0.0 109.978 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.528 ' CE2' ' HE2' ' A' ' 102' ' ' LYS . 81.1 m-85 -64.47 -62.36 1.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.797 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.528 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 3.8 p -65.76 -10.35 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.687 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.517 ' CB ' ' O ' ' A' ' 80' ' ' GLU . 3.4 m -87.97 -85.09 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.368 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.582 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 59.1 m-85 -56.33 109.04 0.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.526 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.404 ' C ' ' CD1' ' A' ' 87' ' ' TYR . 1.3 t0 -58.29 -20.87 46.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.596 ' CE2' ' HG2' ' A' ' 6' ' ' LYS . 6.6 m-30 -113.31 137.42 51.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.534 ' CG1' ' HB2' ' A' ' 111' ' ' ALA . 1.0 OUTLIER -145.45 104.24 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 108.652 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -120.74 156.65 31.37 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.906 -1.121 . . . . 0.0 109.744 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 115' ' ' LEU . 2.4 p -121.26 166.15 14.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.517 -0.739 . . . . 0.0 109.424 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.418 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -75.62 -62.56 1.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.719 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 93' ' ' GLU . 11.5 p-10 -178.62 -138.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.398 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 74.4 mt-10 63.12 -88.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.058 -1.026 . . . . 0.0 109.487 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -85.01 85.75 7.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 0.0 109.069 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.482 ' ND2' HD23 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -51.21 86.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.684 -0.635 . . . . 0.0 110.083 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.526 HD22 ' CG2' ' A' ' 113' ' ' ILE . 0.4 OUTLIER 37.33 40.3 0.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.729 -0.607 . . . . 0.0 110.196 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -90.51 -50.14 6.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.045 -1.035 . . . . 0.0 109.479 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.6 -45.03 12.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.496 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.471 ' HB3' HG22 ' A' ' 113' ' ' ILE . 13.4 mt -62.58 -34.75 77.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.575 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.49 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 21.8 t-20 -62.17 -31.63 72.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -89.69 -11.4 42.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 109.424 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.528 ' HE2' ' CE2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -74.93 -27.13 60.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.33 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.633 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 0.9 OUTLIER -73.8 -20.62 60.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.892 . . . . 0.0 109.339 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.63 -49.9 42.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.256 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -70.48 -19.39 62.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 109.253 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 109' ' ' CYS . 54.6 t -67.08 125.03 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.376 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -66.47 100.55 0.67 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.333 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.87 50.35 1.99 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -53.62 150.9 6.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.263 -0.898 . . . . 0.0 109.838 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 12.0 ptt180 -138.53 7.22 2.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.339 -0.85 . . . . 0.0 109.153 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.534 ' HB2' ' CG1' ' A' ' 88' ' ' ILE . . . -88.03 120.38 29.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.178 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -70.51 132.68 45.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -109.16 133.09 55.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.777 -1.202 . . . . 0.0 110.402 -179.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.8 OUTLIER -178.47 139.21 0.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.482 HD23 ' ND2' ' A' ' 95' ' ' ASN . 0.3 OUTLIER -84.72 167.34 16.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.594 -1.316 . . . . 0.0 109.95 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.768 ' HG ' ' SG ' ' A' ' 148' ' ' CYS . 3.1 mm? -40.59 -44.23 2.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.752 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 54.44 -123.4 27.94 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -131.07 122.68 27.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 109.341 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.533 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.7 m-85 -127.83 3.42 6.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 0.0 109.634 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.587 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 162.58 -51.26 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.3 Cg_exo -49.72 140.43 29.67 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.794 1.663 . . . . 0.0 110.111 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -108.14 112.89 25.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.67 149.37 2.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.356 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 52.29 2.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.364 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.97 131.71 4.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.381 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -105.3 41.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.972 . . . . 0.0 109.165 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 126' ' ' ILE . 14.7 mt 71.44 19.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.98 . . . . 0.0 109.51 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.466 ' HG3' HG21 ' A' ' 126' ' ' ILE . 30.5 mt-10 -62.18 90.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.432 ' HB3' ' NH2' ' A' ' 18' ' ' ARG . 9.8 t70 -145.32 102.39 4.36 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.195 -0.941 . . . . 0.0 109.401 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -49.26 139.86 27.18 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.868 1.712 . . . . 0.0 110.308 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER 51.91 -161.72 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.479 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 131' ' ' TYR . 8.4 p90 -94.88 30.24 2.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 132' ' ' TYR . . . 43.63 -131.97 6.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -179.71 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -1.187 . . . . 0.0 109.475 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -78.09 123.48 26.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 135' ' ' ASP . . . 44.35 29.51 0.38 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.09 35.18 3.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.877 . . . . 0.0 109.459 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 58' ' ' ARG . 5.0 t80 -133.24 -55.56 0.91 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.12 -44.53 68.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.0 109.388 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.7 m -60.52 -36.8 79.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.37 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.87 -53.54 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.324 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.579 ' CD2' HG22 ' A' ' 21' ' ' ILE . 2.4 t80 -59.56 -24.27 63.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.553 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -85.02 -24.45 28.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 0.0 109.931 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -13.77 42.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.091 -1.006 . . . . 0.0 109.498 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -90.3 -7.28 53.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 109.665 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 25' ' ' VAL . 73.9 t -62.04 -63.62 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.218 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.44 ' HB3' ' HB1' ' A' ' 151' ' ' ALA . 4.2 mpt_? -68.62 -22.36 64.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.107 -0.996 . . . . 0.0 109.095 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.768 ' SG ' ' HG ' ' A' ' 116' ' ' LEU . 1.6 m -44.4 -28.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 108.823 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.762 ' SG ' HD13 ' A' ' 29' ' ' LEU . 1.5 p -111.79 -33.7 6.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.49 -0.756 . . . . 0.0 109.036 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.527 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.91 -61.18 2.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 147' ' ' ARG . . . -51.94 -28.05 15.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -84.35 -31.63 24.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.311 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 157' ' ' ARG . 13.8 tp -62.81 -54.14 43.54 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.039 -1.038 . . . . 0.0 108.792 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.525 ' HA ' ' CB ' ' A' ' 157' ' ' ARG . 5.6 pt-20 -44.31 -40.23 5.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.193 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -57.66 -63.16 1.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.519 ' HB ' ' CE2' ' A' ' 87' ' ' TYR . 27.8 m -93.28 33.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.335 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.555 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -97.16 2.66 51.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.773 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.658 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER 52.53 162.76 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.846 0.831 . . . . 0.0 110.392 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.503 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 2.0 m -150.29 107.54 3.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.98 -1.075 . . . . 0.0 109.496 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.635 HG13 ' CZ3' ' A' ' 39' ' ' TRP . 0.8 OUTLIER -102.9 138.55 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.583 HD11 ' CE1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -139.62 107.7 5.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.407 -0.808 . . . . 0.0 109.503 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.524 ' CE1' ' CD1' ' A' ' 89' ' ' LEU . 5.6 m-85 -93.79 156.79 16.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.418 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 10' ' ' PHE . 2.0 t -148.36 155.84 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.717 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -176.84 134.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -50.26 171.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.26 -0.9 . . . . 0.0 109.431 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' LEU . . . 44.06 41.05 5.98 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.459 ' O ' HG22 ' A' ' 16' ' ' ILE . 8.8 t30 -67.68 91.77 0.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.469 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -162.17 -39.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.132 -0.98 . . . . 0.0 109.723 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 1.8 p -150.84 81.18 1.33 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 109.73 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.576 ' CD ' ' N ' ' A' ' 19' ' ' SER . 0.0 OUTLIER 165.14 -76.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 109.188 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.748 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -67.63 -49.23 40.97 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.389 -0.819 . . . . 0.0 110.337 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 19' ' ' SER . 71.8 Cg_exo -48.06 -20.33 2.1 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.964 1.776 . . . . 0.0 111.19 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.782 HG23 ' SG ' ' A' ' 145' ' ' CYS . 9.3 mt -64.83 -48.04 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 120.94 -1.1 . . . . 0.0 109.382 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.771 ' HA ' ' SG ' ' A' ' 145' ' ' CYS . . . -57.8 -19.28 27.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 109.353 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 24' ' ' ALA . 8.9 tm-20 -76.7 -70.21 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.216 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' OE1' ' A' ' 23' ' ' GLU . . . -44.22 -47.77 9.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.358 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.667 HG23 ' SG ' ' A' ' 145' ' ' CYS . 63.6 t -54.17 -49.95 58.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 109.297 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.54 ' HB2' ' CB ' ' A' ' 149' ' ' CYS . 1.1 t80 -50.49 -37.9 41.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.031 -1.043 . . . . 0.0 108.379 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.483 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -56.71 -45.05 82.09 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.191 -0.943 . . . . 0.0 108.841 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -81.61 -8.92 59.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.83 . . . . 0.0 110.104 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.632 ' CD1' ' SG ' ' A' ' 149' ' ' CYS . 3.9 mt -86.43 -31.08 21.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 109.323 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.59 ' CG2' ' N ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -90.85 -56.65 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 1.2 m -44.8 -32.05 1.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.106 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.32 -42.58 44.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.105 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.52 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 4.4 tp60 -72.62 -6.85 47.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.411 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 33.9 t30 76.65 48.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 109.699 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.552 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 3.8 pt -140.42 8.66 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 109.626 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.59 ' N ' ' CG2' ' A' ' 30' ' ' VAL . 24.5 p -68.06 -41.59 81.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.488 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.98 -20.17 3.21 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.284 -0.885 . . . . 0.0 109.361 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.555 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 2.2 m-20 -121.11 45.29 2.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.936 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.658 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 6.7 m95 -150.33 129.04 12.35 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.871 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.95 87.73 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.502 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.4 mt -94.27 142.32 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.343 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.55 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 t0 -164.31 178.3 7.62 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.0 p -179.74 169.85 1.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.06 -1.025 . . . . 0.0 109.739 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.12 -163.03 28.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.5 171.82 7.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -1.164 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.438 HG23 HD13 ' A' ' 99' ' ' LEU . 93.3 t -104.74 -8.08 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.555 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.04 174.36 6.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.457 ' HA ' HG22 ' A' ' 51' ' ' VAL . 29.6 t70 -110.2 30.45 6.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.51 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.515 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.7 OUTLIER -102.49 -49.28 3.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.444 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -90.22 38.23 0.92 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.867 . . . . 0.0 109.65 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 48' ' ' ASP . 73.2 t -82.13 94.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.347 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.38 -17.15 44.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' HB3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -47.18 136.83 8.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -1.087 . . . . 0.0 109.451 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.35 159.34 50.63 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.462 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 56' ' ' ASP . 53.4 Cg_endo -71.59 -3.4 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.015 1.81 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' PRO . 72.0 m-20 61.57 140.97 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 109.443 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.425 ' O ' HG11 ' A' ' 60' ' ' VAL . 56.6 Cg_endo -73.49 -1.34 10.53 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.901 1.734 . . . . 0.0 110.395 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.433 ' O ' ' OG ' ' A' ' 61' ' ' SER . 67.6 mtt180 -72.95 -28.11 62.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.13 -0.981 . . . . 0.0 109.611 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 63' ' ' LEU . . . -88.94 -39.94 13.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.456 HG11 ' N ' ' A' ' 61' ' ' SER . 10.8 p -44.45 -25.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.597 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.456 ' N ' HG11 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -48.34 -89.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.295 -0.878 . . . . 0.0 109.846 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.686 ' SG ' ' OE2' ' A' ' 139' ' ' GLU . 3.7 t -73.54 -3.75 29.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.035 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.497 ' HA ' ' CE2' ' A' ' 142' ' ' TYR . 0.3 OUTLIER -86.56 -74.35 0.43 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.023 -1.048 . . . . 0.0 108.953 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.49 74.14 8.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.43 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -146.29 -53.83 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.643 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -80.72 -23.16 39.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.26 61.63 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.492 ' CG1' ' O ' ' A' ' 63' ' ' LEU . 21.7 mm -113.29 156.08 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -1.174 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -147.55 96.67 2.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.371 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 70' ' ' THR . 9.6 t -113.73 72.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.88 54.94 3.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 0.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.564 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.5 p-80 -133.63 155.66 49.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -0.955 . . . . 0.0 109.453 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.61 170.43 8.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 0.0 109.451 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -90.56 148.33 22.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 109.526 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.43 ' HA ' HG12 ' A' ' 51' ' ' VAL . 3.1 mmt-85 -151.75 152.26 32.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.409 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.453 ' HB2' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -80.57 135.44 36.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.401 ' O ' ' OE1' ' A' ' 76' ' ' GLN . 8.7 p -56.89 146.94 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.87 165.47 26.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.445 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.458 ' HG2' HG11 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -46.01 -36.72 5.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.468 ' O ' ' OG1' ' A' ' 84' ' ' THR . 7.8 tt0 -59.69 -56.78 17.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 109.655 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 9.3 m-20 -50.54 -40.67 52.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -0.884 . . . . 0.0 109.808 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 102' ' ' LYS . 43.4 m-85 -53.53 -58.13 8.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.072 -1.017 . . . . 0.0 109.335 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.522 ' HA ' ' CG ' ' A' ' 110' ' ' ARG . 0.8 OUTLIER -78.81 -2.26 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.536 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.573 HG23 ' CE1' ' A' ' 85' ' ' PHE . 56.0 m -78.27 -60.28 2.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.168 -0.957 . . . . 0.0 109.863 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.583 ' CE1' HD11 ' A' ' 9' ' ' LEU . 28.3 m-85 -96.46 178.36 5.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.14 -0.975 . . . . 0.0 109.863 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.459 ' OD1' ' HD3' ' A' ' 110' ' ' ARG . 1.1 t70 -118.2 -22.46 7.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.348 -0.845 . . . . 0.0 109.756 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.537 ' OH ' ' CG ' ' A' ' 6' ' ' LYS . 5.4 m-85 -112.01 67.09 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.98 -1.075 . . . . 0.0 109.623 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.581 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 3.1 mt -79.15 91.06 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.286 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.572 HD23 ' CD2' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -112.04 167.14 10.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.972 -1.08 . . . . 0.0 109.478 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.692 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -139.49 166.23 25.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.86 . . . . 0.0 109.06 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.692 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -66.76 133.56 50.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.388 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.489 ' HB2' HG12 ' A' ' 126' ' ' ILE . 5.7 t70 -42.94 110.06 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.68 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.5 -177.35 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.332 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.8 m -89.54 15.58 9.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -82.31 -14.74 54.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.546 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.456 HD13 HD22 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -86.49 5.13 36.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.098 -1.002 . . . . 0.0 109.604 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -19.25 65.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -0.96 . . . . 0.0 109.165 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.55 -43.19 4.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.872 . . . . 0.0 109.315 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.438 HD13 HG23 ' A' ' 46' ' ' VAL . 13.0 mt -57.61 -34.04 68.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.304 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.442 ' HB2' HD21 ' A' ' 96' ' ' LEU . 4.6 t-20 -69.19 -32.39 71.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.61 0.98 50.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 109.563 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -81.35 -30.21 33.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 109.442 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 p -63.76 -16.69 61.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -84.38 -31.36 24.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.338 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -12.54 43.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.392 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 109' ' ' CYS . 62.8 t -77.17 147.37 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.315 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -83.58 112.21 19.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.203 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.14 37.85 27.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.311 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -43.27 160.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.748 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.6 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 0.0 OUTLIER -150.1 36.36 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.446 -0.784 . . . . 0.0 109.002 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.581 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -119.36 88.75 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -0.811 . . . . 0.0 110.025 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 34.9 mtpt -46.13 121.09 3.08 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.543 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 1.7 mm -95.96 132.25 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.001 -1.062 . . . . 0.0 110.108 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 115' ' ' LEU . 31.7 tp10 -159.09 165.54 33.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.462 -0.774 . . . . 0.0 109.649 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.486 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 22.3 mt -99.13 158.9 15.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.098 -1.001 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.765 HD12 ' SG ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER -68.75 123.79 21.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 109.337 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . 140.77 -179.66 19.04 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 0.7 OUTLIER 74.52 36.91 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -1.184 . . . . 0.0 109.421 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.411 ' HB2' ' HD2' ' A' ' 121' ' ' PRO . 26.7 m-85 -125.23 -140.0 0.29 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.164 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.59 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -71.33 -51.02 10.41 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.0 109.726 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.7 Cg_exo -49.99 96.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.761 1.64 . . . . 0.0 110.275 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 25.0 mt-30 -80.91 -152.67 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.43 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 124' ' ' GLN . 0.3 OUTLIER 65.78 116.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.491 ' O ' ' CB ' ' A' ' 125' ' ' LEU . 2.0 tt0 -60.28 -150.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.159 -0.963 . . . . 0.0 109.431 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.491 ' CB ' ' O ' ' A' ' 124' ' ' GLN . 0.2 OUTLIER 73.55 70.23 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.459 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.489 HG12 ' HB2' ' A' ' 92' ' ' ASP . 3.7 tt -87.57 177.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.18 -0.95 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' ' 92' ' ' ASP . 16.0 mt -82.61 98.54 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 0.0 109.445 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.47 ' HG3' ' OD1' ' A' ' 92' ' ' ASP . 8.9 mt-10 -130.96 55.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.417 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.9 OUTLIER -103.06 164.52 15.35 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.462 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 129' ' ' ASP . 54.9 Cg_endo -72.1 -164.37 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.028 1.819 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -70.93 -25.56 62.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.331 -0.856 . . . . 0.0 109.479 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.05 -81.15 0.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.532 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 114.31 -145.39 18.53 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -71.32 -83.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -1.135 . . . . 0.0 109.541 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.78 -71.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.94 46.26 1.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 109.566 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.422 ' OD2' ' HB ' ' A' ' 140' ' ' THR . 4.5 t70 -119.05 57.73 0.87 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.469 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -98.63 -25.34 14.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.686 ' OE2' ' SG ' ' A' ' 62' ' ' CYS . 4.2 tp10 -72.72 -31.28 64.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.325 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 96.1 m -65.45 -19.42 65.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 109.494 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.536 ' CG1' ' HA ' ' A' ' 18' ' ' ARG . 73.1 t -70.37 -70.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 0.0 109.228 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.633 ' CD2' ' CG2' ' A' ' 21' ' ' ILE . 3.2 t80 -48.19 -48.69 34.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.389 -0.82 . . . . 0.0 109.34 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -65.93 0.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.321 -0.862 . . . . 0.0 109.836 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 140' ' ' THR . 3.2 mm-40 -53.93 -19.26 4.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.782 ' SG ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -69.95 -41.94 73.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.845 . . . . 0.0 109.389 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.548 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 15.2 t -52.87 -60.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.314 -0.866 . . . . 0.0 109.929 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.454 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -69.95 -8.99 53.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.765 ' SG ' HD12 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -69.63 -11.59 60.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.345 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.632 ' SG ' ' CD1' ' A' ' 29' ' ' LEU . 30.2 p -126.26 -41.64 1.89 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.233 -0.917 . . . . 0.0 109.21 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.461 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 0.9 OUTLIER -58.25 -49.87 75.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.002 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 147' ' ' ARG . . . -61.96 -21.54 64.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.458 -0.776 . . . . 0.0 109.236 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.572 ' CD2' HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -90.01 -19.01 24.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.408 -0.808 . . . . 0.0 109.642 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.51 ' CD2' HD12 ' A' ' 35' ' ' ILE . 9.0 tp -83.07 -26.04 31.48 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.03 -1.044 . . . . 0.0 108.748 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.494 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 1.0 OUTLIER -69.94 -29.3 66.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 108.997 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.494 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 2.2 tptt -80.32 -54.72 5.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 108.807 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.496 ' O ' ' HD3' ' A' ' 6' ' ' LYS . 16.5 m -98.33 45.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 108.891 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.533 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.3 0.571 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -126.16 83.44 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.485 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.66 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -41.47 163.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.748 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.593 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 62.4 p -136.62 116.47 13.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.024 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.568 HG11 ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -119.41 142.94 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 109.115 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.574 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -140.38 105.43 4.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 0.0 109.424 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -83.27 158.34 22.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.446 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 90' ' ' CYS . 1.9 t -145.63 142.2 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.441 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -162.15 131.89 4.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 12' ' ' CYS . 12.9 tp -43.34 -56.19 3.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.658 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . -87.35 85.06 1.53 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.455 ' O ' HG21 ' A' ' 16' ' ' ILE . 10.4 t30 -89.19 2.77 53.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -1.128 . . . . 0.0 109.548 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.491 ' C ' ' CD1' ' A' ' 16' ' ' ILE . 2.5 pp -146.86 12.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 109.733 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' ARG . 11.2 t -150.28 -54.89 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.044 -1.035 . . . . 0.0 109.561 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' O ' ' CB ' ' A' ' 19' ' ' SER . 1.0 OUTLIER -43.3 -80.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.429 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER 167.16 66.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.491 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.18 63.4 8.71 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.175 1.917 . . . . 0.0 110.594 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.579 HG22 ' CD2' ' A' ' 142' ' ' TYR . 3.8 mp -90.56 -17.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.013 -1.054 . . . . 0.0 109.732 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.702 ' HB1' ' SD ' ' A' ' 91' ' ' MET . . . -65.27 -32.32 73.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.469 ' HG3' ' HB3' ' A' ' 43' ' ' SER . 1.5 tt0 -77.22 -68.59 0.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.375 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' A' ' 68' ' ' ILE . . . -43.53 -40.54 3.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.193 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 146' ' ' VAL . 50.0 t -61.29 -53.37 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.38 -0.825 . . . . 0.0 109.158 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.579 ' CD1' HG13 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -46.52 -39.68 11.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.106 -0.997 . . . . 0.0 108.453 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.483 ' O ' ' OG1' ' A' ' 31' ' ' THR . 11.0 tpt85 -54.9 -60.18 3.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.165 -0.959 . . . . 0.0 108.97 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -10.18 35.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.893 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.485 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 2.7 mt -83.02 -76.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.064 -1.023 . . . . 0.0 108.971 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.588 ' CG2' ' HA ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -43.45 -46.1 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -60.25 -42.46 95.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.115 . . . . 0.0 109.433 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -69.38 -16.6 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.131 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 1.9 tp60 -98.2 -9.38 25.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.401 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 2.7 t-20 77.18 48.58 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 109.391 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.576 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 2.9 pt -140.82 9.63 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.349 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.588 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 6.2 p -69.93 -35.0 74.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.062 -1.024 . . . . 0.0 109.546 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -58.35 -20.35 42.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.646 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.538 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 11.8 m-20 -124.36 42.98 3.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.695 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.66 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 10.2 m95 -150.04 133.64 16.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.046 -1.034 . . . . 0.0 109.994 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 t -117.85 85.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.841 . . . . 0.0 108.992 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.524 ' CG1' HG12 ' A' ' 8' ' ' VAL . 2.2 mp -90.24 139.24 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 5.3 m-20 -150.53 146.58 26.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.427 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.469 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 74.5 p -116.5 156.76 26.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.53 164.8 32.23 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.16 128.06 51.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -1.147 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.2 t -47.47 -34.45 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.392 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.64 -177.15 3.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.937 . . . . 0.0 109.623 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 8.0 p-10 -102.43 24.59 10.13 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.299 -0.876 . . . . 0.0 109.457 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 38.9 m0 -65.54 -43.09 91.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.47 ' HB3' HG12 ' A' ' 16' ' ' ILE . 2.2 m-80 -119.91 61.49 0.84 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.148 -0.97 . . . . 0.0 109.753 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.502 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 91.1 t -84.7 102.58 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.236 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.61 10.2 63.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 50' ' ' ASN . 15.4 mtt85 -82.09 126.25 31.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -1.149 . . . . 0.0 109.449 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -72.22 150.44 92.1 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.515 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.521 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 53.8 Cg_exo -50.1 137.12 37.51 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.928 1.752 . . . . 0.0 110.31 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.556 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 32.9 p-10 -75.11 127.66 86.23 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.177 -0.952 . . . . 0.0 109.246 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.582 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . 72.1 Cg_exo -43.85 -23.21 0.57 Allowed 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 122.107 1.871 . . . . 0.0 110.618 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -60.27 -53.46 57.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.874 -1.141 . . . . 0.0 108.392 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 61' ' ' SER . . . -76.73 -64.1 1.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.582 ' CG2' ' HA ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.25 -28.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.583 -0.698 . . . . 0.0 109.387 179.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 57' ' ' PRO . 1.7 t -52.7 -53.52 46.45 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.444 -0.785 . . . . 0.0 110.487 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.0 t -70.29 -17.92 63.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.123 -0.985 . . . . 0.0 110.541 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -90.14 -75.34 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.96 -1.087 . . . . 0.0 109.418 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' LEU . 3.6 ttt85 -43.62 -26.53 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 109.624 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -46.23 -66.26 0.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.887 . . . . 0.0 109.406 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 63' ' ' LEU . 12.6 p80 -76.33 -36.82 58.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.03 74.4 0.1 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.517 HG12 ' CB ' ' A' ' 24' ' ' ALA . 6.4 tp -86.53 -12.08 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.214 -1.168 . . . . 0.0 109.237 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.47 ' ND2' ' C ' ' A' ' 68' ' ' ILE . 1.3 p30 40.98 44.88 2.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.518 -0.739 . . . . 0.0 109.811 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -76.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 55.49 76.23 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.114 -0.991 . . . . 0.0 109.414 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.557 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.6 p-80 -150.36 157.15 42.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.553 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.27 134.21 54.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 109.406 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.4 163.99 26.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.479 ' HD2' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -178.56 128.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.327 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 142.74 11.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.877 . . . . 0.0 109.59 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.54 HG13 ' CE2' ' A' ' 82' ' ' PHE . 30.0 t -58.57 162.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.511 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.444 ' N ' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -160.5 161.5 32.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 109.547 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HG2' HG12 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -48.77 -32.27 8.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.313 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.48 ' O ' ' OG1' ' A' ' 84' ' ' THR . 0.9 OUTLIER -64.8 -49.46 70.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.796 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' HB3' HD12 ' A' ' 9' ' ' LEU . 36.4 m-20 -66.61 -26.79 67.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 110.184 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.54 ' CE2' HG13 ' A' ' 77' ' ' VAL . 42.4 m-85 -68.37 -68.45 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 109.727 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.53 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 9.2 p -64.21 -22.02 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 2.5 m -65.42 -71.93 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.126 -0.984 . . . . 0.0 109.527 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 42' ' ' ASP . 84.5 m-85 -73.36 163.8 27.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' OD1' ' HG3' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -112.55 -17.55 12.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -0.843 . . . . 0.0 109.461 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.2 m-85 -119.75 81.32 1.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 109.202 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 1.4 mt -90.59 112.82 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 0.0 109.074 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -133.34 169.22 17.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.998 -1.064 . . . . 0.0 109.286 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.623 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 21.3 m -127.8 177.27 6.94 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.341 -0.849 . . . . 0.0 109.165 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.702 ' SD ' ' HB1' ' A' ' 22' ' ' ALA . 16.6 mmt -85.36 47.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.453 ' HB3' HG21 ' A' ' 126' ' ' ILE . 4.2 m-20 54.38 87.86 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 109.465 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.37 158.24 43.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 109.375 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.0 p -71.89 -15.68 62.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.908 . . . . 0.0 109.459 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -72.24 -10.82 60.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.52 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.623 ' HG ' ' SG ' ' A' ' 90' ' ' CYS . 0.4 OUTLIER -68.14 -31.23 70.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -19.59 4.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.439 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -93.81 -31.33 14.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.482 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.531 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 15.8 mt -66.6 -34.19 77.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.574 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -64.54 -24.55 67.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -91.88 -10.34 39.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 109.418 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.491 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 2.4 mmmm -70.89 -32.99 70.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.892 . . . . 0.0 109.345 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.755 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 14.6 p -62.15 -28.05 69.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -46.68 75.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.355 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -85.02 0.74 50.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.606 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 109' ' ' CYS . 40.4 t -87.73 121.9 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.314 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 106' ' ' VAL . 9.0 tptt -45.03 99.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 106' ' ' VAL . 24.4 m120 48.11 58.75 4.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 109.526 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.755 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -53.78 147.24 12.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 109.793 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.53 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 8.6 ptt180 -131.29 2.12 4.21 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.536 ' O ' ' CD1' ' A' ' 113' ' ' ILE . . . -86.6 118.56 26.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 110.151 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' ILE . 5.5 mtpm? -69.49 106.05 2.85 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -83.23 137.24 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.994 -1.066 . . . . 0.0 110.084 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 1.2 tt0 -176.27 -170.47 0.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.49 -0.756 . . . . 0.0 109.057 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -122.65 118.06 27.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 109.496 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER 59.15 -87.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.839 . . . . 0.0 109.504 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' A' ' 119' ' ' TYR . . . 166.04 -175.28 41.62 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.9 p -109.65 64.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -1.174 . . . . 0.0 109.487 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.441 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.9 m-85 -120.16 -140.86 0.34 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.176 -0.952 . . . . 0.0 109.143 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 0.2 OUTLIER 169.03 63.07 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.071 -1.018 . . . . 0.0 109.43 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.6 -4.98 16.09 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.048 1.832 . . . . 0.0 110.243 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -161.37 -149.75 0.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.4 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 150.35 49.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -76.6 123.59 26.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -166.61 138.1 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.497 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.471 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 10.2 mm -95.35 150.47 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.362 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.462 ' N ' HG21 ' A' ' 126' ' ' ILE . 3.0 mp -106.23 81.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.507 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.471 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 66.2 mt-10 -121.71 81.85 1.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.431 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 1.4 p30 -158.58 85.35 2.46 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.559 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 132' ' ' TYR . 50.7 Cg_endo -71.08 171.75 15.28 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.959 1.773 . . . . 0.0 110.283 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -43.58 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -134.21 -47.11 0.77 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.362 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 114.8 84.87 1.25 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.63 -66.61 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -1.142 . . . . 0.0 109.487 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -179.9 89.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.475 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 50.84 34.74 10.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 109.455 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.94 79.05 9.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.1 -61.25 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.39 -45.95 88.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 m -47.23 -33.03 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.42 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.62 -45.86 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.422 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.579 ' CD2' HG22 ' A' ' 21' ' ' ILE . 8.7 t80 -57.7 -46.68 84.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -58.54 -56.43 22.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.962 . . . . 0.0 109.344 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.755 ' O ' ' SG ' ' A' ' 148' ' ' CYS . 15.7 mt-30 -64.85 -13.05 54.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 109.417 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.565 ' HA ' ' SG ' ' A' ' 148' ' ' CYS . 3.5 m -83.85 -27.02 29.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.315 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.541 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 87.6 t -55.14 -53.92 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.279 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -15.86 53.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.238 -0.914 . . . . 0.0 109.334 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.755 ' SG ' ' O ' ' A' ' 144' ' ' GLN . 5.3 m -50.17 -23.44 2.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 0.0 108.713 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.618 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -122.01 -42.48 2.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.238 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.485 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . 55.2 ttt-85 -59.19 -49.55 77.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.041 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.24 -19.8 48.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.827 . . . . 0.0 109.07 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.408 ' CZ ' HG22 ' A' ' 156' ' ' VAL . 1.7 t80 -89.44 -25.42 21.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -0.831 . . . . 0.0 109.372 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.53 ' CD1' HD13 ' A' ' 35' ' ' ILE . 10.1 tp -77.79 -26.72 49.89 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.037 -1.039 . . . . 0.0 108.911 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 2.5 pt-20 -67.8 -30.39 69.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -0.968 . . . . 0.0 109.105 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.505 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -79.93 -51.34 9.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.89 . . . . 0.0 109.043 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.479 ' O ' ' HD3' ' A' ' 6' ' ' LYS . 15.4 m -99.2 42.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 108.995 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.426 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.452 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 5' ' ' THR . 12.2 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.328 0.585 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.548 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -149.67 75.94 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 109.223 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.648 ' CB ' ' CH2' ' A' ' 39' ' ' TRP . 22.3 mttp -51.46 -178.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 0.0 109.695 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.499 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 48.8 m -147.17 116.76 7.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.4 -0.813 . . . . 0.0 109.158 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.577 HG13 ' CZ ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -124.03 150.99 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 109.075 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.595 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -149.16 108.65 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.156 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.487 ' CZ ' HD11 ' A' ' 116' ' ' LEU . 1.9 m-85 -81.52 157.38 24.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.685 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 59.5 t -138.8 149.87 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.883 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -169.04 133.4 1.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.415 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.4 tp -44.74 -61.76 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.87 . . . . 0.0 109.477 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 15' ' ' ASN . . . -49.58 -88.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 14' ' ' GLY . 20.6 t30 76.69 17.82 1.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -1.102 . . . . 0.0 109.6 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER -169.1 -71.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.598 ' SG ' ' OH ' ' A' ' 131' ' ' TYR . 4.8 p -76.72 -26.84 55.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.449 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 19' ' ' SER . 25.8 ttm180 -62.18 -13.13 24.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.249 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' ARG . 7.3 m 68.48 60.72 0.68 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.293 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 19' ' ' SER . 40.9 Cg_endo -69.35 81.33 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.965 1.777 . . . . 0.0 110.458 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.528 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 6.8 mm -83.44 -15.61 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.87 . . . . 0.0 109.34 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.499 ' HB3' ' CB ' ' A' ' 148' ' ' CYS . . . -63.99 -51.65 63.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.132 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -60.34 -58.71 7.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 108.933 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.557 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -44.57 -38.0 3.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -0.849 . . . . 0.0 108.884 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.738 ' CG1' ' SG ' ' A' ' 149' ' ' CYS . 70.4 t -60.32 -56.51 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.247 -0.908 . . . . 0.0 108.831 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.636 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 0.4 OUTLIER -43.58 -32.19 0.89 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.476 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -62.82 -52.88 61.44 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 108.853 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -63.29 -58.28 7.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.21 -0.931 . . . . 0.0 109.663 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.627 HD11 ' SG ' ' A' ' 149' ' ' CYS . 29.9 mt -43.47 -66.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 109.761 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 36' ' ' SER . 3.0 p -58.8 -24.78 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 109.995 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 14.4 m -99.8 30.7 3.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.553 -1.342 . . . . 0.0 109.262 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -149.69 46.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.591 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -179.24 32.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -0.812 . . . . 0.0 109.041 -179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 33' ' ' GLN . 9.8 m120 46.7 42.08 11.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.591 ' CG2' ' HB3' ' A' ' 33' ' ' GLN . 1.7 tt -130.64 -5.38 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.247 0.546 . . . . 0.0 109.779 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -74.26 -33.27 63.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.937 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -76.08 1.79 14.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.64 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.548 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 23.7 m-20 -128.8 37.91 4.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 109.785 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.648 ' CH2' ' CB ' ' A' ' 6' ' ' LYS . 18.2 m95 -150.62 139.89 21.28 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.853 -1.154 . . . . 0.0 110.899 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.486 HG13 ' CE2' ' A' ' 85' ' ' PHE . 44.1 t -112.04 73.62 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.526 ' CG1' HG12 ' A' ' 8' ' ' VAL . 2.9 mt -89.91 140.42 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -0.819 . . . . 0.0 109.862 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 14.7 t0 -149.06 -168.27 3.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.477 -0.764 . . . . 0.0 109.175 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.411 ' OG ' ' OD1' ' A' ' 15' ' ' ASN . 29.6 t -134.48 169.96 16.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 109.691 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.78 153.85 25.55 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.13 -18.43 6.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -1.142 . . . . 0.0 109.714 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.526 ' CG2' HG12 ' A' ' 11' ' ' VAL . 58.1 t 56.98 17.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.381 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.563 ' HB3' ' CZ2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -145.26 144.71 30.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.299 -0.875 . . . . 0.0 109.413 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.456 ' HA ' HG22 ' A' ' 51' ' ' VAL . 5.0 m-20 -91.65 32.63 1.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.614 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -97.19 -33.95 11.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 109.331 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 11.8 m-20 -125.43 46.78 2.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.639 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 48' ' ' ASP . 89.8 t -71.95 85.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.353 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.461 ' HA2' ' CG ' ' A' ' 73' ' ' LYS . . . 115.96 -6.44 19.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.523 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 2.5 mtt85 -76.55 96.25 4.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -1.113 . . . . 0.0 109.599 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.575 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -50.91 -179.36 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.123 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 61.5 Cg_exo -49.59 133.8 32.45 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.833 1.689 . . . . 0.0 110.239 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -43.76 145.3 1.22 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.465 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.463 ' HA ' HG13 ' A' ' 60' ' ' VAL . 53.9 Cg_exo -50.09 -21.1 6.08 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.941 1.76 . . . . 0.0 110.386 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.2 mtt-85 -83.04 -50.41 8.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.758 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 63' ' ' LEU . . . -90.25 11.98 19.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 110.077 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 61' ' ' SER . 7.3 p -90.01 -49.14 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.042 -1.036 . . . . 0.0 109.607 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.521 ' N ' HG12 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -91.53 -29.84 16.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.132 -0.98 . . . . 0.0 109.682 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.9 m -90.17 20.38 4.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.597 ' CD2' ' CG2' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -64.68 102.47 0.58 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.772 -1.205 . . . . 0.0 108.412 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.581 ' HD3' ' CE2' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 59.36 15.56 4.46 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.741 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 64' ' ' ARG . 5.1 p30 35.29 100.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.008 0.908 . . . . 0.0 111.086 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 57.91 24.44 10.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 0.0 109.902 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.513 ' HA3' ' NE ' ' A' ' 64' ' ' ARG . . . -128.09 -4.66 5.46 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.597 ' CG2' ' CD2' ' A' ' 63' ' ' LEU . 25.2 mm -148.0 156.94 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -1.19 . . . . 0.0 109.698 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -141.51 83.52 1.87 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.244 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.425 HG21 ' HB3' ' A' ' 24' ' ' ALA . 26.1 p -70.3 159.88 33.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.62 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -169.1 28.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.247 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.535 ' CD2' ' N ' ' A' ' 73' ' ' LYS . 8.7 t60 -124.27 157.75 34.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.36 -0.838 . . . . 0.0 109.254 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.535 ' N ' ' CD2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -89.71 -147.24 0.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 109.532 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 75' ' ' ARG . . . -137.75 -81.78 0.34 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.544 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.515 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 75.08 113.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.953 . . . . 0.0 109.392 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' ARG . 2.3 tt0 -43.68 143.05 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.428 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 46' ' ' VAL . 5.0 t -57.68 164.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -169.19 165.9 10.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.353 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.527 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -43.61 -31.88 0.85 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' O ' ' OG1' ' A' ' 84' ' ' THR . 36.4 tt0 -59.41 -57.22 13.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.293 -0.88 . . . . 0.0 109.616 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.47 ' O ' HD13 ' A' ' 88' ' ' ILE . 6.6 m-20 -66.11 -17.71 64.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.87 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.577 ' CD2' HG23 ' A' ' 106' ' ' VAL . 10.5 m-85 -70.47 -74.78 0.13 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.047 -1.033 . . . . 0.0 109.308 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 7.4 p -61.49 -24.2 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.458 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.579 HG23 ' CE1' ' A' ' 85' ' ' PHE . 5.8 m -64.45 -73.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.97 . . . . 0.0 109.448 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.595 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 57.1 m-85 -75.98 154.83 35.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.681 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 63.3 m-20 -108.71 -16.62 14.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.421 -0.799 . . . . 0.0 109.485 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.561 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 22.9 m-85 -118.25 67.74 0.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.64 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.594 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 3.1 mt -79.61 93.91 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.316 -0.865 . . . . 0.0 109.077 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -106.04 178.88 4.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 109.502 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.685 ' SG ' ' HB ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -132.88 176.82 8.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.346 -0.846 . . . . 0.0 109.41 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.501 ' CE ' HD12 ' A' ' 116' ' ' LEU . 1.5 mmt -85.35 45.08 1.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.915 . . . . 0.0 109.594 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 0.7 OUTLIER 54.71 106.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.602 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -177.24 155.2 1.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.492 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -7.95 36.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -66.61 -16.05 63.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.449 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -64.51 -22.31 66.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 109.537 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -55.55 -24.22 31.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.13 -43.35 11.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.364 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.465 ' HB3' HG23 ' A' ' 113' ' ' ILE . 9.2 mt -67.92 -13.23 61.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.65 -32.39 23.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.39 16.28 18.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.451 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 0.5 OUTLIER -104.0 -19.37 14.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.535 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 96.5 p -71.06 -45.96 62.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.524 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.462 ' OD1' ' HG2' ' A' ' 105' ' ' GLN . 19.1 p-10 -62.18 -29.38 70.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.462 ' HG2' ' OD1' ' A' ' 104' ' ' ASN . 1.4 mm-40 -87.72 -15.24 37.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.949 . . . . 0.0 109.379 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.577 HG23 ' CD2' ' A' ' 82' ' ' PHE . 25.6 t -71.36 150.18 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.261 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 108' ' ' ASN . 3.2 tptt -71.92 87.16 1.01 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.271 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 107' ' ' LYS . 50.3 t30 68.28 45.42 1.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 109.485 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -56.76 149.69 17.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 0.0 109.817 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 1.9 ptm180 -138.75 9.73 2.63 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.594 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -86.34 91.79 8.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.432 -0.792 . . . . 0.0 110.404 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -47.95 122.31 4.96 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 1.3 mm -95.54 140.6 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.817 -1.177 . . . . 0.0 110.281 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 1.2 tt0 -168.61 -177.74 3.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -125.31 156.73 38.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.065 -1.022 . . . . 0.0 109.634 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.751 HD23 ' SG ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER -43.69 -26.64 0.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . -63.2 89.26 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER 170.38 -35.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -1.117 . . . . 0.0 109.461 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.435 ' CD2' ' HA ' ' A' ' 152' ' ' PHE . 22.9 m-85 -105.91 76.04 1.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 109.433 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 123' ' ' LYS . 2.1 m-20 -143.18 84.12 10.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.897 . . . . 0.0 109.622 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.18 -36.13 45.13 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.996 1.797 . . . . 0.0 110.237 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 122' ' ' GLN . 8.5 pt20 -155.44 68.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.429 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HB3' ' OD1' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -169.97 128.86 0.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.305 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.93 95.62 3.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.326 -0.859 . . . . 0.0 109.466 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.14 -43.3 0.56 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.568 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.504 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 28.1 mm 57.51 102.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 109.461 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.467 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 4.6 tt -77.05 96.57 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.517 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.504 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 21.4 mt-10 -119.17 39.04 3.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 109.425 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -72.93 146.94 88.19 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 109.478 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -72.14 -175.38 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.957 1.771 . . . . 0.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.598 ' OH ' ' SG ' ' A' ' 17' ' ' CYS . 40.6 t80 -68.7 -13.23 62.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.398 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -92.15 -28.93 16.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.85 176.59 43.65 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -79.96 -56.46 4.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.42 -71.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.872 . . . . 0.0 109.487 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.56 42.59 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.873 . . . . 0.0 109.494 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -82.9 74.89 9.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.577 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.47 ' HA ' HG13 ' A' ' 141' ' ' VAL . 3.9 t80 -130.54 -39.25 1.29 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 0.0 109.477 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -80.65 -47.32 14.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.21 -0.932 . . . . 0.0 109.383 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.3 m -64.84 -40.39 95.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.386 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.761 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 8.7 p -52.33 -27.22 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.581 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 3.1 t80 -83.52 -47.89 10.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.356 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -49.81 -53.63 24.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.74 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HG3' ' N ' ' A' ' 145' ' ' CYS . 0.9 OUTLIER -73.94 -23.27 59.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.812 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.761 ' SG ' ' O ' ' A' ' 141' ' ' VAL . 1.8 m -68.07 -20.35 64.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.572 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 25' ' ' VAL . 55.5 t -64.38 -70.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.953 . . . . 0.0 109.354 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.47 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 2.1 mtt-85 -63.5 -16.71 61.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.948 . . . . 0.0 109.354 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.751 ' SG ' HD23 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -46.3 -31.07 2.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 0.0 109.094 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.738 ' SG ' ' CG1' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -116.85 -30.99 5.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -0.873 . . . . 0.0 109.144 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.527 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 67.8 ttt-85 -71.68 -56.25 6.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 108.964 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 147' ' ' ARG . . . -50.83 -32.14 19.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.427 -0.796 . . . . 0.0 109.234 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.577 ' CE1' HG22 ' A' ' 156' ' ' VAL . 1.1 t80 -79.12 -33.21 44.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.419 -0.801 . . . . 0.0 109.384 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.487 HD23 ' CD1' ' A' ' 35' ' ' ILE . 14.7 tp -67.22 -18.29 65.17 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.148 -0.97 . . . . 0.0 108.755 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 49.2 mm-40 -68.67 -63.6 1.03 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 108.832 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -53.13 -47.59 68.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 108.826 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.577 HG22 ' CE1' ' A' ' 152' ' ' PHE . 18.5 m -98.12 51.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 108.838 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.358 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.583 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 6' ' ' LYS . 1.8 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.536 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -47.71 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 109.6 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.67 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -47.14 175.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.225 -0.922 . . . . 0.0 109.584 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.581 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 1.4 m -149.62 105.88 3.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.235 -0.916 . . . . 0.0 109.43 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.599 HG13 ' CZ3' ' A' ' 39' ' ' TRP . 2.0 p -111.5 138.92 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.248 -0.908 . . . . 0.0 110.202 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.559 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -133.76 129.37 36.54 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.535 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 1.3 m-85 -110.41 155.57 22.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 110.036 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.758 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 40.0 t -144.29 145.67 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' HG2' ' A' ' 91' ' ' MET . 2.9 m -163.74 48.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.097 -1.002 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.7 OUTLIER 42.47 -95.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.427 -0.795 . . . . 0.0 109.577 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -60.37 89.09 0.03 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 4.5 t-20 -90.28 26.97 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -1.114 . . . . 0.0 109.457 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -122.63 -8.34 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.39 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -161.09 151.32 17.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.455 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' A' ' 19' ' ' SER . 0.0 OUTLIER 51.96 63.17 2.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 162.44 -51.1 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.86 . . . . 0.0 109.823 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 19' ' ' SER . 66.1 Cg_exo -48.61 -21.94 3.9 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.909 1.739 . . . . 0.0 110.529 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.751 ' HB ' ' SG ' ' A' ' 145' ' ' CYS . 3.6 mm -66.59 -49.15 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.061 -1.025 . . . . 0.0 109.21 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.581 ' HB1' ' SG ' ' A' ' 145' ' ' CYS . . . -62.14 -18.29 60.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.137 -0.977 . . . . 0.0 109.272 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ALA . 18.3 tt0 -81.07 -82.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 109.41 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -44.23 -33.2 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.993 . . . . 0.0 109.357 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 21' ' ' ILE . 44.3 t -65.72 -49.72 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.858 . . . . 0.0 109.426 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CE1' ' CG1' ' A' ' 30' ' ' VAL . 1.1 t80 -53.43 -39.96 64.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.946 -1.096 . . . . 0.0 108.346 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -51.53 -67.16 0.27 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.282 -0.887 . . . . 0.0 108.961 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.481 ' HA ' ' OG1' ' A' ' 31' ' ' THR . 28.9 tttt -73.15 -0.32 13.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 110.009 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 46.3 tp -85.32 -33.33 22.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 109.011 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.636 ' CG1' ' CE1' ' A' ' 26' ' ' PHE . 2.0 m -90.34 -31.05 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -66.19 -33.04 74.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.662 -0.649 . . . . 0.0 109.348 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -66.84 -19.91 65.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 108.99 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.516 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 6.6 mm-40 -100.53 -3.01 31.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.434 -0.791 . . . . 0.0 109.531 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.9 OUTLIER 76.74 45.78 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.701 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.496 ' CD1' HD22 ' A' ' 153' ' ' LEU . 4.1 pt -137.41 3.24 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 0.0 109.942 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.576 ' N ' HG21 ' A' ' 30' ' ' VAL . 4.3 p -72.04 -30.77 65.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.928 -1.108 . . . . 0.0 109.48 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -60.62 -13.99 17.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.855 . . . . 0.0 109.277 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.536 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 6.2 m-20 -129.01 48.15 2.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.67 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 5.7 m95 -150.11 143.43 25.08 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.888 -1.133 . . . . 0.0 110.666 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 t -117.54 81.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.498 ' CG1' ' CG1' ' A' ' 8' ' ' VAL . 3.5 mt -89.91 137.79 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.724 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -164.89 117.38 1.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.428 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 1.3 p -82.76 -171.62 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.965 . . . . 0.0 109.377 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.519 ' HA3' ' CG2' ' A' ' 77' ' ' VAL . . . -178.87 166.5 36.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.51 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . . . -97.21 -167.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -1.106 . . . . 0.0 109.289 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.458 HG21 ' CG1' ' A' ' 11' ' ' VAL . 38.5 t -121.2 -12.75 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.113 -0.992 . . . . 0.0 109.346 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -125.8 -153.66 0.58 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.526 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.531 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -119.85 -21.93 7.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 109.438 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.448 ' CD1' ' N ' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -54.9 -18.35 4.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.564 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.51 ' ND2' ' HB3' ' A' ' 45' ' ' ALA . 13.0 p30 -115.26 42.11 2.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 70.4 t -101.72 114.79 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.0 -6.99 83.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 49' ' ' TRP . 6.6 mtt180 -72.43 103.32 3.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -1.135 . . . . 0.0 109.507 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.1 p -59.82 154.64 46.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.537 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.04 158.77 3.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.974 1.783 . . . . 0.0 110.323 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.533 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -74.26 157.83 86.15 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 53.4 Cg_endo -71.87 -3.14 12.62 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.949 1.766 . . . . 0.0 110.256 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -89.49 -47.63 7.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.61 -16.77 40.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.454 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 9.8 p -65.09 -32.8 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.522 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.41 -10.17 54.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.4 m -80.82 -21.93 40.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -90.21 -66.66 0.9 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.027 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.9 ttm180 -47.33 -24.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.39 -0.819 . . . . 0.0 109.539 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -71.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -66.93 -8.79 32.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 109.644 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.8 69.3 0.81 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.531 ' HB ' ' CB ' ' A' ' 63' ' ' LEU . 10.3 mm -109.42 160.8 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -1.104 . . . . 0.0 109.458 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.454 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 3.4 m120 -129.51 102.44 6.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.395 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.24 147.22 41.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -150.58 36.73 0.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.206 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -119.03 125.4 49.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.341 -0.85 . . . . 0.0 109.541 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 38.05 1.04 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.412 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 75' ' ' ARG . . . 65.94 169.54 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.898 . . . . 0.0 109.5 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 168.06 152.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -82.35 129.85 34.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.519 ' CG2' ' HA3' ' A' ' 44' ' ' GLY . 42.8 t -71.0 103.15 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 65.9 p -72.12 -164.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 109.095 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.551 ' HB2' ' CG2' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -86.29 -23.87 26.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.042 -1.036 . . . . 0.0 109.257 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 84' ' ' THR . 20.1 tt0 -65.46 -33.08 75.11 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.407 -0.808 . . . . 0.0 108.845 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -68.16 -17.86 64.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.39 -0.818 . . . . 0.0 108.975 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.546 ' HA ' ' CB ' ' A' ' 111' ' ' ALA . 32.1 m-85 -82.49 -65.24 1.03 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.364 -0.835 . . . . 0.0 109.208 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.45 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 9.5 p -62.76 -19.17 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' GLU . 14.1 m -78.66 -67.47 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.0 109.244 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.559 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 53.3 m-85 -68.81 135.42 51.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.219 -0.926 . . . . 0.0 109.452 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -78.17 -23.63 47.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 7' ' ' SER . 6.9 m-85 -115.6 147.58 40.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.898 . . . . 0.0 109.539 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.524 HD11 ' CB ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -156.82 95.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.366 -0.834 . . . . 0.0 108.832 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.579 HD12 ' CD2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -114.1 156.88 23.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 109.749 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 36.1 t -124.6 146.48 49.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.476 -0.765 . . . . 0.0 109.059 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.767 ' HG2' ' SG ' ' A' ' 12' ' ' CYS . 20.4 mmt -42.91 150.71 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.69 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 128' ' ' GLU . 0.6 OUTLIER -45.16 -24.68 0.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 128' ' ' GLU . 9.5 mt-10 -41.29 -89.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.336 -0.852 . . . . 0.0 109.589 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 96' ' ' LEU . 39.2 p -79.41 83.09 5.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.246 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.496 ' HB2' ' CD2' ' A' ' 115' ' ' LEU . 17.3 p-10 -52.3 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.569 -0.707 . . . . 0.0 109.605 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.584 ' CD2' ' CG2' ' A' ' 113' ' ' ILE . 0.3 OUTLIER 41.56 27.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.625 -0.672 . . . . 0.0 109.9 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -90.28 -29.71 17.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.547 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.48 -38.63 7.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.514 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.464 HD12 ' CG2' ' A' ' 88' ' ' ILE . 8.9 mt -67.05 -37.06 83.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.474 ' HB2' HD21 ' A' ' 96' ' ' LEU . 29.7 t30 -57.18 -19.49 20.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -89.73 -32.74 16.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.439 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.453 ' O ' HG22 ' A' ' 106' ' ' VAL . 9.5 mmmt -59.02 -32.88 70.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.882 . . . . 0.0 109.353 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 t -68.31 -31.59 71.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.244 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.09 -32.05 71.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -90.93 -11.28 39.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 109.302 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.551 ' CG2' ' HB2' ' A' ' 79' ' ' LYS . 81.5 t -86.08 140.73 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 119.35 23.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.342 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 109' ' ' CYS . 1.5 m-20 50.99 40.0 24.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.142 -0.974 . . . . 0.0 109.179 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -42.77 138.71 1.86 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.365 -0.834 . . . . 0.0 109.92 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.567 ' CB ' ' CZ ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -125.13 -5.12 7.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.806 . . . . 0.0 109.063 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.546 ' CB ' ' HA ' ' A' ' 82' ' ' PHE . . . -62.86 93.1 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.85 . . . . 0.0 110.207 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 86' ' ' ASP . 11.7 ttmt -46.29 106.48 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.584 ' CG2' ' CD2' ' A' ' 96' ' ' LEU . 2.9 mm -83.29 164.74 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.046 -1.034 . . . . 0.0 110.956 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 4.1 mt-10 176.47 -176.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.496 ' CD2' ' HB2' ' A' ' 95' ' ' ASN . 1.2 pp -141.49 138.75 33.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 0.0 109.84 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.65 HD23 ' SG ' ' A' ' 148' ' ' CYS . 0.4 OUTLIER -53.37 119.96 5.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.0 109.449 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -157.2 -159.84 9.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.58 114.36 2.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.477 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.0 m-85 -112.45 -17.83 12.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.583 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 163.84 -51.68 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.605 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 58.3 Cg_exo -49.26 164.41 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.698 1.599 . . . . 0.0 110.2 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -96.2 143.33 27.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.69 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 125' ' ' LEU . 3.9 tp60 -104.64 12.96 32.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 109.594 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.492 ' C ' ' O ' ' A' ' 124' ' ' GLN . 14.6 tp 33.47 81.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.169 0.509 . . . . 0.0 110.514 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.463 HD11 ' OD2' ' A' ' 92' ' ' ASP . 13.4 mm -48.15 143.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 109.201 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 127' ' ' ILE . 2.1 tt -119.9 95.3 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 94.4 mt-10 -121.86 69.2 0.93 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.432 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -114.73 144.9 32.79 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.505 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.91 -91.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.034 1.823 . . . . 0.0 110.278 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.495 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 32.5 t80 -166.32 50.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.329 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.76 109.88 4.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.33 145.91 16.41 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -110.44 -28.7 8.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -1.065 . . . . 0.0 109.371 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.439 ' OD1' ' CB ' ' A' ' 137' ' ' ASP . 2.6 p30 -91.71 17.8 8.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 45.47 49.55 10.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.439 ' CB ' ' OD1' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -79.98 79.05 6.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.47 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.415 ' CZ ' ' N ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -113.93 -10.05 12.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.499 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.46 -45.57 21.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 7.7 m -57.52 -25.35 59.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 18' ' ' ARG . 45.3 t -76.96 -36.46 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.565 ' CD2' HG22 ' A' ' 21' ' ' ILE . 4.7 t80 -64.37 -43.81 93.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -71.06 -48.95 49.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.66 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.577 ' O ' ' SG ' ' A' ' 148' ' ' CYS . 0.0 OUTLIER -59.33 -21.41 59.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.627 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.751 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.5 m -72.14 -32.6 67.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.446 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 77.7 t -49.49 -51.73 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.938 . . . . 0.0 109.289 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.417 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -77.68 -27.59 50.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.424 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.741 ' SG ' ' HA ' ' A' ' 145' ' ' CYS . 67.6 m -44.21 -26.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.138 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.576 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -115.11 -28.75 6.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.226 -0.921 . . . . 0.0 109.452 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.525 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . 30.9 ttt85 -71.04 -59.2 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 108.99 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -49.43 -22.22 1.12 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.388 -0.82 . . . . 0.0 109.611 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.579 ' CD2' HD12 ' A' ' 89' ' ' LEU . 1.3 t80 -90.19 -34.98 15.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 110.061 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 157' ' ' ARG . 11.2 tp -67.28 -46.47 73.51 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.807 -1.183 . . . . 0.0 109.16 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 11.4 pt-20 -49.87 -38.23 34.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 108.638 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.412 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -59.98 -60.53 3.68 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.457 HG22 ' CH2' ' A' ' 39' ' ' TRP . 31.8 m -92.17 31.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.363 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.415 ' C ' ' OD1' ' A' ' 38' ' ' ASN . 59.5 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.556 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -87.93 75.95 8.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.667 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -41.33 153.04 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.759 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.586 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -133.23 117.29 17.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.082 -1.012 . . . . 0.0 109.579 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.587 HG13 ' CE2' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -121.41 154.99 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.927 . . . . 0.0 109.591 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.584 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -149.99 106.53 3.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.868 . . . . 0.0 109.184 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.569 ' CD1' HD11 ' A' ' 89' ' ' LEU . 1.9 m-85 -88.41 155.15 19.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.777 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 2.0 t -145.94 149.83 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.232 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -166.35 154.0 9.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.539 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.7 tp -55.63 -67.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.02 78.92 1.5 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 50' ' ' ASN . 42.5 p-10 -92.2 43.46 1.13 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -1.159 . . . . 0.0 109.419 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.505 HD11 ' N ' ' A' ' 17' ' ' CYS . 1.1 pp -132.88 -31.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 109.949 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.686 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -148.46 12.5 0.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.913 -1.117 . . . . 0.0 110.257 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.536 ' CG ' HG22 ' A' ' 141' ' ' VAL . 7.5 ttt-85 -125.35 -52.33 1.62 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.0 109.472 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.653 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -80.0 -44.35 1.48 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 110.949 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 19' ' ' SER . 73.5 Cg_exo -46.72 -17.0 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.99 1.793 . . . . 0.0 112.313 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.581 HG21 ' CD1' ' A' ' 142' ' ' TYR . 0.9 OUTLIER -74.74 -45.33 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.336 -1.478 . . . . 0.0 108.894 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.764 ' HB1' ' SG ' ' A' ' 145' ' ' CYS . . . -67.8 -42.98 80.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.01 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' CD ' ' HB2' ' A' ' 43' ' ' SER . 4.3 tt0 -58.59 -58.57 7.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 108.764 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HB3' ' CG2' ' A' ' 68' ' ' ILE . . . -46.02 -36.87 6.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.327 -0.858 . . . . 0.0 108.841 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 146' ' ' VAL . 16.5 t -63.03 -52.12 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.274 -0.891 . . . . 0.0 108.952 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.587 ' CE2' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -52.53 -21.47 3.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.459 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -70.88 -56.06 7.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -78.07 1.43 21.06 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.533 HD23 ' CB ' ' A' ' 150' ' ' ARG . 9.9 tp -94.22 -36.14 12.15 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.1 p -91.07 -14.66 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 1.4 m -99.1 17.28 20.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.914 -1.116 . . . . 0.0 109.521 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.96 55.39 1.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 108.993 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.545 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 3.2 tp60 173.47 31.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.559 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 33' ' ' GLN . 0.3 OUTLIER 45.34 39.47 4.42 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -178.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 33' ' ' GLN . 2.3 tt -124.68 -6.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.53 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -75.53 -22.23 57.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -0.892 . . . . 0.0 109.798 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -88.45 26.9 1.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.152 -0.968 . . . . 0.0 109.19 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.556 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 0.7 OUTLIER -159.06 40.19 0.22 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.323 -0.861 . . . . 0.0 109.396 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.667 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 14.4 m95 -150.14 156.62 41.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.956 -1.09 . . . . 0.0 111.121 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.38 72.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.535 ' CG1' ' CG1' ' A' ' 8' ' ' VAL . 2.8 mt -89.66 129.56 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.397 -0.814 . . . . 0.0 110.395 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.456 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . 5.6 t0 -144.95 147.74 33.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.446 -0.783 . . . . 0.0 108.955 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.424 ' HB2' ' CD ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -120.17 159.23 25.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.035 -1.041 . . . . 0.0 109.75 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.68 179.47 39.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.11 145.6 29.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -1.119 . . . . 0.0 109.401 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.454 HG12 ' HG ' ' A' ' 99' ' ' LEU . 70.8 t -57.1 -35.2 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.92 -164.11 1.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.436 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.43 57.59 3.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.902 . . . . 0.0 109.474 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -89.03 -33.9 16.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.336 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HB2' ' OD1' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -146.98 47.95 1.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.361 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.2 t -58.86 112.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.43 ' HA2' ' HG3' ' A' ' 73' ' ' LYS . . . 51.43 51.36 37.63 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 54' ' ' SER . 7.8 mtt180 -95.98 18.47 13.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -1.192 . . . . 0.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER 58.53 151.93 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.62 -0.675 . . . . 0.0 109.631 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.17 128.22 13.62 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.98 1.787 . . . . 0.0 110.186 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' A' ' 17' ' ' CYS . 55.5 m-20 -48.02 154.91 0.93 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.465 ' O ' HG11 ' A' ' 60' ' ' VAL . 55.5 Cg_endo -71.7 -4.77 15.71 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.024 1.816 . . . . 0.0 110.306 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -62.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.25 -18.38 65.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 109.4 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 57' ' ' PRO . 9.8 p -63.96 -41.45 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.179 -0.951 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 8.8 p -77.02 -3.31 38.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.665 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 t -90.14 -33.02 16.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.41 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.38 -55.07 3.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.274 -0.892 . . . . 0.0 109.207 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.461 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 7.7 ptm180 -56.87 -16.54 6.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.386 -0.821 . . . . 0.0 109.642 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.501 ' OD1' ' CD2' ' A' ' 66' ' ' HIS . 12.6 t-20 -66.46 -81.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.501 ' CD2' ' OD1' ' A' ' 65' ' ' ASN . 1.0 OUTLIER -150.7 20.57 0.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.588 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.03 -97.19 2.39 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.489 ' CG2' ' HB3' ' A' ' 24' ' ' ALA . 2.6 mp -119.46 161.29 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -1.13 . . . . 0.0 109.413 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.489 ' N ' HG21 ' A' ' 68' ' ' ILE . 2.2 m-80 -118.25 54.61 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.116 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 9.5 t -58.37 151.18 20.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.571 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -144.55 14.38 1.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.264 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 18.7 t60 -78.45 146.78 34.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.569 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 4.0 tptm -93.67 131.54 38.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 73' ' ' LYS . . . -48.42 176.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.548 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.51 139.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.466 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.07 131.41 44.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 109.51 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.52 ' CG1' ' CE1' ' A' ' 82' ' ' PHE . 71.8 t -48.75 131.54 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 109.334 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 79' ' ' LYS . 20.5 p -111.86 160.35 17.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.636 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HG2' HG11 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -43.17 -44.3 5.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.573 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' O ' ' OG1' ' A' ' 84' ' ' THR . 23.6 tt0 -57.7 -47.82 81.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.837 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.464 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 1.1 m-20 -53.94 -43.78 70.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 109.983 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.52 ' CE1' ' CG1' ' A' ' 77' ' ' VAL . 49.6 m-85 -54.53 -50.89 66.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.499 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.542 ' HA ' ' CG ' ' A' ' 110' ' ' ARG . 1.0 OUTLIER -87.05 0.59 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 109.767 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.572 HG23 ' CE1' ' A' ' 85' ' ' PHE . 13.5 m -77.79 -53.32 7.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 110.244 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.584 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 16.7 m-85 -100.85 174.58 5.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.064 -1.022 . . . . 0.0 110.412 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.422 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 19.5 t0 -112.41 -19.84 12.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.466 -0.771 . . . . 0.0 109.578 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 7' ' ' SER . 1.4 m-85 -116.89 86.97 2.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 0.0 109.23 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.573 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 1.5 mt -95.73 123.45 47.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.339 -0.851 . . . . 0.0 109.327 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -149.59 153.38 37.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 109.267 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.542 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 4.7 p -127.37 167.59 15.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.557 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.524 ' SD ' ' SG ' ' A' ' 148' ' ' CYS . 16.9 mmt -60.89 142.04 56.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 16.9 m-20 -43.52 116.29 0.92 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.439 ' HA ' ' HG2' ' A' ' 128' ' ' GLU . 11.3 tt0 -176.34 163.01 2.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.493 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 t -83.31 8.74 12.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -75.91 -11.97 60.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.542 ' HG ' ' SG ' ' A' ' 90' ' ' CYS . 0.9 OUTLIER -74.19 -2.37 24.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 0.0 109.607 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 13.7 ttt85 -63.63 -25.19 68.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.169 -0.957 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 0.4 OUTLIER -95.54 -43.91 7.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.395 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.454 ' HG ' HG12 ' A' ' 46' ' ' VAL . 6.0 mt -53.65 -44.71 69.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.357 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.48 -29.53 70.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.228 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -89.89 -5.8 56.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.903 . . . . 0.0 109.461 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.465 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 0.6 OUTLIER -81.63 -20.93 38.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -0.874 . . . . 0.0 109.32 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -63.57 -36.59 84.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.826 . . . . 0.0 109.591 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -32.45 73.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.424 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -92.66 9.73 33.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.244 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 109' ' ' CYS . 49.1 t -98.68 145.29 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.392 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.39 106.54 5.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.064 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 109' ' ' CYS . 8.2 t-20 47.73 46.68 18.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.002 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.515 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -41.76 145.6 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.561 -0.712 . . . . 0.0 109.704 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.542 ' CG ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -137.6 25.15 2.88 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.311 -0.868 . . . . 0.0 109.111 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.573 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -106.73 131.43 53.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.392 -0.817 . . . . 0.0 109.858 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 88' ' ' ILE . 7.2 mtpt -83.19 100.22 10.43 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.497 HD11 ' N ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -76.32 135.46 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.734 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.46 -177.97 5.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.419 -0.801 . . . . 0.0 109.36 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.405 ' HG ' HD11 ' A' ' 96' ' ' LEU . 60.8 mt -110.71 152.75 26.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.652 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.77 HD12 ' SG ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -69.08 -9.92 55.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.475 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 92' ' ' ASP . . . -45.94 -29.18 3.14 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.3 168.88 19.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -1.085 . . . . 0.0 109.471 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 55.41 73.65 0.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.37 75.54 13.63 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.13 105.89 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.915 1.743 . . . . 0.0 110.294 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 57.49 178.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.96 42.76 22.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.63 120.26 11.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tp -168.28 101.33 0.43 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.524 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.516 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 15.1 mm -54.28 141.09 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 127' ' ' ILE . 14.8 mt -100.76 57.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.93 . . . . 0.0 109.351 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.516 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 21.0 mt-10 -88.07 132.42 34.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.444 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 1.1 p30 -158.05 158.7 30.22 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 129' ' ' ASP . 51.4 Cg_endo -71.27 -90.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.038 1.825 . . . . 0.0 110.226 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.1 -42.84 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.454 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.09 100.02 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.07 -116.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -160.27 -55.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -1.162 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.41 18.48 15.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.622 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 137' ' ' ASP . . . -55.92 -20.41 15.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.321 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 0.7 OUTLIER 74.79 126.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.578 ' CD1' HG13 ' A' ' 141' ' ' VAL . 80.8 t80 -82.42 0.74 40.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.605 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -79.47 -34.2 41.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.146 -0.971 . . . . 0.0 109.461 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.453 ' CG2' ' N ' ' A' ' 141' ' ' VAL . 15.0 t -76.4 -42.23 45.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.578 HG13 ' CD1' ' A' ' 138' ' ' PHE . 9.0 p -46.64 -29.22 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.581 ' CD1' HG21 ' A' ' 21' ' ' ILE . 1.4 t80 -90.18 -46.34 8.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.102 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.03 -64.56 0.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.682 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -55.76 -20.09 13.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.102 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.764 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -72.33 -39.08 68.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.331 -0.856 . . . . 0.0 109.344 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.545 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 90.1 t -53.21 -71.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.034 -1.041 . . . . 0.0 109.74 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.531 ' HA ' ' CB ' ' A' ' 150' ' ' ARG . 13.1 mtm180 -62.49 -21.18 65.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.088 -1.007 . . . . 0.0 109.606 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -45.81 -27.44 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.985 -1.072 . . . . 0.0 108.18 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.585 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -111.62 -23.12 10.86 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.533 ' CB ' HD23 ' A' ' 29' ' ' LEU . 8.5 ttp180 -76.48 -64.49 1.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.389 -0.819 . . . . 0.0 109.257 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -45.72 -37.87 6.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.257 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.46 ' O ' HG23 ' A' ' 156' ' ' VAL . 1.9 t80 -74.71 -37.38 62.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.42 -0.8 . . . . 0.0 109.3 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . 13.3 tp -67.14 -16.96 64.64 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.211 -0.93 . . . . 0.0 108.718 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -72.37 -50.52 26.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.035 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -42.43 98.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 108.841 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.479 ' O ' ' CD ' ' A' ' 6' ' ' LYS . 17.0 m -103.84 42.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 109.056 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.461 ' HA ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.466 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.358 0.599 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.545 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -151.48 83.59 1.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.248 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.637 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -41.53 162.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.868 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.585 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 2.5 m -142.8 114.7 8.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 108.999 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.578 HG11 ' CZ3' ' A' ' 39' ' ' TRP . 0.6 OUTLIER -118.01 147.77 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.733 -179.256 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.583 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -149.99 116.4 5.77 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' A' ' 116' ' ' LEU . 2.5 m-85 -91.87 160.33 15.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 0.0 109.858 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.589 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 4.2 t -145.98 149.48 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.546 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -174.13 121.91 0.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 12' ' ' CYS . 44.6 tp -43.46 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 109.582 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . 148.96 -73.75 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER 68.7 14.33 8.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -1.096 . . . . 0.0 109.425 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.41 12.73 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.425 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 18' ' ' ARG . 15.3 t 179.12 137.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.77 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 23.7 ttm-85 84.15 -52.22 0.13 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.75 -0.594 . . . . 0.0 109.664 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -79.56 -50.1 1.32 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 110.049 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 19' ' ' SER . 70.2 Cg_exo -48.37 -33.66 23.23 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.902 1.735 . . . . 0.0 110.876 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.586 HG22 ' CD2' ' A' ' 142' ' ' TYR . 5.4 mm -65.75 -61.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.961 -1.087 . . . . 0.0 109.655 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.6 ' HB1' ' SG ' ' A' ' 145' ' ' CYS . . . -62.5 -12.77 24.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 109.539 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 2.4 tm-20 -77.98 -74.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.401 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.447 ' HB2' ' CG2' ' A' ' 68' ' ' ILE . . . -53.96 -33.96 58.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 108.841 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.547 ' CG1' ' CD1' ' A' ' 29' ' ' LEU . 49.6 t -56.29 -59.75 2.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.393 -0.817 . . . . 0.0 109.202 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.591 ' CD1' HG11 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -47.52 -41.26 20.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.974 -1.079 . . . . 0.0 108.506 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.505 ' O ' ' OG1' ' A' ' 31' ' ' THR . 5.8 ttt85 -45.7 -60.07 2.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.006 -1.059 . . . . 0.0 109.403 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.46 ' HA ' ' OG1' ' A' ' 31' ' ' THR . 0.3 OUTLIER -75.32 -13.03 60.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.41 -0.806 . . . . 0.0 111.003 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.547 ' CD1' ' CG1' ' A' ' 25' ' ' VAL . 42.1 mt -76.37 -30.85 57.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.846 -1.159 . . . . 0.0 109.433 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.591 HG11 ' CD1' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -90.76 -31.85 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -60.86 -31.81 71.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 109.076 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.46 -40.61 89.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.357 -0.839 . . . . 0.0 109.328 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 32.0 tp60 -80.67 -6.54 58.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.874 . . . . 0.0 109.515 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 1.5 m120 72.67 47.44 0.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.532 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 5.9 pt -129.72 -1.14 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.917 . . . . 0.0 109.656 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.578 ' CA ' ' CG2' ' A' ' 30' ' ' VAL . 2.1 p -58.36 -44.46 88.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 109.657 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.12 -28.03 6.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.548 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.545 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 5.3 m-20 -112.58 46.1 1.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.637 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 7.6 m95 -149.86 144.54 26.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.157 -0.964 . . . . 0.0 110.194 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.8 t -124.16 78.11 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.567 ' CG1' ' CG1' ' A' ' 8' ' ' VAL . 2.6 mt -90.02 139.11 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.869 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -150.75 -173.53 4.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.285 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.449 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 1.1 t -126.46 165.95 18.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.692 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.93 131.94 4.82 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.537 ' O ' ' CG1' ' A' ' 46' ' ' VAL . . . -93.41 -39.24 11.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.301 -1.117 . . . . 0.0 109.583 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER 80.84 -6.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.695 . . . . 0.0 109.466 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.0 m -141.31 137.33 32.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.487 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 1.3 t70 -88.38 14.1 10.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.516 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -86.25 3.45 43.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.695 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 49' ' ' TRP . 3.9 m-20 -144.46 22.78 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.577 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.53 ' CG1' ' HA ' ' A' ' 75' ' ' ARG . 60.9 t -64.85 128.37 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.05 -18.15 42.16 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.86 113.17 2.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -1.116 . . . . 0.0 109.365 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.4 m -76.45 153.01 83.79 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 56' ' ' ASP . 53.7 Cg_exo -50.25 143.72 25.33 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.957 1.771 . . . . 0.0 110.266 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 55' ' ' PRO . 4.5 m-20 -44.79 151.92 0.58 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.9 -6.0 18.19 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 121.93 1.753 . . . . 0.0 110.31 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.746 ' O ' ' SG ' ' A' ' 62' ' ' CYS . 16.0 mtt180 -86.26 -33.85 20.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.366 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.14 -25.07 22.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.319 -0.863 . . . . 0.0 109.446 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.525 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 9.9 p -64.71 -44.78 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.456 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.515 ' N ' HG12 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -69.64 -8.46 47.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.631 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.746 ' SG ' ' O ' ' A' ' 58' ' ' ARG . 13.1 m -89.89 -66.71 0.9 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.53 ' N ' HD21 ' A' ' 63' ' ' LEU . 1.7 pt? -57.78 -25.31 60.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.368 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.471 ' NH2' ' HG3' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -91.56 30.89 1.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.349 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -133.21 -46.0 0.84 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.574 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -83.59 -33.58 25.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.441 ' O ' HG12 ' A' ' 68' ' ' ILE . . . 136.22 98.5 0.54 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.457 HG13 ' HB2' ' A' ' 63' ' ' LEU . 15.6 mm -149.42 -68.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -1.127 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 21.4 m-80 68.65 116.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.391 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 t -105.01 167.69 9.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.537 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -161.71 39.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.456 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' A' ' 73' ' ' LYS . 8.6 t60 -155.16 144.66 21.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.508 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' CD2' ' A' ' 72' ' ' HIS . 0.9 OUTLIER -115.82 151.18 35.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 73' ' ' LYS . . . -44.11 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.53 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.5 tpp180 69.15 8.1 6.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER 61.32 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.438 HG13 ' HA ' ' A' ' 46' ' ' VAL . 11.6 p -53.85 165.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.85 161.96 37.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HG2' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -50.63 -41.57 55.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.274 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' OG1' ' A' ' 84' ' ' THR . 0.3 OUTLIER -54.0 -41.13 67.61 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.354 -0.841 . . . . 0.0 109.53 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.426 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 0.9 OUTLIER -62.15 -31.88 72.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 109.842 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.466 ' HA ' ' HB1' ' A' ' 111' ' ' ALA . 77.6 m-85 -66.23 -59.2 3.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.063 -1.023 . . . . 0.0 109.399 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.52 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 2.6 p -72.98 -9.14 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.506 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 3.4 m -81.76 -78.06 0.2 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.222 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.583 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 37.2 m-85 -70.06 156.52 39.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.253 -0.905 . . . . 0.0 109.315 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -106.43 -12.68 15.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.654 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 7' ' ' SER . 2.2 m-85 -121.88 78.21 1.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 109.712 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.586 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 2.8 mt -89.3 91.66 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.306 -0.872 . . . . 0.0 108.964 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.45 168.26 9.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 0.0 109.352 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.589 ' SG ' ' HB ' ' A' ' 11' ' ' VAL . 3.9 m -136.51 175.21 9.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.259 -0.9 . . . . 0.0 109.292 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 16.8 mmt -84.07 12.51 6.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.46 ' O ' HD23 ' A' ' 115' ' ' LEU . 1.3 p30 170.66 176.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.579 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.495 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -107.34 -14.69 14.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 93' ' ' GLU . 0.5 OUTLIER -44.26 -53.0 7.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.582 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -89.16 -24.34 22.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.916 . . . . 0.0 109.571 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.459 HD12 HG23 ' A' ' 113' ' ' ILE . 2.6 tt -58.7 -21.19 54.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.95 -28.24 0.44 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -94.65 -33.24 13.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.502 ' CD1' HG13 ' A' ' 11' ' ' VAL . 15.4 mt -67.17 -14.48 62.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -85.5 -31.78 22.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.98 -11.93 40.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -67.86 -42.47 81.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.434 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.686 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 1.1 p -53.03 -22.66 6.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.397 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -72.02 -44.05 64.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.383 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -83.08 -9.93 58.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.554 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.539 HG13 ' CA ' ' A' ' 109' ' ' CYS . 41.1 t -76.8 135.49 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.448 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -68.65 108.41 3.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 t30 51.93 48.98 21.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.279 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.686 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -48.36 148.77 1.78 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.282 -0.886 . . . . 0.0 109.773 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.52 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -136.95 5.21 2.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.417 -0.802 . . . . 0.0 109.206 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -85.44 94.43 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 110.388 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -52.82 122.88 10.02 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.544 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -96.97 129.38 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.79 -1.194 . . . . 0.0 110.114 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -155.3 -171.98 4.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 0.0 109.224 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 93' ' ' GLU . 20.2 mt -117.49 162.66 17.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.969 . . . . 0.0 109.517 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.595 HD23 ' SG ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -85.85 58.71 5.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -123.07 -2.22 9.29 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 15.62 24.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -1.187 . . . . 0.0 109.487 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.434 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 2.8 m-85 -135.76 70.57 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -166.63 133.83 2.05 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.164 -0.96 . . . . 0.0 109.382 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.65 -30.55 29.03 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.769 1.646 . . . . 0.0 110.168 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -128.3 132.44 48.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.39 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -64.65 140.44 58.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.182 -0.949 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 125' ' ' LEU . 1.1 mt-30 -108.76 16.82 22.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.253 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.471 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 1.6 tt 39.66 61.07 1.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.756 -0.59 . . . . 0.0 109.842 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.519 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 7.2 mm 62.08 139.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 0.0 109.345 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 129' ' ' ASP . 2.8 mp -101.43 -55.21 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.84 . . . . 0.0 109.365 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.519 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 33.5 mt-10 48.0 -92.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER 51.44 92.55 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.489 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.1 157.11 3.1 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.901 1.734 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -98.92 87.3 3.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -138.6 -74.83 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.525 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -142.73 117.79 1.17 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 137' ' ' ASP . 2.4 p30 -105.8 148.06 27.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -1.149 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.92 74.48 7.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 66.03 33.14 7.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 134' ' ' ASN . 0.4 OUTLIER -105.89 56.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 109.564 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -111.36 -42.04 3.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 109.355 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -70.42 -36.15 73.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 0.0 109.307 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.435 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 56.8 m -65.81 -17.66 64.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.226 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.511 ' CG1' ' HA ' ' A' ' 18' ' ' ARG . 22.3 t -81.67 -43.89 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.586 ' CD2' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.54 -25.89 65.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.216 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -83.9 -46.76 11.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.91 . . . . 0.0 109.651 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 141' ' ' VAL . 16.2 pt20 -67.23 -13.3 61.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.24 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.77 ' SG ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -79.09 -19.21 51.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 109.457 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.54 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 54.4 t -61.3 -56.27 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.926 . . . . 0.0 109.27 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.87 -12.29 60.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.288 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.595 ' SG ' HD23 ' A' ' 116' ' ' LEU . 1.2 m -56.12 -18.78 10.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.15 -0.969 . . . . 0.0 108.988 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.567 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -124.42 -40.71 2.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.418 -0.801 . . . . 0.0 109.229 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -59.15 -46.36 88.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 108.71 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.487 ' O ' ' CG ' ' A' ' 154' ' ' GLU . . . -65.68 -18.97 65.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.474 -0.766 . . . . 0.0 109.098 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.581 ' CZ ' HG22 ' A' ' 156' ' ' VAL . 4.6 t80 -90.07 -19.35 24.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.416 -0.802 . . . . 0.0 109.489 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . 14.5 tp -78.7 -22.74 46.22 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.037 -1.04 . . . . 0.0 108.768 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 151' ' ' ALA . 4.4 pt-20 -72.0 -33.71 68.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.1 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.455 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 5.8 mmtp -76.19 -51.65 11.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.916 . . . . 0.0 108.864 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.581 HG22 ' CZ ' ' A' ' 152' ' ' PHE . 17.8 m -103.56 58.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.393 -0.817 . . . . 0.0 108.935 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.559 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 38' ' ' ASN . 1.9 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -130.64 82.75 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.933 . . . . 0.0 109.803 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.645 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -43.12 156.8 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -136.38 113.74 10.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.377 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.577 HG22 ' CE2' ' A' ' 152' ' ' PHE . 1.0 OUTLIER -117.8 142.71 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.571 HD11 ' CD1' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -142.23 116.61 9.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.445 -0.784 . . . . 0.0 109.136 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.774 ' CZ ' ' SG ' ' A' ' 148' ' ' CYS . 2.0 m-85 -91.1 161.51 15.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.583 ' CG1' ' CG2' ' A' ' 46' ' ' VAL . 74.5 t -149.47 152.93 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.461 ' HB3' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -178.28 126.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.437 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.95 124.95 13.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.48 62.47 1.87 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -84.02 74.85 10.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.425 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -144.19 12.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.627 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.442 ' SG ' HD13 ' A' ' 16' ' ' ILE . 0.8 OUTLIER 173.74 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.716 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 19' ' ' SER . 2.4 ttm105 -94.6 66.68 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 109.572 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.59 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 162.44 -51.08 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.644 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 19' ' ' SER . 57.2 Cg_exo -49.89 -20.83 5.31 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.882 1.721 . . . . 0.0 110.425 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.757 HG23 ' SG ' ' A' ' 145' ' ' CYS . 1.9 mm -64.89 -51.16 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.147 -0.97 . . . . 0.0 109.183 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.672 ' O ' ' SG ' ' A' ' 149' ' ' CYS . . . -63.33 -19.87 65.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.48 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -73.51 -74.67 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.273 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' CB ' ' HB ' ' A' ' 70' ' ' THR . . . -44.2 -28.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 108.91 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.77 HG22 ' SG ' ' A' ' 145' ' ' CYS . 97.3 t -68.23 -53.32 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.328 -0.858 . . . . 0.0 109.21 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.623 ' CE1' ' CD1' ' A' ' 41' ' ' ILE . 5.2 t80 -46.22 -39.58 10.05 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.527 ' HD3' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -58.02 -53.36 59.07 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.385 -0.822 . . . . 0.0 109.202 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -76.67 -1.37 27.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 0.0 109.792 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.755 HD13 ' SG ' ' A' ' 149' ' ' CYS . 81.4 mt -92.55 -32.85 14.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.013 -1.054 . . . . 0.0 109.316 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.605 ' CG2' ' CA ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -90.71 -49.87 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -52.6 -22.17 4.72 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.272 -0.893 . . . . 0.0 109.167 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -90.67 -31.41 16.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.029 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -79.16 -79.71 0.13 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 109.224 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 4.0 m-20 161.92 42.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.398 -0.814 . . . . 0.0 109.955 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.536 HD12 ' CA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -139.15 11.55 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.976 -1.078 . . . . 0.0 109.837 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.605 ' CA ' ' CG2' ' A' ' 30' ' ' VAL . 4.3 p -62.57 -21.36 65.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.944 -1.097 . . . . 0.0 109.51 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 3.4 m-20 -93.11 34.23 1.13 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.317 -0.865 . . . . 0.0 108.753 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.527 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 6.6 m-20 -177.06 48.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 109.684 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.645 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 9.8 m95 -149.99 144.19 25.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.89 -1.131 . . . . 0.0 110.383 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.65 81.59 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.623 ' CD1' ' CE1' ' A' ' 26' ' ' PHE . 2.7 mp -89.93 137.77 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.831 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.575 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 4.4 m-20 -148.44 173.52 13.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -122.76 161.33 24.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.444 ' HA3' ' CG2' ' A' ' 77' ' ' VAL . . . -143.89 147.75 19.19 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' A' ' 46' ' ' VAL . . . -116.79 -19.73 9.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -1.17 . . . . 0.0 109.558 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.583 ' CG2' ' CG1' ' A' ' 11' ' ' VAL . 4.5 t 69.92 6.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.07 164.03 31.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.601 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.478 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 48.5 p30 -110.45 11.59 23.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.865 . . . . 0.0 109.424 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -89.93 6.67 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.745 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.485 ' OD1' ' CD ' ' A' ' 53' ' ' ARG . 4.3 m-80 -147.81 29.76 0.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.58 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 26.0 t -78.55 78.51 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 109.283 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.464 ' HA2' ' HD3' ' A' ' 73' ' ' LYS . . . 134.79 -19.86 3.92 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' CD ' ' OD1' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -63.42 90.68 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.417 -1.049 . . . . 0.0 109.409 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.451 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 13.4 p -55.72 161.91 2.96 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.856 . . . . 0.0 109.448 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 54' ' ' SER . 53.5 Cg_exo -50.44 153.79 6.99 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.043 1.829 . . . . 0.0 110.199 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 18.5 m-20 -75.38 144.91 78.84 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.928 . . . . 0.0 109.486 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.474 ' O ' HG11 ' A' ' 60' ' ' VAL . 51.6 Cg_exo -51.07 -19.63 6.17 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.959 1.773 . . . . 0.0 110.496 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -79.56 -45.64 18.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.147 -0.971 . . . . 0.0 109.821 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.517 ' O ' ' CD2' ' A' ' 63' ' ' LEU . . . -71.3 -17.98 62.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 109.885 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 64' ' ' ARG . 8.8 p -72.38 -28.15 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.932 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.505 ' N ' HG11 ' A' ' 60' ' ' VAL . 14.7 m -64.2 -20.18 65.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.812 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.29 -75.06 0.47 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.198 -0.939 . . . . 0.0 109.745 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' O ' ' CG2' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -53.87 -18.47 3.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.726 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.531 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 4.3 ttt180 -112.72 51.63 0.81 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.09 -1.006 . . . . 0.0 109.633 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 61' ' ' SER . 4.6 t-20 -129.27 -78.46 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 109.245 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -54.62 -33.05 59.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.317 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.86 104.76 1.34 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -133.63 -174.36 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -1.169 . . . . 0.0 109.324 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.527 ' CB ' ' HD3' ' A' ' 27' ' ' ARG . 67.0 m-80 -140.18 118.01 11.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.505 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.524 ' HB ' ' CB ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -142.18 -87.32 0.15 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.451 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.412 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . 60.18 20.49 9.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.333 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.544 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.5 p-80 -90.09 157.4 17.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HD3' ' HA2' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -107.87 150.13 27.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.21 170.69 15.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.939 . . . . 0.0 109.551 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -174.83 153.27 1.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.442 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.439 ' N ' ' HG3' ' A' ' 75' ' ' ARG . 31.6 tt0 -77.04 138.78 39.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.444 ' CG2' ' HA3' ' A' ' 44' ' ' GLY . 77.8 t -67.33 141.98 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 2.7 p -127.95 164.75 21.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.556 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' HG2' ' CG1' ' A' ' 106' ' ' VAL . 0.6 OUTLIER -51.1 -45.36 61.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.477 ' O ' ' OG1' ' A' ' 84' ' ' THR . 32.7 tt0 -53.9 -38.21 64.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.481 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 78' ' ' THR . 7.3 m-20 -59.11 -41.17 87.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.748 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 94.4 m-85 -61.84 -54.31 43.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.513 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.534 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 1.2 p -75.9 -5.84 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 109.612 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.527 HG23 ' CE1' ' A' ' 85' ' ' PHE . 4.0 m -85.89 -71.7 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.314 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 42' ' ' ASP . 71.6 m-85 -74.3 161.62 29.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 83.3 m-20 -109.16 -21.81 12.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.673 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.7 m-85 -116.06 73.32 0.84 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.076 -1.015 . . . . 0.0 109.58 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.55 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 3.0 mt -86.15 89.81 2.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -100.5 174.3 6.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.041 -1.037 . . . . 0.0 109.441 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.528 ' SG ' ' CD1' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -150.05 159.8 44.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.431 -0.793 . . . . 0.0 109.091 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.753 ' HE3' ' SG ' ' A' ' 148' ' ' CYS . 32.6 mmt -67.49 167.86 12.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -0.96 . . . . 0.0 109.201 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER -59.52 -149.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.793 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 92' ' ' ASP . 0.1 OUTLIER 76.87 -179.04 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.345 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 m -89.01 36.01 0.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -89.94 -15.47 31.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.471 ' CD1' ' HB3' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -86.74 -16.31 36.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 109.466 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 21.1 ttt85 -65.91 -11.42 46.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.0 -1.063 . . . . 0.0 109.169 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 13.8 t70 -108.36 -35.09 6.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.259 -0.9 . . . . 0.0 109.183 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.528 ' CD1' ' SG ' ' A' ' 90' ' ' CYS . 8.9 mt -69.18 -50.6 46.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.362 -0.836 . . . . 0.0 109.41 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -54.52 -26.18 30.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.415 -0.803 . . . . 0.0 109.406 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.83 -24.24 19.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.907 . . . . 0.0 109.478 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 0.3 OUTLIER -65.94 -39.5 90.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.749 ' OG ' ' SG ' ' A' ' 109' ' ' CYS . 45.1 t -59.72 -17.95 38.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 0.0 109.319 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.31 -40.17 31.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 5.4 pt20 -76.85 -18.16 58.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 109' ' ' CYS . 92.9 t -69.22 147.9 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.436 ' N ' HG11 ' A' ' 106' ' ' VAL . 5.0 mmtm -89.41 108.49 19.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.274 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.18 42.04 4.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.074 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.749 ' SG ' ' OG ' ' A' ' 103' ' ' SER . 0.0 OUTLIER -52.35 152.44 3.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 0.0 109.894 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 4.0 ptm180 -140.32 8.75 2.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.424 -0.797 . . . . 0.0 109.184 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.55 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -90.65 91.51 8.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 110.313 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 111' ' ' ALA . 13.7 mtpt -47.33 116.97 1.57 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 1.7 mm -93.65 135.98 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.858 -1.151 . . . . 0.0 110.685 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.6 tt0 -160.89 -176.27 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -134.82 151.59 51.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.017 -1.052 . . . . 0.0 109.495 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.798 ' CD2' ' SG ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -42.25 135.17 2.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.443 -0.785 . . . . 0.0 109.669 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.31 -120.01 1.67 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.6 p -148.65 117.64 6.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -1.185 . . . . 0.0 109.6 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.525 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 23.9 m-85 -115.47 31.35 6.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.35 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.575 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 162.89 -51.24 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.404 -0.81 . . . . 0.0 109.539 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.5 Cg_exo -49.92 146.89 15.61 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.845 1.697 . . . . 0.0 110.071 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.67 11.36 32.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.118 -0.989 . . . . 0.0 109.672 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.57 146.66 25.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -112.85 62.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.392 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.27 76.32 1.56 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.541 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.53 HD12 ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -74.62 137.77 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.265 -0.897 . . . . 0.0 109.083 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.574 ' CG1' ' CB ' ' A' ' 144' ' ' GLN . 95.2 mt -39.56 106.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.515 -0.741 . . . . 0.0 109.941 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.489 ' CG ' ' OD2' ' A' ' 92' ' ' ASP . 15.1 mt-10 -142.26 79.74 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.458 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 130' ' ' PRO . 0.9 OUTLIER -150.73 104.45 3.05 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.456 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 129' ' ' ASP . 54.4 Cg_exo -49.68 -174.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.755 1.636 . . . . 0.0 110.29 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -100.12 14.02 32.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.595 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.96 26.44 9.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.42 -105.38 1.58 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -113.48 -159.72 0.7 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -1.191 . . . . 0.0 109.384 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -119.21 -23.78 6.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.39 10.75 9.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -97.74 61.33 1.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.27 -51.26 2.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.561 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -27.29 34.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 109.363 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 61.0 m -61.79 -49.03 77.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.337 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 145' ' ' CYS . 53.5 t -53.6 -40.72 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 0.0 109.377 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.579 ' CD2' ' CG2' ' A' ' 21' ' ' ILE . 2.2 t80 -61.28 -48.4 81.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.417 ' NE2' ' HA ' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -55.01 -65.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 109.951 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.574 ' CB ' ' CG1' ' A' ' 127' ' ' ILE . 21.0 mm100 -53.38 -19.03 3.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.868 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.77 ' SG ' HG22 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -77.7 -38.09 48.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.117 -0.989 . . . . 0.0 109.645 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.546 ' N ' ' SG ' ' A' ' 145' ' ' CYS . 2.9 t -51.57 -53.55 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.087 -1.008 . . . . 0.0 109.218 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.43 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.9 OUTLIER -79.05 -12.54 60.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.861 . . . . 0.0 109.344 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.798 ' SG ' ' CD2' ' A' ' 116' ' ' LEU . 36.2 t -56.46 -40.4 74.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.224 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.755 ' SG ' HD13 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -103.06 -29.26 11.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.365 -0.834 . . . . 0.0 109.52 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.517 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 2.2 ttt180 -72.21 -59.65 2.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 147' ' ' ARG . . . -57.19 -19.82 23.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.454 -0.779 . . . . 0.0 109.206 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.577 ' CE2' HG22 ' A' ' 8' ' ' VAL . 2.6 t80 -90.59 -26.86 19.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.51 -0.744 . . . . 0.0 109.833 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 153' ' ' LEU . 8.7 tp -75.16 -25.68 58.52 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.912 -1.117 . . . . 0.0 109.109 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -69.22 -46.82 66.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.36 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -63.3 -54.75 32.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.475 ' O ' ' HD3' ' A' ' 6' ' ' LYS . 17.5 m -102.87 54.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.256 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.466 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.55 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 5' ' ' THR . 18.0 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.549 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -175.24 84.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.343 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.655 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -42.59 163.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.585 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 74.4 m -145.58 109.83 4.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.107 -0.996 . . . . 0.0 109.586 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.631 HG13 ' CZ3' ' A' ' 39' ' ' TRP . 1.5 p -110.75 144.79 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.217 -0.927 . . . . 0.0 109.627 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.583 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -141.49 126.04 17.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.125 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.498 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.0 m-85 -105.53 156.42 18.25 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 109.569 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.512 ' CG1' HD13 ' A' ' 99' ' ' LEU . 25.2 t -139.13 154.86 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.77 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.558 ' SG ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -170.62 129.79 0.84 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.423 -0.798 . . . . 0.0 109.16 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 12' ' ' CYS . 1.0 OUTLIER -42.39 -65.28 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.558 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . -87.43 87.59 1.55 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.442 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 3.0 t-20 -90.04 40.76 1.02 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -1.129 . . . . 0.0 109.353 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 53' ' ' ARG . 1.8 pp -157.24 -40.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.925 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.55 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 0.9 OUTLIER -102.65 -15.33 16.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.496 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 14' ' ' GLY . 3.0 mmm-85 -75.53 0.18 18.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.599 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.518 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 10.0 p 60.14 56.08 4.29 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 109.568 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 19' ' ' SER . 45.3 Cg_endo -70.05 83.05 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.999 1.799 . . . . 0.0 109.941 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.536 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 3.2 mm -88.68 -21.02 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.796 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.69 ' CB ' ' SG ' ' A' ' 148' ' ' CYS . . . -54.52 -24.57 21.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.05 -1.031 . . . . 0.0 109.873 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 8.0 tp10 -76.75 -83.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 0.0 110.021 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -41.71 -30.75 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 109.836 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 21' ' ' ILE . 60.9 t -64.32 -58.04 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.359 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.583 ' CD2' HG12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -46.9 -41.72 16.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.108 -0.995 . . . . 0.0 108.64 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.488 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.1 OUTLIER -50.23 -66.42 0.39 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.237 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -13.71 29.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 110.164 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.541 HD13 ' SG ' ' A' ' 149' ' ' CYS . 8.5 mt -77.18 -78.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.161 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.603 ' CG2' ' HA ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -42.73 -47.66 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.39 -0.819 . . . . 0.0 109.653 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -51.14 -46.69 62.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.81 -1.181 . . . . 0.0 109.502 -179.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.42 -30.16 70.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.962 . . . . 0.0 109.03 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.527 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 1.1 tt0 -79.68 -10.13 59.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 8.7 t30 77.61 25.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.453 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.564 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 1.6 pt -117.63 11.56 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.315 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.603 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 89.3 p -73.5 -12.35 60.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.683 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -83.94 10.1 10.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 109.332 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.549 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 3.1 m-20 -155.38 51.99 0.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.655 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 7.9 m95 -150.3 154.37 37.74 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.902 -1.123 . . . . 0.0 110.865 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 t -130.49 80.59 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.583 HG12 ' CD2' ' A' ' 26' ' ' PHE . 3.3 mt -90.64 138.99 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.255 -0.903 . . . . 0.0 109.87 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.415 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -145.73 -178.71 6.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.82 . . . . 0.0 109.154 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.7 t -170.27 135.91 1.33 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.682 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.8 -177.06 33.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . . . -95.12 141.02 29.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -1.183 . . . . 0.0 109.461 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.499 HG11 ' N ' ' A' ' 47' ' ' SER . 8.4 p -58.0 -24.71 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.344 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.499 ' N ' HG11 ' A' ' 46' ' ' VAL . 19.4 m -124.43 170.88 10.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.372 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HA ' HG22 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -81.07 75.61 8.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.366 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.57 -32.68 6.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 45' ' ' ALA . 4.1 p-10 -132.08 34.56 3.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.597 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 76' ' ' GLN . 77.7 t -65.87 110.19 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.55 16.03 41.3 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 8.7 mtt-85 -120.72 86.64 2.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -1.171 . . . . 0.0 109.44 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -47.08 172.46 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.316 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 52.2 Cg_exo -50.95 123.78 12.46 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.885 1.723 . . . . 0.0 110.037 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 1.8 m-20 -43.09 155.89 0.27 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.604 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.448 ' O ' HG11 ' A' ' 60' ' ' VAL . 53.7 Cg_endo -71.68 -6.87 20.03 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.873 1.715 . . . . 0.0 110.142 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -34.65 18.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.06 26.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.447 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' ARG . 11.1 p -65.57 -36.55 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.875 . . . . 0.0 109.389 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 79.2 p -60.74 -15.96 34.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.3 t -85.51 -52.5 5.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -88.26 6.42 37.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.584 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.477 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 12.9 tpt180 -112.7 -36.09 5.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.504 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 61' ' ' SER . 53.8 t30 -52.37 -47.14 66.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.474 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -74.45 -49.71 21.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.41 93.54 0.71 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -118.22 -178.92 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -1.163 . . . . 0.0 109.407 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -120.64 104.45 9.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.171 -0.955 . . . . 0.0 109.505 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 t -137.93 123.1 19.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.439 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.89 69.58 0.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -0.926 . . . . 0.0 109.459 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.51 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.1 p-80 -156.18 178.43 10.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.401 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 139.42 52.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -60.56 153.34 23.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.933 . . . . 0.0 109.216 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 74' ' ' ALA . 2.2 mmt85 -149.95 125.6 10.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.472 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 1.4 tt0 -51.11 140.03 16.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 78' ' ' THR . 54.5 t -56.68 165.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.507 ' N ' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -163.96 164.25 23.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.503 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.01 -37.68 33.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.292 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.48 ' O ' ' OG1' ' A' ' 84' ' ' THR . 1.1 tp10 -59.98 -52.7 64.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.884 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.458 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 1.1 m-20 -54.28 -49.39 69.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.142 -0.973 . . . . 0.0 110.11 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 62.9 m-85 -48.85 -68.74 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.145 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.464 ' O ' ' HD3' ' A' ' 110' ' ' ARG . 4.1 p -66.38 -10.86 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.233 -0.917 . . . . 0.0 109.994 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.487 HG23 ' CD2' ' A' ' 85' ' ' PHE . 3.3 m -78.43 -85.14 0.07 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.583 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 51.9 m-85 -62.09 132.63 53.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.587 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -72.11 -15.17 61.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.857 . . . . 0.0 109.465 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.7 m-85 -124.89 136.35 53.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.32 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.586 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 2.0 mt -142.74 89.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 109.254 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.56 HD12 ' CD2' ' A' ' 152' ' ' PHE . 0.1 OUTLIER -112.79 148.18 35.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.872 -1.143 . . . . 0.0 109.547 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.766 ' SG ' HD11 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -99.22 -179.58 4.28 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.262 -0.899 . . . . 0.0 108.654 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.822 ' CE ' ' SG ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -76.01 1.54 15.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.088 -1.007 . . . . 0.0 109.604 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.472 ' OD2' ' HA ' ' A' ' 128' ' ' GLU . 20.3 p30 178.34 -165.36 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.126 -0.984 . . . . 0.0 109.382 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.417 ' HG3' HD21 ' A' ' 115' ' ' LEU . 1.9 tt0 -97.0 -31.11 12.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.714 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.4 p -45.37 -41.17 8.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.928 . . . . 0.0 109.79 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -90.01 -26.35 20.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.206 -0.934 . . . . 0.0 109.795 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -62.15 -28.92 69.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.105 -0.997 . . . . 0.0 109.717 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -49.97 -21.87 1.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.702 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -104.09 -33.33 8.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.766 HD11 ' SG ' ' A' ' 90' ' ' CYS . 11.2 mt -74.09 -7.69 53.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.854 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' HB2' HD21 ' A' ' 96' ' ' LEU . 54.2 t-20 -90.33 -23.06 21.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -96.67 -9.17 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 109.698 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -73.36 -26.79 61.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.602 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.402 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 1.1 p -52.89 -42.37 65.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.566 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.37 -61.28 2.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.478 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.28 -21.32 5.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.247 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 109' ' ' CYS . 97.6 t -79.68 130.21 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.511 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -76.47 117.84 18.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.272 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.4 42.7 27.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 109.233 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.14 144.65 6.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.825 . . . . 0.0 109.946 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -135.17 2.51 3.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 0.0 109.202 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -80.71 102.01 9.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.118 -0.989 . . . . 0.0 109.904 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.46 95.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 2.1 mm -65.33 158.44 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.071 -1.018 . . . . 0.0 110.321 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.522 ' CA ' HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 177.31 -168.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 0.8 OUTLIER -147.21 147.88 30.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.048 -1.032 . . . . 0.0 109.68 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.703 HD23 ' SG ' ' A' ' 148' ' ' CYS . 69.0 tp -53.1 99.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . -175.24 177.18 47.26 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 1.7 m 79.6 -73.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.969 . . . . 0.0 109.689 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -100.67 57.82 0.92 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.949 . . . . 0.0 109.395 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -116.78 144.05 32.63 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.387 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CB ' ' NH2' ' A' ' 147' ' ' ARG . 55.7 Cg_endo -72.9 -163.56 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.887 1.725 . . . . 0.0 110.214 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER 73.58 -151.66 0.05 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.599 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.44 ' O ' ' HE3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -126.05 77.67 1.7 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.459 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.91 43.94 26.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.48 143.85 26.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.857 . . . . 0.0 109.487 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.1 mm -138.12 130.29 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 127' ' ' ILE . 10.9 tt -84.42 71.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.259 -0.9 . . . . 0.0 109.017 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.472 ' HA ' ' OD2' ' A' ' 92' ' ' ASP . 2.4 mt-10 -72.06 -67.47 0.54 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.732 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.49 79.36 54.52 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.723 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.44 ' HG3' ' CG1' ' A' ' 127' ' ' ILE . 53.6 Cg_endo -72.43 -21.05 23.2 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.968 1.779 . . . . 0.0 110.078 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.55 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 10.1 t80 -59.5 -24.7 63.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -111.25 84.32 1.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.878 . . . . 0.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -130.68 -135.96 3.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -122.4 -157.32 0.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -1.101 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.08 -22.0 12.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.43 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.72 25.21 2.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.407 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 138' ' ' PHE . 10.1 t0 -122.84 -142.55 0.32 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.271 -0.893 . . . . 0.0 109.151 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ASP . 1.3 t80 82.73 -42.98 0.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.554 -0.716 . . . . 0.0 109.793 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.07 -35.67 80.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.989 -1.069 . . . . 0.0 109.41 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.8 m -66.9 -28.66 68.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.275 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.513 HG11 ' N ' ' A' ' 142' ' ' TYR . 2.3 p -60.54 -30.84 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.274 -0.891 . . . . 0.0 109.366 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.513 ' N ' HG11 ' A' ' 141' ' ' VAL . 1.7 t80 -85.09 -53.13 5.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 0.0 109.271 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -28.27 10.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.14 -47.74 7.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.487 ' CB ' ' HB ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -53.57 -21.87 7.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.333 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.521 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 60.2 t -51.03 -55.18 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.228 -0.92 . . . . 0.0 109.286 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.529 ' NH2' ' CB ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -79.13 -18.46 53.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.292 -0.88 . . . . 0.0 109.304 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.822 ' SG ' ' CE ' ' A' ' 91' ' ' MET . 36.1 t -46.41 -25.88 0.74 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.088 -1.007 . . . . 0.0 108.844 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 2.5 p -119.95 -40.68 2.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.421 -0.8 . . . . 0.0 109.274 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.482 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 7.0 ttm-85 -62.23 -52.29 64.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 108.876 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 147' ' ' ARG . . . -58.73 -18.82 34.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.878 . . . . 0.0 108.985 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.56 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -90.23 -25.68 20.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.783 . . . . 0.0 109.6 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . 11.5 tp -75.61 -21.93 57.34 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.048 -1.032 . . . . 0.0 108.688 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -68.31 -48.39 65.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.902 . . . . 0.0 109.223 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -64.56 -48.85 73.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.014 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.473 ' O ' ' HD3' ' A' ' 6' ' ' LYS . 16.2 m -101.41 51.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.112 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.487 -179.833 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.451 0.643 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.574 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -63.9 101.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.408 -0.807 . . . . 0.0 109.543 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.696 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -44.21 166.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.83 179.226 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.605 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 15.5 p -136.39 112.86 9.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.931 -1.105 . . . . 0.0 109.275 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.546 ' CG1' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -115.71 134.22 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 109.64 -179.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.633 ' CD1' ' CD1' ' A' ' 85' ' ' PHE . 1.9 tp -124.73 118.17 25.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.26 102.34 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.021 -1.049 . . . . 0.0 109.755 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 44' ' ' GLY . 3.0 t -106.26 151.07 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 108.977 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.48 136.56 11.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.954 -1.091 . . . . 0.0 109.815 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.91 117.19 1.77 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 109.057 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.36 75.27 1.18 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.503 ' O ' ' CG ' ' A' ' 20' ' ' PRO . 5.3 t-20 -57.64 -14.99 6.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -1.11 . . . . 0.0 109.625 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' A' ' 17' ' ' CYS . 1.1 pp -111.01 -158.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.999 -1.063 . . . . 0.0 109.301 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER 59.81 115.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.043 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER 77.9 -2.88 2.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.286 -179.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.524 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 1.4 t 45.26 96.85 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 109.856 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 52.8 Cg_exo -48.08 88.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.562 1.508 . . . . 0.0 109.667 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.529 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 2.0 mp -78.21 -11.72 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -0.868 . . . . 0.0 109.946 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.806 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -67.52 -43.18 81.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.99 -1.069 . . . . 0.0 108.976 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ALA . 1.6 tm-20 -76.15 -57.12 4.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.255 -0.903 . . . . 0.0 109.052 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 68' ' ' ILE . . . -44.76 -41.25 6.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.887 . . . . 0.0 108.982 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.539 ' CG1' ' HA ' ' A' ' 146' ' ' VAL . 53.0 t -62.85 -51.23 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.807 . . . . 0.0 109.23 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.586 ' CD1' HG11 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -46.28 -36.72 6.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 108.547 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.475 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -62.07 -52.83 62.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.058 -1.026 . . . . 0.0 108.395 179.066 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -84.18 11.03 8.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 108.955 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.539 HD22 ' CA ' ' A' ' 150' ' ' ARG . 45.5 tp -97.43 -46.97 5.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.401 -0.812 . . . . 0.0 109.107 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.595 ' CG2' ' CA ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -91.09 -39.24 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.488 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 0.4 OUTLIER -69.54 -8.44 47.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.593 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 9.0 t70 -95.99 -15.46 22.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.013 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 4.6 tp60 -102.68 -82.0 0.49 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.488 -0.757 . . . . 0.0 109.245 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 26.0 t30 172.84 46.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.449 -0.782 . . . . 0.0 108.899 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.554 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 1.4 pt -143.64 17.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.793 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.595 ' CA ' ' CG2' ' A' ' 30' ' ' VAL . 79.3 p -85.39 -26.97 26.12 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.792 -1.192 . . . . 0.0 109.355 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -58.49 -27.05 64.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.574 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 2.6 m-20 -118.96 42.69 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.576 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.696 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 11.6 m95 -150.0 119.8 7.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.994 -1.066 . . . . 0.0 110.563 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.62 91.63 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 26' ' ' PHE . 3.2 mt -92.41 129.1 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.918 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -154.2 137.15 15.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.319 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -107.75 178.07 4.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 109.394 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' CG1' ' A' ' 11' ' ' VAL . . . -168.27 171.21 42.46 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.47 ' O ' ' OE1' ' A' ' 76' ' ' GLN . . . -92.85 151.91 19.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -1.138 . . . . 0.0 109.419 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.58 -17.21 6.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.28 -0.888 . . . . 0.0 108.786 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.458 ' O ' ' OE1' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -101.14 -148.34 0.37 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.386 -0.822 . . . . 0.0 109.505 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -150.28 16.11 0.82 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.079 -1.013 . . . . 0.0 109.715 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -100.22 0.22 39.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.6 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.444 ' OD1' ' CB ' ' A' ' 45' ' ' ALA . 8.1 p30 -118.6 5.8 11.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.9 t -56.29 110.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.473 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.55 29.84 9.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.426 ' C ' HG23 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -123.59 131.88 53.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 109.352 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 10.1 p -95.12 162.5 24.66 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 54' ' ' SER . 52.7 Cg_exo -50.99 144.42 27.92 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.974 1.783 . . . . 0.0 110.166 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.406 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 8.0 m-20 -53.54 153.04 8.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.457 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.438 ' O ' HG13 ' A' ' 60' ' ' VAL . 50.1 Cg_endo -71.14 -15.05 32.07 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.043 1.829 . . . . 0.0 110.116 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -37.46 16.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 19' ' ' SER . . . -90.15 -11.57 40.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.504 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -74.63 -30.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.497 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.89 0.18 21.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.586 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 66' ' ' HIS . 57.9 m -90.0 -18.44 26.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.322 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.12 -52.79 4.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.175 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -64.87 -10.44 28.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.875 . . . . 0.0 109.62 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.65 -85.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.604 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.564 ' CD2' HG12 ' A' ' 68' ' ' ILE . 1.7 p-80 -60.55 -25.42 66.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 109.555 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.26 107.62 1.66 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.564 HG12 ' CD2' ' A' ' 66' ' ' HIS . 17.1 mm -148.54 154.33 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -1.157 . . . . 0.0 109.493 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.505 ' ND2' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -137.52 119.35 15.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.483 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 t -121.57 174.98 6.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.981 . . . . 0.0 109.453 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -167.9 75.27 0.13 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -169.33 134.01 1.45 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.2 tptt -95.34 59.23 2.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.206 -0.934 . . . . 0.0 109.495 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . 51.79 -92.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.682 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER 59.53 151.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 109.534 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.47 ' OE1' ' O ' ' A' ' 45' ' ' ALA . 34.2 tp60 -90.27 133.52 34.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 78' ' ' THR . 47.5 t -45.32 161.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.494 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.463 ' N ' ' CG1' ' A' ' 77' ' ' VAL . 0.2 OUTLIER -126.14 170.55 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.727 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HG2' HG12 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -58.11 -53.52 57.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.862 . . . . 0.0 109.534 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' ' OG1' ' A' ' 84' ' ' THR . 9.6 tt0 -50.59 -42.81 56.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 109.746 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.451 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 6.7 m-20 -58.56 -42.19 87.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.673 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CE2' HD21 ' A' ' 99' ' ' LEU . 10.5 m-85 -57.22 -51.2 70.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 109.334 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.557 ' CG2' ' CB ' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -80.17 -5.35 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.988 -1.07 . . . . 0.0 109.68 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 16.2 m -81.27 -58.7 2.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -0.831 . . . . 0.0 110.236 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.633 ' CD1' ' CD1' ' A' ' 9' ' ' LEU . 38.8 m-85 -77.54 165.2 24.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 110.192 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -108.68 -36.69 6.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -0.807 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -109.44 78.77 1.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 108.651 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.589 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 3.2 mt -86.44 87.26 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.915 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -96.98 174.75 6.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.025 -1.047 . . . . 0.0 109.205 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.53 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 1.1 p -149.93 148.2 28.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.383 -0.823 . . . . 0.0 109.375 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.621 ' HE1' ' SG ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -49.27 147.71 2.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 109.295 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.533 ' CB ' HG21 ' A' ' 126' ' ' ILE . 0.7 OUTLIER -52.23 -20.31 2.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 109.794 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 92' ' ' ASP . 2.3 mt-10 -43.02 -69.04 0.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 96' ' ' LEU . 12.2 t -87.34 85.62 7.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.904 . . . . 0.0 108.83 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.498 ' O ' ' C ' ' A' ' 96' ' ' LEU . 20.2 t-20 -50.28 86.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.752 -0.592 . . . . 0.0 110.285 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.557 ' CD2' ' CG2' ' A' ' 113' ' ' ILE . 0.7 OUTLIER 29.93 51.7 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.185 0.517 . . . . 0.0 110.683 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.421 ' HG2' ' N ' ' A' ' 98' ' ' ASP . 3.0 ttt85 -88.08 -91.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 109.59 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -57.22 -50.71 72.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 109.619 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.568 HD21 ' CE2' ' A' ' 82' ' ' PHE . 5.0 mt -48.89 -26.97 2.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 0.0 109.678 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.468 ' HB2' HD21 ' A' ' 96' ' ' LEU . 34.4 t-20 -79.85 -38.31 33.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.96 3.06 54.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.626 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.476 ' CB ' ' CE2' ' A' ' 82' ' ' PHE . 23.8 mmmt -84.88 -25.77 27.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.331 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -29.16 68.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -68.32 -60.21 2.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -54.42 -23.55 16.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 109.136 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.483 HG13 ' HA ' ' A' ' 109' ' ' CYS . 38.8 t -82.3 105.71 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.426 -0.796 . . . . 0.0 109.415 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -44.31 117.27 1.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.546 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 107' ' ' LYS . 5.4 m-20 42.83 58.26 3.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.649 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -47.76 164.26 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.33 -0.856 . . . . 0.0 110.333 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.649 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 1.8 tpt180 -150.54 61.1 0.95 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.589 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -147.15 89.72 1.82 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.253 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 111' ' ' ALA . 6.1 mtpp -44.0 110.17 0.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.557 ' CG2' ' CD2' ' A' ' 96' ' ' LEU . 2.1 mm -87.2 144.42 9.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.036 -1.04 . . . . 0.0 110.503 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -163.95 -179.64 6.39 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.472 ' CD1' ' OD2' ' A' ' 92' ' ' ASP . 1.0 OUTLIER -132.35 146.3 51.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.94 -1.1 . . . . 0.0 109.482 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.773 HD12 ' SG ' ' A' ' 148' ' ' CYS . 1.4 tp -43.97 120.21 2.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.36 157.98 23.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.48 100.7 0.38 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -1.123 . . . . 0.0 109.523 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -90.18 -87.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -0.873 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.58 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -67.01 -61.62 4.63 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.695 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 55.2 Cg_endo -71.9 162.45 41.9 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.765 1.643 . . . . 0.0 110.361 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -108.69 24.52 12.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.53 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.95 104.76 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.942 . . . . 0.0 109.633 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.98 60.85 6.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.464 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -109.12 -54.35 2.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 109.513 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.533 HG21 ' CB ' ' A' ' 92' ' ' ASP . 8.2 mm 61.8 145.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.421 ' N ' HG21 ' A' ' 126' ' ' ILE . 77.3 mt -109.04 93.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.398 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.527 ' CG ' ' OD1' ' A' ' 92' ' ' ASP . 34.4 mt-10 -124.29 8.35 8.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.577 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -94.56 146.56 31.69 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.451 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.94 170.75 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.928 1.752 . . . . 0.0 110.232 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CD1' ' A' ' 131' ' ' TYR . 14.2 p90 -103.11 125.89 50.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.458 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -146.69 111.24 5.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.865 . . . . 0.0 109.467 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -45.91 95.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 132' ' ' TYR . 1.3 m-80 -135.35 6.73 3.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -1.187 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' A' ' 136' ' ' ALA . 1.3 m-20 70.54 164.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 135' ' ' ASP . . . 73.77 5.29 4.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.492 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -135.4 105.48 6.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.555 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -174.86 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.541 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -86.31 -17.1 35.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.531 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 36.7 m -82.4 -25.0 34.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.753 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 74.2 t -76.55 -44.86 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 142' ' ' TYR . 2.6 t80 -74.74 -38.32 62.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.572 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -61.66 -61.52 2.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 148' ' ' CYS . 4.0 mt-30 -61.74 -29.36 70.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 109.507 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.806 ' SG ' ' N ' ' A' ' 22' ' ' ALA . 4.7 m -58.88 -40.2 83.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 109.68 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.539 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 84.0 t -51.57 -72.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 109.53 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -11.29 39.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.419 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 116' ' ' LEU . 20.2 t -53.78 -26.2 22.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.102 -0.999 . . . . 0.0 108.797 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.599 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -119.11 -30.57 4.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.394 -0.816 . . . . 0.0 109.251 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.539 ' CA ' HD22 ' A' ' 29' ' ' LEU . 11.0 ttt180 -67.48 -52.42 39.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.937 . . . . 0.0 108.856 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.9 -21.38 20.0 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.449 -0.782 . . . . 0.0 109.023 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.517 ' O ' ' CG2' ' A' ' 156' ' ' VAL . 1.5 t80 -90.63 -27.44 19.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.517 -0.74 . . . . 0.0 109.815 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.472 HD22 HD11 ' A' ' 35' ' ' ILE . 7.5 tp -78.06 -25.2 47.61 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.992 -1.067 . . . . 0.0 108.741 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.28 -51.15 60.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.922 . . . . 0.0 109.18 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -55.3 25.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.395 -0.816 . . . . 0.0 109.336 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 152' ' ' PHE . 18.6 m -95.4 43.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.262 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.417 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 1.8 tmm_? . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.567 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 6' ' ' LYS . 3.9 p . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.563 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 18.1 p -49.99 90.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 0.0 109.571 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.633 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.7 OUTLIER -45.19 170.14 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.035 -1.04 . . . . 0.0 109.396 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.55 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -142.39 146.91 35.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.029 -1.045 . . . . 0.0 109.811 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.585 HG13 ' CE2' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -150.78 146.08 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 109.037 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.56 HD12 ' CD1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -133.01 126.74 32.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.722 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.529 ' CE1' ' HE2' ' A' ' 91' ' ' MET . 0.6 OUTLIER -109.18 124.39 50.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 108.897 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 2.1 t -125.35 158.19 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 91' ' ' MET . 0.6 OUTLIER -177.99 131.2 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.794 . . . . 0.0 109.185 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.491 ' HB2' ' ND2' ' A' ' 95' ' ' ASN . 0.7 OUTLIER -43.7 149.98 0.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 109.579 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.456 ' HA2' ' OD1' ' A' ' 50' ' ' ASN . . . 46.76 66.57 1.74 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.511 ' ND2' ' HG3' ' A' ' 20' ' ' PRO . 2.7 t-20 -88.8 67.64 8.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -1.113 . . . . 0.0 109.695 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -138.71 6.46 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.154 -0.966 . . . . 0.0 109.731 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.621 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 1.7 p 179.75 138.21 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.017 . . . . 0.0 109.618 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.621 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 1.9 mtm180 83.6 -48.6 0.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.815 -0.553 . . . . 0.0 109.65 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.615 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -82.97 -48.53 0.79 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 110.175 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 19' ' ' SER . 63.4 Cg_exo -49.58 -19.4 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.957 1.771 . . . . 0.0 111.047 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.587 HG22 ' CD2' ' A' ' 142' ' ' TYR . 2.5 mp -64.29 -44.93 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.87 -1.144 . . . . 0.0 109.4 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.756 ' CB ' ' SG ' ' A' ' 145' ' ' CYS . . . -61.36 -35.29 77.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.507 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' OE2' ' HB2' ' A' ' 43' ' ' SER . 2.4 tt0 -70.19 -69.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.317 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HB3' ' CG2' ' A' ' 68' ' ' ILE . . . -43.64 -33.31 1.17 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.135 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 21' ' ' ILE . 58.7 t -65.26 -49.62 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.864 . . . . 0.0 108.754 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.585 ' CE2' HG13 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -50.41 -29.85 11.09 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.47 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -68.48 -50.71 50.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 109.2 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -20.07 66.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.457 HD23 ' HG3' ' A' ' 150' ' ' ARG . 11.5 mt -86.97 -28.34 22.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.047 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 36' ' ' SER . 2.5 p -90.22 -8.85 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -107.96 0.95 22.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -115.01 45.93 1.52 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.004 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.548 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -178.7 29.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.5 t30 45.35 45.88 10.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.548 ' CG2' ' HB3' ' A' ' 33' ' ' GLN . 1.3 tt -127.39 -1.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.229 0.538 . . . . 0.0 109.795 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 30' ' ' VAL . 45.8 t -74.08 -45.83 46.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.737 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 5' ' ' THR . 0.4 OUTLIER -59.87 -12.67 8.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 110.225 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.563 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 0.9 OUTLIER -116.02 37.28 3.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.986 -1.071 . . . . 0.0 109.993 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.633 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 12.8 m95 -150.48 157.76 43.38 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.854 -1.153 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.87 72.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.565 HG22 ' CD2' ' A' ' 26' ' ' PHE . 2.5 mp -89.47 141.13 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 110.248 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -148.23 -165.83 2.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.503 -0.748 . . . . 0.0 109.048 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.434 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -165.67 165.82 18.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.685 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . 178.39 -170.48 42.56 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.38 -176.67 3.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.199 . . . . 0.0 109.346 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.443 ' CG1' ' HG ' ' A' ' 99' ' ' LEU . 39.3 t -93.7 -0.37 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.823 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.56 -178.24 6.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.505 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 2.0 p-10 -84.3 69.36 10.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -99.26 -77.68 0.52 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.423 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.456 ' OD1' ' HA2' ' A' ' 14' ' ' GLY . 30.5 m120 -96.0 37.67 1.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.357 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 80.1 t -64.33 106.84 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' A' ' 73' ' ' LYS . . . 106.69 -34.14 5.93 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 1.5 mtt180 -61.59 96.91 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -1.174 . . . . 0.0 109.487 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.75 164.55 1.59 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 56' ' ' ASP . 53.4 Cg_exo -50.57 119.52 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.035 1.823 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -43.41 150.07 0.54 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.688 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.523 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 50.9 Cg_exo -52.13 -18.03 6.73 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.098 1.865 . . . . 0.0 110.613 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -78.76 -46.04 19.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.052 -1.03 . . . . 0.0 109.889 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . . . -90.04 1.91 55.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -0.937 . . . . 0.0 110.055 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 5.5 p -90.02 -44.61 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.048 -1.032 . . . . 0.0 109.681 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.517 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 53.3 p -79.07 -15.56 58.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.599 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -73.8 -27.6 61.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 109.349 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.586 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -89.44 -52.57 4.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 108.943 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -14.09 16.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.814 . . . . 0.0 109.554 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -68.23 -61.06 2.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.547 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -69.67 -35.21 74.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.155 -0.966 . . . . 0.0 109.598 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 68' ' ' ILE . . . 141.11 -10.11 2.77 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.524 ' CG2' ' HB3' ' A' ' 24' ' ' ALA . 17.0 mm -43.82 159.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -1.154 . . . . 0.0 109.626 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.49 ' N ' HG23 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -131.5 175.37 9.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -160.09 -86.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.474 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . 65.62 16.76 10.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.574 ' CE1' ' OD1' ' A' ' 42' ' ' ASP . 24.8 t60 -126.4 149.35 49.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.953 . . . . 0.0 109.46 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 0.4 OUTLIER -101.58 140.99 35.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.491 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 73' ' ' LYS . . . -42.56 -66.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.822 . . . . 0.0 109.723 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 65.31 164.9 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.343 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 77' ' ' VAL . 47.8 tt0 -100.98 156.01 17.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.491 HG11 ' N ' ' A' ' 78' ' ' THR . 91.7 t -81.22 146.96 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.925 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.491 ' N ' HG11 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -142.61 161.1 38.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.521 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.508 ' CG ' HG11 ' A' ' 106' ' ' VAL . 2.4 tmtt? -42.87 -34.77 1.01 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.469 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.467 ' O ' ' OG1' ' A' ' 84' ' ' THR . 1.0 OUTLIER -61.57 -53.25 58.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.879 . . . . 0.0 109.681 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 3.5 m-20 -66.93 -19.01 65.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 109.823 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.777 ' HB3' ' SG ' ' A' ' 109' ' ' CYS . 13.1 m-85 -68.88 -68.59 0.39 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 109.532 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.474 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 9.9 p -67.29 -23.25 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 4.6 m -60.65 -67.59 0.38 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.56 ' CD1' HD12 ' A' ' 9' ' ' LEU . 82.5 m-85 -74.83 156.21 36.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 0.0 109.532 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -90.32 -36.33 14.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.322 -0.861 . . . . 0.0 109.387 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 7' ' ' SER . 17.5 m-85 -109.77 151.91 26.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.575 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.596 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 1.7 mt -153.69 80.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 108.833 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.467 HD22 ' CE1' ' A' ' 152' ' ' PHE . 0.1 OUTLIER -91.58 -174.75 3.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 109.583 -179.436 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.736 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -148.31 172.15 14.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.303 -0.873 . . . . 0.0 109.212 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.736 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -84.54 45.4 1.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 109.704 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.463 ' OD2' ' CG2' ' A' ' 127' ' ' ILE . 2.6 m-20 65.15 -144.52 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.537 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 128' ' ' GLU . 27.6 mt-10 73.5 158.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.6 m -81.08 6.41 13.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.624 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 13' ' ' LEU . 2.9 m120 -71.8 -9.32 58.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.473 HD23 HG23 ' A' ' 113' ' ' ILE . 4.4 mt -81.45 -10.16 59.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.414 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -61.28 -21.84 64.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.01 -39.58 8.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.833 . . . . 0.0 109.467 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.443 ' HG ' ' CG1' ' A' ' 46' ' ' VAL . 8.6 mt -66.94 -18.76 65.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.93 . . . . 0.0 109.39 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -77.89 -33.48 51.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.86 -19.92 24.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -57.3 -35.09 69.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 109.452 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.528 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 0.3 OUTLIER -50.2 -49.09 53.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.375 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -64.71 -36.23 83.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.136 -0.977 . . . . 0.0 109.436 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.59 -4.8 55.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.212 -0.93 . . . . 0.0 109.473 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.841 ' CB ' ' SG ' ' A' ' 109' ' ' CYS . 41.2 t -86.32 117.98 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 108' ' ' ASN . 0.1 OUTLIER -53.14 105.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 108.644 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.447 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 15.7 m120 60.52 70.68 0.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.033 -1.042 . . . . 0.0 108.576 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.841 ' SG ' ' CB ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -88.57 136.44 32.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 110.364 -179.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.485 ' O ' ' HG3' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -128.96 1.81 5.31 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.596 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -83.3 110.58 18.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.446 -0.784 . . . . 0.0 110.164 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.16 125.39 26.23 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -100.04 132.0 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.94 -1.1 . . . . 0.0 110.29 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 10.3 mt-10 -163.79 -174.04 3.49 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -125.24 165.87 17.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.767 ' CD2' ' SG ' ' A' ' 148' ' ' CYS . 3.5 tp -42.51 -74.4 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.701 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.88 -110.73 3.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.565 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 1.8 t -151.56 136.24 17.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.461 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 118' ' ' SER . 23.9 m-85 -136.76 32.14 2.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.929 . . . . 0.0 109.586 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 163.06 -51.53 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.0 Cg_exo -49.46 162.62 0.53 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.799 1.666 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.77 45.04 1.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.883 . . . . 0.0 109.43 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 166.43 33.24 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -0.971 . . . . 0.0 109.413 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.03 90.08 4.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.343 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tt -103.04 138.68 39.57 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -0.925 . . . . 0.0 109.614 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.473 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 12.0 mm -143.93 125.95 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.398 -0.813 . . . . 0.0 109.301 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.493 ' O ' HG21 ' A' ' 127' ' ' ILE . 1.5 tt -105.08 78.22 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 109.113 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 129' ' ' ASP . 6.7 mt-10 -77.12 -95.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 128' ' ' GLU . 2.0 m-20 47.51 95.12 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.323 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 131' ' ' TYR . 69.4 Cg_exo -47.33 -67.84 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.774 1.65 . . . . 0.0 110.347 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 130' ' ' PRO . 20.9 t80 178.83 61.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.505 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' GLY . 87.9 m-85 -141.14 16.92 2.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.457 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 132' ' ' TYR . . . 59.23 154.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -120.96 -26.81 5.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -1.114 . . . . 0.0 109.471 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.84 -160.92 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.362 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.67 77.34 6.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.405 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.21 108.96 4.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.519 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 8.9 t80 -123.23 -51.28 1.88 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.497 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -69.62 -33.28 72.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.503 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.2 m -49.2 -43.87 42.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.464 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.7 t -65.9 -48.2 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.848 . . . . 0.0 109.493 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.587 ' CD2' HG22 ' A' ' 21' ' ' ILE . 2.8 t80 -53.0 -27.98 21.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.332 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -83.73 -38.29 21.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.82 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -75.54 -11.43 60.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.686 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.762 ' HA ' ' SG ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -89.97 -10.35 45.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.527 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 53.5 t -62.01 -48.94 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 109.234 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 1.2 mtt180 -79.72 -15.0 58.34 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.178 -0.951 . . . . 0.0 109.376 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.767 ' SG ' ' CD2' ' A' ' 116' ' ' LEU . 21.2 m -50.16 -24.0 2.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.086 -1.009 . . . . 0.0 108.635 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.676 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -120.18 -39.17 2.83 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.443 -0.786 . . . . 0.0 109.025 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.457 ' HG3' HD23 ' A' ' 29' ' ' LEU . 13.7 ttp85 -63.6 -53.71 47.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 108.703 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 147' ' ' ARG . . . -60.17 -36.13 76.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -0.774 . . . . 0.0 109.175 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.569 ' CE2' HG22 ' A' ' 156' ' ' VAL . 6.8 t80 -74.84 -19.12 60.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.384 -0.822 . . . . 0.0 109.515 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.455 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 14.4 tp -77.96 -19.59 54.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.099 -1.0 . . . . 0.0 108.744 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -70.59 -46.89 62.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 108.769 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -66.74 -53.71 30.48 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 0.0 108.986 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.569 HG22 ' CE2' ' A' ' 152' ' ' PHE . 5.7 m -92.72 34.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 109.086 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.455 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 117.944 -1.026 . . . . 0.0 109.587 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.579 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 65.8 p -74.68 108.82 7.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.661 ' CB ' ' CH2' ' A' ' 39' ' ' TRP . 35.8 mttp -63.7 -168.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.9 -1.125 . . . . 0.0 108.993 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.575 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -145.99 107.28 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 109.834 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.6 HG11 ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -111.86 150.57 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.576 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.4 tt -149.83 104.17 3.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.139 -0.975 . . . . 0.0 109.555 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.476 ' CZ ' HD13 ' A' ' 116' ' ' LEU . 2.8 m-85 -81.96 164.38 21.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.95 . . . . 0.0 109.379 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 90' ' ' CYS . 58.5 t -150.31 161.87 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.133 -0.979 . . . . 0.0 109.936 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.542 ' SG ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -178.4 142.09 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.39 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.475 HD13 ' CH2' ' A' ' 49' ' ' TRP . 13.2 tp -43.58 -79.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.686 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 15' ' ' ASN . . . -46.99 -74.33 0.25 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 14' ' ' GLY . 25.8 t30 76.61 20.47 1.42 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -1.124 . . . . 0.0 109.321 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 15' ' ' ASN . 1.2 pp -156.65 30.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.444 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.6 m -135.01 -84.84 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.585 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.521 ' HB2' ' CG2' ' A' ' 141' ' ' VAL . 0.0 OUTLIER -115.42 -7.84 12.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -75.06 -51.02 3.68 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.786 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 19' ' ' SER . 55.9 Cg_exo -49.66 -21.23 5.23 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.855 1.703 . . . . 0.0 110.674 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.757 ' HB ' ' SG ' ' A' ' 145' ' ' CYS . 7.9 mm -60.31 -48.6 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.315 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.576 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -64.72 -20.27 66.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.932 . . . . 0.0 109.738 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.513 ' OE1' ' CB ' ' A' ' 43' ' ' SER . 4.7 mt-10 -77.22 -81.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.12 -0.987 . . . . 0.0 109.521 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.518 ' CB ' HG12 ' A' ' 68' ' ' ILE . . . -45.21 -40.28 7.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.31 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 21' ' ' ILE . 54.1 t -59.87 -51.34 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.22 -0.925 . . . . 0.0 109.402 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.637 ' CE1' ' CG1' ' A' ' 30' ' ' VAL . 1.2 t80 -46.41 -42.06 14.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.024 . . . . 0.0 108.698 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -55.12 -59.81 4.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.533 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 0.1 OUTLIER -76.73 2.88 13.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.823 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 146' ' ' VAL . 3.2 mt -94.0 -29.89 15.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.149 -0.97 . . . . 0.0 108.733 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.637 ' CG1' ' CE1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -84.54 -42.51 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.56 ' CA ' ' HB3' ' A' ' 36' ' ' SER . 1.9 t -42.47 -28.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 30' ' ' VAL . 5.7 t70 -58.07 -55.34 36.15 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.474 -0.766 . . . . 0.0 108.992 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.548 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -73.08 -2.79 22.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.91 . . . . 0.0 109.368 179.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.5 OUTLIER 79.91 54.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.395 -0.815 . . . . 0.0 109.589 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.544 HG13 ' CG2' ' A' ' 30' ' ' VAL . 5.7 pt -144.78 9.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.141 -0.974 . . . . 0.0 109.987 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.633 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 9.7 p -69.16 -22.88 63.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.85 -1.156 . . . . 0.0 109.124 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.74 -20.64 38.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.312 -0.868 . . . . 0.0 108.799 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.579 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 3.0 m-80 -110.31 44.54 1.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -0.845 . . . . 0.0 109.283 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.661 ' CH2' ' CB ' ' A' ' 6' ' ' LYS . 10.9 m95 -150.66 129.46 12.42 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.611 -1.236 . . . . 0.0 110.746 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.441 HG13 ' CE2' ' A' ' 85' ' ' PHE . 56.6 t -99.14 79.21 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.567 HG12 ' CD2' ' A' ' 26' ' ' PHE . 6.9 mt -89.9 128.2 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.934 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.567 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -137.24 -159.53 0.96 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.482 -0.761 . . . . 0.0 109.06 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.513 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 60.3 p -151.85 172.53 16.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.112 -0.992 . . . . 0.0 109.852 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 10' ' ' PHE . . . -146.8 163.45 28.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' A' ' 46' ' ' VAL . . . -128.92 -29.53 2.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -1.184 . . . . 0.0 109.878 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 45' ' ' ALA . 15.8 t 67.23 9.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 109.332 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.579 ' HB3' ' CE2' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -125.43 141.19 52.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.905 . . . . 0.0 109.358 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.462 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -84.01 6.28 22.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.697 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.628 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -102.9 -33.56 9.28 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 109.409 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 3.2 m120 -91.98 12.65 21.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.086 -1.009 . . . . 0.0 109.397 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 76' ' ' GLN . 13.3 t -75.33 85.22 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.74 -5.38 9.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.425 ' CD ' ' HA ' ' A' ' 50' ' ' ASN . 18.5 mtp180 -79.64 104.16 10.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -1.188 . . . . 0.0 109.468 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -66.04 173.98 1.89 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.375 -0.828 . . . . 0.0 109.59 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 53.3 Cg_exo -50.75 137.96 41.78 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.066 1.844 . . . . 0.0 110.288 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.37 145.71 66.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.416 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HA ' HG13 ' A' ' 60' ' ' VAL . 52.5 Cg_exo -50.5 -22.38 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.969 1.78 . . . . 0.0 110.345 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -85.55 -37.71 19.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.534 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.88 -4.91 59.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 109.674 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 57' ' ' PRO . 9.9 p -80.82 -28.37 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -81.98 -19.01 41.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.498 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.463 ' HB3' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -74.05 -33.91 63.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.511 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.14 -56.16 3.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.135 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -22.62 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.417 -0.802 . . . . 0.0 109.744 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 61' ' ' SER . 52.2 t-20 -70.66 -50.89 31.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.67 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -83.48 -5.04 59.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.945 . . . . 0.0 109.696 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.66 102.3 0.26 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.518 HG12 ' CB ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -126.23 -33.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -1.118 . . . . 0.0 109.56 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 13.0 m-80 70.77 49.42 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.355 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.85 142.39 57.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.85 18.17 1.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.502 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.547 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.4 p-80 -103.01 155.42 18.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' ALA . 11.9 tptt -124.75 26.77 7.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 73' ' ' LYS . . . 56.94 161.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.611 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.418 ' HG3' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -168.27 171.74 9.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.407 -0.808 . . . . 0.0 109.256 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.472 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 2.6 tt0 -93.19 21.2 6.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.321 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 78' ' ' THR . 0.8 OUTLIER 52.2 178.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 109.598 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER 176.0 162.86 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.522 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -44.11 -35.99 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 109.469 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 84' ' ' THR . 2.9 tp10 -59.61 -48.86 80.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.783 . . . . 0.0 109.555 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' HD13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -65.3 -13.3 58.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.58 ' CD2' HG23 ' A' ' 106' ' ' VAL . 6.3 m-85 -80.64 -75.86 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.46 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 14.8 p -54.08 -38.05 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 108.81 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.495 ' CB ' ' O ' ' A' ' 80' ' ' GLU . 38.8 m -58.02 -65.34 0.66 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.657 -0.652 . . . . 0.0 109.451 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 79.2 m-85 -81.36 125.3 30.21 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.33 -0.856 . . . . 0.0 109.499 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -73.8 -17.08 61.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.312 -0.867 . . . . 0.0 109.406 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 7' ' ' SER . 4.4 m-85 -130.07 131.08 45.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 109.861 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.592 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 5.1 mt -135.48 88.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 108.754 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -104.74 165.48 11.03 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.856 -1.152 . . . . 0.0 109.968 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.657 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -143.43 166.77 23.85 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.657 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -68.47 139.88 55.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.325 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.487 ' HB2' HD13 ' A' ' 126' ' ' ILE . 52.9 t0 -43.88 126.02 4.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 1.2 tt0 176.21 161.31 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.294 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -75.76 -6.86 52.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -74.73 -7.87 54.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.913 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.638 ' HG ' ' SG ' ' A' ' 90' ' ' CYS . 0.6 OUTLIER -89.19 7.04 37.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.937 . . . . 0.0 109.645 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -14.73 58.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 99' ' ' LEU . 2.8 p30 -92.77 -33.64 14.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.553 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.53 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 20.3 mt -71.58 -37.33 71.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.57 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.07 -31.69 71.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.543 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -10.0 45.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.569 ' HB3' ' CE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -71.69 -24.03 61.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.95 . . . . 0.0 109.56 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.8 p -70.02 -11.31 60.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.6 -23.97 21.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.581 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -102.7 8.99 39.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.925 . . . . 0.0 109.499 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.58 HG23 ' CD2' ' A' ' 82' ' ' PHE . 24.4 t -101.85 143.37 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 109.345 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 108' ' ' ASN . 5.7 mtmt -75.31 121.75 22.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 109.298 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 107' ' ' LYS . 2.2 m120 43.78 41.45 3.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.172 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.528 ' CA ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -42.92 142.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.349 -0.844 . . . . 0.0 110.138 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 109' ' ' CYS . 24.5 mmm180 -123.39 -2.57 8.49 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.592 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -84.24 106.68 16.05 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.39 -0.819 . . . . 0.0 110.722 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.95 98.02 2.41 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -72.85 131.28 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -0.999 . . . . 0.0 110.483 -178.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.8 tt0 -172.8 148.54 1.86 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 117' ' ' GLY . 1.6 pp -90.66 157.0 17.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.438 -1.414 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -40.13 -68.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.483 -0.761 . . . . 0.0 109.925 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.522 ' N ' HD13 ' A' ' 115' ' ' LEU . . . 66.43 168.82 3.07 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.1 m -69.15 88.91 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.513 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.495 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -63.05 -37.25 86.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.454 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.569 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 166.68 -63.14 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.581 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 45.3 Cg_endo -68.72 -18.19 42.22 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.804 1.669 . . . . 0.0 110.365 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.89 162.27 19.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.27 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 12.5 ptpt -143.35 54.14 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.932 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.449 ' CB ' ' O ' ' A' ' 123' ' ' LYS . 0.6 OUTLIER 71.74 61.11 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.437 ' HB3' ' NE2' ' A' ' 144' ' ' GLN . 0.1 OUTLIER -158.35 44.36 0.3 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.922 . . . . 0.0 109.437 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.532 HD11 ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -89.62 130.84 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.957 . . . . 0.0 109.387 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.532 ' N ' HD11 ' A' ' 126' ' ' ILE . 5.4 mt -41.58 99.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.749 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.452 ' HG2' ' OD2' ' A' ' 92' ' ' ASP . 31.5 mt-10 -117.53 28.94 8.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 0.0 109.38 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.13 148.3 35.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.1 -37.06 5.07 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.013 1.808 . . . . 0.0 110.114 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -161.79 -53.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.238 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -132.85 98.86 4.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.389 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.21 -47.51 89.24 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.15 -164.24 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -1.134 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -104.31 150.76 24.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.925 . . . . 0.0 109.455 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 135' ' ' ASP . . . 70.56 11.38 7.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.57 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.466 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 0.5 OUTLIER -97.51 10.45 39.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.44 ' O ' HG11 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -76.16 -16.12 59.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.476 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -90.06 -51.8 5.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.609 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.73 -19.25 65.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.556 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 142' ' ' TYR . 5.2 p -75.34 -47.4 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.912 . . . . 0.0 109.227 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.597 ' CD2' HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -60.27 -39.5 87.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -39.83 85.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 109.485 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.437 ' NE2' ' HB3' ' A' ' 125' ' ' LEU . 10.7 mm100 -62.95 -33.76 76.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.87 . . . . 0.0 109.356 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.757 ' HA ' ' SG ' ' A' ' 148' ' ' CYS . 1.2 m -62.18 -21.51 65.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 109.498 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.527 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 86.6 t -56.47 -58.67 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 108.882 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -13.18 61.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.248 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.757 ' SG ' ' HA ' ' A' ' 145' ' ' CYS . 99.6 m -62.77 -12.3 23.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.543 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -125.53 -37.33 2.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -59.35 -42.4 91.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 109.158 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.31 -23.36 67.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 109.091 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.625 ' CZ ' ' CG2' ' A' ' 156' ' ' VAL . 1.5 t80 -89.17 -22.95 22.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.829 . . . . 0.0 109.528 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.536 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 21.4 tp -77.12 -18.03 58.22 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.919 -1.113 . . . . 0.0 108.9 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.86 -47.89 19.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.15 -0.969 . . . . 0.0 109.116 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -67.01 -52.74 38.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 108.977 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.625 ' CG2' ' CZ ' ' A' ' 152' ' ' PHE . 31.4 m -95.19 31.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.367 -0.833 . . . . 0.0 109.078 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.536 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.595 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.404 0.621 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.56 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -78.12 77.93 4.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.427 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.649 ' CG ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -41.22 118.08 0.97 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.342 -0.849 . . . . 0.0 109.657 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -107.01 122.54 46.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.931 -1.105 . . . . 0.0 109.786 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.582 HG13 ' CZ ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -125.92 122.39 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 0.0 109.543 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' CD2' ' CD2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -122.11 145.24 48.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.27 -0.893 . . . . 0.0 108.89 179.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.556 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 4.0 m-85 -103.86 158.74 16.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.082 -1.011 . . . . 0.0 109.884 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.536 ' CG1' HG21 ' A' ' 46' ' ' VAL . 85.7 t -144.28 147.06 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.416 -0.803 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -160.38 141.46 12.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.534 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' CYS . 9.2 tp -44.49 -68.06 0.23 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.236 -0.915 . . . . 0.0 109.476 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.18 -79.95 0.08 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.479 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 2.0 t-20 65.85 39.19 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.125 -1.221 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 1.7 pp -143.75 13.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.601 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 40.9 t 177.21 -71.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.728 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 19' ' ' SER . 65.6 mtt85 -84.4 75.9 10.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.682 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.581 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 163.19 -50.99 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.697 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 19' ' ' SER . 51.3 Cg_exo -51.59 -19.63 7.71 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.865 1.71 . . . . 0.0 110.589 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.756 HG23 ' SG ' ' A' ' 145' ' ' CYS . 3.4 mt -75.64 -39.77 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.949 . . . . 0.0 109.81 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.786 ' HB2' ' SG ' ' A' ' 148' ' ' CYS . . . -62.99 -40.05 96.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.048 -1.033 . . . . 0.0 109.375 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -70.92 -59.22 2.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.908 . . . . 0.0 109.208 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.57 ' CB ' ' CG2' ' A' ' 68' ' ' ILE . . . -45.95 -34.38 3.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.9 . . . . 0.0 108.992 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.773 HG22 ' SG ' ' A' ' 145' ' ' CYS . 46.0 t -66.25 -47.52 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.35 -0.844 . . . . 0.0 109.284 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.604 ' CD1' HG12 ' A' ' 41' ' ' ILE . 1.9 t80 -47.98 -43.47 29.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.827 -1.171 . . . . 0.0 108.02 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -54.2 -62.86 1.38 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.067 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -79.92 10.76 3.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.271 -0.893 . . . . 0.0 110.221 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.766 HD21 ' SG ' ' A' ' 149' ' ' CYS . 48.7 tp -98.58 -34.68 10.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 108.911 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.602 HG13 ' CD1' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -90.86 -44.44 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.247 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -49.35 -29.1 5.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -0.916 . . . . 0.0 109.138 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -80.68 -37.1 31.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 108.993 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.531 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.5 OUTLIER -73.21 -11.0 60.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.413 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.2 OUTLIER 78.49 32.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.713 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.524 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 4.6 pt -123.21 3.77 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 109.431 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.593 ' CA ' ' CG2' ' A' ' 30' ' ' VAL . 60.7 p -62.87 -31.38 72.4 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.097 -1.002 . . . . 0.0 109.457 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -54.85 -25.17 26.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.45 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.56 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 0.9 OUTLIER -126.66 40.21 3.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.751 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.635 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 21.9 m95 -146.92 104.78 3.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.968 -1.083 . . . . 0.0 110.33 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 7' ' ' SER . 45.0 t -97.74 106.77 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.604 HG12 ' CD1' ' A' ' 26' ' ' PHE . 3.6 mp -107.37 146.58 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.066 -1.021 . . . . 0.0 110.501 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.52 ' N ' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -140.66 -164.93 1.83 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.792 . . . . 0.0 109.496 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.1 176.89 8.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.377 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -163.86 159.21 31.93 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 46' ' ' VAL . . . -129.78 -31.03 2.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -1.153 . . . . 0.0 109.72 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.536 HG21 ' CG1' ' A' ' 11' ' ' VAL . 3.8 t 74.76 6.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.438 ' HB2' ' CD2' ' A' ' 49' ' ' TRP . 5.5 p -126.5 126.63 44.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.433 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.5 2.59 15.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.577 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -102.27 1.46 35.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -0.997 . . . . 0.0 109.362 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -122.05 8.82 9.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.311 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.0 t -71.51 92.3 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.301 -0.874 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . 116.41 7.13 14.48 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -84.45 82.94 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -1.165 . . . . 0.0 109.45 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 73' ' ' LYS . 86.1 p -43.63 153.28 0.4 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 0.0 109.482 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 54' ' ' SER . 54.1 Cg_exo -49.98 -176.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.979 1.786 . . . . 0.0 110.258 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.18 139.08 36.47 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.393 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.417 ' O ' HG11 ' A' ' 60' ' ' VAL . 52.3 Cg_exo -51.03 -21.1 8.31 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.879 1.719 . . . . 0.0 110.369 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -87.94 -39.55 14.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.661 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.49 6.3 34.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 61' ' ' SER . 9.9 p -85.39 -38.25 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.421 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 4.2 m -76.55 -15.85 59.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.355 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.439 ' HB3' HD22 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -70.25 -29.43 66.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.846 . . . . 0.0 109.433 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -87.8 -55.32 3.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 108.902 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 -64.09 -10.51 22.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 109.563 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -59.06 -84.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.811 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.449 ' CE1' HG12 ' A' ' 68' ' ' ILE . 8.0 p80 -74.53 -24.91 59.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 109.773 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.458 ' O ' HG12 ' A' ' 68' ' ' ILE . . . 131.32 109.94 1.28 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.57 ' CG2' ' CB ' ' A' ' 24' ' ' ALA . 14.3 mm -150.16 -38.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -1.1 . . . . 0.0 109.603 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 68' ' ' ILE . 4.8 p30 51.63 173.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.81 . . . . 0.0 109.627 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 69' ' ' ASN . 20.5 p -157.43 -54.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 57.81 34.6 24.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.364 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -149.23 124.63 10.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 1.1 tppm? -98.21 27.36 4.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.902 . . . . 0.0 109.575 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 73' ' ' LYS . . . 73.91 131.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.527 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 74' ' ' ALA . 5.5 mmt180 -143.95 142.22 30.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.535 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 77' ' ' VAL . 2.2 tt0 -66.2 119.94 12.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 76' ' ' GLN . 4.1 t -45.43 170.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.485 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -153.78 175.9 12.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.445 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HG2' HG11 ' A' ' 106' ' ' VAL . 2.5 tmtt? -68.05 -45.03 75.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.624 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.459 ' O ' ' OG1' ' A' ' 84' ' ' THR . 37.3 tt0 -57.98 -44.86 87.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.543 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 1.3 m-20 -64.5 -30.35 71.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.801 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 78' ' ' THR . 12.5 m-85 -64.24 -67.01 0.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 109.755 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 84' ' ' THR . 6.0 p -64.08 -20.07 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.481 ' N ' HG11 ' A' ' 83' ' ' VAL . 6.0 m -69.96 -32.68 71.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.367 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 81' ' ' ASP . 27.4 m-85 -106.37 158.45 16.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.488 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' C ' ' CD1' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -108.87 -2.57 18.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.631 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.649 ' CE1' ' CG ' ' A' ' 6' ' ' LYS . 5.8 m-85 -138.42 139.85 39.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -150.78 116.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.233 -0.917 . . . . 0.0 109.288 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.581 HD13 ' CE2' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -129.53 153.98 47.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.315 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -122.72 169.83 10.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.36 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.447 ' O ' ' C ' ' A' ' 92' ' ' ASP . 6.3 mmt -81.06 74.1 8.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.33 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 94' ' ' SER . 0.1 OUTLIER 39.68 -101.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.778 . . . . 0.0 109.853 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 92' ' ' ASP . 45.9 mt-10 42.64 -96.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.072 -1.017 . . . . 0.0 109.262 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 96' ' ' LEU . 1.3 m -88.2 87.31 7.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 108.601 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -39.14 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.081 0.467 . . . . 0.0 110.773 -179.12 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 94' ' ' SER . 0.8 OUTLIER 32.72 36.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.119 0.485 . . . . 0.0 110.394 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 95' ' ' ASN . 7.3 ttt180 -91.21 -17.39 26.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.013 -1.054 . . . . 0.0 110.024 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.7 -51.01 2.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 0.0 110.046 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.476 ' HB3' HG23 ' A' ' 113' ' ' ILE . 11.4 mt -65.73 -18.38 65.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 109.807 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 7.7 t-20 -72.97 -22.91 60.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.969 . . . . 0.0 109.168 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -89.68 -23.41 21.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.285 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 10.9 mmmt -66.37 -30.12 70.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.343 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.0 p -72.87 -21.77 60.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.337 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -71.83 -35.21 69.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.296 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 1.2 pt20 -89.06 2.8 53.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 109.487 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 109' ' ' CYS . 70.8 t -92.99 122.49 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.189 -0.944 . . . . 0.0 109.299 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -56.48 102.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.274 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.431 ' O ' HG22 ' A' ' 83' ' ' VAL . 5.6 m120 52.48 59.22 4.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.146 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.549 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -54.25 156.96 2.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.4 -0.812 . . . . 0.0 109.803 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.549 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 3.1 mtt180 -123.94 -23.06 4.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.445 -0.785 . . . . 0.0 109.367 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.538 ' O ' ' CD1' ' A' ' 113' ' ' ILE . . . -70.55 92.41 0.84 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.377 -0.827 . . . . 0.0 110.278 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 101.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.552 ' CG2' ' CD2' ' A' ' 96' ' ' LEU . 1.8 mm -62.65 160.15 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.217 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 1.7 mt-10 173.82 -169.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.06 156.87 43.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.925 -1.109 . . . . 0.0 109.582 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.428 HD12 ' CA ' ' A' ' 148' ' ' CYS . 1.0 OUTLIER -59.09 -40.91 86.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -48.74 -28.62 7.21 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.79 -49.01 59.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -1.104 . . . . 0.0 109.503 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -86.32 -94.19 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.94 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.474 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 5.3 t70 67.13 67.4 0.61 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.497 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 51.9 Cg_exo -51.62 -173.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.962 1.775 . . . . 0.0 110.208 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 55.07 -92.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.379 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 121' ' ' PRO . 12.0 pttt -102.92 148.34 25.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.337 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -97.26 119.86 36.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -159.03 0.97 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.525 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 1.5 mm -127.92 -2.97 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 126' ' ' ILE . 39.9 mt 60.67 -89.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.145 -0.972 . . . . 0.0 109.265 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.525 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 4.2 mt-10 45.62 68.52 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.547 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.83 119.54 51.07 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.224 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.46 178.1 5.36 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.773 1.649 . . . . 0.0 110.325 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 3.9 m-85 -74.16 -1.31 19.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.649 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -92.01 74.11 5.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.383 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 132' ' ' TYR . . . -57.11 -159.97 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.4 -53.7 5.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -1.167 . . . . 0.0 109.389 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -170.89 101.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.25 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 48.75 30.12 2.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.111 -0.993 . . . . 0.0 109.156 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.87 76.43 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.45 -16.75 17.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.37 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.69 -27.33 27.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' VAL . 54.9 m -56.09 -54.63 42.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.454 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 18' ' ' ARG . 10.0 t -43.56 -55.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.262 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -48.51 -46.53 38.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -58.21 8.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.876 . . . . 0.0 109.798 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -67.68 -7.18 24.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -0.95 . . . . 0.0 109.419 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.773 ' SG ' HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -83.19 -28.56 29.21 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.306 -0.871 . . . . 0.0 109.361 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.531 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 40.3 t -65.35 -50.73 71.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.259 -0.9 . . . . 0.0 109.309 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.41 -19.19 62.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.084 -1.01 . . . . 0.0 108.831 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.786 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -52.34 -25.03 8.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.285 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.766 ' SG ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -112.45 -33.29 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -0.835 . . . . 0.0 109.856 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.516 ' N ' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -70.65 -56.84 5.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 109.307 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 154' ' ' GLU . . . -54.37 -21.97 11.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.545 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.581 ' CE1' HG22 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -90.32 -29.57 18.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 109.763 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.516 ' CD2' HD12 ' A' ' 35' ' ' ILE . 10.7 tp -75.48 -25.22 57.16 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.939 -1.101 . . . . 0.0 109.0 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -71.31 -32.66 68.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.907 . . . . 0.0 109.218 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.68 -43.45 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.184 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.591 ' HB ' ' CE2' ' A' ' 87' ' ' TYR . 17.1 m -101.34 25.69 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.393 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.5 ' O ' ' NE ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.407 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 1.7 p -120.89 160.82 22.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.654 ' CB ' ' CZ3' ' A' ' 39' ' ' TRP . 11.2 mttm -108.48 -168.42 1.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.25 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.48 ' HB2' ' HA ' ' A' ' 85' ' ' PHE . 3.1 p -140.43 105.37 4.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 109.44 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.572 HG11 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -122.86 143.11 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.412 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.582 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -140.6 115.34 9.58 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -92.04 157.59 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.076 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.522 ' CG1' HG21 ' A' ' 46' ' ' VAL . 16.8 t -140.35 142.16 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -0.785 . . . . 0.0 109.425 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.766 ' SG ' ' HA ' ' A' ' 15' ' ' ASN . 1.6 p -147.9 19.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.456 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 8.9 tp 63.64 -96.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 109.981 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 15' ' ' ASN . . . -47.33 -60.17 5.36 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.766 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . 5.3 t-20 66.8 14.76 9.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -1.162 . . . . 0.0 109.302 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.507 HD11 ' N ' ' A' ' 17' ' ' CYS . 2.6 pp -135.71 -37.95 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.438 -0.789 . . . . 0.0 108.959 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.507 ' N ' HD11 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -122.28 -24.05 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -56.84 -76.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 109.231 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.576 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 46.0 p 179.46 61.2 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.931 -1.106 . . . . 0.0 110.406 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.576 ' HD3' ' N ' ' A' ' 19' ' ' SER . 49.5 Cg_exo -56.12 -17.5 20.15 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.713 1.609 . . . . 0.0 110.052 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.572 HG22 ' CD2' ' A' ' 142' ' ' TYR . 10.8 mm -41.6 -38.52 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.52 -0.737 . . . . 0.0 110.264 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.831 ' CA ' ' SG ' ' A' ' 148' ' ' CYS . . . -53.96 -51.39 64.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.042 . . . . 0.0 109.679 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -66.36 -56.77 9.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.011 . . . . 0.0 109.356 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 68' ' ' ILE . . . -46.7 -25.08 0.65 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.958 . . . . 0.0 109.074 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.765 HG13 ' SG ' ' A' ' 149' ' ' CYS . 84.6 t -78.36 -43.32 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.264 -0.898 . . . . 0.0 109.36 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.573 ' CG ' ' HB2' ' A' ' 149' ' ' CYS . 0.2 OUTLIER -57.51 -21.44 37.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -78.52 -58.57 3.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 28' ' ' LYS . 10.0 tmtt? -75.89 2.77 11.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.356 -0.84 . . . . 0.0 109.225 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.763 HD21 ' SG ' ' A' ' 149' ' ' CYS . 34.2 tp -102.78 -37.17 7.99 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 36' ' ' SER . 9.8 p -90.82 -4.87 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 8.6 m -106.2 11.46 31.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.728 -1.233 . . . . 0.0 109.401 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -127.6 53.83 1.73 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 109.138 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.536 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.6 OUTLIER 175.56 31.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.486 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 33' ' ' GLN . 2.8 t-20 46.18 37.06 3.6 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.536 ' CG2' ' HB3' ' A' ' 33' ' ' GLN . 2.0 tt -121.17 -4.6 9.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.693 -177.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -73.49 -53.26 11.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.058 -1.026 . . . . 0.0 110.506 -178.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 25.7 p-10 -56.93 -14.47 3.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.198 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.529 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 69.6 m-20 -109.12 36.62 2.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.924 -1.11 . . . . 0.0 110.464 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.654 ' CZ3' ' CB ' ' A' ' 6' ' ' LYS . 17.8 m95 -150.95 136.9 18.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.486 -1.384 . . . . 0.0 111.516 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.97 74.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.524 ' CG1' HG12 ' A' ' 8' ' ' VAL . 3.1 mt -90.11 144.5 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.456 -0.777 . . . . 0.0 109.934 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.7 OUTLIER -142.31 -173.97 3.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 109.22 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.5 p -126.26 160.92 28.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.765 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -141.43 137.45 8.08 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.469 ' HB2' ' OD1' ' A' ' 50' ' ' ASN . . . -118.01 -9.29 10.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -1.194 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.522 HG21 ' CG1' ' A' ' 11' ' ' VAL . 2.5 t 55.05 21.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.2 t -160.42 160.01 31.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.524 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.462 ' HA ' HG22 ' A' ' 51' ' ' VAL . 10.7 p-10 -105.5 11.68 32.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.536 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -88.04 11.13 16.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.543 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.51 ' HA ' ' CD ' ' A' ' 53' ' ' ARG . 3.4 p-10 -144.89 13.91 1.5 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 76' ' ' GLN . 67.2 t -65.16 112.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 109.249 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.37 22.53 58.54 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' CD ' ' HA ' ' A' ' 50' ' ' ASN . 39.0 mtp180 -106.25 85.12 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.519 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' ARG . 2.5 p -46.36 162.22 0.26 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.281 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 56' ' ' ASP . 52.6 Cg_exo -50.51 140.65 35.34 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.897 1.731 . . . . 0.0 110.142 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.468 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 6.2 m-20 -43.75 166.08 0.11 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.466 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' A' ' 56' ' ' ASP . 49.7 Cg_endo -70.91 -7.2 20.88 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.987 1.791 . . . . 0.0 110.193 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -90.19 -40.5 12.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.9 . . . . 0.0 109.365 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.462 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -89.6 -16.88 29.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.423 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -57.25 -27.81 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.92 . . . . 0.0 109.548 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -79.97 -48.82 12.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.408 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.533 ' SG ' ' CD2' ' A' ' 142' ' ' TYR . 6.3 t -45.76 -30.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.23 -45.1 9.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.935 . . . . 0.0 109.104 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.63 19.94 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.67 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 61' ' ' SER . 15.1 t-20 -91.35 -53.54 4.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.361 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.525 ' CE1' ' OH ' ' A' ' 142' ' ' TYR . 9.5 p80 -102.98 -31.79 10.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.21 109.9 1.29 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.519 HG12 ' CB ' ' A' ' 24' ' ' ALA . 8.5 tp -120.98 -26.83 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -1.163 . . . . 0.0 109.428 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 1.3 m120 76.13 41.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.413 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 70' ' ' THR . 5.2 t -63.38 110.64 1.99 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.88 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.0 -23.55 5.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.469 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 22.7 t60 -84.74 132.76 34.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.295 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.469 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -95.91 154.17 17.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 109.542 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 50' ' ' ASN . . . -46.6 169.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HG3' ' N ' ' A' ' 76' ' ' GLN . 0.6 OUTLIER -169.16 161.48 10.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 109.484 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.526 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -96.61 128.77 43.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.528 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.9 t -65.74 135.85 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 109.357 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -138.62 165.28 27.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.873 . . . . 0.0 109.505 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HG2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -44.09 -39.1 4.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.477 ' O ' ' OG1' ' A' ' 84' ' ' THR . 28.3 tt0 -54.19 -53.28 55.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.885 . . . . 0.0 109.546 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.483 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 2.7 m-20 -50.92 -46.89 61.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.37 -0.831 . . . . 0.0 110.125 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.482 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 77.6 m-85 -51.05 -63.11 1.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.535 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 2.3 p -73.62 -4.04 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -0.861 . . . . 0.0 110.021 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 14.3 m -81.3 -65.45 1.01 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 50.2 m-85 -87.11 173.68 9.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.892 . . . . 0.0 110.001 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.565 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -116.9 -15.22 10.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.724 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 86' ' ' ASP . 1.6 m-85 -123.0 74.56 1.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.068 -1.02 . . . . 0.0 109.659 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.554 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 2.6 mt -85.22 94.04 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.52 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -105.58 -179.82 4.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.958 -1.089 . . . . 0.0 109.467 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.73 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -142.94 172.69 12.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.52 ' CE ' ' HA ' ' A' ' 91' ' ' MET . 30.9 mmt -67.52 -7.77 28.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 109.669 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 115' ' ' LEU . 5.7 p30 174.05 -176.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.0 . . . . 0.0 109.406 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -83.44 -7.58 59.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.78 -49.97 70.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.578 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -83.68 9.98 10.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.501 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.73 ' HG ' ' SG ' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -100.17 16.49 24.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.0 ttt-85 -84.87 -22.63 29.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.503 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 102' ' ' LYS . 0.9 OUTLIER -107.07 -32.64 7.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.466 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.474 HD21 ' CZ ' ' A' ' 82' ' ' PHE . 24.5 mt -73.57 -36.01 65.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 5.5 t30 -66.17 -35.09 79.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.324 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -89.84 0.09 57.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.374 -0.829 . . . . 0.0 109.457 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 98' ' ' ASP . 0.7 OUTLIER -92.18 -22.33 19.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.478 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m -70.42 -12.61 61.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 0.0 109.41 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -86.27 -30.83 22.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -92.44 -10.36 38.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 109.348 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 109' ' ' CYS . 39.0 t -71.76 140.13 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -75.13 117.1 16.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.231 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.418 ' O ' HG22 ' A' ' 83' ' ' VAL . 2.5 m-80 48.28 46.38 20.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.539 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.11 150.88 2.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.96 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 5.8 ptm180 -140.58 9.9 2.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.467 -0.771 . . . . 0.0 109.111 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.554 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -98.39 116.07 29.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 110.321 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -70.57 124.22 23.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -99.1 114.95 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.795 -1.191 . . . . 0.0 110.498 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 20.7 mt-10 -147.51 -177.5 5.73 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 126' ' ' ILE . 0.4 OUTLIER -126.07 153.7 44.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.97 -1.081 . . . . 0.0 109.746 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.533 ' CD2' ' HA ' ' A' ' 148' ' ' CYS . 0.3 OUTLIER -43.47 104.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.373 -0.83 . . . . 0.0 109.521 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.38 157.17 16.45 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 m -65.06 93.75 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -1.133 . . . . 0.0 109.375 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -77.14 -93.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.598 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 1.1 m-20 -71.81 -62.27 1.7 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.054 -1.029 . . . . 0.0 109.789 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 55.5 Cg_endo -72.05 126.16 11.58 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.795 1.663 . . . . 0.0 110.256 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -105.13 111.99 24.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -150.56 158.12 43.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.551 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -88.42 98.44 11.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 176.57 108.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.534 ' O ' ' CG2' ' A' ' 127' ' ' ILE . 1.8 tt -121.23 28.16 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 126' ' ' ILE . 20.0 tt 41.28 41.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.402 -0.811 . . . . 0.0 109.838 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.513 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 1.3 mt-10 -87.48 51.23 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 109.423 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.56 104.34 55.35 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.928 . . . . 0.0 109.42 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -49.4 169.83 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.8 1.667 . . . . 0.0 110.228 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.412 ' C ' ' CD1' ' A' ' 131' ' ' TYR . 3.0 t80 -84.79 106.09 16.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.55 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -146.4 -64.71 0.3 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 135.56 114.74 1.41 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -154.5 -49.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -1.1 . . . . 0.0 109.518 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.72 -19.6 20.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 56.65 24.6 9.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.509 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -127.99 87.89 2.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.453 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 29.0 p90 -71.48 -10.36 59.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.5 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -62.88 -34.84 78.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.412 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 0.2 OUTLIER -63.54 -25.78 68.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.309 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 19' ' ' SER . 27.7 t -79.1 -31.11 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.312 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.572 ' CD2' HG22 ' A' ' 21' ' ' ILE . 6.1 t80 -69.18 -50.92 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.567 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -65.41 -41.6 93.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.952 . . . . 0.0 109.514 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 140' ' ' THR . 0.8 OUTLIER -68.87 -14.37 62.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.51 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 4.6 m -89.94 -8.6 51.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 25' ' ' VAL . 46.2 t -62.57 -68.73 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.713 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.498 ' HB3' ' CB ' ' A' ' 151' ' ' ALA . 0.7 OUTLIER -58.94 -15.61 13.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.824 -1.173 . . . . 0.0 109.157 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' CYS . . . . . 0.831 ' SG ' ' CA ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -44.26 -32.97 1.43 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.202 -0.936 . . . . 0.0 108.582 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . 0.765 ' SG ' HG13 ' A' ' 25' ' ' VAL . 1.6 p -115.09 -24.38 8.58 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.535 ' N ' ' CD2' ' A' ' 29' ' ' LEU . 9.5 ttt-85 -76.55 -60.98 2.11 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.498 ' CB ' ' HB3' ' A' ' 147' ' ' ARG . . . -49.67 -36.51 25.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.441 -0.787 . . . . 0.0 109.149 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.431 ' CE2' HG22 ' A' ' 156' ' ' VAL . 17.0 t80 -77.9 -31.64 51.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.532 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.482 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 11.7 tp -67.9 -13.18 61.95 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.166 -0.959 . . . . 0.0 108.815 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 1.8 mt-10 -76.9 -53.41 7.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.898 . . . . 0.0 109.122 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -47.61 84.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.962 . . . . 0.0 109.117 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.484 ' O ' ' HD2' ' A' ' 6' ' ' LYS . 14.1 m -97.64 25.6 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 109.083 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.482 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.548 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -98.7 113.55 25.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.467 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -67.33 172.57 4.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.69 150.16 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.564 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.547 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -84.95 71.0 10.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.877 . . . . 0.0 109.442 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 9.3 ttmt -41.93 162.94 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.157 -0.964 . . . . 0.0 109.573 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 m -139.16 135.96 34.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 0.0 109.912 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.579 HG13 ' CZ ' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -141.7 155.53 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 108.927 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.603 ' CD1' ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -150.11 115.98 5.61 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 109.064 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.0 m-85 -86.8 151.56 23.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.512 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.518 ' HB ' ' CD1' ' A' ' 99' ' ' LEU . 5.4 t -143.82 157.92 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.59 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER 173.08 128.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -44.91 150.09 0.4 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.181 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.03 88.27 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 15' ' ' ASN . 25.6 t-20 -85.5 15.19 4.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -1.14 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 2.0 pp -119.22 131.79 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.613 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.78 ' SG ' ' CZ ' ' A' ' 138' ' ' PHE . 34.8 t 66.8 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.71 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.529 ' CG ' HG12 ' A' ' 141' ' ' VAL . 0.3 OUTLIER 43.11 78.63 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.681 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER 163.63 -61.48 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 0.0 109.94 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 19' ' ' SER . 52.1 Cg_endo -71.16 -1.25 9.28 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.85 1.7 . . . . 0.0 110.848 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.682 ' HB ' ' SG ' ' A' ' 145' ' ' CYS . 3.8 mm -74.6 -48.12 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.985 -1.072 . . . . 0.0 109.575 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.632 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -57.35 -27.85 62.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.551 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -73.27 -71.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -0.954 . . . . 0.0 109.318 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 68' ' ' ILE . . . -44.89 -26.97 0.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 108.887 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.822 ' CG1' ' SG ' ' A' ' 149' ' ' CYS . 72.2 t -70.23 -54.36 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.404 -0.81 . . . . 0.0 109.214 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.682 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 2.1 t80 -45.57 -35.78 4.21 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.461 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.3 OUTLIER -63.8 -57.66 9.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.425 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -55.97 -21.15 19.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.857 . . . . 0.0 109.652 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.768 HD13 ' SG ' ' A' ' 149' ' ' CYS . 39.7 mt -85.62 -30.79 22.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.212 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 36' ' ' SER . 2.9 p -90.67 -6.23 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.407 -0.808 . . . . 0.0 109.348 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -105.14 5.91 32.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.033 -1.042 . . . . 0.0 109.848 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 4.4 t0 -128.02 59.74 1.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 109.133 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HB3' HG23 ' A' ' 35' ' ' ILE . 1.0 OUTLIER 171.28 31.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.831 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.4 t-20 45.11 32.01 0.84 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 33' ' ' GLN . 2.7 tt -112.79 -7.31 11.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.687 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -73.11 -25.06 60.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.658 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -84.47 16.26 3.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 0.0 109.778 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.547 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 8.6 m-80 -144.46 36.13 1.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.481 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.623 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 22.1 m95 -150.18 150.39 31.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.986 -1.071 . . . . 0.0 111.029 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.5 t -128.31 70.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.582 HG12 ' CE1' ' A' ' 26' ' ' PHE . 2.4 mp -89.56 140.22 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.398 -0.814 . . . . 0.0 110.626 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -146.25 171.58 14.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.507 -0.745 . . . . 0.0 109.268 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.8 p -105.1 162.38 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.975 . . . . 0.0 109.614 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.559 ' CA ' ' CG2' ' A' ' 77' ' ' VAL . . . -143.05 122.76 1.97 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.531 ' O ' ' CG1' ' A' ' 46' ' ' VAL . . . -87.08 -41.26 13.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.142 -1.21 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER 80.25 -5.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.795 . . . . 0.0 109.436 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 76' ' ' GLN . 0.4 OUTLIER -126.49 179.61 5.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 109.371 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.507 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 19.3 t70 -120.38 7.87 10.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -91.55 -32.98 15.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.327 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -101.85 31.16 3.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 73.9 t -76.31 96.79 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.19 57.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -79.37 86.64 5.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -1.161 . . . . 0.0 109.555 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 53' ' ' ARG . 4.0 m -45.42 159.6 0.28 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.873 . . . . 0.0 109.369 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.45 152.41 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.98 1.787 . . . . 0.0 110.255 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.19 152.36 96.55 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.531 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 51.6 Cg_exo -51.22 -19.97 7.16 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.021 1.814 . . . . 0.0 110.475 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.409 ' O ' ' SG ' ' A' ' 62' ' ' CYS . 2.7 mtp180 -81.89 -47.78 12.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -0.961 . . . . 0.0 109.796 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.86 4.58 49.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.946 . . . . 0.0 109.807 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 6.8 p -89.93 -43.92 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.043 -1.036 . . . . 0.0 109.628 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.509 ' N ' HG12 ' A' ' 60' ' ' VAL . 3.8 p -76.82 -17.85 58.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.95 . . . . 0.0 109.521 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 58' ' ' ARG . 79.7 m -78.26 -62.29 1.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.523 ' CG ' HG23 ' A' ' 68' ' ' ILE . 1.0 OUTLIER -60.69 -27.99 68.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.567 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.2 ttp85 -96.94 33.37 1.91 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.649 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 61' ' ' SER . 9.1 t-20 -131.5 -43.07 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.345 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.86 -22.15 34.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.36 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 28' ' ' LYS . . . 113.16 83.33 1.22 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.523 HG23 ' CG ' ' A' ' 63' ' ' LEU . 1.3 tp -122.22 -24.5 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -1.16 . . . . 0.0 109.656 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 9.3 m-80 63.52 98.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.557 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.404 ' HB ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -124.23 91.39 3.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.77 53.55 1.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.58 ' CD2' ' N ' ' A' ' 73' ' ' LYS . 20.6 t60 -143.94 155.87 44.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.447 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.58 ' N ' ' CD2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -104.75 130.75 52.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 75' ' ' ARG . . . -43.99 -69.9 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.601 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 61.06 158.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.373 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 47' ' ' SER . 22.6 tt0 -88.39 123.78 33.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.442 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.559 ' CG2' ' CA ' ' A' ' 44' ' ' GLY . 21.3 t -47.56 151.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.86 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.477 ' N ' HG11 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -141.09 165.17 28.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.663 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' CG ' HG11 ' A' ' 106' ' ' VAL . 3.2 tmtt? -43.18 -41.67 3.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 109.495 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 84' ' ' THR . 24.4 tp10 -56.08 -48.37 76.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 109.553 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.487 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 1.2 m-20 -62.32 -34.02 75.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.77 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.688 ' HB3' ' SG ' ' A' ' 109' ' ' CYS . 79.3 m-85 -65.65 -79.07 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 110.163 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.521 ' CG1' ' N ' ' A' ' 84' ' ' THR . 7.3 p -48.13 -46.94 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.07 -1.019 . . . . 0.0 109.256 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.521 ' N ' ' CG1' ' A' ' 83' ' ' VAL . 16.4 m -45.85 -82.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.335 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.603 ' CE2' ' CD1' ' A' ' 9' ' ' LEU . 21.0 m-85 -57.13 166.5 1.07 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.317 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.33 -25.62 5.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.58 ' CE2' ' HG2' ' A' ' 6' ' ' LYS . 6.3 m-30 -109.38 72.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.107 -0.996 . . . . 0.0 109.852 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 1.3 mt -82.82 96.57 3.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.428 -0.795 . . . . 0.0 109.62 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.472 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -109.85 179.97 3.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.019 -1.051 . . . . 0.0 108.91 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -147.58 172.49 13.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.13 -0.982 . . . . 0.0 109.689 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.433 ' HE3' ' CD1' ' A' ' 116' ' ' LEU . 31.5 mmt -85.46 46.59 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.362 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' SER . 10.1 t70 56.93 -93.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.568 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 94' ' ' SER . 27.4 tt0 43.53 -94.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.305 -0.872 . . . . 0.0 109.338 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.6 ' O ' ' N ' ' A' ' 96' ' ' LEU . 4.6 p -85.67 88.2 7.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.09 -1.006 . . . . 0.0 108.71 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 96' ' ' LEU . 25.5 p-10 -31.94 85.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.091 0.472 . . . . 0.0 111.195 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' SER . 4.1 mt 29.48 56.98 0.15 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.244 0.545 . . . . 0.0 110.747 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -91.35 -50.96 5.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.082 -1.011 . . . . 0.0 109.65 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -92.77 -64.13 1.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.928 . . . . 0.0 109.653 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.518 ' CD1' ' HB ' ' A' ' 11' ' ' VAL . 17.3 mt -44.02 -40.11 4.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.217 -0.927 . . . . 0.0 109.668 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.504 ' OD1' ' CD1' ' A' ' 96' ' ' LEU . 3.2 t30 -61.59 -49.31 77.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -0.98 . . . . 0.0 109.182 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.83 14.6 11.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 108.918 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -86.25 -40.41 15.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.479 -0.763 . . . . 0.0 109.356 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.593 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 1.3 p -65.86 -11.79 49.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.42 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.4 -36.82 68.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -99.19 8.6 44.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.663 HG22 ' SG ' ' A' ' 109' ' ' CYS . 46.7 t -83.54 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.367 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 108' ' ' ASN . 12.1 tptp -62.53 88.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 108.832 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 107' ' ' LYS . 9.2 t30 73.99 71.06 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 108.932 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -85.01 143.72 28.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.315 -0.866 . . . . 0.0 109.901 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.476 ' O ' ' CG ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -143.82 13.58 1.7 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 108.985 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.539 ' CB ' HG13 ' A' ' 88' ' ' ILE . . . -89.85 97.22 11.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.965 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' ALA . 15.0 mttt -46.66 123.63 5.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 1.1 mm -99.36 139.59 20.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.875 -1.141 . . . . 0.0 110.372 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -167.11 -177.43 3.73 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' N ' ' CD2' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -134.0 145.73 49.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.009 -1.057 . . . . 0.0 109.642 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.634 HD23 ' SG ' ' A' ' 148' ' ' CYS . 0.0 OUTLIER -43.24 152.54 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.328 -0.858 . . . . 0.0 109.448 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -158.43 -143.76 3.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 123' ' ' LYS . 2.0 p -87.24 109.19 19.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.166 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 151' ' ' ALA . 15.9 m-85 -112.27 -81.96 0.59 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.41 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.582 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -61.56 -61.47 7.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.654 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 52.3 Cg_endo -71.78 -161.68 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.77 1.647 . . . . 0.0 110.209 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -144.35 36.61 1.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 118' ' ' SER . 12.2 ptpt -111.49 159.07 18.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.242 -0.911 . . . . 0.0 109.566 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.7 81.87 7.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.49 112.79 25.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 109.386 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.5 ' CG2' ' CG ' ' A' ' 92' ' ' ASP . 6.6 mm -124.8 152.35 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.314 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.425 ' C ' ' OD2' ' A' ' 92' ' ' ASP . 2.9 mm -92.25 64.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.155 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.474 ' HG3' HG23 ' A' ' 126' ' ' ILE . 3.0 mt-10 -85.55 46.75 1.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.668 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -127.24 144.79 51.89 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.68 -42.9 1.52 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.876 1.717 . . . . 0.0 110.218 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.96 178.4 4.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.379 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -124.98 12.65 8.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 109.458 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 96.51 -115.7 5.27 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.74 -48.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -1.154 . . . . 0.0 109.335 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 135' ' ' ASP . 0.9 OUTLIER -102.26 159.71 15.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 135' ' ' ASP . . . 74.18 5.92 4.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.534 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -177.42 120.88 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.78 ' CZ ' ' SG ' ' A' ' 17' ' ' CYS . 2.0 t80 -170.85 -50.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.323 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 140' ' ' THR . 2.5 pt-20 -66.66 -28.61 68.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.411 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.417 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 32.4 m -62.18 -43.93 97.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.387 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.529 HG12 ' CG ' ' A' ' 18' ' ' ARG . 39.2 t -61.59 -57.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.234 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.591 ' CD2' HG22 ' A' ' 21' ' ' ILE . 1.4 t80 -46.52 -38.22 9.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 0.0 109.131 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.86 -39.27 79.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.737 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -68.66 -13.13 62.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.682 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.3 m -88.15 -12.56 43.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.476 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 95.8 t -58.54 -60.41 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.299 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.442 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -74.4 -18.49 60.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.897 . . . . 0.0 109.377 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.634 ' SG ' HD23 ' A' ' 116' ' ' LEU . 1.2 m -46.72 -32.21 3.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.151 -0.968 . . . . 0.0 109.184 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.822 ' SG ' ' CG1' ' A' ' 25' ' ' VAL . 1.0 OUTLIER -114.07 -30.01 6.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 109.175 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.53 ' CA ' HD11 ' A' ' 29' ' ' LEU . 18.2 ttt180 -75.22 -57.72 3.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 0.0 109.109 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 147' ' ' ARG . . . -51.77 -31.53 27.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.349 -0.844 . . . . 0.0 109.199 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.583 ' CE1' HG22 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -83.39 -29.36 28.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.813 . . . . 0.0 109.343 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.98 -18.11 65.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.067 -1.021 . . . . 0.0 108.666 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 3.7 mm-40 -70.09 -45.43 66.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.024 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -46.38 81.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.284 -0.885 . . . . 0.0 108.953 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.583 HG22 ' CE1' ' A' ' 152' ' ' PHE . 6.4 m -95.3 25.17 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.084 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 1.1 tmm_? . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.557 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.91 30.31 5.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.421 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 67.18 170.8 0.26 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 5' ' ' THR . 14.5 t -88.21 143.55 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.361 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -149.43 71.94 1.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.605 ' HB3' ' CH2' ' A' ' 39' ' ' TRP . 0.3 OUTLIER -42.28 166.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.151 -0.968 . . . . 0.0 110.304 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 85' ' ' PHE . 33.4 t -143.75 127.22 16.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.512 -0.742 . . . . 0.0 109.147 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.608 ' CG1' ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -131.09 153.25 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 108.904 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.582 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -146.21 123.52 11.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.445 -0.784 . . . . 0.0 108.997 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.2 m-85 -95.2 165.99 12.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.995 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 46' ' ' VAL . 2.0 t -147.38 149.11 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.349 -0.844 . . . . 0.0 109.644 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER 177.13 114.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 tp -46.74 156.94 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.0 109.405 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.35 49.55 75.14 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.461 ' OD1' ' HG3' ' A' ' 20' ' ' PRO . 43.4 t30 -74.29 82.09 1.86 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.133 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.446 HD11 ' HB3' ' A' ' 17' ' ' CYS . 1.2 pp -152.55 -52.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.712 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.692 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -134.61 34.73 3.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.641 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -171.37 60.07 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 109.372 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.737 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 163.59 -51.68 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 109.599 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 19' ' ' SER . 54.1 Cg_exo -49.29 -21.27 4.41 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.839 1.692 . . . . 0.0 110.455 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.579 HG22 ' CD2' ' A' ' 142' ' ' TYR . 18.5 mm -58.97 -51.28 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.165 -0.96 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.757 ' HB3' ' SG ' ' A' ' 145' ' ' CYS . . . -59.99 -16.97 34.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.136 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' OE1' ' CA ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -81.92 -72.81 0.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.221 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.525 ' HB3' ' CG2' ' A' ' 70' ' ' THR . . . -43.49 -39.18 3.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.001 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.759 HG13 ' SG ' ' A' ' 149' ' ' CYS . 47.2 t -60.83 -58.34 7.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.448 -0.782 . . . . 0.0 108.97 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.581 ' CD1' HG12 ' A' ' 41' ' ' ILE . 2.6 t80 -43.3 -29.12 0.38 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.928 . . . . 0.0 108.615 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.482 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -65.93 -62.2 1.63 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.331 -0.855 . . . . 0.0 109.226 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.08 -43.33 63.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 0.0 109.71 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.762 HD13 ' SG ' ' A' ' 149' ' ' CYS . 25.3 mt -60.39 -36.8 78.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.57 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.4 p -90.03 -4.52 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.504 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 1.4 m -107.21 12.51 28.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.848 -1.158 . . . . 0.0 109.689 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 6.9 t0 -131.84 56.14 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.132 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.526 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.7 OUTLIER 173.56 31.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 109.627 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.1 t30 45.71 36.88 2.93 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.553 HG12 ' CG2' ' A' ' 30' ' ' VAL . 2.1 tt -119.54 -7.37 11.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.959 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -74.64 -37.2 62.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 109.992 -179.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.02 1.01 11.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 110.027 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.532 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 6.8 m-20 -127.18 42.14 3.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.096 -1.003 . . . . 0.0 109.838 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.608 ' CZ3' ' CG1' ' A' ' 8' ' ' VAL . 9.4 m95 -150.23 157.3 42.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.899 -1.126 . . . . 0.0 110.819 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG13 ' CE1' ' A' ' 85' ' ' PHE . 96.5 t -133.06 71.9 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.581 HG12 ' CD1' ' A' ' 26' ' ' PHE . 2.7 mp -89.65 137.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.413 -0.804 . . . . 0.0 110.13 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 3.7 t70 -143.33 -177.21 5.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.449 -0.782 . . . . 0.0 109.312 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.469 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 95.6 p -119.54 163.6 17.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.164 -0.96 . . . . 0.0 109.688 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -142.15 134.43 6.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.42 -12.41 11.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -1.227 . . . . 0.0 109.557 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.587 ' CG2' ' CG1' ' A' ' 11' ' ' VAL . 1.8 t 56.24 17.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.53 ' HB2' ' CE2' ' A' ' 49' ' ' TRP . 1.1 p -151.24 169.82 20.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.529 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 4.5 m-20 -116.8 22.19 12.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.437 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.589 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -95.23 -24.97 16.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 109.24 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -108.88 9.62 26.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.838 . . . . 0.0 109.516 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.529 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 74.3 t -65.17 90.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.76 29.08 4.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -105.32 95.13 5.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -1.158 . . . . 0.0 109.472 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -43.99 162.49 0.19 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.462 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.64 148.86 54.08 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.958 1.772 . . . . 0.0 110.134 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 5.9 t70 -50.75 139.56 21.36 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.272 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' O ' HG11 ' A' ' 60' ' ' VAL . 50.4 Cg_exo -51.93 -18.86 7.42 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.845 1.696 . . . . 0.0 110.439 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.478 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . 8.9 mtm180 -81.96 -39.25 23.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.097 -1.002 . . . . 0.0 109.675 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.38 -1.62 57.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.94 . . . . 0.0 109.842 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.517 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 5.7 p -89.6 -39.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.05 -1.032 . . . . 0.0 109.651 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.449 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -88.46 -8.87 54.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -89.24 -64.44 1.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.646 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.553 ' HA ' ' CE2' ' A' ' 142' ' ' TYR . 1.6 pt? -43.34 -30.64 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.671 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 60' ' ' VAL . 3.5 ptp180 -93.16 41.84 1.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.852 . . . . 0.0 109.468 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -133.48 -43.95 0.83 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.382 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -83.17 -34.17 26.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.18 95.29 0.2 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.456 HG22 ' HB2' ' A' ' 24' ' ' ALA . 17.3 mm -146.08 -75.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -1.152 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 10.5 m-80 65.53 99.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.525 ' CG2' ' HB3' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -130.05 166.48 20.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.484 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -155.04 54.05 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.49 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.561 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.5 p-80 -122.71 170.61 9.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.02 154.48 37.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.554 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.99 122.7 28.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.405 ' HD2' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -129.74 172.36 11.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.417 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 47' ' ' SER . 1.1 tt0 -92.13 122.32 34.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.407 HG21 ' CB ' ' A' ' 81' ' ' ASP . 8.9 p -48.9 145.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.407 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 p -132.83 168.3 18.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.215 -0.928 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HG2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -51.03 -41.37 59.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 109.255 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -59.41 -38.28 80.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.56 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.407 ' CB ' HG21 ' A' ' 77' ' ' VAL . 1.9 m-20 -59.08 -41.09 87.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -0.919 . . . . 0.0 109.978 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.528 ' CE2' ' HE2' ' A' ' 102' ' ' LYS . 81.1 m-85 -64.47 -62.36 1.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.797 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.528 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 3.8 p -65.76 -10.35 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.687 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.517 ' CB ' ' O ' ' A' ' 80' ' ' GLU . 3.4 m -87.97 -85.09 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.368 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.582 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 59.1 m-85 -56.33 109.04 0.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.526 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.404 ' C ' ' CD1' ' A' ' 87' ' ' TYR . 1.3 t0 -58.29 -20.87 46.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.596 ' CE2' ' HG2' ' A' ' 6' ' ' LYS . 6.6 m-30 -113.31 137.42 51.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.534 ' CG1' ' HB2' ' A' ' 111' ' ' ALA . 1.0 OUTLIER -145.45 104.24 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 108.652 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -120.74 156.65 31.37 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.906 -1.121 . . . . 0.0 109.744 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 115' ' ' LEU . 2.4 p -121.26 166.15 14.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.517 -0.739 . . . . 0.0 109.424 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.418 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 0.1 OUTLIER -75.62 -62.56 1.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.719 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 93' ' ' GLU . 11.5 p-10 -178.62 -138.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.398 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 74.4 mt-10 63.12 -88.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.058 -1.026 . . . . 0.0 109.487 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -85.01 85.75 7.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 0.0 109.069 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.482 ' ND2' HD23 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -51.21 86.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.684 -0.635 . . . . 0.0 110.083 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.526 HD22 ' CG2' ' A' ' 113' ' ' ILE . 0.4 OUTLIER 37.33 40.3 0.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.729 -0.607 . . . . 0.0 110.196 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -90.51 -50.14 6.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.045 -1.035 . . . . 0.0 109.479 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.6 -45.03 12.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.496 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.471 ' HB3' HG22 ' A' ' 113' ' ' ILE . 13.4 mt -62.58 -34.75 77.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.575 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.49 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 21.8 t-20 -62.17 -31.63 72.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -89.69 -11.4 42.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 109.424 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.528 ' HE2' ' CE2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -74.93 -27.13 60.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.33 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.633 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 0.9 OUTLIER -73.8 -20.62 60.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.892 . . . . 0.0 109.339 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.63 -49.9 42.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.256 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -70.48 -19.39 62.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 109.253 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 109' ' ' CYS . 54.6 t -67.08 125.03 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.376 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -66.47 100.55 0.67 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.333 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.87 50.35 1.99 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -53.62 150.9 6.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.263 -0.898 . . . . 0.0 109.838 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 12.0 ptt180 -138.53 7.22 2.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.339 -0.85 . . . . 0.0 109.153 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.534 ' HB2' ' CG1' ' A' ' 88' ' ' ILE . . . -88.03 120.38 29.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.178 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -70.51 132.68 45.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -109.16 133.09 55.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.777 -1.202 . . . . 0.0 110.402 -179.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.8 OUTLIER -178.47 139.21 0.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.482 HD23 ' ND2' ' A' ' 95' ' ' ASN . 0.3 OUTLIER -84.72 167.34 16.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.594 -1.316 . . . . 0.0 109.95 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.768 ' HG ' ' SG ' ' A' ' 148' ' ' CYS . 3.1 mm? -40.59 -44.23 2.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.752 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 54.44 -123.4 27.94 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -131.07 122.68 27.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 109.341 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.533 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.7 m-85 -127.83 3.42 6.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 0.0 109.634 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.587 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 162.58 -51.26 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.3 Cg_exo -49.72 140.43 29.67 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.794 1.663 . . . . 0.0 110.111 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -108.14 112.89 25.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.67 149.37 2.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.356 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 52.29 2.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.364 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.97 131.71 4.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.381 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -105.3 41.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.972 . . . . 0.0 109.165 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 126' ' ' ILE . 14.7 mt 71.44 19.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.98 . . . . 0.0 109.51 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.466 ' HG3' HG21 ' A' ' 126' ' ' ILE . 30.5 mt-10 -62.18 90.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.432 ' HB3' ' NH2' ' A' ' 18' ' ' ARG . 9.8 t70 -145.32 102.39 4.36 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.195 -0.941 . . . . 0.0 109.401 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -49.26 139.86 27.18 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.868 1.712 . . . . 0.0 110.308 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER 51.91 -161.72 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.479 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 131' ' ' TYR . 8.4 p90 -94.88 30.24 2.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 132' ' ' TYR . . . 43.63 -131.97 6.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -179.71 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -1.187 . . . . 0.0 109.475 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -78.09 123.48 26.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 135' ' ' ASP . . . 44.35 29.51 0.38 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.09 35.18 3.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.877 . . . . 0.0 109.459 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 58' ' ' ARG . 5.0 t80 -133.24 -55.56 0.91 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.12 -44.53 68.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.0 109.388 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.7 m -60.52 -36.8 79.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.37 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.87 -53.54 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.324 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.579 ' CD2' HG22 ' A' ' 21' ' ' ILE . 2.4 t80 -59.56 -24.27 63.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.553 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -85.02 -24.45 28.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 0.0 109.931 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -13.77 42.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.091 -1.006 . . . . 0.0 109.498 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -90.3 -7.28 53.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 109.665 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 25' ' ' VAL . 73.9 t -62.04 -63.62 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.218 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.44 ' HB3' ' HB1' ' A' ' 151' ' ' ALA . 4.2 mpt_? -68.62 -22.36 64.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.107 -0.996 . . . . 0.0 109.095 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.768 ' SG ' ' HG ' ' A' ' 116' ' ' LEU . 1.6 m -44.4 -28.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 108.823 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.762 ' SG ' HD13 ' A' ' 29' ' ' LEU . 1.5 p -111.79 -33.7 6.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.49 -0.756 . . . . 0.0 109.036 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.527 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.91 -61.18 2.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 147' ' ' ARG . . . -51.94 -28.05 15.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -84.35 -31.63 24.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.311 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 157' ' ' ARG . 13.8 tp -62.81 -54.14 43.54 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.039 -1.038 . . . . 0.0 108.792 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.525 ' HA ' ' CB ' ' A' ' 157' ' ' ARG . 5.6 pt-20 -44.31 -40.23 5.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.193 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -57.66 -63.16 1.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.519 ' HB ' ' CE2' ' A' ' 87' ' ' TYR . 27.8 m -93.28 33.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.335 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -97.65 106.07 18.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.415 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -141.95 142.65 33.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.72 133.04 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.875 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.555 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -97.16 2.66 51.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.773 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.658 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER 52.53 162.76 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.846 0.831 . . . . 0.0 110.392 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.503 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 2.0 m -150.29 107.54 3.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.98 -1.075 . . . . 0.0 109.496 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.635 HG13 ' CZ3' ' A' ' 39' ' ' TRP . 0.8 OUTLIER -102.9 138.55 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.583 HD11 ' CE1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -139.62 107.7 5.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.407 -0.808 . . . . 0.0 109.503 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.524 ' CE1' ' CD1' ' A' ' 89' ' ' LEU . 5.6 m-85 -93.79 156.79 16.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.418 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 10' ' ' PHE . 2.0 t -148.36 155.84 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.717 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -176.84 134.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -50.26 171.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.26 -0.9 . . . . 0.0 109.431 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' LEU . . . 44.06 41.05 5.98 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.459 ' O ' HG22 ' A' ' 16' ' ' ILE . 8.8 t30 -67.68 91.77 0.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.469 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -162.17 -39.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.132 -0.98 . . . . 0.0 109.723 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 18' ' ' ARG . 1.8 p -150.84 81.18 1.33 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 109.73 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.576 ' CD ' ' N ' ' A' ' 19' ' ' SER . 0.0 OUTLIER 165.14 -76.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 109.188 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.748 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -67.63 -49.23 40.97 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.389 -0.819 . . . . 0.0 110.337 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 19' ' ' SER . 71.8 Cg_exo -48.06 -20.33 2.1 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.964 1.776 . . . . 0.0 111.19 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.782 HG23 ' SG ' ' A' ' 145' ' ' CYS . 9.3 mt -64.83 -48.04 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 120.94 -1.1 . . . . 0.0 109.382 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.771 ' HA ' ' SG ' ' A' ' 145' ' ' CYS . . . -57.8 -19.28 27.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 109.353 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 24' ' ' ALA . 8.9 tm-20 -76.7 -70.21 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.216 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' OE1' ' A' ' 23' ' ' GLU . . . -44.22 -47.77 9.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.358 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.667 HG23 ' SG ' ' A' ' 145' ' ' CYS . 63.6 t -54.17 -49.95 58.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 109.297 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.54 ' HB2' ' CB ' ' A' ' 149' ' ' CYS . 1.1 t80 -50.49 -37.9 41.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.031 -1.043 . . . . 0.0 108.379 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.483 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -56.71 -45.05 82.09 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.191 -0.943 . . . . 0.0 108.841 179.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -81.61 -8.92 59.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.83 . . . . 0.0 110.104 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.632 ' CD1' ' SG ' ' A' ' 149' ' ' CYS . 3.9 mt -86.43 -31.08 21.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 109.323 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.59 ' CG2' ' N ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -90.85 -56.65 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 1.2 m -44.8 -32.05 1.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.106 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.32 -42.58 44.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.105 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.52 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 4.4 tp60 -72.62 -6.85 47.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.411 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 33.9 t30 76.65 48.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 109.699 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.552 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 3.8 pt -140.42 8.66 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 109.626 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.59 ' N ' ' CG2' ' A' ' 30' ' ' VAL . 24.5 p -68.06 -41.59 81.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.488 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.98 -20.17 3.21 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.284 -0.885 . . . . 0.0 109.361 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.555 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 2.2 m-20 -121.11 45.29 2.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.936 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.658 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 6.7 m95 -150.33 129.04 12.35 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.871 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.95 87.73 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.502 ' HA ' HG11 ' A' ' 8' ' ' VAL . 3.4 mt -94.27 142.32 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.343 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.55 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 t0 -164.31 178.3 7.62 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.0 p -179.74 169.85 1.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.06 -1.025 . . . . 0.0 109.739 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.12 -163.03 28.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.5 171.82 7.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -1.164 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.438 HG23 HD13 ' A' ' 99' ' ' LEU . 93.3 t -104.74 -8.08 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.555 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.04 174.36 6.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.457 ' HA ' HG22 ' A' ' 51' ' ' VAL . 29.6 t70 -110.2 30.45 6.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.51 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.515 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.7 OUTLIER -102.49 -49.28 3.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.444 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -90.22 38.23 0.92 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.867 . . . . 0.0 109.65 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 48' ' ' ASP . 73.2 t -82.13 94.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.347 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.38 -17.15 44.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' HB3' HG23 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -47.18 136.83 8.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -1.087 . . . . 0.0 109.451 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.35 159.34 50.63 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.462 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 56' ' ' ASP . 53.4 Cg_endo -71.59 -3.4 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.015 1.81 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' PRO . 72.0 m-20 61.57 140.97 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 109.443 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.425 ' O ' HG11 ' A' ' 60' ' ' VAL . 56.6 Cg_endo -73.49 -1.34 10.53 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.901 1.734 . . . . 0.0 110.395 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.433 ' O ' ' OG ' ' A' ' 61' ' ' SER . 67.6 mtt180 -72.95 -28.11 62.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.13 -0.981 . . . . 0.0 109.611 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 63' ' ' LEU . . . -88.94 -39.94 13.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.456 HG11 ' N ' ' A' ' 61' ' ' SER . 10.8 p -44.45 -25.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.597 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.456 ' N ' HG11 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -48.34 -89.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.295 -0.878 . . . . 0.0 109.846 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.686 ' SG ' ' OE2' ' A' ' 139' ' ' GLU . 3.7 t -73.54 -3.75 29.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.035 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.497 ' HA ' ' CE2' ' A' ' 142' ' ' TYR . 0.3 OUTLIER -86.56 -74.35 0.43 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.023 -1.048 . . . . 0.0 108.953 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.49 74.14 8.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.43 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -146.29 -53.83 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.643 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -80.72 -23.16 39.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.26 61.63 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.492 ' CG1' ' O ' ' A' ' 63' ' ' LEU . 21.7 mm -113.29 156.08 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -1.174 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -147.55 96.67 2.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.371 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 70' ' ' THR . 9.6 t -113.73 72.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.88 54.94 3.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 0.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.564 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.5 p-80 -133.63 155.66 49.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -0.955 . . . . 0.0 109.453 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.61 170.43 8.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 0.0 109.451 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -90.56 148.33 22.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 109.526 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.43 ' HA ' HG12 ' A' ' 51' ' ' VAL . 3.1 mmt-85 -151.75 152.26 32.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.409 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.453 ' HB2' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -80.57 135.44 36.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.401 ' O ' ' OE1' ' A' ' 76' ' ' GLN . 8.7 p -56.89 146.94 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.87 165.47 26.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.445 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.458 ' HG2' HG11 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -46.01 -36.72 5.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.468 ' O ' ' OG1' ' A' ' 84' ' ' THR . 7.8 tt0 -59.69 -56.78 17.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 109.655 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 9.3 m-20 -50.54 -40.67 52.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -0.884 . . . . 0.0 109.808 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 102' ' ' LYS . 43.4 m-85 -53.53 -58.13 8.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.072 -1.017 . . . . 0.0 109.335 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.522 ' HA ' ' CG ' ' A' ' 110' ' ' ARG . 0.8 OUTLIER -78.81 -2.26 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.536 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.573 HG23 ' CE1' ' A' ' 85' ' ' PHE . 56.0 m -78.27 -60.28 2.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.168 -0.957 . . . . 0.0 109.863 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.583 ' CE1' HD11 ' A' ' 9' ' ' LEU . 28.3 m-85 -96.46 178.36 5.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.14 -0.975 . . . . 0.0 109.863 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.459 ' OD1' ' HD3' ' A' ' 110' ' ' ARG . 1.1 t70 -118.2 -22.46 7.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.348 -0.845 . . . . 0.0 109.756 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.537 ' OH ' ' CG ' ' A' ' 6' ' ' LYS . 5.4 m-85 -112.01 67.09 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.98 -1.075 . . . . 0.0 109.623 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.581 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 3.1 mt -79.15 91.06 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.286 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.572 HD23 ' CD2' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -112.04 167.14 10.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.972 -1.08 . . . . 0.0 109.478 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.692 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -139.49 166.23 25.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.86 . . . . 0.0 109.06 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.692 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -66.76 133.56 50.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.388 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.489 ' HB2' HG12 ' A' ' 126' ' ' ILE . 5.7 t70 -42.94 110.06 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.68 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.5 -177.35 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.332 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.8 m -89.54 15.58 9.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -82.31 -14.74 54.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.546 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.456 HD13 HD22 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -86.49 5.13 36.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.098 -1.002 . . . . 0.0 109.604 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -19.25 65.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -0.96 . . . . 0.0 109.165 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.55 -43.19 4.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.872 . . . . 0.0 109.315 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.438 HD13 HG23 ' A' ' 46' ' ' VAL . 13.0 mt -57.61 -34.04 68.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.304 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.442 ' HB2' HD21 ' A' ' 96' ' ' LEU . 4.6 t-20 -69.19 -32.39 71.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.61 0.98 50.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 109.563 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -81.35 -30.21 33.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 109.442 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 p -63.76 -16.69 61.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -84.38 -31.36 24.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.338 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -12.54 43.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.392 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 109' ' ' CYS . 62.8 t -77.17 147.37 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.315 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -83.58 112.21 19.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.203 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.14 37.85 27.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.311 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -43.27 160.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.748 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.6 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 0.0 OUTLIER -150.1 36.36 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.446 -0.784 . . . . 0.0 109.002 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.581 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -119.36 88.75 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -0.811 . . . . 0.0 110.025 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 34.9 mtpt -46.13 121.09 3.08 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.543 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 1.7 mm -95.96 132.25 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.001 -1.062 . . . . 0.0 110.108 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.486 ' HG3' ' N ' ' A' ' 115' ' ' LEU . 31.7 tp10 -159.09 165.54 33.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.462 -0.774 . . . . 0.0 109.649 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.486 ' N ' ' HG3' ' A' ' 114' ' ' GLU . 22.3 mt -99.13 158.9 15.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.098 -1.001 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.765 HD12 ' SG ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER -68.75 123.79 21.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 109.337 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . 140.77 -179.66 19.04 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 0.7 OUTLIER 74.52 36.91 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -1.184 . . . . 0.0 109.421 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.411 ' HB2' ' HD2' ' A' ' 121' ' ' PRO . 26.7 m-85 -125.23 -140.0 0.29 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.164 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.59 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -71.33 -51.02 10.41 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.0 109.726 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.7 Cg_exo -49.99 96.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.761 1.64 . . . . 0.0 110.275 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 25.0 mt-30 -80.91 -152.67 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.43 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 124' ' ' GLN . 0.3 OUTLIER 65.78 116.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.491 ' O ' ' CB ' ' A' ' 125' ' ' LEU . 2.0 tt0 -60.28 -150.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.159 -0.963 . . . . 0.0 109.431 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.491 ' CB ' ' O ' ' A' ' 124' ' ' GLN . 0.2 OUTLIER 73.55 70.23 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.459 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.489 HG12 ' HB2' ' A' ' 92' ' ' ASP . 3.7 tt -87.57 177.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.18 -0.95 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' ' 92' ' ' ASP . 16.0 mt -82.61 98.54 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 0.0 109.445 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.47 ' HG3' ' OD1' ' A' ' 92' ' ' ASP . 8.9 mt-10 -130.96 55.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.417 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.9 OUTLIER -103.06 164.52 15.35 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.462 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 129' ' ' ASP . 54.9 Cg_endo -72.1 -164.37 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.028 1.819 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -70.93 -25.56 62.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.331 -0.856 . . . . 0.0 109.479 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.05 -81.15 0.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.532 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 114.31 -145.39 18.53 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -71.32 -83.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -1.135 . . . . 0.0 109.541 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.78 -71.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.94 46.26 1.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 109.566 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.422 ' OD2' ' HB ' ' A' ' 140' ' ' THR . 4.5 t70 -119.05 57.73 0.87 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.469 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -98.63 -25.34 14.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.686 ' OE2' ' SG ' ' A' ' 62' ' ' CYS . 4.2 tp10 -72.72 -31.28 64.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.325 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 96.1 m -65.45 -19.42 65.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 109.494 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.536 ' CG1' ' HA ' ' A' ' 18' ' ' ARG . 73.1 t -70.37 -70.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 0.0 109.228 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.633 ' CD2' ' CG2' ' A' ' 21' ' ' ILE . 3.2 t80 -48.19 -48.69 34.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.389 -0.82 . . . . 0.0 109.34 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -65.93 0.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.321 -0.862 . . . . 0.0 109.836 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 140' ' ' THR . 3.2 mm-40 -53.93 -19.26 4.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.782 ' SG ' HG23 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -69.95 -41.94 73.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.845 . . . . 0.0 109.389 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.548 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 15.2 t -52.87 -60.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.314 -0.866 . . . . 0.0 109.929 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.454 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.2 OUTLIER -69.95 -8.99 53.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 -179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.765 ' SG ' HD12 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -69.63 -11.59 60.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.345 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.632 ' SG ' ' CD1' ' A' ' 29' ' ' LEU . 30.2 p -126.26 -41.64 1.89 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.233 -0.917 . . . . 0.0 109.21 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.461 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 0.9 OUTLIER -58.25 -49.87 75.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.002 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 147' ' ' ARG . . . -61.96 -21.54 64.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.458 -0.776 . . . . 0.0 109.236 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.572 ' CD2' HD23 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -90.01 -19.01 24.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.408 -0.808 . . . . 0.0 109.642 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.51 ' CD2' HD12 ' A' ' 35' ' ' ILE . 9.0 tp -83.07 -26.04 31.48 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.03 -1.044 . . . . 0.0 108.748 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.494 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 1.0 OUTLIER -69.94 -29.3 66.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 108.997 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.494 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 2.2 tptt -80.32 -54.72 5.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 108.807 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.496 ' O ' ' HD3' ' A' ' 6' ' ' LYS . 16.5 m -98.33 45.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 108.891 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.533 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.295 0.569 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -157.86 53.77 0.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.387 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -142.8 108.76 5.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.453 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.74 147.85 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.549 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -126.16 83.44 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.485 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.66 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -41.47 163.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.748 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.593 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 62.4 p -136.62 116.47 13.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.024 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.568 HG11 ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -119.41 142.94 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 109.115 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.574 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -140.38 105.43 4.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 0.0 109.424 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -83.27 158.34 22.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.446 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 90' ' ' CYS . 1.9 t -145.63 142.2 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.441 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -162.15 131.89 4.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 12' ' ' CYS . 12.9 tp -43.34 -56.19 3.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.658 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . -87.35 85.06 1.53 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.455 ' O ' HG21 ' A' ' 16' ' ' ILE . 10.4 t30 -89.19 2.77 53.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -1.128 . . . . 0.0 109.548 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.491 ' C ' ' CD1' ' A' ' 16' ' ' ILE . 2.5 pp -146.86 12.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 109.733 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 18' ' ' ARG . 11.2 t -150.28 -54.89 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.044 -1.035 . . . . 0.0 109.561 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' O ' ' CB ' ' A' ' 19' ' ' SER . 1.0 OUTLIER -43.3 -80.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.429 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER 167.16 66.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.491 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.18 63.4 8.71 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.175 1.917 . . . . 0.0 110.594 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.579 HG22 ' CD2' ' A' ' 142' ' ' TYR . 3.8 mp -90.56 -17.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.013 -1.054 . . . . 0.0 109.732 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.702 ' HB1' ' SD ' ' A' ' 91' ' ' MET . . . -65.27 -32.32 73.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.469 ' HG3' ' HB3' ' A' ' 43' ' ' SER . 1.5 tt0 -77.22 -68.59 0.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.375 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' A' ' 68' ' ' ILE . . . -43.53 -40.54 3.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.193 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 146' ' ' VAL . 50.0 t -61.29 -53.37 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.38 -0.825 . . . . 0.0 109.158 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.579 ' CD1' HG13 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -46.52 -39.68 11.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.106 -0.997 . . . . 0.0 108.453 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.483 ' O ' ' OG1' ' A' ' 31' ' ' THR . 11.0 tpt85 -54.9 -60.18 3.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.165 -0.959 . . . . 0.0 108.97 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -10.18 35.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.893 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.485 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 2.7 mt -83.02 -76.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.064 -1.023 . . . . 0.0 108.971 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.588 ' CG2' ' HA ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -43.45 -46.1 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -60.25 -42.46 95.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.115 . . . . 0.0 109.433 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -69.38 -16.6 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.131 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 1.9 tp60 -98.2 -9.38 25.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.401 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 2.7 t-20 77.18 48.58 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 109.391 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.576 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 2.9 pt -140.82 9.63 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.349 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.588 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 6.2 p -69.93 -35.0 74.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.062 -1.024 . . . . 0.0 109.546 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -58.35 -20.35 42.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.646 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.538 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 11.8 m-20 -124.36 42.98 3.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.695 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.66 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 10.2 m95 -150.04 133.64 16.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.046 -1.034 . . . . 0.0 109.994 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 t -117.85 85.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.841 . . . . 0.0 108.992 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.524 ' CG1' HG12 ' A' ' 8' ' ' VAL . 2.2 mp -90.24 139.24 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 5.3 m-20 -150.53 146.58 26.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.427 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.469 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 74.5 p -116.5 156.76 26.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.53 164.8 32.23 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.16 128.06 51.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -1.147 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.2 t -47.47 -34.45 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.392 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.64 -177.15 3.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.937 . . . . 0.0 109.623 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 8.0 p-10 -102.43 24.59 10.13 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.299 -0.876 . . . . 0.0 109.457 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 38.9 m0 -65.54 -43.09 91.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.47 ' HB3' HG12 ' A' ' 16' ' ' ILE . 2.2 m-80 -119.91 61.49 0.84 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.148 -0.97 . . . . 0.0 109.753 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.502 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 91.1 t -84.7 102.58 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.236 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.61 10.2 63.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 50' ' ' ASN . 15.4 mtt85 -82.09 126.25 31.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -1.149 . . . . 0.0 109.449 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -72.22 150.44 92.1 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.515 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.521 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 53.8 Cg_exo -50.1 137.12 37.51 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.928 1.752 . . . . 0.0 110.31 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.556 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 32.9 p-10 -75.11 127.66 86.23 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.177 -0.952 . . . . 0.0 109.246 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.582 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . 72.1 Cg_exo -43.85 -23.21 0.57 Allowed 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 122.107 1.871 . . . . 0.0 110.618 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.445 ' O ' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -60.27 -53.46 57.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.874 -1.141 . . . . 0.0 108.392 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 61' ' ' SER . . . -76.73 -64.1 1.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.582 ' CG2' ' HA ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.25 -28.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.583 -0.698 . . . . 0.0 109.387 179.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 57' ' ' PRO . 1.7 t -52.7 -53.52 46.45 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.444 -0.785 . . . . 0.0 110.487 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.0 t -70.29 -17.92 63.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.123 -0.985 . . . . 0.0 110.541 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.554 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -90.14 -75.34 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.96 -1.087 . . . . 0.0 109.418 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' LEU . 3.6 ttt85 -43.62 -26.53 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 109.624 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -46.23 -66.26 0.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.887 . . . . 0.0 109.406 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 63' ' ' LEU . 12.6 p80 -76.33 -36.82 58.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.03 74.4 0.1 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.517 HG12 ' CB ' ' A' ' 24' ' ' ALA . 6.4 tp -86.53 -12.08 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.214 -1.168 . . . . 0.0 109.237 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.47 ' ND2' ' C ' ' A' ' 68' ' ' ILE . 1.3 p30 40.98 44.88 2.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.518 -0.739 . . . . 0.0 109.811 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -76.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 55.49 76.23 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.114 -0.991 . . . . 0.0 109.414 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.557 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.6 p-80 -150.36 157.15 42.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.553 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.27 134.21 54.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 109.406 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.4 163.99 26.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.479 ' HD2' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -178.56 128.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.327 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.98 142.74 11.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.877 . . . . 0.0 109.59 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.54 HG13 ' CE2' ' A' ' 82' ' ' PHE . 30.0 t -58.57 162.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.511 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.444 ' N ' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -160.5 161.5 32.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 109.547 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HG2' HG12 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -48.77 -32.27 8.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.313 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.48 ' O ' ' OG1' ' A' ' 84' ' ' THR . 0.9 OUTLIER -64.8 -49.46 70.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.796 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' HB3' HD12 ' A' ' 9' ' ' LEU . 36.4 m-20 -66.61 -26.79 67.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 110.184 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.54 ' CE2' HG13 ' A' ' 77' ' ' VAL . 42.4 m-85 -68.37 -68.45 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 109.727 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.53 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 9.2 p -64.21 -22.02 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 2.5 m -65.42 -71.93 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.126 -0.984 . . . . 0.0 109.527 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 42' ' ' ASP . 84.5 m-85 -73.36 163.8 27.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' OD1' ' HG3' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -112.55 -17.55 12.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -0.843 . . . . 0.0 109.461 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.2 m-85 -119.75 81.32 1.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 109.202 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 1.4 mt -90.59 112.82 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 0.0 109.074 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -133.34 169.22 17.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.998 -1.064 . . . . 0.0 109.286 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.623 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 21.3 m -127.8 177.27 6.94 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.341 -0.849 . . . . 0.0 109.165 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.702 ' SD ' ' HB1' ' A' ' 22' ' ' ALA . 16.6 mmt -85.36 47.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.453 ' HB3' HG21 ' A' ' 126' ' ' ILE . 4.2 m-20 54.38 87.86 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 109.465 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.37 158.24 43.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 109.375 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.0 p -71.89 -15.68 62.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.908 . . . . 0.0 109.459 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -72.24 -10.82 60.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.52 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.623 ' HG ' ' SG ' ' A' ' 90' ' ' CYS . 0.4 OUTLIER -68.14 -31.23 70.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -19.59 4.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.439 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -93.81 -31.33 14.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.482 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.531 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 15.8 mt -66.6 -34.19 77.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.574 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -64.54 -24.55 67.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -91.88 -10.34 39.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 109.418 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.491 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 2.4 mmmm -70.89 -32.99 70.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.892 . . . . 0.0 109.345 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.755 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 14.6 p -62.15 -28.05 69.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -46.68 75.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.355 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -85.02 0.74 50.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.606 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 109' ' ' CYS . 40.4 t -87.73 121.9 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.314 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 106' ' ' VAL . 9.0 tptt -45.03 99.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 106' ' ' VAL . 24.4 m120 48.11 58.75 4.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 109.526 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.755 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -53.78 147.24 12.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 109.793 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.53 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 8.6 ptt180 -131.29 2.12 4.21 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.536 ' O ' ' CD1' ' A' ' 113' ' ' ILE . . . -86.6 118.56 26.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 110.151 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' ILE . 5.5 mtpm? -69.49 106.05 2.85 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -83.23 137.24 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.994 -1.066 . . . . 0.0 110.084 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 1.2 tt0 -176.27 -170.47 0.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.49 -0.756 . . . . 0.0 109.057 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -122.65 118.06 27.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 109.496 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER 59.15 -87.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.839 . . . . 0.0 109.504 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' A' ' 119' ' ' TYR . . . 166.04 -175.28 41.62 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.9 p -109.65 64.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -1.174 . . . . 0.0 109.487 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.441 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.9 m-85 -120.16 -140.86 0.34 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.176 -0.952 . . . . 0.0 109.143 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 0.2 OUTLIER 169.03 63.07 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.071 -1.018 . . . . 0.0 109.43 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.6 -4.98 16.09 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.048 1.832 . . . . 0.0 110.243 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -161.37 -149.75 0.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.4 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 150.35 49.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -76.6 123.59 26.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -166.61 138.1 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.497 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.471 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 10.2 mm -95.35 150.47 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.362 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.462 ' N ' HG21 ' A' ' 126' ' ' ILE . 3.0 mp -106.23 81.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.507 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.471 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 66.2 mt-10 -121.71 81.85 1.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.431 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 1.4 p30 -158.58 85.35 2.46 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.559 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 132' ' ' TYR . 50.7 Cg_endo -71.08 171.75 15.28 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.959 1.773 . . . . 0.0 110.283 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -43.58 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -134.21 -47.11 0.77 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.362 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 114.8 84.87 1.25 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.63 -66.61 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -1.142 . . . . 0.0 109.487 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -179.9 89.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.475 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 50.84 34.74 10.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 109.455 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.94 79.05 9.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.1 -61.25 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.39 -45.95 88.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 m -47.23 -33.03 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.42 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 44.7 t -67.62 -45.86 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.422 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.579 ' CD2' HG22 ' A' ' 21' ' ' ILE . 8.7 t80 -57.7 -46.68 84.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -58.54 -56.43 22.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.962 . . . . 0.0 109.344 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.755 ' O ' ' SG ' ' A' ' 148' ' ' CYS . 15.7 mt-30 -64.85 -13.05 54.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 109.417 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.565 ' HA ' ' SG ' ' A' ' 148' ' ' CYS . 3.5 m -83.85 -27.02 29.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.315 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.541 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 87.6 t -55.14 -53.92 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.279 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.41 -15.86 53.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.238 -0.914 . . . . 0.0 109.334 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.755 ' SG ' ' O ' ' A' ' 144' ' ' GLN . 5.3 m -50.17 -23.44 2.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 0.0 108.713 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.618 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -122.01 -42.48 2.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.238 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.485 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . 55.2 ttt-85 -59.19 -49.55 77.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.041 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.24 -19.8 48.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.827 . . . . 0.0 109.07 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.408 ' CZ ' HG22 ' A' ' 156' ' ' VAL . 1.7 t80 -89.44 -25.42 21.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -0.831 . . . . 0.0 109.372 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.53 ' CD1' HD13 ' A' ' 35' ' ' ILE . 10.1 tp -77.79 -26.72 49.89 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.037 -1.039 . . . . 0.0 108.911 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 2.5 pt-20 -67.8 -30.39 69.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -0.968 . . . . 0.0 109.105 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.505 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -79.93 -51.34 9.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.89 . . . . 0.0 109.043 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.479 ' O ' ' HD3' ' A' ' 6' ' ' LYS . 15.4 m -99.2 42.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 108.995 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.426 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.452 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -81.36 -169.14 2.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.912 . . . . 0.0 109.409 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.96 87.75 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 5' ' ' THR . 12.2 p -71.75 157.09 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.607 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.548 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -149.67 75.94 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 109.223 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.648 ' CB ' ' CH2' ' A' ' 39' ' ' TRP . 22.3 mttp -51.46 -178.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 0.0 109.695 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.499 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 48.8 m -147.17 116.76 7.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.4 -0.813 . . . . 0.0 109.158 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.577 HG13 ' CZ ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -124.03 150.99 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 109.075 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.595 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -149.16 108.65 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.156 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.487 ' CZ ' HD11 ' A' ' 116' ' ' LEU . 1.9 m-85 -81.52 157.38 24.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.685 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 59.5 t -138.8 149.87 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.883 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -169.04 133.4 1.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.415 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.4 tp -44.74 -61.76 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.87 . . . . 0.0 109.477 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 15' ' ' ASN . . . -49.58 -88.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 14' ' ' GLY . 20.6 t30 76.69 17.82 1.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -1.102 . . . . 0.0 109.6 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER -169.1 -71.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.598 ' SG ' ' OH ' ' A' ' 131' ' ' TYR . 4.8 p -76.72 -26.84 55.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.449 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 19' ' ' SER . 25.8 ttm180 -62.18 -13.13 24.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.249 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' ARG . 7.3 m 68.48 60.72 0.68 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.293 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 19' ' ' SER . 40.9 Cg_endo -69.35 81.33 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.965 1.777 . . . . 0.0 110.458 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.528 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 6.8 mm -83.44 -15.61 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.87 . . . . 0.0 109.34 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.499 ' HB3' ' CB ' ' A' ' 148' ' ' CYS . . . -63.99 -51.65 63.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.132 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -60.34 -58.71 7.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 108.933 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.557 ' CB ' ' CD2' ' A' ' 63' ' ' LEU . . . -44.57 -38.0 3.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -0.849 . . . . 0.0 108.884 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.738 ' CG1' ' SG ' ' A' ' 149' ' ' CYS . 70.4 t -60.32 -56.51 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.247 -0.908 . . . . 0.0 108.831 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.636 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 0.4 OUTLIER -43.58 -32.19 0.89 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.476 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -62.82 -52.88 61.44 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 108.853 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -63.29 -58.28 7.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.21 -0.931 . . . . 0.0 109.663 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.627 HD11 ' SG ' ' A' ' 149' ' ' CYS . 29.9 mt -43.47 -66.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 109.761 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 36' ' ' SER . 3.0 p -58.8 -24.78 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 109.995 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 14.4 m -99.8 30.7 3.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.553 -1.342 . . . . 0.0 109.262 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -149.69 46.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.591 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -179.24 32.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -0.812 . . . . 0.0 109.041 -179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 33' ' ' GLN . 9.8 m120 46.7 42.08 11.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.591 ' CG2' ' HB3' ' A' ' 33' ' ' GLN . 1.7 tt -130.64 -5.38 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.247 0.546 . . . . 0.0 109.779 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -74.26 -33.27 63.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.937 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -76.08 1.79 14.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.64 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.548 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 23.7 m-20 -128.8 37.91 4.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 109.785 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.648 ' CH2' ' CB ' ' A' ' 6' ' ' LYS . 18.2 m95 -150.62 139.89 21.28 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.853 -1.154 . . . . 0.0 110.899 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.486 HG13 ' CE2' ' A' ' 85' ' ' PHE . 44.1 t -112.04 73.62 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.526 ' CG1' HG12 ' A' ' 8' ' ' VAL . 2.9 mt -89.91 140.42 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -0.819 . . . . 0.0 109.862 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 14.7 t0 -149.06 -168.27 3.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.477 -0.764 . . . . 0.0 109.175 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.411 ' OG ' ' OD1' ' A' ' 15' ' ' ASN . 29.6 t -134.48 169.96 16.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 109.691 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.78 153.85 25.55 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.13 -18.43 6.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -1.142 . . . . 0.0 109.714 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.526 ' CG2' HG12 ' A' ' 11' ' ' VAL . 58.1 t 56.98 17.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.381 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.563 ' HB3' ' CZ2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -145.26 144.71 30.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.299 -0.875 . . . . 0.0 109.413 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.456 ' HA ' HG22 ' A' ' 51' ' ' VAL . 5.0 m-20 -91.65 32.63 1.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.614 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.5 OUTLIER -97.19 -33.95 11.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 109.331 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 11.8 m-20 -125.43 46.78 2.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.639 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 48' ' ' ASP . 89.8 t -71.95 85.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.353 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.461 ' HA2' ' CG ' ' A' ' 73' ' ' LYS . . . 115.96 -6.44 19.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.523 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 2.5 mtt85 -76.55 96.25 4.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -1.113 . . . . 0.0 109.599 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.575 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -50.91 -179.36 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.123 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 61.5 Cg_exo -49.59 133.8 32.45 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.833 1.689 . . . . 0.0 110.239 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -43.76 145.3 1.22 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.465 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.463 ' HA ' HG13 ' A' ' 60' ' ' VAL . 53.9 Cg_exo -50.09 -21.1 6.08 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.941 1.76 . . . . 0.0 110.386 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.2 mtt-85 -83.04 -50.41 8.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.758 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' O ' ' CD1' ' A' ' 63' ' ' LEU . . . -90.25 11.98 19.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 110.077 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 61' ' ' SER . 7.3 p -90.01 -49.14 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.042 -1.036 . . . . 0.0 109.607 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.521 ' N ' HG12 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -91.53 -29.84 16.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.132 -0.98 . . . . 0.0 109.682 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.9 m -90.17 20.38 4.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.597 ' CD2' ' CG2' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -64.68 102.47 0.58 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.772 -1.205 . . . . 0.0 108.412 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.581 ' HD3' ' CE2' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 59.36 15.56 4.46 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.741 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 64' ' ' ARG . 5.1 p30 35.29 100.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.008 0.908 . . . . 0.0 111.086 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 57.91 24.44 10.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 0.0 109.902 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.513 ' HA3' ' NE ' ' A' ' 64' ' ' ARG . . . -128.09 -4.66 5.46 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.597 ' CG2' ' CD2' ' A' ' 63' ' ' LEU . 25.2 mm -148.0 156.94 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -1.19 . . . . 0.0 109.698 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -141.51 83.52 1.87 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.244 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.425 HG21 ' HB3' ' A' ' 24' ' ' ALA . 26.1 p -70.3 159.88 33.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.62 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -169.1 28.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.247 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.535 ' CD2' ' N ' ' A' ' 73' ' ' LYS . 8.7 t60 -124.27 157.75 34.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.36 -0.838 . . . . 0.0 109.254 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.535 ' N ' ' CD2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -89.71 -147.24 0.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 109.532 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 75' ' ' ARG . . . -137.75 -81.78 0.34 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.544 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.515 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 75.08 113.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.953 . . . . 0.0 109.392 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 75' ' ' ARG . 2.3 tt0 -43.68 143.05 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.428 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 46' ' ' VAL . 5.0 t -57.68 164.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -169.19 165.9 10.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.353 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.527 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -43.61 -31.88 0.85 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' O ' ' OG1' ' A' ' 84' ' ' THR . 36.4 tt0 -59.41 -57.22 13.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.293 -0.88 . . . . 0.0 109.616 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.47 ' O ' HD13 ' A' ' 88' ' ' ILE . 6.6 m-20 -66.11 -17.71 64.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.87 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.577 ' CD2' HG23 ' A' ' 106' ' ' VAL . 10.5 m-85 -70.47 -74.78 0.13 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.047 -1.033 . . . . 0.0 109.308 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 7.4 p -61.49 -24.2 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.458 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.579 HG23 ' CE1' ' A' ' 85' ' ' PHE . 5.8 m -64.45 -73.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.97 . . . . 0.0 109.448 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.595 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 57.1 m-85 -75.98 154.83 35.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.681 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 63.3 m-20 -108.71 -16.62 14.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.421 -0.799 . . . . 0.0 109.485 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.561 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 22.9 m-85 -118.25 67.74 0.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.64 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.594 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 3.1 mt -79.61 93.91 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.316 -0.865 . . . . 0.0 109.077 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -106.04 178.88 4.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 109.502 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.685 ' SG ' ' HB ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -132.88 176.82 8.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.346 -0.846 . . . . 0.0 109.41 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.501 ' CE ' HD12 ' A' ' 116' ' ' LEU . 1.5 mmt -85.35 45.08 1.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.915 . . . . 0.0 109.594 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 92' ' ' ASP . 0.7 OUTLIER 54.71 106.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.602 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -177.24 155.2 1.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.492 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -7.95 36.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -66.61 -16.05 63.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.449 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -64.51 -22.31 66.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 109.537 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -55.55 -24.22 31.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.13 -43.35 11.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.364 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.465 ' HB3' HG23 ' A' ' 113' ' ' ILE . 9.2 mt -67.92 -13.23 61.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.65 -32.39 23.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.39 16.28 18.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.451 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 0.5 OUTLIER -104.0 -19.37 14.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.535 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 96.5 p -71.06 -45.96 62.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.524 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.462 ' OD1' ' HG2' ' A' ' 105' ' ' GLN . 19.1 p-10 -62.18 -29.38 70.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.462 ' HG2' ' OD1' ' A' ' 104' ' ' ASN . 1.4 mm-40 -87.72 -15.24 37.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.949 . . . . 0.0 109.379 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.577 HG23 ' CD2' ' A' ' 82' ' ' PHE . 25.6 t -71.36 150.18 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.261 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 108' ' ' ASN . 3.2 tptt -71.92 87.16 1.01 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.271 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 107' ' ' LYS . 50.3 t30 68.28 45.42 1.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 109.485 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.538 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -56.76 149.69 17.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 0.0 109.817 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 1.9 ptm180 -138.75 9.73 2.63 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.594 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -86.34 91.79 8.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.432 -0.792 . . . . 0.0 110.404 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -47.95 122.31 4.96 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 1.3 mm -95.54 140.6 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.817 -1.177 . . . . 0.0 110.281 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 1.2 tt0 -168.61 -177.74 3.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -125.31 156.73 38.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.065 -1.022 . . . . 0.0 109.634 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.751 HD23 ' SG ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER -43.69 -26.64 0.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . -63.2 89.26 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER 170.38 -35.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -1.117 . . . . 0.0 109.461 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.435 ' CD2' ' HA ' ' A' ' 152' ' ' PHE . 22.9 m-85 -105.91 76.04 1.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 109.433 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.456 ' OD1' ' HB3' ' A' ' 123' ' ' LYS . 2.1 m-20 -143.18 84.12 10.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.897 . . . . 0.0 109.622 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.18 -36.13 45.13 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.996 1.797 . . . . 0.0 110.237 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 122' ' ' GLN . 8.5 pt20 -155.44 68.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.429 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HB3' ' OD1' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -169.97 128.86 0.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.305 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.93 95.62 3.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.326 -0.859 . . . . 0.0 109.466 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.14 -43.3 0.56 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.568 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.504 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 28.1 mm 57.51 102.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 109.461 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.467 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 4.6 tt -77.05 96.57 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.517 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.504 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 21.4 mt-10 -119.17 39.04 3.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 109.425 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -72.93 146.94 88.19 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 109.478 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -72.14 -175.38 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.957 1.771 . . . . 0.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.598 ' OH ' ' SG ' ' A' ' 17' ' ' CYS . 40.6 t80 -68.7 -13.23 62.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.398 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -92.15 -28.93 16.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.85 176.59 43.65 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -79.96 -56.46 4.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.42 -71.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.872 . . . . 0.0 109.487 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.56 42.59 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.873 . . . . 0.0 109.494 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -82.9 74.89 9.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.577 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.47 ' HA ' HG13 ' A' ' 141' ' ' VAL . 3.9 t80 -130.54 -39.25 1.29 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 0.0 109.477 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -80.65 -47.32 14.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.21 -0.932 . . . . 0.0 109.383 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.3 m -64.84 -40.39 95.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.386 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.761 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 8.7 p -52.33 -27.22 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.581 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 3.1 t80 -83.52 -47.89 10.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.356 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -49.81 -53.63 24.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.74 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HG3' ' N ' ' A' ' 145' ' ' CYS . 0.9 OUTLIER -73.94 -23.27 59.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.812 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.761 ' SG ' ' O ' ' A' ' 141' ' ' VAL . 1.8 m -68.07 -20.35 64.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.572 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 25' ' ' VAL . 55.5 t -64.38 -70.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.953 . . . . 0.0 109.354 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.47 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 2.1 mtt-85 -63.5 -16.71 61.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.948 . . . . 0.0 109.354 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.751 ' SG ' HD23 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -46.3 -31.07 2.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 0.0 109.094 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.738 ' SG ' ' CG1' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -116.85 -30.99 5.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -0.873 . . . . 0.0 109.144 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.527 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 67.8 ttt-85 -71.68 -56.25 6.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 108.964 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 147' ' ' ARG . . . -50.83 -32.14 19.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.427 -0.796 . . . . 0.0 109.234 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.577 ' CE1' HG22 ' A' ' 156' ' ' VAL . 1.1 t80 -79.12 -33.21 44.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.419 -0.801 . . . . 0.0 109.384 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.487 HD23 ' CD1' ' A' ' 35' ' ' ILE . 14.7 tp -67.22 -18.29 65.17 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.148 -0.97 . . . . 0.0 108.755 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 49.2 mm-40 -68.67 -63.6 1.03 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 108.832 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -53.13 -47.59 68.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 108.826 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.577 HG22 ' CE1' ' A' ' 152' ' ' PHE . 18.5 m -98.12 51.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 108.838 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.358 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.583 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 29.0 mt-10 60.09 92.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.71 119.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 6' ' ' LYS . 1.8 t -120.45 26.6 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.404 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.536 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -47.71 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 109.6 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.67 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -47.14 175.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.225 -0.922 . . . . 0.0 109.584 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.581 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 1.4 m -149.62 105.88 3.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.235 -0.916 . . . . 0.0 109.43 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.599 HG13 ' CZ3' ' A' ' 39' ' ' TRP . 2.0 p -111.5 138.92 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.248 -0.908 . . . . 0.0 110.202 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.559 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -133.76 129.37 36.54 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.535 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 1.3 m-85 -110.41 155.57 22.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 110.036 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.758 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 40.0 t -144.29 145.67 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' HG2' ' A' ' 91' ' ' MET . 2.9 m -163.74 48.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.097 -1.002 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.7 OUTLIER 42.47 -95.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.427 -0.795 . . . . 0.0 109.577 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -60.37 89.09 0.03 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 4.5 t-20 -90.28 26.97 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -1.114 . . . . 0.0 109.457 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -122.63 -8.34 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.39 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -161.09 151.32 17.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.455 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' A' ' 19' ' ' SER . 0.0 OUTLIER 51.96 63.17 2.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 162.44 -51.1 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.86 . . . . 0.0 109.823 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 19' ' ' SER . 66.1 Cg_exo -48.61 -21.94 3.9 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.909 1.739 . . . . 0.0 110.529 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.751 ' HB ' ' SG ' ' A' ' 145' ' ' CYS . 3.6 mm -66.59 -49.15 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.061 -1.025 . . . . 0.0 109.21 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.581 ' HB1' ' SG ' ' A' ' 145' ' ' CYS . . . -62.14 -18.29 60.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.137 -0.977 . . . . 0.0 109.272 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ALA . 18.3 tt0 -81.07 -82.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 109.41 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -44.23 -33.2 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.993 . . . . 0.0 109.357 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 21' ' ' ILE . 44.3 t -65.72 -49.72 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.858 . . . . 0.0 109.426 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.636 ' CE1' ' CG1' ' A' ' 30' ' ' VAL . 1.1 t80 -53.43 -39.96 64.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.946 -1.096 . . . . 0.0 108.346 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -51.53 -67.16 0.27 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.282 -0.887 . . . . 0.0 108.961 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.481 ' HA ' ' OG1' ' A' ' 31' ' ' THR . 28.9 tttt -73.15 -0.32 13.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 110.009 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 150' ' ' ARG . 46.3 tp -85.32 -33.33 22.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 109.011 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.636 ' CG1' ' CE1' ' A' ' 26' ' ' PHE . 2.0 m -90.34 -31.05 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -66.19 -33.04 74.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.662 -0.649 . . . . 0.0 109.348 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -66.84 -19.91 65.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 108.99 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.516 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 6.6 mm-40 -100.53 -3.01 31.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.434 -0.791 . . . . 0.0 109.531 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.9 OUTLIER 76.74 45.78 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.701 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.496 ' CD1' HD22 ' A' ' 153' ' ' LEU . 4.1 pt -137.41 3.24 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 0.0 109.942 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.576 ' N ' HG21 ' A' ' 30' ' ' VAL . 4.3 p -72.04 -30.77 65.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.928 -1.108 . . . . 0.0 109.48 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -60.62 -13.99 17.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.855 . . . . 0.0 109.277 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.536 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 6.2 m-20 -129.01 48.15 2.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.67 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 5.7 m95 -150.11 143.43 25.08 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.888 -1.133 . . . . 0.0 110.666 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 t -117.54 81.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.498 ' CG1' ' CG1' ' A' ' 8' ' ' VAL . 3.5 mt -89.91 137.79 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.724 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -164.89 117.38 1.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.428 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 1.3 p -82.76 -171.62 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.965 . . . . 0.0 109.377 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.519 ' HA3' ' CG2' ' A' ' 77' ' ' VAL . . . -178.87 166.5 36.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.51 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . . . -97.21 -167.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -1.106 . . . . 0.0 109.289 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.458 HG21 ' CG1' ' A' ' 11' ' ' VAL . 38.5 t -121.2 -12.75 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.113 -0.992 . . . . 0.0 109.346 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -125.8 -153.66 0.58 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.526 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.531 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -119.85 -21.93 7.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 109.438 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.448 ' CD1' ' N ' ' A' ' 50' ' ' ASN . 0.7 OUTLIER -54.9 -18.35 4.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.564 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.51 ' ND2' ' HB3' ' A' ' 45' ' ' ALA . 13.0 p30 -115.26 42.11 2.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 70.4 t -101.72 114.79 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.0 -6.99 83.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 49' ' ' TRP . 6.6 mtt180 -72.43 103.32 3.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -1.135 . . . . 0.0 109.507 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.1 p -59.82 154.64 46.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.537 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.04 158.77 3.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.974 1.783 . . . . 0.0 110.323 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.533 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -74.26 157.83 86.15 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 53.4 Cg_endo -71.87 -3.14 12.62 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.949 1.766 . . . . 0.0 110.256 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -89.49 -47.63 7.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.61 -16.77 40.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.454 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 9.8 p -65.09 -32.8 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.522 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.41 -10.17 54.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.4 m -80.82 -21.93 40.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.533 ' N ' HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -90.21 -66.66 0.9 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.027 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.9 ttm180 -47.33 -24.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.39 -0.819 . . . . 0.0 109.539 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -71.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -66.93 -8.79 32.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 109.644 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.8 69.3 0.81 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.531 ' HB ' ' CB ' ' A' ' 63' ' ' LEU . 10.3 mm -109.42 160.8 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -1.104 . . . . 0.0 109.458 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.454 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 3.4 m120 -129.51 102.44 6.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.395 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.24 147.22 41.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -150.58 36.73 0.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.206 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -119.03 125.4 49.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.341 -0.85 . . . . 0.0 109.541 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 38.05 1.04 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.412 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 75' ' ' ARG . . . 65.94 169.54 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.898 . . . . 0.0 109.5 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 168.06 152.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -82.35 129.85 34.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.519 ' CG2' ' HA3' ' A' ' 44' ' ' GLY . 42.8 t -71.0 103.15 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 65.9 p -72.12 -164.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 109.095 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.551 ' HB2' ' CG2' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -86.29 -23.87 26.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.042 -1.036 . . . . 0.0 109.257 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 84' ' ' THR . 20.1 tt0 -65.46 -33.08 75.11 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.407 -0.808 . . . . 0.0 108.845 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -68.16 -17.86 64.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.39 -0.818 . . . . 0.0 108.975 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.546 ' HA ' ' CB ' ' A' ' 111' ' ' ALA . 32.1 m-85 -82.49 -65.24 1.03 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.364 -0.835 . . . . 0.0 109.208 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.45 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 9.5 p -62.76 -19.17 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' GLU . 14.1 m -78.66 -67.47 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.0 109.244 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.559 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 53.3 m-85 -68.81 135.42 51.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.219 -0.926 . . . . 0.0 109.452 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -78.17 -23.63 47.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 7' ' ' SER . 6.9 m-85 -115.6 147.58 40.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.898 . . . . 0.0 109.539 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.524 HD11 ' CB ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -156.82 95.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.366 -0.834 . . . . 0.0 108.832 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.579 HD12 ' CD2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -114.1 156.88 23.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 109.749 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 36.1 t -124.6 146.48 49.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.476 -0.765 . . . . 0.0 109.059 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.767 ' HG2' ' SG ' ' A' ' 12' ' ' CYS . 20.4 mmt -42.91 150.71 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.69 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 128' ' ' GLU . 0.6 OUTLIER -45.16 -24.68 0.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 128' ' ' GLU . 9.5 mt-10 -41.29 -89.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.336 -0.852 . . . . 0.0 109.589 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 96' ' ' LEU . 39.2 p -79.41 83.09 5.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.246 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.496 ' HB2' ' CD2' ' A' ' 115' ' ' LEU . 17.3 p-10 -52.3 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.569 -0.707 . . . . 0.0 109.605 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.584 ' CD2' ' CG2' ' A' ' 113' ' ' ILE . 0.3 OUTLIER 41.56 27.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.625 -0.672 . . . . 0.0 109.9 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -90.28 -29.71 17.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.547 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.48 -38.63 7.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.514 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.464 HD12 ' CG2' ' A' ' 88' ' ' ILE . 8.9 mt -67.05 -37.06 83.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.474 ' HB2' HD21 ' A' ' 96' ' ' LEU . 29.7 t30 -57.18 -19.49 20.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -89.73 -32.74 16.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.439 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.453 ' O ' HG22 ' A' ' 106' ' ' VAL . 9.5 mmmt -59.02 -32.88 70.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.882 . . . . 0.0 109.353 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 t -68.31 -31.59 71.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.244 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.09 -32.05 71.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -90.93 -11.28 39.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 109.302 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.551 ' CG2' ' HB2' ' A' ' 79' ' ' LYS . 81.5 t -86.08 140.73 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 119.35 23.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.342 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 109' ' ' CYS . 1.5 m-20 50.99 40.0 24.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.142 -0.974 . . . . 0.0 109.179 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -42.77 138.71 1.86 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.365 -0.834 . . . . 0.0 109.92 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.567 ' CB ' ' CZ ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -125.13 -5.12 7.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.806 . . . . 0.0 109.063 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.546 ' CB ' ' HA ' ' A' ' 82' ' ' PHE . . . -62.86 93.1 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.85 . . . . 0.0 110.207 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 86' ' ' ASP . 11.7 ttmt -46.29 106.48 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.584 ' CG2' ' CD2' ' A' ' 96' ' ' LEU . 2.9 mm -83.29 164.74 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.046 -1.034 . . . . 0.0 110.956 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 4.1 mt-10 176.47 -176.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.496 ' CD2' ' HB2' ' A' ' 95' ' ' ASN . 1.2 pp -141.49 138.75 33.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 0.0 109.84 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.65 HD23 ' SG ' ' A' ' 148' ' ' CYS . 0.4 OUTLIER -53.37 119.96 5.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.0 109.449 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -157.2 -159.84 9.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.58 114.36 2.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.477 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.0 m-85 -112.45 -17.83 12.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.583 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 163.84 -51.68 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.605 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 58.3 Cg_exo -49.26 164.41 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.698 1.599 . . . . 0.0 110.2 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -96.2 143.33 27.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.69 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 125' ' ' LEU . 3.9 tp60 -104.64 12.96 32.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 109.594 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.492 ' C ' ' O ' ' A' ' 124' ' ' GLN . 14.6 tp 33.47 81.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.169 0.509 . . . . 0.0 110.514 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.463 HD11 ' OD2' ' A' ' 92' ' ' ASP . 13.4 mm -48.15 143.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 109.201 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 127' ' ' ILE . 2.1 tt -119.9 95.3 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 94.4 mt-10 -121.86 69.2 0.93 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.432 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -114.73 144.9 32.79 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.505 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.91 -91.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.034 1.823 . . . . 0.0 110.278 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.495 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 32.5 t80 -166.32 50.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.329 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.76 109.88 4.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.33 145.91 16.41 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -110.44 -28.7 8.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -1.065 . . . . 0.0 109.371 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.439 ' OD1' ' CB ' ' A' ' 137' ' ' ASP . 2.6 p30 -91.71 17.8 8.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 45.47 49.55 10.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.439 ' CB ' ' OD1' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -79.98 79.05 6.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.47 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.415 ' CZ ' ' N ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -113.93 -10.05 12.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.499 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.46 -45.57 21.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 7.7 m -57.52 -25.35 59.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 18' ' ' ARG . 45.3 t -76.96 -36.46 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.565 ' CD2' HG22 ' A' ' 21' ' ' ILE . 4.7 t80 -64.37 -43.81 93.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -71.06 -48.95 49.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.66 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.577 ' O ' ' SG ' ' A' ' 148' ' ' CYS . 0.0 OUTLIER -59.33 -21.41 59.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.627 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.751 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.5 m -72.14 -32.6 67.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.446 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 77.7 t -49.49 -51.73 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.938 . . . . 0.0 109.289 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.417 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -77.68 -27.59 50.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.424 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.741 ' SG ' ' HA ' ' A' ' 145' ' ' CYS . 67.6 m -44.21 -26.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.138 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.576 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -115.11 -28.75 6.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.226 -0.921 . . . . 0.0 109.452 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.525 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . 30.9 ttt85 -71.04 -59.2 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 108.99 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -49.43 -22.22 1.12 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.388 -0.82 . . . . 0.0 109.611 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.579 ' CD2' HD12 ' A' ' 89' ' ' LEU . 1.3 t80 -90.19 -34.98 15.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 110.061 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 157' ' ' ARG . 11.2 tp -67.28 -46.47 73.51 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.807 -1.183 . . . . 0.0 109.16 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 11.4 pt-20 -49.87 -38.23 34.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 108.638 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.412 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -59.98 -60.53 3.68 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.457 HG22 ' CH2' ' A' ' 39' ' ' TRP . 31.8 m -92.17 31.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.363 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.272 0.558 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -109.39 77.07 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -47.85 136.77 10.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.415 ' C ' ' OD1' ' A' ' 38' ' ' ASN . 59.5 t -117.01 148.77 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.478 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.556 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -87.93 75.95 8.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.667 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -41.33 153.04 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.759 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.586 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -133.23 117.29 17.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.082 -1.012 . . . . 0.0 109.579 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.587 HG13 ' CE2' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -121.41 154.99 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.927 . . . . 0.0 109.591 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.584 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -149.99 106.53 3.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.868 . . . . 0.0 109.184 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.569 ' CD1' HD11 ' A' ' 89' ' ' LEU . 1.9 m-85 -88.41 155.15 19.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.777 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 2.0 t -145.94 149.83 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.232 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -166.35 154.0 9.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.539 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.7 tp -55.63 -67.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.02 78.92 1.5 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 50' ' ' ASN . 42.5 p-10 -92.2 43.46 1.13 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -1.159 . . . . 0.0 109.419 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.505 HD11 ' N ' ' A' ' 17' ' ' CYS . 1.1 pp -132.88 -31.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 109.949 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.686 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER -148.46 12.5 0.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.913 -1.117 . . . . 0.0 110.257 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.536 ' CG ' HG22 ' A' ' 141' ' ' VAL . 7.5 ttt-85 -125.35 -52.33 1.62 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.0 109.472 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.653 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -80.0 -44.35 1.48 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 110.949 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 19' ' ' SER . 73.5 Cg_exo -46.72 -17.0 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.99 1.793 . . . . 0.0 112.313 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.581 HG21 ' CD1' ' A' ' 142' ' ' TYR . 0.9 OUTLIER -74.74 -45.33 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.336 -1.478 . . . . 0.0 108.894 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.764 ' HB1' ' SG ' ' A' ' 145' ' ' CYS . . . -67.8 -42.98 80.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.01 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' CD ' ' HB2' ' A' ' 43' ' ' SER . 4.3 tt0 -58.59 -58.57 7.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 108.764 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HB3' ' CG2' ' A' ' 68' ' ' ILE . . . -46.02 -36.87 6.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.327 -0.858 . . . . 0.0 108.841 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 146' ' ' VAL . 16.5 t -63.03 -52.12 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.274 -0.891 . . . . 0.0 108.952 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.587 ' CE2' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -52.53 -21.47 3.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.459 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -70.88 -56.06 7.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -78.07 1.43 21.06 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.533 HD23 ' CB ' ' A' ' 150' ' ' ARG . 9.9 tp -94.22 -36.14 12.15 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 36' ' ' SER . 4.1 p -91.07 -14.66 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 1.4 m -99.1 17.28 20.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.914 -1.116 . . . . 0.0 109.521 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.96 55.39 1.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 108.993 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.545 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 3.2 tp60 173.47 31.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.559 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 33' ' ' GLN . 0.3 OUTLIER 45.34 39.47 4.42 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -178.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 33' ' ' GLN . 2.3 tt -124.68 -6.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.53 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -75.53 -22.23 57.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -0.892 . . . . 0.0 109.798 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -88.45 26.9 1.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.152 -0.968 . . . . 0.0 109.19 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.556 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 0.7 OUTLIER -159.06 40.19 0.22 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.323 -0.861 . . . . 0.0 109.396 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.667 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 14.4 m95 -150.14 156.62 41.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.956 -1.09 . . . . 0.0 111.121 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.38 72.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.535 ' CG1' ' CG1' ' A' ' 8' ' ' VAL . 2.8 mt -89.66 129.56 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.397 -0.814 . . . . 0.0 110.395 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . 5.6 t0 -144.95 147.74 33.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.446 -0.783 . . . . 0.0 108.955 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.424 ' HB2' ' CD ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -120.17 159.23 25.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.035 -1.041 . . . . 0.0 109.75 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.68 179.47 39.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.11 145.6 29.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -1.119 . . . . 0.0 109.401 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.454 HG12 ' HG ' ' A' ' 99' ' ' LEU . 70.8 t -57.1 -35.2 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.92 -164.11 1.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.436 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.43 57.59 3.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.902 . . . . 0.0 109.474 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -89.03 -33.9 16.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.336 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HB2' ' OD1' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -146.98 47.95 1.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.361 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 76.2 t -58.86 112.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.43 ' HA2' ' HG3' ' A' ' 73' ' ' LYS . . . 51.43 51.36 37.63 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 54' ' ' SER . 7.8 mtt180 -95.98 18.47 13.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -1.192 . . . . 0.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER 58.53 151.93 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.62 -0.675 . . . . 0.0 109.631 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.17 128.22 13.62 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.98 1.787 . . . . 0.0 110.186 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.443 ' OD2' ' HB3' ' A' ' 17' ' ' CYS . 55.5 m-20 -48.02 154.91 0.93 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.465 ' O ' HG11 ' A' ' 60' ' ' VAL . 55.5 Cg_endo -71.7 -4.77 15.71 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.024 1.816 . . . . 0.0 110.306 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -62.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.25 -18.38 65.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 109.4 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 57' ' ' PRO . 9.8 p -63.96 -41.45 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.179 -0.951 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 8.8 p -77.02 -3.31 38.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.665 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.7 t -90.14 -33.02 16.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.41 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.38 -55.07 3.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.274 -0.892 . . . . 0.0 109.207 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.461 ' HD3' ' HA ' ' A' ' 61' ' ' SER . 7.7 ptm180 -56.87 -16.54 6.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.386 -0.821 . . . . 0.0 109.642 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.501 ' OD1' ' CD2' ' A' ' 66' ' ' HIS . 12.6 t-20 -66.46 -81.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.501 ' CD2' ' OD1' ' A' ' 65' ' ' ASN . 1.0 OUTLIER -150.7 20.57 0.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.588 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.03 -97.19 2.39 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.489 ' CG2' ' HB3' ' A' ' 24' ' ' ALA . 2.6 mp -119.46 161.29 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -1.13 . . . . 0.0 109.413 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.489 ' N ' HG21 ' A' ' 68' ' ' ILE . 2.2 m-80 -118.25 54.61 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.116 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 9.5 t -58.37 151.18 20.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.571 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -144.55 14.38 1.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.264 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 18.7 t60 -78.45 146.78 34.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.569 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 4.0 tptm -93.67 131.54 38.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 73' ' ' LYS . . . -48.42 176.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.548 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.51 139.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.466 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.07 131.41 44.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 109.51 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.52 ' CG1' ' CE1' ' A' ' 82' ' ' PHE . 71.8 t -48.75 131.54 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 109.334 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 79' ' ' LYS . 20.5 p -111.86 160.35 17.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.636 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HG2' HG11 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -43.17 -44.3 5.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.573 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' O ' ' OG1' ' A' ' 84' ' ' THR . 23.6 tt0 -57.7 -47.82 81.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.837 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.464 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 1.1 m-20 -53.94 -43.78 70.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 109.983 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.52 ' CE1' ' CG1' ' A' ' 77' ' ' VAL . 49.6 m-85 -54.53 -50.89 66.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.499 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.542 ' HA ' ' CG ' ' A' ' 110' ' ' ARG . 1.0 OUTLIER -87.05 0.59 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 109.767 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.572 HG23 ' CE1' ' A' ' 85' ' ' PHE . 13.5 m -77.79 -53.32 7.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 110.244 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.584 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 16.7 m-85 -100.85 174.58 5.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.064 -1.022 . . . . 0.0 110.412 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.422 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 19.5 t0 -112.41 -19.84 12.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.466 -0.771 . . . . 0.0 109.578 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 7' ' ' SER . 1.4 m-85 -116.89 86.97 2.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 0.0 109.23 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.573 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 1.5 mt -95.73 123.45 47.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.339 -0.851 . . . . 0.0 109.327 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -149.59 153.38 37.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 109.267 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.542 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 4.7 p -127.37 167.59 15.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.557 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.524 ' SD ' ' SG ' ' A' ' 148' ' ' CYS . 16.9 mmt -60.89 142.04 56.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 16.9 m-20 -43.52 116.29 0.92 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.439 ' HA ' ' HG2' ' A' ' 128' ' ' GLU . 11.3 tt0 -176.34 163.01 2.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.493 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 t -83.31 8.74 12.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -75.91 -11.97 60.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.542 ' HG ' ' SG ' ' A' ' 90' ' ' CYS . 0.9 OUTLIER -74.19 -2.37 24.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 0.0 109.607 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 13.7 ttt85 -63.63 -25.19 68.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.169 -0.957 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 0.4 OUTLIER -95.54 -43.91 7.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.395 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.454 ' HG ' HG12 ' A' ' 46' ' ' VAL . 6.0 mt -53.65 -44.71 69.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.357 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.48 -29.53 70.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.228 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -89.89 -5.8 56.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.903 . . . . 0.0 109.461 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.465 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 0.6 OUTLIER -81.63 -20.93 38.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -0.874 . . . . 0.0 109.32 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -63.57 -36.59 84.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.826 . . . . 0.0 109.591 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -32.45 73.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.424 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -92.66 9.73 33.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.244 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 109' ' ' CYS . 49.1 t -98.68 145.29 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.392 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.39 106.54 5.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.064 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 109' ' ' CYS . 8.2 t-20 47.73 46.68 18.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.002 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.515 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -41.76 145.6 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.561 -0.712 . . . . 0.0 109.704 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.542 ' CG ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -137.6 25.15 2.88 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.311 -0.868 . . . . 0.0 109.111 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.573 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -106.73 131.43 53.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.392 -0.817 . . . . 0.0 109.858 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 88' ' ' ILE . 7.2 mtpt -83.19 100.22 10.43 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.497 HD11 ' N ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -76.32 135.46 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.734 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.46 -177.97 5.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.419 -0.801 . . . . 0.0 109.36 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.405 ' HG ' HD11 ' A' ' 96' ' ' LEU . 60.8 mt -110.71 152.75 26.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.652 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.77 HD12 ' SG ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -69.08 -9.92 55.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.475 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 92' ' ' ASP . . . -45.94 -29.18 3.14 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.3 168.88 19.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -1.085 . . . . 0.0 109.471 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 55.41 73.65 0.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.37 75.54 13.63 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.13 105.89 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.915 1.743 . . . . 0.0 110.294 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 57.49 178.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.96 42.76 22.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.63 120.26 11.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tp -168.28 101.33 0.43 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.524 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.516 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 15.1 mm -54.28 141.09 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.511 ' CG2' ' O ' ' A' ' 127' ' ' ILE . 14.8 mt -100.76 57.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.93 . . . . 0.0 109.351 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.516 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 21.0 mt-10 -88.07 132.42 34.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.444 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 1.1 p30 -158.05 158.7 30.22 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 129' ' ' ASP . 51.4 Cg_endo -71.27 -90.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.038 1.825 . . . . 0.0 110.226 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.1 -42.84 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.454 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.09 100.02 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.07 -116.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -160.27 -55.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -1.162 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.41 18.48 15.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.622 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 137' ' ' ASP . . . -55.92 -20.41 15.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.321 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 0.7 OUTLIER 74.79 126.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.578 ' CD1' HG13 ' A' ' 141' ' ' VAL . 80.8 t80 -82.42 0.74 40.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.605 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -79.47 -34.2 41.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.146 -0.971 . . . . 0.0 109.461 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.453 ' CG2' ' N ' ' A' ' 141' ' ' VAL . 15.0 t -76.4 -42.23 45.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.578 HG13 ' CD1' ' A' ' 138' ' ' PHE . 9.0 p -46.64 -29.22 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.581 ' CD1' HG21 ' A' ' 21' ' ' ILE . 1.4 t80 -90.18 -46.34 8.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.102 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.03 -64.56 0.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.682 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -55.76 -20.09 13.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.102 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.764 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -72.33 -39.08 68.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.331 -0.856 . . . . 0.0 109.344 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.545 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 90.1 t -53.21 -71.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.034 -1.041 . . . . 0.0 109.74 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.531 ' HA ' ' CB ' ' A' ' 150' ' ' ARG . 13.1 mtm180 -62.49 -21.18 65.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.088 -1.007 . . . . 0.0 109.606 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -45.81 -27.44 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.985 -1.072 . . . . 0.0 108.18 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.585 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -111.62 -23.12 10.86 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.533 ' CB ' HD23 ' A' ' 29' ' ' LEU . 8.5 ttp180 -76.48 -64.49 1.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.389 -0.819 . . . . 0.0 109.257 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -45.72 -37.87 6.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.257 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.46 ' O ' HG23 ' A' ' 156' ' ' VAL . 1.9 t80 -74.71 -37.38 62.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.42 -0.8 . . . . 0.0 109.3 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . 13.3 tp -67.14 -16.96 64.64 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.211 -0.93 . . . . 0.0 108.718 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -72.37 -50.52 26.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.035 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -42.43 98.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 108.841 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.479 ' O ' ' CD ' ' A' ' 6' ' ' LYS . 17.0 m -103.84 42.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 109.056 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.461 ' HA ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.466 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 3' ' ' GLN . 41.8 mt-10 -101.14 71.09 1.37 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.476 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.536 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 39.2 mt-30 -152.15 157.28 41.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.95 . . . . 0.0 109.606 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 3' ' ' GLN . 4.1 p 48.31 178.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.607 -0.683 . . . . 0.0 109.887 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.545 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -151.48 83.59 1.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.248 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.637 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -41.53 162.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.868 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.585 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 2.5 m -142.8 114.7 8.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 108.999 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.578 HG11 ' CZ3' ' A' ' 39' ' ' TRP . 0.6 OUTLIER -118.01 147.77 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.733 -179.256 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.583 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -149.99 116.4 5.77 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' A' ' 116' ' ' LEU . 2.5 m-85 -91.87 160.33 15.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 0.0 109.858 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.589 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 4.2 t -145.98 149.48 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.546 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -174.13 121.91 0.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 12' ' ' CYS . 44.6 tp -43.46 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 109.582 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . 148.96 -73.75 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER 68.7 14.33 8.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -1.096 . . . . 0.0 109.425 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.41 12.73 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.425 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 18' ' ' ARG . 15.3 t 179.12 137.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.77 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 23.7 ttm-85 84.15 -52.22 0.13 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.75 -0.594 . . . . 0.0 109.664 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -79.56 -50.1 1.32 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 110.049 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 19' ' ' SER . 70.2 Cg_exo -48.37 -33.66 23.23 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.902 1.735 . . . . 0.0 110.876 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.586 HG22 ' CD2' ' A' ' 142' ' ' TYR . 5.4 mm -65.75 -61.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.961 -1.087 . . . . 0.0 109.655 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.6 ' HB1' ' SG ' ' A' ' 145' ' ' CYS . . . -62.5 -12.77 24.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 109.539 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 2.4 tm-20 -77.98 -74.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.401 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.447 ' HB2' ' CG2' ' A' ' 68' ' ' ILE . . . -53.96 -33.96 58.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 108.841 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.547 ' CG1' ' CD1' ' A' ' 29' ' ' LEU . 49.6 t -56.29 -59.75 2.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.393 -0.817 . . . . 0.0 109.202 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.591 ' CD1' HG11 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -47.52 -41.26 20.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.974 -1.079 . . . . 0.0 108.506 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.505 ' O ' ' OG1' ' A' ' 31' ' ' THR . 5.8 ttt85 -45.7 -60.07 2.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.006 -1.059 . . . . 0.0 109.403 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' HA ' ' OG1' ' A' ' 31' ' ' THR . 0.3 OUTLIER -75.32 -13.03 60.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.41 -0.806 . . . . 0.0 111.003 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.547 ' CD1' ' CG1' ' A' ' 25' ' ' VAL . 42.1 mt -76.37 -30.85 57.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.846 -1.159 . . . . 0.0 109.433 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.591 HG11 ' CD1' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -90.76 -31.85 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -60.86 -31.81 71.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 109.076 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.46 -40.61 89.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.357 -0.839 . . . . 0.0 109.328 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.464 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 32.0 tp60 -80.67 -6.54 58.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.874 . . . . 0.0 109.515 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 1.5 m120 72.67 47.44 0.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.532 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 5.9 pt -129.72 -1.14 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.917 . . . . 0.0 109.656 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.578 ' CA ' ' CG2' ' A' ' 30' ' ' VAL . 2.1 p -58.36 -44.46 88.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 109.657 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.12 -28.03 6.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.548 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.545 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 5.3 m-20 -112.58 46.1 1.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.637 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 7.6 m95 -149.86 144.54 26.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.157 -0.964 . . . . 0.0 110.194 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.8 t -124.16 78.11 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.567 ' CG1' ' CG1' ' A' ' 8' ' ' VAL . 2.6 mt -90.02 139.11 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.869 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -150.75 -173.53 4.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.285 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.449 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 1.1 t -126.46 165.95 18.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.692 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.93 131.94 4.82 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.537 ' O ' ' CG1' ' A' ' 46' ' ' VAL . . . -93.41 -39.24 11.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.301 -1.117 . . . . 0.0 109.583 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER 80.84 -6.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.695 . . . . 0.0 109.466 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.0 m -141.31 137.33 32.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.487 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 1.3 t70 -88.38 14.1 10.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.516 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -86.25 3.45 43.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.695 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 49' ' ' TRP . 3.9 m-20 -144.46 22.78 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.577 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.53 ' CG1' ' HA ' ' A' ' 75' ' ' ARG . 60.9 t -64.85 128.37 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.05 -18.15 42.16 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.86 113.17 2.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -1.116 . . . . 0.0 109.365 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.4 m -76.45 153.01 83.79 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 56' ' ' ASP . 53.7 Cg_exo -50.25 143.72 25.33 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.957 1.771 . . . . 0.0 110.266 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 55' ' ' PRO . 4.5 m-20 -44.79 151.92 0.58 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.9 -6.0 18.19 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 121.93 1.753 . . . . 0.0 110.31 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.746 ' O ' ' SG ' ' A' ' 62' ' ' CYS . 16.0 mtt180 -86.26 -33.85 20.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.366 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.14 -25.07 22.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.319 -0.863 . . . . 0.0 109.446 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.525 ' HA ' ' CD2' ' A' ' 63' ' ' LEU . 9.9 p -64.71 -44.78 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.456 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.515 ' N ' HG12 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -69.64 -8.46 47.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.631 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.746 ' SG ' ' O ' ' A' ' 58' ' ' ARG . 13.1 m -89.89 -66.71 0.9 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.53 ' N ' HD21 ' A' ' 63' ' ' LEU . 1.7 pt? -57.78 -25.31 60.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.368 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.471 ' NH2' ' HG3' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -91.56 30.89 1.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.349 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -133.21 -46.0 0.84 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.574 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -83.59 -33.58 25.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.441 ' O ' HG12 ' A' ' 68' ' ' ILE . . . 136.22 98.5 0.54 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.457 HG13 ' HB2' ' A' ' 63' ' ' LEU . 15.6 mm -149.42 -68.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -1.127 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 21.4 m-80 68.65 116.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.391 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 t -105.01 167.69 9.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.537 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -161.71 39.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.456 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' A' ' 73' ' ' LYS . 8.6 t60 -155.16 144.66 21.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.508 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' CD2' ' A' ' 72' ' ' HIS . 0.9 OUTLIER -115.82 151.18 35.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 73' ' ' LYS . . . -44.11 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' HA ' ' CG1' ' A' ' 51' ' ' VAL . 1.5 tpp180 69.15 8.1 6.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER 61.32 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.438 HG13 ' HA ' ' A' ' 46' ' ' VAL . 11.6 p -53.85 165.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.85 161.96 37.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HG2' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -50.63 -41.57 55.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.274 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' OG1' ' A' ' 84' ' ' THR . 0.3 OUTLIER -54.0 -41.13 67.61 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.354 -0.841 . . . . 0.0 109.53 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.426 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 0.9 OUTLIER -62.15 -31.88 72.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 109.842 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' HA ' ' HB1' ' A' ' 111' ' ' ALA . 77.6 m-85 -66.23 -59.2 3.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.063 -1.023 . . . . 0.0 109.399 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.52 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 2.6 p -72.98 -9.14 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.506 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 3.4 m -81.76 -78.06 0.2 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.222 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.583 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 37.2 m-85 -70.06 156.52 39.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.253 -0.905 . . . . 0.0 109.315 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -106.43 -12.68 15.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.654 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 7' ' ' SER . 2.2 m-85 -121.88 78.21 1.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 109.712 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.586 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 2.8 mt -89.3 91.66 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.306 -0.872 . . . . 0.0 108.964 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.45 168.26 9.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 0.0 109.352 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.589 ' SG ' ' HB ' ' A' ' 11' ' ' VAL . 3.9 m -136.51 175.21 9.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.259 -0.9 . . . . 0.0 109.292 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 16.8 mmt -84.07 12.51 6.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.46 ' O ' HD23 ' A' ' 115' ' ' LEU . 1.3 p30 170.66 176.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.579 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.495 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -107.34 -14.69 14.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 93' ' ' GLU . 0.5 OUTLIER -44.26 -53.0 7.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.582 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -89.16 -24.34 22.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.916 . . . . 0.0 109.571 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.459 HD12 HG23 ' A' ' 113' ' ' ILE . 2.6 tt -58.7 -21.19 54.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.95 -28.24 0.44 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -94.65 -33.24 13.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.502 ' CD1' HG13 ' A' ' 11' ' ' VAL . 15.4 mt -67.17 -14.48 62.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -85.5 -31.78 22.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.98 -11.93 40.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -67.86 -42.47 81.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.434 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.686 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 1.1 p -53.03 -22.66 6.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.397 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -72.02 -44.05 64.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.383 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -83.08 -9.93 58.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.554 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.539 HG13 ' CA ' ' A' ' 109' ' ' CYS . 41.1 t -76.8 135.49 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.448 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -68.65 108.41 3.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.1 t30 51.93 48.98 21.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.279 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.686 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -48.36 148.77 1.78 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.282 -0.886 . . . . 0.0 109.773 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.52 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -136.95 5.21 2.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.417 -0.802 . . . . 0.0 109.206 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -85.44 94.43 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 110.388 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -52.82 122.88 10.02 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.544 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -96.97 129.38 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.79 -1.194 . . . . 0.0 110.114 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -155.3 -171.98 4.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 0.0 109.224 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 93' ' ' GLU . 20.2 mt -117.49 162.66 17.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.969 . . . . 0.0 109.517 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.595 HD23 ' SG ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -85.85 58.71 5.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -123.07 -2.22 9.29 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 15.62 24.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -1.187 . . . . 0.0 109.487 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.434 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 2.8 m-85 -135.76 70.57 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -166.63 133.83 2.05 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.164 -0.96 . . . . 0.0 109.382 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.65 -30.55 29.03 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.769 1.646 . . . . 0.0 110.168 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -128.3 132.44 48.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.39 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -64.65 140.44 58.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.182 -0.949 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 125' ' ' LEU . 1.1 mt-30 -108.76 16.82 22.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.253 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.471 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 1.6 tt 39.66 61.07 1.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.756 -0.59 . . . . 0.0 109.842 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.519 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 7.2 mm 62.08 139.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 0.0 109.345 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 129' ' ' ASP . 2.8 mp -101.43 -55.21 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.84 . . . . 0.0 109.365 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.519 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 33.5 mt-10 48.0 -92.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER 51.44 92.55 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.489 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.1 157.11 3.1 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.901 1.734 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -98.92 87.3 3.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -138.6 -74.83 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.525 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -142.73 117.79 1.17 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 137' ' ' ASP . 2.4 p30 -105.8 148.06 27.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -1.149 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.92 74.48 7.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 66.03 33.14 7.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 134' ' ' ASN . 0.4 OUTLIER -105.89 56.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 109.564 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -111.36 -42.04 3.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 109.355 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -70.42 -36.15 73.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 0.0 109.307 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.435 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 56.8 m -65.81 -17.66 64.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.226 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.511 ' CG1' ' HA ' ' A' ' 18' ' ' ARG . 22.3 t -81.67 -43.89 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.586 ' CD2' HG22 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.54 -25.89 65.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.216 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -83.9 -46.76 11.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.91 . . . . 0.0 109.651 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 141' ' ' VAL . 16.2 pt20 -67.23 -13.3 61.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.24 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.77 ' SG ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -79.09 -19.21 51.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 109.457 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.54 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 54.4 t -61.3 -56.27 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.926 . . . . 0.0 109.27 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.87 -12.29 60.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.288 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.595 ' SG ' HD23 ' A' ' 116' ' ' LEU . 1.2 m -56.12 -18.78 10.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.15 -0.969 . . . . 0.0 108.988 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.567 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -124.42 -40.71 2.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.418 -0.801 . . . . 0.0 109.229 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -59.15 -46.36 88.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 108.71 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.487 ' O ' ' CG ' ' A' ' 154' ' ' GLU . . . -65.68 -18.97 65.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.474 -0.766 . . . . 0.0 109.098 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.581 ' CZ ' HG22 ' A' ' 156' ' ' VAL . 4.6 t80 -90.07 -19.35 24.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.416 -0.802 . . . . 0.0 109.489 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . 14.5 tp -78.7 -22.74 46.22 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.037 -1.04 . . . . 0.0 108.768 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 151' ' ' ALA . 4.4 pt-20 -72.0 -33.71 68.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.1 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.455 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 5.8 mmtp -76.19 -51.65 11.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.916 . . . . 0.0 108.864 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.581 HG22 ' CZ ' ' A' ' 152' ' ' PHE . 17.8 m -103.56 58.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.393 -0.817 . . . . 0.0 108.935 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.559 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.29 0.567 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.44 132.03 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.354 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -137.51 82.2 1.91 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.705 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 38' ' ' ASN . 1.9 t -75.73 152.14 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 109.118 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -130.64 82.75 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.933 . . . . 0.0 109.803 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.645 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -43.12 156.8 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -136.38 113.74 10.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.377 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.577 HG22 ' CE2' ' A' ' 152' ' ' PHE . 1.0 OUTLIER -117.8 142.71 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.571 HD11 ' CD1' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -142.23 116.61 9.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.445 -0.784 . . . . 0.0 109.136 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.774 ' CZ ' ' SG ' ' A' ' 148' ' ' CYS . 2.0 m-85 -91.1 161.51 15.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.583 ' CG1' ' CG2' ' A' ' 46' ' ' VAL . 74.5 t -149.47 152.93 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.461 ' HB3' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -178.28 126.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.437 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.95 124.95 13.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.48 62.47 1.87 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -84.02 74.85 10.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.425 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -144.19 12.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.627 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.442 ' SG ' HD13 ' A' ' 16' ' ' ILE . 0.8 OUTLIER 173.74 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.716 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 19' ' ' SER . 2.4 ttm105 -94.6 66.68 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 109.572 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.59 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 162.44 -51.08 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.644 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 19' ' ' SER . 57.2 Cg_exo -49.89 -20.83 5.31 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.882 1.721 . . . . 0.0 110.425 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.757 HG23 ' SG ' ' A' ' 145' ' ' CYS . 1.9 mm -64.89 -51.16 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.147 -0.97 . . . . 0.0 109.183 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.672 ' O ' ' SG ' ' A' ' 149' ' ' CYS . . . -63.33 -19.87 65.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.48 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -73.51 -74.67 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.273 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' CB ' ' HB ' ' A' ' 70' ' ' THR . . . -44.2 -28.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 108.91 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.77 HG22 ' SG ' ' A' ' 145' ' ' CYS . 97.3 t -68.23 -53.32 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.328 -0.858 . . . . 0.0 109.21 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.623 ' CE1' ' CD1' ' A' ' 41' ' ' ILE . 5.2 t80 -46.22 -39.58 10.05 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.527 ' HD3' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -58.02 -53.36 59.07 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.385 -0.822 . . . . 0.0 109.202 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' HG3' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -76.67 -1.37 27.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 0.0 109.792 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.755 HD13 ' SG ' ' A' ' 149' ' ' CYS . 81.4 mt -92.55 -32.85 14.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.013 -1.054 . . . . 0.0 109.316 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.605 ' CG2' ' CA ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -90.71 -49.87 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -52.6 -22.17 4.72 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.272 -0.893 . . . . 0.0 109.167 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -90.67 -31.41 16.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.029 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -79.16 -79.71 0.13 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 109.224 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 4.0 m-20 161.92 42.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.398 -0.814 . . . . 0.0 109.955 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.536 HD12 ' CA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -139.15 11.55 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.976 -1.078 . . . . 0.0 109.837 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.605 ' CA ' ' CG2' ' A' ' 30' ' ' VAL . 4.3 p -62.57 -21.36 65.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.944 -1.097 . . . . 0.0 109.51 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 3.4 m-20 -93.11 34.23 1.13 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.317 -0.865 . . . . 0.0 108.753 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.527 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 6.6 m-20 -177.06 48.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 109.684 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.645 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 9.8 m95 -149.99 144.19 25.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.89 -1.131 . . . . 0.0 110.383 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.65 81.59 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.623 ' CD1' ' CE1' ' A' ' 26' ' ' PHE . 2.7 mp -89.93 137.77 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.831 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.575 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 4.4 m-20 -148.44 173.52 13.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -122.76 161.33 24.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.444 ' HA3' ' CG2' ' A' ' 77' ' ' VAL . . . -143.89 147.75 19.19 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' A' ' 46' ' ' VAL . . . -116.79 -19.73 9.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -1.17 . . . . 0.0 109.558 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.583 ' CG2' ' CG1' ' A' ' 11' ' ' VAL . 4.5 t 69.92 6.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.07 164.03 31.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.601 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.478 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 48.5 p30 -110.45 11.59 23.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.865 . . . . 0.0 109.424 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -89.93 6.67 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.745 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.485 ' OD1' ' CD ' ' A' ' 53' ' ' ARG . 4.3 m-80 -147.81 29.76 0.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.58 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 26.0 t -78.55 78.51 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 109.283 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' HA2' ' HD3' ' A' ' 73' ' ' LYS . . . 134.79 -19.86 3.92 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' CD ' ' OD1' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -63.42 90.68 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.417 -1.049 . . . . 0.0 109.409 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.451 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 13.4 p -55.72 161.91 2.96 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.856 . . . . 0.0 109.448 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 54' ' ' SER . 53.5 Cg_exo -50.44 153.79 6.99 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.043 1.829 . . . . 0.0 110.199 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 18.5 m-20 -75.38 144.91 78.84 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.928 . . . . 0.0 109.486 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.474 ' O ' HG11 ' A' ' 60' ' ' VAL . 51.6 Cg_exo -51.07 -19.63 6.17 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.959 1.773 . . . . 0.0 110.496 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -79.56 -45.64 18.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.147 -0.971 . . . . 0.0 109.821 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.517 ' O ' ' CD2' ' A' ' 63' ' ' LEU . . . -71.3 -17.98 62.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 109.885 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 64' ' ' ARG . 8.8 p -72.38 -28.15 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.932 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.505 ' N ' HG11 ' A' ' 60' ' ' VAL . 14.7 m -64.2 -20.18 65.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.812 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.29 -75.06 0.47 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.198 -0.939 . . . . 0.0 109.745 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.524 ' O ' ' CG2' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -53.87 -18.47 3.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.726 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.531 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 4.3 ttt180 -112.72 51.63 0.81 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.09 -1.006 . . . . 0.0 109.633 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 61' ' ' SER . 4.6 t-20 -129.27 -78.46 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 109.245 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -54.62 -33.05 59.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.317 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.86 104.76 1.34 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 63' ' ' LEU . 0.8 OUTLIER -133.63 -174.36 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -1.169 . . . . 0.0 109.324 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.527 ' CB ' ' HD3' ' A' ' 27' ' ' ARG . 67.0 m-80 -140.18 118.01 11.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.505 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.524 ' HB ' ' CB ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -142.18 -87.32 0.15 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.451 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.412 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . 60.18 20.49 9.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.333 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.544 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.5 p-80 -90.09 157.4 17.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HD3' ' HA2' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -107.87 150.13 27.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.21 170.69 15.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.939 . . . . 0.0 109.551 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 76' ' ' GLN . 0.0 OUTLIER -174.83 153.27 1.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.442 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.439 ' N ' ' HG3' ' A' ' 75' ' ' ARG . 31.6 tt0 -77.04 138.78 39.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.444 ' CG2' ' HA3' ' A' ' 44' ' ' GLY . 77.8 t -67.33 141.98 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 2.7 p -127.95 164.75 21.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.556 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' HG2' ' CG1' ' A' ' 106' ' ' VAL . 0.6 OUTLIER -51.1 -45.36 61.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.477 ' O ' ' OG1' ' A' ' 84' ' ' THR . 32.7 tt0 -53.9 -38.21 64.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.481 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 78' ' ' THR . 7.3 m-20 -59.11 -41.17 87.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.748 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 94.4 m-85 -61.84 -54.31 43.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.513 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.534 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 1.2 p -75.9 -5.84 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 109.612 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.527 HG23 ' CE1' ' A' ' 85' ' ' PHE . 4.0 m -85.89 -71.7 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.314 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 42' ' ' ASP . 71.6 m-85 -74.3 161.62 29.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 83.3 m-20 -109.16 -21.81 12.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.673 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.7 m-85 -116.06 73.32 0.84 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.076 -1.015 . . . . 0.0 109.58 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.55 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 3.0 mt -86.15 89.81 2.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.562 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -100.5 174.3 6.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.041 -1.037 . . . . 0.0 109.441 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.528 ' SG ' ' CD1' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -150.05 159.8 44.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.431 -0.793 . . . . 0.0 109.091 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.753 ' HE3' ' SG ' ' A' ' 148' ' ' CYS . 32.6 mmt -67.49 167.86 12.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -0.96 . . . . 0.0 109.201 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER -59.52 -149.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.793 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 92' ' ' ASP . 0.1 OUTLIER 76.87 -179.04 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.345 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 m -89.01 36.01 0.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -89.94 -15.47 31.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.471 ' CD1' ' HB3' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -86.74 -16.31 36.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 109.466 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 21.1 ttt85 -65.91 -11.42 46.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.0 -1.063 . . . . 0.0 109.169 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 13.8 t70 -108.36 -35.09 6.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.259 -0.9 . . . . 0.0 109.183 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.528 ' CD1' ' SG ' ' A' ' 90' ' ' CYS . 8.9 mt -69.18 -50.6 46.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.362 -0.836 . . . . 0.0 109.41 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -54.52 -26.18 30.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.415 -0.803 . . . . 0.0 109.406 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.83 -24.24 19.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.907 . . . . 0.0 109.478 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 0.3 OUTLIER -65.94 -39.5 90.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.749 ' OG ' ' SG ' ' A' ' 109' ' ' CYS . 45.1 t -59.72 -17.95 38.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 0.0 109.319 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.31 -40.17 31.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 5.4 pt20 -76.85 -18.16 58.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 109' ' ' CYS . 92.9 t -69.22 147.9 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.436 ' N ' HG11 ' A' ' 106' ' ' VAL . 5.0 mmtm -89.41 108.49 19.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.274 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.18 42.04 4.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.074 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.749 ' SG ' ' OG ' ' A' ' 103' ' ' SER . 0.0 OUTLIER -52.35 152.44 3.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 0.0 109.894 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 4.0 ptm180 -140.32 8.75 2.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.424 -0.797 . . . . 0.0 109.184 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.55 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -90.65 91.51 8.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 110.313 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 111' ' ' ALA . 13.7 mtpt -47.33 116.97 1.57 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 1.7 mm -93.65 135.98 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.858 -1.151 . . . . 0.0 110.685 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.6 tt0 -160.89 -176.27 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -134.82 151.59 51.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.017 -1.052 . . . . 0.0 109.495 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.798 ' CD2' ' SG ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -42.25 135.17 2.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.443 -0.785 . . . . 0.0 109.669 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.31 -120.01 1.67 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.6 p -148.65 117.64 6.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -1.185 . . . . 0.0 109.6 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.525 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 23.9 m-85 -115.47 31.35 6.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.35 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.575 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 162.89 -51.24 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.404 -0.81 . . . . 0.0 109.539 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.5 Cg_exo -49.92 146.89 15.61 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.845 1.697 . . . . 0.0 110.071 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.67 11.36 32.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.118 -0.989 . . . . 0.0 109.672 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.57 146.66 25.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -112.85 62.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.392 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.27 76.32 1.56 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.541 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.53 HD12 ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -74.62 137.77 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.265 -0.897 . . . . 0.0 109.083 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.574 ' CG1' ' CB ' ' A' ' 144' ' ' GLN . 95.2 mt -39.56 106.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.515 -0.741 . . . . 0.0 109.941 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.489 ' CG ' ' OD2' ' A' ' 92' ' ' ASP . 15.1 mt-10 -142.26 79.74 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.458 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 130' ' ' PRO . 0.9 OUTLIER -150.73 104.45 3.05 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.456 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 129' ' ' ASP . 54.4 Cg_exo -49.68 -174.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.755 1.636 . . . . 0.0 110.29 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -100.12 14.02 32.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.595 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.96 26.44 9.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.42 -105.38 1.58 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -113.48 -159.72 0.7 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -1.191 . . . . 0.0 109.384 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -119.21 -23.78 6.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.39 10.75 9.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -97.74 61.33 1.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.27 -51.26 2.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.561 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -27.29 34.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 109.363 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 61.0 m -61.79 -49.03 77.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.337 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 145' ' ' CYS . 53.5 t -53.6 -40.72 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 0.0 109.377 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.579 ' CD2' ' CG2' ' A' ' 21' ' ' ILE . 2.2 t80 -61.28 -48.4 81.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.417 ' NE2' ' HA ' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -55.01 -65.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 109.951 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.574 ' CB ' ' CG1' ' A' ' 127' ' ' ILE . 21.0 mm100 -53.38 -19.03 3.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.868 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.77 ' SG ' HG22 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -77.7 -38.09 48.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.117 -0.989 . . . . 0.0 109.645 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.546 ' N ' ' SG ' ' A' ' 145' ' ' CYS . 2.9 t -51.57 -53.55 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.087 -1.008 . . . . 0.0 109.218 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.43 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.9 OUTLIER -79.05 -12.54 60.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.861 . . . . 0.0 109.344 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.798 ' SG ' ' CD2' ' A' ' 116' ' ' LEU . 36.2 t -56.46 -40.4 74.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.224 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.755 ' SG ' HD13 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -103.06 -29.26 11.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.365 -0.834 . . . . 0.0 109.52 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.517 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 2.2 ttt180 -72.21 -59.65 2.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 147' ' ' ARG . . . -57.19 -19.82 23.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.454 -0.779 . . . . 0.0 109.206 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.577 ' CE2' HG22 ' A' ' 8' ' ' VAL . 2.6 t80 -90.59 -26.86 19.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.51 -0.744 . . . . 0.0 109.833 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 153' ' ' LEU . 8.7 tp -75.16 -25.68 58.52 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.912 -1.117 . . . . 0.0 109.109 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -69.22 -46.82 66.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.36 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -63.3 -54.75 32.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.475 ' O ' ' HD3' ' A' ' 6' ' ' LYS . 17.5 m -102.87 54.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.256 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.466 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.55 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.281 0.562 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 2' ' ' GLU . 23.0 mm-40 -118.58 61.0 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 4' ' ' VAL . 1.8 tt0 -114.07 66.54 0.67 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 5' ' ' THR . 18.0 t -44.93 147.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.361 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.549 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -175.24 84.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.343 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.655 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -42.59 163.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.585 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 74.4 m -145.58 109.83 4.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.107 -0.996 . . . . 0.0 109.586 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.631 HG13 ' CZ3' ' A' ' 39' ' ' TRP . 1.5 p -110.75 144.79 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.217 -0.927 . . . . 0.0 109.627 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.583 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -141.49 126.04 17.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.125 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.498 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.0 m-85 -105.53 156.42 18.25 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 109.569 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.512 ' CG1' HD13 ' A' ' 99' ' ' LEU . 25.2 t -139.13 154.86 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.77 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.558 ' SG ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -170.62 129.79 0.84 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.423 -0.798 . . . . 0.0 109.16 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 12' ' ' CYS . 1.0 OUTLIER -42.39 -65.28 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.558 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . -87.43 87.59 1.55 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.442 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 3.0 t-20 -90.04 40.76 1.02 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -1.129 . . . . 0.0 109.353 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 53' ' ' ARG . 1.8 pp -157.24 -40.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.925 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.55 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 0.9 OUTLIER -102.65 -15.33 16.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.496 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 14' ' ' GLY . 3.0 mmm-85 -75.53 0.18 18.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.599 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.518 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 10.0 p 60.14 56.08 4.29 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 109.568 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 19' ' ' SER . 45.3 Cg_endo -70.05 83.05 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.999 1.799 . . . . 0.0 109.941 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.536 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 3.2 mm -88.68 -21.02 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.796 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.69 ' CB ' ' SG ' ' A' ' 148' ' ' CYS . . . -54.52 -24.57 21.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.05 -1.031 . . . . 0.0 109.873 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 8.0 tp10 -76.75 -83.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 0.0 110.021 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -41.71 -30.75 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 109.836 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 21' ' ' ILE . 60.9 t -64.32 -58.04 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.359 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.583 ' CD2' HG12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -46.9 -41.72 16.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.108 -0.995 . . . . 0.0 108.64 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.488 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.1 OUTLIER -50.23 -66.42 0.39 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.237 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -13.71 29.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 110.164 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.541 HD13 ' SG ' ' A' ' 149' ' ' CYS . 8.5 mt -77.18 -78.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.161 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.603 ' CG2' ' HA ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -42.73 -47.66 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.39 -0.819 . . . . 0.0 109.653 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -51.14 -46.69 62.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.81 -1.181 . . . . 0.0 109.502 -179.368 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.42 -30.16 70.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.962 . . . . 0.0 109.03 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.527 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 1.1 tt0 -79.68 -10.13 59.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 8.7 t30 77.61 25.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.453 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.564 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 1.6 pt -117.63 11.56 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.315 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.603 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 89.3 p -73.5 -12.35 60.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.683 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -83.94 10.1 10.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 109.332 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.549 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 3.1 m-20 -155.38 51.99 0.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.655 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 7.9 m95 -150.3 154.37 37.74 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.902 -1.123 . . . . 0.0 110.865 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.2 t -130.49 80.59 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.583 HG12 ' CD2' ' A' ' 26' ' ' PHE . 3.3 mt -90.64 138.99 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.255 -0.903 . . . . 0.0 109.87 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.415 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -145.73 -178.71 6.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.82 . . . . 0.0 109.154 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.7 t -170.27 135.91 1.33 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.682 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.8 -177.06 33.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB3' ' OD1' ' A' ' 50' ' ' ASN . . . -95.12 141.02 29.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -1.183 . . . . 0.0 109.461 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.499 HG11 ' N ' ' A' ' 47' ' ' SER . 8.4 p -58.0 -24.71 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.344 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.499 ' N ' HG11 ' A' ' 46' ' ' VAL . 19.4 m -124.43 170.88 10.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.372 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HA ' HG22 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -81.07 75.61 8.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.366 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.57 -32.68 6.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 45' ' ' ALA . 4.1 p-10 -132.08 34.56 3.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.597 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 76' ' ' GLN . 77.7 t -65.87 110.19 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.55 16.03 41.3 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 8.7 mtt-85 -120.72 86.64 2.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -1.171 . . . . 0.0 109.44 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -47.08 172.46 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.316 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 52.2 Cg_exo -50.95 123.78 12.46 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.885 1.723 . . . . 0.0 110.037 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 1.8 m-20 -43.09 155.89 0.27 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.604 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.448 ' O ' HG11 ' A' ' 60' ' ' VAL . 53.7 Cg_endo -71.68 -6.87 20.03 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.873 1.715 . . . . 0.0 110.142 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -34.65 18.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.06 26.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.447 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' ARG . 11.1 p -65.57 -36.55 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.875 . . . . 0.0 109.389 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 79.2 p -60.74 -15.96 34.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.3 t -85.51 -52.5 5.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -88.26 6.42 37.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.584 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.477 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 12.9 tpt180 -112.7 -36.09 5.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.504 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 61' ' ' SER . 53.8 t30 -52.37 -47.14 66.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.474 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -74.45 -49.71 21.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.41 93.54 0.71 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -118.22 -178.92 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -1.163 . . . . 0.0 109.407 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -120.64 104.45 9.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.171 -0.955 . . . . 0.0 109.505 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 t -137.93 123.1 19.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.439 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.89 69.58 0.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -0.926 . . . . 0.0 109.459 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.51 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.1 p-80 -156.18 178.43 10.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.401 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 139.42 52.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -60.56 153.34 23.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.933 . . . . 0.0 109.216 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 74' ' ' ALA . 2.2 mmt85 -149.95 125.6 10.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.472 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 1.4 tt0 -51.11 140.03 16.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 78' ' ' THR . 54.5 t -56.68 165.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.507 ' N ' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -163.96 164.25 23.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.503 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.01 -37.68 33.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.292 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.48 ' O ' ' OG1' ' A' ' 84' ' ' THR . 1.1 tp10 -59.98 -52.7 64.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.884 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.458 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 1.1 m-20 -54.28 -49.39 69.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.142 -0.973 . . . . 0.0 110.11 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 62.9 m-85 -48.85 -68.74 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.145 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.464 ' O ' ' HD3' ' A' ' 110' ' ' ARG . 4.1 p -66.38 -10.86 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.233 -0.917 . . . . 0.0 109.994 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.487 HG23 ' CD2' ' A' ' 85' ' ' PHE . 3.3 m -78.43 -85.14 0.07 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.583 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 51.9 m-85 -62.09 132.63 53.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.587 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -72.11 -15.17 61.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.857 . . . . 0.0 109.465 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.7 m-85 -124.89 136.35 53.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.32 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.586 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 2.0 mt -142.74 89.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 109.254 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.56 HD12 ' CD2' ' A' ' 152' ' ' PHE . 0.1 OUTLIER -112.79 148.18 35.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.872 -1.143 . . . . 0.0 109.547 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.766 ' SG ' HD11 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -99.22 -179.58 4.28 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.262 -0.899 . . . . 0.0 108.654 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.822 ' CE ' ' SG ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -76.01 1.54 15.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.088 -1.007 . . . . 0.0 109.604 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.472 ' OD2' ' HA ' ' A' ' 128' ' ' GLU . 20.3 p30 178.34 -165.36 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.126 -0.984 . . . . 0.0 109.382 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.417 ' HG3' HD21 ' A' ' 115' ' ' LEU . 1.9 tt0 -97.0 -31.11 12.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.714 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.4 p -45.37 -41.17 8.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.928 . . . . 0.0 109.79 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -90.01 -26.35 20.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.206 -0.934 . . . . 0.0 109.795 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -62.15 -28.92 69.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.105 -0.997 . . . . 0.0 109.717 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -49.97 -21.87 1.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.702 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -104.09 -33.33 8.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.766 HD11 ' SG ' ' A' ' 90' ' ' CYS . 11.2 mt -74.09 -7.69 53.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.854 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' HB2' HD21 ' A' ' 96' ' ' LEU . 54.2 t-20 -90.33 -23.06 21.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -96.67 -9.17 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 109.698 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -73.36 -26.79 61.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.602 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.402 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 1.1 p -52.89 -42.37 65.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.566 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.37 -61.28 2.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.478 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.28 -21.32 5.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.247 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 109' ' ' CYS . 97.6 t -79.68 130.21 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.511 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -76.47 117.84 18.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.272 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.4 42.7 27.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 109.233 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.14 144.65 6.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.825 . . . . 0.0 109.946 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -135.17 2.51 3.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 0.0 109.202 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -80.71 102.01 9.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.118 -0.989 . . . . 0.0 109.904 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.46 95.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 2.1 mm -65.33 158.44 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.071 -1.018 . . . . 0.0 110.321 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.522 ' CA ' HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 177.31 -168.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 0.8 OUTLIER -147.21 147.88 30.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.048 -1.032 . . . . 0.0 109.68 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.703 HD23 ' SG ' ' A' ' 148' ' ' CYS . 69.0 tp -53.1 99.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . -175.24 177.18 47.26 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 1.7 m 79.6 -73.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.969 . . . . 0.0 109.689 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -100.67 57.82 0.92 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.949 . . . . 0.0 109.395 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -116.78 144.05 32.63 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.387 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CB ' ' NH2' ' A' ' 147' ' ' ARG . 55.7 Cg_endo -72.9 -163.56 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.887 1.725 . . . . 0.0 110.214 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER 73.58 -151.66 0.05 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.599 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.44 ' O ' ' HE3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -126.05 77.67 1.7 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.459 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.91 43.94 26.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.48 143.85 26.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.857 . . . . 0.0 109.487 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.1 mm -138.12 130.29 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 127' ' ' ILE . 10.9 tt -84.42 71.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.259 -0.9 . . . . 0.0 109.017 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.472 ' HA ' ' OD2' ' A' ' 92' ' ' ASP . 2.4 mt-10 -72.06 -67.47 0.54 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.732 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.49 79.36 54.52 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.723 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.44 ' HG3' ' CG1' ' A' ' 127' ' ' ILE . 53.6 Cg_endo -72.43 -21.05 23.2 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.968 1.779 . . . . 0.0 110.078 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.55 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 10.1 t80 -59.5 -24.7 63.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -111.25 84.32 1.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.878 . . . . 0.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -130.68 -135.96 3.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -122.4 -157.32 0.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -1.101 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.08 -22.0 12.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.43 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.72 25.21 2.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.407 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 138' ' ' PHE . 10.1 t0 -122.84 -142.55 0.32 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.271 -0.893 . . . . 0.0 109.151 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ASP . 1.3 t80 82.73 -42.98 0.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.554 -0.716 . . . . 0.0 109.793 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.07 -35.67 80.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.989 -1.069 . . . . 0.0 109.41 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.8 m -66.9 -28.66 68.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.275 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.513 HG11 ' N ' ' A' ' 142' ' ' TYR . 2.3 p -60.54 -30.84 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.274 -0.891 . . . . 0.0 109.366 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.513 ' N ' HG11 ' A' ' 141' ' ' VAL . 1.7 t80 -85.09 -53.13 5.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 0.0 109.271 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -28.27 10.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.14 -47.74 7.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.487 ' CB ' ' HB ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -53.57 -21.87 7.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.333 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.521 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 60.2 t -51.03 -55.18 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.228 -0.92 . . . . 0.0 109.286 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.529 ' NH2' ' CB ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -79.13 -18.46 53.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.292 -0.88 . . . . 0.0 109.304 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.822 ' SG ' ' CE ' ' A' ' 91' ' ' MET . 36.1 t -46.41 -25.88 0.74 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.088 -1.007 . . . . 0.0 108.844 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.578 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 2.5 p -119.95 -40.68 2.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.421 -0.8 . . . . 0.0 109.274 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.482 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 7.0 ttm-85 -62.23 -52.29 64.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 108.876 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 147' ' ' ARG . . . -58.73 -18.82 34.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.878 . . . . 0.0 108.985 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.56 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -90.23 -25.68 20.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.783 . . . . 0.0 109.6 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . 11.5 tp -75.61 -21.93 57.34 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.048 -1.032 . . . . 0.0 108.688 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -68.31 -48.39 65.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.902 . . . . 0.0 109.223 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -64.56 -48.85 73.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.014 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.473 ' O ' ' HD3' ' A' ' 6' ' ' LYS . 16.2 m -101.41 51.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.112 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.487 -179.833 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.343 0.592 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 3' ' ' GLN . 5.2 tt0 -155.43 145.0 21.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.36 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER 43.88 69.37 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.218 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p -85.23 161.71 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.853 . . . . 0.0 109.803 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.574 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -63.9 101.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.408 -0.807 . . . . 0.0 109.543 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.696 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -44.21 166.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.83 179.226 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.605 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 15.5 p -136.39 112.86 9.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.931 -1.105 . . . . 0.0 109.275 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.546 ' CG1' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -115.71 134.22 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 109.64 -179.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.633 ' CD1' ' CD1' ' A' ' 85' ' ' PHE . 1.9 tp -124.73 118.17 25.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.26 102.34 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.021 -1.049 . . . . 0.0 109.755 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 44' ' ' GLY . 3.0 t -106.26 151.07 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 108.977 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.48 136.56 11.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.954 -1.091 . . . . 0.0 109.815 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.91 117.19 1.77 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 109.057 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.36 75.27 1.18 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.503 ' O ' ' CG ' ' A' ' 20' ' ' PRO . 5.3 t-20 -57.64 -14.99 6.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -1.11 . . . . 0.0 109.625 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' A' ' 17' ' ' CYS . 1.1 pp -111.01 -158.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.999 -1.063 . . . . 0.0 109.301 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER 59.81 115.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.043 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER 77.9 -2.88 2.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.286 -179.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.524 ' O ' ' CD1' ' A' ' 21' ' ' ILE . 1.4 t 45.26 96.85 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 109.856 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 52.8 Cg_exo -48.08 88.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.562 1.508 . . . . 0.0 109.667 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.529 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 2.0 mp -78.21 -11.72 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -0.868 . . . . 0.0 109.946 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.806 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -67.52 -43.18 81.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.99 -1.069 . . . . 0.0 108.976 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ALA . 1.6 tm-20 -76.15 -57.12 4.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.255 -0.903 . . . . 0.0 109.052 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 68' ' ' ILE . . . -44.76 -41.25 6.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.887 . . . . 0.0 108.982 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.539 ' CG1' ' HA ' ' A' ' 146' ' ' VAL . 53.0 t -62.85 -51.23 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.807 . . . . 0.0 109.23 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.586 ' CD1' HG11 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -46.28 -36.72 6.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 108.547 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.475 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -62.07 -52.83 62.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.058 -1.026 . . . . 0.0 108.395 179.066 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -84.18 11.03 8.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 108.955 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.539 HD22 ' CA ' ' A' ' 150' ' ' ARG . 45.5 tp -97.43 -46.97 5.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.401 -0.812 . . . . 0.0 109.107 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.595 ' CG2' ' CA ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -91.09 -39.24 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.488 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 0.4 OUTLIER -69.54 -8.44 47.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.593 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 9.0 t70 -95.99 -15.46 22.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.013 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 4.6 tp60 -102.68 -82.0 0.49 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.488 -0.757 . . . . 0.0 109.245 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 26.0 t30 172.84 46.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.449 -0.782 . . . . 0.0 108.899 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.554 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 1.4 pt -143.64 17.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.793 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.595 ' CA ' ' CG2' ' A' ' 30' ' ' VAL . 79.3 p -85.39 -26.97 26.12 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.792 -1.192 . . . . 0.0 109.355 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -58.49 -27.05 64.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.574 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 2.6 m-20 -118.96 42.69 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.576 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.696 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 11.6 m95 -150.0 119.8 7.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.994 -1.066 . . . . 0.0 110.563 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.62 91.63 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 26' ' ' PHE . 3.2 mt -92.41 129.1 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.918 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -154.2 137.15 15.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.319 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -107.75 178.07 4.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 109.394 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' CG1' ' A' ' 11' ' ' VAL . . . -168.27 171.21 42.46 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.47 ' O ' ' OE1' ' A' ' 76' ' ' GLN . . . -92.85 151.91 19.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -1.138 . . . . 0.0 109.419 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.58 -17.21 6.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.28 -0.888 . . . . 0.0 108.786 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.458 ' O ' ' OE1' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -101.14 -148.34 0.37 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.386 -0.822 . . . . 0.0 109.505 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -150.28 16.11 0.82 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.079 -1.013 . . . . 0.0 109.715 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -100.22 0.22 39.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.6 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.444 ' OD1' ' CB ' ' A' ' 45' ' ' ALA . 8.1 p30 -118.6 5.8 11.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.9 t -56.29 110.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.473 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.55 29.84 9.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.426 ' C ' HG23 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -123.59 131.88 53.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 109.352 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 10.1 p -95.12 162.5 24.66 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 54' ' ' SER . 52.7 Cg_exo -50.99 144.42 27.92 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.974 1.783 . . . . 0.0 110.166 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.406 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 8.0 m-20 -53.54 153.04 8.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.457 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' O ' HG13 ' A' ' 60' ' ' VAL . 50.1 Cg_endo -71.14 -15.05 32.07 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.043 1.829 . . . . 0.0 110.116 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -37.46 16.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 19' ' ' SER . . . -90.15 -11.57 40.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.504 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -74.63 -30.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.497 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.89 0.18 21.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.586 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 66' ' ' HIS . 57.9 m -90.0 -18.44 26.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.322 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.12 -52.79 4.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.175 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -64.87 -10.44 28.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.875 . . . . 0.0 109.62 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.65 -85.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.604 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.564 ' CD2' HG12 ' A' ' 68' ' ' ILE . 1.7 p-80 -60.55 -25.42 66.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 109.555 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.26 107.62 1.66 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.564 HG12 ' CD2' ' A' ' 66' ' ' HIS . 17.1 mm -148.54 154.33 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -1.157 . . . . 0.0 109.493 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.505 ' ND2' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -137.52 119.35 15.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.483 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 t -121.57 174.98 6.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.981 . . . . 0.0 109.453 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -167.9 75.27 0.13 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -169.33 134.01 1.45 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.2 tptt -95.34 59.23 2.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.206 -0.934 . . . . 0.0 109.495 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' ARG . . . 51.79 -92.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.682 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER 59.53 151.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 109.534 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.47 ' OE1' ' O ' ' A' ' 45' ' ' ALA . 34.2 tp60 -90.27 133.52 34.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 78' ' ' THR . 47.5 t -45.32 161.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.494 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.463 ' N ' ' CG1' ' A' ' 77' ' ' VAL . 0.2 OUTLIER -126.14 170.55 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.727 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HG2' HG12 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -58.11 -53.52 57.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.862 . . . . 0.0 109.534 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' ' OG1' ' A' ' 84' ' ' THR . 9.6 tt0 -50.59 -42.81 56.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 109.746 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.451 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 6.7 m-20 -58.56 -42.19 87.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.673 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.568 ' CE2' HD21 ' A' ' 99' ' ' LEU . 10.5 m-85 -57.22 -51.2 70.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 109.334 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.557 ' CG2' ' CB ' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -80.17 -5.35 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.988 -1.07 . . . . 0.0 109.68 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 16.2 m -81.27 -58.7 2.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -0.831 . . . . 0.0 110.236 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.633 ' CD1' ' CD1' ' A' ' 9' ' ' LEU . 38.8 m-85 -77.54 165.2 24.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 110.192 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -108.68 -36.69 6.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -0.807 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -109.44 78.77 1.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 108.651 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.589 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 3.2 mt -86.44 87.26 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.915 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -96.98 174.75 6.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.025 -1.047 . . . . 0.0 109.205 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.53 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 1.1 p -149.93 148.2 28.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.383 -0.823 . . . . 0.0 109.375 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.621 ' HE1' ' SG ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -49.27 147.71 2.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 109.295 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.533 ' CB ' HG21 ' A' ' 126' ' ' ILE . 0.7 OUTLIER -52.23 -20.31 2.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 109.794 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 92' ' ' ASP . 2.3 mt-10 -43.02 -69.04 0.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 96' ' ' LEU . 12.2 t -87.34 85.62 7.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.904 . . . . 0.0 108.83 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.498 ' O ' ' C ' ' A' ' 96' ' ' LEU . 20.2 t-20 -50.28 86.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.752 -0.592 . . . . 0.0 110.285 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.557 ' CD2' ' CG2' ' A' ' 113' ' ' ILE . 0.7 OUTLIER 29.93 51.7 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.185 0.517 . . . . 0.0 110.683 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.421 ' HG2' ' N ' ' A' ' 98' ' ' ASP . 3.0 ttt85 -88.08 -91.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 109.59 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -57.22 -50.71 72.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 109.619 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.568 HD21 ' CE2' ' A' ' 82' ' ' PHE . 5.0 mt -48.89 -26.97 2.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 0.0 109.678 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.468 ' HB2' HD21 ' A' ' 96' ' ' LEU . 34.4 t-20 -79.85 -38.31 33.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.96 3.06 54.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.626 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.476 ' CB ' ' CE2' ' A' ' 82' ' ' PHE . 23.8 mmmt -84.88 -25.77 27.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.331 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -29.16 68.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -68.32 -60.21 2.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -54.42 -23.55 16.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 109.136 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.483 HG13 ' HA ' ' A' ' 109' ' ' CYS . 38.8 t -82.3 105.71 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.426 -0.796 . . . . 0.0 109.415 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -44.31 117.27 1.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.546 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 107' ' ' LYS . 5.4 m-20 42.83 58.26 3.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.649 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -47.76 164.26 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.33 -0.856 . . . . 0.0 110.333 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.649 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 1.8 tpt180 -150.54 61.1 0.95 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.589 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -147.15 89.72 1.82 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.253 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 111' ' ' ALA . 6.1 mtpp -44.0 110.17 0.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.557 ' CG2' ' CD2' ' A' ' 96' ' ' LEU . 2.1 mm -87.2 144.42 9.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.036 -1.04 . . . . 0.0 110.503 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -163.95 -179.64 6.39 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.472 ' CD1' ' OD2' ' A' ' 92' ' ' ASP . 1.0 OUTLIER -132.35 146.3 51.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.94 -1.1 . . . . 0.0 109.482 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.773 HD12 ' SG ' ' A' ' 148' ' ' CYS . 1.4 tp -43.97 120.21 2.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.36 157.98 23.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.48 100.7 0.38 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -1.123 . . . . 0.0 109.523 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -90.18 -87.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -0.873 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.58 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -67.01 -61.62 4.63 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.695 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 55.2 Cg_endo -71.9 162.45 41.9 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.765 1.643 . . . . 0.0 110.361 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -108.69 24.52 12.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.53 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.95 104.76 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.942 . . . . 0.0 109.633 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.98 60.85 6.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.464 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -109.12 -54.35 2.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 109.513 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.533 HG21 ' CB ' ' A' ' 92' ' ' ASP . 8.2 mm 61.8 145.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.421 ' N ' HG21 ' A' ' 126' ' ' ILE . 77.3 mt -109.04 93.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.398 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.527 ' CG ' ' OD1' ' A' ' 92' ' ' ASP . 34.4 mt-10 -124.29 8.35 8.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.577 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -94.56 146.56 31.69 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.451 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.94 170.75 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.928 1.752 . . . . 0.0 110.232 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CD1' ' A' ' 131' ' ' TYR . 14.2 p90 -103.11 125.89 50.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.458 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -146.69 111.24 5.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.865 . . . . 0.0 109.467 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -45.91 95.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 132' ' ' TYR . 1.3 m-80 -135.35 6.73 3.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -1.187 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' A' ' 136' ' ' ALA . 1.3 m-20 70.54 164.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 135' ' ' ASP . . . 73.77 5.29 4.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.492 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -135.4 105.48 6.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.555 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -174.86 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.541 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -86.31 -17.1 35.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.531 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 36.7 m -82.4 -25.0 34.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.753 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 74.2 t -76.55 -44.86 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 142' ' ' TYR . 2.6 t80 -74.74 -38.32 62.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.572 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -61.66 -61.52 2.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 148' ' ' CYS . 4.0 mt-30 -61.74 -29.36 70.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 109.507 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.806 ' SG ' ' N ' ' A' ' 22' ' ' ALA . 4.7 m -58.88 -40.2 83.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 109.68 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.539 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 84.0 t -51.57 -72.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 109.53 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -11.29 39.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.419 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 116' ' ' LEU . 20.2 t -53.78 -26.2 22.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.102 -0.999 . . . . 0.0 108.797 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.599 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -119.11 -30.57 4.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.394 -0.816 . . . . 0.0 109.251 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.539 ' CA ' HD22 ' A' ' 29' ' ' LEU . 11.0 ttt180 -67.48 -52.42 39.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.937 . . . . 0.0 108.856 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -55.9 -21.38 20.0 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.449 -0.782 . . . . 0.0 109.023 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.517 ' O ' ' CG2' ' A' ' 156' ' ' VAL . 1.5 t80 -90.63 -27.44 19.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.517 -0.74 . . . . 0.0 109.815 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.472 HD22 HD11 ' A' ' 35' ' ' ILE . 7.5 tp -78.06 -25.2 47.61 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.992 -1.067 . . . . 0.0 108.741 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.28 -51.15 60.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.922 . . . . 0.0 109.18 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -55.3 25.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.395 -0.816 . . . . 0.0 109.336 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 152' ' ' PHE . 18.6 m -95.4 43.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.262 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.417 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 1.8 tmm_? . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.567 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 54.72 175.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.31 -0.869 . . . . 0.0 109.502 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -102.33 -169.14 1.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.373 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 6' ' ' LYS . 3.9 p -64.71 151.23 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.563 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 18.1 p -49.99 90.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 0.0 109.571 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.633 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.7 OUTLIER -45.19 170.14 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.035 -1.04 . . . . 0.0 109.396 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.55 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -142.39 146.91 35.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.029 -1.045 . . . . 0.0 109.811 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.585 HG13 ' CE2' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -150.78 146.08 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 109.037 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.56 HD12 ' CD1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -133.01 126.74 32.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.722 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.529 ' CE1' ' HE2' ' A' ' 91' ' ' MET . 0.6 OUTLIER -109.18 124.39 50.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 108.897 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 2.1 t -125.35 158.19 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 91' ' ' MET . 0.6 OUTLIER -177.99 131.2 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.794 . . . . 0.0 109.185 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.491 ' HB2' ' ND2' ' A' ' 95' ' ' ASN . 0.7 OUTLIER -43.7 149.98 0.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 109.579 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.456 ' HA2' ' OD1' ' A' ' 50' ' ' ASN . . . 46.76 66.57 1.74 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.511 ' ND2' ' HG3' ' A' ' 20' ' ' PRO . 2.7 t-20 -88.8 67.64 8.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -1.113 . . . . 0.0 109.695 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -138.71 6.46 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.154 -0.966 . . . . 0.0 109.731 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.621 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 1.7 p 179.75 138.21 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.017 . . . . 0.0 109.618 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.621 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 1.9 mtm180 83.6 -48.6 0.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.815 -0.553 . . . . 0.0 109.65 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.615 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -82.97 -48.53 0.79 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 110.175 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 19' ' ' SER . 63.4 Cg_exo -49.58 -19.4 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.957 1.771 . . . . 0.0 111.047 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.587 HG22 ' CD2' ' A' ' 142' ' ' TYR . 2.5 mp -64.29 -44.93 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.87 -1.144 . . . . 0.0 109.4 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.756 ' CB ' ' SG ' ' A' ' 145' ' ' CYS . . . -61.36 -35.29 77.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.507 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' OE2' ' HB2' ' A' ' 43' ' ' SER . 2.4 tt0 -70.19 -69.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.317 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HB3' ' CG2' ' A' ' 68' ' ' ILE . . . -43.64 -33.31 1.17 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.135 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 21' ' ' ILE . 58.7 t -65.26 -49.62 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.864 . . . . 0.0 108.754 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.585 ' CE2' HG13 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -50.41 -29.85 11.09 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.47 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -68.48 -50.71 50.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 109.2 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -20.07 66.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.457 HD23 ' HG3' ' A' ' 150' ' ' ARG . 11.5 mt -86.97 -28.34 22.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.047 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 36' ' ' SER . 2.5 p -90.22 -8.85 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -107.96 0.95 22.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -115.01 45.93 1.52 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.004 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.548 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -178.7 29.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.5 t30 45.35 45.88 10.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.548 ' CG2' ' HB3' ' A' ' 33' ' ' GLN . 1.3 tt -127.39 -1.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.229 0.538 . . . . 0.0 109.795 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 30' ' ' VAL . 45.8 t -74.08 -45.83 46.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.737 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 5' ' ' THR . 0.4 OUTLIER -59.87 -12.67 8.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 110.225 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.563 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 0.9 OUTLIER -116.02 37.28 3.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.986 -1.071 . . . . 0.0 109.993 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.633 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 12.8 m95 -150.48 157.76 43.38 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.854 -1.153 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.87 72.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.565 HG22 ' CD2' ' A' ' 26' ' ' PHE . 2.5 mp -89.47 141.13 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 110.248 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -148.23 -165.83 2.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.503 -0.748 . . . . 0.0 109.048 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -165.67 165.82 18.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.685 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . 178.39 -170.48 42.56 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.38 -176.67 3.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.199 . . . . 0.0 109.346 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.443 ' CG1' ' HG ' ' A' ' 99' ' ' LEU . 39.3 t -93.7 -0.37 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.823 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.56 -178.24 6.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.505 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 2.0 p-10 -84.3 69.36 10.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -99.26 -77.68 0.52 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.423 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.456 ' OD1' ' HA2' ' A' ' 14' ' ' GLY . 30.5 m120 -96.0 37.67 1.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.357 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 80.1 t -64.33 106.84 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' A' ' 73' ' ' LYS . . . 106.69 -34.14 5.93 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 1.5 mtt180 -61.59 96.91 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -1.174 . . . . 0.0 109.487 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.75 164.55 1.59 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 56' ' ' ASP . 53.4 Cg_exo -50.57 119.52 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.035 1.823 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -43.41 150.07 0.54 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.688 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.523 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 50.9 Cg_exo -52.13 -18.03 6.73 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.098 1.865 . . . . 0.0 110.613 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -78.76 -46.04 19.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.052 -1.03 . . . . 0.0 109.889 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . . . -90.04 1.91 55.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -0.937 . . . . 0.0 110.055 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 5.5 p -90.02 -44.61 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.048 -1.032 . . . . 0.0 109.681 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.517 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 53.3 p -79.07 -15.56 58.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.599 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -73.8 -27.6 61.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 109.349 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.586 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -89.44 -52.57 4.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 108.943 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -14.09 16.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.814 . . . . 0.0 109.554 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -68.23 -61.06 2.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.547 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -69.67 -35.21 74.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.155 -0.966 . . . . 0.0 109.598 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 68' ' ' ILE . . . 141.11 -10.11 2.77 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.524 ' CG2' ' HB3' ' A' ' 24' ' ' ALA . 17.0 mm -43.82 159.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -1.154 . . . . 0.0 109.626 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.49 ' N ' HG23 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -131.5 175.37 9.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -160.09 -86.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.474 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . 65.62 16.76 10.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.574 ' CE1' ' OD1' ' A' ' 42' ' ' ASP . 24.8 t60 -126.4 149.35 49.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.953 . . . . 0.0 109.46 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 0.4 OUTLIER -101.58 140.99 35.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.491 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 73' ' ' LYS . . . -42.56 -66.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.822 . . . . 0.0 109.723 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 65.31 164.9 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.343 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 77' ' ' VAL . 47.8 tt0 -100.98 156.01 17.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.491 HG11 ' N ' ' A' ' 78' ' ' THR . 91.7 t -81.22 146.96 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.925 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.491 ' N ' HG11 ' A' ' 77' ' ' VAL . 0.8 OUTLIER -142.61 161.1 38.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.521 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.508 ' CG ' HG11 ' A' ' 106' ' ' VAL . 2.4 tmtt? -42.87 -34.77 1.01 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.469 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' O ' ' OG1' ' A' ' 84' ' ' THR . 1.0 OUTLIER -61.57 -53.25 58.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.879 . . . . 0.0 109.681 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 3.5 m-20 -66.93 -19.01 65.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 109.823 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.777 ' HB3' ' SG ' ' A' ' 109' ' ' CYS . 13.1 m-85 -68.88 -68.59 0.39 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 109.532 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.474 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 9.9 p -67.29 -23.25 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 4.6 m -60.65 -67.59 0.38 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.56 ' CD1' HD12 ' A' ' 9' ' ' LEU . 82.5 m-85 -74.83 156.21 36.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 0.0 109.532 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -90.32 -36.33 14.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.322 -0.861 . . . . 0.0 109.387 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 7' ' ' SER . 17.5 m-85 -109.77 151.91 26.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.575 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.596 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 1.7 mt -153.69 80.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 108.833 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.467 HD22 ' CE1' ' A' ' 152' ' ' PHE . 0.1 OUTLIER -91.58 -174.75 3.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 109.583 -179.436 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.736 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -148.31 172.15 14.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.303 -0.873 . . . . 0.0 109.212 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.736 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -84.54 45.4 1.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 109.704 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.463 ' OD2' ' CG2' ' A' ' 127' ' ' ILE . 2.6 m-20 65.15 -144.52 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.537 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 128' ' ' GLU . 27.6 mt-10 73.5 158.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.6 m -81.08 6.41 13.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.624 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 13' ' ' LEU . 2.9 m120 -71.8 -9.32 58.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.473 HD23 HG23 ' A' ' 113' ' ' ILE . 4.4 mt -81.45 -10.16 59.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.414 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -61.28 -21.84 64.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.01 -39.58 8.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.833 . . . . 0.0 109.467 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.443 ' HG ' ' CG1' ' A' ' 46' ' ' VAL . 8.6 mt -66.94 -18.76 65.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.93 . . . . 0.0 109.39 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -77.89 -33.48 51.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.86 -19.92 24.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -57.3 -35.09 69.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 109.452 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.528 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 0.3 OUTLIER -50.2 -49.09 53.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.375 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -64.71 -36.23 83.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.136 -0.977 . . . . 0.0 109.436 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.59 -4.8 55.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.212 -0.93 . . . . 0.0 109.473 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.841 ' CB ' ' SG ' ' A' ' 109' ' ' CYS . 41.2 t -86.32 117.98 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 108' ' ' ASN . 0.1 OUTLIER -53.14 105.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 108.644 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.447 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 15.7 m120 60.52 70.68 0.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.033 -1.042 . . . . 0.0 108.576 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.841 ' SG ' ' CB ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -88.57 136.44 32.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 110.364 -179.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.485 ' O ' ' HG3' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -128.96 1.81 5.31 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.596 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -83.3 110.58 18.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.446 -0.784 . . . . 0.0 110.164 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.16 125.39 26.23 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -100.04 132.0 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.94 -1.1 . . . . 0.0 110.29 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 10.3 mt-10 -163.79 -174.04 3.49 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -125.24 165.87 17.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.767 ' CD2' ' SG ' ' A' ' 148' ' ' CYS . 3.5 tp -42.51 -74.4 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.701 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.88 -110.73 3.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.565 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 1.8 t -151.56 136.24 17.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.461 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 118' ' ' SER . 23.9 m-85 -136.76 32.14 2.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.929 . . . . 0.0 109.586 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 163.06 -51.53 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.0 Cg_exo -49.46 162.62 0.53 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.799 1.666 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.77 45.04 1.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.883 . . . . 0.0 109.43 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 166.43 33.24 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -0.971 . . . . 0.0 109.413 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.03 90.08 4.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.343 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tt -103.04 138.68 39.57 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -0.925 . . . . 0.0 109.614 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.473 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 12.0 mm -143.93 125.95 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.398 -0.813 . . . . 0.0 109.301 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.493 ' O ' HG21 ' A' ' 127' ' ' ILE . 1.5 tt -105.08 78.22 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 109.113 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 129' ' ' ASP . 6.7 mt-10 -77.12 -95.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 128' ' ' GLU . 2.0 m-20 47.51 95.12 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.323 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 131' ' ' TYR . 69.4 Cg_exo -47.33 -67.84 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.774 1.65 . . . . 0.0 110.347 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 130' ' ' PRO . 20.9 t80 178.83 61.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.505 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' GLY . 87.9 m-85 -141.14 16.92 2.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.457 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 132' ' ' TYR . . . 59.23 154.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -120.96 -26.81 5.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -1.114 . . . . 0.0 109.471 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.84 -160.92 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.362 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.67 77.34 6.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.405 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.21 108.96 4.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.519 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 8.9 t80 -123.23 -51.28 1.88 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.497 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -69.62 -33.28 72.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.503 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.2 m -49.2 -43.87 42.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.464 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.7 t -65.9 -48.2 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.848 . . . . 0.0 109.493 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.587 ' CD2' HG22 ' A' ' 21' ' ' ILE . 2.8 t80 -53.0 -27.98 21.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.332 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -83.73 -38.29 21.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.82 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -75.54 -11.43 60.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.686 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.762 ' HA ' ' SG ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -89.97 -10.35 45.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.527 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 53.5 t -62.01 -48.94 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 109.234 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 1.2 mtt180 -79.72 -15.0 58.34 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.178 -0.951 . . . . 0.0 109.376 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.767 ' SG ' ' CD2' ' A' ' 116' ' ' LEU . 21.2 m -50.16 -24.0 2.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.086 -1.009 . . . . 0.0 108.635 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.676 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -120.18 -39.17 2.83 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.443 -0.786 . . . . 0.0 109.025 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.457 ' HG3' HD23 ' A' ' 29' ' ' LEU . 13.7 ttp85 -63.6 -53.71 47.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 108.703 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 147' ' ' ARG . . . -60.17 -36.13 76.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -0.774 . . . . 0.0 109.175 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.569 ' CE2' HG22 ' A' ' 156' ' ' VAL . 6.8 t80 -74.84 -19.12 60.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.384 -0.822 . . . . 0.0 109.515 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.455 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 14.4 tp -77.96 -19.59 54.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.099 -1.0 . . . . 0.0 108.744 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -70.59 -46.89 62.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 108.769 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -66.74 -53.71 30.48 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 0.0 108.986 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.569 HG22 ' CE2' ' A' ' 152' ' ' PHE . 5.7 m -92.72 34.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 109.086 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.455 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 117.944 -1.026 . . . . 0.0 109.587 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 2.1 tt0 68.12 34.53 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.834 . . . . 0.0 109.526 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.61 42.68 3.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.16 162.84 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.579 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 65.8 p -74.68 108.82 7.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.661 ' CB ' ' CH2' ' A' ' 39' ' ' TRP . 35.8 mttp -63.7 -168.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.9 -1.125 . . . . 0.0 108.993 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.575 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -145.99 107.28 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 109.834 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.6 HG11 ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -111.86 150.57 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.576 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 1.4 tt -149.83 104.17 3.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.139 -0.975 . . . . 0.0 109.555 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.476 ' CZ ' HD13 ' A' ' 116' ' ' LEU . 2.8 m-85 -81.96 164.38 21.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.95 . . . . 0.0 109.379 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 90' ' ' CYS . 58.5 t -150.31 161.87 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.133 -0.979 . . . . 0.0 109.936 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.542 ' SG ' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -178.4 142.09 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.39 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.475 HD13 ' CH2' ' A' ' 49' ' ' TRP . 13.2 tp -43.58 -79.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.686 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 15' ' ' ASN . . . -46.99 -74.33 0.25 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.513 ' CB ' ' O ' ' A' ' 14' ' ' GLY . 25.8 t30 76.61 20.47 1.42 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -1.124 . . . . 0.0 109.321 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 15' ' ' ASN . 1.2 pp -156.65 30.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.444 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.6 m -135.01 -84.84 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.585 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.521 ' HB2' ' CG2' ' A' ' 141' ' ' VAL . 0.0 OUTLIER -115.42 -7.84 12.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -75.06 -51.02 3.68 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.786 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 19' ' ' SER . 55.9 Cg_exo -49.66 -21.23 5.23 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.855 1.703 . . . . 0.0 110.674 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.757 ' HB ' ' SG ' ' A' ' 145' ' ' CYS . 7.9 mm -60.31 -48.6 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.315 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.576 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -64.72 -20.27 66.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.932 . . . . 0.0 109.738 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.513 ' OE1' ' CB ' ' A' ' 43' ' ' SER . 4.7 mt-10 -77.22 -81.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.12 -0.987 . . . . 0.0 109.521 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.518 ' CB ' HG12 ' A' ' 68' ' ' ILE . . . -45.21 -40.28 7.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.31 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 21' ' ' ILE . 54.1 t -59.87 -51.34 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.22 -0.925 . . . . 0.0 109.402 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.637 ' CE1' ' CG1' ' A' ' 30' ' ' VAL . 1.2 t80 -46.41 -42.06 14.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.024 . . . . 0.0 108.698 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -55.12 -59.81 4.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.533 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 0.1 OUTLIER -76.73 2.88 13.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.823 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 146' ' ' VAL . 3.2 mt -94.0 -29.89 15.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.149 -0.97 . . . . 0.0 108.733 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.637 ' CG1' ' CE1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -84.54 -42.51 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.56 ' CA ' ' HB3' ' A' ' 36' ' ' SER . 1.9 t -42.47 -28.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 30' ' ' VAL . 5.7 t70 -58.07 -55.34 36.15 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.474 -0.766 . . . . 0.0 108.992 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.548 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -73.08 -2.79 22.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.91 . . . . 0.0 109.368 179.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.5 OUTLIER 79.91 54.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.395 -0.815 . . . . 0.0 109.589 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.544 HG13 ' CG2' ' A' ' 30' ' ' VAL . 5.7 pt -144.78 9.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.141 -0.974 . . . . 0.0 109.987 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.633 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 9.7 p -69.16 -22.88 63.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.85 -1.156 . . . . 0.0 109.124 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.74 -20.64 38.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.312 -0.868 . . . . 0.0 108.799 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.579 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 3.0 m-80 -110.31 44.54 1.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -0.845 . . . . 0.0 109.283 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.661 ' CH2' ' CB ' ' A' ' 6' ' ' LYS . 10.9 m95 -150.66 129.46 12.42 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.611 -1.236 . . . . 0.0 110.746 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.441 HG13 ' CE2' ' A' ' 85' ' ' PHE . 56.6 t -99.14 79.21 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.567 HG12 ' CD2' ' A' ' 26' ' ' PHE . 6.9 mt -89.9 128.2 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.934 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.567 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -137.24 -159.53 0.96 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.482 -0.761 . . . . 0.0 109.06 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.513 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 60.3 p -151.85 172.53 16.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.112 -0.992 . . . . 0.0 109.852 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 10' ' ' PHE . . . -146.8 163.45 28.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' A' ' 46' ' ' VAL . . . -128.92 -29.53 2.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -1.184 . . . . 0.0 109.878 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 45' ' ' ALA . 15.8 t 67.23 9.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 109.332 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.579 ' HB3' ' CE2' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -125.43 141.19 52.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.905 . . . . 0.0 109.358 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -84.01 6.28 22.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.697 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.628 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -102.9 -33.56 9.28 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 109.409 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 3.2 m120 -91.98 12.65 21.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.086 -1.009 . . . . 0.0 109.397 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 76' ' ' GLN . 13.3 t -75.33 85.22 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.74 -5.38 9.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.425 ' CD ' ' HA ' ' A' ' 50' ' ' ASN . 18.5 mtp180 -79.64 104.16 10.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -1.188 . . . . 0.0 109.468 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -66.04 173.98 1.89 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.375 -0.828 . . . . 0.0 109.59 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 53.3 Cg_exo -50.75 137.96 41.78 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.066 1.844 . . . . 0.0 110.288 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.37 145.71 66.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.416 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HA ' HG13 ' A' ' 60' ' ' VAL . 52.5 Cg_exo -50.5 -22.38 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.969 1.78 . . . . 0.0 110.345 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -85.55 -37.71 19.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.534 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.88 -4.91 59.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 109.674 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 57' ' ' PRO . 9.9 p -80.82 -28.37 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -81.98 -19.01 41.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.498 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.463 ' HB3' HD22 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -74.05 -33.91 63.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.511 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.14 -56.16 3.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.135 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -22.62 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.417 -0.802 . . . . 0.0 109.744 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 61' ' ' SER . 52.2 t-20 -70.66 -50.89 31.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.67 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -83.48 -5.04 59.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.945 . . . . 0.0 109.696 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.66 102.3 0.26 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.518 HG12 ' CB ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -126.23 -33.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -1.118 . . . . 0.0 109.56 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 13.0 m-80 70.77 49.42 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.355 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.85 142.39 57.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.85 18.17 1.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.502 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.547 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.4 p-80 -103.01 155.42 18.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' ALA . 11.9 tptt -124.75 26.77 7.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 73' ' ' LYS . . . 56.94 161.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.611 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.418 ' HG3' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -168.27 171.74 9.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.407 -0.808 . . . . 0.0 109.256 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.472 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 2.6 tt0 -93.19 21.2 6.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.321 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 78' ' ' THR . 0.8 OUTLIER 52.2 178.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 109.598 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER 176.0 162.86 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.522 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -44.11 -35.99 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 109.469 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 84' ' ' THR . 2.9 tp10 -59.61 -48.86 80.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.783 . . . . 0.0 109.555 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' HD13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -65.3 -13.3 58.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.58 ' CD2' HG23 ' A' ' 106' ' ' VAL . 6.3 m-85 -80.64 -75.86 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.46 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 14.8 p -54.08 -38.05 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 108.81 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.495 ' CB ' ' O ' ' A' ' 80' ' ' GLU . 38.8 m -58.02 -65.34 0.66 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.657 -0.652 . . . . 0.0 109.451 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 79.2 m-85 -81.36 125.3 30.21 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.33 -0.856 . . . . 0.0 109.499 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -73.8 -17.08 61.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.312 -0.867 . . . . 0.0 109.406 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 7' ' ' SER . 4.4 m-85 -130.07 131.08 45.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 109.861 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.592 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 5.1 mt -135.48 88.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 108.754 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -104.74 165.48 11.03 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.856 -1.152 . . . . 0.0 109.968 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.657 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -143.43 166.77 23.85 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.657 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -68.47 139.88 55.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.325 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.487 ' HB2' HD13 ' A' ' 126' ' ' ILE . 52.9 t0 -43.88 126.02 4.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 1.2 tt0 176.21 161.31 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.294 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -75.76 -6.86 52.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -74.73 -7.87 54.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.913 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.638 ' HG ' ' SG ' ' A' ' 90' ' ' CYS . 0.6 OUTLIER -89.19 7.04 37.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.937 . . . . 0.0 109.645 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -14.73 58.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 99' ' ' LEU . 2.8 p30 -92.77 -33.64 14.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.553 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.53 ' HB2' ' CD2' ' A' ' 96' ' ' LEU . 20.3 mt -71.58 -37.33 71.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.57 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.07 -31.69 71.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.543 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -10.0 45.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.569 ' HB3' ' CE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -71.69 -24.03 61.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.95 . . . . 0.0 109.56 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.8 p -70.02 -11.31 60.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.6 -23.97 21.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.581 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -102.7 8.99 39.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.925 . . . . 0.0 109.499 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.58 HG23 ' CD2' ' A' ' 82' ' ' PHE . 24.4 t -101.85 143.37 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 109.345 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 108' ' ' ASN . 5.7 mtmt -75.31 121.75 22.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 109.298 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 107' ' ' LYS . 2.2 m120 43.78 41.45 3.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.172 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.528 ' CA ' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -42.92 142.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.349 -0.844 . . . . 0.0 110.138 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' A' ' 109' ' ' CYS . 24.5 mmm180 -123.39 -2.57 8.49 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.592 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -84.24 106.68 16.05 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.39 -0.819 . . . . 0.0 110.722 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.95 98.02 2.41 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 1.0 OUTLIER -72.85 131.28 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -0.999 . . . . 0.0 110.483 -178.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.8 tt0 -172.8 148.54 1.86 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 117' ' ' GLY . 1.6 pp -90.66 157.0 17.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.438 -1.414 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -40.13 -68.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.483 -0.761 . . . . 0.0 109.925 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.522 ' N ' HD13 ' A' ' 115' ' ' LEU . . . 66.43 168.82 3.07 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.1 m -69.15 88.91 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.513 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.495 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -63.05 -37.25 86.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.454 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.569 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 166.68 -63.14 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.581 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 45.3 Cg_endo -68.72 -18.19 42.22 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.804 1.669 . . . . 0.0 110.365 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.89 162.27 19.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.27 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 12.5 ptpt -143.35 54.14 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.932 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.449 ' CB ' ' O ' ' A' ' 123' ' ' LYS . 0.6 OUTLIER 71.74 61.11 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.437 ' HB3' ' NE2' ' A' ' 144' ' ' GLN . 0.1 OUTLIER -158.35 44.36 0.3 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.922 . . . . 0.0 109.437 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.532 HD11 ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -89.62 130.84 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.957 . . . . 0.0 109.387 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.532 ' N ' HD11 ' A' ' 126' ' ' ILE . 5.4 mt -41.58 99.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.749 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.452 ' HG2' ' OD2' ' A' ' 92' ' ' ASP . 31.5 mt-10 -117.53 28.94 8.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 0.0 109.38 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.13 148.3 35.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.1 -37.06 5.07 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.013 1.808 . . . . 0.0 110.114 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -161.79 -53.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.238 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -132.85 98.86 4.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.389 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.21 -47.51 89.24 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.15 -164.24 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -1.134 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -104.31 150.76 24.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.925 . . . . 0.0 109.455 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 135' ' ' ASP . . . 70.56 11.38 7.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.57 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.466 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 0.5 OUTLIER -97.51 10.45 39.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.44 ' O ' HG11 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -76.16 -16.12 59.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.476 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -90.06 -51.8 5.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.609 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.73 -19.25 65.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.556 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 142' ' ' TYR . 5.2 p -75.34 -47.4 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.912 . . . . 0.0 109.227 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.597 ' CD2' HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -60.27 -39.5 87.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -39.83 85.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 109.485 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.437 ' NE2' ' HB3' ' A' ' 125' ' ' LEU . 10.7 mm100 -62.95 -33.76 76.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.87 . . . . 0.0 109.356 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.757 ' HA ' ' SG ' ' A' ' 148' ' ' CYS . 1.2 m -62.18 -21.51 65.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 109.498 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.527 ' O ' ' CD1' ' A' ' 29' ' ' LEU . 86.6 t -56.47 -58.67 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 108.882 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -13.18 61.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.248 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.757 ' SG ' ' HA ' ' A' ' 145' ' ' CYS . 99.6 m -62.77 -12.3 23.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.543 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -125.53 -37.33 2.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -59.35 -42.4 91.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 109.158 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.31 -23.36 67.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 109.091 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.625 ' CZ ' ' CG2' ' A' ' 156' ' ' VAL . 1.5 t80 -89.17 -22.95 22.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.829 . . . . 0.0 109.528 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.536 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 21.4 tp -77.12 -18.03 58.22 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.919 -1.113 . . . . 0.0 108.9 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.86 -47.89 19.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.15 -0.969 . . . . 0.0 109.116 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -67.01 -52.74 38.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 108.977 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.625 ' CG2' ' CZ ' ' A' ' 152' ' ' PHE . 31.4 m -95.19 31.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.367 -0.833 . . . . 0.0 109.078 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.536 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.595 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -104.6 115.76 30.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.513 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -76.38 151.63 36.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.326 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 t -133.67 167.06 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.81 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.56 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -78.12 77.93 4.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.427 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.649 ' CG ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -41.22 118.08 0.97 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.342 -0.849 . . . . 0.0 109.657 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -107.01 122.54 46.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.931 -1.105 . . . . 0.0 109.786 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.582 HG13 ' CZ ' ' A' ' 26' ' ' PHE . 0.3 OUTLIER -125.92 122.39 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 0.0 109.543 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' CD2' ' CD2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -122.11 145.24 48.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.27 -0.893 . . . . 0.0 108.89 179.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.556 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 4.0 m-85 -103.86 158.74 16.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.082 -1.011 . . . . 0.0 109.884 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.536 ' CG1' HG21 ' A' ' 46' ' ' VAL . 85.7 t -144.28 147.06 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.416 -0.803 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -160.38 141.46 12.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.534 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' CYS . 9.2 tp -44.49 -68.06 0.23 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.236 -0.915 . . . . 0.0 109.476 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.18 -79.95 0.08 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.479 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 2.0 t-20 65.85 39.19 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.125 -1.221 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 1.7 pp -143.75 13.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.601 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 40.9 t 177.21 -71.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.728 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 19' ' ' SER . 65.6 mtt85 -84.4 75.9 10.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.682 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.581 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 163.19 -50.99 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.697 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 19' ' ' SER . 51.3 Cg_exo -51.59 -19.63 7.71 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.865 1.71 . . . . 0.0 110.589 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.756 HG23 ' SG ' ' A' ' 145' ' ' CYS . 3.4 mt -75.64 -39.77 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.949 . . . . 0.0 109.81 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.786 ' HB2' ' SG ' ' A' ' 148' ' ' CYS . . . -62.99 -40.05 96.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.048 -1.033 . . . . 0.0 109.375 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -70.92 -59.22 2.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.908 . . . . 0.0 109.208 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.57 ' CB ' ' CG2' ' A' ' 68' ' ' ILE . . . -45.95 -34.38 3.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.9 . . . . 0.0 108.992 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.773 HG22 ' SG ' ' A' ' 145' ' ' CYS . 46.0 t -66.25 -47.52 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.35 -0.844 . . . . 0.0 109.284 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.604 ' CD1' HG12 ' A' ' 41' ' ' ILE . 1.9 t80 -47.98 -43.47 29.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.827 -1.171 . . . . 0.0 108.02 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -54.2 -62.86 1.38 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.067 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -79.92 10.76 3.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.271 -0.893 . . . . 0.0 110.221 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.766 HD21 ' SG ' ' A' ' 149' ' ' CYS . 48.7 tp -98.58 -34.68 10.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 108.911 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.602 HG13 ' CD1' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -90.86 -44.44 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.247 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -49.35 -29.1 5.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -0.916 . . . . 0.0 109.138 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -80.68 -37.1 31.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 108.993 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.531 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.5 OUTLIER -73.21 -11.0 60.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.413 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.2 OUTLIER 78.49 32.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.713 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.524 ' CG1' ' CG2' ' A' ' 30' ' ' VAL . 4.6 pt -123.21 3.77 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 109.431 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.593 ' CA ' ' CG2' ' A' ' 30' ' ' VAL . 60.7 p -62.87 -31.38 72.4 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.097 -1.002 . . . . 0.0 109.457 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -54.85 -25.17 26.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.45 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.56 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 0.9 OUTLIER -126.66 40.21 3.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.751 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.635 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 21.9 m95 -146.92 104.78 3.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.968 -1.083 . . . . 0.0 110.33 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 7' ' ' SER . 45.0 t -97.74 106.77 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.604 HG12 ' CD1' ' A' ' 26' ' ' PHE . 3.6 mp -107.37 146.58 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.066 -1.021 . . . . 0.0 110.501 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.52 ' N ' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -140.66 -164.93 1.83 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.792 . . . . 0.0 109.496 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.1 176.89 8.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.377 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -163.86 159.21 31.93 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 46' ' ' VAL . . . -129.78 -31.03 2.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -1.153 . . . . 0.0 109.72 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.536 HG21 ' CG1' ' A' ' 11' ' ' VAL . 3.8 t 74.76 6.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.438 ' HB2' ' CD2' ' A' ' 49' ' ' TRP . 5.5 p -126.5 126.63 44.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.433 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.5 2.59 15.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.577 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -102.27 1.46 35.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -0.997 . . . . 0.0 109.362 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -122.05 8.82 9.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.311 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.0 t -71.51 92.3 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.301 -0.874 . . . . 0.0 109.436 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . 116.41 7.13 14.48 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -84.45 82.94 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -1.165 . . . . 0.0 109.45 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 73' ' ' LYS . 86.1 p -43.63 153.28 0.4 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 0.0 109.482 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 54' ' ' SER . 54.1 Cg_exo -49.98 -176.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.979 1.786 . . . . 0.0 110.258 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.18 139.08 36.47 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.393 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.417 ' O ' HG11 ' A' ' 60' ' ' VAL . 52.3 Cg_exo -51.03 -21.1 8.31 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.879 1.719 . . . . 0.0 110.369 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -87.94 -39.55 14.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.661 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.49 6.3 34.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 61' ' ' SER . 9.9 p -85.39 -38.25 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.421 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 4.2 m -76.55 -15.85 59.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.355 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.439 ' HB3' HD22 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -70.25 -29.43 66.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.846 . . . . 0.0 109.433 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -87.8 -55.32 3.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 108.902 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 -64.09 -10.51 22.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 109.563 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -59.06 -84.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.811 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.449 ' CE1' HG12 ' A' ' 68' ' ' ILE . 8.0 p80 -74.53 -24.91 59.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 109.773 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.458 ' O ' HG12 ' A' ' 68' ' ' ILE . . . 131.32 109.94 1.28 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.57 ' CG2' ' CB ' ' A' ' 24' ' ' ALA . 14.3 mm -150.16 -38.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -1.1 . . . . 0.0 109.603 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 68' ' ' ILE . 4.8 p30 51.63 173.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.81 . . . . 0.0 109.627 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 69' ' ' ASN . 20.5 p -157.43 -54.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 57.81 34.6 24.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.364 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -149.23 124.63 10.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 1.1 tppm? -98.21 27.36 4.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.902 . . . . 0.0 109.575 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 73' ' ' LYS . . . 73.91 131.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.527 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 74' ' ' ALA . 5.5 mmt180 -143.95 142.22 30.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.535 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 77' ' ' VAL . 2.2 tt0 -66.2 119.94 12.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 76' ' ' GLN . 4.1 t -45.43 170.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.485 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -153.78 175.9 12.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.445 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HG2' HG11 ' A' ' 106' ' ' VAL . 2.5 tmtt? -68.05 -45.03 75.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.624 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.459 ' O ' ' OG1' ' A' ' 84' ' ' THR . 37.3 tt0 -57.98 -44.86 87.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.543 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 1.3 m-20 -64.5 -30.35 71.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.801 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 78' ' ' THR . 12.5 m-85 -64.24 -67.01 0.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 109.755 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 84' ' ' THR . 6.0 p -64.08 -20.07 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.481 ' N ' HG11 ' A' ' 83' ' ' VAL . 6.0 m -69.96 -32.68 71.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.367 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 81' ' ' ASP . 27.4 m-85 -106.37 158.45 16.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.488 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' C ' ' CD1' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -108.87 -2.57 18.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.631 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.649 ' CE1' ' CG ' ' A' ' 6' ' ' LYS . 5.8 m-85 -138.42 139.85 39.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -150.78 116.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.233 -0.917 . . . . 0.0 109.288 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.581 HD13 ' CE2' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -129.53 153.98 47.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.315 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -122.72 169.83 10.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.36 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.447 ' O ' ' C ' ' A' ' 92' ' ' ASP . 6.3 mmt -81.06 74.1 8.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.33 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 94' ' ' SER . 0.1 OUTLIER 39.68 -101.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.778 . . . . 0.0 109.853 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 92' ' ' ASP . 45.9 mt-10 42.64 -96.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.072 -1.017 . . . . 0.0 109.262 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 96' ' ' LEU . 1.3 m -88.2 87.31 7.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 108.601 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -39.14 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.081 0.467 . . . . 0.0 110.773 -179.12 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 94' ' ' SER . 0.8 OUTLIER 32.72 36.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.119 0.485 . . . . 0.0 110.394 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 95' ' ' ASN . 7.3 ttt180 -91.21 -17.39 26.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.013 -1.054 . . . . 0.0 110.024 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.7 -51.01 2.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 0.0 110.046 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.476 ' HB3' HG23 ' A' ' 113' ' ' ILE . 11.4 mt -65.73 -18.38 65.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 109.807 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 7.7 t-20 -72.97 -22.91 60.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.969 . . . . 0.0 109.168 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -89.68 -23.41 21.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.285 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 10.9 mmmt -66.37 -30.12 70.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.343 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.0 p -72.87 -21.77 60.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.337 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -71.83 -35.21 69.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.296 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 1.2 pt20 -89.06 2.8 53.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 109.487 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 109' ' ' CYS . 70.8 t -92.99 122.49 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.189 -0.944 . . . . 0.0 109.299 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -56.48 102.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.274 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.431 ' O ' HG22 ' A' ' 83' ' ' VAL . 5.6 m120 52.48 59.22 4.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.146 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.549 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -54.25 156.96 2.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.4 -0.812 . . . . 0.0 109.803 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.549 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 3.1 mtt180 -123.94 -23.06 4.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.445 -0.785 . . . . 0.0 109.367 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.538 ' O ' ' CD1' ' A' ' 113' ' ' ILE . . . -70.55 92.41 0.84 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.377 -0.827 . . . . 0.0 110.278 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 101.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.552 ' CG2' ' CD2' ' A' ' 96' ' ' LEU . 1.8 mm -62.65 160.15 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.217 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 1.7 mt-10 173.82 -169.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.06 156.87 43.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.925 -1.109 . . . . 0.0 109.582 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.428 HD12 ' CA ' ' A' ' 148' ' ' CYS . 1.0 OUTLIER -59.09 -40.91 86.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -48.74 -28.62 7.21 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.79 -49.01 59.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -1.104 . . . . 0.0 109.503 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -86.32 -94.19 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.94 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.474 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 5.3 t70 67.13 67.4 0.61 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.497 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 51.9 Cg_exo -51.62 -173.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.962 1.775 . . . . 0.0 110.208 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 55.07 -92.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.379 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 121' ' ' PRO . 12.0 pttt -102.92 148.34 25.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.337 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -97.26 119.86 36.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -159.03 0.97 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.525 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 1.5 mm -127.92 -2.97 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 126' ' ' ILE . 39.9 mt 60.67 -89.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.145 -0.972 . . . . 0.0 109.265 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.525 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 4.2 mt-10 45.62 68.52 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.547 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.83 119.54 51.07 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.224 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.46 178.1 5.36 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.773 1.649 . . . . 0.0 110.325 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 3.9 m-85 -74.16 -1.31 19.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.649 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -92.01 74.11 5.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.383 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 132' ' ' TYR . . . -57.11 -159.97 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.4 -53.7 5.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -1.167 . . . . 0.0 109.389 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -170.89 101.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.25 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 48.75 30.12 2.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.111 -0.993 . . . . 0.0 109.156 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.87 76.43 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.45 -16.75 17.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.37 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.69 -27.33 27.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' VAL . 54.9 m -56.09 -54.63 42.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.454 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 18' ' ' ARG . 10.0 t -43.56 -55.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.262 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -48.51 -46.53 38.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -58.21 8.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.876 . . . . 0.0 109.798 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -67.68 -7.18 24.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -0.95 . . . . 0.0 109.419 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.773 ' SG ' HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -83.19 -28.56 29.21 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.306 -0.871 . . . . 0.0 109.361 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.531 ' HA ' ' CG1' ' A' ' 25' ' ' VAL . 40.3 t -65.35 -50.73 71.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.259 -0.9 . . . . 0.0 109.309 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.41 -19.19 62.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.084 -1.01 . . . . 0.0 108.831 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.786 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -52.34 -25.03 8.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.285 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.766 ' SG ' HD21 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -112.45 -33.29 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -0.835 . . . . 0.0 109.856 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.516 ' N ' ' CD2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -70.65 -56.84 5.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 109.307 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 154' ' ' GLU . . . -54.37 -21.97 11.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.545 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.581 ' CE1' HG22 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -90.32 -29.57 18.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 109.763 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.516 ' CD2' HD12 ' A' ' 35' ' ' ILE . 10.7 tp -75.48 -25.22 57.16 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.939 -1.101 . . . . 0.0 109.0 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -71.31 -32.66 68.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.907 . . . . 0.0 109.218 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.68 -43.45 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.184 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.591 ' HB ' ' CE2' ' A' ' 87' ' ' TYR . 17.1 m -101.34 25.69 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.393 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.5 ' O ' ' NE ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.407 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 61.4 54.2 3.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -120.79 27.83 8.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 109.552 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.88 152.26 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.154 -0.966 . . . . 0.0 109.372 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 38' ' ' ASN . 1.7 p -120.89 160.82 22.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.654 ' CB ' ' CZ3' ' A' ' 39' ' ' TRP . 11.2 mttm -108.48 -168.42 1.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.25 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.48 ' HB2' ' HA ' ' A' ' 85' ' ' PHE . 3.1 p -140.43 105.37 4.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 109.44 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.572 HG11 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -122.86 143.11 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.412 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.582 ' HB2' ' CD2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -140.6 115.34 9.58 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -92.04 157.59 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.076 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.522 ' CG1' HG21 ' A' ' 46' ' ' VAL . 16.8 t -140.35 142.16 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -0.785 . . . . 0.0 109.425 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.766 ' SG ' ' HA ' ' A' ' 15' ' ' ASN . 1.6 p -147.9 19.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.456 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 8.9 tp 63.64 -96.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 109.981 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 15' ' ' ASN . . . -47.33 -60.17 5.36 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.766 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . 5.3 t-20 66.8 14.76 9.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -1.162 . . . . 0.0 109.302 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.507 HD11 ' N ' ' A' ' 17' ' ' CYS . 2.6 pp -135.71 -37.95 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.438 -0.789 . . . . 0.0 108.959 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.507 ' N ' HD11 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -122.28 -24.05 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -56.84 -76.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 109.231 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.576 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 46.0 p 179.46 61.2 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.931 -1.106 . . . . 0.0 110.406 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.576 ' HD3' ' N ' ' A' ' 19' ' ' SER . 49.5 Cg_exo -56.12 -17.5 20.15 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.713 1.609 . . . . 0.0 110.052 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.572 HG22 ' CD2' ' A' ' 142' ' ' TYR . 10.8 mm -41.6 -38.52 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.52 -0.737 . . . . 0.0 110.264 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.831 ' CA ' ' SG ' ' A' ' 148' ' ' CYS . . . -53.96 -51.39 64.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.042 . . . . 0.0 109.679 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -66.36 -56.77 9.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.011 . . . . 0.0 109.356 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 68' ' ' ILE . . . -46.7 -25.08 0.65 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.958 . . . . 0.0 109.074 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.765 HG13 ' SG ' ' A' ' 149' ' ' CYS . 84.6 t -78.36 -43.32 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.264 -0.898 . . . . 0.0 109.36 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.573 ' CG ' ' HB2' ' A' ' 149' ' ' CYS . 0.2 OUTLIER -57.51 -21.44 37.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -78.52 -58.57 3.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 28' ' ' LYS . 10.0 tmtt? -75.89 2.77 11.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.356 -0.84 . . . . 0.0 109.225 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.763 HD21 ' SG ' ' A' ' 149' ' ' CYS . 34.2 tp -102.78 -37.17 7.99 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 36' ' ' SER . 9.8 p -90.82 -4.87 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 8.6 m -106.2 11.46 31.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.728 -1.233 . . . . 0.0 109.401 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -127.6 53.83 1.73 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 109.138 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.536 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.6 OUTLIER 175.56 31.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.486 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 33' ' ' GLN . 2.8 t-20 46.18 37.06 3.6 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.536 ' CG2' ' HB3' ' A' ' 33' ' ' GLN . 2.0 tt -121.17 -4.6 9.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.693 -177.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -73.49 -53.26 11.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.058 -1.026 . . . . 0.0 110.506 -178.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 25.7 p-10 -56.93 -14.47 3.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.198 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.529 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 69.6 m-20 -109.12 36.62 2.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.924 -1.11 . . . . 0.0 110.464 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.654 ' CZ3' ' CB ' ' A' ' 6' ' ' LYS . 17.8 m95 -150.95 136.9 18.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.486 -1.384 . . . . 0.0 111.516 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.97 74.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.524 ' CG1' HG12 ' A' ' 8' ' ' VAL . 3.1 mt -90.11 144.5 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.456 -0.777 . . . . 0.0 109.934 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.7 OUTLIER -142.31 -173.97 3.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 109.22 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.5 p -126.26 160.92 28.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.765 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -141.43 137.45 8.08 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.469 ' HB2' ' OD1' ' A' ' 50' ' ' ASN . . . -118.01 -9.29 10.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -1.194 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.522 HG21 ' CG1' ' A' ' 11' ' ' VAL . 2.5 t 55.05 21.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.2 t -160.42 160.01 31.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.524 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' HA ' HG22 ' A' ' 51' ' ' VAL . 10.7 p-10 -105.5 11.68 32.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.536 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -88.04 11.13 16.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.543 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.51 ' HA ' ' CD ' ' A' ' 53' ' ' ARG . 3.4 p-10 -144.89 13.91 1.5 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 76' ' ' GLN . 67.2 t -65.16 112.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 109.249 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.37 22.53 58.54 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' CD ' ' HA ' ' A' ' 50' ' ' ASN . 39.0 mtp180 -106.25 85.12 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.519 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' ARG . 2.5 p -46.36 162.22 0.26 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.281 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 56' ' ' ASP . 52.6 Cg_exo -50.51 140.65 35.34 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.897 1.731 . . . . 0.0 110.142 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.468 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 6.2 m-20 -43.75 166.08 0.11 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.466 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' A' ' 56' ' ' ASP . 49.7 Cg_endo -70.91 -7.2 20.88 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.987 1.791 . . . . 0.0 110.193 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -90.19 -40.5 12.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.9 . . . . 0.0 109.365 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.462 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -89.6 -16.88 29.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.423 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.0 p -57.25 -27.81 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.92 . . . . 0.0 109.548 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -79.97 -48.82 12.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.408 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.533 ' SG ' ' CD2' ' A' ' 142' ' ' TYR . 6.3 t -45.76 -30.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.23 -45.1 9.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.935 . . . . 0.0 109.104 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.63 19.94 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.67 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 61' ' ' SER . 15.1 t-20 -91.35 -53.54 4.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.361 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.525 ' CE1' ' OH ' ' A' ' 142' ' ' TYR . 9.5 p80 -102.98 -31.79 10.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.21 109.9 1.29 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.519 HG12 ' CB ' ' A' ' 24' ' ' ALA . 8.5 tp -120.98 -26.83 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -1.163 . . . . 0.0 109.428 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 1.3 m120 76.13 41.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.413 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.428 HG22 ' O ' ' A' ' 70' ' ' THR . 5.2 t -63.38 110.64 1.99 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.88 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.0 -23.55 5.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.469 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 22.7 t60 -84.74 132.76 34.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.295 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.469 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -95.91 154.17 17.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 109.542 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 50' ' ' ASN . . . -46.6 169.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HG3' ' N ' ' A' ' 76' ' ' GLN . 0.6 OUTLIER -169.16 161.48 10.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 109.484 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.526 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -96.61 128.77 43.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.528 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.9 t -65.74 135.85 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 109.357 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -138.62 165.28 27.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.873 . . . . 0.0 109.505 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HG2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -44.09 -39.1 4.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.477 ' O ' ' OG1' ' A' ' 84' ' ' THR . 28.3 tt0 -54.19 -53.28 55.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.885 . . . . 0.0 109.546 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.483 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 2.7 m-20 -50.92 -46.89 61.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.37 -0.831 . . . . 0.0 110.125 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.482 ' O ' ' CB ' ' A' ' 111' ' ' ALA . 77.6 m-85 -51.05 -63.11 1.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.535 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 2.3 p -73.62 -4.04 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -0.861 . . . . 0.0 110.021 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.483 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 14.3 m -81.3 -65.45 1.01 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 50.2 m-85 -87.11 173.68 9.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.892 . . . . 0.0 110.001 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.565 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -116.9 -15.22 10.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.724 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 86' ' ' ASP . 1.6 m-85 -123.0 74.56 1.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.068 -1.02 . . . . 0.0 109.659 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.554 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 2.6 mt -85.22 94.04 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.52 HD11 ' CZ ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -105.58 -179.82 4.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.958 -1.089 . . . . 0.0 109.467 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.73 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -142.94 172.69 12.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.52 ' CE ' ' HA ' ' A' ' 91' ' ' MET . 30.9 mmt -67.52 -7.77 28.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 109.669 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 115' ' ' LEU . 5.7 p30 174.05 -176.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.0 . . . . 0.0 109.406 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -83.44 -7.58 59.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.78 -49.97 70.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.578 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -83.68 9.98 10.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.501 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.73 ' HG ' ' SG ' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -100.17 16.49 24.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.0 ttt-85 -84.87 -22.63 29.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.503 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 102' ' ' LYS . 0.9 OUTLIER -107.07 -32.64 7.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.466 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.474 HD21 ' CZ ' ' A' ' 82' ' ' PHE . 24.5 mt -73.57 -36.01 65.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 5.5 t30 -66.17 -35.09 79.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.324 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -89.84 0.09 57.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.374 -0.829 . . . . 0.0 109.457 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 98' ' ' ASP . 0.7 OUTLIER -92.18 -22.33 19.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.478 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m -70.42 -12.61 61.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 0.0 109.41 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -86.27 -30.83 22.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -92.44 -10.36 38.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 109.348 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 109' ' ' CYS . 39.0 t -71.76 140.13 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -75.13 117.1 16.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.231 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.418 ' O ' HG22 ' A' ' 83' ' ' VAL . 2.5 m-80 48.28 46.38 20.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.539 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.11 150.88 2.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.96 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 5.8 ptm180 -140.58 9.9 2.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.467 -0.771 . . . . 0.0 109.111 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.554 ' CB ' ' CD1' ' A' ' 88' ' ' ILE . . . -98.39 116.07 29.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 110.321 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -70.57 124.22 23.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -99.1 114.95 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.795 -1.191 . . . . 0.0 110.498 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 20.7 mt-10 -147.51 -177.5 5.73 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 126' ' ' ILE . 0.4 OUTLIER -126.07 153.7 44.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.97 -1.081 . . . . 0.0 109.746 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.533 ' CD2' ' HA ' ' A' ' 148' ' ' CYS . 0.3 OUTLIER -43.47 104.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.373 -0.83 . . . . 0.0 109.521 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.38 157.17 16.45 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 m -65.06 93.75 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -1.133 . . . . 0.0 109.375 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -77.14 -93.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.598 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 1.1 m-20 -71.81 -62.27 1.7 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.054 -1.029 . . . . 0.0 109.789 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 55.5 Cg_endo -72.05 126.16 11.58 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.795 1.663 . . . . 0.0 110.256 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -105.13 111.99 24.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -150.56 158.12 43.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.551 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -88.42 98.44 11.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 176.57 108.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.534 ' O ' ' CG2' ' A' ' 127' ' ' ILE . 1.8 tt -121.23 28.16 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 126' ' ' ILE . 20.0 tt 41.28 41.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.402 -0.811 . . . . 0.0 109.838 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.513 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 1.3 mt-10 -87.48 51.23 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 109.423 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.56 104.34 55.35 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.928 . . . . 0.0 109.42 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -49.4 169.83 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.8 1.667 . . . . 0.0 110.228 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.412 ' C ' ' CD1' ' A' ' 131' ' ' TYR . 3.0 t80 -84.79 106.09 16.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.55 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -146.4 -64.71 0.3 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 135.56 114.74 1.41 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -154.5 -49.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -1.1 . . . . 0.0 109.518 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.72 -19.6 20.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 56.65 24.6 9.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.509 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -127.99 87.89 2.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.453 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 29.0 p90 -71.48 -10.36 59.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.5 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -62.88 -34.84 78.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.412 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 0.2 OUTLIER -63.54 -25.78 68.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.309 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 19' ' ' SER . 27.7 t -79.1 -31.11 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.312 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.572 ' CD2' HG22 ' A' ' 21' ' ' ILE . 6.1 t80 -69.18 -50.92 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.567 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -65.41 -41.6 93.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.952 . . . . 0.0 109.514 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 140' ' ' THR . 0.8 OUTLIER -68.87 -14.37 62.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.51 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 4.6 m -89.94 -8.6 51.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 25' ' ' VAL . 46.2 t -62.57 -68.73 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.713 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.498 ' HB3' ' CB ' ' A' ' 151' ' ' ALA . 0.7 OUTLIER -58.94 -15.61 13.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.824 -1.173 . . . . 0.0 109.157 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . 0.831 ' SG ' ' CA ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -44.26 -32.97 1.43 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.202 -0.936 . . . . 0.0 108.582 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . 0.765 ' SG ' HG13 ' A' ' 25' ' ' VAL . 1.6 p -115.09 -24.38 8.58 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.535 ' N ' ' CD2' ' A' ' 29' ' ' LEU . 9.5 ttt-85 -76.55 -60.98 2.11 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.498 ' CB ' ' HB3' ' A' ' 147' ' ' ARG . . . -49.67 -36.51 25.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.441 -0.787 . . . . 0.0 109.149 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.431 ' CE2' HG22 ' A' ' 156' ' ' VAL . 17.0 t80 -77.9 -31.64 51.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.532 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.482 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 11.7 tp -67.9 -13.18 61.95 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.166 -0.959 . . . . 0.0 108.815 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 1.8 mt-10 -76.9 -53.41 7.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.898 . . . . 0.0 109.122 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -47.61 84.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.962 . . . . 0.0 109.117 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.484 ' O ' ' HD2' ' A' ' 6' ' ' LYS . 14.1 m -97.64 25.6 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 109.083 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.482 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.548 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.304 0.573 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.665 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -84.95 71.0 10.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.877 . . . . 0.0 109.442 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 9.3 ttmt -41.93 162.94 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.157 -0.964 . . . . 0.0 109.573 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 m -139.16 135.96 34.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 0.0 109.912 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.765 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -141.7 155.53 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 108.927 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.792 HD13 ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -150.11 115.98 5.61 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 109.064 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.0 m-85 -86.8 151.56 23.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.512 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.651 ' HB ' HD11 ' A' ' 99' ' ' LEU . 5.4 t -143.82 157.92 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.59 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER 173.08 128.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -44.91 150.09 0.4 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.181 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.03 88.27 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 25.6 t-20 -85.5 15.19 4.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -1.14 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 2.0 pp -119.22 131.79 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.613 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.78 ' SG ' ' CZ ' ' A' ' 138' ' ' PHE . 34.8 t 66.8 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.71 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.659 ' HA ' HG11 ' A' ' 141' ' ' VAL . 0.3 OUTLIER 43.11 78.63 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.681 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER 163.63 -61.48 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 0.0 109.94 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 19' ' ' SER . 52.1 Cg_endo -71.16 -1.25 9.28 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.85 1.7 . . . . 0.0 110.848 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.007 HG21 ' HA ' ' A' ' 142' ' ' TYR . 3.8 mm -74.6 -48.12 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.985 -1.072 . . . . 0.0 109.575 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.632 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -57.35 -27.85 62.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.551 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -73.27 -71.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -0.954 . . . . 0.0 109.318 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.492 ' O ' HG13 ' A' ' 68' ' ' ILE . . . -44.89 -26.97 0.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 108.887 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.96 HG12 ' SG ' ' A' ' 149' ' ' CYS . 72.2 t -70.23 -54.36 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.404 -0.81 . . . . 0.0 109.214 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.682 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 2.1 t80 -45.57 -35.78 4.21 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -63.8 -57.66 9.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.425 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -55.97 -21.15 19.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.857 . . . . 0.0 109.652 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.859 HD22 ' HG3' ' A' ' 150' ' ' ARG . 39.7 mt -85.62 -30.79 22.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.212 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.929 HG22 ' HA ' ' A' ' 36' ' ' SER . 2.9 p -90.67 -6.23 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.407 -0.808 . . . . 0.0 109.348 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -105.14 5.91 32.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.033 -1.042 . . . . 0.0 109.848 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 4.4 t0 -128.02 59.74 1.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 109.133 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.501 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER 171.28 31.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.831 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.4 t-20 45.11 32.01 0.84 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.838 HG12 HG23 ' A' ' 30' ' ' VAL . 2.7 tt -112.79 -7.31 11.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.687 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.929 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -73.11 -25.06 60.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.658 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -84.47 16.26 3.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 0.0 109.778 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.665 ' HA ' HG22 ' A' ' 5' ' ' THR . 8.6 m-80 -144.46 36.13 1.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.481 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.765 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 22.1 m95 -150.18 150.39 31.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.986 -1.071 . . . . 0.0 111.029 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 40' ' ' VAL . 80.5 t -128.31 70.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 26' ' ' PHE . 2.4 mp -89.56 140.22 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.398 -0.814 . . . . 0.0 110.626 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.521 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -146.25 171.58 14.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.507 -0.745 . . . . 0.0 109.268 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.8 p -105.1 162.38 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.975 . . . . 0.0 109.614 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.559 ' CA ' ' CG2' ' A' ' 77' ' ' VAL . . . -143.05 122.76 1.97 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -87.08 -41.26 13.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.142 -1.21 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER 80.25 -5.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.795 . . . . 0.0 109.436 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 76' ' ' GLN . 0.4 OUTLIER -126.49 179.61 5.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 109.371 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.515 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 19.3 t70 -120.38 7.87 10.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.564 ' N ' ' CD1' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -91.55 -32.98 15.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.327 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -101.85 31.16 3.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 73.9 t -76.31 96.79 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.19 57.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -79.37 86.64 5.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -1.161 . . . . 0.0 109.555 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 53' ' ' ARG . 4.0 m -45.42 159.6 0.28 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.873 . . . . 0.0 109.369 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.45 152.41 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.98 1.787 . . . . 0.0 110.255 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.19 152.36 96.55 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.587 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 51.6 Cg_exo -51.22 -19.97 7.16 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.021 1.814 . . . . 0.0 110.475 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -81.89 -47.78 12.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -0.961 . . . . 0.0 109.796 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.747 ' O ' HD22 ' A' ' 63' ' ' LEU . . . -89.86 4.58 49.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.946 . . . . 0.0 109.807 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.587 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 6.8 p -89.93 -43.92 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.043 -1.036 . . . . 0.0 109.628 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.525 ' N ' HG13 ' A' ' 60' ' ' VAL . 3.8 p -76.82 -17.85 58.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.95 . . . . 0.0 109.521 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.7 m -78.26 -62.29 1.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -60.69 -27.99 68.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.567 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.749 ' H ' HD23 ' A' ' 63' ' ' LEU . 7.2 ttp85 -96.94 33.37 1.91 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.649 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' SER . 1.7 t30 -131.5 -43.07 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.345 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -82.86 -22.15 34.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.36 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.449 ' O ' ' HD3' ' A' ' 28' ' ' LYS . . . 113.16 83.33 1.22 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 25' ' ' VAL . 1.3 tp -122.22 -24.5 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -1.16 . . . . 0.0 109.656 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 11.0 m120 63.52 98.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.557 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.23 91.39 3.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.77 53.55 1.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.515 ' CE1' ' O ' ' A' ' 73' ' ' LYS . 38.9 t-80 -143.94 155.87 44.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.447 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.515 ' O ' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -104.75 130.75 52.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 75' ' ' ARG . . . -43.99 -69.9 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.601 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.495 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 61.06 158.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.373 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 47' ' ' SER . 22.6 tt0 -88.39 123.78 33.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.442 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.559 ' CG2' ' CA ' ' A' ' 44' ' ' GLY . 21.3 t -47.56 151.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.86 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -141.09 165.17 28.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.663 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.631 ' CG ' HG13 ' A' ' 106' ' ' VAL . 3.2 tmtt? -43.18 -41.67 3.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 109.495 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 84' ' ' THR . 24.4 tp10 -56.08 -48.37 76.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 109.553 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.487 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 1.2 m-20 -62.32 -34.02 75.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.77 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.826 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 79.3 m-85 -65.65 -79.07 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 110.163 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.663 HG23 ' HB3' ' A' ' 110' ' ' ARG . 7.3 p -48.13 -46.94 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.07 -1.019 . . . . 0.0 109.256 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.603 ' N ' HG13 ' A' ' 83' ' ' VAL . 16.4 m -45.85 -82.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.335 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.792 ' CE2' HD13 ' A' ' 9' ' ' LEU . 21.0 m-85 -57.13 166.5 1.07 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.317 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.33 -25.62 5.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.618 ' CD2' HG11 ' A' ' 156' ' ' VAL . 6.3 m-30 -109.38 72.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.107 -0.996 . . . . 0.0 109.852 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.907 HG13 ' HB1' ' A' ' 111' ' ' ALA . 1.3 mt -82.82 96.57 3.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.428 -0.795 . . . . 0.0 109.62 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -109.85 179.97 3.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.019 -1.051 . . . . 0.0 108.91 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -147.58 172.49 13.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.13 -0.982 . . . . 0.0 109.689 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.51 ' CE ' HD13 ' A' ' 116' ' ' LEU . 31.5 mmt -85.46 46.59 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.362 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' SER . 10.1 t70 56.93 -93.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.568 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.506 ' HG2' ' N ' ' A' ' 94' ' ' SER . 27.4 tt0 43.53 -94.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.305 -0.872 . . . . 0.0 109.338 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.6 ' O ' ' N ' ' A' ' 96' ' ' LEU . 4.6 p -85.67 88.2 7.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.09 -1.006 . . . . 0.0 108.71 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 96' ' ' LEU . 25.5 p-10 -31.94 85.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.091 0.472 . . . . 0.0 111.195 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.964 HD13 ' OD1' ' A' ' 100' ' ' ASN . 4.1 mt 29.48 56.98 0.15 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.244 0.545 . . . . 0.0 110.747 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -91.35 -50.96 5.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.082 -1.011 . . . . 0.0 109.65 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -92.77 -64.13 1.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.928 . . . . 0.0 109.653 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.651 HD11 ' HB ' ' A' ' 11' ' ' VAL . 17.3 mt -44.02 -40.11 4.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.217 -0.927 . . . . 0.0 109.668 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.964 ' OD1' HD13 ' A' ' 96' ' ' LEU . 3.2 t30 -61.59 -49.31 77.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -0.98 . . . . 0.0 109.182 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.83 14.6 11.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 108.918 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.683 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.8 OUTLIER -86.25 -40.41 15.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.479 -0.763 . . . . 0.0 109.356 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.6 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 1.3 p -65.86 -11.79 49.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.42 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.4 -36.82 68.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -99.19 8.6 44.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.825 HG11 ' SG ' ' A' ' 109' ' ' CYS . 46.7 t -83.54 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.367 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 108' ' ' ASN . 12.1 tptp -62.53 88.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 108.832 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 107' ' ' LYS . 9.2 t30 73.99 71.06 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 108.932 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.825 ' SG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -85.01 143.72 28.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.315 -0.866 . . . . 0.0 109.901 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.663 ' HB3' HG23 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -143.82 13.58 1.7 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 108.985 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.907 ' HB1' HG13 ' A' ' 88' ' ' ILE . . . -89.85 97.22 11.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.965 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' ALA . 15.0 mttt -46.66 123.63 5.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.61 ' CG2' HD21 ' A' ' 96' ' ' LEU . 1.1 mm -99.36 139.59 20.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.875 -1.141 . . . . 0.0 110.372 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -167.11 -177.43 3.73 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.663 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -134.0 145.73 49.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.009 -1.057 . . . . 0.0 109.642 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.882 HD21 ' HA ' ' A' ' 148' ' ' CYS . 0.0 OUTLIER -43.24 152.54 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.328 -0.858 . . . . 0.0 109.448 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -158.43 -143.76 3.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 123' ' ' LYS . 2.0 p -87.24 109.19 19.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.166 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -112.27 -81.96 0.59 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.41 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.582 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -61.56 -61.47 7.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.654 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 52.3 Cg_endo -71.78 -161.68 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.77 1.647 . . . . 0.0 110.209 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -144.35 36.61 1.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 118' ' ' SER . 12.2 ptpt -111.49 159.07 18.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.242 -0.911 . . . . 0.0 109.566 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.7 81.87 7.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.49 112.79 25.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 109.386 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.5 ' CG2' ' CG ' ' A' ' 92' ' ' ASP . 6.6 mm -124.8 152.35 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.314 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.425 ' C ' ' OD2' ' A' ' 92' ' ' ASP . 2.9 mm -92.25 64.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.155 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.459 ' HA ' ' OD2' ' A' ' 92' ' ' ASP . 3.0 mt-10 -85.55 46.75 1.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.668 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -127.24 144.79 51.89 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.68 -42.9 1.52 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.876 1.717 . . . . 0.0 110.218 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.96 178.4 4.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.379 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -124.98 12.65 8.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 109.458 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 96.51 -115.7 5.27 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.74 -48.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -1.154 . . . . 0.0 109.335 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.9 OUTLIER -102.26 159.71 15.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 74.18 5.92 4.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.534 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -177.42 120.88 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.78 ' CZ ' ' SG ' ' A' ' 17' ' ' CYS . 2.0 t80 -170.85 -50.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.323 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 140' ' ' THR . 2.5 pt-20 -66.66 -28.61 68.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.411 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.419 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 32.4 m -62.18 -43.93 97.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.387 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 18' ' ' ARG . 39.2 t -61.59 -57.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.234 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 1.007 ' HA ' HG21 ' A' ' 21' ' ' ILE . 1.4 t80 -46.52 -38.22 9.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 0.0 109.131 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -39.27 79.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.737 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -68.66 -13.13 62.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.693 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.3 m -88.15 -12.56 43.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.754 ' HA ' HG11 ' A' ' 25' ' ' VAL . 95.8 t -58.54 -60.41 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.299 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.813 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -74.4 -18.49 60.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.897 . . . . 0.0 109.377 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.882 ' HA ' HD21 ' A' ' 116' ' ' LEU . 1.2 m -46.72 -32.21 3.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.151 -0.968 . . . . 0.0 109.184 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.96 ' SG ' HG12 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -114.07 -30.01 6.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 109.175 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.859 ' HG3' HD22 ' A' ' 29' ' ' LEU . 18.2 ttt180 -75.22 -57.72 3.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 0.0 109.109 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.813 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -51.77 -31.53 27.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.349 -0.844 . . . . 0.0 109.199 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.743 ' CE1' HG21 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -83.39 -29.36 28.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.813 . . . . 0.0 109.343 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.98 -18.11 65.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.067 -1.021 . . . . 0.0 108.666 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 3.7 mm-40 -70.09 -45.43 66.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.024 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -46.38 81.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.284 -0.885 . . . . 0.0 108.953 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.743 HG21 ' CE1' ' A' ' 152' ' ' PHE . 6.4 m -95.3 25.17 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.084 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 1.1 tmm_? . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.557 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.944 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -149.43 71.94 1.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.611 ' HG2' ' CE2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -42.28 166.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.151 -0.968 . . . . 0.0 110.304 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 85' ' ' PHE . 33.4 t -143.75 127.22 16.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.512 -0.742 . . . . 0.0 109.147 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.971 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -131.09 153.25 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 108.904 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.623 HD22 ' CD1' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -146.21 123.52 11.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.445 -0.784 . . . . 0.0 108.997 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.2 m-85 -95.2 165.99 12.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.995 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.635 HG11 HD11 ' A' ' 99' ' ' LEU . 2.0 t -147.38 149.11 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.349 -0.844 . . . . 0.0 109.644 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.761 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER 177.13 114.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 tp -46.74 156.94 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.0 109.405 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.35 49.55 75.14 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.445 ' OD1' ' HG3' ' A' ' 20' ' ' PRO . 43.4 t30 -74.29 82.09 1.86 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.133 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.566 HD12 ' N ' ' A' ' 17' ' ' CYS . 1.2 pp -152.55 -52.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.712 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.692 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -134.61 34.73 3.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.641 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -171.37 60.07 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 109.372 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.761 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 163.59 -51.68 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 109.599 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 19' ' ' SER . 54.1 Cg_exo -49.29 -21.27 4.41 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.839 1.692 . . . . 0.0 110.455 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.001 HG21 ' HA ' ' A' ' 142' ' ' TYR . 18.5 mm -58.97 -51.28 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.165 -0.96 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.781 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . . . -59.99 -16.97 34.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.136 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.51 ' OE1' ' CA ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -81.92 -72.81 0.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.221 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -43.49 -39.18 3.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.001 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 21' ' ' ILE . 47.2 t -60.83 -58.34 7.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.448 -0.782 . . . . 0.0 108.97 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 2.6 t80 -43.3 -29.12 0.38 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.928 . . . . 0.0 108.615 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.62 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -65.93 -62.2 1.63 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.331 -0.855 . . . . 0.0 109.226 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.08 -43.33 63.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 0.0 109.71 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.791 HD22 ' HG3' ' A' ' 150' ' ' ARG . 25.3 mt -60.39 -36.8 78.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.93 HG22 ' HA ' ' A' ' 36' ' ' SER . 4.4 p -90.03 -4.52 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.504 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -107.21 12.51 28.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.848 -1.158 . . . . 0.0 109.689 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 6.9 t0 -131.84 56.14 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.132 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.552 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.7 OUTLIER 173.56 31.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 109.627 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.1 t30 45.71 36.88 2.93 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.889 HG12 HG23 ' A' ' 30' ' ' VAL . 2.1 tt -119.54 -7.37 11.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.959 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.93 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -74.64 -37.2 62.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 109.992 -179.099 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.02 1.01 11.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 110.027 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.944 ' HA ' HG22 ' A' ' 5' ' ' THR . 6.8 m-20 -127.18 42.14 3.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.096 -1.003 . . . . 0.0 109.838 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.971 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 9.4 m95 -150.23 157.3 42.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.899 -1.126 . . . . 0.0 110.819 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.552 HG12 ' CE1' ' A' ' 85' ' ' PHE . 96.5 t -133.06 71.9 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.578 ' CG1' HG13 ' A' ' 8' ' ' VAL . 2.7 mp -89.65 137.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.413 -0.804 . . . . 0.0 110.13 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 3.7 t70 -143.33 -177.21 5.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.449 -0.782 . . . . 0.0 109.312 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.5 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 95.6 p -119.54 163.6 17.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.164 -0.96 . . . . 0.0 109.688 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -142.15 134.43 6.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.562 ' HB1' HD21 ' A' ' 50' ' ' ASN . . . -116.42 -12.41 11.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -1.227 . . . . 0.0 109.557 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.616 ' HA ' HG12 ' A' ' 77' ' ' VAL . 1.8 t 56.24 17.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' ' CE2' ' A' ' 49' ' ' TRP . 1.1 p -151.24 169.82 20.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HA ' HG23 ' A' ' 51' ' ' VAL . 4.5 m-20 -116.8 22.19 12.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.437 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.589 ' N ' ' CD1' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -95.23 -24.97 16.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 109.24 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.562 HD21 ' HB1' ' A' ' 45' ' ' ALA . 6.5 p30 -108.88 9.62 26.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.838 . . . . 0.0 109.516 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 48' ' ' ASP . 74.3 t -65.17 90.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.76 29.08 4.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -105.32 95.13 5.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -1.158 . . . . 0.0 109.472 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -43.99 162.49 0.19 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.462 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.64 148.86 54.08 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.958 1.772 . . . . 0.0 110.134 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 5.9 t70 -50.75 139.56 21.36 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.272 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.496 ' O ' HG12 ' A' ' 60' ' ' VAL . 50.4 Cg_exo -51.93 -18.86 7.42 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.845 1.696 . . . . 0.0 110.439 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.492 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . 8.9 mtm180 -81.96 -39.25 23.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.097 -1.002 . . . . 0.0 109.675 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.792 ' O ' HD22 ' A' ' 63' ' ' LEU . . . -90.38 -1.62 57.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.94 . . . . 0.0 109.842 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.517 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 5.7 p -89.6 -39.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.05 -1.032 . . . . 0.0 109.651 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.46 ' N ' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -88.46 -8.87 54.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -89.24 -64.44 1.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.646 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.792 HD22 ' O ' ' A' ' 59' ' ' ALA . 1.6 pt? -43.34 -30.64 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.671 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.729 ' H ' HD23 ' A' ' 63' ' ' LEU . 3.5 ptp180 -93.16 41.84 1.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.852 . . . . 0.0 109.468 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -133.48 -43.95 0.83 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.382 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -83.17 -34.17 26.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.18 95.29 0.2 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.484 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 17.3 mm -146.08 -75.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -1.152 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 m120 65.53 99.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.05 166.48 20.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -155.04 54.05 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.49 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -122.71 170.61 9.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.487 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.02 154.48 37.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.554 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.99 122.7 28.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.461 ' HD2' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -129.74 172.36 11.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.417 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' SER . 1.1 tt0 -92.13 122.32 34.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.616 HG12 ' HA ' ' A' ' 46' ' ' VAL . 8.9 p -48.9 145.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.407 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 p -132.83 168.3 18.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.215 -0.928 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.582 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -51.03 -41.37 59.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 109.255 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -59.41 -38.28 80.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.56 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.08 -41.09 87.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -0.919 . . . . 0.0 109.978 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.813 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 81.1 m-85 -64.47 -62.36 1.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.797 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.528 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 3.8 p -65.76 -10.35 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.687 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.637 HG22 ' N ' ' A' ' 85' ' ' PHE . 3.4 m -87.97 -85.09 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.368 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.637 ' N ' HG22 ' A' ' 84' ' ' THR . 59.1 m-85 -56.33 109.04 0.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.526 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.404 ' C ' ' CD1' ' A' ' 87' ' ' TYR . 1.3 t0 -58.29 -20.87 46.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.611 ' CE2' ' HG2' ' A' ' 6' ' ' LYS . 6.6 m-30 -113.31 137.42 51.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.933 HG13 ' HB1' ' A' ' 111' ' ' ALA . 1.0 OUTLIER -145.45 104.24 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 108.652 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.66 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -120.74 156.65 31.37 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.906 -1.121 . . . . 0.0 109.744 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 115' ' ' LEU . 2.4 p -121.26 166.15 14.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.517 -0.739 . . . . 0.0 109.424 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.499 ' HE3' HD23 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -75.62 -62.56 1.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.719 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 93' ' ' GLU . 11.5 p-10 -178.62 -138.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.398 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 74.4 mt-10 63.12 -88.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.058 -1.026 . . . . 0.0 109.487 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -85.01 85.75 7.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 0.0 109.069 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.47 ' O ' ' C ' ' A' ' 96' ' ' LEU . 3.8 t30 -51.21 86.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.684 -0.635 . . . . 0.0 110.083 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.978 HD22 ' HB2' ' A' ' 100' ' ' ASN . 0.4 OUTLIER 37.33 40.3 0.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.729 -0.607 . . . . 0.0 110.196 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -90.51 -50.14 6.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.045 -1.035 . . . . 0.0 109.479 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.6 -45.03 12.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.496 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.635 HD11 HG11 ' A' ' 11' ' ' VAL . 13.4 mt -62.58 -34.75 77.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.575 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.978 ' HB2' HD22 ' A' ' 96' ' ' LEU . 21.8 t-20 -62.17 -31.63 72.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -89.69 -11.4 42.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 109.424 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.888 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -74.93 -27.13 60.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.33 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.639 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 0.9 OUTLIER -73.8 -20.62 60.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.892 . . . . 0.0 109.339 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.63 -49.9 42.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.256 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -70.48 -19.39 62.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 109.253 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 102' ' ' LYS . 54.6 t -67.08 125.03 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.376 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -66.47 100.55 0.67 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.333 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.87 50.35 1.99 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -53.62 150.9 6.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.263 -0.898 . . . . 0.0 109.838 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 12.0 ptt180 -138.53 7.22 2.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.339 -0.85 . . . . 0.0 109.153 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.933 ' HB1' HG13 ' A' ' 88' ' ' ILE . . . -88.03 120.38 29.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.178 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.47 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -70.51 132.68 45.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.84 ' HB ' HD11 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -109.16 133.09 55.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.777 -1.202 . . . . 0.0 110.402 -179.203 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.8 OUTLIER -178.47 139.21 0.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -84.72 167.34 16.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.594 -1.316 . . . . 0.0 109.95 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.956 HD11 ' HA ' ' A' ' 148' ' ' CYS . 3.1 mm? -40.59 -44.23 2.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.752 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 54.44 -123.4 27.94 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -131.07 122.68 27.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 109.341 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.533 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.7 m-85 -127.83 3.42 6.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 0.0 109.634 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.587 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 162.58 -51.26 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.3 Cg_exo -49.72 140.43 29.67 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.794 1.663 . . . . 0.0 110.111 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -108.14 112.89 25.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.67 149.37 2.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.356 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 52.29 2.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.364 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.97 131.71 4.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.381 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.797 HG23 ' O ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -105.3 41.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.972 . . . . 0.0 109.165 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 126' ' ' ILE . 14.7 mt 71.44 19.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.98 . . . . 0.0 109.51 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.685 ' HG3' HG22 ' A' ' 126' ' ' ILE . 30.5 mt-10 -62.18 90.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' HB3' ' NH2' ' A' ' 18' ' ' ARG . 9.8 t70 -145.32 102.39 4.36 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.195 -0.941 . . . . 0.0 109.401 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -49.26 139.86 27.18 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.868 1.712 . . . . 0.0 110.308 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER 51.91 -161.72 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.479 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 131' ' ' TYR . 8.4 p90 -94.88 30.24 2.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 132' ' ' TYR . . . 43.63 -131.97 6.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -179.71 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -1.187 . . . . 0.0 109.475 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -78.09 123.48 26.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 135' ' ' ASP . . . 44.35 29.51 0.38 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.09 35.18 3.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.877 . . . . 0.0 109.459 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.492 ' CE2' ' HB3' ' A' ' 58' ' ' ARG . 5.0 t80 -133.24 -55.56 0.91 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.12 -44.53 68.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.0 109.388 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.7 m -60.52 -36.8 79.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.37 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.87 -53.54 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.324 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 1.001 ' HA ' HG21 ' A' ' 21' ' ' ILE . 2.4 t80 -59.56 -24.27 63.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.553 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -85.02 -24.45 28.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 0.0 109.931 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -13.77 42.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.091 -1.006 . . . . 0.0 109.498 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.781 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -90.3 -7.28 53.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 109.665 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.873 ' HA ' HG11 ' A' ' 25' ' ' VAL . 73.9 t -62.04 -63.62 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.218 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.451 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 4.2 mpt_? -68.62 -22.36 64.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.107 -0.996 . . . . 0.0 109.095 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.956 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.6 m -44.4 -28.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 108.823 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.629 ' SG ' ' CD1' ' A' ' 29' ' ' LEU . 1.5 p -111.79 -33.7 6.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.49 -0.756 . . . . 0.0 109.036 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.791 ' HG3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.91 -61.18 2.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -51.94 -28.05 15.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.451 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -84.35 -31.63 24.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.311 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 157' ' ' ARG . 13.8 tp -62.81 -54.14 43.54 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.039 -1.038 . . . . 0.0 108.792 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.522 ' HA ' ' CB ' ' A' ' 157' ' ' ARG . 5.6 pt-20 -44.31 -40.23 5.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.193 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -57.66 -63.16 1.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 87' ' ' TYR . 27.8 m -93.28 33.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.335 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 1.078 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -97.16 2.66 51.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.773 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.677 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER 52.53 162.76 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.846 0.831 . . . . 0.0 110.392 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 85' ' ' PHE . 2.0 m -150.29 107.54 3.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.98 -1.075 . . . . 0.0 109.496 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.837 HG11 ' HE2' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -102.9 138.55 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -139.62 107.7 5.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.407 -0.808 . . . . 0.0 109.503 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.808 ' CE1' HD13 ' A' ' 89' ' ' LEU . 5.6 m-85 -93.79 156.79 16.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.418 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 t -148.36 155.84 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.717 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -176.84 134.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.66 HD21 ' CZ3' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -50.26 171.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.26 -0.9 . . . . 0.0 109.431 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' LEU . . . 44.06 41.05 5.98 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.686 ' O ' HG23 ' A' ' 16' ' ' ILE . 8.8 t30 -67.68 91.77 0.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.469 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -162.17 -39.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.132 -0.98 . . . . 0.0 109.723 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.51 ' SG ' HD12 ' A' ' 16' ' ' ILE . 1.8 p -150.84 81.18 1.33 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 109.73 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.789 ' HA ' HG11 ' A' ' 141' ' ' VAL . 0.0 OUTLIER 165.14 -76.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 109.188 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.762 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -67.63 -49.23 40.97 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.389 -0.819 . . . . 0.0 110.337 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 19' ' ' SER . 71.8 Cg_exo -48.06 -20.33 2.1 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.964 1.776 . . . . 0.0 111.19 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.748 HG21 ' HA ' ' A' ' 142' ' ' TYR . 9.3 mt -64.83 -48.04 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 120.94 -1.1 . . . . 0.0 109.382 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.776 ' HA ' ' SG ' ' A' ' 145' ' ' CYS . . . -57.8 -19.28 27.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 109.353 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 24' ' ' ALA . 8.9 tm-20 -76.7 -70.21 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.216 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HB1' HG23 ' A' ' 68' ' ' ILE . . . -44.22 -47.77 9.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.358 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.867 HG11 ' HA ' ' A' ' 146' ' ' VAL . 63.6 t -54.17 -49.95 58.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 109.297 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.837 ' HE2' HG11 ' A' ' 8' ' ' VAL . 1.1 t80 -50.49 -37.9 41.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.031 -1.043 . . . . 0.0 108.379 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -45.05 82.09 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.191 -0.943 . . . . 0.0 108.841 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -81.61 -8.92 59.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.83 . . . . 0.0 110.104 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.689 HD22 ' HB2' ' A' ' 150' ' ' ARG . 3.9 mt -86.43 -31.08 21.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 109.323 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.804 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -90.85 -56.65 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.504 ' N ' HG22 ' A' ' 30' ' ' VAL . 1.2 m -44.8 -32.05 1.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.106 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.32 -42.58 44.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.105 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.52 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 4.4 tp60 -72.62 -6.85 47.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.411 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 33.9 t30 76.65 48.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 109.699 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.804 ' CG1' HG23 ' A' ' 30' ' ' VAL . 3.8 pt -140.42 8.66 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 109.626 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.615 ' HA ' HG21 ' A' ' 30' ' ' VAL . 24.5 p -68.06 -41.59 81.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.488 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.98 -20.17 3.21 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.284 -0.885 . . . . 0.0 109.361 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 1.078 ' HA ' HG22 ' A' ' 5' ' ' THR . 2.2 m-20 -121.11 45.29 2.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.936 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.677 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 6.7 m95 -150.33 129.04 12.35 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.871 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.95 87.73 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.534 ' HA ' HG13 ' A' ' 8' ' ' VAL . 3.4 mt -94.27 142.32 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.343 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.573 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 t0 -164.31 178.3 7.62 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.0 p -179.74 169.85 1.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.06 -1.025 . . . . 0.0 109.739 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.12 -163.03 28.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 15' ' ' ASN . . . -107.5 171.82 7.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -1.164 . . . . 0.0 109.487 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.523 HG22 HD11 ' A' ' 99' ' ' LEU . 93.3 t -104.74 -8.08 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.555 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.04 174.36 6.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.485 ' OD1' HG21 ' A' ' 51' ' ' VAL . 29.6 t70 -110.2 30.45 6.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.51 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.66 ' CZ3' HD21 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -102.49 -49.28 3.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.444 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -90.22 38.23 0.92 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.867 . . . . 0.0 109.65 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.485 HG21 ' OD1' ' A' ' 48' ' ' ASP . 73.2 t -82.13 94.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.347 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.559 ' H ' ' HB3' ' A' ' 74' ' ' ALA . . . 105.38 -17.15 44.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.18 136.83 8.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -1.087 . . . . 0.0 109.451 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.35 159.34 50.63 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.462 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 56' ' ' ASP . 53.4 Cg_endo -71.59 -3.4 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.015 1.81 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' PRO . 72.0 m-20 61.57 140.97 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 109.443 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.814 ' O ' HG12 ' A' ' 60' ' ' VAL . 56.6 Cg_endo -73.49 -1.34 10.53 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.901 1.734 . . . . 0.0 110.395 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.433 ' O ' ' OG ' ' A' ' 61' ' ' SER . 67.6 mtt180 -72.95 -28.11 62.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.13 -0.981 . . . . 0.0 109.611 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 63' ' ' LEU . . . -88.94 -39.94 13.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.814 HG12 ' O ' ' A' ' 57' ' ' PRO . 10.8 p -44.45 -25.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.597 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 58' ' ' ARG . 0.2 OUTLIER -48.34 -89.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.295 -0.878 . . . . 0.0 109.846 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.675 ' SG ' ' OE2' ' A' ' 139' ' ' GLU . 3.7 t -73.54 -3.75 29.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.035 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.57 ' HG ' HG21 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -86.56 -74.35 0.43 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.023 -1.048 . . . . 0.0 108.953 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.448 ' CB ' HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -81.49 74.14 8.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.43 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -146.29 -53.83 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.643 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -80.72 -23.16 39.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.26 61.63 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.642 HG23 ' HB1' ' A' ' 24' ' ' ALA . 21.7 mm -113.29 156.08 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -1.174 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.42 ' N ' HG22 ' A' ' 68' ' ' ILE . 6.0 m120 -147.55 96.67 2.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.371 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 70' ' ' THR . 9.6 t -113.73 72.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.88 54.94 3.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 0.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -133.63 155.66 49.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -0.955 . . . . 0.0 109.453 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.61 170.43 8.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 0.0 109.451 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.559 ' HB3' ' H ' ' A' ' 52' ' ' GLY . . . -90.56 148.33 22.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 109.526 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' HA ' HG13 ' A' ' 51' ' ' VAL . 3.1 mmt-85 -151.75 152.26 32.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.409 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 77' ' ' VAL . 1.4 tt0 -80.57 135.44 36.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.549 ' O ' ' NE2' ' A' ' 76' ' ' GLN . 8.7 p -56.89 146.94 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.87 165.47 26.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.445 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.759 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -46.01 -36.72 5.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' ' OG1' ' A' ' 84' ' ' THR . 7.8 tt0 -59.69 -56.78 17.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 109.655 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 9.3 m-20 -50.54 -40.67 52.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -0.884 . . . . 0.0 109.808 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.941 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 43.4 m-85 -53.53 -58.13 8.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.072 -1.017 . . . . 0.0 109.335 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.544 ' HA ' ' CG ' ' A' ' 110' ' ' ARG . 0.8 OUTLIER -78.81 -2.26 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.536 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 56.0 m -78.27 -60.28 2.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.168 -0.957 . . . . 0.0 109.863 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.771 ' CD1' HD13 ' A' ' 9' ' ' LEU . 28.3 m-85 -96.46 178.36 5.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.14 -0.975 . . . . 0.0 109.863 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.481 ' OD1' ' HD3' ' A' ' 110' ' ' ARG . 1.1 t70 -118.2 -22.46 7.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.348 -0.845 . . . . 0.0 109.756 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.537 ' OH ' ' CG ' ' A' ' 6' ' ' LYS . 5.4 m-85 -112.01 67.09 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.98 -1.075 . . . . 0.0 109.623 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.933 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.1 mt -79.15 91.06 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.286 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.827 HD21 ' CE2' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -112.04 167.14 10.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.972 -1.08 . . . . 0.0 109.478 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.692 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -139.49 166.23 25.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.86 . . . . 0.0 109.06 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.692 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -66.76 133.56 50.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.388 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.82 ' CG ' HG21 ' A' ' 126' ' ' ILE . 5.7 t70 -42.94 110.06 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.68 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.5 -177.35 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.332 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.8 m -89.54 15.58 9.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -82.31 -14.74 54.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.546 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.62 HD21 ' CG2' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -86.49 5.13 36.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.098 -1.002 . . . . 0.0 109.604 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -19.25 65.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -0.96 . . . . 0.0 109.165 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.55 -43.19 4.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.872 . . . . 0.0 109.315 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.56 HD23 ' HZ ' ' A' ' 82' ' ' PHE . 13.0 mt -57.61 -34.04 68.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.304 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -69.19 -32.39 71.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.61 0.98 50.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 109.563 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -81.35 -30.21 33.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 109.442 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 p -63.76 -16.69 61.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -84.38 -31.36 24.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.338 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -12.54 43.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.392 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.759 HG13 ' HG2' ' A' ' 79' ' ' LYS . 62.8 t -77.17 147.37 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.315 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -83.58 112.21 19.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.203 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.14 37.85 27.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.311 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -43.27 160.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.748 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.6 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 0.0 OUTLIER -150.1 36.36 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.446 -0.784 . . . . 0.0 109.002 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.941 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -119.36 88.75 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -0.811 . . . . 0.0 110.025 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 111' ' ' ALA . 34.9 mtpt -46.13 121.09 3.08 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.62 ' CG2' HD21 ' A' ' 96' ' ' LEU . 1.7 mm -95.96 132.25 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.001 -1.062 . . . . 0.0 110.108 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 31.7 tp10 -159.09 165.54 33.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.462 -0.774 . . . . 0.0 109.649 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.586 ' CD2' HD12 ' A' ' 96' ' ' LEU . 22.3 mt -99.13 158.9 15.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.098 -1.001 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.944 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.5 OUTLIER -68.75 123.79 21.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 109.337 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . 140.77 -179.66 19.04 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 0.7 OUTLIER 74.52 36.91 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -1.184 . . . . 0.0 109.421 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.437 ' HB2' ' HD2' ' A' ' 121' ' ' PRO . 26.7 m-85 -125.23 -140.0 0.29 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.164 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.59 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -71.33 -51.02 10.41 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.0 109.726 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.7 Cg_exo -49.99 96.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.761 1.64 . . . . 0.0 110.275 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 25.0 mt-30 -80.91 -152.67 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.43 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 124' ' ' GLN . 0.3 OUTLIER 65.78 116.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.491 ' O ' ' CB ' ' A' ' 125' ' ' LEU . 2.0 tt0 -60.28 -150.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.159 -0.963 . . . . 0.0 109.431 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.503 ' HA ' HD22 ' A' ' 125' ' ' LEU . 0.2 OUTLIER 73.55 70.23 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.459 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.944 HD11 ' O ' ' A' ' 116' ' ' LEU . 3.7 tt -87.57 177.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.18 -0.95 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.48 HG21 HH12 ' A' ' 18' ' ' ARG . 16.0 mt -82.61 98.54 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 0.0 109.445 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.482 ' HG3' ' OD1' ' A' ' 92' ' ' ASP . 8.9 mt-10 -130.96 55.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.9 OUTLIER -103.06 164.52 15.35 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.462 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 129' ' ' ASP . 54.9 Cg_endo -72.1 -164.37 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.028 1.819 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -70.93 -25.56 62.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.331 -0.856 . . . . 0.0 109.479 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.05 -81.15 0.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.532 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 114.31 -145.39 18.53 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -71.32 -83.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -1.135 . . . . 0.0 109.541 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.78 -71.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.94 46.26 1.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 109.566 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.43 ' OD2' ' HB ' ' A' ' 140' ' ' THR . 4.5 t70 -119.05 57.73 0.87 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.469 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -98.63 -25.34 14.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.675 ' OE2' ' SG ' ' A' ' 62' ' ' CYS . 4.2 tp10 -72.72 -31.28 64.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.325 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 96.1 m -65.45 -19.42 65.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 109.494 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.789 HG11 ' HA ' ' A' ' 18' ' ' ARG . 73.1 t -70.37 -70.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 0.0 109.228 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.748 ' HA ' HG21 ' A' ' 21' ' ' ILE . 3.2 t80 -48.19 -48.69 34.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.389 -0.82 . . . . 0.0 109.34 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -65.93 0.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.321 -0.862 . . . . 0.0 109.836 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 140' ' ' THR . 3.2 mm-40 -53.93 -19.26 4.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.776 ' SG ' ' HA ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -69.95 -41.94 73.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.845 . . . . 0.0 109.389 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.867 ' HA ' HG11 ' A' ' 25' ' ' VAL . 15.2 t -52.87 -60.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.314 -0.866 . . . . 0.0 109.929 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -8.99 53.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.928 ' SG ' HD22 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -69.63 -11.59 60.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.345 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.632 ' SG ' ' CD1' ' A' ' 29' ' ' LEU . 30.2 p -126.26 -41.64 1.89 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.233 -0.917 . . . . 0.0 109.21 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.689 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -58.25 -49.87 75.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.002 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.96 -21.54 64.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.458 -0.776 . . . . 0.0 109.236 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.827 ' CE2' HD21 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -90.01 -19.01 24.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.408 -0.808 . . . . 0.0 109.642 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.655 HD13 ' HZ ' ' A' ' 26' ' ' PHE . 9.0 tp -83.07 -26.04 31.48 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.03 -1.044 . . . . 0.0 108.748 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 1.0 OUTLIER -69.94 -29.3 66.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 108.997 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.49 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 2.2 tptt -80.32 -54.72 5.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 108.807 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 152' ' ' PHE . 16.5 m -98.33 45.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 108.891 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.405 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.533 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.3 0.571 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.879 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -126.16 83.44 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.485 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.68 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -41.47 163.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.748 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.593 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 62.4 p -136.62 116.47 13.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.024 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.779 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -119.41 142.94 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 109.115 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.595 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -140.38 105.43 4.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 0.0 109.424 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -83.27 158.34 22.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.446 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 90' ' ' CYS . 1.9 t -145.63 142.2 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.441 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -162.15 131.89 4.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 13' ' ' LEU . 12.9 tp -43.34 -56.19 3.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.658 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . -87.35 85.06 1.53 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 13.4 t-20 -89.19 2.77 53.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -1.128 . . . . 0.0 109.548 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.727 HD12 ' C ' ' A' ' 16' ' ' ILE . 2.5 pp -146.86 12.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 109.733 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.44 ' N ' HD12 ' A' ' 16' ' ' ILE . 11.2 t -150.28 -54.89 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.044 -1.035 . . . . 0.0 109.561 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.481 ' HB2' ' HA3' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -43.3 -80.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.429 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.692 ' HB2' HG11 ' A' ' 141' ' ' VAL . 0.3 OUTLIER 167.16 66.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.491 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.18 63.4 8.71 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.175 1.917 . . . . 0.0 110.594 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 25' ' ' VAL . 3.8 mp -90.56 -17.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.013 -1.054 . . . . 0.0 109.732 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.594 ' O ' ' SG ' ' A' ' 149' ' ' CYS . . . -65.27 -32.32 73.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 43' ' ' SER . 1.5 tt0 -77.22 -68.59 0.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.375 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.737 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -43.53 -40.54 3.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.193 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.037 HG11 ' HA ' ' A' ' 146' ' ' VAL . 50.0 t -61.29 -53.37 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.38 -0.825 . . . . 0.0 109.158 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.555 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -46.52 -39.68 11.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.106 -0.997 . . . . 0.0 108.453 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.456 ' O ' ' OG1' ' A' ' 31' ' ' THR . 11.0 tpt85 -54.9 -60.18 3.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.165 -0.959 . . . . 0.0 108.97 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -10.18 35.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.893 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.831 HD12 HG12 ' A' ' 25' ' ' VAL . 2.7 mt -83.02 -76.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.064 -1.023 . . . . 0.0 108.971 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.893 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -43.45 -46.1 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -60.25 -42.46 95.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.115 . . . . 0.0 109.433 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -69.38 -16.6 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.131 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 1.9 tp60 -98.2 -9.38 25.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.401 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 2.7 t-20 77.18 48.58 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 109.391 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.893 ' CG1' HG23 ' A' ' 30' ' ' VAL . 2.9 pt -140.82 9.63 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.349 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.622 ' HA ' HG21 ' A' ' 30' ' ' VAL . 6.2 p -69.93 -35.0 74.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.062 -1.024 . . . . 0.0 109.546 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -58.35 -20.35 42.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.646 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.879 ' HA ' HG22 ' A' ' 5' ' ' THR . 11.8 m-20 -124.36 42.98 3.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.695 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.779 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 10.2 m95 -150.04 133.64 16.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.046 -1.034 . . . . 0.0 109.994 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 t -117.85 85.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.841 . . . . 0.0 108.992 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.646 HD11 HG11 ' A' ' 30' ' ' VAL . 2.2 mp -90.24 139.24 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 5.3 m-20 -150.53 146.58 26.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.427 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 74.5 p -116.5 156.76 26.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.53 164.8 32.23 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.16 128.06 51.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -1.147 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.702 HG22 HD11 ' A' ' 99' ' ' LEU . 86.2 t -47.47 -34.45 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.64 -177.15 3.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.937 . . . . 0.0 109.623 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.506 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 8.0 p-10 -102.43 24.59 10.13 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.299 -0.876 . . . . 0.0 109.457 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.465 ' N ' ' CD1' ' A' ' 49' ' ' TRP . 38.9 m0 -65.54 -43.09 91.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.5 ' HB3' HG12 ' A' ' 16' ' ' ILE . 2.2 m-80 -119.91 61.49 0.84 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.148 -0.97 . . . . 0.0 109.753 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 91.1 t -84.7 102.58 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.236 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.61 10.2 63.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.445 ' HB3' HG21 ' A' ' 16' ' ' ILE . 15.4 mtt85 -82.09 126.25 31.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -1.149 . . . . 0.0 109.449 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -72.22 150.44 92.1 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.515 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.546 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 53.8 Cg_exo -50.1 137.12 37.51 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.928 1.752 . . . . 0.0 110.31 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 60' ' ' VAL . 32.9 p-10 -75.11 127.66 86.23 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.177 -0.952 . . . . 0.0 109.246 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.854 ' HA ' HG23 ' A' ' 60' ' ' VAL . 72.1 Cg_exo -43.85 -23.21 0.57 Allowed 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 122.107 1.871 . . . . 0.0 110.618 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -60.27 -53.46 57.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.874 -1.141 . . . . 0.0 108.392 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 61' ' ' SER . . . -76.73 -64.1 1.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.854 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.25 -28.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.583 -0.698 . . . . 0.0 109.387 179.294 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 57' ' ' PRO . 1.7 t -52.7 -53.52 46.45 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.444 -0.785 . . . . 0.0 110.487 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.456 ' C ' HD23 ' A' ' 63' ' ' LEU . 35.0 t -70.29 -17.92 63.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.123 -0.985 . . . . 0.0 110.541 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.763 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -90.14 -75.34 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.96 -1.087 . . . . 0.0 109.418 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' LEU . 3.6 ttt85 -43.62 -26.53 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 109.624 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -46.23 -66.26 0.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.887 . . . . 0.0 109.406 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -76.33 -36.82 58.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.03 74.4 0.1 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.757 HD11 ' HA ' ' A' ' 25' ' ' VAL . 6.4 tp -86.53 -12.08 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.214 -1.168 . . . . 0.0 109.237 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 68' ' ' ILE . 2.7 p-10 40.98 44.88 2.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.518 -0.739 . . . . 0.0 109.811 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.655 HG23 ' H ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -57.02 -76.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 109.515 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.655 ' H ' HG23 ' A' ' 70' ' ' THR . . . 55.49 76.23 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.114 -0.991 . . . . 0.0 109.414 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.557 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.6 p-80 -150.36 157.15 42.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.553 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.27 134.21 54.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 109.406 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HB2' ' OD1' ' A' ' 15' ' ' ASN . . . -75.4 163.99 26.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.5 ' HD2' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -178.56 128.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.327 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.456 ' H ' HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -50.98 142.74 11.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.877 . . . . 0.0 109.59 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.525 HG12 ' CE2' ' A' ' 82' ' ' PHE . 30.0 t -58.57 162.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.511 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.466 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -160.5 161.5 32.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 109.547 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -48.77 -32.27 8.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.313 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 84' ' ' THR . 0.9 OUTLIER -64.8 -49.46 70.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.796 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -66.61 -26.79 67.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 110.184 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.932 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 42.4 m-85 -68.37 -68.45 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 109.727 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 110' ' ' ARG . 9.2 p -64.21 -22.02 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 85' ' ' PHE . 2.5 m -65.42 -71.93 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.126 -0.984 . . . . 0.0 109.527 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.595 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 84.5 m-85 -73.36 163.8 27.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.415 ' OD1' ' HG3' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -112.55 -17.55 12.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -0.843 . . . . 0.0 109.461 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.2 m-85 -119.75 81.32 1.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 109.202 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.883 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 1.4 mt -90.59 112.82 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 0.0 109.074 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -133.34 169.22 17.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.998 -1.064 . . . . 0.0 109.286 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.64 ' SG ' HD12 ' A' ' 99' ' ' LEU . 21.3 m -127.8 177.27 6.94 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.341 -0.849 . . . . 0.0 109.165 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.675 ' HE2' ' HA ' ' A' ' 91' ' ' MET . 16.6 mmt -85.36 47.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.894 ' OD1' HD23 ' A' ' 116' ' ' LEU . 4.2 m-20 54.38 87.86 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 109.465 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.37 158.24 43.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 109.375 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.0 p -71.89 -15.68 62.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.908 . . . . 0.0 109.459 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -72.24 -10.82 60.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.52 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.914 HD23 ' HB2' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -68.14 -31.23 70.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -19.59 4.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.439 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -93.81 -31.33 14.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.482 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.914 ' HB2' HD23 ' A' ' 96' ' ' LEU . 15.8 mt -66.6 -34.19 77.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.574 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.54 -24.55 67.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -91.88 -10.34 39.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 109.418 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.941 ' O ' HG23 ' A' ' 106' ' ' VAL . 2.4 mmmm -70.89 -32.99 70.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.892 . . . . 0.0 109.345 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.776 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 14.6 p -62.15 -28.05 69.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -46.68 75.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.355 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -85.02 0.74 50.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.606 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 102' ' ' LYS . 40.4 t -87.73 121.9 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.314 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 106' ' ' VAL . 9.0 tptt -45.03 99.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 106' ' ' VAL . 85.8 m-20 48.11 58.75 4.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 109.526 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.776 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -53.78 147.24 12.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 109.793 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.556 ' HB3' HG23 ' A' ' 83' ' ' VAL . 8.6 ptt180 -131.29 2.12 4.21 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.932 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -86.6 118.56 26.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 110.151 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' ILE . 5.5 mtpm? -69.49 106.05 2.85 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.803 HG21 ' HB3' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -83.23 137.24 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.994 -1.066 . . . . 0.0 110.084 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.909 ' O ' HD11 ' A' ' 96' ' ' LEU . 1.2 tt0 -176.27 -170.47 0.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.49 -0.756 . . . . 0.0 109.057 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.717 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -122.65 118.06 27.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 109.496 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.905 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER 59.15 -87.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.839 . . . . 0.0 109.504 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 119' ' ' TYR . . . 166.04 -175.28 41.62 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.9 p -109.65 64.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -1.174 . . . . 0.0 109.487 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.441 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.9 m-85 -120.16 -140.86 0.34 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.176 -0.952 . . . . 0.0 109.143 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 0.2 OUTLIER 169.03 63.07 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.071 -1.018 . . . . 0.0 109.43 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.411 ' HG3' ' HB2' ' A' ' 151' ' ' ALA . 55.2 Cg_endo -71.6 -4.98 16.09 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.048 1.832 . . . . 0.0 110.243 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -161.37 -149.75 0.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.4 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 150.35 49.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -76.6 123.59 26.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -166.61 138.1 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.497 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.575 HG23 ' HB3' ' A' ' 92' ' ' ASP . 10.2 mm -95.35 150.47 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.362 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 3.0 mp -106.23 81.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.507 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.469 ' HG3' HG22 ' A' ' 126' ' ' ILE . 66.2 mt-10 -121.71 81.85 1.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.431 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.4 p30 -158.58 85.35 2.46 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.559 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 132' ' ' TYR . 50.7 Cg_endo -71.08 171.75 15.28 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.959 1.773 . . . . 0.0 110.283 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -43.58 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -134.21 -47.11 0.77 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.362 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 114.8 84.87 1.25 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.63 -66.61 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -1.142 . . . . 0.0 109.487 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -179.9 89.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.475 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 50.84 34.74 10.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 109.455 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.94 79.05 9.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.1 -61.25 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.39 -45.95 88.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 m -47.23 -33.03 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.42 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 19' ' ' SER . 44.7 t -67.62 -45.86 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.422 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 142' ' ' TYR . 8.7 t80 -57.7 -46.68 84.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -58.54 -56.43 22.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.962 . . . . 0.0 109.344 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.755 ' O ' ' SG ' ' A' ' 148' ' ' CYS . 15.7 mt-30 -64.85 -13.05 54.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 109.417 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.571 ' HA ' ' SG ' ' A' ' 148' ' ' CYS . 3.5 m -83.85 -27.02 29.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.315 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 1.037 ' HA ' HG11 ' A' ' 25' ' ' VAL . 87.6 t -55.14 -53.92 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.279 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.408 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -81.41 -15.86 53.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.238 -0.914 . . . . 0.0 109.334 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.905 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.3 m -50.17 -23.44 2.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 0.0 108.713 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.594 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -122.01 -42.48 2.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.238 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.484 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . 55.2 ttt-85 -59.19 -49.55 77.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.041 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.411 ' HB2' ' HG3' ' A' ' 121' ' ' PRO . . . -59.24 -19.8 48.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.827 . . . . 0.0 109.07 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.682 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 1.7 t80 -89.44 -25.42 21.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -0.831 . . . . 0.0 109.372 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.728 HD21 HD13 ' A' ' 35' ' ' ILE . 10.1 tp -77.79 -26.72 49.89 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.037 -1.039 . . . . 0.0 108.911 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 2.5 pt-20 -67.8 -30.39 69.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -0.968 . . . . 0.0 109.105 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.506 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -79.93 -51.34 9.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.89 . . . . 0.0 109.043 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.682 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 15.4 m -99.2 42.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 108.995 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.459 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.452 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 12.2 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.328 0.585 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.957 HG22 ' HA ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -149.67 75.94 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 109.223 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.663 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 22.3 mttp -51.46 -178.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 0.0 109.695 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.499 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 48.8 m -147.17 116.76 7.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.4 -0.813 . . . . 0.0 109.158 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.695 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -124.03 150.99 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 109.075 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.697 HD22 HG12 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -149.16 108.65 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.156 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.51 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 1.9 m-85 -81.52 157.38 24.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.895 HG11 HD11 ' A' ' 99' ' ' LEU . 59.5 t -138.8 149.87 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.883 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -169.04 133.4 1.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.415 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.619 HD11 ' CH2' ' A' ' 49' ' ' TRP . 13.4 tp -44.74 -61.76 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.87 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 15' ' ' ASN . . . -49.58 -88.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.865 ' O ' HG23 ' A' ' 16' ' ' ILE . 2.4 t-20 76.69 17.82 1.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -1.102 . . . . 0.0 109.6 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.865 HG23 ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER -169.1 -71.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 4.8 p -76.72 -26.84 55.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.449 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 19' ' ' SER . 25.8 ttm180 -62.18 -13.13 24.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.249 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 18' ' ' ARG . 7.3 m 68.48 60.72 0.68 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.293 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 19' ' ' SER . 40.9 Cg_endo -69.35 81.33 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.965 1.777 . . . . 0.0 110.458 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.992 ' O ' HG23 ' A' ' 25' ' ' VAL . 6.8 mm -83.44 -15.61 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.87 . . . . 0.0 109.34 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.769 ' HB1' ' HB3' ' A' ' 148' ' ' CYS . . . -63.99 -51.65 63.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.132 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -60.34 -58.71 7.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 108.933 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.871 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -44.57 -38.0 3.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -0.849 . . . . 0.0 108.884 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 21' ' ' ILE . 70.4 t -60.32 -56.51 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.247 -0.908 . . . . 0.0 108.831 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.636 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 0.4 OUTLIER -43.58 -32.19 0.89 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -62.82 -52.88 61.44 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 108.853 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.519 ' HG3' HD13 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -63.29 -58.28 7.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.21 -0.931 . . . . 0.0 109.663 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.636 HD12 ' SG ' ' A' ' 149' ' ' CYS . 29.9 mt -43.47 -66.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 109.761 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.967 HG22 ' HA ' ' A' ' 36' ' ' SER . 3.0 p -58.8 -24.78 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 109.995 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 31' ' ' THR . 14.4 m -99.8 30.7 3.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.553 -1.342 . . . . 0.0 109.262 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -149.69 46.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.62 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -179.24 32.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -0.812 . . . . 0.0 109.041 -179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 33' ' ' GLN . 9.8 m120 46.7 42.08 11.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.826 HG12 HG23 ' A' ' 30' ' ' VAL . 1.7 tt -130.64 -5.38 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.247 0.546 . . . . 0.0 109.779 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.967 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -74.26 -33.27 63.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.937 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -76.08 1.79 14.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.64 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.957 ' HA ' HG22 ' A' ' 5' ' ' THR . 23.7 m-20 -128.8 37.91 4.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 109.785 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.695 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 18.2 m95 -150.62 139.89 21.28 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.853 -1.154 . . . . 0.0 110.899 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG12 ' CE2' ' A' ' 85' ' ' PHE . 44.1 t -112.04 73.62 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.495 ' CG1' HG13 ' A' ' 8' ' ' VAL . 2.9 mt -89.91 140.42 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -0.819 . . . . 0.0 109.862 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.718 ' OD1' ' CE1' ' A' ' 72' ' ' HIS . 14.7 t0 -149.06 -168.27 3.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.477 -0.764 . . . . 0.0 109.175 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.473 ' OG ' ' ND2' ' A' ' 15' ' ' ASN . 29.6 t -134.48 169.96 16.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 109.691 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.78 153.85 25.55 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.13 -18.43 6.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -1.142 . . . . 0.0 109.714 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 46' ' ' VAL . 58.1 t 56.98 17.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.381 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.578 ' HB3' ' CZ2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -145.26 144.71 30.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.299 -0.875 . . . . 0.0 109.413 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.487 ' HA ' HG23 ' A' ' 51' ' ' VAL . 5.0 m-20 -91.65 32.63 1.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.619 ' CH2' HD11 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -97.19 -33.95 11.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 109.331 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 11.8 m-20 -125.43 46.78 2.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.639 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.843 HG13 ' HA ' ' A' ' 75' ' ' ARG . 89.8 t -71.95 85.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.353 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.47 ' HA2' ' CG ' ' A' ' 73' ' ' LYS . . . 115.96 -6.44 19.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.523 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 2.5 mtt85 -76.55 96.25 4.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -1.113 . . . . 0.0 109.599 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.804 ' O ' HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -50.91 -179.36 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.123 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 61.5 Cg_exo -49.59 133.8 32.45 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.833 1.689 . . . . 0.0 110.239 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.579 ' OD1' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -43.76 145.3 1.22 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.465 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' VAL . 53.9 Cg_exo -50.09 -21.1 6.08 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.941 1.76 . . . . 0.0 110.386 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.2 mtt-85 -83.04 -50.41 8.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.758 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 1.04 ' O ' HD12 ' A' ' 63' ' ' LEU . . . -90.25 11.98 19.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 110.077 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.598 HG13 ' N ' ' A' ' 61' ' ' SER . 7.3 p -90.01 -49.14 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.042 -1.036 . . . . 0.0 109.607 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.598 ' N ' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -91.53 -29.84 16.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.132 -0.98 . . . . 0.0 109.682 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.9 m -90.17 20.38 4.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.04 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -64.68 102.47 0.58 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.772 -1.205 . . . . 0.0 108.412 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.596 ' HG3' ' CE1' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 59.36 15.56 4.46 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.741 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 64' ' ' ARG . 3.0 p-10 35.29 100.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.008 0.908 . . . . 0.0 111.086 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 21.4 m80 57.91 24.44 10.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 0.0 109.902 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.518 ' HA3' ' NE ' ' A' ' 64' ' ' ARG . . . -128.09 -4.66 5.46 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.932 HG21 ' CD2' ' A' ' 63' ' ' LEU . 25.2 mm -148.0 156.94 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -1.19 . . . . 0.0 109.698 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' HG22 ' A' ' 68' ' ' ILE . 3.8 m120 -141.51 83.52 1.87 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.244 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.59 HG21 HD13 ' A' ' 63' ' ' LEU . 26.1 p -70.3 159.88 33.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.62 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -169.1 28.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.247 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.718 ' CE1' ' OD1' ' A' ' 42' ' ' ASP . 62.4 t-80 -124.27 157.75 34.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.36 -0.838 . . . . 0.0 109.254 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.47 ' CG ' ' HA2' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -89.71 -147.24 0.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 109.532 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 75' ' ' ARG . . . -137.75 -81.78 0.34 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.544 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.843 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 75.08 113.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.953 . . . . 0.0 109.392 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.647 ' H ' HG22 ' A' ' 51' ' ' VAL . 2.3 tt0 -43.68 143.05 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.428 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.606 HG23 ' H ' ' A' ' 46' ' ' VAL . 5.0 t -57.68 164.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -169.19 165.9 10.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.353 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.595 ' CG ' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -43.61 -31.88 0.85 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' OG1' ' A' ' 84' ' ' THR . 36.4 tt0 -59.41 -57.22 13.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.293 -0.88 . . . . 0.0 109.616 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.516 ' HB3' HD13 ' A' ' 9' ' ' LEU . 6.6 m-20 -66.11 -17.71 64.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.87 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.764 ' CD2' HG21 ' A' ' 106' ' ' VAL . 10.5 m-85 -70.47 -74.78 0.13 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.047 -1.033 . . . . 0.0 109.308 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 7.4 p -61.49 -24.2 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.458 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 5.8 m -64.45 -73.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.97 . . . . 0.0 109.448 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.622 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 57.1 m-85 -75.98 154.83 35.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.681 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 63.3 m-20 -108.71 -16.62 14.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.421 -0.799 . . . . 0.0 109.485 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.563 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 22.9 m-85 -118.25 67.74 0.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.64 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.917 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.1 mt -79.61 93.91 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.316 -0.865 . . . . 0.0 109.077 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -106.04 178.88 4.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 109.502 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.691 ' SG ' ' HB ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -132.88 176.82 8.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.346 -0.846 . . . . 0.0 109.41 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.688 ' O ' HG23 ' A' ' 127' ' ' ILE . 1.5 mmt -85.35 45.08 1.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.915 . . . . 0.0 109.594 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.693 ' HB3' HG23 ' A' ' 126' ' ' ILE . 0.7 OUTLIER 54.71 106.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.602 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -177.24 155.2 1.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.492 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -7.95 36.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -66.61 -16.05 63.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.449 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.564 HD21 HG22 ' A' ' 113' ' ' ILE . 0.3 OUTLIER -64.51 -22.31 66.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 109.537 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -55.55 -24.22 31.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.13 -43.35 11.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.364 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.895 HD11 HG11 ' A' ' 11' ' ' VAL . 9.2 mt -67.92 -13.23 61.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.65 -32.39 23.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.39 16.28 18.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.961 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -104.0 -19.37 14.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.56 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 96.5 p -71.06 -45.96 62.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.524 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.476 ' OD1' ' HG2' ' A' ' 105' ' ' GLN . 19.1 p-10 -62.18 -29.38 70.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.476 ' HG2' ' OD1' ' A' ' 104' ' ' ASN . 5.9 mm100 -87.72 -15.24 37.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.949 . . . . 0.0 109.379 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 102' ' ' LYS . 25.6 t -71.36 150.18 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.261 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 108' ' ' ASN . 3.2 tptt -71.92 87.16 1.01 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.271 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 107' ' ' LYS . 50.3 t30 68.28 45.42 1.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 109.485 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -56.76 149.69 17.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 0.0 109.817 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 1.9 ptm180 -138.75 9.73 2.63 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.917 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -86.34 91.79 8.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.432 -0.792 . . . . 0.0 110.404 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -47.95 122.31 4.96 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 111' ' ' ALA . 1.3 mm -95.54 140.6 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.817 -1.177 . . . . 0.0 110.281 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 1.2 tt0 -168.61 -177.74 3.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -125.31 156.73 38.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.065 -1.022 . . . . 0.0 109.634 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.684 ' CD2' ' SG ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER -43.69 -26.64 0.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . -63.2 89.26 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER 170.38 -35.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -1.117 . . . . 0.0 109.461 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.447 ' CD2' ' HA ' ' A' ' 152' ' ' PHE . 22.9 m-85 -105.91 76.04 1.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 109.433 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 123' ' ' LYS . 2.1 m-20 -143.18 84.12 10.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.897 . . . . 0.0 109.622 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.18 -36.13 45.13 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.996 1.797 . . . . 0.0 110.237 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 122' ' ' GLN . 8.5 pt20 -155.44 68.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.429 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB3' ' OD1' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -169.97 128.86 0.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.305 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.93 95.62 3.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.326 -0.859 . . . . 0.0 109.466 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.14 -43.3 0.56 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.568 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.716 HG22 ' HG3' ' A' ' 128' ' ' GLU . 28.1 mm 57.51 102.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 109.461 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 91' ' ' MET . 4.6 tt -77.05 96.57 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.517 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.716 ' HG3' HG22 ' A' ' 126' ' ' ILE . 21.4 mt-10 -119.17 39.04 3.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 109.425 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -72.93 146.94 88.19 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 109.478 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -72.14 -175.38 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.957 1.771 . . . . 0.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.535 ' CD1' ' O ' ' A' ' 131' ' ' TYR . 40.6 t80 -68.7 -13.23 62.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.398 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -92.15 -28.93 16.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.85 176.59 43.65 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -79.96 -56.46 4.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.42 -71.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.872 . . . . 0.0 109.487 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.56 42.59 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.873 . . . . 0.0 109.494 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -82.9 74.89 9.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.577 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.735 ' O ' HG12 ' A' ' 141' ' ' VAL . 3.9 t80 -130.54 -39.25 1.29 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 0.0 109.477 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -80.65 -47.32 14.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.21 -0.932 . . . . 0.0 109.383 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.3 m -64.84 -40.39 95.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.386 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.761 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 8.7 p -52.33 -27.22 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.596 ' CE1' ' HG3' ' A' ' 64' ' ' ARG . 3.1 t80 -83.52 -47.89 10.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.356 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -49.81 -53.63 24.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.74 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HG3' ' N ' ' A' ' 145' ' ' CYS . 0.9 OUTLIER -73.94 -23.27 59.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.812 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.761 ' SG ' ' O ' ' A' ' 141' ' ' VAL . 1.8 m -68.07 -20.35 64.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.572 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.68 ' HA ' HG11 ' A' ' 25' ' ' VAL . 55.5 t -64.38 -70.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.953 . . . . 0.0 109.354 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.722 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 2.1 mtt-85 -63.5 -16.71 61.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.948 . . . . 0.0 109.354 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.769 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -46.3 -31.07 2.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 0.0 109.094 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.771 ' SG ' HG12 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -116.85 -30.99 5.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -0.873 . . . . 0.0 109.144 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.523 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 67.8 ttt-85 -71.68 -56.25 6.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 108.964 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.722 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -50.83 -32.14 19.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.427 -0.796 . . . . 0.0 109.234 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.891 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 1.1 t80 -79.12 -33.21 44.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.419 -0.801 . . . . 0.0 109.384 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.7 tp -67.22 -18.29 65.17 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.148 -0.97 . . . . 0.0 108.755 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 49.2 mm-40 -68.67 -63.6 1.03 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 108.832 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -53.13 -47.59 68.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 108.826 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.891 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 18.5 m -98.12 51.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 108.838 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.358 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.583 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 6' ' ' LYS . 1.8 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.938 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -47.71 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 109.6 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.691 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -47.14 175.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.225 -0.922 . . . . 0.0 109.584 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.581 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 1.4 m -149.62 105.88 3.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.235 -0.916 . . . . 0.0 109.43 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.983 HG11 ' CE2' ' A' ' 26' ' ' PHE . 2.0 p -111.5 138.92 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.248 -0.908 . . . . 0.0 110.202 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.668 HD22 ' CD1' ' A' ' 88' ' ' ILE . 0.5 OUTLIER -133.76 129.37 36.54 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.56 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 1.3 m-85 -110.41 155.57 22.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 110.036 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.758 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 40.0 t -144.29 145.67 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.781 ' SG ' ' HG2' ' A' ' 91' ' ' MET . 2.9 m -163.74 48.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.097 -1.002 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.672 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.7 OUTLIER 42.47 -95.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.427 -0.795 . . . . 0.0 109.577 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -60.37 89.09 0.03 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.423 HD21 ' HA ' ' A' ' 74' ' ' ALA . 33.4 t30 -90.28 26.97 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -1.114 . . . . 0.0 109.457 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 53' ' ' ARG . 1.2 pp -122.63 -8.34 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.39 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -161.09 151.32 17.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.455 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.611 ' HD3' HD11 ' A' ' 127' ' ' ILE . 0.0 OUTLIER 51.96 63.17 2.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 162.44 -51.1 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.86 . . . . 0.0 109.823 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 19' ' ' SER . 66.1 Cg_exo -48.61 -21.94 3.9 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.909 1.739 . . . . 0.0 110.529 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.962 HG21 ' HA ' ' A' ' 142' ' ' TYR . 3.6 mm -66.59 -49.15 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.061 -1.025 . . . . 0.0 109.21 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.568 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -62.14 -18.29 60.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.137 -0.977 . . . . 0.0 109.272 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ALA . 18.3 tt0 -81.07 -82.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 109.41 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -44.23 -33.2 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.993 . . . . 0.0 109.357 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.839 HG11 ' HA ' ' A' ' 146' ' ' VAL . 44.3 t -65.72 -49.72 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.858 . . . . 0.0 109.426 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.983 ' CE2' HG11 ' A' ' 8' ' ' VAL . 1.1 t80 -53.43 -39.96 64.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.946 -1.096 . . . . 0.0 108.346 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -51.53 -67.16 0.27 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.282 -0.887 . . . . 0.0 108.961 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HA ' ' OG1' ' A' ' 31' ' ' THR . 28.9 tttt -73.15 -0.32 13.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 110.009 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.953 HD21 ' HB2' ' A' ' 150' ' ' ARG . 46.3 tp -85.32 -33.33 22.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 109.011 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.884 HG12 ' CE1' ' A' ' 26' ' ' PHE . 2.0 m -90.34 -31.05 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.977 HG23 ' CB ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -66.19 -33.04 74.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.662 -0.649 . . . . 0.0 109.348 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -66.84 -19.91 65.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 108.99 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.516 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 6.6 mm-40 -100.53 -3.01 31.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.434 -0.791 . . . . 0.0 109.531 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.9 OUTLIER 76.74 45.78 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.701 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.738 ' CD1' HD21 ' A' ' 153' ' ' LEU . 4.1 pt -137.41 3.24 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 0.0 109.942 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.977 ' CB ' HG23 ' A' ' 31' ' ' THR . 4.3 p -72.04 -30.77 65.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.928 -1.108 . . . . 0.0 109.48 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -60.62 -13.99 17.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.855 . . . . 0.0 109.277 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.938 ' HA ' HG22 ' A' ' 5' ' ' THR . 6.2 m-20 -129.01 48.15 2.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.691 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 5.7 m95 -150.11 143.43 25.08 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.888 -1.133 . . . . 0.0 110.666 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 t -117.54 81.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.67 HD11 HG11 ' A' ' 30' ' ' VAL . 3.5 mt -89.91 137.79 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.724 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -164.89 117.38 1.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.428 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 1.3 p -82.76 -171.62 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.965 . . . . 0.0 109.377 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.521 ' HA3' ' CG2' ' A' ' 77' ' ' VAL . . . -178.87 166.5 36.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.811 ' HB1' ' ND2' ' A' ' 50' ' ' ASN . . . -97.21 -167.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -1.106 . . . . 0.0 109.289 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.672 HG23 ' H ' ' A' ' 13' ' ' LEU . 38.5 t -121.2 -12.75 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.113 -0.992 . . . . 0.0 109.346 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -125.8 -153.66 0.58 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.526 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.687 ' HA ' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -119.85 -21.93 7.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 109.438 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.503 ' HZ2' HD21 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -54.9 -18.35 4.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.564 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.811 ' ND2' ' HB1' ' A' ' 45' ' ' ALA . 13.0 p30 -115.26 42.11 2.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.896 HG13 ' HD3' ' A' ' 75' ' ' ARG . 70.4 t -101.72 114.79 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.0 -6.99 83.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 16' ' ' ILE . 6.6 mtt180 -72.43 103.32 3.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -1.135 . . . . 0.0 109.507 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.1 p -59.82 154.64 46.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.537 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.04 158.77 3.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.974 1.783 . . . . 0.0 110.323 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -74.26 157.83 86.15 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.513 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 53.4 Cg_endo -71.87 -3.14 12.62 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.949 1.766 . . . . 0.0 110.256 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -89.49 -47.63 7.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB1' HD11 ' A' ' 21' ' ' ILE . . . -84.61 -16.77 40.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.454 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.513 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 9.8 p -65.09 -32.8 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.522 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.41 -10.17 54.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.4 m -80.82 -21.93 40.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -90.21 -66.66 0.9 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.027 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.9 ttm180 -47.33 -24.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.39 -0.819 . . . . 0.0 109.539 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -71.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -66.93 -8.79 32.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 109.644 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.8 69.3 0.81 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.597 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 10.3 mm -109.42 160.8 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -1.104 . . . . 0.0 109.458 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.498 ' N ' HG22 ' A' ' 68' ' ' ILE . 3.4 m120 -129.51 102.44 6.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.395 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -116.24 147.22 41.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.59 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -150.58 36.73 0.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.206 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -119.03 125.4 49.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.341 -0.85 . . . . 0.0 109.541 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -93.21 38.05 1.04 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.412 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 73' ' ' LYS . . . 65.94 169.54 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.898 . . . . 0.0 109.5 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.896 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 168.06 152.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -82.35 129.85 34.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.521 ' CG2' ' HA3' ' A' ' 44' ' ' GLY . 42.8 t -71.0 103.15 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 65.9 p -72.12 -164.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 109.095 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.878 ' HB2' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -86.29 -23.87 26.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.042 -1.036 . . . . 0.0 109.257 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 84' ' ' THR . 20.1 tt0 -65.46 -33.08 75.11 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.407 -0.808 . . . . 0.0 108.845 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -68.16 -17.86 64.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.39 -0.818 . . . . 0.0 108.975 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.827 ' CA ' ' HB2' ' A' ' 111' ' ' ALA . 32.1 m-85 -82.49 -65.24 1.03 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.364 -0.835 . . . . 0.0 109.208 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 110' ' ' ARG . 9.5 p -62.76 -19.17 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' GLU . 14.1 m -78.66 -67.47 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.0 109.244 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.579 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 53.3 m-85 -68.81 135.42 51.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.219 -0.926 . . . . 0.0 109.452 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -78.17 -23.63 47.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 7' ' ' SER . 6.9 m-85 -115.6 147.58 40.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.898 . . . . 0.0 109.539 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.859 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -156.82 95.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.366 -0.834 . . . . 0.0 108.832 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -114.1 156.88 23.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 109.749 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.508 ' HB2' HD12 ' A' ' 99' ' ' LEU . 36.1 t -124.6 146.48 49.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.476 -0.765 . . . . 0.0 109.059 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.781 ' HG2' ' SG ' ' A' ' 12' ' ' CYS . 20.4 mmt -42.91 150.71 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.69 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.512 ' OD1' HD12 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -45.16 -24.68 0.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 128' ' ' GLU . 9.5 mt-10 -41.29 -89.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.336 -0.852 . . . . 0.0 109.589 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 96' ' ' LEU . 39.2 p -79.41 83.09 5.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.246 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.811 ' HB2' HD22 ' A' ' 115' ' ' LEU . 17.3 p-10 -52.3 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.569 -0.707 . . . . 0.0 109.605 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.992 HD21 HG21 ' A' ' 113' ' ' ILE . 0.3 OUTLIER 41.56 27.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.625 -0.672 . . . . 0.0 109.9 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -90.28 -29.71 17.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.547 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.48 -38.63 7.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.514 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 90' ' ' CYS . 8.9 mt -67.05 -37.06 83.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.645 ' HB2' HD22 ' A' ' 96' ' ' LEU . 29.7 t30 -57.18 -19.49 20.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -89.73 -32.74 16.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.439 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.717 ' O ' HG23 ' A' ' 106' ' ' VAL . 9.5 mmmt -59.02 -32.88 70.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.882 . . . . 0.0 109.353 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 t -68.31 -31.59 71.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.244 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.09 -32.05 71.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -90.93 -11.28 39.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 109.302 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.878 HG22 ' HB2' ' A' ' 79' ' ' LYS . 81.5 t -86.08 140.73 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 119.35 23.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.342 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 109' ' ' CYS . 1.5 m-20 50.99 40.0 24.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.142 -0.974 . . . . 0.0 109.179 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -42.77 138.71 1.86 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.365 -0.834 . . . . 0.0 109.92 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.567 ' CB ' ' CZ ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -125.13 -5.12 7.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.806 . . . . 0.0 109.063 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.859 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -62.86 93.1 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.85 . . . . 0.0 110.207 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 86' ' ' ASP . 11.7 ttmt -46.29 106.48 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.992 HG21 HD21 ' A' ' 96' ' ' LEU . 2.9 mm -83.29 164.74 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.046 -1.034 . . . . 0.0 110.956 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.564 ' HB3' HD23 ' A' ' 89' ' ' LEU . 4.1 mt-10 176.47 -176.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.811 HD22 ' HB2' ' A' ' 95' ' ' ASN . 1.2 pp -141.49 138.75 33.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 0.0 109.84 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.4 OUTLIER -53.37 119.96 5.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.0 109.449 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -157.2 -159.84 9.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.58 114.36 2.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.477 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.0 m-85 -112.45 -17.83 12.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.583 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 163.84 -51.68 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.605 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 58.3 Cg_exo -49.26 164.41 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.698 1.599 . . . . 0.0 110.2 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -96.2 143.33 27.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.69 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 125' ' ' LEU . 3.9 tp60 -104.64 12.96 32.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 109.594 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.492 ' C ' ' O ' ' A' ' 124' ' ' GLN . 14.6 tp 33.47 81.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.169 0.509 . . . . 0.0 110.514 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.512 HD12 ' OD1' ' A' ' 92' ' ' ASP . 13.4 mm -48.15 143.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 109.201 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.612 HG23 ' O ' ' A' ' 127' ' ' ILE . 2.1 tt -119.9 95.3 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 94.4 mt-10 -121.86 69.2 0.93 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.432 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -114.73 144.9 32.79 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.505 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.91 -91.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.034 1.823 . . . . 0.0 110.278 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.495 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 32.5 t80 -166.32 50.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.329 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.76 109.88 4.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.33 145.91 16.41 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -110.44 -28.7 8.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -1.065 . . . . 0.0 109.371 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.439 ' OD1' ' CB ' ' A' ' 137' ' ' ASP . 2.6 p30 -91.71 17.8 8.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 45.47 49.55 10.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.439 ' CB ' ' OD1' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -79.98 79.05 6.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.47 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.415 ' CZ ' ' N ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -113.93 -10.05 12.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.499 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.46 -45.57 21.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 7.7 m -57.52 -25.35 59.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 18' ' ' ARG . 45.3 t -76.96 -36.46 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.962 ' HA ' HG21 ' A' ' 21' ' ' ILE . 4.7 t80 -64.37 -43.81 93.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -71.06 -48.95 49.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.66 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 148' ' ' CYS . 0.0 OUTLIER -59.33 -21.41 59.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.627 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.76 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.5 m -72.14 -32.6 67.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.839 ' HA ' HG11 ' A' ' 25' ' ' VAL . 77.7 t -49.49 -51.73 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.938 . . . . 0.0 109.289 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.448 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -77.68 -27.59 50.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.424 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.749 ' SG ' ' HA ' ' A' ' 145' ' ' CYS . 67.6 m -44.21 -26.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.138 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.601 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -115.11 -28.75 6.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.226 -0.921 . . . . 0.0 109.452 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.953 ' HB2' HD21 ' A' ' 29' ' ' LEU . 30.9 ttt85 -71.04 -59.2 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 108.99 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -49.43 -22.22 1.12 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.388 -0.82 . . . . 0.0 109.611 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 89' ' ' LEU . 1.3 t80 -90.19 -34.98 15.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 110.061 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.738 HD21 ' CD1' ' A' ' 35' ' ' ILE . 11.2 tp -67.28 -46.47 73.51 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.807 -1.183 . . . . 0.0 109.16 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 11.4 pt-20 -49.87 -38.23 34.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 108.638 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -59.98 -60.53 3.68 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.493 HG11 ' CE1' ' A' ' 87' ' ' TYR . 31.8 m -92.17 31.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.363 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.415 ' C ' ' OD1' ' A' ' 38' ' ' ASN . 59.5 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.781 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -87.93 75.95 8.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.684 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -41.33 153.04 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.759 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.586 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -133.23 117.29 17.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.082 -1.012 . . . . 0.0 109.579 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.719 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.4 OUTLIER -121.41 154.99 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.927 . . . . 0.0 109.591 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -149.99 106.53 3.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.868 . . . . 0.0 109.184 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.918 ' CE1' HD13 ' A' ' 89' ' ' LEU . 1.9 m-85 -88.41 155.15 19.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.777 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 2.0 t -145.94 149.83 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.232 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -166.35 154.0 9.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.539 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.7 tp -55.63 -67.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.02 78.92 1.5 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.643 ' ND2' ' HB2' ' A' ' 45' ' ' ALA . 42.5 p-10 -92.2 43.46 1.13 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -1.159 . . . . 0.0 109.419 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.848 HD12 ' H ' ' A' ' 17' ' ' CYS . 1.1 pp -132.88 -31.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 109.949 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.848 ' H ' HD12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -148.46 12.5 0.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.913 -1.117 . . . . 0.0 110.257 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.497 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 7.5 ttt-85 -125.35 -52.33 1.62 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.0 109.472 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.653 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -80.0 -44.35 1.48 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 110.949 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 19' ' ' SER . 73.5 Cg_exo -46.72 -17.0 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.99 1.793 . . . . 0.0 112.313 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.004 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -74.74 -45.33 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.336 -1.478 . . . . 0.0 108.894 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 145' ' ' CYS . . . -67.8 -42.98 80.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.01 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.432 ' CD ' ' HB2' ' A' ' 43' ' ' SER . 4.3 tt0 -58.59 -58.57 7.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 108.764 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.72 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -46.02 -36.87 6.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.327 -0.858 . . . . 0.0 108.841 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 21' ' ' ILE . 16.5 t -63.03 -52.12 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.274 -0.891 . . . . 0.0 108.952 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -52.53 -21.47 3.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -56.06 7.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.1 tttt -78.07 1.43 21.06 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.874 HD21 ' HG3' ' A' ' 150' ' ' ARG . 9.9 tp -94.22 -36.14 12.15 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.921 HG22 ' HA ' ' A' ' 36' ' ' SER . 4.1 p -91.07 -14.66 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -99.1 17.28 20.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.914 -1.116 . . . . 0.0 109.521 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.96 55.39 1.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 108.993 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.572 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 3.2 tp60 173.47 31.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.559 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 33' ' ' GLN . 0.3 OUTLIER 45.34 39.47 4.42 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -178.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.874 HG12 HG23 ' A' ' 30' ' ' VAL . 2.3 tt -124.68 -6.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.53 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.921 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -75.53 -22.23 57.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -0.892 . . . . 0.0 109.798 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -88.45 26.9 1.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.152 -0.968 . . . . 0.0 109.19 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.781 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.7 OUTLIER -159.06 40.19 0.22 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.323 -0.861 . . . . 0.0 109.396 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.719 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 14.4 m95 -150.14 156.62 41.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.956 -1.09 . . . . 0.0 111.121 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.38 72.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.551 HG13 ' CG1' ' A' ' 8' ' ' VAL . 2.8 mt -89.66 129.56 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.397 -0.814 . . . . 0.0 110.395 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.456 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . 5.6 t0 -144.95 147.74 33.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.446 -0.783 . . . . 0.0 108.955 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.432 ' HB2' ' CD ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -120.17 159.23 25.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.035 -1.041 . . . . 0.0 109.75 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.68 179.47 39.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.643 ' HB2' ' ND2' ' A' ' 15' ' ' ASN . . . -104.11 145.6 29.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -1.119 . . . . 0.0 109.401 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.451 HG22 ' CD1' ' A' ' 99' ' ' LEU . 70.8 t -57.1 -35.2 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.92 -164.11 1.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.436 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.495 ' HA ' HG23 ' A' ' 51' ' ' VAL . 1.6 m-20 -92.43 57.59 3.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.902 . . . . 0.0 109.474 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -89.03 -33.9 16.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.336 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -146.98 47.95 1.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.361 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 48' ' ' ASP . 76.2 t -58.86 112.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA2' ' HG3' ' A' ' 73' ' ' LYS . . . 51.43 51.36 37.63 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 54' ' ' SER . 7.8 mtt180 -95.98 18.47 13.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -1.192 . . . . 0.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER 58.53 151.93 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.62 -0.675 . . . . 0.0 109.631 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.17 128.22 13.62 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.98 1.787 . . . . 0.0 110.186 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 17' ' ' CYS . 55.5 m-20 -48.02 154.91 0.93 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.518 ' O ' HG12 ' A' ' 60' ' ' VAL . 55.5 Cg_endo -71.7 -4.77 15.71 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.024 1.816 . . . . 0.0 110.306 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -62.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.25 -18.38 65.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 109.4 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.594 HG22 ' HD2' ' A' ' 64' ' ' ARG . 9.8 p -63.96 -41.45 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.179 -0.951 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.515 ' N ' HG13 ' A' ' 60' ' ' VAL . 8.8 p -77.02 -3.31 38.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.665 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.485 ' C ' HD23 ' A' ' 63' ' ' LEU . 1.7 t -90.14 -33.02 16.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.41 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.798 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.38 -55.07 3.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.274 -0.892 . . . . 0.0 109.207 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.594 ' HD2' HG22 ' A' ' 60' ' ' VAL . 7.7 ptm180 -56.87 -16.54 6.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.386 -0.821 . . . . 0.0 109.642 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 61' ' ' SER . 12.6 t-20 -66.46 -81.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.401 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 5.5 p-80 -150.7 20.57 0.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.588 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.03 -97.19 2.39 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.72 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 2.6 mp -119.46 161.29 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -1.13 . . . . 0.0 109.413 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.486 ' N ' HG22 ' A' ' 68' ' ' ILE . 6.5 m120 -118.25 54.61 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.116 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -58.37 151.18 20.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.571 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -144.55 14.38 1.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.264 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.417 ' CE1' ' O ' ' A' ' 73' ' ' LYS . 38.4 t-80 -78.45 146.78 34.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.474 ' HG3' ' HA2' ' A' ' 52' ' ' GLY . 4.0 tptm -93.67 131.54 38.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 73' ' ' LYS . . . -48.42 176.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.548 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.467 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 171.51 139.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.466 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.405 ' H ' HG22 ' A' ' 51' ' ' VAL . 2.1 tt0 -70.07 131.41 44.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 109.51 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.647 HG12 ' CE1' ' A' ' 82' ' ' PHE . 71.8 t -48.75 131.54 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 109.334 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 79' ' ' LYS . 20.5 p -111.86 160.35 17.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.636 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -43.17 -44.3 5.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.573 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' O ' ' OG1' ' A' ' 84' ' ' THR . 23.6 tt0 -57.7 -47.82 81.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.837 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 1.1 m-20 -53.94 -43.78 70.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 109.983 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.894 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 49.6 m-85 -54.53 -50.89 66.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.499 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.567 ' HA ' ' CG ' ' A' ' 110' ' ' ARG . 1.0 OUTLIER -87.05 0.59 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 109.767 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.48 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 13.5 m -77.79 -53.32 7.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 110.244 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.606 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 16.7 m-85 -100.85 174.58 5.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.064 -1.022 . . . . 0.0 110.412 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 19.5 t0 -112.41 -19.84 12.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.466 -0.771 . . . . 0.0 109.578 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 7' ' ' SER . 1.4 m-85 -116.89 86.97 2.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 0.0 109.23 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.882 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 1.5 mt -95.73 123.45 47.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.339 -0.851 . . . . 0.0 109.327 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.918 HD13 ' CE1' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -149.59 153.38 37.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 109.267 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.55 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 4.7 p -127.37 167.59 15.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.557 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.536 ' HE1' ' HB2' ' A' ' 116' ' ' LEU . 16.9 mmt -60.89 142.04 56.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.682 ' HB3' HG23 ' A' ' 126' ' ' ILE . 16.9 m-20 -43.52 116.29 0.92 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 128' ' ' GLU . 11.3 tt0 -176.34 163.01 2.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.493 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 t -83.31 8.74 12.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -75.91 -11.97 60.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.588 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.9 OUTLIER -74.19 -2.37 24.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 0.0 109.607 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 13.7 ttt85 -63.63 -25.19 68.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.169 -0.957 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 0.4 OUTLIER -95.54 -43.91 7.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.395 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.516 ' HB3' HG21 ' A' ' 113' ' ' ILE . 6.0 mt -53.65 -44.71 69.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.357 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.48 -29.53 70.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.228 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -89.89 -5.8 56.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.903 . . . . 0.0 109.461 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.984 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -81.63 -20.93 38.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -0.874 . . . . 0.0 109.32 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -63.57 -36.59 84.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.826 . . . . 0.0 109.591 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -32.45 73.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.424 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -92.66 9.73 33.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.244 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.984 HG23 ' O ' ' A' ' 102' ' ' LYS . 49.1 t -98.68 145.29 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.392 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -73.39 106.54 5.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.064 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 109' ' ' CYS . 8.2 t-20 47.73 46.68 18.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.002 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.522 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -41.76 145.6 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.561 -0.712 . . . . 0.0 109.704 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.567 ' CG ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -137.6 25.15 2.88 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.311 -0.868 . . . . 0.0 109.111 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.894 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -106.73 131.43 53.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.392 -0.817 . . . . 0.0 109.858 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 88' ' ' ILE . 7.2 mtpt -83.19 100.22 10.43 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.662 HD13 ' N ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -76.32 135.46 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.734 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.46 -177.97 5.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.419 -0.801 . . . . 0.0 109.36 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.508 ' CD2' HD12 ' A' ' 96' ' ' LEU . 60.8 mt -110.71 152.75 26.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.652 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.677 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -69.08 -9.92 55.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.475 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 92' ' ' ASP . . . -45.94 -29.18 3.14 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.3 168.88 19.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -1.085 . . . . 0.0 109.471 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 55.41 73.65 0.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.37 75.54 13.63 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.13 105.89 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.915 1.743 . . . . 0.0 110.294 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 57.49 178.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.96 42.76 22.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.63 120.26 11.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tp -168.28 101.33 0.43 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.524 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.943 HG21 ' OE2' ' A' ' 128' ' ' GLU . 15.1 mm -54.28 141.09 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 127' ' ' ILE . 14.8 mt -100.76 57.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.93 . . . . 0.0 109.351 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.943 ' OE2' HG21 ' A' ' 126' ' ' ILE . 21.0 mt-10 -88.07 132.42 34.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.449 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 1.1 p30 -158.05 158.7 30.22 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 129' ' ' ASP . 51.4 Cg_endo -71.27 -90.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.038 1.825 . . . . 0.0 110.226 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.1 -42.84 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.454 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.09 100.02 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.07 -116.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -160.27 -55.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -1.162 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.41 18.48 15.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.622 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 137' ' ' ASP . . . -55.92 -20.41 15.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.321 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 0.7 OUTLIER 74.79 126.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.731 ' O ' HG12 ' A' ' 141' ' ' VAL . 80.8 t80 -82.42 0.74 40.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.605 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -79.47 -34.2 41.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.146 -0.971 . . . . 0.0 109.461 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.541 HG23 ' N ' ' A' ' 141' ' ' VAL . 15.0 t -76.4 -42.23 45.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 138' ' ' PHE . 9.0 p -46.64 -29.22 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.749 ' CD1' HG22 ' A' ' 21' ' ' ILE . 1.4 t80 -90.18 -46.34 8.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.102 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.03 -64.56 0.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.682 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -55.76 -20.09 13.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.102 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -72.33 -39.08 68.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.331 -0.856 . . . . 0.0 109.344 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.83 ' HA ' HG11 ' A' ' 25' ' ' VAL . 90.1 t -53.21 -71.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.034 -1.041 . . . . 0.0 109.74 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.54 ' HA ' ' CB ' ' A' ' 150' ' ' ARG . 13.1 mtm180 -62.49 -21.18 65.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.088 -1.007 . . . . 0.0 109.606 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.677 ' HA ' HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -45.81 -27.44 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.985 -1.072 . . . . 0.0 108.18 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.607 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -111.62 -23.12 10.86 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.874 ' HG3' HD21 ' A' ' 29' ' ' LEU . 8.5 ttp180 -76.48 -64.49 1.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.389 -0.819 . . . . 0.0 109.257 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -45.72 -37.87 6.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.257 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.667 ' O ' HG22 ' A' ' 156' ' ' VAL . 1.9 t80 -74.71 -37.38 62.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.42 -0.8 . . . . 0.0 109.3 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . 13.3 tp -67.14 -16.96 64.64 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.211 -0.93 . . . . 0.0 108.718 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -72.37 -50.52 26.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.035 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -42.43 98.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 108.841 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 152' ' ' PHE . 17.0 m -103.84 42.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 109.056 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.466 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.703 HG22 ' H ' ' A' ' 5' ' ' THR . 4.1 p . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.358 0.599 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.957 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -151.48 83.59 1.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.248 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.652 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -41.53 162.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.868 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.585 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 2.5 m -142.8 114.7 8.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 108.999 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.716 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.6 OUTLIER -118.01 147.77 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.733 -179.256 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -149.99 116.4 5.77 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 89' ' ' LEU . 2.5 m-85 -91.87 160.33 15.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 0.0 109.858 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.069 HG11 HD11 ' A' ' 99' ' ' LEU . 4.2 t -145.98 149.48 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.546 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -174.13 121.91 0.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.445 HD11 ' CZ2' ' A' ' 49' ' ' TRP . 44.6 tp -43.46 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 109.582 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . 148.96 -73.75 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.7 14.33 8.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -1.096 . . . . 0.0 109.425 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.616 HG21 ' HD3' ' A' ' 53' ' ' ARG . 1.3 pp -131.41 12.73 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 18' ' ' ARG . 15.3 t 179.12 137.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.77 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 23.7 ttm-85 84.15 -52.22 0.13 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.75 -0.594 . . . . 0.0 109.664 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -79.56 -50.1 1.32 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 110.049 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 19' ' ' SER . 70.2 Cg_exo -48.37 -33.66 23.23 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.902 1.735 . . . . 0.0 110.876 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.022 HG21 ' HA ' ' A' ' 142' ' ' TYR . 5.4 mm -65.75 -61.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.961 -1.087 . . . . 0.0 109.655 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.444 ' N ' ' HB3' ' A' ' 145' ' ' CYS . . . -62.5 -12.77 24.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 109.539 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 2.4 tm-20 -77.98 -74.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.401 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -53.96 -33.96 58.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 108.841 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.085 HG11 ' HA ' ' A' ' 146' ' ' VAL . 49.6 t -56.29 -59.75 2.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.393 -0.817 . . . . 0.0 109.202 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.736 ' CD1' HG12 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -47.52 -41.26 20.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.974 -1.079 . . . . 0.0 108.506 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.505 ' O ' ' OG1' ' A' ' 31' ' ' THR . 5.8 ttt85 -45.7 -60.07 2.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.006 -1.059 . . . . 0.0 109.403 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.481 ' HA ' ' OG1' ' A' ' 31' ' ' THR . 0.3 OUTLIER -75.32 -13.03 60.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.41 -0.806 . . . . 0.0 111.003 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.943 ' CD1' HG12 ' A' ' 25' ' ' VAL . 42.1 mt -76.37 -30.85 57.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.846 -1.159 . . . . 0.0 109.433 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.763 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -90.76 -31.85 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -60.86 -31.81 71.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 109.076 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.46 -40.61 89.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.357 -0.839 . . . . 0.0 109.328 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.532 ' HB3' HG23 ' A' ' 35' ' ' ILE . 32.0 tp60 -80.67 -6.54 58.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.874 . . . . 0.0 109.515 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 1.5 m120 72.67 47.44 0.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.763 ' CG1' HG23 ' A' ' 30' ' ' VAL . 5.9 pt -129.72 -1.14 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.917 . . . . 0.0 109.656 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 30' ' ' VAL . 2.1 p -58.36 -44.46 88.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 109.657 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.12 -28.03 6.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.548 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.957 ' HA ' HG22 ' A' ' 5' ' ' THR . 5.3 m-20 -112.58 46.1 1.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.716 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 7.6 m95 -149.86 144.54 26.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.157 -0.964 . . . . 0.0 110.194 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.718 HG12 ' CE1' ' A' ' 85' ' ' PHE . 33.8 t -124.16 78.11 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.568 ' HA ' HG13 ' A' ' 8' ' ' VAL . 2.6 mt -90.02 139.11 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.869 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.602 ' OD1' ' CD2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -150.75 -173.53 4.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.285 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.439 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 1.1 t -126.46 165.95 18.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.692 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.93 131.94 4.82 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.747 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -93.41 -39.24 11.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.301 -1.117 . . . . 0.0 109.583 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER 80.84 -6.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.695 . . . . 0.0 109.466 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.0 m -141.31 137.33 32.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.624 ' HA ' HG23 ' A' ' 51' ' ' VAL . 1.3 t70 -88.38 14.1 10.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.516 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -86.25 3.45 43.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.695 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 49' ' ' TRP . 3.9 m-20 -144.46 22.78 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.577 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.984 HG13 ' HA ' ' A' ' 75' ' ' ARG . 60.9 t -64.85 128.37 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.05 -18.15 42.16 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.616 ' HD3' HG21 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -62.86 113.17 2.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -1.116 . . . . 0.0 109.365 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.4 m -76.45 153.01 83.79 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 56' ' ' ASP . 53.7 Cg_exo -50.25 143.72 25.33 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.957 1.771 . . . . 0.0 110.266 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 55' ' ' PRO . 4.5 m-20 -44.79 151.92 0.58 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.9 -6.0 18.19 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 121.93 1.753 . . . . 0.0 110.31 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.746 ' O ' ' SG ' ' A' ' 62' ' ' CYS . 16.0 mtt180 -86.26 -33.85 20.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.366 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB2' ' HZ ' ' A' ' 138' ' ' PHE . . . -89.14 -25.07 22.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.319 -0.863 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.583 HG13 ' N ' ' A' ' 61' ' ' SER . 9.9 p -64.71 -44.78 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.456 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.583 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -69.64 -8.46 47.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.631 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.746 ' SG ' ' O ' ' A' ' 58' ' ' ARG . 13.1 m -89.89 -66.71 0.9 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.593 HD12 HG21 ' A' ' 68' ' ' ILE . 1.7 pt? -57.78 -25.31 60.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.368 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.483 ' H ' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -91.56 30.89 1.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.349 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -133.21 -46.0 0.84 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.574 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -83.59 -33.58 25.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.427 ' O ' HG12 ' A' ' 68' ' ' ILE . . . 136.22 98.5 0.54 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.593 HG21 HD12 ' A' ' 63' ' ' LEU . 15.6 mm -149.42 -68.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -1.127 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 21.4 m-80 68.65 116.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.391 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 t -105.01 167.69 9.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.537 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -161.71 39.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.456 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.634 ' CE1' ' O ' ' A' ' 73' ' ' LYS . 9.5 t-80 -155.16 144.66 21.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.508 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.634 ' O ' ' CE1' ' A' ' 72' ' ' HIS . 0.9 OUTLIER -115.82 151.18 35.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' ARG . . . -44.11 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.984 ' HA ' HG13 ' A' ' 51' ' ' VAL . 1.5 tpp180 69.15 8.1 6.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 75' ' ' ARG . 2.5 tt0 61.32 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 78' ' ' THR . 11.6 p -53.85 165.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.564 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -143.85 161.96 37.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.677 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -50.63 -41.57 55.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.274 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 84' ' ' THR . 0.3 OUTLIER -54.0 -41.13 67.61 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.354 -0.841 . . . . 0.0 109.53 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.443 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 0.9 OUTLIER -62.15 -31.88 72.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 109.842 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.685 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 77.6 m-85 -66.23 -59.2 3.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.063 -1.023 . . . . 0.0 109.399 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.52 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 2.6 p -72.98 -9.14 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.506 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 85' ' ' PHE . 3.4 m -81.76 -78.06 0.2 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.222 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.718 ' CE1' HG12 ' A' ' 40' ' ' VAL . 37.2 m-85 -70.06 156.52 39.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.253 -0.905 . . . . 0.0 109.315 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -106.43 -12.68 15.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.654 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 7' ' ' SER . 2.2 m-85 -121.88 78.21 1.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 109.712 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.92 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 2.8 mt -89.3 91.66 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.306 -0.872 . . . . 0.0 108.964 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.687 HD21 ' CE1' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -107.45 168.26 9.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 0.0 109.352 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 11' ' ' VAL . 3.9 m -136.51 175.21 9.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.259 -0.9 . . . . 0.0 109.292 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 16.8 mmt -84.07 12.51 6.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.447 ' O ' ' CD2' ' A' ' 115' ' ' LEU . 1.3 p30 170.66 176.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.579 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.733 ' HB2' HD11 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -107.34 -14.69 14.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 93' ' ' GLU . 0.5 OUTLIER -44.26 -53.0 7.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.582 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -89.16 -24.34 22.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.916 . . . . 0.0 109.571 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.84 ' O ' HD23 ' A' ' 96' ' ' LEU . 2.6 tt -58.7 -21.19 54.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.95 -28.24 0.44 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -94.65 -33.24 13.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.069 HD11 HG11 ' A' ' 11' ' ' VAL . 15.4 mt -67.17 -14.48 62.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -85.5 -31.78 22.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.98 -11.93 40.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.447 ' HE2' ' CZ ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -67.86 -42.47 81.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.434 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.698 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 1.1 p -53.03 -22.66 6.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.397 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -72.02 -44.05 64.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.383 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -83.08 -9.93 58.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.554 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.677 HG13 ' HG2' ' A' ' 79' ' ' LYS . 41.1 t -76.8 135.49 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.448 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -68.65 108.41 3.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.482 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.1 t30 51.93 48.98 21.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.279 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -48.36 148.77 1.78 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.282 -0.886 . . . . 0.0 109.773 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.52 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -136.95 5.21 2.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.417 -0.802 . . . . 0.0 109.206 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.92 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -85.44 94.43 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 110.388 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -52.82 122.88 10.02 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -96.97 129.38 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.79 -1.194 . . . . 0.0 110.114 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -155.3 -171.98 4.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 0.0 109.224 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 93' ' ' GLU . 20.2 mt -117.49 162.66 17.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.969 . . . . 0.0 109.517 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.658 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -85.85 58.71 5.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -123.07 -2.22 9.29 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 15.62 24.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -1.187 . . . . 0.0 109.487 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.434 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 2.8 m-85 -135.76 70.57 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -166.63 133.83 2.05 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.164 -0.96 . . . . 0.0 109.382 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.65 -30.55 29.03 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.769 1.646 . . . . 0.0 110.168 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -128.3 132.44 48.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.39 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -64.65 140.44 58.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.182 -0.949 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 125' ' ' LEU . 1.1 mt-30 -108.76 16.82 22.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.253 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.723 ' O ' HD23 ' A' ' 125' ' ' LEU . 1.6 tt 39.66 61.07 1.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.756 -0.59 . . . . 0.0 109.842 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.515 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 7.2 mm 62.08 139.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 0.0 109.345 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 129' ' ' ASP . 2.8 mp -101.43 -55.21 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.84 . . . . 0.0 109.365 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.515 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 33.5 mt-10 48.0 -92.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER 51.44 92.55 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.489 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.1 157.11 3.1 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.901 1.734 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -98.92 87.3 3.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -138.6 -74.83 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.525 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -142.73 117.79 1.17 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 137' ' ' ASP . 2.4 p30 -105.8 148.06 27.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -1.149 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -80.92 74.48 7.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 66.03 33.14 7.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.443 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 134' ' ' ASN . 0.4 OUTLIER -105.89 56.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 109.564 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.481 ' HZ ' ' HB2' ' A' ' 59' ' ' ALA . 66.9 t80 -111.36 -42.04 3.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 109.355 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -70.42 -36.15 73.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 0.0 109.307 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 56.8 m -65.81 -17.66 64.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.226 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 18' ' ' ARG . 22.3 t -81.67 -43.89 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 1.022 ' HA ' HG21 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.54 -25.89 65.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.216 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -83.9 -46.76 11.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.91 . . . . 0.0 109.651 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' A' ' 141' ' ' VAL . 16.2 pt20 -67.23 -13.3 61.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.24 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.77 ' SG ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -79.09 -19.21 51.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 109.457 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 1.085 ' HA ' HG11 ' A' ' 25' ' ' VAL . 54.4 t -61.3 -56.27 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.926 . . . . 0.0 109.27 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.87 -12.29 60.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.288 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.658 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.2 m -56.12 -18.78 10.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.15 -0.969 . . . . 0.0 108.988 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.588 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -124.42 -40.71 2.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.418 -0.801 . . . . 0.0 109.229 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.609 ' HB2' HD13 ' A' ' 29' ' ' LEU . 1.7 ttp180 -59.15 -46.36 88.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 108.71 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.487 ' O ' ' CG ' ' A' ' 154' ' ' GLU . . . -65.68 -18.97 65.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.474 -0.766 . . . . 0.0 109.098 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.934 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 4.6 t80 -90.07 -19.35 24.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.416 -0.802 . . . . 0.0 109.489 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.613 HD13 ' HZ ' ' A' ' 26' ' ' PHE . 14.5 tp -78.7 -22.74 46.22 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.037 -1.04 . . . . 0.0 108.768 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 151' ' ' ALA . 4.4 pt-20 -72.0 -33.71 68.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.1 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.458 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 5.8 mmtp -76.19 -51.65 11.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.916 . . . . 0.0 108.864 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.934 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 17.8 m -103.56 58.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.393 -0.817 . . . . 0.0 108.935 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.559 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 38' ' ' ASN . 1.9 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.852 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -130.64 82.75 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.933 . . . . 0.0 109.803 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.662 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -43.12 156.8 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -136.38 113.74 10.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.377 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.676 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 1.0 OUTLIER -117.8 142.71 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.572 HD22 ' CD1' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -142.23 116.61 9.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.445 -0.784 . . . . 0.0 109.136 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.763 ' CZ ' ' SG ' ' A' ' 148' ' ' CYS . 2.0 m-85 -91.1 161.51 15.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.651 HG11 HD11 ' A' ' 99' ' ' LEU . 74.5 t -149.47 152.93 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.475 ' HB3' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -178.28 126.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.437 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.95 124.95 13.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.48 62.47 1.87 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -84.02 74.85 10.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.425 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.642 HD12 ' SG ' ' A' ' 17' ' ' CYS . 0.6 OUTLIER -144.19 12.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.627 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.642 ' SG ' HD12 ' A' ' 16' ' ' ILE . 0.8 OUTLIER 173.74 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.716 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.585 ' HA ' HG11 ' A' ' 141' ' ' VAL . 2.4 ttm105 -94.6 66.68 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 109.572 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.59 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 162.44 -51.08 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.644 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 19' ' ' SER . 57.2 Cg_exo -49.89 -20.83 5.31 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.882 1.721 . . . . 0.0 110.425 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.881 HG21 ' HA ' ' A' ' 142' ' ' TYR . 1.9 mm -64.89 -51.16 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.147 -0.97 . . . . 0.0 109.183 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.67 ' O ' ' SG ' ' A' ' 149' ' ' CYS . . . -63.33 -19.87 65.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.48 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -73.51 -74.67 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.273 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB2' ' HB ' ' A' ' 70' ' ' THR . . . -44.2 -28.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 108.91 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.981 HG11 ' HA ' ' A' ' 146' ' ' VAL . 97.3 t -68.23 -53.32 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.328 -0.858 . . . . 0.0 109.21 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.807 ' CE1' HD11 ' A' ' 41' ' ' ILE . 5.2 t80 -46.22 -39.58 10.05 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.534 ' HD3' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -58.02 -53.36 59.07 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.385 -0.822 . . . . 0.0 109.202 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -76.67 -1.37 27.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 0.0 109.792 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.922 ' CD1' HG12 ' A' ' 25' ' ' VAL . 81.4 mt -92.55 -32.85 14.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.013 -1.054 . . . . 0.0 109.316 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.923 ' HA ' HD11 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -90.71 -49.87 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -52.6 -22.17 4.72 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.272 -0.893 . . . . 0.0 109.167 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -90.67 -31.41 16.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.029 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -79.16 -79.71 0.13 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 109.224 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 4.0 m-20 161.92 42.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.398 -0.814 . . . . 0.0 109.955 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.923 HD11 ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -139.15 11.55 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.976 -1.078 . . . . 0.0 109.837 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.678 ' N ' HG23 ' A' ' 30' ' ' VAL . 4.3 p -62.57 -21.36 65.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.944 -1.097 . . . . 0.0 109.51 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 3.4 m-20 -93.11 34.23 1.13 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.317 -0.865 . . . . 0.0 108.753 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.852 ' HA ' HG22 ' A' ' 5' ' ' THR . 6.6 m-20 -177.06 48.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 109.684 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.676 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 9.8 m95 -149.99 144.19 25.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.89 -1.131 . . . . 0.0 110.383 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.65 81.59 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.807 HD11 ' CE1' ' A' ' 26' ' ' PHE . 2.7 mp -89.93 137.77 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.831 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.581 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 4.4 m-20 -148.44 173.52 13.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -122.76 161.33 24.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.458 ' HA3' ' CG2' ' A' ' 77' ' ' VAL . . . -143.89 147.75 19.19 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 46' ' ' VAL . . . -116.79 -19.73 9.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -1.17 . . . . 0.0 109.558 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.583 ' CG2' ' CG1' ' A' ' 11' ' ' VAL . 4.5 t 69.92 6.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.07 164.03 31.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.601 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.493 ' HA ' HG23 ' A' ' 51' ' ' VAL . 48.5 p30 -110.45 11.59 23.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.865 . . . . 0.0 109.424 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -89.93 6.67 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.745 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.485 ' OD1' ' CD ' ' A' ' 53' ' ' ARG . 4.3 m-80 -147.81 29.76 0.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.58 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 75' ' ' ARG . 26.0 t -78.55 78.51 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 109.283 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA2' ' HD3' ' A' ' 73' ' ' LYS . . . 134.79 -19.86 3.92 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -63.42 90.68 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.417 -1.049 . . . . 0.0 109.409 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 13.4 p -55.72 161.91 2.96 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.856 . . . . 0.0 109.448 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 54' ' ' SER . 53.5 Cg_exo -50.44 153.79 6.99 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.043 1.829 . . . . 0.0 110.199 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 18.5 m-20 -75.38 144.91 78.84 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.928 . . . . 0.0 109.486 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.878 ' O ' HG12 ' A' ' 60' ' ' VAL . 51.6 Cg_exo -51.07 -19.63 6.17 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.959 1.773 . . . . 0.0 110.496 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -79.56 -45.64 18.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.147 -0.971 . . . . 0.0 109.821 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.679 ' O ' HD23 ' A' ' 63' ' ' LEU . . . -71.3 -17.98 62.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 109.885 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.878 HG12 ' O ' ' A' ' 57' ' ' PRO . 8.8 p -72.38 -28.15 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.932 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 14.7 m -64.2 -20.18 65.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.812 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.29 -75.06 0.47 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.198 -0.939 . . . . 0.0 109.745 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -53.87 -18.47 3.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.726 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.551 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 4.3 ttt180 -112.72 51.63 0.81 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.09 -1.006 . . . . 0.0 109.633 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' SER . 4.6 t-20 -129.27 -78.46 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 109.245 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -54.62 -33.05 59.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.317 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.86 104.76 1.34 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.889 HD11 ' HA ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -133.63 -174.36 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -1.169 . . . . 0.0 109.324 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.534 ' CB ' ' HD3' ' A' ' 27' ' ' ARG . 32.0 m120 -140.18 118.01 11.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.505 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -142.18 -87.32 0.15 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.451 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.518 ' H ' HG23 ' A' ' 70' ' ' THR . . . 60.18 20.49 9.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.333 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -90.09 157.4 17.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.495 ' HD3' ' HA2' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -107.87 150.13 27.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.21 170.69 15.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.939 . . . . 0.0 109.551 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.649 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -174.83 153.27 1.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.442 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.431 ' N ' ' HG3' ' A' ' 75' ' ' ARG . 6.1 tt0 -77.04 138.78 39.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.458 ' CG2' ' HA3' ' A' ' 44' ' ' GLY . 77.8 t -67.33 141.98 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 2.7 p -127.95 164.75 21.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.556 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.91 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -51.1 -45.36 61.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.407 ' O ' ' OG1' ' A' ' 84' ' ' THR . 32.7 tt0 -53.9 -38.21 64.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.481 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 78' ' ' THR . 7.3 m-20 -59.11 -41.17 87.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.748 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.805 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 94.4 m-85 -61.84 -54.31 43.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.513 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 108' ' ' ASN . 1.2 p -75.9 -5.84 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 109.612 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 4.0 m -85.89 -71.7 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.314 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 42' ' ' ASP . 71.6 m-85 -74.3 161.62 29.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -109.16 -21.81 12.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.673 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.7 m-85 -116.06 73.32 0.84 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.076 -1.015 . . . . 0.0 109.58 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.901 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.0 mt -86.15 89.81 2.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -100.5 174.3 6.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.041 -1.037 . . . . 0.0 109.441 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.637 ' SG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -150.05 159.8 44.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.431 -0.793 . . . . 0.0 109.091 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.619 ' HE1' ' SG ' ' A' ' 148' ' ' CYS . 32.6 mmt -67.49 167.86 12.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -0.96 . . . . 0.0 109.201 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -59.52 -149.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.793 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 92' ' ' ASP . 0.1 OUTLIER 76.87 -179.04 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.345 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 m -89.01 36.01 0.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.481 ' ND2' ' OE1' ' A' ' 93' ' ' GLU . 79.9 m-20 -89.94 -15.47 31.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -86.74 -16.31 36.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 109.466 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 21.1 ttt85 -65.91 -11.42 46.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.0 -1.063 . . . . 0.0 109.169 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 13.8 t70 -108.36 -35.09 6.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.259 -0.9 . . . . 0.0 109.183 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.673 ' HB2' HD23 ' A' ' 96' ' ' LEU . 8.9 mt -69.18 -50.6 46.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.362 -0.836 . . . . 0.0 109.41 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -54.52 -26.18 30.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.415 -0.803 . . . . 0.0 109.406 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.83 -24.24 19.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.907 . . . . 0.0 109.478 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -65.94 -39.5 90.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.722 ' HG ' ' HG ' ' A' ' 109' ' ' CYS . 45.1 t -59.72 -17.95 38.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 0.0 109.319 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.31 -40.17 31.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 5.4 pt20 -76.85 -18.16 58.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.91 HG13 ' HG2' ' A' ' 79' ' ' LYS . 92.9 t -69.22 147.9 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -89.41 108.49 19.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.274 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.549 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.4 OUTLIER 65.18 42.04 4.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.074 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.722 ' HG ' ' HG ' ' A' ' 103' ' ' SER . 0.0 OUTLIER -52.35 152.44 3.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 0.0 109.894 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 4.0 ptm180 -140.32 8.75 2.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.424 -0.797 . . . . 0.0 109.184 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.901 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -90.65 91.51 8.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 110.313 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 111' ' ' ALA . 13.7 mtpt -47.33 116.97 1.57 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 111' ' ' ALA . 1.7 mm -93.65 135.98 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.858 -1.151 . . . . 0.0 110.685 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.532 ' HB3' HD23 ' A' ' 89' ' ' LEU . 2.6 tt0 -160.89 -176.27 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.726 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.6 OUTLIER -134.82 151.59 51.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.017 -1.052 . . . . 0.0 109.495 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.071 HD21 ' SG ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -42.25 135.17 2.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.443 -0.785 . . . . 0.0 109.669 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.31 -120.01 1.67 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.6 p -148.65 117.64 6.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -1.185 . . . . 0.0 109.6 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.525 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 23.9 m-85 -115.47 31.35 6.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.35 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.575 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 162.89 -51.24 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.404 -0.81 . . . . 0.0 109.539 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.5 Cg_exo -49.92 146.89 15.61 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.845 1.697 . . . . 0.0 110.071 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.67 11.36 32.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.118 -0.989 . . . . 0.0 109.672 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.57 146.66 25.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -112.85 62.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.392 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.27 76.32 1.56 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.541 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -74.62 137.77 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.265 -0.897 . . . . 0.0 109.083 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.609 HD11 ' CB ' ' A' ' 144' ' ' GLN . 95.2 mt -39.56 106.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.515 -0.741 . . . . 0.0 109.941 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.494 ' HG3' HG23 ' A' ' 126' ' ' ILE . 15.1 mt-10 -142.26 79.74 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.458 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 130' ' ' PRO . 0.9 OUTLIER -150.73 104.45 3.05 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.456 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 129' ' ' ASP . 54.4 Cg_exo -49.68 -174.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.755 1.636 . . . . 0.0 110.29 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -100.12 14.02 32.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.595 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.96 26.44 9.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.42 -105.38 1.58 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -113.48 -159.72 0.7 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -1.191 . . . . 0.0 109.384 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -119.21 -23.78 6.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.39 10.75 9.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -97.74 61.33 1.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.27 -51.26 2.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.561 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -27.29 34.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 109.363 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 61.0 m -61.79 -49.03 77.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.337 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 18' ' ' ARG . 53.5 t -53.6 -40.72 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 0.0 109.377 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.881 ' HA ' HG21 ' A' ' 21' ' ' ILE . 2.2 t80 -61.28 -48.4 81.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -65.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 109.951 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.609 ' CB ' HD11 ' A' ' 127' ' ' ILE . 21.0 mm100 -53.38 -19.03 3.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.868 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.709 ' SG ' HG22 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -77.7 -38.09 48.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.117 -0.989 . . . . 0.0 109.645 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.981 ' HA ' HG11 ' A' ' 25' ' ' VAL . 2.9 t -51.57 -53.55 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.087 -1.008 . . . . 0.0 109.218 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -12.54 60.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.861 . . . . 0.0 109.344 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 1.071 ' SG ' HD21 ' A' ' 116' ' ' LEU . 36.2 t -56.46 -40.4 74.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.224 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.67 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -103.06 -29.26 11.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.365 -0.834 . . . . 0.0 109.52 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.736 ' HG3' HD22 ' A' ' 29' ' ' LEU . 2.2 ttt180 -72.21 -59.65 2.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.19 -19.82 23.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.454 -0.779 . . . . 0.0 109.206 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.636 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 2.6 t80 -90.59 -26.86 19.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.51 -0.744 . . . . 0.0 109.833 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.63 HD13 ' CZ ' ' A' ' 26' ' ' PHE . 8.7 tp -75.16 -25.68 58.52 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.912 -1.117 . . . . 0.0 109.109 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -69.22 -46.82 66.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.36 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -63.3 -54.75 32.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.636 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 17.5 m -102.87 54.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.256 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.508 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.55 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 5' ' ' THR . 18.0 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -175.24 84.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.343 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.67 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -42.59 163.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.585 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 74.4 m -145.58 109.83 4.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.107 -0.996 . . . . 0.0 109.586 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.924 HG11 ' CE2' ' A' ' 26' ' ' PHE . 1.5 p -110.75 144.79 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.217 -0.927 . . . . 0.0 109.627 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.607 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -141.49 126.04 17.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.125 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.0 m-85 -105.53 156.42 18.25 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 109.569 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.726 HG11 HD11 ' A' ' 99' ' ' LEU . 25.2 t -139.13 154.86 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.77 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.558 ' SG ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -170.62 129.79 0.84 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.423 -0.798 . . . . 0.0 109.16 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 12' ' ' CYS . 1.0 OUTLIER -42.39 -65.28 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.558 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . -87.43 87.59 1.55 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.528 ' O ' HG23 ' A' ' 16' ' ' ILE . 40.2 t30 -90.04 40.76 1.02 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -1.129 . . . . 0.0 109.353 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.551 HD12 ' N ' ' A' ' 17' ' ' CYS . 1.8 pp -157.24 -40.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.925 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.561 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 0.9 OUTLIER -102.65 -15.33 16.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.496 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 14' ' ' GLY . 3.0 mmm-85 -75.53 0.18 18.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.599 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.816 ' OG ' HG21 ' A' ' 141' ' ' VAL . 10.0 p 60.14 56.08 4.29 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 109.568 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 19' ' ' SER . 45.3 Cg_endo -70.05 83.05 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.999 1.799 . . . . 0.0 109.941 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.724 HG22 HG23 ' A' ' 25' ' ' VAL . 3.2 mm -88.68 -21.02 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.796 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.69 ' CB ' ' SG ' ' A' ' 148' ' ' CYS . . . -54.52 -24.57 21.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.05 -1.031 . . . . 0.0 109.873 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 8.0 tp10 -76.75 -83.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 0.0 110.021 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.604 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -41.71 -30.75 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 109.836 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.018 HG11 ' HA ' ' A' ' 146' ' ' VAL . 60.9 t -64.32 -58.04 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.359 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.924 ' CE2' HG11 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -46.9 -41.72 16.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.108 -0.995 . . . . 0.0 108.64 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.1 OUTLIER -50.23 -66.42 0.39 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.237 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -13.71 29.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 110.164 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.746 HD22 ' HG3' ' A' ' 150' ' ' ARG . 8.5 mt -77.18 -78.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.161 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.864 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -42.73 -47.66 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.39 -0.819 . . . . 0.0 109.653 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -51.14 -46.69 62.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.81 -1.181 . . . . 0.0 109.502 -179.368 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.42 -30.16 70.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.962 . . . . 0.0 109.03 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.559 ' HB3' HG23 ' A' ' 35' ' ' ILE . 1.1 tt0 -79.68 -10.13 59.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 8.7 t30 77.61 25.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.453 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.864 ' CG1' HG23 ' A' ' 30' ' ' VAL . 1.6 pt -117.63 11.56 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.315 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.604 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 89.3 p -73.5 -12.35 60.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.683 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -83.94 10.1 10.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 109.332 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.678 ' HA ' HG22 ' A' ' 5' ' ' THR . 3.1 m-20 -155.38 51.99 0.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.67 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 7.9 m95 -150.3 154.37 37.74 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.902 -1.123 . . . . 0.0 110.865 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG12 ' HE1' ' A' ' 85' ' ' PHE . 10.2 t -130.49 80.59 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.59 HG12 ' CD2' ' A' ' 26' ' ' PHE . 3.3 mt -90.64 138.99 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.255 -0.903 . . . . 0.0 109.87 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -145.73 -178.71 6.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.82 . . . . 0.0 109.154 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.7 t -170.27 135.91 1.33 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.682 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.8 -177.06 33.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.785 ' HB2' ' OD1' ' A' ' 50' ' ' ASN . . . -95.12 141.02 29.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -1.183 . . . . 0.0 109.461 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.505 ' CG2' ' HG ' ' A' ' 99' ' ' LEU . 8.4 p -58.0 -24.71 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.344 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.4 m -124.43 170.88 10.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.372 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.587 ' CG ' HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -81.07 75.61 8.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.366 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.57 -32.68 6.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.785 ' OD1' ' HB2' ' A' ' 45' ' ' ALA . 4.1 p-10 -132.08 34.56 3.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.597 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.587 HG21 ' CG ' ' A' ' 48' ' ' ASP . 77.7 t -65.87 110.19 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.55 16.03 41.3 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 8.7 mtt-85 -120.72 86.64 2.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -1.171 . . . . 0.0 109.44 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -47.08 172.46 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.316 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 54' ' ' SER . 52.2 Cg_exo -50.95 123.78 12.46 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.885 1.723 . . . . 0.0 110.037 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 1.8 m-20 -43.09 155.89 0.27 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.604 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 60' ' ' VAL . 53.7 Cg_endo -71.68 -6.87 20.03 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.873 1.715 . . . . 0.0 110.142 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -34.65 18.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.06 26.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.447 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 57' ' ' PRO . 11.1 p -65.57 -36.55 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.875 . . . . 0.0 109.389 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 79.2 p -60.74 -15.96 34.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.3 t -85.51 -52.5 5.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.578 ' HB3' HG23 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -88.26 6.42 37.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.584 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.477 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 12.9 tpt180 -112.7 -36.09 5.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.504 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 61' ' ' SER . 53.8 t30 -52.37 -47.14 66.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.474 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -74.45 -49.71 21.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.41 93.54 0.71 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.917 HD11 ' HA ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -118.22 -178.92 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -1.163 . . . . 0.0 109.407 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -120.64 104.45 9.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.171 -0.955 . . . . 0.0 109.505 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 t -137.93 123.1 19.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.439 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.89 69.58 0.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -0.926 . . . . 0.0 109.459 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -156.18 178.43 10.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.401 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 139.42 52.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -60.56 153.34 23.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.933 . . . . 0.0 109.216 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 74' ' ' ALA . 2.2 mmt85 -149.95 125.6 10.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.557 ' H ' HG22 ' A' ' 51' ' ' VAL . 1.4 tt0 -51.11 140.03 16.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.584 HG12 ' N ' ' A' ' 78' ' ' THR . 54.5 t -56.68 165.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.584 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -163.96 164.25 23.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.503 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.611 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.01 -37.68 33.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.292 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.424 ' O ' ' OG1' ' A' ' 84' ' ' THR . 1.1 tp10 -59.98 -52.7 64.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.884 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 1.1 m-20 -54.28 -49.39 69.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.142 -0.973 . . . . 0.0 110.11 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.872 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 62.9 m-85 -48.85 -68.74 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.145 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.479 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 4.1 p -66.38 -10.86 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.233 -0.917 . . . . 0.0 109.994 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 85' ' ' PHE . 3.3 m -78.43 -85.14 0.07 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.639 ' N ' HG22 ' A' ' 84' ' ' THR . 51.9 m-85 -62.09 132.63 53.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.587 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -72.11 -15.17 61.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.857 . . . . 0.0 109.465 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.7 m-85 -124.89 136.35 53.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.32 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.933 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 2.0 mt -142.74 89.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 109.254 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.816 HD23 ' HB3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -112.79 148.18 35.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.872 -1.143 . . . . 0.0 109.547 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.533 ' SG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -99.22 -179.58 4.28 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.262 -0.899 . . . . 0.0 108.654 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.822 ' CE ' ' SG ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -76.01 1.54 15.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.088 -1.007 . . . . 0.0 109.604 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 20.3 p30 178.34 -165.36 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.126 -0.984 . . . . 0.0 109.382 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.504 ' CB ' HD22 ' A' ' 115' ' ' LEU . 1.9 tt0 -97.0 -31.11 12.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.714 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.4 p -45.37 -41.17 8.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.928 . . . . 0.0 109.79 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -90.01 -26.35 20.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.206 -0.934 . . . . 0.0 109.795 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.582 HD12 ' HB3' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -62.15 -28.92 69.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.105 -0.997 . . . . 0.0 109.717 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -49.97 -21.87 1.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.702 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -104.09 -33.33 8.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.726 HD11 HG11 ' A' ' 11' ' ' VAL . 11.2 mt -74.09 -7.69 53.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.854 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.525 ' HB2' HD22 ' A' ' 96' ' ' LEU . 54.2 t-20 -90.33 -23.06 21.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -96.67 -9.17 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 109.698 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.794 ' O ' HG23 ' A' ' 106' ' ' VAL . 1.8 mmmt -73.36 -26.79 61.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.602 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.41 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 1.1 p -52.89 -42.37 65.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.566 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.37 -61.28 2.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.478 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.28 -21.32 5.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.247 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 102' ' ' LYS . 97.6 t -79.68 130.21 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.511 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -76.47 117.84 18.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.272 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.4 42.7 27.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 109.233 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.14 144.65 6.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.825 . . . . 0.0 109.946 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -135.17 2.51 3.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 0.0 109.202 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.933 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -80.71 102.01 9.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.118 -0.989 . . . . 0.0 109.904 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.46 95.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.691 HD13 ' O ' ' A' ' 111' ' ' ALA . 2.1 mm -65.33 158.44 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.071 -1.018 . . . . 0.0 110.321 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.816 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER 177.31 -168.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -147.21 147.88 30.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.048 -1.032 . . . . 0.0 109.68 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.725 HD22 ' SG ' ' A' ' 148' ' ' CYS . 69.0 tp -53.1 99.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . -175.24 177.18 47.26 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 1.7 m 79.6 -73.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.969 . . . . 0.0 109.689 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -100.67 57.82 0.92 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.949 . . . . 0.0 109.395 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -116.78 144.05 32.63 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.387 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CB ' ' NH2' ' A' ' 147' ' ' ARG . 55.7 Cg_endo -72.9 -163.56 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.887 1.725 . . . . 0.0 110.214 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER 73.58 -151.66 0.05 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.599 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -126.05 77.67 1.7 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.459 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.91 43.94 26.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.48 143.85 26.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.857 . . . . 0.0 109.487 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.1 mm -138.12 130.29 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 127' ' ' ILE . 10.9 tt -84.42 71.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.259 -0.9 . . . . 0.0 109.017 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.481 ' HA ' ' OD2' ' A' ' 92' ' ' ASP . 2.4 mt-10 -72.06 -67.47 0.54 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.732 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.49 79.36 54.52 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.723 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.42 ' HG3' ' CG1' ' A' ' 127' ' ' ILE . 53.6 Cg_endo -72.43 -21.05 23.2 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.968 1.779 . . . . 0.0 110.078 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.561 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 10.1 t80 -59.5 -24.7 63.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -111.25 84.32 1.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.878 . . . . 0.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -130.68 -135.96 3.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -122.4 -157.32 0.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -1.101 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.08 -22.0 12.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.43 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.72 25.21 2.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.407 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 138' ' ' PHE . 10.1 t0 -122.84 -142.55 0.32 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.271 -0.893 . . . . 0.0 109.151 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.959 ' O ' HG12 ' A' ' 141' ' ' VAL . 1.3 t80 82.73 -42.98 0.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.554 -0.716 . . . . 0.0 109.793 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.07 -35.67 80.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.989 -1.069 . . . . 0.0 109.41 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.8 m -66.9 -28.66 68.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.275 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.959 HG12 ' O ' ' A' ' 138' ' ' PHE . 2.3 p -60.54 -30.84 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.274 -0.891 . . . . 0.0 109.366 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 146' ' ' VAL . 1.7 t80 -85.09 -53.13 5.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 0.0 109.271 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -28.27 10.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.14 -47.74 7.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.497 ' CB ' ' HB ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -53.57 -21.87 7.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.333 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 1.018 ' HA ' HG11 ' A' ' 25' ' ' VAL . 60.2 t -51.03 -55.18 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.228 -0.92 . . . . 0.0 109.286 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -79.13 -18.46 53.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.292 -0.88 . . . . 0.0 109.304 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.822 ' SG ' ' CE ' ' A' ' 91' ' ' MET . 36.1 t -46.41 -25.88 0.74 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.088 -1.007 . . . . 0.0 108.844 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.591 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 2.5 p -119.95 -40.68 2.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.421 -0.8 . . . . 0.0 109.274 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.746 ' HG3' HD22 ' A' ' 29' ' ' LEU . 7.0 ttm-85 -62.23 -52.29 64.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 108.876 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -58.73 -18.82 34.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.878 . . . . 0.0 108.985 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.744 ' CE2' HD11 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -90.23 -25.68 20.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.783 . . . . 0.0 109.6 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.624 HD11 ' CD1' ' A' ' 35' ' ' ILE . 11.5 tp -75.61 -21.93 57.34 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.048 -1.032 . . . . 0.0 108.688 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -68.31 -48.39 65.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.902 . . . . 0.0 109.223 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -64.56 -48.85 73.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.014 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 152' ' ' PHE . 16.2 m -101.41 51.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.112 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.487 -179.833 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.539 HG22 ' N ' ' A' ' 5' ' ' THR . 8.2 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.451 0.643 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 1.014 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -63.9 101.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.408 -0.807 . . . . 0.0 109.543 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.718 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -44.21 166.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.83 179.226 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.605 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 15.5 p -136.39 112.86 9.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.931 -1.105 . . . . 0.0 109.275 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.79 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -115.71 134.22 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 109.64 -179.524 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.99 HD13 ' CD1' ' A' ' 85' ' ' PHE . 1.9 tp -124.73 118.17 25.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.26 102.34 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.021 -1.049 . . . . 0.0 109.755 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.795 HG13 ' O ' ' A' ' 44' ' ' GLY . 3.0 t -106.26 151.07 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 108.977 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.48 136.56 11.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.954 -1.091 . . . . 0.0 109.815 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -47.91 117.19 1.77 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 109.057 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.36 75.27 1.18 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.503 ' O ' ' CG ' ' A' ' 20' ' ' PRO . 5.3 t-20 -57.64 -14.99 6.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -1.11 . . . . 0.0 109.625 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.707 HD12 ' N ' ' A' ' 17' ' ' CYS . 1.1 pp -111.01 -158.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.999 -1.063 . . . . 0.0 109.301 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.707 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER 59.81 115.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.043 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER 77.9 -2.88 2.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.286 -179.508 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.893 ' O ' HD12 ' A' ' 21' ' ' ILE . 1.4 t 45.26 96.85 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 109.856 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 52.8 Cg_exo -48.08 88.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.562 1.508 . . . . 0.0 109.667 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 19' ' ' SER . 2.0 mp -78.21 -11.72 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -0.868 . . . . 0.0 109.946 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.851 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -67.52 -43.18 81.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.99 -1.069 . . . . 0.0 108.976 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ALA . 1.6 tm-20 -76.15 -57.12 4.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.255 -0.903 . . . . 0.0 109.052 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.623 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -44.76 -41.25 6.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.887 . . . . 0.0 108.982 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.056 HG11 ' HA ' ' A' ' 146' ' ' VAL . 53.0 t -62.85 -51.23 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.807 . . . . 0.0 109.23 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.653 ' CD1' HG12 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -46.28 -36.72 6.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 108.547 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.427 ' HD2' ' OD1' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -62.07 -52.83 62.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.058 -1.026 . . . . 0.0 108.395 179.066 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -84.18 11.03 8.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 108.955 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.82 HD21 ' CB ' ' A' ' 150' ' ' ARG . 45.5 tp -97.43 -46.97 5.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.401 -0.812 . . . . 0.0 109.107 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.732 HG11 HD11 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -91.09 -39.24 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.212 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.5 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 0.4 OUTLIER -69.54 -8.44 47.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.593 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 9.0 t70 -95.99 -15.46 22.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.013 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 4.6 tp60 -102.68 -82.0 0.49 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.488 -0.757 . . . . 0.0 109.245 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 26.0 t30 172.84 46.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.449 -0.782 . . . . 0.0 108.899 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.806 HD12 HD21 ' A' ' 153' ' ' LEU . 1.4 pt -143.64 17.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.793 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.617 ' HB3' HG22 ' A' ' 30' ' ' VAL . 79.3 p -85.39 -26.97 26.12 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.792 -1.192 . . . . 0.0 109.355 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -58.49 -27.05 64.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 1.014 ' HA ' HG22 ' A' ' 5' ' ' THR . 2.6 m-20 -118.96 42.69 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.576 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.79 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 11.6 m95 -150.0 119.8 7.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.994 -1.066 . . . . 0.0 110.563 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.62 91.63 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.732 HD11 HG11 ' A' ' 30' ' ' VAL . 3.2 mt -92.41 129.1 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.918 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -154.2 137.15 15.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.319 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -107.75 178.07 4.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 109.394 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.795 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -168.27 171.21 42.46 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.47 ' O ' ' OE1' ' A' ' 76' ' ' GLN . . . -92.85 151.91 19.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -1.138 . . . . 0.0 109.419 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 13' ' ' LEU . 6.9 p -99.58 -17.21 6.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.28 -0.888 . . . . 0.0 108.786 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.458 ' O ' ' OE1' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -101.14 -148.34 0.37 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.386 -0.822 . . . . 0.0 109.505 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -150.28 16.11 0.82 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.079 -1.013 . . . . 0.0 109.715 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -100.22 0.22 39.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.6 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.444 ' OD1' ' CB ' ' A' ' 45' ' ' ALA . 8.1 p30 -118.6 5.8 11.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.9 t -56.29 110.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.473 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.55 29.84 9.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.542 ' HB3' HG21 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -123.59 131.88 53.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 109.352 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 10.1 p -95.12 162.5 24.66 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 54' ' ' SER . 52.7 Cg_exo -50.99 144.42 27.92 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.974 1.783 . . . . 0.0 110.166 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 8.0 m-20 -53.54 153.04 8.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.457 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 60' ' ' VAL . 50.1 Cg_endo -71.14 -15.05 32.07 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.043 1.829 . . . . 0.0 110.116 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -37.46 16.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.548 ' CB ' ' HB2' ' A' ' 19' ' ' SER . . . -90.15 -11.57 40.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.504 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -74.63 -30.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.497 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.89 0.18 21.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.586 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.485 ' C ' HD23 ' A' ' 63' ' ' LEU . 57.9 m -90.0 -18.44 26.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.322 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.8 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.12 -52.79 4.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.175 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -64.87 -10.44 28.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.875 . . . . 0.0 109.62 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.65 -85.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.604 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.585 ' CD2' HG12 ' A' ' 68' ' ' ILE . 1.7 p-80 -60.55 -25.42 66.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 109.555 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.26 107.62 1.66 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.623 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 17.1 mm -148.54 154.33 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -1.157 . . . . 0.0 109.493 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.505 ' ND2' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -137.52 119.35 15.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.483 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 t -121.57 174.98 6.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.981 . . . . 0.0 109.453 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -167.9 75.27 0.13 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -169.33 134.01 1.45 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.2 tptt -95.34 59.23 2.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.206 -0.934 . . . . 0.0 109.495 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 53' ' ' ARG . . . 51.79 -92.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.682 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER 59.53 151.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 109.534 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' A' ' 76' ' ' GLN . 34.2 tp60 -90.27 133.52 34.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 78' ' ' THR . 47.5 t -45.32 161.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.494 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.504 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -126.14 170.55 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.727 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.909 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -58.11 -53.52 57.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.862 . . . . 0.0 109.534 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -50.59 -42.81 56.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 109.746 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.466 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 6.7 m-20 -58.56 -42.19 87.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.673 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 1.021 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 10.5 m-85 -57.22 -51.2 70.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 109.334 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -80.17 -5.35 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.988 -1.07 . . . . 0.0 109.68 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 16.2 m -81.27 -58.7 2.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -0.831 . . . . 0.0 110.236 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.99 ' CD1' HD13 ' A' ' 9' ' ' LEU . 38.8 m-85 -77.54 165.2 24.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 110.192 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -108.68 -36.69 6.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -0.807 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -109.44 78.77 1.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 108.651 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.953 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.2 mt -86.44 87.26 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.915 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.603 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -96.98 174.75 6.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.025 -1.047 . . . . 0.0 109.205 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 1.1 p -149.93 148.2 28.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.383 -0.823 . . . . 0.0 109.375 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.615 ' HE2' ' SG ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -49.27 147.71 2.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 109.295 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.995 ' OD2' HD12 ' A' ' 126' ' ' ILE . 0.7 OUTLIER -52.23 -20.31 2.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 109.794 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 92' ' ' ASP . 2.3 mt-10 -43.02 -69.04 0.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 96' ' ' LEU . 12.2 t -87.34 85.62 7.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.904 . . . . 0.0 108.83 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.498 ' O ' ' C ' ' A' ' 96' ' ' LEU . 20.2 t-20 -50.28 86.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.752 -0.592 . . . . 0.0 110.285 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.052 HD21 ' CG2' ' A' ' 113' ' ' ILE . 0.7 OUTLIER 29.93 51.7 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.185 0.517 . . . . 0.0 110.683 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 98' ' ' ASP . 3.0 ttt85 -88.08 -91.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 109.59 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -57.22 -50.71 72.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 109.619 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.664 HD23 ' CZ ' ' A' ' 82' ' ' PHE . 5.0 mt -48.89 -26.97 2.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 0.0 109.678 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.64 ' HB2' HD22 ' A' ' 96' ' ' LEU . 34.4 t-20 -79.85 -38.31 33.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.96 3.06 54.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.626 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.941 ' O ' HG23 ' A' ' 106' ' ' VAL . 23.8 mmmt -84.88 -25.77 27.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.331 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -29.16 68.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -68.32 -60.21 2.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -54.42 -23.55 16.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 109.136 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 102' ' ' LYS . 38.8 t -82.3 105.71 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.426 -0.796 . . . . 0.0 109.415 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -44.31 117.27 1.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.546 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 107' ' ' LYS . 5.4 m-20 42.83 58.26 3.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.649 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -47.76 164.26 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.33 -0.856 . . . . 0.0 110.333 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.649 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 1.8 tpt180 -150.54 61.1 0.95 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 1.021 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -147.15 89.72 1.82 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.253 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 111' ' ' ALA . 6.1 mtpp -44.0 110.17 0.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 1.052 ' CG2' HD21 ' A' ' 96' ' ' LEU . 2.1 mm -87.2 144.42 9.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.036 -1.04 . . . . 0.0 110.503 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.493 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -163.95 -179.64 6.39 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.472 ' CD1' ' OD2' ' A' ' 92' ' ' ASP . 1.0 OUTLIER -132.35 146.3 51.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.94 -1.1 . . . . 0.0 109.482 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.848 HD13 ' SG ' ' A' ' 148' ' ' CYS . 1.4 tp -43.97 120.21 2.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.36 157.98 23.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.48 100.7 0.38 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -1.123 . . . . 0.0 109.523 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -90.18 -87.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -0.873 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.58 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -67.01 -61.62 4.63 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.695 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 55.2 Cg_endo -71.9 162.45 41.9 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.765 1.643 . . . . 0.0 110.361 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -108.69 24.52 12.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.53 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.95 104.76 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.942 . . . . 0.0 109.633 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.98 60.85 6.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.475 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -109.12 -54.35 2.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 109.513 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.995 HD12 ' OD2' ' A' ' 92' ' ' ASP . 8.2 mm 61.8 145.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 77.3 mt -109.04 93.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.398 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.527 ' CG ' ' OD1' ' A' ' 92' ' ' ASP . 34.4 mt-10 -124.29 8.35 8.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.577 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -94.56 146.56 31.69 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.451 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.94 170.75 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.928 1.752 . . . . 0.0 110.232 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.559 ' CD1' ' O ' ' A' ' 131' ' ' TYR . 14.2 p90 -103.11 125.89 50.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.458 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -146.69 111.24 5.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.865 . . . . 0.0 109.467 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -45.91 95.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -135.35 6.73 3.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -1.187 . . . . 0.0 109.472 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.652 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 1.3 m-20 70.54 164.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 73.77 5.29 4.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.492 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -135.4 105.48 6.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.555 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -174.86 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.541 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -86.31 -17.1 35.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.531 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 36.7 m -82.4 -25.0 34.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.75 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 74.2 t -76.55 -44.86 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.549 ' CD1' HG21 ' A' ' 21' ' ' ILE . 2.6 t80 -74.74 -38.32 62.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.572 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -61.66 -61.52 2.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 148' ' ' CYS . 4.0 mt-30 -61.74 -29.36 70.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 109.507 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.806 ' SG ' ' N ' ' A' ' 22' ' ' ALA . 4.7 m -58.88 -40.2 83.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 109.68 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 1.056 ' HA ' HG11 ' A' ' 25' ' ' VAL . 84.0 t -51.57 -72.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 109.53 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.416 ' HG2' ' HB2' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -65.24 -11.29 39.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.419 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.851 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 20.2 t -53.78 -26.2 22.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.102 -0.999 . . . . 0.0 108.797 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.597 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -119.11 -30.57 4.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.394 -0.816 . . . . 0.0 109.251 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.82 ' CB ' HD21 ' A' ' 29' ' ' LEU . 11.0 ttt180 -67.48 -52.42 39.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.937 . . . . 0.0 108.856 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.416 ' HB2' ' HG2' ' A' ' 147' ' ' ARG . . . -55.9 -21.38 20.0 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.449 -0.782 . . . . 0.0 109.023 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.848 ' O ' HG22 ' A' ' 156' ' ' VAL . 1.5 t80 -90.63 -27.44 19.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.517 -0.74 . . . . 0.0 109.815 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.806 HD21 HD12 ' A' ' 35' ' ' ILE . 7.5 tp -78.06 -25.2 47.61 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.992 -1.067 . . . . 0.0 108.741 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 150' ' ' ARG . 1.8 mt-10 -66.28 -51.15 60.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.922 . . . . 0.0 109.18 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -55.3 25.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.395 -0.816 . . . . 0.0 109.336 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 152' ' ' PHE . 18.6 m -95.4 43.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.262 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.455 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 1.8 tmm_? . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.567 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 6' ' ' LYS . 3.9 p . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 1.03 HG22 ' HA ' ' A' ' 38' ' ' ASN . 18.1 p -49.99 90.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 0.0 109.571 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.639 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.7 OUTLIER -45.19 170.14 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.035 -1.04 . . . . 0.0 109.396 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.55 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -142.39 146.91 35.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.029 -1.045 . . . . 0.0 109.811 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.876 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -150.78 146.08 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 109.037 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.639 HD13 ' CD1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -133.01 126.74 32.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.722 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.442 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -109.18 124.39 50.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 108.897 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.505 HG13 ' C ' ' A' ' 44' ' ' GLY . 2.1 t -125.35 158.19 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 91' ' ' MET . 0.6 OUTLIER -177.99 131.2 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.794 . . . . 0.0 109.185 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.502 ' HB2' ' ND2' ' A' ' 95' ' ' ASN . 0.7 OUTLIER -43.7 149.98 0.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 109.579 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 50' ' ' ASN . . . 46.76 66.57 1.74 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -88.8 67.64 8.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -1.113 . . . . 0.0 109.695 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -138.71 6.46 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.154 -0.966 . . . . 0.0 109.731 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.647 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 1.7 p 179.75 138.21 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.017 . . . . 0.0 109.618 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.647 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 1.9 mtm180 83.6 -48.6 0.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.815 -0.553 . . . . 0.0 109.65 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.615 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -82.97 -48.53 0.79 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 110.175 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 19' ' ' SER . 63.4 Cg_exo -49.58 -19.4 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.957 1.771 . . . . 0.0 111.047 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.956 HG21 ' HA ' ' A' ' 142' ' ' TYR . 2.5 mp -64.29 -44.93 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.87 -1.144 . . . . 0.0 109.4 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.199 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . . . -61.36 -35.29 77.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.507 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.462 ' OE2' ' HB2' ' A' ' 43' ' ' SER . 2.4 tt0 -70.19 -69.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.317 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.832 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -43.64 -33.31 1.17 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.135 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.987 HG11 ' HA ' ' A' ' 146' ' ' VAL . 58.7 t -65.26 -49.62 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.864 . . . . 0.0 108.754 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.836 ' CE2' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -50.41 -29.85 11.09 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -68.48 -50.71 50.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 109.2 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -20.07 66.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.776 HD11 HG12 ' A' ' 25' ' ' VAL . 11.5 mt -86.97 -28.34 22.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.047 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 36' ' ' SER . 2.5 p -90.22 -8.85 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.96 0.95 22.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -115.01 45.93 1.52 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.004 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.574 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -178.7 29.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.5 t30 45.35 45.88 10.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.76 HG12 HG23 ' A' ' 30' ' ' VAL . 1.3 tt -127.39 -1.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.229 0.538 . . . . 0.0 109.795 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.814 ' HA ' HG22 ' A' ' 30' ' ' VAL . 45.8 t -74.08 -45.83 46.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.737 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.87 -12.67 8.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 110.225 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 1.03 ' HA ' HG22 ' A' ' 5' ' ' THR . 2.2 m-20 -116.02 37.28 3.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.986 -1.071 . . . . 0.0 109.993 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.876 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 12.8 m95 -150.48 157.76 43.38 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.854 -1.153 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.87 72.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.473 HG21 ' HB3' ' A' ' 26' ' ' PHE . 2.5 mp -89.47 141.13 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 110.248 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.23 -165.83 2.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.503 -0.748 . . . . 0.0 109.048 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.462 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -165.67 165.82 18.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.685 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.505 ' C ' HG13 ' A' ' 11' ' ' VAL . . . 178.39 -170.48 42.56 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.38 -176.67 3.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.199 . . . . 0.0 109.346 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.812 HG13 ' HG ' ' A' ' 99' ' ' LEU . 39.3 t -93.7 -0.37 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.823 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.56 -178.24 6.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.514 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 2.0 p-10 -84.3 69.36 10.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -99.26 -77.68 0.52 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.423 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 14' ' ' GLY . 30.5 m120 -96.0 37.67 1.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.357 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 80.1 t -64.33 106.84 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.458 ' HA2' ' HG2' ' A' ' 73' ' ' LYS . . . 106.69 -34.14 5.93 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.601 ' O ' HG22 ' A' ' 16' ' ' ILE . 1.5 mtt180 -61.59 96.91 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -1.174 . . . . 0.0 109.487 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.75 164.55 1.59 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 56' ' ' ASP . 53.4 Cg_exo -50.57 119.52 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.035 1.823 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -43.41 150.07 0.54 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.688 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.59 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 50.9 Cg_exo -52.13 -18.03 6.73 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.098 1.865 . . . . 0.0 110.613 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -78.76 -46.04 19.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.052 -1.03 . . . . 0.0 109.889 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . . . -90.04 1.91 55.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -0.937 . . . . 0.0 110.055 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.59 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 5.5 p -90.02 -44.61 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.048 -1.032 . . . . 0.0 109.681 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.535 ' N ' HG13 ' A' ' 60' ' ' VAL . 53.3 p -79.07 -15.56 58.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.599 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.446 ' C ' HD23 ' A' ' 63' ' ' LEU . 1.2 m -73.8 -27.6 61.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 109.349 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.806 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -89.44 -52.57 4.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 108.943 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -14.09 16.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.814 . . . . 0.0 109.554 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -68.23 -61.06 2.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.547 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -69.67 -35.21 74.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.155 -0.966 . . . . 0.0 109.598 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 68' ' ' ILE . . . 141.11 -10.11 2.77 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.832 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 17.0 mm -43.82 159.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -1.154 . . . . 0.0 109.626 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.494 ' N ' HG22 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -131.5 175.37 9.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.522 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -160.09 -86.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 70' ' ' THR . . . 65.62 16.76 10.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -126.4 149.35 49.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.953 . . . . 0.0 109.46 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.458 ' HG2' ' HA2' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -101.58 140.99 35.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.491 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 75' ' ' ARG . . . -42.56 -66.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.822 . . . . 0.0 109.723 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 65.31 164.9 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.343 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.483 ' HG2' ' N ' ' A' ' 77' ' ' VAL . 47.8 tt0 -100.98 156.01 17.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.483 ' N ' ' HG2' ' A' ' 76' ' ' GLN . 91.7 t -81.22 146.96 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.925 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -142.61 161.1 38.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.521 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG2' HG13 ' A' ' 106' ' ' VAL . 2.4 tmtt? -42.87 -34.77 1.01 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.469 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' OG1' ' A' ' 84' ' ' THR . 1.0 OUTLIER -61.57 -53.25 58.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.879 . . . . 0.0 109.681 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.42 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 3.5 m-20 -66.93 -19.01 65.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 109.823 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.897 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 13.1 m-85 -68.88 -68.59 0.39 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 109.532 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.647 HG23 ' HB3' ' A' ' 110' ' ' ARG . 9.9 p -67.29 -23.25 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 4.6 m -60.65 -67.59 0.38 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.639 ' CD1' HD13 ' A' ' 9' ' ' LEU . 82.5 m-85 -74.83 156.21 36.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 0.0 109.532 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.447 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -90.32 -36.33 14.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.322 -0.861 . . . . 0.0 109.387 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 7' ' ' SER . 17.5 m-85 -109.77 151.91 26.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.575 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.93 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 1.7 mt -153.69 80.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 108.833 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.507 HD21 ' CE1' ' A' ' 152' ' ' PHE . 0.1 OUTLIER -91.58 -174.75 3.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 109.583 -179.436 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.736 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -148.31 172.15 14.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.303 -0.873 . . . . 0.0 109.212 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.736 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -84.54 45.4 1.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 109.704 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.463 ' OD2' ' CG2' ' A' ' 127' ' ' ILE . 2.6 m-20 65.15 -144.52 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.537 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 128' ' ' GLU . 27.6 mt-10 73.5 158.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.6 m -81.08 6.41 13.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.624 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 13' ' ' LEU . 2.9 m120 -71.8 -9.32 58.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 99' ' ' LEU . 4.4 mt -81.45 -10.16 59.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.414 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -61.28 -21.84 64.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.01 -39.58 8.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.833 . . . . 0.0 109.467 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.812 ' HG ' HG13 ' A' ' 46' ' ' VAL . 8.6 mt -66.94 -18.76 65.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.93 . . . . 0.0 109.39 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -77.89 -33.48 51.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.86 -19.92 24.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.74 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -57.3 -35.09 69.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 109.452 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.538 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 0.3 OUTLIER -50.2 -49.09 53.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.375 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -64.71 -36.23 83.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.136 -0.977 . . . . 0.0 109.436 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.59 -4.8 55.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.212 -0.93 . . . . 0.0 109.473 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.957 HG11 ' SG ' ' A' ' 109' ' ' CYS . 41.2 t -86.32 117.98 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 108' ' ' ASN . 0.1 OUTLIER -53.14 105.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 108.644 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.457 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 15.7 m120 60.52 70.68 0.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.033 -1.042 . . . . 0.0 108.576 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.957 ' SG ' HG11 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -88.57 136.44 32.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 110.364 -179.045 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.647 ' HB3' HG23 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -128.96 1.81 5.31 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.022 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.93 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -83.3 110.58 18.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.446 -0.784 . . . . 0.0 110.164 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.16 125.39 26.23 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -100.04 132.0 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.94 -1.1 . . . . 0.0 110.29 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 10.3 mt-10 -163.79 -174.04 3.49 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -125.24 165.87 17.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.99 HD21 ' SG ' ' A' ' 148' ' ' CYS . 3.5 tp -42.51 -74.4 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.701 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.88 -110.73 3.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.565 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 1.8 t -151.56 136.24 17.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.461 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 118' ' ' SER . 23.9 m-85 -136.76 32.14 2.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.929 . . . . 0.0 109.586 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 163.06 -51.53 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.0 Cg_exo -49.46 162.62 0.53 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.799 1.666 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.77 45.04 1.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.883 . . . . 0.0 109.43 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 166.43 33.24 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -0.971 . . . . 0.0 109.413 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.03 90.08 4.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.343 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tt -103.04 138.68 39.57 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -0.925 . . . . 0.0 109.614 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.494 HG22 ' HG3' ' A' ' 128' ' ' GLU . 12.0 mm -143.93 125.95 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.398 -0.813 . . . . 0.0 109.301 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 127' ' ' ILE . 1.5 tt -105.08 78.22 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 109.113 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.494 ' HG3' HG22 ' A' ' 126' ' ' ILE . 6.7 mt-10 -77.12 -95.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 128' ' ' GLU . 2.0 m-20 47.51 95.12 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.323 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 131' ' ' TYR . 69.4 Cg_exo -47.33 -67.84 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.774 1.65 . . . . 0.0 110.347 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 130' ' ' PRO . 20.9 t80 178.83 61.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.505 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' GLY . 87.9 m-85 -141.14 16.92 2.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.457 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 132' ' ' TYR . . . 59.23 154.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -120.96 -26.81 5.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -1.114 . . . . 0.0 109.471 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.84 -160.92 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.362 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.67 77.34 6.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.405 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.21 108.96 4.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.519 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 8.9 t80 -123.23 -51.28 1.88 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.497 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -69.62 -33.28 72.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.503 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.2 m -49.2 -43.87 42.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.464 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.7 t -65.9 -48.2 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.848 . . . . 0.0 109.493 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.956 ' HA ' HG21 ' A' ' 21' ' ' ILE . 2.8 t80 -53.0 -27.98 21.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.332 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -83.73 -38.29 21.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.82 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -75.54 -11.43 60.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.686 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 1.199 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -89.97 -10.35 45.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.987 ' HA ' HG11 ' A' ' 25' ' ' VAL . 53.5 t -62.01 -48.94 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 109.234 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 1.2 mtt180 -79.72 -15.0 58.34 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.178 -0.951 . . . . 0.0 109.376 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.99 ' SG ' HD21 ' A' ' 116' ' ' LEU . 21.2 m -50.16 -24.0 2.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.086 -1.009 . . . . 0.0 108.635 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.605 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -120.18 -39.17 2.83 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.443 -0.786 . . . . 0.0 109.025 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.463 ' HG3' HD22 ' A' ' 29' ' ' LEU . 13.7 ttp85 -63.6 -53.71 47.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 108.703 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -60.17 -36.13 76.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -0.774 . . . . 0.0 109.175 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.949 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 6.8 t80 -74.84 -19.12 60.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.384 -0.822 . . . . 0.0 109.515 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.455 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 14.4 tp -77.96 -19.59 54.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.099 -1.0 . . . . 0.0 108.744 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -70.59 -46.89 62.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 108.769 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -66.74 -53.71 30.48 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 0.0 108.986 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.949 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 5.7 m -92.72 34.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 109.086 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.455 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 117.944 -1.026 . . . . 0.0 109.587 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 5' ' ' THR . 9.9 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 1.098 HG22 ' HA ' ' A' ' 38' ' ' ASN . 65.8 p -74.68 108.82 7.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.661 ' CB ' ' CH2' ' A' ' 39' ' ' TRP . 35.8 mttp -63.7 -168.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.9 -1.125 . . . . 0.0 108.993 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.575 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -145.99 107.28 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 109.834 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.726 HG12 ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -111.86 150.57 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.713 HD22 HG12 ' A' ' 88' ' ' ILE . 1.4 tt -149.83 104.17 3.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.139 -0.975 . . . . 0.0 109.555 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.483 ' HE1' HD12 ' A' ' 116' ' ' LEU . 2.8 m-85 -81.96 164.38 21.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.95 . . . . 0.0 109.379 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.783 HG11 HD11 ' A' ' 99' ' ' LEU . 58.5 t -150.31 161.87 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.133 -0.979 . . . . 0.0 109.936 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.526 ' N ' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -178.4 142.09 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.39 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.732 HD11 ' HH2' ' A' ' 49' ' ' TRP . 13.2 tp -43.58 -79.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.686 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 15' ' ' ASN . . . -46.99 -74.33 0.25 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.524 HD22 ' HB2' ' A' ' 45' ' ' ALA . 25.8 t30 76.61 20.47 1.42 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -1.124 . . . . 0.0 109.321 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 15' ' ' ASN . 1.2 pp -156.65 30.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.444 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.6 m -135.01 -84.84 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.585 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.543 ' HB2' ' CG2' ' A' ' 141' ' ' VAL . 0.0 OUTLIER -115.42 -7.84 12.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -75.06 -51.02 3.68 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.786 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 19' ' ' SER . 55.9 Cg_exo -49.66 -21.23 5.23 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.855 1.703 . . . . 0.0 110.674 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.982 HG21 ' HA ' ' A' ' 142' ' ' TYR . 7.9 mm -60.31 -48.6 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.315 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.576 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -64.72 -20.27 66.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.932 . . . . 0.0 109.738 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.513 ' OE1' ' CB ' ' A' ' 43' ' ' SER . 4.7 mt-10 -77.22 -81.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.12 -0.987 . . . . 0.0 109.521 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.686 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -45.21 -40.28 7.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.31 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.022 ' HA ' HD11 ' A' ' 68' ' ' ILE . 54.1 t -59.87 -51.34 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.22 -0.925 . . . . 0.0 109.402 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.919 ' CE1' HG12 ' A' ' 30' ' ' VAL . 1.2 t80 -46.41 -42.06 14.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.024 . . . . 0.0 108.698 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -55.12 -59.81 4.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 0.1 OUTLIER -76.73 2.88 13.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.823 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.691 HD11 HG13 ' A' ' 146' ' ' VAL . 3.2 mt -94.0 -29.89 15.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.149 -0.97 . . . . 0.0 108.733 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.919 HG12 ' CE1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -84.54 -42.51 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.569 ' CA ' ' HB3' ' A' ' 36' ' ' SER . 1.9 t -42.47 -28.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 30' ' ' VAL . 5.7 t70 -58.07 -55.34 36.15 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.474 -0.766 . . . . 0.0 108.992 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.548 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 4.9 tp60 -73.08 -2.79 22.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.91 . . . . 0.0 109.368 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.5 OUTLIER 79.91 54.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.395 -0.815 . . . . 0.0 109.589 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.664 HD11 HD21 ' A' ' 153' ' ' LEU . 5.7 pt -144.78 9.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.141 -0.974 . . . . 0.0 109.987 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.637 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 9.7 p -69.16 -22.88 63.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.85 -1.156 . . . . 0.0 109.124 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.74 -20.64 38.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.312 -0.868 . . . . 0.0 108.799 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 1.098 ' HA ' HG22 ' A' ' 5' ' ' THR . 3.0 m-80 -110.31 44.54 1.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -0.845 . . . . 0.0 109.283 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.726 ' CE3' HG12 ' A' ' 8' ' ' VAL . 10.9 m95 -150.66 129.46 12.42 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.611 -1.236 . . . . 0.0 110.746 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 40' ' ' VAL . 56.6 t -99.14 79.21 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.567 HG12 ' CD2' ' A' ' 26' ' ' PHE . 6.9 mt -89.9 128.2 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.934 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -137.24 -159.53 0.96 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.482 -0.761 . . . . 0.0 109.06 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.513 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 60.3 p -151.85 172.53 16.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.112 -0.992 . . . . 0.0 109.852 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 11' ' ' VAL . . . -146.8 163.45 28.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.524 ' HB2' HD22 ' A' ' 15' ' ' ASN . . . -128.92 -29.53 2.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -1.184 . . . . 0.0 109.878 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.501 HG23 ' CG1' ' A' ' 11' ' ' VAL . 15.8 t 67.23 9.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 109.332 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.593 ' HB3' ' CE2' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -125.43 141.19 52.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.905 . . . . 0.0 109.358 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -84.01 6.28 22.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.697 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.732 ' HH2' HD11 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -102.9 -33.56 9.28 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 109.409 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.435 ' HA ' ' CD ' ' A' ' 53' ' ' ARG . 3.2 m120 -91.98 12.65 21.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.086 -1.009 . . . . 0.0 109.397 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 75' ' ' ARG . 13.3 t -75.33 85.22 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.74 -5.38 9.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.438 ' HB2' HG21 ' A' ' 16' ' ' ILE . 18.5 mtp180 -79.64 104.16 10.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -1.188 . . . . 0.0 109.468 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -66.04 173.98 1.89 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.375 -0.828 . . . . 0.0 109.59 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 53.3 Cg_exo -50.75 137.96 41.78 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.066 1.844 . . . . 0.0 110.288 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -57.37 145.71 66.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.416 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.706 ' O ' HG12 ' A' ' 60' ' ' VAL . 52.5 Cg_exo -50.5 -22.38 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.969 1.78 . . . . 0.0 110.345 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -85.55 -37.71 19.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.534 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.88 -4.91 59.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 109.674 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -80.82 -28.37 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -81.98 -19.01 41.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.498 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.467 ' C ' HD23 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -74.05 -33.91 63.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.511 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.781 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.14 -56.16 3.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.135 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -22.62 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.417 -0.802 . . . . 0.0 109.744 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 61' ' ' SER . 52.2 t-20 -70.66 -50.89 31.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.67 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -83.48 -5.04 59.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.945 . . . . 0.0 109.696 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.66 102.3 0.26 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.022 HD11 ' HA ' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -126.23 -33.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -1.118 . . . . 0.0 109.56 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 10.3 m120 70.77 49.42 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.355 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.85 142.39 57.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.85 18.17 1.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.502 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -103.01 155.42 18.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' ALA . 11.9 tptt -124.75 26.77 7.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 73' ' ' LYS . . . 56.94 161.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.611 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.564 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -168.27 171.74 9.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.407 -0.808 . . . . 0.0 109.256 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.482 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 2.6 tt0 -93.19 21.2 6.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.321 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 78' ' ' THR . 0.8 OUTLIER 52.2 178.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 109.598 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER 176.0 162.86 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.654 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -44.11 -35.99 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 109.469 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 84' ' ' THR . 2.9 tp10 -59.61 -48.86 80.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.783 . . . . 0.0 109.555 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.441 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -65.3 -13.3 58.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.744 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 6.3 m-85 -80.64 -75.86 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.729 HG23 ' HG2' ' A' ' 110' ' ' ARG . 14.8 p -54.08 -38.05 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 108.81 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.512 ' N ' HG13 ' A' ' 83' ' ' VAL . 38.8 m -58.02 -65.34 0.66 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.657 -0.652 . . . . 0.0 109.451 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.587 ' CE2' ' HB2' ' A' ' 42' ' ' ASP . 79.2 m-85 -81.36 125.3 30.21 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.33 -0.856 . . . . 0.0 109.499 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -73.8 -17.08 61.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.312 -0.867 . . . . 0.0 109.406 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 7' ' ' SER . 4.4 m-85 -130.07 131.08 45.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 109.861 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.852 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 5.1 mt -135.48 88.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 108.754 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -104.74 165.48 11.03 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.856 -1.152 . . . . 0.0 109.968 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.657 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -143.43 166.77 23.85 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.657 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -68.47 139.88 55.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.325 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.495 ' HB2' HD12 ' A' ' 126' ' ' ILE . 52.9 t0 -43.88 126.02 4.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 1.2 tt0 176.21 161.31 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.294 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -75.76 -6.86 52.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -74.73 -7.87 54.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.913 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.646 ' HG ' ' SG ' ' A' ' 90' ' ' CYS . 0.6 OUTLIER -89.19 7.04 37.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.937 . . . . 0.0 109.645 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -14.73 58.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 99' ' ' LEU . 2.8 p30 -92.77 -33.64 14.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.553 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.785 ' HB3' HG21 ' A' ' 113' ' ' ILE . 20.3 mt -71.58 -37.33 71.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.57 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.07 -31.69 71.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.543 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -10.0 45.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -71.69 -24.03 61.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.95 . . . . 0.0 109.56 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.41 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 1.8 p -70.02 -11.31 60.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.6 -23.97 21.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.581 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -102.7 8.99 39.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.925 . . . . 0.0 109.499 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.654 HG13 ' HG2' ' A' ' 79' ' ' LYS . 24.4 t -101.85 143.37 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 109.345 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 108' ' ' ASN . 5.7 mtmt -75.31 121.75 22.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 109.298 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 107' ' ' LYS . 2.2 m120 43.78 41.45 3.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.172 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.518 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -42.92 142.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.349 -0.844 . . . . 0.0 110.138 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.729 ' HG2' HG23 ' A' ' 83' ' ' VAL . 24.5 mmm180 -123.39 -2.57 8.49 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.852 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -84.24 106.68 16.05 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.39 -0.819 . . . . 0.0 110.722 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.95 98.02 2.41 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.785 HG21 ' HB3' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -72.85 131.28 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -0.999 . . . . 0.0 110.483 -178.377 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.8 tt0 -172.8 148.54 1.86 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.602 ' HB3' HD12 ' A' ' 96' ' ' LEU . 1.6 pp -90.66 157.0 17.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.438 -1.414 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.905 HD11 ' O ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -40.13 -68.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.483 -0.761 . . . . 0.0 109.925 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.563 ' N ' HD12 ' A' ' 115' ' ' LEU . . . 66.43 168.82 3.07 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.1 m -69.15 88.91 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.513 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.495 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -63.05 -37.25 86.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.454 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.569 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 166.68 -63.14 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.581 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 45.3 Cg_endo -68.72 -18.19 42.22 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.804 1.669 . . . . 0.0 110.365 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.89 162.27 19.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.27 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 124' ' ' GLN . 12.5 ptpt -143.35 54.14 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.932 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.449 ' CB ' ' O ' ' A' ' 123' ' ' LYS . 0.6 OUTLIER 71.74 61.11 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -158.35 44.36 0.3 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.922 . . . . 0.0 109.437 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -89.62 130.84 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.957 . . . . 0.0 109.387 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 126' ' ' ILE . 5.4 mt -41.58 99.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.749 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.47 ' HG2' ' OD2' ' A' ' 92' ' ' ASP . 31.5 mt-10 -117.53 28.94 8.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 0.0 109.38 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.13 148.3 35.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.1 -37.06 5.07 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.013 1.808 . . . . 0.0 110.114 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -161.79 -53.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.238 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -132.85 98.86 4.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.389 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.21 -47.51 89.24 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.15 -164.24 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -1.134 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -104.31 150.76 24.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.925 . . . . 0.0 109.455 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 70.56 11.38 7.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.57 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 0.5 OUTLIER -97.51 10.45 39.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.452 ' O ' HG12 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -76.16 -16.12 59.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.476 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -90.06 -51.8 5.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.609 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 140' ' ' THR . 1.0 OUTLIER -67.73 -19.25 65.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.556 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 142' ' ' TYR . 5.2 p -75.34 -47.4 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.912 . . . . 0.0 109.227 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.982 ' HA ' HG21 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -60.27 -39.5 87.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -39.83 85.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 109.485 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -62.95 -33.76 76.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.87 . . . . 0.0 109.356 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.768 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.2 m -62.18 -21.51 65.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 109.498 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.691 HG13 HD11 ' A' ' 29' ' ' LEU . 86.6 t -56.47 -58.67 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 108.882 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -13.18 61.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.248 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.905 ' O ' HD11 ' A' ' 116' ' ' LEU . 99.6 m -62.77 -12.3 23.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.565 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -125.53 -37.33 2.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -59.35 -42.4 91.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 109.158 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.31 -23.36 67.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 109.091 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 1.137 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 1.5 t80 -89.17 -22.95 22.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.829 . . . . 0.0 109.528 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.664 HD21 HD11 ' A' ' 35' ' ' ILE . 21.4 tp -77.12 -18.03 58.22 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.919 -1.113 . . . . 0.0 108.9 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.86 -47.89 19.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.15 -0.969 . . . . 0.0 109.116 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -67.01 -52.74 38.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 108.977 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 1.137 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 31.4 m -95.19 31.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.367 -0.833 . . . . 0.0 109.078 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.536 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.595 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 5' ' ' THR . 7.2 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.404 0.621 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.893 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -78.12 77.93 4.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.427 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.649 ' CG ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -41.22 118.08 0.97 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.342 -0.849 . . . . 0.0 109.657 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -107.01 122.54 46.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.931 -1.105 . . . . 0.0 109.786 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.943 ' O ' HG23 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -125.92 122.39 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 0.0 109.543 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -122.11 145.24 48.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.27 -0.893 . . . . 0.0 108.89 179.437 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 4.0 m-85 -103.86 158.74 16.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.082 -1.011 . . . . 0.0 109.884 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.741 HG22 ' HA3' ' A' ' 44' ' ' GLY . 85.7 t -144.28 147.06 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.416 -0.803 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -160.38 141.46 12.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.534 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' CYS . 9.2 tp -44.49 -68.06 0.23 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.236 -0.915 . . . . 0.0 109.476 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.18 -79.95 0.08 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.479 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 2.0 t-20 65.85 39.19 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.125 -1.221 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 1.7 pp -143.75 13.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.601 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 40.9 t 177.21 -71.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.728 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 19' ' ' SER . 65.6 mtt85 -84.4 75.9 10.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.682 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.581 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 163.19 -50.99 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.697 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 19' ' ' SER . 51.3 Cg_exo -51.59 -19.63 7.71 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.865 1.71 . . . . 0.0 110.589 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.758 HG22 ' SG ' ' A' ' 145' ' ' CYS . 3.4 mt -75.64 -39.77 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.949 . . . . 0.0 109.81 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 1.253 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -62.99 -40.05 96.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.048 -1.033 . . . . 0.0 109.375 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -70.92 -59.22 2.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.908 . . . . 0.0 109.208 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.829 ' HB1' HG22 ' A' ' 68' ' ' ILE . . . -45.95 -34.38 3.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.9 . . . . 0.0 108.992 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.007 HG11 ' HA ' ' A' ' 146' ' ' VAL . 46.0 t -66.25 -47.52 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.35 -0.844 . . . . 0.0 109.284 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.706 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 1.9 t80 -47.98 -43.47 29.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.827 -1.171 . . . . 0.0 108.02 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.475 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -54.2 -62.86 1.38 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.067 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -79.92 10.76 3.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.271 -0.893 . . . . 0.0 110.221 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.832 HD22 ' SG ' ' A' ' 149' ' ' CYS . 48.7 tp -98.58 -34.68 10.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 108.911 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.749 HG23 HG12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -90.86 -44.44 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.247 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -49.35 -29.1 5.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -0.916 . . . . 0.0 109.138 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -80.68 -37.1 31.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 108.993 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.531 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.5 OUTLIER -73.21 -11.0 60.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.413 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 5.5 t-20 78.49 32.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.713 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.781 HD13 HD21 ' A' ' 153' ' ' LEU . 4.6 pt -123.21 3.77 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 109.431 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.593 ' CA ' ' CG2' ' A' ' 30' ' ' VAL . 60.7 p -62.87 -31.38 72.4 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.097 -1.002 . . . . 0.0 109.457 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -54.85 -25.17 26.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.45 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.893 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -126.66 40.21 3.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.751 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.738 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 21.9 m95 -146.92 104.78 3.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.968 -1.083 . . . . 0.0 110.33 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' SER . 45.0 t -97.74 106.77 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.943 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.6 mp -107.37 146.58 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.066 -1.021 . . . . 0.0 110.501 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.444 ' C ' ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -140.66 -164.93 1.83 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.792 . . . . 0.0 109.496 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.1 176.89 8.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.377 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.741 ' HA3' HG22 ' A' ' 11' ' ' VAL . . . -163.86 159.21 31.93 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.489 ' C ' HG23 ' A' ' 46' ' ' VAL . . . -129.78 -31.03 2.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -1.153 . . . . 0.0 109.72 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.646 HG23 ' CG1' ' A' ' 11' ' ' VAL . 3.8 t 74.76 6.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.462 ' HB2' ' CD2' ' A' ' 49' ' ' TRP . 5.5 p -126.5 126.63 44.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.433 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.5 2.59 15.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.577 ' N ' ' CD1' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -102.27 1.46 35.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -0.997 . . . . 0.0 109.362 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -122.05 8.82 9.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.311 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.676 HG13 ' HA ' ' A' ' 75' ' ' ARG . 7.0 t -71.51 92.3 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.301 -0.874 . . . . 0.0 109.436 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . 116.41 7.13 14.48 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -84.45 82.94 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -1.165 . . . . 0.0 109.45 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.469 ' HB3' ' HD2' ' A' ' 73' ' ' LYS . 86.1 p -43.63 153.28 0.4 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 0.0 109.482 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 54' ' ' SER . 54.1 Cg_exo -49.98 -176.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.979 1.786 . . . . 0.0 110.258 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.18 139.08 36.47 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.393 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.629 ' O ' HG12 ' A' ' 60' ' ' VAL . 52.3 Cg_exo -51.03 -21.1 8.31 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.879 1.719 . . . . 0.0 110.369 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -87.94 -39.55 14.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.661 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.49 6.3 34.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -85.39 -38.25 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.458 ' N ' HG13 ' A' ' 60' ' ' VAL . 4.2 m -76.55 -15.85 59.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.355 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.454 ' C ' HD23 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -70.25 -29.43 66.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.846 . . . . 0.0 109.433 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.811 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -87.8 -55.32 3.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 108.902 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 -64.09 -10.51 22.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 109.563 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -59.06 -84.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.811 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -74.53 -24.91 59.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 109.773 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.447 ' O ' HG12 ' A' ' 68' ' ' ILE . . . 131.32 109.94 1.28 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.829 HG22 ' HB1' ' A' ' 24' ' ' ALA . 14.3 mm -150.16 -38.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -1.1 . . . . 0.0 109.603 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 68' ' ' ILE . 4.8 p30 51.63 173.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.81 . . . . 0.0 109.627 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.464 HG23 ' C ' ' A' ' 69' ' ' ASN . 20.5 p -157.43 -54.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 57.81 34.6 24.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.364 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -149.23 124.63 10.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 1.1 tppm? -98.21 27.36 4.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.902 . . . . 0.0 109.575 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 73' ' ' LYS . . . 73.91 131.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.527 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.676 ' HA ' HG13 ' A' ' 51' ' ' VAL . 5.5 mmt180 -143.95 142.22 30.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.535 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 77' ' ' VAL . 2.2 tt0 -66.2 119.94 12.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 78' ' ' THR . 4.1 t -45.43 170.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.516 ' H ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -153.78 175.9 12.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.445 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HG2' HG13 ' A' ' 106' ' ' VAL . 2.5 tmtt? -68.05 -45.03 75.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.624 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' O ' ' OG1' ' A' ' 84' ' ' THR . 37.3 tt0 -57.98 -44.86 87.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.543 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 1.3 m-20 -64.5 -30.35 71.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.801 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 78' ' ' THR . 12.5 m-85 -64.24 -67.01 0.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 109.755 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 110' ' ' ARG . 6.0 p -64.08 -20.07 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 6.0 m -69.96 -32.68 71.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.367 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 81' ' ' ASP . 27.4 m-85 -106.37 158.45 16.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.488 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' C ' ' CD1' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -108.87 -2.57 18.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.631 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.649 ' CE1' ' CG ' ' A' ' 6' ' ' LYS . 5.8 m-85 -138.42 139.85 39.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.855 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -150.78 116.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.233 -0.917 . . . . 0.0 109.288 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.938 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -129.53 153.98 47.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.315 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -122.72 169.83 10.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.36 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.451 ' HB2' ' HB2' ' A' ' 12' ' ' CYS . 6.3 mmt -81.06 74.1 8.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.33 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 94' ' ' SER . 0.1 OUTLIER 39.68 -101.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.778 . . . . 0.0 109.853 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 92' ' ' ASP . 45.9 mt-10 42.64 -96.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.072 -1.017 . . . . 0.0 109.262 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 96' ' ' LEU . 1.3 m -88.2 87.31 7.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 108.601 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -39.14 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.081 0.467 . . . . 0.0 110.773 -179.12 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.074 HD21 ' CG2' ' A' ' 113' ' ' ILE . 0.8 OUTLIER 32.72 36.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.119 0.485 . . . . 0.0 110.394 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 95' ' ' ASN . 7.3 ttt180 -91.21 -17.39 26.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.013 -1.054 . . . . 0.0 110.024 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.7 -51.01 2.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 0.0 110.046 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.6 HD12 ' SG ' ' A' ' 90' ' ' CYS . 11.4 mt -65.73 -18.38 65.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 109.807 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.729 ' HB2' HD22 ' A' ' 96' ' ' LEU . 61.6 t30 -72.97 -22.91 60.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.969 . . . . 0.0 109.168 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -89.68 -23.41 21.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.285 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.858 ' O ' HG23 ' A' ' 106' ' ' VAL . 10.9 mmmt -66.37 -30.12 70.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.343 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.0 p -72.87 -21.77 60.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.337 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -71.83 -35.21 69.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.296 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 1.2 pt20 -89.06 2.8 53.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 109.487 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 102' ' ' LYS . 70.8 t -92.99 122.49 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.189 -0.944 . . . . 0.0 109.299 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -56.48 102.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.274 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 m120 52.48 59.22 4.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.146 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.549 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -54.25 156.96 2.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.4 -0.812 . . . . 0.0 109.803 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.549 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 3.1 mtt180 -123.94 -23.06 4.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.445 -0.785 . . . . 0.0 109.367 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.855 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -70.55 92.41 0.84 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.377 -0.827 . . . . 0.0 110.278 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 101.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 1.074 ' CG2' HD21 ' A' ' 96' ' ' LEU . 1.8 mm -62.65 160.15 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.217 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.576 ' HB3' HD23 ' A' ' 89' ' ' LEU . 1.7 mt-10 173.82 -169.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 118' ' ' SER . 0.7 OUTLIER -147.06 156.87 43.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.925 -1.109 . . . . 0.0 109.582 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.718 HD11 ' HA ' ' A' ' 148' ' ' CYS . 1.0 OUTLIER -59.09 -40.91 86.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -48.74 -28.62 7.21 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -50.79 -49.01 59.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -1.104 . . . . 0.0 109.503 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -86.32 -94.19 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.94 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.477 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 5.3 t70 67.13 67.4 0.61 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.497 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 51.9 Cg_exo -51.62 -173.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.962 1.775 . . . . 0.0 110.208 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 55.07 -92.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.379 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 121' ' ' PRO . 12.0 pttt -102.92 148.34 25.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.337 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -97.26 119.86 36.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -159.03 0.97 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.519 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 1.5 mm -127.92 -2.97 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.695 HG22 ' N ' ' A' ' 128' ' ' GLU . 39.9 mt 60.67 -89.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.145 -0.972 . . . . 0.0 109.265 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.695 ' N ' HG22 ' A' ' 127' ' ' ILE . 4.2 mt-10 45.62 68.52 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.547 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.83 119.54 51.07 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.224 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.46 178.1 5.36 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.773 1.649 . . . . 0.0 110.325 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.442 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 3.9 m-85 -74.16 -1.31 19.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.649 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -92.01 74.11 5.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.383 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 132' ' ' TYR . . . -57.11 -159.97 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.4 -53.7 5.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -1.167 . . . . 0.0 109.389 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -170.89 101.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.25 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 48.75 30.12 2.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.111 -0.993 . . . . 0.0 109.156 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.87 76.43 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.45 -16.75 17.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.37 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.69 -27.33 27.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' VAL . 54.9 m -56.09 -54.63 42.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.454 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 18' ' ' ARG . 10.0 t -43.56 -55.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.262 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -48.51 -46.53 38.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -58.21 8.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.876 . . . . 0.0 109.798 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -67.68 -7.18 24.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -0.95 . . . . 0.0 109.419 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.758 ' SG ' HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -83.19 -28.56 29.21 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.306 -0.871 . . . . 0.0 109.361 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 1.007 ' HA ' HG11 ' A' ' 25' ' ' VAL . 40.3 t -65.35 -50.73 71.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.259 -0.9 . . . . 0.0 109.309 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.41 -19.19 62.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.084 -1.01 . . . . 0.0 108.831 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 1.253 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -52.34 -25.03 8.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.285 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.832 ' SG ' HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -112.45 -33.29 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -0.835 . . . . 0.0 109.856 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.775 ' CA ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -70.65 -56.84 5.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 109.307 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 154' ' ' GLU . . . -54.37 -21.97 11.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.545 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.98 ' O ' HG22 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -90.32 -29.57 18.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 109.763 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.781 HD21 HD13 ' A' ' 35' ' ' ILE . 10.7 tp -75.48 -25.22 57.16 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.939 -1.101 . . . . 0.0 109.0 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -71.31 -32.66 68.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.907 . . . . 0.0 109.218 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.68 -43.45 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.184 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.98 HG22 ' O ' ' A' ' 152' ' ' PHE . 17.1 m -101.34 25.69 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.393 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.5 ' NE ' ' O ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.407 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.935 HG22 ' HA ' ' A' ' 38' ' ' ASN . 1.7 p -120.89 160.82 22.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.654 ' CB ' ' CZ3' ' A' ' 39' ' ' TRP . 11.2 mttm -108.48 -168.42 1.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.25 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.51 ' HB2' ' HA ' ' A' ' 85' ' ' PHE . 3.1 p -140.43 105.37 4.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 109.44 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.829 HG21 ' HE2' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -122.86 143.11 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.412 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.61 HD22 HG12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -140.6 115.34 9.58 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -92.04 157.59 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.076 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.984 HG11 HD11 ' A' ' 99' ' ' LEU . 16.8 t -140.35 142.16 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -0.785 . . . . 0.0 109.425 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' HA ' ' A' ' 15' ' ' ASN . 1.6 p -147.9 19.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 8.9 tp 63.64 -96.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 109.981 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 15' ' ' ASN . . . -47.33 -60.17 5.36 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.767 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . 56.9 t30 66.8 14.76 9.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -1.162 . . . . 0.0 109.302 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.886 HD12 ' N ' ' A' ' 17' ' ' CYS . 2.6 pp -135.71 -37.95 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.438 -0.789 . . . . 0.0 108.959 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.886 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -122.28 -24.05 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -56.84 -76.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 109.231 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.588 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 46.0 p 179.46 61.2 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.931 -1.106 . . . . 0.0 110.406 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 19' ' ' SER . 49.5 Cg_exo -56.12 -17.5 20.15 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.713 1.609 . . . . 0.0 110.052 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.977 ' O ' HG23 ' A' ' 25' ' ' VAL . 10.8 mm -41.6 -38.52 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.52 -0.737 . . . . 0.0 110.264 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.954 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -53.96 -51.39 64.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.042 . . . . 0.0 109.679 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -66.36 -56.77 9.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.011 . . . . 0.0 109.356 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 1.029 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -46.7 -25.08 0.65 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.958 . . . . 0.0 109.074 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.977 HG23 ' O ' ' A' ' 21' ' ' ILE . 84.6 t -78.36 -43.32 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.264 -0.898 . . . . 0.0 109.36 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.829 ' HE2' HG21 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -57.51 -21.44 37.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -58.57 3.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 28' ' ' LYS . 10.0 tmtt? -75.89 2.77 11.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.356 -0.84 . . . . 0.0 109.225 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.956 HD11 ' HG3' ' A' ' 150' ' ' ARG . 34.2 tp -102.78 -37.17 7.99 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.955 HG23 HG12 ' A' ' 35' ' ' ILE . 9.8 p -90.82 -4.87 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 31' ' ' THR . 8.6 m -106.2 11.46 31.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.728 -1.233 . . . . 0.0 109.401 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -127.6 53.83 1.73 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 109.138 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.564 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.6 OUTLIER 175.56 31.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.486 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 33' ' ' GLN . 36.7 t30 46.18 37.06 3.6 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.955 HG12 HG23 ' A' ' 30' ' ' VAL . 2.0 tt -121.17 -4.6 9.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.693 -177.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.927 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -73.49 -53.26 11.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.058 -1.026 . . . . 0.0 110.506 -178.713 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 25.7 p-10 -56.93 -14.47 3.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.198 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.935 ' HA ' HG22 ' A' ' 5' ' ' THR . 69.6 m-20 -109.12 36.62 2.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.924 -1.11 . . . . 0.0 110.464 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.654 ' CZ3' ' CB ' ' A' ' 6' ' ' LYS . 17.8 m95 -150.95 136.9 18.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.486 -1.384 . . . . 0.0 111.516 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.97 74.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.518 ' CG1' HG13 ' A' ' 8' ' ' VAL . 3.1 mt -90.11 144.5 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.456 -0.777 . . . . 0.0 109.934 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.7 OUTLIER -142.31 -173.97 3.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 109.22 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.5 p -126.26 160.92 28.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.765 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -141.43 137.45 8.08 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.51 ' HB1' ' OD1' ' A' ' 50' ' ' ASN . . . -118.01 -9.29 10.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -1.194 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.615 ' CG2' HG11 ' A' ' 11' ' ' VAL . 2.5 t 55.05 21.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.4 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 38.2 t -160.42 160.01 31.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.524 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.59 ' HA ' HG23 ' A' ' 51' ' ' VAL . 10.7 p-10 -105.5 11.68 32.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.536 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -88.04 11.13 16.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.543 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.539 HD22 ' HB1' ' A' ' 74' ' ' ALA . 3.4 p-10 -144.89 13.91 1.5 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 48' ' ' ASP . 67.2 t -65.16 112.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 109.249 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.37 22.53 58.54 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.538 ' O ' HG22 ' A' ' 16' ' ' ILE . 39.0 mtp180 -106.25 85.12 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.519 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' ARG . 2.5 p -46.36 162.22 0.26 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.281 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 56' ' ' ASP . 52.6 Cg_exo -50.51 140.65 35.34 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.897 1.731 . . . . 0.0 110.142 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 6.2 m-20 -43.75 166.08 0.11 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.466 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 56' ' ' ASP . 49.7 Cg_endo -70.91 -7.2 20.88 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.987 1.791 . . . . 0.0 110.193 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -90.19 -40.5 12.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.9 . . . . 0.0 109.365 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -89.6 -16.88 29.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.423 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 57' ' ' PRO . 7.0 p -57.25 -27.81 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.92 . . . . 0.0 109.548 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -79.97 -48.82 12.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.408 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.506 ' SG ' ' CD2' ' A' ' 142' ' ' TYR . 6.3 t -45.76 -30.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.801 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.23 -45.1 9.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.935 . . . . 0.0 109.104 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.63 19.94 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.67 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 61' ' ' SER . 15.1 t-20 -91.35 -53.54 4.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.361 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.525 ' CE1' ' OH ' ' A' ' 142' ' ' TYR . 9.5 p80 -102.98 -31.79 10.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.21 109.9 1.29 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.029 HG12 ' HB1' ' A' ' 24' ' ' ALA . 8.5 tp -120.98 -26.83 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -1.163 . . . . 0.0 109.428 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 3.0 m-20 76.13 41.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.413 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 70' ' ' THR . 5.2 t -63.38 110.64 1.99 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.88 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.0 -23.55 5.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -84.74 132.76 34.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.295 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -95.91 154.17 17.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 109.542 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.539 ' HB1' HD22 ' A' ' 50' ' ' ASN . . . -46.6 169.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 76' ' ' GLN . 0.6 OUTLIER -169.16 161.48 10.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 109.484 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.54 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -96.61 128.77 43.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.528 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 46' ' ' VAL . 55.9 t -65.74 135.85 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 109.357 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -138.62 165.28 27.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.873 . . . . 0.0 109.505 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -44.09 -39.1 4.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' O ' ' OG1' ' A' ' 84' ' ' THR . 28.3 tt0 -54.19 -53.28 55.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.885 . . . . 0.0 109.546 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 2.7 m-20 -50.92 -46.89 61.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.37 -0.831 . . . . 0.0 110.125 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.774 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 77.6 m-85 -51.05 -63.11 1.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 108' ' ' ASN . 2.3 p -73.62 -4.04 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -0.861 . . . . 0.0 110.021 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 14.3 m -81.3 -65.45 1.01 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.602 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 50.2 m-85 -87.11 173.68 9.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.892 . . . . 0.0 110.001 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.586 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -116.9 -15.22 10.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.724 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CE1' ' HB3' ' A' ' 86' ' ' ASP . 1.6 m-85 -123.0 74.56 1.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.068 -1.02 . . . . 0.0 109.659 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.891 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 2.6 mt -85.22 94.04 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -105.58 -179.82 4.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.958 -1.089 . . . . 0.0 109.467 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.739 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -142.94 172.69 12.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.74 ' HE2' ' HA ' ' A' ' 91' ' ' MET . 30.9 mmt -67.52 -7.77 28.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 109.669 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 115' ' ' LEU . 5.7 p30 174.05 -176.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.0 . . . . 0.0 109.406 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -83.44 -7.58 59.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.78 -49.97 70.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.578 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -83.68 9.98 10.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.501 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.957 HD21 HG22 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -100.17 16.49 24.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.0 ttt-85 -84.87 -22.63 29.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.503 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 102' ' ' LYS . 0.9 OUTLIER -107.07 -32.64 7.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.466 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.984 HD11 HG11 ' A' ' 11' ' ' VAL . 24.5 mt -73.57 -36.01 65.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.493 ' HB2' HD22 ' A' ' 96' ' ' LEU . 5.5 t30 -66.17 -35.09 79.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.324 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -89.84 0.09 57.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.374 -0.829 . . . . 0.0 109.457 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.73 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -92.18 -22.33 19.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.478 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m -70.42 -12.61 61.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 0.0 109.41 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -86.27 -30.83 22.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -92.44 -10.36 38.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 109.348 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 102' ' ' LYS . 39.0 t -71.76 140.13 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -75.13 117.1 16.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.231 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.6 m120 48.28 46.38 20.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.544 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.11 150.88 2.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.96 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 5.8 ptm180 -140.58 9.9 2.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.467 -0.771 . . . . 0.0 109.111 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.891 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -98.39 116.07 29.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 110.321 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -70.57 124.22 23.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.957 HG22 HD21 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -99.1 114.95 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.795 -1.191 . . . . 0.0 110.498 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 20.7 mt-10 -147.51 -177.5 5.73 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 1.064 HD12 HD11 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -126.07 153.7 44.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.97 -1.081 . . . . 0.0 109.746 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.903 HD21 ' HA ' ' A' ' 148' ' ' CYS . 0.3 OUTLIER -43.47 104.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.373 -0.83 . . . . 0.0 109.521 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.38 157.17 16.45 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 m -65.06 93.75 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -1.133 . . . . 0.0 109.375 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -77.14 -93.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.598 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 1.1 m-20 -71.81 -62.27 1.7 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.054 -1.029 . . . . 0.0 109.789 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 55.5 Cg_endo -72.05 126.16 11.58 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.795 1.663 . . . . 0.0 110.256 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -105.13 111.99 24.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -150.56 158.12 43.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.551 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -88.42 98.44 11.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 176.57 108.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 1.064 HD11 HD12 ' A' ' 115' ' ' LEU . 1.8 tt -121.23 28.16 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 126' ' ' ILE . 20.0 tt 41.28 41.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.402 -0.811 . . . . 0.0 109.838 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.519 ' HG3' HG23 ' A' ' 126' ' ' ILE . 1.3 mt-10 -87.48 51.23 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 109.423 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.56 104.34 55.35 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.928 . . . . 0.0 109.42 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -49.4 169.83 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.8 1.667 . . . . 0.0 110.228 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.412 ' C ' ' CD1' ' A' ' 131' ' ' TYR . 3.0 t80 -84.79 106.09 16.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.55 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -146.4 -64.71 0.3 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 135.56 114.74 1.41 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -154.5 -49.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -1.1 . . . . 0.0 109.518 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.72 -19.6 20.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 56.65 24.6 9.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.509 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -127.99 87.89 2.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.453 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 29.0 p90 -71.48 -10.36 59.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.5 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -62.88 -34.84 78.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.412 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 0.2 OUTLIER -63.54 -25.78 68.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.309 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.554 ' CG1' ' HB2' ' A' ' 19' ' ' SER . 27.7 t -79.1 -31.11 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.312 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.962 ' HA ' HG21 ' A' ' 21' ' ' ILE . 6.1 t80 -69.18 -50.92 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.567 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -65.41 -41.6 93.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.952 . . . . 0.0 109.514 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 140' ' ' THR . 0.8 OUTLIER -68.87 -14.37 62.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 4.6 m -89.94 -8.6 51.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.868 ' HA ' HG11 ' A' ' 25' ' ' VAL . 46.2 t -62.57 -68.73 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.713 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.8 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 0.7 OUTLIER -58.94 -15.61 13.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.824 -1.173 . . . . 0.0 109.157 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' CYS . . . . . 0.954 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -44.26 -32.97 1.43 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.202 -0.936 . . . . 0.0 108.582 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.895 ' SG ' HG12 ' A' ' 25' ' ' VAL . 1.6 p -115.09 -24.38 8.58 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.956 ' HG3' HD11 ' A' ' 29' ' ' LEU . 9.5 ttt-85 -76.55 -60.98 2.11 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.8 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -49.67 -36.51 25.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.441 -0.787 . . . . 0.0 109.149 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.737 ' CE2' HG21 ' A' ' 156' ' ' VAL . 17.0 t80 -77.9 -31.64 51.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.532 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.482 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 11.7 tp -67.9 -13.18 61.95 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.166 -0.959 . . . . 0.0 108.815 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 1.8 mt-10 -76.9 -53.41 7.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.898 . . . . 0.0 109.122 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -47.61 84.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.962 . . . . 0.0 109.117 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.737 HG21 ' CE2' ' A' ' 152' ' ' PHE . 14.1 m -97.64 25.6 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 109.083 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.482 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.548 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -98.7 113.55 25.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.467 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -67.33 172.57 4.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.69 150.16 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.564 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.665 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -84.95 71.0 10.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.877 . . . . 0.0 109.442 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 9.3 ttmt -41.93 162.94 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.157 -0.964 . . . . 0.0 109.573 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 m -139.16 135.96 34.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 0.0 109.912 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.765 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -141.7 155.53 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 108.927 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.792 HD13 ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -150.11 115.98 5.61 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 109.064 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.0 m-85 -86.8 151.56 23.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.512 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.651 ' HB ' HD11 ' A' ' 99' ' ' LEU . 5.4 t -143.82 157.92 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.59 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER 173.08 128.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -44.91 150.09 0.4 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.181 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.03 88.27 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 15' ' ' ASN . 25.6 t-20 -85.5 15.19 4.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -1.14 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 2.0 pp -119.22 131.79 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.613 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.78 ' SG ' ' CZ ' ' A' ' 138' ' ' PHE . 34.8 t 66.8 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.71 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.659 ' HA ' HG11 ' A' ' 141' ' ' VAL . 0.3 OUTLIER 43.11 78.63 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.681 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER 163.63 -61.48 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 0.0 109.94 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 19' ' ' SER . 52.1 Cg_endo -71.16 -1.25 9.28 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.85 1.7 . . . . 0.0 110.848 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.007 HG21 ' HA ' ' A' ' 142' ' ' TYR . 3.8 mm -74.6 -48.12 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.985 -1.072 . . . . 0.0 109.575 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.632 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -57.35 -27.85 62.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.551 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -73.27 -71.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -0.954 . . . . 0.0 109.318 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.492 ' O ' HG13 ' A' ' 68' ' ' ILE . . . -44.89 -26.97 0.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 108.887 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.96 HG12 ' SG ' ' A' ' 149' ' ' CYS . 72.2 t -70.23 -54.36 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.404 -0.81 . . . . 0.0 109.214 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.682 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 2.1 t80 -45.57 -35.78 4.21 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -63.8 -57.66 9.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.425 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -55.97 -21.15 19.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.857 . . . . 0.0 109.652 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.859 HD22 ' HG3' ' A' ' 150' ' ' ARG . 39.7 mt -85.62 -30.79 22.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.212 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.929 HG22 ' HA ' ' A' ' 36' ' ' SER . 2.9 p -90.67 -6.23 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.407 -0.808 . . . . 0.0 109.348 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -105.14 5.91 32.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.033 -1.042 . . . . 0.0 109.848 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 4.4 t0 -128.02 59.74 1.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 109.133 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.501 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER 171.28 31.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.831 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.4 t-20 45.11 32.01 0.84 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.838 HG12 HG23 ' A' ' 30' ' ' VAL . 2.7 tt -112.79 -7.31 11.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.687 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.929 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -73.11 -25.06 60.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.658 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -84.47 16.26 3.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 0.0 109.778 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.665 ' HA ' HG22 ' A' ' 5' ' ' THR . 8.6 m-80 -144.46 36.13 1.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.481 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.765 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 22.1 m95 -150.18 150.39 31.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.986 -1.071 . . . . 0.0 111.029 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 40' ' ' VAL . 80.5 t -128.31 70.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 26' ' ' PHE . 2.4 mp -89.56 140.22 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.398 -0.814 . . . . 0.0 110.626 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -146.25 171.58 14.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.507 -0.745 . . . . 0.0 109.268 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.8 p -105.1 162.38 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.975 . . . . 0.0 109.614 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.559 ' CA ' ' CG2' ' A' ' 77' ' ' VAL . . . -143.05 122.76 1.97 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -87.08 -41.26 13.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.142 -1.21 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER 80.25 -5.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.795 . . . . 0.0 109.436 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 76' ' ' GLN . 0.4 OUTLIER -126.49 179.61 5.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 109.371 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.515 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 19.3 t70 -120.38 7.87 10.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.564 ' N ' ' CD1' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -91.55 -32.98 15.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.327 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -101.85 31.16 3.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 73.9 t -76.31 96.79 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.19 57.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -79.37 86.64 5.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -1.161 . . . . 0.0 109.555 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 53' ' ' ARG . 4.0 m -45.42 159.6 0.28 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.873 . . . . 0.0 109.369 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.45 152.41 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.98 1.787 . . . . 0.0 110.255 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.19 152.36 96.55 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.587 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 51.6 Cg_exo -51.22 -19.97 7.16 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.021 1.814 . . . . 0.0 110.475 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -81.89 -47.78 12.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -0.961 . . . . 0.0 109.796 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.747 ' O ' HD22 ' A' ' 63' ' ' LEU . . . -89.86 4.58 49.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.946 . . . . 0.0 109.807 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.587 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 6.8 p -89.93 -43.92 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.043 -1.036 . . . . 0.0 109.628 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.525 ' N ' HG13 ' A' ' 60' ' ' VAL . 3.8 p -76.82 -17.85 58.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.95 . . . . 0.0 109.521 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.7 m -78.26 -62.29 1.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -60.69 -27.99 68.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.567 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.749 ' H ' HD23 ' A' ' 63' ' ' LEU . 7.2 ttp85 -96.94 33.37 1.91 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.649 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' SER . 1.7 t30 -131.5 -43.07 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.345 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -82.86 -22.15 34.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.36 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.449 ' O ' ' HD3' ' A' ' 28' ' ' LYS . . . 113.16 83.33 1.22 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 25' ' ' VAL . 1.3 tp -122.22 -24.5 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -1.16 . . . . 0.0 109.656 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 11.0 m120 63.52 98.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.557 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.23 91.39 3.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.77 53.55 1.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.515 ' CE1' ' O ' ' A' ' 73' ' ' LYS . 38.9 t-80 -143.94 155.87 44.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.447 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.515 ' O ' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -104.75 130.75 52.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 75' ' ' ARG . . . -43.99 -69.9 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.601 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.495 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 61.06 158.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.373 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 47' ' ' SER . 22.6 tt0 -88.39 123.78 33.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.442 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.559 ' CG2' ' CA ' ' A' ' 44' ' ' GLY . 21.3 t -47.56 151.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.86 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -141.09 165.17 28.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.663 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.631 ' CG ' HG13 ' A' ' 106' ' ' VAL . 3.2 tmtt? -43.18 -41.67 3.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 109.495 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 84' ' ' THR . 24.4 tp10 -56.08 -48.37 76.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 109.553 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.487 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 1.2 m-20 -62.32 -34.02 75.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.77 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.826 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 79.3 m-85 -65.65 -79.07 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 110.163 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.663 HG23 ' HB3' ' A' ' 110' ' ' ARG . 7.3 p -48.13 -46.94 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.07 -1.019 . . . . 0.0 109.256 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.603 ' N ' HG13 ' A' ' 83' ' ' VAL . 16.4 m -45.85 -82.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.335 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.792 ' CE2' HD13 ' A' ' 9' ' ' LEU . 21.0 m-85 -57.13 166.5 1.07 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.317 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.33 -25.62 5.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.618 ' CD2' HG11 ' A' ' 156' ' ' VAL . 6.3 m-30 -109.38 72.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.107 -0.996 . . . . 0.0 109.852 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.907 HG13 ' HB1' ' A' ' 111' ' ' ALA . 1.3 mt -82.82 96.57 3.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.428 -0.795 . . . . 0.0 109.62 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -109.85 179.97 3.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.019 -1.051 . . . . 0.0 108.91 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -147.58 172.49 13.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.13 -0.982 . . . . 0.0 109.689 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.51 ' CE ' HD13 ' A' ' 116' ' ' LEU . 31.5 mmt -85.46 46.59 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.362 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' SER . 10.1 t70 56.93 -93.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.568 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.506 ' HG2' ' N ' ' A' ' 94' ' ' SER . 27.4 tt0 43.53 -94.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.305 -0.872 . . . . 0.0 109.338 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.6 ' O ' ' N ' ' A' ' 96' ' ' LEU . 4.6 p -85.67 88.2 7.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.09 -1.006 . . . . 0.0 108.71 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 96' ' ' LEU . 25.5 p-10 -31.94 85.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.091 0.472 . . . . 0.0 111.195 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.964 HD13 ' OD1' ' A' ' 100' ' ' ASN . 4.1 mt 29.48 56.98 0.15 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.244 0.545 . . . . 0.0 110.747 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -91.35 -50.96 5.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.082 -1.011 . . . . 0.0 109.65 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -92.77 -64.13 1.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.928 . . . . 0.0 109.653 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.651 HD11 ' HB ' ' A' ' 11' ' ' VAL . 17.3 mt -44.02 -40.11 4.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.217 -0.927 . . . . 0.0 109.668 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.964 ' OD1' HD13 ' A' ' 96' ' ' LEU . 3.2 t30 -61.59 -49.31 77.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -0.98 . . . . 0.0 109.182 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.83 14.6 11.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 108.918 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.683 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.8 OUTLIER -86.25 -40.41 15.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.479 -0.763 . . . . 0.0 109.356 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.6 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 1.3 p -65.86 -11.79 49.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.42 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.4 -36.82 68.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -99.19 8.6 44.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.825 HG11 ' SG ' ' A' ' 109' ' ' CYS . 46.7 t -83.54 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.367 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 108' ' ' ASN . 12.1 tptp -62.53 88.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 108.832 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 107' ' ' LYS . 9.2 t30 73.99 71.06 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 108.932 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.825 ' SG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -85.01 143.72 28.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.315 -0.866 . . . . 0.0 109.901 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.663 ' HB3' HG23 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -143.82 13.58 1.7 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 108.985 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.907 ' HB1' HG13 ' A' ' 88' ' ' ILE . . . -89.85 97.22 11.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.965 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' ALA . 15.0 mttt -46.66 123.63 5.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.61 ' CG2' HD21 ' A' ' 96' ' ' LEU . 1.1 mm -99.36 139.59 20.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.875 -1.141 . . . . 0.0 110.372 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -167.11 -177.43 3.73 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.663 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -134.0 145.73 49.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.009 -1.057 . . . . 0.0 109.642 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.882 HD21 ' HA ' ' A' ' 148' ' ' CYS . 0.0 OUTLIER -43.24 152.54 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.328 -0.858 . . . . 0.0 109.448 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -158.43 -143.76 3.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 123' ' ' LYS . 2.0 p -87.24 109.19 19.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.166 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -112.27 -81.96 0.59 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.41 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.582 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -61.56 -61.47 7.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.654 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 52.3 Cg_endo -71.78 -161.68 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.77 1.647 . . . . 0.0 110.209 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -144.35 36.61 1.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 118' ' ' SER . 12.2 ptpt -111.49 159.07 18.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.242 -0.911 . . . . 0.0 109.566 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.7 81.87 7.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.49 112.79 25.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 109.386 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.5 ' CG2' ' CG ' ' A' ' 92' ' ' ASP . 6.6 mm -124.8 152.35 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.314 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.425 ' C ' ' OD2' ' A' ' 92' ' ' ASP . 2.9 mm -92.25 64.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.155 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.459 ' HA ' ' OD2' ' A' ' 92' ' ' ASP . 3.0 mt-10 -85.55 46.75 1.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.668 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -127.24 144.79 51.89 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.68 -42.9 1.52 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.876 1.717 . . . . 0.0 110.218 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.96 178.4 4.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.379 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -124.98 12.65 8.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 109.458 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 96.51 -115.7 5.27 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.74 -48.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -1.154 . . . . 0.0 109.335 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.9 OUTLIER -102.26 159.71 15.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 74.18 5.92 4.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.534 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -177.42 120.88 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.78 ' CZ ' ' SG ' ' A' ' 17' ' ' CYS . 2.0 t80 -170.85 -50.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.323 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 140' ' ' THR . 2.5 pt-20 -66.66 -28.61 68.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.411 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.419 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 32.4 m -62.18 -43.93 97.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.387 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 18' ' ' ARG . 39.2 t -61.59 -57.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.234 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 1.007 ' HA ' HG21 ' A' ' 21' ' ' ILE . 1.4 t80 -46.52 -38.22 9.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 0.0 109.131 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.86 -39.27 79.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.737 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -68.66 -13.13 62.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.693 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.3 m -88.15 -12.56 43.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.754 ' HA ' HG11 ' A' ' 25' ' ' VAL . 95.8 t -58.54 -60.41 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.299 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.813 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -74.4 -18.49 60.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.897 . . . . 0.0 109.377 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.882 ' HA ' HD21 ' A' ' 116' ' ' LEU . 1.2 m -46.72 -32.21 3.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.151 -0.968 . . . . 0.0 109.184 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.96 ' SG ' HG12 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -114.07 -30.01 6.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 109.175 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.859 ' HG3' HD22 ' A' ' 29' ' ' LEU . 18.2 ttt180 -75.22 -57.72 3.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 0.0 109.109 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.813 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -51.77 -31.53 27.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.349 -0.844 . . . . 0.0 109.199 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.743 ' CE1' HG21 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -83.39 -29.36 28.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.813 . . . . 0.0 109.343 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.98 -18.11 65.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.067 -1.021 . . . . 0.0 108.666 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 3.7 mm-40 -70.09 -45.43 66.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.024 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -46.38 81.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.284 -0.885 . . . . 0.0 108.953 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.743 HG21 ' CE1' ' A' ' 152' ' ' PHE . 6.4 m -95.3 25.17 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.084 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 1.1 tmm_? . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.557 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.91 30.31 5.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.421 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 67.18 170.8 0.26 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -88.21 143.55 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.361 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.944 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -149.43 71.94 1.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.611 ' HG2' ' CE2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -42.28 166.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.151 -0.968 . . . . 0.0 110.304 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 85' ' ' PHE . 33.4 t -143.75 127.22 16.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.512 -0.742 . . . . 0.0 109.147 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.971 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -131.09 153.25 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 108.904 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.623 HD22 ' CD1' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -146.21 123.52 11.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.445 -0.784 . . . . 0.0 108.997 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.2 m-85 -95.2 165.99 12.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.995 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.635 HG11 HD11 ' A' ' 99' ' ' LEU . 2.0 t -147.38 149.11 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.349 -0.844 . . . . 0.0 109.644 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.761 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER 177.13 114.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 tp -46.74 156.94 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.0 109.405 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.35 49.55 75.14 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.445 ' OD1' ' HG3' ' A' ' 20' ' ' PRO . 43.4 t30 -74.29 82.09 1.86 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.133 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.566 HD12 ' N ' ' A' ' 17' ' ' CYS . 1.2 pp -152.55 -52.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.712 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.692 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -134.61 34.73 3.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.641 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -171.37 60.07 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 109.372 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.761 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 163.59 -51.68 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 109.599 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 19' ' ' SER . 54.1 Cg_exo -49.29 -21.27 4.41 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.839 1.692 . . . . 0.0 110.455 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.001 HG21 ' HA ' ' A' ' 142' ' ' TYR . 18.5 mm -58.97 -51.28 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.165 -0.96 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.781 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . . . -59.99 -16.97 34.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.136 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' OE1' ' CA ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -81.92 -72.81 0.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.221 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -43.49 -39.18 3.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.001 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 21' ' ' ILE . 47.2 t -60.83 -58.34 7.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.448 -0.782 . . . . 0.0 108.97 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 2.6 t80 -43.3 -29.12 0.38 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.928 . . . . 0.0 108.615 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.62 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -65.93 -62.2 1.63 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.331 -0.855 . . . . 0.0 109.226 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.08 -43.33 63.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 0.0 109.71 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.791 HD22 ' HG3' ' A' ' 150' ' ' ARG . 25.3 mt -60.39 -36.8 78.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.93 HG22 ' HA ' ' A' ' 36' ' ' SER . 4.4 p -90.03 -4.52 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.504 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -107.21 12.51 28.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.848 -1.158 . . . . 0.0 109.689 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 6.9 t0 -131.84 56.14 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.132 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.552 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.7 OUTLIER 173.56 31.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 109.627 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.1 t30 45.71 36.88 2.93 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.889 HG12 HG23 ' A' ' 30' ' ' VAL . 2.1 tt -119.54 -7.37 11.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.959 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.93 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -74.64 -37.2 62.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 109.992 -179.099 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.02 1.01 11.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 110.027 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.944 ' HA ' HG22 ' A' ' 5' ' ' THR . 6.8 m-20 -127.18 42.14 3.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.096 -1.003 . . . . 0.0 109.838 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.971 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 9.4 m95 -150.23 157.3 42.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.899 -1.126 . . . . 0.0 110.819 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.552 HG12 ' CE1' ' A' ' 85' ' ' PHE . 96.5 t -133.06 71.9 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.578 ' CG1' HG13 ' A' ' 8' ' ' VAL . 2.7 mp -89.65 137.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.413 -0.804 . . . . 0.0 110.13 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 3.7 t70 -143.33 -177.21 5.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.449 -0.782 . . . . 0.0 109.312 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.5 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 95.6 p -119.54 163.6 17.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.164 -0.96 . . . . 0.0 109.688 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -142.15 134.43 6.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.562 ' HB1' HD21 ' A' ' 50' ' ' ASN . . . -116.42 -12.41 11.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -1.227 . . . . 0.0 109.557 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.616 ' HA ' HG12 ' A' ' 77' ' ' VAL . 1.8 t 56.24 17.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' ' CE2' ' A' ' 49' ' ' TRP . 1.1 p -151.24 169.82 20.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HA ' HG23 ' A' ' 51' ' ' VAL . 4.5 m-20 -116.8 22.19 12.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.437 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.589 ' N ' ' CD1' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -95.23 -24.97 16.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 109.24 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.562 HD21 ' HB1' ' A' ' 45' ' ' ALA . 6.5 p30 -108.88 9.62 26.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.838 . . . . 0.0 109.516 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 48' ' ' ASP . 74.3 t -65.17 90.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.76 29.08 4.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -105.32 95.13 5.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -1.158 . . . . 0.0 109.472 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -43.99 162.49 0.19 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.462 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.64 148.86 54.08 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.958 1.772 . . . . 0.0 110.134 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 5.9 t70 -50.75 139.56 21.36 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.272 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.496 ' O ' HG12 ' A' ' 60' ' ' VAL . 50.4 Cg_exo -51.93 -18.86 7.42 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.845 1.696 . . . . 0.0 110.439 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.492 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . 8.9 mtm180 -81.96 -39.25 23.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.097 -1.002 . . . . 0.0 109.675 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.792 ' O ' HD22 ' A' ' 63' ' ' LEU . . . -90.38 -1.62 57.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.94 . . . . 0.0 109.842 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.517 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 5.7 p -89.6 -39.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.05 -1.032 . . . . 0.0 109.651 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.46 ' N ' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -88.46 -8.87 54.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -89.24 -64.44 1.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.646 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.792 HD22 ' O ' ' A' ' 59' ' ' ALA . 1.6 pt? -43.34 -30.64 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.671 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.729 ' H ' HD23 ' A' ' 63' ' ' LEU . 3.5 ptp180 -93.16 41.84 1.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.852 . . . . 0.0 109.468 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -133.48 -43.95 0.83 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.382 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -83.17 -34.17 26.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.18 95.29 0.2 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.484 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 17.3 mm -146.08 -75.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -1.152 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 m120 65.53 99.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.05 166.48 20.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -155.04 54.05 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.49 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -122.71 170.61 9.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.487 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.02 154.48 37.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.554 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.99 122.7 28.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.461 ' HD2' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -129.74 172.36 11.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.417 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' SER . 1.1 tt0 -92.13 122.32 34.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.616 HG12 ' HA ' ' A' ' 46' ' ' VAL . 8.9 p -48.9 145.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.407 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 p -132.83 168.3 18.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.215 -0.928 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.582 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -51.03 -41.37 59.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 109.255 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -59.41 -38.28 80.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.56 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.08 -41.09 87.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -0.919 . . . . 0.0 109.978 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.813 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 81.1 m-85 -64.47 -62.36 1.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.797 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.528 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 3.8 p -65.76 -10.35 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.687 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.637 HG22 ' N ' ' A' ' 85' ' ' PHE . 3.4 m -87.97 -85.09 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.368 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.637 ' N ' HG22 ' A' ' 84' ' ' THR . 59.1 m-85 -56.33 109.04 0.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.526 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.404 ' C ' ' CD1' ' A' ' 87' ' ' TYR . 1.3 t0 -58.29 -20.87 46.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.611 ' CE2' ' HG2' ' A' ' 6' ' ' LYS . 6.6 m-30 -113.31 137.42 51.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.933 HG13 ' HB1' ' A' ' 111' ' ' ALA . 1.0 OUTLIER -145.45 104.24 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 108.652 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.66 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -120.74 156.65 31.37 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.906 -1.121 . . . . 0.0 109.744 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 115' ' ' LEU . 2.4 p -121.26 166.15 14.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.517 -0.739 . . . . 0.0 109.424 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.499 ' HE3' HD23 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -75.62 -62.56 1.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.719 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 93' ' ' GLU . 11.5 p-10 -178.62 -138.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.398 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 74.4 mt-10 63.12 -88.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.058 -1.026 . . . . 0.0 109.487 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -85.01 85.75 7.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 0.0 109.069 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.47 ' O ' ' C ' ' A' ' 96' ' ' LEU . 3.8 t30 -51.21 86.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.684 -0.635 . . . . 0.0 110.083 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.978 HD22 ' HB2' ' A' ' 100' ' ' ASN . 0.4 OUTLIER 37.33 40.3 0.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.729 -0.607 . . . . 0.0 110.196 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -90.51 -50.14 6.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.045 -1.035 . . . . 0.0 109.479 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.6 -45.03 12.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.496 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.635 HD11 HG11 ' A' ' 11' ' ' VAL . 13.4 mt -62.58 -34.75 77.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.575 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.978 ' HB2' HD22 ' A' ' 96' ' ' LEU . 21.8 t-20 -62.17 -31.63 72.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -89.69 -11.4 42.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 109.424 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.888 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -74.93 -27.13 60.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.33 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.639 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 0.9 OUTLIER -73.8 -20.62 60.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.892 . . . . 0.0 109.339 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.63 -49.9 42.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.256 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -70.48 -19.39 62.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 109.253 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 102' ' ' LYS . 54.6 t -67.08 125.03 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.376 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -66.47 100.55 0.67 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.333 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.87 50.35 1.99 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -53.62 150.9 6.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.263 -0.898 . . . . 0.0 109.838 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 12.0 ptt180 -138.53 7.22 2.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.339 -0.85 . . . . 0.0 109.153 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.933 ' HB1' HG13 ' A' ' 88' ' ' ILE . . . -88.03 120.38 29.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.178 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.47 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -70.51 132.68 45.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.84 ' HB ' HD11 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -109.16 133.09 55.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.777 -1.202 . . . . 0.0 110.402 -179.203 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.8 OUTLIER -178.47 139.21 0.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -84.72 167.34 16.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.594 -1.316 . . . . 0.0 109.95 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.956 HD11 ' HA ' ' A' ' 148' ' ' CYS . 3.1 mm? -40.59 -44.23 2.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.752 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 54.44 -123.4 27.94 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -131.07 122.68 27.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 109.341 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.533 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.7 m-85 -127.83 3.42 6.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 0.0 109.634 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.587 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 162.58 -51.26 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.3 Cg_exo -49.72 140.43 29.67 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.794 1.663 . . . . 0.0 110.111 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -108.14 112.89 25.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.67 149.37 2.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.356 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 52.29 2.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.364 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.97 131.71 4.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.381 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.797 HG23 ' O ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -105.3 41.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.972 . . . . 0.0 109.165 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 126' ' ' ILE . 14.7 mt 71.44 19.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.98 . . . . 0.0 109.51 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.685 ' HG3' HG22 ' A' ' 126' ' ' ILE . 30.5 mt-10 -62.18 90.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' HB3' ' NH2' ' A' ' 18' ' ' ARG . 9.8 t70 -145.32 102.39 4.36 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.195 -0.941 . . . . 0.0 109.401 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -49.26 139.86 27.18 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.868 1.712 . . . . 0.0 110.308 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER 51.91 -161.72 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.479 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 131' ' ' TYR . 8.4 p90 -94.88 30.24 2.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 132' ' ' TYR . . . 43.63 -131.97 6.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -179.71 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -1.187 . . . . 0.0 109.475 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -78.09 123.48 26.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 135' ' ' ASP . . . 44.35 29.51 0.38 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.09 35.18 3.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.877 . . . . 0.0 109.459 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.492 ' CE2' ' HB3' ' A' ' 58' ' ' ARG . 5.0 t80 -133.24 -55.56 0.91 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.12 -44.53 68.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.0 109.388 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.7 m -60.52 -36.8 79.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.37 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.87 -53.54 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.324 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 1.001 ' HA ' HG21 ' A' ' 21' ' ' ILE . 2.4 t80 -59.56 -24.27 63.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.553 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -85.02 -24.45 28.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 0.0 109.931 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -13.77 42.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.091 -1.006 . . . . 0.0 109.498 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.781 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -90.3 -7.28 53.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 109.665 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.873 ' HA ' HG11 ' A' ' 25' ' ' VAL . 73.9 t -62.04 -63.62 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.218 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.451 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 4.2 mpt_? -68.62 -22.36 64.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.107 -0.996 . . . . 0.0 109.095 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.956 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.6 m -44.4 -28.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 108.823 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.629 ' SG ' ' CD1' ' A' ' 29' ' ' LEU . 1.5 p -111.79 -33.7 6.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.49 -0.756 . . . . 0.0 109.036 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.791 ' HG3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.91 -61.18 2.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -51.94 -28.05 15.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.451 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -84.35 -31.63 24.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.311 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 157' ' ' ARG . 13.8 tp -62.81 -54.14 43.54 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.039 -1.038 . . . . 0.0 108.792 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.522 ' HA ' ' CB ' ' A' ' 157' ' ' ARG . 5.6 pt-20 -44.31 -40.23 5.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.193 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -57.66 -63.16 1.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 87' ' ' TYR . 27.8 m -93.28 33.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.335 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -97.65 106.07 18.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.415 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -141.95 142.65 33.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.72 133.04 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.875 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 1.078 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -97.16 2.66 51.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.773 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.677 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER 52.53 162.76 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.846 0.831 . . . . 0.0 110.392 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 85' ' ' PHE . 2.0 m -150.29 107.54 3.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.98 -1.075 . . . . 0.0 109.496 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.837 HG11 ' HE2' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -102.9 138.55 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -139.62 107.7 5.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.407 -0.808 . . . . 0.0 109.503 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.808 ' CE1' HD13 ' A' ' 89' ' ' LEU . 5.6 m-85 -93.79 156.79 16.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.418 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 t -148.36 155.84 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.717 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -176.84 134.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.66 HD21 ' CZ3' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -50.26 171.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.26 -0.9 . . . . 0.0 109.431 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' LEU . . . 44.06 41.05 5.98 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.686 ' O ' HG23 ' A' ' 16' ' ' ILE . 8.8 t30 -67.68 91.77 0.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.469 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -162.17 -39.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.132 -0.98 . . . . 0.0 109.723 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.51 ' SG ' HD12 ' A' ' 16' ' ' ILE . 1.8 p -150.84 81.18 1.33 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 109.73 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.789 ' HA ' HG11 ' A' ' 141' ' ' VAL . 0.0 OUTLIER 165.14 -76.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 109.188 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.762 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -67.63 -49.23 40.97 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.389 -0.819 . . . . 0.0 110.337 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 19' ' ' SER . 71.8 Cg_exo -48.06 -20.33 2.1 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.964 1.776 . . . . 0.0 111.19 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.748 HG21 ' HA ' ' A' ' 142' ' ' TYR . 9.3 mt -64.83 -48.04 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 120.94 -1.1 . . . . 0.0 109.382 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.776 ' HA ' ' SG ' ' A' ' 145' ' ' CYS . . . -57.8 -19.28 27.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 109.353 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 24' ' ' ALA . 8.9 tm-20 -76.7 -70.21 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.216 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HB1' HG23 ' A' ' 68' ' ' ILE . . . -44.22 -47.77 9.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.358 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.867 HG11 ' HA ' ' A' ' 146' ' ' VAL . 63.6 t -54.17 -49.95 58.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 109.297 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.837 ' HE2' HG11 ' A' ' 8' ' ' VAL . 1.1 t80 -50.49 -37.9 41.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.031 -1.043 . . . . 0.0 108.379 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -45.05 82.09 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.191 -0.943 . . . . 0.0 108.841 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -81.61 -8.92 59.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.83 . . . . 0.0 110.104 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.689 HD22 ' HB2' ' A' ' 150' ' ' ARG . 3.9 mt -86.43 -31.08 21.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 109.323 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.804 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -90.85 -56.65 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.504 ' N ' HG22 ' A' ' 30' ' ' VAL . 1.2 m -44.8 -32.05 1.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.106 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.32 -42.58 44.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.105 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.52 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 4.4 tp60 -72.62 -6.85 47.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.411 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 33.9 t30 76.65 48.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 109.699 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.804 ' CG1' HG23 ' A' ' 30' ' ' VAL . 3.8 pt -140.42 8.66 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 109.626 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.615 ' HA ' HG21 ' A' ' 30' ' ' VAL . 24.5 p -68.06 -41.59 81.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.488 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.98 -20.17 3.21 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.284 -0.885 . . . . 0.0 109.361 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 1.078 ' HA ' HG22 ' A' ' 5' ' ' THR . 2.2 m-20 -121.11 45.29 2.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.936 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.677 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 6.7 m95 -150.33 129.04 12.35 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.871 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.95 87.73 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.534 ' HA ' HG13 ' A' ' 8' ' ' VAL . 3.4 mt -94.27 142.32 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.343 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.573 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 t0 -164.31 178.3 7.62 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.0 p -179.74 169.85 1.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.06 -1.025 . . . . 0.0 109.739 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.12 -163.03 28.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 15' ' ' ASN . . . -107.5 171.82 7.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -1.164 . . . . 0.0 109.487 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.523 HG22 HD11 ' A' ' 99' ' ' LEU . 93.3 t -104.74 -8.08 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.555 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.04 174.36 6.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.485 ' OD1' HG21 ' A' ' 51' ' ' VAL . 29.6 t70 -110.2 30.45 6.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.51 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.66 ' CZ3' HD21 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -102.49 -49.28 3.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.444 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -90.22 38.23 0.92 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.867 . . . . 0.0 109.65 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.485 HG21 ' OD1' ' A' ' 48' ' ' ASP . 73.2 t -82.13 94.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.347 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.559 ' H ' ' HB3' ' A' ' 74' ' ' ALA . . . 105.38 -17.15 44.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.18 136.83 8.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -1.087 . . . . 0.0 109.451 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.35 159.34 50.63 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.462 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 56' ' ' ASP . 53.4 Cg_endo -71.59 -3.4 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.015 1.81 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' PRO . 72.0 m-20 61.57 140.97 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 109.443 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.814 ' O ' HG12 ' A' ' 60' ' ' VAL . 56.6 Cg_endo -73.49 -1.34 10.53 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.901 1.734 . . . . 0.0 110.395 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.433 ' O ' ' OG ' ' A' ' 61' ' ' SER . 67.6 mtt180 -72.95 -28.11 62.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.13 -0.981 . . . . 0.0 109.611 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 63' ' ' LEU . . . -88.94 -39.94 13.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.814 HG12 ' O ' ' A' ' 57' ' ' PRO . 10.8 p -44.45 -25.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.597 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 58' ' ' ARG . 0.2 OUTLIER -48.34 -89.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.295 -0.878 . . . . 0.0 109.846 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.675 ' SG ' ' OE2' ' A' ' 139' ' ' GLU . 3.7 t -73.54 -3.75 29.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.035 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.57 ' HG ' HG21 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -86.56 -74.35 0.43 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.023 -1.048 . . . . 0.0 108.953 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.448 ' CB ' HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -81.49 74.14 8.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.43 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -146.29 -53.83 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.643 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -80.72 -23.16 39.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.26 61.63 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.642 HG23 ' HB1' ' A' ' 24' ' ' ALA . 21.7 mm -113.29 156.08 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -1.174 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.42 ' N ' HG22 ' A' ' 68' ' ' ILE . 6.0 m120 -147.55 96.67 2.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.371 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 70' ' ' THR . 9.6 t -113.73 72.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.88 54.94 3.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 0.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -133.63 155.66 49.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -0.955 . . . . 0.0 109.453 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.61 170.43 8.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 0.0 109.451 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.559 ' HB3' ' H ' ' A' ' 52' ' ' GLY . . . -90.56 148.33 22.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 109.526 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' HA ' HG13 ' A' ' 51' ' ' VAL . 3.1 mmt-85 -151.75 152.26 32.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.409 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.549 ' NE2' ' O ' ' A' ' 77' ' ' VAL . 1.4 tt0 -80.57 135.44 36.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.549 ' O ' ' NE2' ' A' ' 76' ' ' GLN . 8.7 p -56.89 146.94 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.87 165.47 26.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.445 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.759 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -46.01 -36.72 5.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' ' OG1' ' A' ' 84' ' ' THR . 7.8 tt0 -59.69 -56.78 17.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 109.655 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 9.3 m-20 -50.54 -40.67 52.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -0.884 . . . . 0.0 109.808 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.941 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 43.4 m-85 -53.53 -58.13 8.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.072 -1.017 . . . . 0.0 109.335 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.544 ' HA ' ' CG ' ' A' ' 110' ' ' ARG . 0.8 OUTLIER -78.81 -2.26 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.536 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 56.0 m -78.27 -60.28 2.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.168 -0.957 . . . . 0.0 109.863 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.771 ' CD1' HD13 ' A' ' 9' ' ' LEU . 28.3 m-85 -96.46 178.36 5.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.14 -0.975 . . . . 0.0 109.863 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.481 ' OD1' ' HD3' ' A' ' 110' ' ' ARG . 1.1 t70 -118.2 -22.46 7.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.348 -0.845 . . . . 0.0 109.756 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.537 ' OH ' ' CG ' ' A' ' 6' ' ' LYS . 5.4 m-85 -112.01 67.09 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.98 -1.075 . . . . 0.0 109.623 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.933 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.1 mt -79.15 91.06 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.286 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.827 HD21 ' CE2' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -112.04 167.14 10.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.972 -1.08 . . . . 0.0 109.478 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.692 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -139.49 166.23 25.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.86 . . . . 0.0 109.06 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.692 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -66.76 133.56 50.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.388 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.82 ' CG ' HG21 ' A' ' 126' ' ' ILE . 5.7 t70 -42.94 110.06 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.68 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.5 -177.35 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.332 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.8 m -89.54 15.58 9.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -82.31 -14.74 54.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.546 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.62 HD21 ' CG2' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -86.49 5.13 36.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.098 -1.002 . . . . 0.0 109.604 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -19.25 65.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -0.96 . . . . 0.0 109.165 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.55 -43.19 4.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.872 . . . . 0.0 109.315 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.56 HD23 ' HZ ' ' A' ' 82' ' ' PHE . 13.0 mt -57.61 -34.04 68.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.304 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -69.19 -32.39 71.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.61 0.98 50.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 109.563 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -81.35 -30.21 33.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 109.442 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 p -63.76 -16.69 61.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -84.38 -31.36 24.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.338 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -12.54 43.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.392 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.759 HG13 ' HG2' ' A' ' 79' ' ' LYS . 62.8 t -77.17 147.37 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.315 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -83.58 112.21 19.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.203 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.14 37.85 27.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.311 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -43.27 160.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.748 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.6 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 0.0 OUTLIER -150.1 36.36 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.446 -0.784 . . . . 0.0 109.002 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.941 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -119.36 88.75 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -0.811 . . . . 0.0 110.025 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 111' ' ' ALA . 34.9 mtpt -46.13 121.09 3.08 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.62 ' CG2' HD21 ' A' ' 96' ' ' LEU . 1.7 mm -95.96 132.25 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.001 -1.062 . . . . 0.0 110.108 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 31.7 tp10 -159.09 165.54 33.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.462 -0.774 . . . . 0.0 109.649 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.586 ' CD2' HD12 ' A' ' 96' ' ' LEU . 22.3 mt -99.13 158.9 15.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.098 -1.001 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.944 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.5 OUTLIER -68.75 123.79 21.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 109.337 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . 140.77 -179.66 19.04 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 0.7 OUTLIER 74.52 36.91 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -1.184 . . . . 0.0 109.421 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.437 ' HB2' ' HD2' ' A' ' 121' ' ' PRO . 26.7 m-85 -125.23 -140.0 0.29 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.164 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.59 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -71.33 -51.02 10.41 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.0 109.726 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.7 Cg_exo -49.99 96.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.761 1.64 . . . . 0.0 110.275 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 25.0 mt-30 -80.91 -152.67 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.43 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 124' ' ' GLN . 0.3 OUTLIER 65.78 116.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.491 ' O ' ' CB ' ' A' ' 125' ' ' LEU . 2.0 tt0 -60.28 -150.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.159 -0.963 . . . . 0.0 109.431 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.503 ' HA ' HD22 ' A' ' 125' ' ' LEU . 0.2 OUTLIER 73.55 70.23 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.459 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.944 HD11 ' O ' ' A' ' 116' ' ' LEU . 3.7 tt -87.57 177.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.18 -0.95 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.48 HG21 HH12 ' A' ' 18' ' ' ARG . 16.0 mt -82.61 98.54 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 0.0 109.445 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.482 ' HG3' ' OD1' ' A' ' 92' ' ' ASP . 8.9 mt-10 -130.96 55.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.9 OUTLIER -103.06 164.52 15.35 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.462 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 129' ' ' ASP . 54.9 Cg_endo -72.1 -164.37 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.028 1.819 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -70.93 -25.56 62.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.331 -0.856 . . . . 0.0 109.479 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.05 -81.15 0.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.532 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 114.31 -145.39 18.53 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -71.32 -83.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -1.135 . . . . 0.0 109.541 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.78 -71.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.94 46.26 1.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 109.566 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.43 ' OD2' ' HB ' ' A' ' 140' ' ' THR . 4.5 t70 -119.05 57.73 0.87 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.469 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -98.63 -25.34 14.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.675 ' OE2' ' SG ' ' A' ' 62' ' ' CYS . 4.2 tp10 -72.72 -31.28 64.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.325 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 96.1 m -65.45 -19.42 65.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 109.494 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.789 HG11 ' HA ' ' A' ' 18' ' ' ARG . 73.1 t -70.37 -70.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 0.0 109.228 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.748 ' HA ' HG21 ' A' ' 21' ' ' ILE . 3.2 t80 -48.19 -48.69 34.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.389 -0.82 . . . . 0.0 109.34 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -65.93 0.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.321 -0.862 . . . . 0.0 109.836 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 140' ' ' THR . 3.2 mm-40 -53.93 -19.26 4.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.776 ' SG ' ' HA ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -69.95 -41.94 73.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.845 . . . . 0.0 109.389 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.867 ' HA ' HG11 ' A' ' 25' ' ' VAL . 15.2 t -52.87 -60.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.314 -0.866 . . . . 0.0 109.929 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -8.99 53.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.928 ' SG ' HD22 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -69.63 -11.59 60.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.345 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.632 ' SG ' ' CD1' ' A' ' 29' ' ' LEU . 30.2 p -126.26 -41.64 1.89 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.233 -0.917 . . . . 0.0 109.21 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.689 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -58.25 -49.87 75.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.002 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.96 -21.54 64.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.458 -0.776 . . . . 0.0 109.236 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.827 ' CE2' HD21 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -90.01 -19.01 24.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.408 -0.808 . . . . 0.0 109.642 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.655 HD13 ' HZ ' ' A' ' 26' ' ' PHE . 9.0 tp -83.07 -26.04 31.48 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.03 -1.044 . . . . 0.0 108.748 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 1.0 OUTLIER -69.94 -29.3 66.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 108.997 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.49 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 2.2 tptt -80.32 -54.72 5.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 108.807 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 152' ' ' PHE . 16.5 m -98.33 45.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 108.891 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.405 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.533 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.295 0.569 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -157.86 53.77 0.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.387 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -142.8 108.76 5.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.453 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.74 147.85 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.549 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.879 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -126.16 83.44 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.485 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.68 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -41.47 163.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.748 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.593 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 62.4 p -136.62 116.47 13.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.024 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.779 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -119.41 142.94 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 109.115 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.595 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -140.38 105.43 4.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 0.0 109.424 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -83.27 158.34 22.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.446 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 90' ' ' CYS . 1.9 t -145.63 142.2 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.441 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -162.15 131.89 4.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 13' ' ' LEU . 12.9 tp -43.34 -56.19 3.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.658 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . -87.35 85.06 1.53 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 13.4 t-20 -89.19 2.77 53.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -1.128 . . . . 0.0 109.548 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.727 HD12 ' C ' ' A' ' 16' ' ' ILE . 2.5 pp -146.86 12.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 109.733 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.44 ' N ' HD12 ' A' ' 16' ' ' ILE . 11.2 t -150.28 -54.89 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.044 -1.035 . . . . 0.0 109.561 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.481 ' HB2' ' HA3' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -43.3 -80.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.429 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.692 ' HB2' HG11 ' A' ' 141' ' ' VAL . 0.3 OUTLIER 167.16 66.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.491 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.18 63.4 8.71 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.175 1.917 . . . . 0.0 110.594 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 25' ' ' VAL . 3.8 mp -90.56 -17.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.013 -1.054 . . . . 0.0 109.732 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.594 ' O ' ' SG ' ' A' ' 149' ' ' CYS . . . -65.27 -32.32 73.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 43' ' ' SER . 1.5 tt0 -77.22 -68.59 0.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.375 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.737 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -43.53 -40.54 3.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.193 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.037 HG11 ' HA ' ' A' ' 146' ' ' VAL . 50.0 t -61.29 -53.37 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.38 -0.825 . . . . 0.0 109.158 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.555 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -46.52 -39.68 11.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.106 -0.997 . . . . 0.0 108.453 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.456 ' O ' ' OG1' ' A' ' 31' ' ' THR . 11.0 tpt85 -54.9 -60.18 3.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.165 -0.959 . . . . 0.0 108.97 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -10.18 35.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.893 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.831 HD12 HG12 ' A' ' 25' ' ' VAL . 2.7 mt -83.02 -76.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.064 -1.023 . . . . 0.0 108.971 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.893 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -43.45 -46.1 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -60.25 -42.46 95.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.115 . . . . 0.0 109.433 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -69.38 -16.6 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.131 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 1.9 tp60 -98.2 -9.38 25.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.401 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 2.7 t-20 77.18 48.58 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 109.391 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.893 ' CG1' HG23 ' A' ' 30' ' ' VAL . 2.9 pt -140.82 9.63 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.349 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.622 ' HA ' HG21 ' A' ' 30' ' ' VAL . 6.2 p -69.93 -35.0 74.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.062 -1.024 . . . . 0.0 109.546 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -58.35 -20.35 42.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.646 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.879 ' HA ' HG22 ' A' ' 5' ' ' THR . 11.8 m-20 -124.36 42.98 3.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.695 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.779 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 10.2 m95 -150.04 133.64 16.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.046 -1.034 . . . . 0.0 109.994 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 t -117.85 85.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.841 . . . . 0.0 108.992 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.646 HD11 HG11 ' A' ' 30' ' ' VAL . 2.2 mp -90.24 139.24 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 5.3 m-20 -150.53 146.58 26.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.427 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 74.5 p -116.5 156.76 26.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.53 164.8 32.23 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.16 128.06 51.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -1.147 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.702 HG22 HD11 ' A' ' 99' ' ' LEU . 86.2 t -47.47 -34.45 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.64 -177.15 3.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.937 . . . . 0.0 109.623 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.506 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 8.0 p-10 -102.43 24.59 10.13 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.299 -0.876 . . . . 0.0 109.457 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.465 ' N ' ' CD1' ' A' ' 49' ' ' TRP . 38.9 m0 -65.54 -43.09 91.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.5 ' HB3' HG12 ' A' ' 16' ' ' ILE . 2.2 m-80 -119.91 61.49 0.84 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.148 -0.97 . . . . 0.0 109.753 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 91.1 t -84.7 102.58 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.236 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.61 10.2 63.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.445 ' HB3' HG21 ' A' ' 16' ' ' ILE . 15.4 mtt85 -82.09 126.25 31.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -1.149 . . . . 0.0 109.449 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -72.22 150.44 92.1 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.515 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.546 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 53.8 Cg_exo -50.1 137.12 37.51 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.928 1.752 . . . . 0.0 110.31 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 60' ' ' VAL . 32.9 p-10 -75.11 127.66 86.23 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.177 -0.952 . . . . 0.0 109.246 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.854 ' HA ' HG23 ' A' ' 60' ' ' VAL . 72.1 Cg_exo -43.85 -23.21 0.57 Allowed 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 122.107 1.871 . . . . 0.0 110.618 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -60.27 -53.46 57.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.874 -1.141 . . . . 0.0 108.392 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 61' ' ' SER . . . -76.73 -64.1 1.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.854 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.25 -28.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.583 -0.698 . . . . 0.0 109.387 179.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 57' ' ' PRO . 1.7 t -52.7 -53.52 46.45 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.444 -0.785 . . . . 0.0 110.487 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.456 ' C ' HD23 ' A' ' 63' ' ' LEU . 35.0 t -70.29 -17.92 63.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.123 -0.985 . . . . 0.0 110.541 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.763 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -90.14 -75.34 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.96 -1.087 . . . . 0.0 109.418 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' LEU . 3.6 ttt85 -43.62 -26.53 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 109.624 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -46.23 -66.26 0.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.887 . . . . 0.0 109.406 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -76.33 -36.82 58.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.03 74.4 0.1 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.757 HD11 ' HA ' ' A' ' 25' ' ' VAL . 6.4 tp -86.53 -12.08 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.214 -1.168 . . . . 0.0 109.237 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 68' ' ' ILE . 2.7 p-10 40.98 44.88 2.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.518 -0.739 . . . . 0.0 109.811 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.655 HG23 ' H ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -57.02 -76.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 109.515 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.655 ' H ' HG23 ' A' ' 70' ' ' THR . . . 55.49 76.23 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.114 -0.991 . . . . 0.0 109.414 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.557 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.6 p-80 -150.36 157.15 42.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.553 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.27 134.21 54.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 109.406 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HB2' ' OD1' ' A' ' 15' ' ' ASN . . . -75.4 163.99 26.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.5 ' HD2' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -178.56 128.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.327 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.456 ' H ' HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -50.98 142.74 11.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.877 . . . . 0.0 109.59 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.525 HG12 ' CE2' ' A' ' 82' ' ' PHE . 30.0 t -58.57 162.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.511 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.466 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -160.5 161.5 32.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 109.547 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -48.77 -32.27 8.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.313 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 84' ' ' THR . 0.9 OUTLIER -64.8 -49.46 70.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.796 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -66.61 -26.79 67.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 110.184 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.932 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 42.4 m-85 -68.37 -68.45 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 109.727 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 110' ' ' ARG . 9.2 p -64.21 -22.02 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 85' ' ' PHE . 2.5 m -65.42 -71.93 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.126 -0.984 . . . . 0.0 109.527 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.595 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 84.5 m-85 -73.36 163.8 27.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.415 ' OD1' ' HG3' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -112.55 -17.55 12.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -0.843 . . . . 0.0 109.461 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.2 m-85 -119.75 81.32 1.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 109.202 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.883 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 1.4 mt -90.59 112.82 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 0.0 109.074 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -133.34 169.22 17.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.998 -1.064 . . . . 0.0 109.286 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.64 ' SG ' HD12 ' A' ' 99' ' ' LEU . 21.3 m -127.8 177.27 6.94 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.341 -0.849 . . . . 0.0 109.165 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.675 ' HE2' ' HA ' ' A' ' 91' ' ' MET . 16.6 mmt -85.36 47.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.894 ' OD1' HD23 ' A' ' 116' ' ' LEU . 4.2 m-20 54.38 87.86 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 109.465 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.37 158.24 43.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 109.375 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.0 p -71.89 -15.68 62.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.908 . . . . 0.0 109.459 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -72.24 -10.82 60.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.52 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.914 HD23 ' HB2' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -68.14 -31.23 70.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -19.59 4.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.439 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -93.81 -31.33 14.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.482 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.914 ' HB2' HD23 ' A' ' 96' ' ' LEU . 15.8 mt -66.6 -34.19 77.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.574 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -64.54 -24.55 67.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -91.88 -10.34 39.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 109.418 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.941 ' O ' HG23 ' A' ' 106' ' ' VAL . 2.4 mmmm -70.89 -32.99 70.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.892 . . . . 0.0 109.345 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.776 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 14.6 p -62.15 -28.05 69.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -46.68 75.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.355 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -85.02 0.74 50.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.606 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 102' ' ' LYS . 40.4 t -87.73 121.9 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.314 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 106' ' ' VAL . 9.0 tptt -45.03 99.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 106' ' ' VAL . 85.8 m-20 48.11 58.75 4.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 109.526 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.776 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -53.78 147.24 12.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 109.793 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.556 ' HB3' HG23 ' A' ' 83' ' ' VAL . 8.6 ptt180 -131.29 2.12 4.21 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.932 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -86.6 118.56 26.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 110.151 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' ILE . 5.5 mtpm? -69.49 106.05 2.85 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.803 HG21 ' HB3' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -83.23 137.24 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.994 -1.066 . . . . 0.0 110.084 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.909 ' O ' HD11 ' A' ' 96' ' ' LEU . 1.2 tt0 -176.27 -170.47 0.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.49 -0.756 . . . . 0.0 109.057 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.717 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -122.65 118.06 27.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 109.496 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.905 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER 59.15 -87.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.839 . . . . 0.0 109.504 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 119' ' ' TYR . . . 166.04 -175.28 41.62 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.9 p -109.65 64.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -1.174 . . . . 0.0 109.487 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.441 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.9 m-85 -120.16 -140.86 0.34 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.176 -0.952 . . . . 0.0 109.143 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 0.2 OUTLIER 169.03 63.07 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.071 -1.018 . . . . 0.0 109.43 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.411 ' HG3' ' HB2' ' A' ' 151' ' ' ALA . 55.2 Cg_endo -71.6 -4.98 16.09 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.048 1.832 . . . . 0.0 110.243 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -161.37 -149.75 0.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.4 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 150.35 49.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -76.6 123.59 26.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -166.61 138.1 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.497 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.575 HG23 ' HB3' ' A' ' 92' ' ' ASP . 10.2 mm -95.35 150.47 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.362 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 3.0 mp -106.23 81.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.507 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.469 ' HG3' HG22 ' A' ' 126' ' ' ILE . 66.2 mt-10 -121.71 81.85 1.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.431 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.4 p30 -158.58 85.35 2.46 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.559 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 132' ' ' TYR . 50.7 Cg_endo -71.08 171.75 15.28 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.959 1.773 . . . . 0.0 110.283 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -43.58 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -134.21 -47.11 0.77 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.362 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 114.8 84.87 1.25 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.63 -66.61 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -1.142 . . . . 0.0 109.487 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -179.9 89.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.475 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 50.84 34.74 10.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 109.455 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.94 79.05 9.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.1 -61.25 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.39 -45.95 88.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 m -47.23 -33.03 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.42 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 19' ' ' SER . 44.7 t -67.62 -45.86 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.422 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 142' ' ' TYR . 8.7 t80 -57.7 -46.68 84.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -58.54 -56.43 22.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.962 . . . . 0.0 109.344 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.755 ' O ' ' SG ' ' A' ' 148' ' ' CYS . 15.7 mt-30 -64.85 -13.05 54.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 109.417 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.571 ' HA ' ' SG ' ' A' ' 148' ' ' CYS . 3.5 m -83.85 -27.02 29.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.315 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 1.037 ' HA ' HG11 ' A' ' 25' ' ' VAL . 87.6 t -55.14 -53.92 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.279 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.408 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -81.41 -15.86 53.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.238 -0.914 . . . . 0.0 109.334 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.905 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.3 m -50.17 -23.44 2.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 0.0 108.713 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.594 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -122.01 -42.48 2.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.238 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.484 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . 55.2 ttt-85 -59.19 -49.55 77.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.041 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.411 ' HB2' ' HG3' ' A' ' 121' ' ' PRO . . . -59.24 -19.8 48.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.827 . . . . 0.0 109.07 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.682 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 1.7 t80 -89.44 -25.42 21.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -0.831 . . . . 0.0 109.372 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.728 HD21 HD13 ' A' ' 35' ' ' ILE . 10.1 tp -77.79 -26.72 49.89 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.037 -1.039 . . . . 0.0 108.911 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 2.5 pt-20 -67.8 -30.39 69.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -0.968 . . . . 0.0 109.105 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.506 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -79.93 -51.34 9.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.89 . . . . 0.0 109.043 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.682 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 15.4 m -99.2 42.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 108.995 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.459 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.452 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -81.36 -169.14 2.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.912 . . . . 0.0 109.409 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.96 87.75 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 12.2 p -71.75 157.09 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.607 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.957 HG22 ' HA ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -149.67 75.94 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 109.223 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.663 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 22.3 mttp -51.46 -178.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 0.0 109.695 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.499 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 48.8 m -147.17 116.76 7.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.4 -0.813 . . . . 0.0 109.158 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.695 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -124.03 150.99 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 109.075 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.697 HD22 HG12 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -149.16 108.65 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.156 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.51 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 1.9 m-85 -81.52 157.38 24.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.895 HG11 HD11 ' A' ' 99' ' ' LEU . 59.5 t -138.8 149.87 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.883 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -169.04 133.4 1.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.415 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.619 HD11 ' CH2' ' A' ' 49' ' ' TRP . 13.4 tp -44.74 -61.76 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.87 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 15' ' ' ASN . . . -49.58 -88.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.865 ' O ' HG23 ' A' ' 16' ' ' ILE . 2.4 t-20 76.69 17.82 1.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -1.102 . . . . 0.0 109.6 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.865 HG23 ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER -169.1 -71.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 4.8 p -76.72 -26.84 55.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.449 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 19' ' ' SER . 25.8 ttm180 -62.18 -13.13 24.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.249 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 18' ' ' ARG . 7.3 m 68.48 60.72 0.68 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.293 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 19' ' ' SER . 40.9 Cg_endo -69.35 81.33 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.965 1.777 . . . . 0.0 110.458 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.992 ' O ' HG23 ' A' ' 25' ' ' VAL . 6.8 mm -83.44 -15.61 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.87 . . . . 0.0 109.34 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.769 ' HB1' ' HB3' ' A' ' 148' ' ' CYS . . . -63.99 -51.65 63.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.132 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -60.34 -58.71 7.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 108.933 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.871 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -44.57 -38.0 3.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -0.849 . . . . 0.0 108.884 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 21' ' ' ILE . 70.4 t -60.32 -56.51 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.247 -0.908 . . . . 0.0 108.831 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.636 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 0.4 OUTLIER -43.58 -32.19 0.89 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -62.82 -52.88 61.44 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 108.853 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' HG3' HD13 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -63.29 -58.28 7.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.21 -0.931 . . . . 0.0 109.663 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.636 HD12 ' SG ' ' A' ' 149' ' ' CYS . 29.9 mt -43.47 -66.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 109.761 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.967 HG22 ' HA ' ' A' ' 36' ' ' SER . 3.0 p -58.8 -24.78 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 109.995 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 31' ' ' THR . 14.4 m -99.8 30.7 3.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.553 -1.342 . . . . 0.0 109.262 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -149.69 46.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.62 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -179.24 32.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -0.812 . . . . 0.0 109.041 -179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 33' ' ' GLN . 9.8 m120 46.7 42.08 11.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.826 HG12 HG23 ' A' ' 30' ' ' VAL . 1.7 tt -130.64 -5.38 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.247 0.546 . . . . 0.0 109.779 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.967 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -74.26 -33.27 63.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.937 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -76.08 1.79 14.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.64 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.957 ' HA ' HG22 ' A' ' 5' ' ' THR . 23.7 m-20 -128.8 37.91 4.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 109.785 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.695 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 18.2 m95 -150.62 139.89 21.28 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.853 -1.154 . . . . 0.0 110.899 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG12 ' CE2' ' A' ' 85' ' ' PHE . 44.1 t -112.04 73.62 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.495 ' CG1' HG13 ' A' ' 8' ' ' VAL . 2.9 mt -89.91 140.42 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -0.819 . . . . 0.0 109.862 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.718 ' OD1' ' CE1' ' A' ' 72' ' ' HIS . 14.7 t0 -149.06 -168.27 3.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.477 -0.764 . . . . 0.0 109.175 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.473 ' OG ' ' ND2' ' A' ' 15' ' ' ASN . 29.6 t -134.48 169.96 16.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 109.691 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.78 153.85 25.55 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.13 -18.43 6.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -1.142 . . . . 0.0 109.714 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 46' ' ' VAL . 58.1 t 56.98 17.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.381 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.578 ' HB3' ' CZ2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -145.26 144.71 30.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.299 -0.875 . . . . 0.0 109.413 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.487 ' HA ' HG23 ' A' ' 51' ' ' VAL . 5.0 m-20 -91.65 32.63 1.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.619 ' CH2' HD11 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -97.19 -33.95 11.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 109.331 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 11.8 m-20 -125.43 46.78 2.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.639 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.843 HG13 ' HA ' ' A' ' 75' ' ' ARG . 89.8 t -71.95 85.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.353 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.47 ' HA2' ' CG ' ' A' ' 73' ' ' LYS . . . 115.96 -6.44 19.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.523 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 2.5 mtt85 -76.55 96.25 4.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -1.113 . . . . 0.0 109.599 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.804 ' O ' HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -50.91 -179.36 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.123 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 61.5 Cg_exo -49.59 133.8 32.45 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.833 1.689 . . . . 0.0 110.239 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.579 ' OD1' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -43.76 145.3 1.22 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.465 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' VAL . 53.9 Cg_exo -50.09 -21.1 6.08 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.941 1.76 . . . . 0.0 110.386 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.2 mtt-85 -83.04 -50.41 8.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.758 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 1.04 ' O ' HD12 ' A' ' 63' ' ' LEU . . . -90.25 11.98 19.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 110.077 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.598 HG13 ' N ' ' A' ' 61' ' ' SER . 7.3 p -90.01 -49.14 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.042 -1.036 . . . . 0.0 109.607 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.598 ' N ' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -91.53 -29.84 16.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.132 -0.98 . . . . 0.0 109.682 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.9 m -90.17 20.38 4.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.04 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -64.68 102.47 0.58 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.772 -1.205 . . . . 0.0 108.412 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.596 ' HG3' ' CE1' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 59.36 15.56 4.46 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.741 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 64' ' ' ARG . 3.0 p-10 35.29 100.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.008 0.908 . . . . 0.0 111.086 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 21.4 m80 57.91 24.44 10.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 0.0 109.902 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.518 ' HA3' ' NE ' ' A' ' 64' ' ' ARG . . . -128.09 -4.66 5.46 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.932 HG21 ' CD2' ' A' ' 63' ' ' LEU . 25.2 mm -148.0 156.94 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -1.19 . . . . 0.0 109.698 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' HG22 ' A' ' 68' ' ' ILE . 3.8 m120 -141.51 83.52 1.87 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.244 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.59 HG21 HD13 ' A' ' 63' ' ' LEU . 26.1 p -70.3 159.88 33.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.62 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -169.1 28.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.247 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.718 ' CE1' ' OD1' ' A' ' 42' ' ' ASP . 62.4 t-80 -124.27 157.75 34.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.36 -0.838 . . . . 0.0 109.254 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.47 ' CG ' ' HA2' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -89.71 -147.24 0.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 109.532 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 75' ' ' ARG . . . -137.75 -81.78 0.34 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.544 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.843 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 75.08 113.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.953 . . . . 0.0 109.392 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.647 ' H ' HG22 ' A' ' 51' ' ' VAL . 2.3 tt0 -43.68 143.05 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.428 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.606 HG23 ' H ' ' A' ' 46' ' ' VAL . 5.0 t -57.68 164.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -169.19 165.9 10.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.353 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.595 ' CG ' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -43.61 -31.88 0.85 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' OG1' ' A' ' 84' ' ' THR . 36.4 tt0 -59.41 -57.22 13.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.293 -0.88 . . . . 0.0 109.616 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.516 ' HB3' HD13 ' A' ' 9' ' ' LEU . 6.6 m-20 -66.11 -17.71 64.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.87 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.764 ' CD2' HG21 ' A' ' 106' ' ' VAL . 10.5 m-85 -70.47 -74.78 0.13 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.047 -1.033 . . . . 0.0 109.308 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 7.4 p -61.49 -24.2 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.458 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 5.8 m -64.45 -73.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.97 . . . . 0.0 109.448 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.622 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 57.1 m-85 -75.98 154.83 35.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.681 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 63.3 m-20 -108.71 -16.62 14.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.421 -0.799 . . . . 0.0 109.485 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.563 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 22.9 m-85 -118.25 67.74 0.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.64 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.917 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.1 mt -79.61 93.91 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.316 -0.865 . . . . 0.0 109.077 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -106.04 178.88 4.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 109.502 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.691 ' SG ' ' HB ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -132.88 176.82 8.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.346 -0.846 . . . . 0.0 109.41 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.688 ' O ' HG23 ' A' ' 127' ' ' ILE . 1.5 mmt -85.35 45.08 1.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.915 . . . . 0.0 109.594 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.693 ' HB3' HG23 ' A' ' 126' ' ' ILE . 0.7 OUTLIER 54.71 106.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.602 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -177.24 155.2 1.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.492 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -7.95 36.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -66.61 -16.05 63.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.449 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.564 HD21 HG22 ' A' ' 113' ' ' ILE . 0.3 OUTLIER -64.51 -22.31 66.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 109.537 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -55.55 -24.22 31.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.13 -43.35 11.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.364 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.895 HD11 HG11 ' A' ' 11' ' ' VAL . 9.2 mt -67.92 -13.23 61.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.65 -32.39 23.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.39 16.28 18.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.961 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -104.0 -19.37 14.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.56 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 96.5 p -71.06 -45.96 62.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.524 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.476 ' OD1' ' HG2' ' A' ' 105' ' ' GLN . 19.1 p-10 -62.18 -29.38 70.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.476 ' HG2' ' OD1' ' A' ' 104' ' ' ASN . 5.9 mm100 -87.72 -15.24 37.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.949 . . . . 0.0 109.379 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 102' ' ' LYS . 25.6 t -71.36 150.18 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.261 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 108' ' ' ASN . 3.2 tptt -71.92 87.16 1.01 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.271 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 107' ' ' LYS . 50.3 t30 68.28 45.42 1.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 109.485 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -56.76 149.69 17.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 0.0 109.817 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 1.9 ptm180 -138.75 9.73 2.63 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.917 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -86.34 91.79 8.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.432 -0.792 . . . . 0.0 110.404 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -47.95 122.31 4.96 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 111' ' ' ALA . 1.3 mm -95.54 140.6 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.817 -1.177 . . . . 0.0 110.281 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 1.2 tt0 -168.61 -177.74 3.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -125.31 156.73 38.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.065 -1.022 . . . . 0.0 109.634 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.684 ' CD2' ' SG ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER -43.69 -26.64 0.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . -63.2 89.26 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER 170.38 -35.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -1.117 . . . . 0.0 109.461 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.447 ' CD2' ' HA ' ' A' ' 152' ' ' PHE . 22.9 m-85 -105.91 76.04 1.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 109.433 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 123' ' ' LYS . 2.1 m-20 -143.18 84.12 10.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.897 . . . . 0.0 109.622 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.18 -36.13 45.13 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.996 1.797 . . . . 0.0 110.237 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 122' ' ' GLN . 8.5 pt20 -155.44 68.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.429 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB3' ' OD1' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -169.97 128.86 0.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.305 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.93 95.62 3.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.326 -0.859 . . . . 0.0 109.466 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.14 -43.3 0.56 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.568 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.716 HG22 ' HG3' ' A' ' 128' ' ' GLU . 28.1 mm 57.51 102.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 109.461 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 91' ' ' MET . 4.6 tt -77.05 96.57 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.517 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.716 ' HG3' HG22 ' A' ' 126' ' ' ILE . 21.4 mt-10 -119.17 39.04 3.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 109.425 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -72.93 146.94 88.19 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 109.478 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -72.14 -175.38 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.957 1.771 . . . . 0.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.535 ' CD1' ' O ' ' A' ' 131' ' ' TYR . 40.6 t80 -68.7 -13.23 62.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.398 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -92.15 -28.93 16.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.85 176.59 43.65 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -79.96 -56.46 4.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.42 -71.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.872 . . . . 0.0 109.487 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.56 42.59 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.873 . . . . 0.0 109.494 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -82.9 74.89 9.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.577 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.735 ' O ' HG12 ' A' ' 141' ' ' VAL . 3.9 t80 -130.54 -39.25 1.29 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 0.0 109.477 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -80.65 -47.32 14.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.21 -0.932 . . . . 0.0 109.383 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.3 m -64.84 -40.39 95.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.386 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.761 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 8.7 p -52.33 -27.22 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.596 ' CE1' ' HG3' ' A' ' 64' ' ' ARG . 3.1 t80 -83.52 -47.89 10.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.356 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -49.81 -53.63 24.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.74 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HG3' ' N ' ' A' ' 145' ' ' CYS . 0.9 OUTLIER -73.94 -23.27 59.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.812 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.761 ' SG ' ' O ' ' A' ' 141' ' ' VAL . 1.8 m -68.07 -20.35 64.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.572 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.68 ' HA ' HG11 ' A' ' 25' ' ' VAL . 55.5 t -64.38 -70.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.953 . . . . 0.0 109.354 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.722 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 2.1 mtt-85 -63.5 -16.71 61.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.948 . . . . 0.0 109.354 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.769 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -46.3 -31.07 2.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 0.0 109.094 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.771 ' SG ' HG12 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -116.85 -30.99 5.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -0.873 . . . . 0.0 109.144 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.523 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 67.8 ttt-85 -71.68 -56.25 6.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 108.964 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.722 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -50.83 -32.14 19.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.427 -0.796 . . . . 0.0 109.234 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.891 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 1.1 t80 -79.12 -33.21 44.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.419 -0.801 . . . . 0.0 109.384 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.7 tp -67.22 -18.29 65.17 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.148 -0.97 . . . . 0.0 108.755 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 49.2 mm-40 -68.67 -63.6 1.03 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 108.832 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -53.13 -47.59 68.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 108.826 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.891 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 18.5 m -98.12 51.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 108.838 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.358 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.583 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 29.0 mt-10 60.09 92.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.71 119.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 6' ' ' LYS . 1.8 t -120.45 26.6 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.404 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.938 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -47.71 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 109.6 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.691 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -47.14 175.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.225 -0.922 . . . . 0.0 109.584 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.581 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 1.4 m -149.62 105.88 3.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.235 -0.916 . . . . 0.0 109.43 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.983 HG11 ' CE2' ' A' ' 26' ' ' PHE . 2.0 p -111.5 138.92 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.248 -0.908 . . . . 0.0 110.202 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.668 HD22 ' CD1' ' A' ' 88' ' ' ILE . 0.5 OUTLIER -133.76 129.37 36.54 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.56 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 1.3 m-85 -110.41 155.57 22.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 110.036 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.758 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 40.0 t -144.29 145.67 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.781 ' SG ' ' HG2' ' A' ' 91' ' ' MET . 2.9 m -163.74 48.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.097 -1.002 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.672 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.7 OUTLIER 42.47 -95.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.427 -0.795 . . . . 0.0 109.577 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -60.37 89.09 0.03 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.423 HD21 ' HA ' ' A' ' 74' ' ' ALA . 33.4 t30 -90.28 26.97 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -1.114 . . . . 0.0 109.457 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 53' ' ' ARG . 1.2 pp -122.63 -8.34 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.39 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -161.09 151.32 17.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.455 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.611 ' HD3' HD11 ' A' ' 127' ' ' ILE . 0.0 OUTLIER 51.96 63.17 2.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 162.44 -51.1 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.86 . . . . 0.0 109.823 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 19' ' ' SER . 66.1 Cg_exo -48.61 -21.94 3.9 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.909 1.739 . . . . 0.0 110.529 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.962 HG21 ' HA ' ' A' ' 142' ' ' TYR . 3.6 mm -66.59 -49.15 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.061 -1.025 . . . . 0.0 109.21 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.568 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -62.14 -18.29 60.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.137 -0.977 . . . . 0.0 109.272 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ALA . 18.3 tt0 -81.07 -82.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 109.41 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -44.23 -33.2 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.993 . . . . 0.0 109.357 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.839 HG11 ' HA ' ' A' ' 146' ' ' VAL . 44.3 t -65.72 -49.72 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.858 . . . . 0.0 109.426 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.983 ' CE2' HG11 ' A' ' 8' ' ' VAL . 1.1 t80 -53.43 -39.96 64.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.946 -1.096 . . . . 0.0 108.346 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -51.53 -67.16 0.27 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.282 -0.887 . . . . 0.0 108.961 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HA ' ' OG1' ' A' ' 31' ' ' THR . 28.9 tttt -73.15 -0.32 13.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 110.009 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.953 HD21 ' HB2' ' A' ' 150' ' ' ARG . 46.3 tp -85.32 -33.33 22.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 109.011 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.884 HG12 ' CE1' ' A' ' 26' ' ' PHE . 2.0 m -90.34 -31.05 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.977 HG23 ' CB ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -66.19 -33.04 74.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.662 -0.649 . . . . 0.0 109.348 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -66.84 -19.91 65.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 108.99 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.516 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 6.6 mm-40 -100.53 -3.01 31.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.434 -0.791 . . . . 0.0 109.531 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.9 OUTLIER 76.74 45.78 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.701 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.738 ' CD1' HD21 ' A' ' 153' ' ' LEU . 4.1 pt -137.41 3.24 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 0.0 109.942 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.977 ' CB ' HG23 ' A' ' 31' ' ' THR . 4.3 p -72.04 -30.77 65.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.928 -1.108 . . . . 0.0 109.48 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -60.62 -13.99 17.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.855 . . . . 0.0 109.277 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.938 ' HA ' HG22 ' A' ' 5' ' ' THR . 6.2 m-20 -129.01 48.15 2.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.691 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 5.7 m95 -150.11 143.43 25.08 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.888 -1.133 . . . . 0.0 110.666 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 t -117.54 81.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.67 HD11 HG11 ' A' ' 30' ' ' VAL . 3.5 mt -89.91 137.79 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.724 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -164.89 117.38 1.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.428 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 1.3 p -82.76 -171.62 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.965 . . . . 0.0 109.377 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.521 ' HA3' ' CG2' ' A' ' 77' ' ' VAL . . . -178.87 166.5 36.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.811 ' HB1' ' ND2' ' A' ' 50' ' ' ASN . . . -97.21 -167.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -1.106 . . . . 0.0 109.289 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.672 HG23 ' H ' ' A' ' 13' ' ' LEU . 38.5 t -121.2 -12.75 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.113 -0.992 . . . . 0.0 109.346 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -125.8 -153.66 0.58 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.526 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.687 ' HA ' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -119.85 -21.93 7.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 109.438 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.503 ' HZ2' HD21 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -54.9 -18.35 4.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.564 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.811 ' ND2' ' HB1' ' A' ' 45' ' ' ALA . 13.0 p30 -115.26 42.11 2.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.896 HG13 ' HD3' ' A' ' 75' ' ' ARG . 70.4 t -101.72 114.79 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.0 -6.99 83.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 16' ' ' ILE . 6.6 mtt180 -72.43 103.32 3.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -1.135 . . . . 0.0 109.507 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.1 p -59.82 154.64 46.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.537 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.04 158.77 3.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.974 1.783 . . . . 0.0 110.323 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -74.26 157.83 86.15 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.513 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 53.4 Cg_endo -71.87 -3.14 12.62 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.949 1.766 . . . . 0.0 110.256 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -89.49 -47.63 7.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB1' HD11 ' A' ' 21' ' ' ILE . . . -84.61 -16.77 40.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.454 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.513 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 9.8 p -65.09 -32.8 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.522 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.41 -10.17 54.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.4 m -80.82 -21.93 40.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -90.21 -66.66 0.9 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.027 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.9 ttm180 -47.33 -24.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.39 -0.819 . . . . 0.0 109.539 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -71.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -66.93 -8.79 32.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 109.644 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.8 69.3 0.81 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.597 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 10.3 mm -109.42 160.8 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -1.104 . . . . 0.0 109.458 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.498 ' N ' HG22 ' A' ' 68' ' ' ILE . 3.4 m120 -129.51 102.44 6.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.395 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -116.24 147.22 41.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.59 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -150.58 36.73 0.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.206 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -119.03 125.4 49.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.341 -0.85 . . . . 0.0 109.541 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -93.21 38.05 1.04 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.412 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 73' ' ' LYS . . . 65.94 169.54 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.898 . . . . 0.0 109.5 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.896 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 168.06 152.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -82.35 129.85 34.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.521 ' CG2' ' HA3' ' A' ' 44' ' ' GLY . 42.8 t -71.0 103.15 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 65.9 p -72.12 -164.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 109.095 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.878 ' HB2' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -86.29 -23.87 26.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.042 -1.036 . . . . 0.0 109.257 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 84' ' ' THR . 20.1 tt0 -65.46 -33.08 75.11 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.407 -0.808 . . . . 0.0 108.845 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -68.16 -17.86 64.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.39 -0.818 . . . . 0.0 108.975 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.827 ' CA ' ' HB2' ' A' ' 111' ' ' ALA . 32.1 m-85 -82.49 -65.24 1.03 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.364 -0.835 . . . . 0.0 109.208 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 110' ' ' ARG . 9.5 p -62.76 -19.17 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' GLU . 14.1 m -78.66 -67.47 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.0 109.244 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.579 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 53.3 m-85 -68.81 135.42 51.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.219 -0.926 . . . . 0.0 109.452 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -78.17 -23.63 47.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 7' ' ' SER . 6.9 m-85 -115.6 147.58 40.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.898 . . . . 0.0 109.539 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.859 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -156.82 95.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.366 -0.834 . . . . 0.0 108.832 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -114.1 156.88 23.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 109.749 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.508 ' HB2' HD12 ' A' ' 99' ' ' LEU . 36.1 t -124.6 146.48 49.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.476 -0.765 . . . . 0.0 109.059 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.781 ' HG2' ' SG ' ' A' ' 12' ' ' CYS . 20.4 mmt -42.91 150.71 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.69 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.512 ' OD1' HD12 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -45.16 -24.68 0.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 128' ' ' GLU . 9.5 mt-10 -41.29 -89.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.336 -0.852 . . . . 0.0 109.589 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 96' ' ' LEU . 39.2 p -79.41 83.09 5.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.246 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.811 ' HB2' HD22 ' A' ' 115' ' ' LEU . 17.3 p-10 -52.3 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.569 -0.707 . . . . 0.0 109.605 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.992 HD21 HG21 ' A' ' 113' ' ' ILE . 0.3 OUTLIER 41.56 27.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.625 -0.672 . . . . 0.0 109.9 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -90.28 -29.71 17.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.547 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.48 -38.63 7.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.514 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 90' ' ' CYS . 8.9 mt -67.05 -37.06 83.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.645 ' HB2' HD22 ' A' ' 96' ' ' LEU . 29.7 t30 -57.18 -19.49 20.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -89.73 -32.74 16.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.439 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.717 ' O ' HG23 ' A' ' 106' ' ' VAL . 9.5 mmmt -59.02 -32.88 70.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.882 . . . . 0.0 109.353 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 t -68.31 -31.59 71.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.244 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.09 -32.05 71.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -90.93 -11.28 39.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 109.302 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.878 HG22 ' HB2' ' A' ' 79' ' ' LYS . 81.5 t -86.08 140.73 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 119.35 23.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.342 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 109' ' ' CYS . 1.5 m-20 50.99 40.0 24.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.142 -0.974 . . . . 0.0 109.179 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -42.77 138.71 1.86 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.365 -0.834 . . . . 0.0 109.92 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.567 ' CB ' ' CZ ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -125.13 -5.12 7.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.806 . . . . 0.0 109.063 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.859 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -62.86 93.1 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.85 . . . . 0.0 110.207 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 86' ' ' ASP . 11.7 ttmt -46.29 106.48 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.992 HG21 HD21 ' A' ' 96' ' ' LEU . 2.9 mm -83.29 164.74 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.046 -1.034 . . . . 0.0 110.956 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.564 ' HB3' HD23 ' A' ' 89' ' ' LEU . 4.1 mt-10 176.47 -176.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.811 HD22 ' HB2' ' A' ' 95' ' ' ASN . 1.2 pp -141.49 138.75 33.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 0.0 109.84 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.4 OUTLIER -53.37 119.96 5.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.0 109.449 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -157.2 -159.84 9.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.58 114.36 2.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.477 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.0 m-85 -112.45 -17.83 12.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.583 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 163.84 -51.68 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.605 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 58.3 Cg_exo -49.26 164.41 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.698 1.599 . . . . 0.0 110.2 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -96.2 143.33 27.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.69 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 125' ' ' LEU . 3.9 tp60 -104.64 12.96 32.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 109.594 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.492 ' C ' ' O ' ' A' ' 124' ' ' GLN . 14.6 tp 33.47 81.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.169 0.509 . . . . 0.0 110.514 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.512 HD12 ' OD1' ' A' ' 92' ' ' ASP . 13.4 mm -48.15 143.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 109.201 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.612 HG23 ' O ' ' A' ' 127' ' ' ILE . 2.1 tt -119.9 95.3 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 94.4 mt-10 -121.86 69.2 0.93 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.432 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -114.73 144.9 32.79 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.505 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.91 -91.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.034 1.823 . . . . 0.0 110.278 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.495 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 32.5 t80 -166.32 50.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.329 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.76 109.88 4.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.33 145.91 16.41 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -110.44 -28.7 8.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -1.065 . . . . 0.0 109.371 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.439 ' OD1' ' CB ' ' A' ' 137' ' ' ASP . 2.6 p30 -91.71 17.8 8.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 45.47 49.55 10.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.439 ' CB ' ' OD1' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -79.98 79.05 6.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.47 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.415 ' CZ ' ' N ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -113.93 -10.05 12.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.499 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.46 -45.57 21.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 7.7 m -57.52 -25.35 59.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 18' ' ' ARG . 45.3 t -76.96 -36.46 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.962 ' HA ' HG21 ' A' ' 21' ' ' ILE . 4.7 t80 -64.37 -43.81 93.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -71.06 -48.95 49.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.66 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 148' ' ' CYS . 0.0 OUTLIER -59.33 -21.41 59.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.627 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.76 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.5 m -72.14 -32.6 67.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.839 ' HA ' HG11 ' A' ' 25' ' ' VAL . 77.7 t -49.49 -51.73 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.938 . . . . 0.0 109.289 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.448 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -77.68 -27.59 50.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.424 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.749 ' SG ' ' HA ' ' A' ' 145' ' ' CYS . 67.6 m -44.21 -26.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.138 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.601 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -115.11 -28.75 6.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.226 -0.921 . . . . 0.0 109.452 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.953 ' HB2' HD21 ' A' ' 29' ' ' LEU . 30.9 ttt85 -71.04 -59.2 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 108.99 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -49.43 -22.22 1.12 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.388 -0.82 . . . . 0.0 109.611 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 89' ' ' LEU . 1.3 t80 -90.19 -34.98 15.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 110.061 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.738 HD21 ' CD1' ' A' ' 35' ' ' ILE . 11.2 tp -67.28 -46.47 73.51 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.807 -1.183 . . . . 0.0 109.16 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 11.4 pt-20 -49.87 -38.23 34.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 108.638 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -59.98 -60.53 3.68 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.493 HG11 ' CE1' ' A' ' 87' ' ' TYR . 31.8 m -92.17 31.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.363 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.272 0.558 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -109.39 77.07 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -47.85 136.77 10.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.415 ' C ' ' OD1' ' A' ' 38' ' ' ASN . 59.5 t -117.01 148.77 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.478 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.781 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -87.93 75.95 8.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.684 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -41.33 153.04 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.759 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.586 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -133.23 117.29 17.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.082 -1.012 . . . . 0.0 109.579 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.719 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.4 OUTLIER -121.41 154.99 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.927 . . . . 0.0 109.591 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -149.99 106.53 3.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.868 . . . . 0.0 109.184 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.918 ' CE1' HD13 ' A' ' 89' ' ' LEU . 1.9 m-85 -88.41 155.15 19.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.777 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 2.0 t -145.94 149.83 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.232 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -166.35 154.0 9.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.539 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.7 tp -55.63 -67.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.02 78.92 1.5 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.643 ' ND2' ' HB2' ' A' ' 45' ' ' ALA . 42.5 p-10 -92.2 43.46 1.13 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -1.159 . . . . 0.0 109.419 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.848 HD12 ' H ' ' A' ' 17' ' ' CYS . 1.1 pp -132.88 -31.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 109.949 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.848 ' H ' HD12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -148.46 12.5 0.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.913 -1.117 . . . . 0.0 110.257 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.497 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 7.5 ttt-85 -125.35 -52.33 1.62 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.0 109.472 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.653 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -80.0 -44.35 1.48 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 110.949 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 19' ' ' SER . 73.5 Cg_exo -46.72 -17.0 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.99 1.793 . . . . 0.0 112.313 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.004 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -74.74 -45.33 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.336 -1.478 . . . . 0.0 108.894 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 145' ' ' CYS . . . -67.8 -42.98 80.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.01 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.432 ' CD ' ' HB2' ' A' ' 43' ' ' SER . 4.3 tt0 -58.59 -58.57 7.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 108.764 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.72 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -46.02 -36.87 6.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.327 -0.858 . . . . 0.0 108.841 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 21' ' ' ILE . 16.5 t -63.03 -52.12 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.274 -0.891 . . . . 0.0 108.952 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -52.53 -21.47 3.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -56.06 7.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 5.1 tttt -78.07 1.43 21.06 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.874 HD21 ' HG3' ' A' ' 150' ' ' ARG . 9.9 tp -94.22 -36.14 12.15 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.921 HG22 ' HA ' ' A' ' 36' ' ' SER . 4.1 p -91.07 -14.66 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -99.1 17.28 20.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.914 -1.116 . . . . 0.0 109.521 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.96 55.39 1.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 108.993 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.572 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 3.2 tp60 173.47 31.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.559 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 33' ' ' GLN . 0.3 OUTLIER 45.34 39.47 4.42 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -178.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.874 HG12 HG23 ' A' ' 30' ' ' VAL . 2.3 tt -124.68 -6.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.53 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.921 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -75.53 -22.23 57.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -0.892 . . . . 0.0 109.798 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -88.45 26.9 1.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.152 -0.968 . . . . 0.0 109.19 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.781 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.7 OUTLIER -159.06 40.19 0.22 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.323 -0.861 . . . . 0.0 109.396 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.719 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 14.4 m95 -150.14 156.62 41.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.956 -1.09 . . . . 0.0 111.121 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.38 72.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.551 HG13 ' CG1' ' A' ' 8' ' ' VAL . 2.8 mt -89.66 129.56 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.397 -0.814 . . . . 0.0 110.395 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . 5.6 t0 -144.95 147.74 33.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.446 -0.783 . . . . 0.0 108.955 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.432 ' HB2' ' CD ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -120.17 159.23 25.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.035 -1.041 . . . . 0.0 109.75 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.68 179.47 39.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.643 ' HB2' ' ND2' ' A' ' 15' ' ' ASN . . . -104.11 145.6 29.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -1.119 . . . . 0.0 109.401 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.451 HG22 ' CD1' ' A' ' 99' ' ' LEU . 70.8 t -57.1 -35.2 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.92 -164.11 1.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.436 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.495 ' HA ' HG23 ' A' ' 51' ' ' VAL . 1.6 m-20 -92.43 57.59 3.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.902 . . . . 0.0 109.474 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -89.03 -33.9 16.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.336 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -146.98 47.95 1.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.361 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 48' ' ' ASP . 76.2 t -58.86 112.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA2' ' HG3' ' A' ' 73' ' ' LYS . . . 51.43 51.36 37.63 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 54' ' ' SER . 7.8 mtt180 -95.98 18.47 13.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -1.192 . . . . 0.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER 58.53 151.93 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.62 -0.675 . . . . 0.0 109.631 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.17 128.22 13.62 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.98 1.787 . . . . 0.0 110.186 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 17' ' ' CYS . 55.5 m-20 -48.02 154.91 0.93 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.518 ' O ' HG12 ' A' ' 60' ' ' VAL . 55.5 Cg_endo -71.7 -4.77 15.71 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.024 1.816 . . . . 0.0 110.306 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -62.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.25 -18.38 65.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 109.4 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.594 HG22 ' HD2' ' A' ' 64' ' ' ARG . 9.8 p -63.96 -41.45 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.179 -0.951 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.515 ' N ' HG13 ' A' ' 60' ' ' VAL . 8.8 p -77.02 -3.31 38.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.665 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.485 ' C ' HD23 ' A' ' 63' ' ' LEU . 1.7 t -90.14 -33.02 16.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.41 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.798 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.38 -55.07 3.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.274 -0.892 . . . . 0.0 109.207 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.594 ' HD2' HG22 ' A' ' 60' ' ' VAL . 7.7 ptm180 -56.87 -16.54 6.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.386 -0.821 . . . . 0.0 109.642 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 61' ' ' SER . 12.6 t-20 -66.46 -81.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.401 ' N ' ' OD1' ' A' ' 65' ' ' ASN . 5.5 p-80 -150.7 20.57 0.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.588 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.03 -97.19 2.39 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.72 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 2.6 mp -119.46 161.29 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -1.13 . . . . 0.0 109.413 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.486 ' N ' HG22 ' A' ' 68' ' ' ILE . 6.5 m120 -118.25 54.61 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.116 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -58.37 151.18 20.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.571 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -144.55 14.38 1.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.264 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.417 ' CE1' ' O ' ' A' ' 73' ' ' LYS . 38.4 t-80 -78.45 146.78 34.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.474 ' HG3' ' HA2' ' A' ' 52' ' ' GLY . 4.0 tptm -93.67 131.54 38.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 73' ' ' LYS . . . -48.42 176.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.548 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.467 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 171.51 139.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.466 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.405 ' H ' HG22 ' A' ' 51' ' ' VAL . 2.1 tt0 -70.07 131.41 44.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 109.51 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.647 HG12 ' CE1' ' A' ' 82' ' ' PHE . 71.8 t -48.75 131.54 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 109.334 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 79' ' ' LYS . 20.5 p -111.86 160.35 17.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.636 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -43.17 -44.3 5.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.573 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' O ' ' OG1' ' A' ' 84' ' ' THR . 23.6 tt0 -57.7 -47.82 81.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.837 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 1.1 m-20 -53.94 -43.78 70.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 109.983 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.894 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 49.6 m-85 -54.53 -50.89 66.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.499 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.567 ' HA ' ' CG ' ' A' ' 110' ' ' ARG . 1.0 OUTLIER -87.05 0.59 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 109.767 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.48 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 13.5 m -77.79 -53.32 7.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 110.244 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.606 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 16.7 m-85 -100.85 174.58 5.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.064 -1.022 . . . . 0.0 110.412 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 19.5 t0 -112.41 -19.84 12.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.466 -0.771 . . . . 0.0 109.578 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 7' ' ' SER . 1.4 m-85 -116.89 86.97 2.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 0.0 109.23 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.882 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 1.5 mt -95.73 123.45 47.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.339 -0.851 . . . . 0.0 109.327 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.918 HD13 ' CE1' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -149.59 153.38 37.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 109.267 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.55 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 4.7 p -127.37 167.59 15.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.557 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.536 ' HE1' ' HB2' ' A' ' 116' ' ' LEU . 16.9 mmt -60.89 142.04 56.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.682 ' HB3' HG23 ' A' ' 126' ' ' ILE . 16.9 m-20 -43.52 116.29 0.92 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 128' ' ' GLU . 11.3 tt0 -176.34 163.01 2.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.493 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 t -83.31 8.74 12.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -75.91 -11.97 60.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.588 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.9 OUTLIER -74.19 -2.37 24.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 0.0 109.607 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 13.7 ttt85 -63.63 -25.19 68.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.169 -0.957 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 0.4 OUTLIER -95.54 -43.91 7.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.395 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.516 ' HB3' HG21 ' A' ' 113' ' ' ILE . 6.0 mt -53.65 -44.71 69.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.357 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.48 -29.53 70.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.228 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -89.89 -5.8 56.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.903 . . . . 0.0 109.461 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.984 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -81.63 -20.93 38.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -0.874 . . . . 0.0 109.32 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -63.57 -36.59 84.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.826 . . . . 0.0 109.591 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -32.45 73.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.424 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -92.66 9.73 33.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.244 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.984 HG23 ' O ' ' A' ' 102' ' ' LYS . 49.1 t -98.68 145.29 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.392 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -73.39 106.54 5.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.064 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 109' ' ' CYS . 8.2 t-20 47.73 46.68 18.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.002 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.522 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -41.76 145.6 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.561 -0.712 . . . . 0.0 109.704 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.567 ' CG ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -137.6 25.15 2.88 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.311 -0.868 . . . . 0.0 109.111 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.894 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -106.73 131.43 53.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.392 -0.817 . . . . 0.0 109.858 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 88' ' ' ILE . 7.2 mtpt -83.19 100.22 10.43 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.662 HD13 ' N ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -76.32 135.46 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.734 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.46 -177.97 5.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.419 -0.801 . . . . 0.0 109.36 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.508 ' CD2' HD12 ' A' ' 96' ' ' LEU . 60.8 mt -110.71 152.75 26.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.652 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.677 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -69.08 -9.92 55.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.475 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 92' ' ' ASP . . . -45.94 -29.18 3.14 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.3 168.88 19.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -1.085 . . . . 0.0 109.471 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 55.41 73.65 0.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.37 75.54 13.63 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.13 105.89 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.915 1.743 . . . . 0.0 110.294 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 57.49 178.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.96 42.76 22.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.63 120.26 11.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tp -168.28 101.33 0.43 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.524 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.943 HG21 ' OE2' ' A' ' 128' ' ' GLU . 15.1 mm -54.28 141.09 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 127' ' ' ILE . 14.8 mt -100.76 57.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.93 . . . . 0.0 109.351 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.943 ' OE2' HG21 ' A' ' 126' ' ' ILE . 21.0 mt-10 -88.07 132.42 34.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.449 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 1.1 p30 -158.05 158.7 30.22 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 129' ' ' ASP . 51.4 Cg_endo -71.27 -90.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.038 1.825 . . . . 0.0 110.226 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.1 -42.84 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.454 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.09 100.02 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.07 -116.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -160.27 -55.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -1.162 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.41 18.48 15.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.622 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 137' ' ' ASP . . . -55.92 -20.41 15.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.321 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 0.7 OUTLIER 74.79 126.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.731 ' O ' HG12 ' A' ' 141' ' ' VAL . 80.8 t80 -82.42 0.74 40.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.605 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -79.47 -34.2 41.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.146 -0.971 . . . . 0.0 109.461 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.541 HG23 ' N ' ' A' ' 141' ' ' VAL . 15.0 t -76.4 -42.23 45.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 138' ' ' PHE . 9.0 p -46.64 -29.22 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.749 ' CD1' HG22 ' A' ' 21' ' ' ILE . 1.4 t80 -90.18 -46.34 8.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.102 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.03 -64.56 0.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.682 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -55.76 -20.09 13.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.102 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -72.33 -39.08 68.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.331 -0.856 . . . . 0.0 109.344 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.83 ' HA ' HG11 ' A' ' 25' ' ' VAL . 90.1 t -53.21 -71.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.034 -1.041 . . . . 0.0 109.74 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.54 ' HA ' ' CB ' ' A' ' 150' ' ' ARG . 13.1 mtm180 -62.49 -21.18 65.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.088 -1.007 . . . . 0.0 109.606 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.677 ' HA ' HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -45.81 -27.44 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.985 -1.072 . . . . 0.0 108.18 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.607 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -111.62 -23.12 10.86 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.874 ' HG3' HD21 ' A' ' 29' ' ' LEU . 8.5 ttp180 -76.48 -64.49 1.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.389 -0.819 . . . . 0.0 109.257 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -45.72 -37.87 6.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.257 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.667 ' O ' HG22 ' A' ' 156' ' ' VAL . 1.9 t80 -74.71 -37.38 62.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.42 -0.8 . . . . 0.0 109.3 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . 13.3 tp -67.14 -16.96 64.64 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.211 -0.93 . . . . 0.0 108.718 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -72.37 -50.52 26.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.035 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -42.43 98.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 108.841 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 152' ' ' PHE . 17.0 m -103.84 42.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 109.056 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.466 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 3' ' ' GLN . 41.8 mt-10 -101.14 71.09 1.37 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.476 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.803 ' O ' HG12 ' A' ' 4' ' ' VAL . 39.2 mt-30 -152.15 157.28 41.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.95 . . . . 0.0 109.606 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.803 HG12 ' O ' ' A' ' 3' ' ' GLN . 4.1 p 48.31 178.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.607 -0.683 . . . . 0.0 109.887 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.957 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -151.48 83.59 1.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.248 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.652 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -41.53 162.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.868 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.585 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 2.5 m -142.8 114.7 8.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 108.999 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.716 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.6 OUTLIER -118.01 147.77 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.733 -179.256 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -149.99 116.4 5.77 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 89' ' ' LEU . 2.5 m-85 -91.87 160.33 15.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 0.0 109.858 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.069 HG11 HD11 ' A' ' 99' ' ' LEU . 4.2 t -145.98 149.48 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.546 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -174.13 121.91 0.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.445 HD11 ' CZ2' ' A' ' 49' ' ' TRP . 44.6 tp -43.46 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 109.582 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . 148.96 -73.75 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.7 14.33 8.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -1.096 . . . . 0.0 109.425 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.616 HG21 ' HD3' ' A' ' 53' ' ' ARG . 1.3 pp -131.41 12.73 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 18' ' ' ARG . 15.3 t 179.12 137.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.77 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 23.7 ttm-85 84.15 -52.22 0.13 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.75 -0.594 . . . . 0.0 109.664 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -79.56 -50.1 1.32 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 110.049 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 19' ' ' SER . 70.2 Cg_exo -48.37 -33.66 23.23 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.902 1.735 . . . . 0.0 110.876 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.022 HG21 ' HA ' ' A' ' 142' ' ' TYR . 5.4 mm -65.75 -61.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.961 -1.087 . . . . 0.0 109.655 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.444 ' N ' ' HB3' ' A' ' 145' ' ' CYS . . . -62.5 -12.77 24.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 109.539 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 2.4 tm-20 -77.98 -74.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.401 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -53.96 -33.96 58.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 108.841 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.085 HG11 ' HA ' ' A' ' 146' ' ' VAL . 49.6 t -56.29 -59.75 2.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.393 -0.817 . . . . 0.0 109.202 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.736 ' CD1' HG12 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -47.52 -41.26 20.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.974 -1.079 . . . . 0.0 108.506 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.505 ' O ' ' OG1' ' A' ' 31' ' ' THR . 5.8 ttt85 -45.7 -60.07 2.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.006 -1.059 . . . . 0.0 109.403 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.481 ' HA ' ' OG1' ' A' ' 31' ' ' THR . 0.3 OUTLIER -75.32 -13.03 60.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.41 -0.806 . . . . 0.0 111.003 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.943 ' CD1' HG12 ' A' ' 25' ' ' VAL . 42.1 mt -76.37 -30.85 57.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.846 -1.159 . . . . 0.0 109.433 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.763 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -90.76 -31.85 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -60.86 -31.81 71.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 109.076 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.46 -40.61 89.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.357 -0.839 . . . . 0.0 109.328 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.532 ' HB3' HG23 ' A' ' 35' ' ' ILE . 32.0 tp60 -80.67 -6.54 58.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.874 . . . . 0.0 109.515 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 1.5 m120 72.67 47.44 0.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.763 ' CG1' HG23 ' A' ' 30' ' ' VAL . 5.9 pt -129.72 -1.14 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.917 . . . . 0.0 109.656 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 30' ' ' VAL . 2.1 p -58.36 -44.46 88.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 109.657 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.12 -28.03 6.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.548 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.957 ' HA ' HG22 ' A' ' 5' ' ' THR . 5.3 m-20 -112.58 46.1 1.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.716 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 7.6 m95 -149.86 144.54 26.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.157 -0.964 . . . . 0.0 110.194 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.718 HG12 ' CE1' ' A' ' 85' ' ' PHE . 33.8 t -124.16 78.11 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.568 ' HA ' HG13 ' A' ' 8' ' ' VAL . 2.6 mt -90.02 139.11 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.869 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.602 ' OD1' ' CD2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -150.75 -173.53 4.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.285 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.439 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 1.1 t -126.46 165.95 18.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.692 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.93 131.94 4.82 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.747 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -93.41 -39.24 11.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.301 -1.117 . . . . 0.0 109.583 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER 80.84 -6.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.695 . . . . 0.0 109.466 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.0 m -141.31 137.33 32.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.624 ' HA ' HG23 ' A' ' 51' ' ' VAL . 1.3 t70 -88.38 14.1 10.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.516 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -86.25 3.45 43.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.695 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 49' ' ' TRP . 3.9 m-20 -144.46 22.78 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.577 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.984 HG13 ' HA ' ' A' ' 75' ' ' ARG . 60.9 t -64.85 128.37 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.05 -18.15 42.16 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.616 ' HD3' HG21 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -62.86 113.17 2.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -1.116 . . . . 0.0 109.365 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.4 m -76.45 153.01 83.79 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 56' ' ' ASP . 53.7 Cg_exo -50.25 143.72 25.33 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.957 1.771 . . . . 0.0 110.266 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 55' ' ' PRO . 4.5 m-20 -44.79 151.92 0.58 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.9 -6.0 18.19 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 121.93 1.753 . . . . 0.0 110.31 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.746 ' O ' ' SG ' ' A' ' 62' ' ' CYS . 16.0 mtt180 -86.26 -33.85 20.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.366 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB2' ' HZ ' ' A' ' 138' ' ' PHE . . . -89.14 -25.07 22.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.319 -0.863 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.583 HG13 ' N ' ' A' ' 61' ' ' SER . 9.9 p -64.71 -44.78 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.456 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.583 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -69.64 -8.46 47.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.631 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.746 ' SG ' ' O ' ' A' ' 58' ' ' ARG . 13.1 m -89.89 -66.71 0.9 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.593 HD12 HG21 ' A' ' 68' ' ' ILE . 1.7 pt? -57.78 -25.31 60.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.368 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.483 ' H ' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -91.56 30.89 1.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.349 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -133.21 -46.0 0.84 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.574 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -83.59 -33.58 25.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.427 ' O ' HG12 ' A' ' 68' ' ' ILE . . . 136.22 98.5 0.54 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.593 HG21 HD12 ' A' ' 63' ' ' LEU . 15.6 mm -149.42 -68.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -1.127 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 21.4 m-80 68.65 116.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.391 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 t -105.01 167.69 9.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.537 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -161.71 39.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.456 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.634 ' CE1' ' O ' ' A' ' 73' ' ' LYS . 9.5 t-80 -155.16 144.66 21.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.508 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.634 ' O ' ' CE1' ' A' ' 72' ' ' HIS . 0.9 OUTLIER -115.82 151.18 35.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' ARG . . . -44.11 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.984 ' HA ' HG13 ' A' ' 51' ' ' VAL . 1.5 tpp180 69.15 8.1 6.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 75' ' ' ARG . 2.5 tt0 61.32 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 78' ' ' THR . 11.6 p -53.85 165.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.564 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -143.85 161.96 37.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.677 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -50.63 -41.57 55.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.274 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 84' ' ' THR . 0.3 OUTLIER -54.0 -41.13 67.61 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.354 -0.841 . . . . 0.0 109.53 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.443 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 0.9 OUTLIER -62.15 -31.88 72.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 109.842 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.685 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 77.6 m-85 -66.23 -59.2 3.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.063 -1.023 . . . . 0.0 109.399 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.52 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 2.6 p -72.98 -9.14 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.506 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 85' ' ' PHE . 3.4 m -81.76 -78.06 0.2 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.222 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.718 ' CE1' HG12 ' A' ' 40' ' ' VAL . 37.2 m-85 -70.06 156.52 39.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.253 -0.905 . . . . 0.0 109.315 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -106.43 -12.68 15.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.654 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 7' ' ' SER . 2.2 m-85 -121.88 78.21 1.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 109.712 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.92 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 2.8 mt -89.3 91.66 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.306 -0.872 . . . . 0.0 108.964 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.687 HD21 ' CE1' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -107.45 168.26 9.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 0.0 109.352 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 11' ' ' VAL . 3.9 m -136.51 175.21 9.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.259 -0.9 . . . . 0.0 109.292 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 16.8 mmt -84.07 12.51 6.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.447 ' O ' ' CD2' ' A' ' 115' ' ' LEU . 1.3 p30 170.66 176.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.579 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.733 ' HB2' HD11 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -107.34 -14.69 14.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 93' ' ' GLU . 0.5 OUTLIER -44.26 -53.0 7.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.582 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -89.16 -24.34 22.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.916 . . . . 0.0 109.571 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.84 ' O ' HD23 ' A' ' 96' ' ' LEU . 2.6 tt -58.7 -21.19 54.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.95 -28.24 0.44 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -94.65 -33.24 13.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.069 HD11 HG11 ' A' ' 11' ' ' VAL . 15.4 mt -67.17 -14.48 62.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -85.5 -31.78 22.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.98 -11.93 40.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.447 ' HE2' ' CZ ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -67.86 -42.47 81.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.434 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.698 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 1.1 p -53.03 -22.66 6.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.397 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -72.02 -44.05 64.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.383 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -83.08 -9.93 58.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.554 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.677 HG13 ' HG2' ' A' ' 79' ' ' LYS . 41.1 t -76.8 135.49 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.448 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -68.65 108.41 3.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.482 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.1 t30 51.93 48.98 21.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.279 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -48.36 148.77 1.78 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.282 -0.886 . . . . 0.0 109.773 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.52 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -136.95 5.21 2.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.417 -0.802 . . . . 0.0 109.206 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.92 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -85.44 94.43 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 110.388 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -52.82 122.88 10.02 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -96.97 129.38 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.79 -1.194 . . . . 0.0 110.114 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -155.3 -171.98 4.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 0.0 109.224 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 93' ' ' GLU . 20.2 mt -117.49 162.66 17.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.969 . . . . 0.0 109.517 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.658 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -85.85 58.71 5.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -123.07 -2.22 9.29 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 15.62 24.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -1.187 . . . . 0.0 109.487 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.434 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 2.8 m-85 -135.76 70.57 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -166.63 133.83 2.05 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.164 -0.96 . . . . 0.0 109.382 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.65 -30.55 29.03 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.769 1.646 . . . . 0.0 110.168 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -128.3 132.44 48.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.39 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -64.65 140.44 58.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.182 -0.949 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 125' ' ' LEU . 1.1 mt-30 -108.76 16.82 22.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.253 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.723 ' O ' HD23 ' A' ' 125' ' ' LEU . 1.6 tt 39.66 61.07 1.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.756 -0.59 . . . . 0.0 109.842 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.515 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 7.2 mm 62.08 139.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 0.0 109.345 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 129' ' ' ASP . 2.8 mp -101.43 -55.21 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.84 . . . . 0.0 109.365 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.515 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 33.5 mt-10 48.0 -92.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER 51.44 92.55 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.489 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.1 157.11 3.1 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.901 1.734 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -98.92 87.3 3.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -138.6 -74.83 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.525 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -142.73 117.79 1.17 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 137' ' ' ASP . 2.4 p30 -105.8 148.06 27.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -1.149 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -80.92 74.48 7.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 66.03 33.14 7.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.443 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 134' ' ' ASN . 0.4 OUTLIER -105.89 56.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 109.564 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.481 ' HZ ' ' HB2' ' A' ' 59' ' ' ALA . 66.9 t80 -111.36 -42.04 3.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 109.355 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -70.42 -36.15 73.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 0.0 109.307 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 56.8 m -65.81 -17.66 64.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.226 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 18' ' ' ARG . 22.3 t -81.67 -43.89 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 1.022 ' HA ' HG21 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.54 -25.89 65.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.216 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -83.9 -46.76 11.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.91 . . . . 0.0 109.651 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' A' ' 141' ' ' VAL . 16.2 pt20 -67.23 -13.3 61.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.24 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.77 ' SG ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -79.09 -19.21 51.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 109.457 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 1.085 ' HA ' HG11 ' A' ' 25' ' ' VAL . 54.4 t -61.3 -56.27 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.926 . . . . 0.0 109.27 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.87 -12.29 60.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.288 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.658 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.2 m -56.12 -18.78 10.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.15 -0.969 . . . . 0.0 108.988 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.588 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -124.42 -40.71 2.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.418 -0.801 . . . . 0.0 109.229 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.609 ' HB2' HD13 ' A' ' 29' ' ' LEU . 1.7 ttp180 -59.15 -46.36 88.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 108.71 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.487 ' O ' ' CG ' ' A' ' 154' ' ' GLU . . . -65.68 -18.97 65.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.474 -0.766 . . . . 0.0 109.098 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.934 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 4.6 t80 -90.07 -19.35 24.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.416 -0.802 . . . . 0.0 109.489 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.613 HD13 ' HZ ' ' A' ' 26' ' ' PHE . 14.5 tp -78.7 -22.74 46.22 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.037 -1.04 . . . . 0.0 108.768 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 151' ' ' ALA . 4.4 pt-20 -72.0 -33.71 68.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.1 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.458 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 5.8 mmtp -76.19 -51.65 11.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.916 . . . . 0.0 108.864 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.934 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 17.8 m -103.56 58.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.393 -0.817 . . . . 0.0 108.935 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.559 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.29 0.567 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.44 132.03 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.354 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HG2' ' OD1' ' A' ' 38' ' ' ASN . 12.3 tt0 -137.51 82.2 1.91 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.705 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 38' ' ' ASN . 1.9 t -75.73 152.14 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 109.118 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.852 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -130.64 82.75 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.933 . . . . 0.0 109.803 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.662 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -43.12 156.8 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -136.38 113.74 10.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.377 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.676 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 1.0 OUTLIER -117.8 142.71 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.572 HD22 ' CD1' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -142.23 116.61 9.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.445 -0.784 . . . . 0.0 109.136 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.763 ' CZ ' ' SG ' ' A' ' 148' ' ' CYS . 2.0 m-85 -91.1 161.51 15.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.651 HG11 HD11 ' A' ' 99' ' ' LEU . 74.5 t -149.47 152.93 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.475 ' HB3' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -178.28 126.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.437 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.95 124.95 13.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.48 62.47 1.87 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -84.02 74.85 10.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.425 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.642 HD12 ' SG ' ' A' ' 17' ' ' CYS . 0.6 OUTLIER -144.19 12.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.627 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.642 ' SG ' HD12 ' A' ' 16' ' ' ILE . 0.8 OUTLIER 173.74 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.716 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.585 ' HA ' HG11 ' A' ' 141' ' ' VAL . 2.4 ttm105 -94.6 66.68 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 109.572 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.59 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 162.44 -51.08 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.644 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 19' ' ' SER . 57.2 Cg_exo -49.89 -20.83 5.31 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.882 1.721 . . . . 0.0 110.425 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.881 HG21 ' HA ' ' A' ' 142' ' ' TYR . 1.9 mm -64.89 -51.16 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.147 -0.97 . . . . 0.0 109.183 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.67 ' O ' ' SG ' ' A' ' 149' ' ' CYS . . . -63.33 -19.87 65.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.48 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -73.51 -74.67 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.273 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB2' ' HB ' ' A' ' 70' ' ' THR . . . -44.2 -28.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 108.91 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.981 HG11 ' HA ' ' A' ' 146' ' ' VAL . 97.3 t -68.23 -53.32 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.328 -0.858 . . . . 0.0 109.21 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.807 ' CE1' HD11 ' A' ' 41' ' ' ILE . 5.2 t80 -46.22 -39.58 10.05 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.534 ' HD3' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -58.02 -53.36 59.07 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.385 -0.822 . . . . 0.0 109.202 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -76.67 -1.37 27.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 0.0 109.792 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.922 ' CD1' HG12 ' A' ' 25' ' ' VAL . 81.4 mt -92.55 -32.85 14.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.013 -1.054 . . . . 0.0 109.316 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.923 ' HA ' HD11 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -90.71 -49.87 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -52.6 -22.17 4.72 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.272 -0.893 . . . . 0.0 109.167 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -90.67 -31.41 16.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.029 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -79.16 -79.71 0.13 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 109.224 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 4.0 m-20 161.92 42.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.398 -0.814 . . . . 0.0 109.955 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.923 HD11 ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -139.15 11.55 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.976 -1.078 . . . . 0.0 109.837 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.678 ' N ' HG23 ' A' ' 30' ' ' VAL . 4.3 p -62.57 -21.36 65.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.944 -1.097 . . . . 0.0 109.51 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 3.4 m-20 -93.11 34.23 1.13 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.317 -0.865 . . . . 0.0 108.753 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.852 ' HA ' HG22 ' A' ' 5' ' ' THR . 6.6 m-20 -177.06 48.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 109.684 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.676 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 9.8 m95 -149.99 144.19 25.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.89 -1.131 . . . . 0.0 110.383 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.65 81.59 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.807 HD11 ' CE1' ' A' ' 26' ' ' PHE . 2.7 mp -89.93 137.77 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.831 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.581 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 4.4 m-20 -148.44 173.52 13.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -122.76 161.33 24.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.458 ' HA3' ' CG2' ' A' ' 77' ' ' VAL . . . -143.89 147.75 19.19 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 46' ' ' VAL . . . -116.79 -19.73 9.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -1.17 . . . . 0.0 109.558 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.583 ' CG2' ' CG1' ' A' ' 11' ' ' VAL . 4.5 t 69.92 6.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.07 164.03 31.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.601 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.493 ' HA ' HG23 ' A' ' 51' ' ' VAL . 48.5 p30 -110.45 11.59 23.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.865 . . . . 0.0 109.424 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -89.93 6.67 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.745 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.485 ' OD1' ' CD ' ' A' ' 53' ' ' ARG . 4.3 m-80 -147.81 29.76 0.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.58 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 75' ' ' ARG . 26.0 t -78.55 78.51 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 109.283 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA2' ' HD3' ' A' ' 73' ' ' LYS . . . 134.79 -19.86 3.92 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -63.42 90.68 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.417 -1.049 . . . . 0.0 109.409 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 13.4 p -55.72 161.91 2.96 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.856 . . . . 0.0 109.448 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 54' ' ' SER . 53.5 Cg_exo -50.44 153.79 6.99 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.043 1.829 . . . . 0.0 110.199 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 18.5 m-20 -75.38 144.91 78.84 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.928 . . . . 0.0 109.486 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.878 ' O ' HG12 ' A' ' 60' ' ' VAL . 51.6 Cg_exo -51.07 -19.63 6.17 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.959 1.773 . . . . 0.0 110.496 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -79.56 -45.64 18.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.147 -0.971 . . . . 0.0 109.821 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.679 ' O ' HD23 ' A' ' 63' ' ' LEU . . . -71.3 -17.98 62.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 109.885 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.878 HG12 ' O ' ' A' ' 57' ' ' PRO . 8.8 p -72.38 -28.15 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.932 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 14.7 m -64.2 -20.18 65.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.812 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.29 -75.06 0.47 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.198 -0.939 . . . . 0.0 109.745 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -53.87 -18.47 3.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.726 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.551 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 4.3 ttt180 -112.72 51.63 0.81 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.09 -1.006 . . . . 0.0 109.633 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' SER . 4.6 t-20 -129.27 -78.46 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 109.245 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -54.62 -33.05 59.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.317 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.86 104.76 1.34 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.889 HD11 ' HA ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -133.63 -174.36 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -1.169 . . . . 0.0 109.324 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.534 ' CB ' ' HD3' ' A' ' 27' ' ' ARG . 32.0 m120 -140.18 118.01 11.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.505 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -142.18 -87.32 0.15 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.451 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.518 ' H ' HG23 ' A' ' 70' ' ' THR . . . 60.18 20.49 9.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.333 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -90.09 157.4 17.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.495 ' HD3' ' HA2' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -107.87 150.13 27.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.21 170.69 15.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.939 . . . . 0.0 109.551 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.649 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -174.83 153.27 1.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.442 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.431 ' N ' ' HG3' ' A' ' 75' ' ' ARG . 6.1 tt0 -77.04 138.78 39.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.458 ' CG2' ' HA3' ' A' ' 44' ' ' GLY . 77.8 t -67.33 141.98 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 2.7 p -127.95 164.75 21.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.556 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.91 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -51.1 -45.36 61.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.407 ' O ' ' OG1' ' A' ' 84' ' ' THR . 32.7 tt0 -53.9 -38.21 64.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.481 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 78' ' ' THR . 7.3 m-20 -59.11 -41.17 87.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.748 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.805 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 94.4 m-85 -61.84 -54.31 43.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.513 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 108' ' ' ASN . 1.2 p -75.9 -5.84 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 109.612 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 4.0 m -85.89 -71.7 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.314 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 42' ' ' ASP . 71.6 m-85 -74.3 161.62 29.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -109.16 -21.81 12.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.673 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.7 m-85 -116.06 73.32 0.84 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.076 -1.015 . . . . 0.0 109.58 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.901 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.0 mt -86.15 89.81 2.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -100.5 174.3 6.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.041 -1.037 . . . . 0.0 109.441 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.637 ' SG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -150.05 159.8 44.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.431 -0.793 . . . . 0.0 109.091 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.619 ' HE1' ' SG ' ' A' ' 148' ' ' CYS . 32.6 mmt -67.49 167.86 12.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -0.96 . . . . 0.0 109.201 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -59.52 -149.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.793 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 92' ' ' ASP . 0.1 OUTLIER 76.87 -179.04 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.345 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 m -89.01 36.01 0.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.481 ' ND2' ' OE1' ' A' ' 93' ' ' GLU . 79.9 m-20 -89.94 -15.47 31.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -86.74 -16.31 36.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 109.466 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 21.1 ttt85 -65.91 -11.42 46.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.0 -1.063 . . . . 0.0 109.169 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 13.8 t70 -108.36 -35.09 6.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.259 -0.9 . . . . 0.0 109.183 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.673 ' HB2' HD23 ' A' ' 96' ' ' LEU . 8.9 mt -69.18 -50.6 46.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.362 -0.836 . . . . 0.0 109.41 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -54.52 -26.18 30.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.415 -0.803 . . . . 0.0 109.406 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.83 -24.24 19.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.907 . . . . 0.0 109.478 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -65.94 -39.5 90.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.722 ' HG ' ' HG ' ' A' ' 109' ' ' CYS . 45.1 t -59.72 -17.95 38.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 0.0 109.319 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.31 -40.17 31.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 5.4 pt20 -76.85 -18.16 58.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.91 HG13 ' HG2' ' A' ' 79' ' ' LYS . 92.9 t -69.22 147.9 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -89.41 108.49 19.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.274 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.549 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.4 OUTLIER 65.18 42.04 4.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.074 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.722 ' HG ' ' HG ' ' A' ' 103' ' ' SER . 0.0 OUTLIER -52.35 152.44 3.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 0.0 109.894 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 4.0 ptm180 -140.32 8.75 2.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.424 -0.797 . . . . 0.0 109.184 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.901 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -90.65 91.51 8.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 110.313 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 111' ' ' ALA . 13.7 mtpt -47.33 116.97 1.57 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 111' ' ' ALA . 1.7 mm -93.65 135.98 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.858 -1.151 . . . . 0.0 110.685 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.532 ' HB3' HD23 ' A' ' 89' ' ' LEU . 2.6 tt0 -160.89 -176.27 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.726 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.6 OUTLIER -134.82 151.59 51.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.017 -1.052 . . . . 0.0 109.495 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.071 HD21 ' SG ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -42.25 135.17 2.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.443 -0.785 . . . . 0.0 109.669 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.31 -120.01 1.67 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.6 p -148.65 117.64 6.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -1.185 . . . . 0.0 109.6 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.525 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 23.9 m-85 -115.47 31.35 6.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.35 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.575 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 162.89 -51.24 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.404 -0.81 . . . . 0.0 109.539 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.5 Cg_exo -49.92 146.89 15.61 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.845 1.697 . . . . 0.0 110.071 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.67 11.36 32.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.118 -0.989 . . . . 0.0 109.672 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.57 146.66 25.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -112.85 62.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.392 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.27 76.32 1.56 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.541 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -74.62 137.77 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.265 -0.897 . . . . 0.0 109.083 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.609 HD11 ' CB ' ' A' ' 144' ' ' GLN . 95.2 mt -39.56 106.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.515 -0.741 . . . . 0.0 109.941 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.494 ' HG3' HG23 ' A' ' 126' ' ' ILE . 15.1 mt-10 -142.26 79.74 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.458 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 130' ' ' PRO . 0.9 OUTLIER -150.73 104.45 3.05 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.456 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 129' ' ' ASP . 54.4 Cg_exo -49.68 -174.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.755 1.636 . . . . 0.0 110.29 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -100.12 14.02 32.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.595 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.96 26.44 9.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.42 -105.38 1.58 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -113.48 -159.72 0.7 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -1.191 . . . . 0.0 109.384 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -119.21 -23.78 6.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.39 10.75 9.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -97.74 61.33 1.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.27 -51.26 2.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.561 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -27.29 34.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 109.363 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 61.0 m -61.79 -49.03 77.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.337 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 18' ' ' ARG . 53.5 t -53.6 -40.72 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 0.0 109.377 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.881 ' HA ' HG21 ' A' ' 21' ' ' ILE . 2.2 t80 -61.28 -48.4 81.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -65.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 109.951 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.609 ' CB ' HD11 ' A' ' 127' ' ' ILE . 21.0 mm100 -53.38 -19.03 3.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.868 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.709 ' SG ' HG22 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -77.7 -38.09 48.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.117 -0.989 . . . . 0.0 109.645 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.981 ' HA ' HG11 ' A' ' 25' ' ' VAL . 2.9 t -51.57 -53.55 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.087 -1.008 . . . . 0.0 109.218 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -12.54 60.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.861 . . . . 0.0 109.344 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 1.071 ' SG ' HD21 ' A' ' 116' ' ' LEU . 36.2 t -56.46 -40.4 74.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.224 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.67 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -103.06 -29.26 11.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.365 -0.834 . . . . 0.0 109.52 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.736 ' HG3' HD22 ' A' ' 29' ' ' LEU . 2.2 ttt180 -72.21 -59.65 2.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.19 -19.82 23.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.454 -0.779 . . . . 0.0 109.206 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.636 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 2.6 t80 -90.59 -26.86 19.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.51 -0.744 . . . . 0.0 109.833 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.63 HD13 ' CZ ' ' A' ' 26' ' ' PHE . 8.7 tp -75.16 -25.68 58.52 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.912 -1.117 . . . . 0.0 109.109 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -69.22 -46.82 66.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.36 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -63.3 -54.75 32.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.636 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 17.5 m -102.87 54.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.256 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.508 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.55 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.281 0.562 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' ' 2' ' ' GLU . 23.0 mm-40 -118.58 61.0 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 4' ' ' VAL . 1.8 tt0 -114.07 66.54 0.67 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 5' ' ' THR . 18.0 t -44.93 147.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.361 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -175.24 84.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.343 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.67 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -42.59 163.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.585 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 74.4 m -145.58 109.83 4.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.107 -0.996 . . . . 0.0 109.586 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.924 HG11 ' CE2' ' A' ' 26' ' ' PHE . 1.5 p -110.75 144.79 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.217 -0.927 . . . . 0.0 109.627 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.607 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -141.49 126.04 17.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.125 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.0 m-85 -105.53 156.42 18.25 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 109.569 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.726 HG11 HD11 ' A' ' 99' ' ' LEU . 25.2 t -139.13 154.86 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.77 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.558 ' SG ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -170.62 129.79 0.84 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.423 -0.798 . . . . 0.0 109.16 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 12' ' ' CYS . 1.0 OUTLIER -42.39 -65.28 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.558 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . -87.43 87.59 1.55 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.528 ' O ' HG23 ' A' ' 16' ' ' ILE . 40.2 t30 -90.04 40.76 1.02 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -1.129 . . . . 0.0 109.353 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.551 HD12 ' N ' ' A' ' 17' ' ' CYS . 1.8 pp -157.24 -40.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.925 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.561 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 0.9 OUTLIER -102.65 -15.33 16.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.496 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 14' ' ' GLY . 3.0 mmm-85 -75.53 0.18 18.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.599 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.816 ' OG ' HG21 ' A' ' 141' ' ' VAL . 10.0 p 60.14 56.08 4.29 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 109.568 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 19' ' ' SER . 45.3 Cg_endo -70.05 83.05 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.999 1.799 . . . . 0.0 109.941 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.724 HG22 HG23 ' A' ' 25' ' ' VAL . 3.2 mm -88.68 -21.02 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.796 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.69 ' CB ' ' SG ' ' A' ' 148' ' ' CYS . . . -54.52 -24.57 21.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.05 -1.031 . . . . 0.0 109.873 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 8.0 tp10 -76.75 -83.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 0.0 110.021 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.604 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -41.71 -30.75 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 109.836 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.018 HG11 ' HA ' ' A' ' 146' ' ' VAL . 60.9 t -64.32 -58.04 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.359 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.924 ' CE2' HG11 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -46.9 -41.72 16.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.108 -0.995 . . . . 0.0 108.64 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.1 OUTLIER -50.23 -66.42 0.39 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.237 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -13.71 29.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 110.164 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.746 HD22 ' HG3' ' A' ' 150' ' ' ARG . 8.5 mt -77.18 -78.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.161 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.864 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -42.73 -47.66 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.39 -0.819 . . . . 0.0 109.653 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -51.14 -46.69 62.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.81 -1.181 . . . . 0.0 109.502 -179.368 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.42 -30.16 70.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.962 . . . . 0.0 109.03 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.559 ' HB3' HG23 ' A' ' 35' ' ' ILE . 1.1 tt0 -79.68 -10.13 59.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 8.7 t30 77.61 25.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.453 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.864 ' CG1' HG23 ' A' ' 30' ' ' VAL . 1.6 pt -117.63 11.56 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.315 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.604 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 89.3 p -73.5 -12.35 60.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.683 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -83.94 10.1 10.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 109.332 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.678 ' HA ' HG22 ' A' ' 5' ' ' THR . 3.1 m-20 -155.38 51.99 0.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.67 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 7.9 m95 -150.3 154.37 37.74 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.902 -1.123 . . . . 0.0 110.865 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG12 ' HE1' ' A' ' 85' ' ' PHE . 10.2 t -130.49 80.59 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.59 HG12 ' CD2' ' A' ' 26' ' ' PHE . 3.3 mt -90.64 138.99 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.255 -0.903 . . . . 0.0 109.87 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -145.73 -178.71 6.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.82 . . . . 0.0 109.154 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.7 t -170.27 135.91 1.33 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.682 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.8 -177.06 33.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.785 ' HB2' ' OD1' ' A' ' 50' ' ' ASN . . . -95.12 141.02 29.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -1.183 . . . . 0.0 109.461 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.505 ' CG2' ' HG ' ' A' ' 99' ' ' LEU . 8.4 p -58.0 -24.71 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.344 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.4 m -124.43 170.88 10.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.372 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.587 ' CG ' HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -81.07 75.61 8.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.366 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.57 -32.68 6.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.785 ' OD1' ' HB2' ' A' ' 45' ' ' ALA . 4.1 p-10 -132.08 34.56 3.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.597 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.587 HG21 ' CG ' ' A' ' 48' ' ' ASP . 77.7 t -65.87 110.19 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.55 16.03 41.3 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 8.7 mtt-85 -120.72 86.64 2.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -1.171 . . . . 0.0 109.44 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -47.08 172.46 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.316 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 54' ' ' SER . 52.2 Cg_exo -50.95 123.78 12.46 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.885 1.723 . . . . 0.0 110.037 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 1.8 m-20 -43.09 155.89 0.27 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.604 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 60' ' ' VAL . 53.7 Cg_endo -71.68 -6.87 20.03 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.873 1.715 . . . . 0.0 110.142 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -34.65 18.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.06 26.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.447 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 57' ' ' PRO . 11.1 p -65.57 -36.55 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.875 . . . . 0.0 109.389 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 79.2 p -60.74 -15.96 34.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.3 t -85.51 -52.5 5.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.578 ' HB3' HG23 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -88.26 6.42 37.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.584 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.477 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 12.9 tpt180 -112.7 -36.09 5.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.504 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 61' ' ' SER . 53.8 t30 -52.37 -47.14 66.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.474 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -74.45 -49.71 21.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.41 93.54 0.71 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.917 HD11 ' HA ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -118.22 -178.92 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -1.163 . . . . 0.0 109.407 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -120.64 104.45 9.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.171 -0.955 . . . . 0.0 109.505 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 t -137.93 123.1 19.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.439 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.89 69.58 0.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -0.926 . . . . 0.0 109.459 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -156.18 178.43 10.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.401 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 139.42 52.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -60.56 153.34 23.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.933 . . . . 0.0 109.216 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 74' ' ' ALA . 2.2 mmt85 -149.95 125.6 10.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.557 ' H ' HG22 ' A' ' 51' ' ' VAL . 1.4 tt0 -51.11 140.03 16.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.584 HG12 ' N ' ' A' ' 78' ' ' THR . 54.5 t -56.68 165.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.584 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -163.96 164.25 23.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.503 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.611 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.01 -37.68 33.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.292 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.424 ' O ' ' OG1' ' A' ' 84' ' ' THR . 1.1 tp10 -59.98 -52.7 64.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.884 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 1.1 m-20 -54.28 -49.39 69.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.142 -0.973 . . . . 0.0 110.11 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.872 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 62.9 m-85 -48.85 -68.74 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.145 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.479 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 4.1 p -66.38 -10.86 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.233 -0.917 . . . . 0.0 109.994 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 85' ' ' PHE . 3.3 m -78.43 -85.14 0.07 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.639 ' N ' HG22 ' A' ' 84' ' ' THR . 51.9 m-85 -62.09 132.63 53.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.587 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -72.11 -15.17 61.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.857 . . . . 0.0 109.465 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.7 m-85 -124.89 136.35 53.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.32 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.933 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 2.0 mt -142.74 89.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 109.254 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.816 HD23 ' HB3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -112.79 148.18 35.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.872 -1.143 . . . . 0.0 109.547 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.533 ' SG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -99.22 -179.58 4.28 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.262 -0.899 . . . . 0.0 108.654 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.822 ' CE ' ' SG ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -76.01 1.54 15.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.088 -1.007 . . . . 0.0 109.604 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 20.3 p30 178.34 -165.36 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.126 -0.984 . . . . 0.0 109.382 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.504 ' CB ' HD22 ' A' ' 115' ' ' LEU . 1.9 tt0 -97.0 -31.11 12.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.714 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.4 p -45.37 -41.17 8.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.928 . . . . 0.0 109.79 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -90.01 -26.35 20.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.206 -0.934 . . . . 0.0 109.795 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.582 HD12 ' HB3' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -62.15 -28.92 69.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.105 -0.997 . . . . 0.0 109.717 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -49.97 -21.87 1.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.702 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -104.09 -33.33 8.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.726 HD11 HG11 ' A' ' 11' ' ' VAL . 11.2 mt -74.09 -7.69 53.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.854 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.525 ' HB2' HD22 ' A' ' 96' ' ' LEU . 54.2 t-20 -90.33 -23.06 21.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -96.67 -9.17 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 109.698 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.794 ' O ' HG23 ' A' ' 106' ' ' VAL . 1.8 mmmt -73.36 -26.79 61.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.602 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.41 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 1.1 p -52.89 -42.37 65.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.566 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.37 -61.28 2.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.478 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.28 -21.32 5.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.247 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 102' ' ' LYS . 97.6 t -79.68 130.21 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.511 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -76.47 117.84 18.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.272 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.4 42.7 27.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 109.233 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.14 144.65 6.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.825 . . . . 0.0 109.946 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -135.17 2.51 3.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 0.0 109.202 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.933 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -80.71 102.01 9.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.118 -0.989 . . . . 0.0 109.904 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.46 95.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.691 HD13 ' O ' ' A' ' 111' ' ' ALA . 2.1 mm -65.33 158.44 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.071 -1.018 . . . . 0.0 110.321 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.816 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER 177.31 -168.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -147.21 147.88 30.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.048 -1.032 . . . . 0.0 109.68 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.725 HD22 ' SG ' ' A' ' 148' ' ' CYS . 69.0 tp -53.1 99.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . -175.24 177.18 47.26 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 1.7 m 79.6 -73.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.969 . . . . 0.0 109.689 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -100.67 57.82 0.92 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.949 . . . . 0.0 109.395 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -116.78 144.05 32.63 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.387 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CB ' ' NH2' ' A' ' 147' ' ' ARG . 55.7 Cg_endo -72.9 -163.56 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.887 1.725 . . . . 0.0 110.214 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER 73.58 -151.66 0.05 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.599 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -126.05 77.67 1.7 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.459 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.91 43.94 26.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.48 143.85 26.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.857 . . . . 0.0 109.487 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.1 mm -138.12 130.29 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 127' ' ' ILE . 10.9 tt -84.42 71.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.259 -0.9 . . . . 0.0 109.017 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.481 ' HA ' ' OD2' ' A' ' 92' ' ' ASP . 2.4 mt-10 -72.06 -67.47 0.54 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.732 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.49 79.36 54.52 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.723 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.42 ' HG3' ' CG1' ' A' ' 127' ' ' ILE . 53.6 Cg_endo -72.43 -21.05 23.2 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.968 1.779 . . . . 0.0 110.078 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.561 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 10.1 t80 -59.5 -24.7 63.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -111.25 84.32 1.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.878 . . . . 0.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -130.68 -135.96 3.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -122.4 -157.32 0.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -1.101 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.08 -22.0 12.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.43 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.72 25.21 2.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.407 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 138' ' ' PHE . 10.1 t0 -122.84 -142.55 0.32 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.271 -0.893 . . . . 0.0 109.151 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.959 ' O ' HG12 ' A' ' 141' ' ' VAL . 1.3 t80 82.73 -42.98 0.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.554 -0.716 . . . . 0.0 109.793 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.07 -35.67 80.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.989 -1.069 . . . . 0.0 109.41 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.8 m -66.9 -28.66 68.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.275 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.959 HG12 ' O ' ' A' ' 138' ' ' PHE . 2.3 p -60.54 -30.84 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.274 -0.891 . . . . 0.0 109.366 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 146' ' ' VAL . 1.7 t80 -85.09 -53.13 5.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 0.0 109.271 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -28.27 10.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.14 -47.74 7.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.497 ' CB ' ' HB ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -53.57 -21.87 7.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.333 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 1.018 ' HA ' HG11 ' A' ' 25' ' ' VAL . 60.2 t -51.03 -55.18 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.228 -0.92 . . . . 0.0 109.286 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -79.13 -18.46 53.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.292 -0.88 . . . . 0.0 109.304 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.822 ' SG ' ' CE ' ' A' ' 91' ' ' MET . 36.1 t -46.41 -25.88 0.74 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.088 -1.007 . . . . 0.0 108.844 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.591 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 2.5 p -119.95 -40.68 2.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.421 -0.8 . . . . 0.0 109.274 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.746 ' HG3' HD22 ' A' ' 29' ' ' LEU . 7.0 ttm-85 -62.23 -52.29 64.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 108.876 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -58.73 -18.82 34.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.878 . . . . 0.0 108.985 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.744 ' CE2' HD11 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -90.23 -25.68 20.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.783 . . . . 0.0 109.6 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.624 HD11 ' CD1' ' A' ' 35' ' ' ILE . 11.5 tp -75.61 -21.93 57.34 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.048 -1.032 . . . . 0.0 108.688 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -68.31 -48.39 65.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.902 . . . . 0.0 109.223 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -64.56 -48.85 73.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.014 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 152' ' ' PHE . 16.2 m -101.41 51.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.112 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.487 -179.833 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.343 0.592 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 3' ' ' GLN . 5.2 tt0 -155.43 145.0 21.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.36 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER 43.88 69.37 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.218 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.539 HG22 ' N ' ' A' ' 5' ' ' THR . 8.2 p -85.23 161.71 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.853 . . . . 0.0 109.803 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 1.014 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -63.9 101.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.408 -0.807 . . . . 0.0 109.543 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.718 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -44.21 166.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.83 179.226 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.605 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 15.5 p -136.39 112.86 9.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.931 -1.105 . . . . 0.0 109.275 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.79 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -115.71 134.22 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 109.64 -179.524 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.99 HD13 ' CD1' ' A' ' 85' ' ' PHE . 1.9 tp -124.73 118.17 25.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.26 102.34 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.021 -1.049 . . . . 0.0 109.755 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.795 HG13 ' O ' ' A' ' 44' ' ' GLY . 3.0 t -106.26 151.07 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 108.977 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.48 136.56 11.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.954 -1.091 . . . . 0.0 109.815 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -47.91 117.19 1.77 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 109.057 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.36 75.27 1.18 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.503 ' O ' ' CG ' ' A' ' 20' ' ' PRO . 5.3 t-20 -57.64 -14.99 6.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -1.11 . . . . 0.0 109.625 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.707 HD12 ' N ' ' A' ' 17' ' ' CYS . 1.1 pp -111.01 -158.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.999 -1.063 . . . . 0.0 109.301 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.707 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER 59.81 115.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.043 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER 77.9 -2.88 2.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.286 -179.508 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.893 ' O ' HD12 ' A' ' 21' ' ' ILE . 1.4 t 45.26 96.85 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 109.856 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 52.8 Cg_exo -48.08 88.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.562 1.508 . . . . 0.0 109.667 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 19' ' ' SER . 2.0 mp -78.21 -11.72 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -0.868 . . . . 0.0 109.946 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.851 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -67.52 -43.18 81.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.99 -1.069 . . . . 0.0 108.976 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ALA . 1.6 tm-20 -76.15 -57.12 4.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.255 -0.903 . . . . 0.0 109.052 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.623 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -44.76 -41.25 6.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.887 . . . . 0.0 108.982 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.056 HG11 ' HA ' ' A' ' 146' ' ' VAL . 53.0 t -62.85 -51.23 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.807 . . . . 0.0 109.23 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.653 ' CD1' HG12 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -46.28 -36.72 6.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 108.547 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.427 ' HD2' ' OD1' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -62.07 -52.83 62.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.058 -1.026 . . . . 0.0 108.395 179.066 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -84.18 11.03 8.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 108.955 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.82 HD21 ' CB ' ' A' ' 150' ' ' ARG . 45.5 tp -97.43 -46.97 5.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.401 -0.812 . . . . 0.0 109.107 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.732 HG11 HD11 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -91.09 -39.24 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.212 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.5 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 0.4 OUTLIER -69.54 -8.44 47.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.593 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 9.0 t70 -95.99 -15.46 22.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.013 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 4.6 tp60 -102.68 -82.0 0.49 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.488 -0.757 . . . . 0.0 109.245 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 26.0 t30 172.84 46.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.449 -0.782 . . . . 0.0 108.899 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.806 HD12 HD21 ' A' ' 153' ' ' LEU . 1.4 pt -143.64 17.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.793 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.617 ' HB3' HG22 ' A' ' 30' ' ' VAL . 79.3 p -85.39 -26.97 26.12 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.792 -1.192 . . . . 0.0 109.355 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -58.49 -27.05 64.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 1.014 ' HA ' HG22 ' A' ' 5' ' ' THR . 2.6 m-20 -118.96 42.69 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.576 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.79 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 11.6 m95 -150.0 119.8 7.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.994 -1.066 . . . . 0.0 110.563 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.62 91.63 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.732 HD11 HG11 ' A' ' 30' ' ' VAL . 3.2 mt -92.41 129.1 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.918 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -154.2 137.15 15.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.319 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -107.75 178.07 4.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 109.394 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.795 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -168.27 171.21 42.46 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.47 ' O ' ' OE1' ' A' ' 76' ' ' GLN . . . -92.85 151.91 19.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -1.138 . . . . 0.0 109.419 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 13' ' ' LEU . 6.9 p -99.58 -17.21 6.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.28 -0.888 . . . . 0.0 108.786 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.458 ' O ' ' OE1' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -101.14 -148.34 0.37 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.386 -0.822 . . . . 0.0 109.505 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -150.28 16.11 0.82 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.079 -1.013 . . . . 0.0 109.715 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -100.22 0.22 39.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.6 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.444 ' OD1' ' CB ' ' A' ' 45' ' ' ALA . 8.1 p30 -118.6 5.8 11.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.9 t -56.29 110.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.473 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.55 29.84 9.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.542 ' HB3' HG21 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -123.59 131.88 53.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 109.352 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 10.1 p -95.12 162.5 24.66 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 54' ' ' SER . 52.7 Cg_exo -50.99 144.42 27.92 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.974 1.783 . . . . 0.0 110.166 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 8.0 m-20 -53.54 153.04 8.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.457 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 60' ' ' VAL . 50.1 Cg_endo -71.14 -15.05 32.07 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.043 1.829 . . . . 0.0 110.116 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -37.46 16.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.548 ' CB ' ' HB2' ' A' ' 19' ' ' SER . . . -90.15 -11.57 40.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.504 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -74.63 -30.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.497 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.89 0.18 21.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.586 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.485 ' C ' HD23 ' A' ' 63' ' ' LEU . 57.9 m -90.0 -18.44 26.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.322 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.8 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.12 -52.79 4.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.175 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -64.87 -10.44 28.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.875 . . . . 0.0 109.62 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.65 -85.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.604 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.585 ' CD2' HG12 ' A' ' 68' ' ' ILE . 1.7 p-80 -60.55 -25.42 66.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 109.555 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.26 107.62 1.66 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.623 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 17.1 mm -148.54 154.33 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -1.157 . . . . 0.0 109.493 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.505 ' ND2' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -137.52 119.35 15.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.483 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 t -121.57 174.98 6.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.981 . . . . 0.0 109.453 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -167.9 75.27 0.13 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -169.33 134.01 1.45 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.2 tptt -95.34 59.23 2.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.206 -0.934 . . . . 0.0 109.495 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 53' ' ' ARG . . . 51.79 -92.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.682 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER 59.53 151.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 109.534 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' A' ' 76' ' ' GLN . 34.2 tp60 -90.27 133.52 34.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 78' ' ' THR . 47.5 t -45.32 161.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.494 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.504 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -126.14 170.55 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.727 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.909 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -58.11 -53.52 57.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.862 . . . . 0.0 109.534 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -50.59 -42.81 56.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 109.746 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.466 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 6.7 m-20 -58.56 -42.19 87.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.673 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 1.021 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 10.5 m-85 -57.22 -51.2 70.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 109.334 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -80.17 -5.35 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.988 -1.07 . . . . 0.0 109.68 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 16.2 m -81.27 -58.7 2.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -0.831 . . . . 0.0 110.236 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.99 ' CD1' HD13 ' A' ' 9' ' ' LEU . 38.8 m-85 -77.54 165.2 24.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 110.192 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -108.68 -36.69 6.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -0.807 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -109.44 78.77 1.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 108.651 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.953 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.2 mt -86.44 87.26 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.915 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.603 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -96.98 174.75 6.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.025 -1.047 . . . . 0.0 109.205 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 1.1 p -149.93 148.2 28.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.383 -0.823 . . . . 0.0 109.375 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.615 ' HE2' ' SG ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -49.27 147.71 2.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 109.295 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.995 ' OD2' HD12 ' A' ' 126' ' ' ILE . 0.7 OUTLIER -52.23 -20.31 2.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 109.794 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 92' ' ' ASP . 2.3 mt-10 -43.02 -69.04 0.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 96' ' ' LEU . 12.2 t -87.34 85.62 7.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.904 . . . . 0.0 108.83 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.498 ' O ' ' C ' ' A' ' 96' ' ' LEU . 20.2 t-20 -50.28 86.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.752 -0.592 . . . . 0.0 110.285 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.052 HD21 ' CG2' ' A' ' 113' ' ' ILE . 0.7 OUTLIER 29.93 51.7 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.185 0.517 . . . . 0.0 110.683 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 98' ' ' ASP . 3.0 ttt85 -88.08 -91.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 109.59 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -57.22 -50.71 72.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 109.619 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.664 HD23 ' CZ ' ' A' ' 82' ' ' PHE . 5.0 mt -48.89 -26.97 2.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 0.0 109.678 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.64 ' HB2' HD22 ' A' ' 96' ' ' LEU . 34.4 t-20 -79.85 -38.31 33.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.96 3.06 54.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.626 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.941 ' O ' HG23 ' A' ' 106' ' ' VAL . 23.8 mmmt -84.88 -25.77 27.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.331 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -29.16 68.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -68.32 -60.21 2.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -54.42 -23.55 16.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 109.136 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 102' ' ' LYS . 38.8 t -82.3 105.71 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.426 -0.796 . . . . 0.0 109.415 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -44.31 117.27 1.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.546 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 107' ' ' LYS . 5.4 m-20 42.83 58.26 3.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.649 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -47.76 164.26 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.33 -0.856 . . . . 0.0 110.333 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.649 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 1.8 tpt180 -150.54 61.1 0.95 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 1.021 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -147.15 89.72 1.82 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.253 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 111' ' ' ALA . 6.1 mtpp -44.0 110.17 0.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 1.052 ' CG2' HD21 ' A' ' 96' ' ' LEU . 2.1 mm -87.2 144.42 9.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.036 -1.04 . . . . 0.0 110.503 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.493 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -163.95 -179.64 6.39 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.472 ' CD1' ' OD2' ' A' ' 92' ' ' ASP . 1.0 OUTLIER -132.35 146.3 51.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.94 -1.1 . . . . 0.0 109.482 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.848 HD13 ' SG ' ' A' ' 148' ' ' CYS . 1.4 tp -43.97 120.21 2.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.36 157.98 23.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.48 100.7 0.38 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -1.123 . . . . 0.0 109.523 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -90.18 -87.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -0.873 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.58 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -67.01 -61.62 4.63 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.695 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 55.2 Cg_endo -71.9 162.45 41.9 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.765 1.643 . . . . 0.0 110.361 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -108.69 24.52 12.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.53 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.95 104.76 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.942 . . . . 0.0 109.633 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.98 60.85 6.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.475 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -109.12 -54.35 2.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 109.513 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.995 HD12 ' OD2' ' A' ' 92' ' ' ASP . 8.2 mm 61.8 145.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 77.3 mt -109.04 93.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.398 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.527 ' CG ' ' OD1' ' A' ' 92' ' ' ASP . 34.4 mt-10 -124.29 8.35 8.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.577 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -94.56 146.56 31.69 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.451 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.94 170.75 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.928 1.752 . . . . 0.0 110.232 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.559 ' CD1' ' O ' ' A' ' 131' ' ' TYR . 14.2 p90 -103.11 125.89 50.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.458 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -146.69 111.24 5.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.865 . . . . 0.0 109.467 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -45.91 95.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -135.35 6.73 3.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -1.187 . . . . 0.0 109.472 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.652 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 1.3 m-20 70.54 164.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 73.77 5.29 4.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.492 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -135.4 105.48 6.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.555 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -174.86 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.541 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -86.31 -17.1 35.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.531 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 36.7 m -82.4 -25.0 34.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.75 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 74.2 t -76.55 -44.86 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.549 ' CD1' HG21 ' A' ' 21' ' ' ILE . 2.6 t80 -74.74 -38.32 62.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.572 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -61.66 -61.52 2.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 148' ' ' CYS . 4.0 mt-30 -61.74 -29.36 70.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 109.507 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.806 ' SG ' ' N ' ' A' ' 22' ' ' ALA . 4.7 m -58.88 -40.2 83.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 109.68 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 1.056 ' HA ' HG11 ' A' ' 25' ' ' VAL . 84.0 t -51.57 -72.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 109.53 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.416 ' HG2' ' HB2' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -65.24 -11.29 39.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.419 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.851 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 20.2 t -53.78 -26.2 22.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.102 -0.999 . . . . 0.0 108.797 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.597 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -119.11 -30.57 4.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.394 -0.816 . . . . 0.0 109.251 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.82 ' CB ' HD21 ' A' ' 29' ' ' LEU . 11.0 ttt180 -67.48 -52.42 39.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.937 . . . . 0.0 108.856 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.416 ' HB2' ' HG2' ' A' ' 147' ' ' ARG . . . -55.9 -21.38 20.0 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.449 -0.782 . . . . 0.0 109.023 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.848 ' O ' HG22 ' A' ' 156' ' ' VAL . 1.5 t80 -90.63 -27.44 19.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.517 -0.74 . . . . 0.0 109.815 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.806 HD21 HD12 ' A' ' 35' ' ' ILE . 7.5 tp -78.06 -25.2 47.61 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.992 -1.067 . . . . 0.0 108.741 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 150' ' ' ARG . 1.8 mt-10 -66.28 -51.15 60.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.922 . . . . 0.0 109.18 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -55.3 25.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.395 -0.816 . . . . 0.0 109.336 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 152' ' ' PHE . 18.6 m -95.4 43.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.262 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.455 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 1.8 tmm_? . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.567 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 54.72 175.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.31 -0.869 . . . . 0.0 109.502 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -102.33 -169.14 1.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.373 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 6' ' ' LYS . 3.9 p -64.71 151.23 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 1.03 HG22 ' HA ' ' A' ' 38' ' ' ASN . 18.1 p -49.99 90.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 0.0 109.571 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.639 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.7 OUTLIER -45.19 170.14 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.035 -1.04 . . . . 0.0 109.396 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.55 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -142.39 146.91 35.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.029 -1.045 . . . . 0.0 109.811 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.876 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -150.78 146.08 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 109.037 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.639 HD13 ' CD1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -133.01 126.74 32.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.722 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.442 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -109.18 124.39 50.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 108.897 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.505 HG13 ' C ' ' A' ' 44' ' ' GLY . 2.1 t -125.35 158.19 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 91' ' ' MET . 0.6 OUTLIER -177.99 131.2 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.794 . . . . 0.0 109.185 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.502 ' HB2' ' ND2' ' A' ' 95' ' ' ASN . 0.7 OUTLIER -43.7 149.98 0.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 109.579 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 50' ' ' ASN . . . 46.76 66.57 1.74 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -88.8 67.64 8.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -1.113 . . . . 0.0 109.695 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -138.71 6.46 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.154 -0.966 . . . . 0.0 109.731 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.647 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 1.7 p 179.75 138.21 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.017 . . . . 0.0 109.618 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.647 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 1.9 mtm180 83.6 -48.6 0.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.815 -0.553 . . . . 0.0 109.65 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.615 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -82.97 -48.53 0.79 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 110.175 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 19' ' ' SER . 63.4 Cg_exo -49.58 -19.4 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.957 1.771 . . . . 0.0 111.047 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.956 HG21 ' HA ' ' A' ' 142' ' ' TYR . 2.5 mp -64.29 -44.93 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.87 -1.144 . . . . 0.0 109.4 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.199 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . . . -61.36 -35.29 77.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.507 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' OE2' ' HB2' ' A' ' 43' ' ' SER . 2.4 tt0 -70.19 -69.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.317 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.832 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -43.64 -33.31 1.17 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.135 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.987 HG11 ' HA ' ' A' ' 146' ' ' VAL . 58.7 t -65.26 -49.62 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.864 . . . . 0.0 108.754 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.836 ' CE2' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -50.41 -29.85 11.09 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -68.48 -50.71 50.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 109.2 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -20.07 66.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.776 HD11 HG12 ' A' ' 25' ' ' VAL . 11.5 mt -86.97 -28.34 22.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.047 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 36' ' ' SER . 2.5 p -90.22 -8.85 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.96 0.95 22.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -115.01 45.93 1.52 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.004 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.574 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -178.7 29.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.5 t30 45.35 45.88 10.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.76 HG12 HG23 ' A' ' 30' ' ' VAL . 1.3 tt -127.39 -1.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.229 0.538 . . . . 0.0 109.795 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.814 ' HA ' HG22 ' A' ' 30' ' ' VAL . 45.8 t -74.08 -45.83 46.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.737 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.87 -12.67 8.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 110.225 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 1.03 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -116.02 37.28 3.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.986 -1.071 . . . . 0.0 109.993 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.876 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 12.8 m95 -150.48 157.76 43.38 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.854 -1.153 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.87 72.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.473 HG21 ' HB3' ' A' ' 26' ' ' PHE . 2.5 mp -89.47 141.13 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 110.248 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.23 -165.83 2.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.503 -0.748 . . . . 0.0 109.048 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.462 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -165.67 165.82 18.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.685 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.505 ' C ' HG13 ' A' ' 11' ' ' VAL . . . 178.39 -170.48 42.56 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.38 -176.67 3.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.199 . . . . 0.0 109.346 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.812 HG13 ' HG ' ' A' ' 99' ' ' LEU . 39.3 t -93.7 -0.37 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.823 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.56 -178.24 6.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.514 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 2.0 p-10 -84.3 69.36 10.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -99.26 -77.68 0.52 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.423 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 14' ' ' GLY . 30.5 m120 -96.0 37.67 1.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.357 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 80.1 t -64.33 106.84 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.458 ' HA2' ' HG2' ' A' ' 73' ' ' LYS . . . 106.69 -34.14 5.93 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.601 ' O ' HG22 ' A' ' 16' ' ' ILE . 1.5 mtt180 -61.59 96.91 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -1.174 . . . . 0.0 109.487 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.75 164.55 1.59 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 56' ' ' ASP . 53.4 Cg_exo -50.57 119.52 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.035 1.823 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -43.41 150.07 0.54 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.688 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.59 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 50.9 Cg_exo -52.13 -18.03 6.73 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.098 1.865 . . . . 0.0 110.613 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -78.76 -46.04 19.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.052 -1.03 . . . . 0.0 109.889 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . . . -90.04 1.91 55.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -0.937 . . . . 0.0 110.055 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.59 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 5.5 p -90.02 -44.61 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.048 -1.032 . . . . 0.0 109.681 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.535 ' N ' HG13 ' A' ' 60' ' ' VAL . 53.3 p -79.07 -15.56 58.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.599 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.446 ' C ' HD23 ' A' ' 63' ' ' LEU . 1.2 m -73.8 -27.6 61.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 109.349 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.806 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -89.44 -52.57 4.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 108.943 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -14.09 16.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.814 . . . . 0.0 109.554 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -68.23 -61.06 2.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.547 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -69.67 -35.21 74.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.155 -0.966 . . . . 0.0 109.598 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 68' ' ' ILE . . . 141.11 -10.11 2.77 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.832 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 17.0 mm -43.82 159.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -1.154 . . . . 0.0 109.626 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.494 ' N ' HG22 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -131.5 175.37 9.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.522 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -160.09 -86.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 70' ' ' THR . . . 65.62 16.76 10.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -126.4 149.35 49.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.953 . . . . 0.0 109.46 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.458 ' HG2' ' HA2' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -101.58 140.99 35.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.491 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 75' ' ' ARG . . . -42.56 -66.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.822 . . . . 0.0 109.723 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 65.31 164.9 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.343 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.483 ' HG2' ' N ' ' A' ' 77' ' ' VAL . 47.8 tt0 -100.98 156.01 17.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.483 ' N ' ' HG2' ' A' ' 76' ' ' GLN . 91.7 t -81.22 146.96 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.925 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -142.61 161.1 38.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.521 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG2' HG13 ' A' ' 106' ' ' VAL . 2.4 tmtt? -42.87 -34.77 1.01 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.469 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' OG1' ' A' ' 84' ' ' THR . 1.0 OUTLIER -61.57 -53.25 58.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.879 . . . . 0.0 109.681 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.42 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 3.5 m-20 -66.93 -19.01 65.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 109.823 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.897 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 13.1 m-85 -68.88 -68.59 0.39 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 109.532 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.647 HG23 ' HB3' ' A' ' 110' ' ' ARG . 9.9 p -67.29 -23.25 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 4.6 m -60.65 -67.59 0.38 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.639 ' CD1' HD13 ' A' ' 9' ' ' LEU . 82.5 m-85 -74.83 156.21 36.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 0.0 109.532 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.447 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -90.32 -36.33 14.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.322 -0.861 . . . . 0.0 109.387 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 7' ' ' SER . 17.5 m-85 -109.77 151.91 26.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.575 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.93 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 1.7 mt -153.69 80.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 108.833 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.507 HD21 ' CE1' ' A' ' 152' ' ' PHE . 0.1 OUTLIER -91.58 -174.75 3.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 109.583 -179.436 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.736 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -148.31 172.15 14.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.303 -0.873 . . . . 0.0 109.212 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.736 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -84.54 45.4 1.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 109.704 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.463 ' OD2' ' CG2' ' A' ' 127' ' ' ILE . 2.6 m-20 65.15 -144.52 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.537 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 128' ' ' GLU . 27.6 mt-10 73.5 158.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.6 m -81.08 6.41 13.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.624 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 13' ' ' LEU . 2.9 m120 -71.8 -9.32 58.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 99' ' ' LEU . 4.4 mt -81.45 -10.16 59.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.414 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -61.28 -21.84 64.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.01 -39.58 8.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.833 . . . . 0.0 109.467 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.812 ' HG ' HG13 ' A' ' 46' ' ' VAL . 8.6 mt -66.94 -18.76 65.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.93 . . . . 0.0 109.39 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -77.89 -33.48 51.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.86 -19.92 24.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.74 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -57.3 -35.09 69.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 109.452 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.538 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 0.3 OUTLIER -50.2 -49.09 53.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.375 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -64.71 -36.23 83.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.136 -0.977 . . . . 0.0 109.436 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.59 -4.8 55.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.212 -0.93 . . . . 0.0 109.473 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.957 HG11 ' SG ' ' A' ' 109' ' ' CYS . 41.2 t -86.32 117.98 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 108' ' ' ASN . 0.1 OUTLIER -53.14 105.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 108.644 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.457 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 15.7 m120 60.52 70.68 0.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.033 -1.042 . . . . 0.0 108.576 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.957 ' SG ' HG11 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -88.57 136.44 32.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 110.364 -179.045 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.647 ' HB3' HG23 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -128.96 1.81 5.31 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.022 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.93 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -83.3 110.58 18.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.446 -0.784 . . . . 0.0 110.164 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.16 125.39 26.23 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -100.04 132.0 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.94 -1.1 . . . . 0.0 110.29 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 10.3 mt-10 -163.79 -174.04 3.49 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -125.24 165.87 17.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.99 HD21 ' SG ' ' A' ' 148' ' ' CYS . 3.5 tp -42.51 -74.4 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.701 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.88 -110.73 3.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.565 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 1.8 t -151.56 136.24 17.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.461 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 118' ' ' SER . 23.9 m-85 -136.76 32.14 2.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.929 . . . . 0.0 109.586 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 163.06 -51.53 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.0 Cg_exo -49.46 162.62 0.53 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.799 1.666 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.77 45.04 1.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.883 . . . . 0.0 109.43 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 166.43 33.24 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -0.971 . . . . 0.0 109.413 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.03 90.08 4.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.343 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tt -103.04 138.68 39.57 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -0.925 . . . . 0.0 109.614 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.494 HG22 ' HG3' ' A' ' 128' ' ' GLU . 12.0 mm -143.93 125.95 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.398 -0.813 . . . . 0.0 109.301 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 127' ' ' ILE . 1.5 tt -105.08 78.22 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 109.113 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.494 ' HG3' HG22 ' A' ' 126' ' ' ILE . 6.7 mt-10 -77.12 -95.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 128' ' ' GLU . 2.0 m-20 47.51 95.12 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.323 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 131' ' ' TYR . 69.4 Cg_exo -47.33 -67.84 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.774 1.65 . . . . 0.0 110.347 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 130' ' ' PRO . 20.9 t80 178.83 61.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.505 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' GLY . 87.9 m-85 -141.14 16.92 2.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.457 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 132' ' ' TYR . . . 59.23 154.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -120.96 -26.81 5.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -1.114 . . . . 0.0 109.471 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.84 -160.92 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.362 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.67 77.34 6.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.405 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.21 108.96 4.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.519 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 8.9 t80 -123.23 -51.28 1.88 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.497 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -69.62 -33.28 72.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.503 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.2 m -49.2 -43.87 42.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.464 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.7 t -65.9 -48.2 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.848 . . . . 0.0 109.493 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.956 ' HA ' HG21 ' A' ' 21' ' ' ILE . 2.8 t80 -53.0 -27.98 21.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.332 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -83.73 -38.29 21.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.82 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -75.54 -11.43 60.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.686 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 1.199 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -89.97 -10.35 45.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.987 ' HA ' HG11 ' A' ' 25' ' ' VAL . 53.5 t -62.01 -48.94 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 109.234 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 1.2 mtt180 -79.72 -15.0 58.34 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.178 -0.951 . . . . 0.0 109.376 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.99 ' SG ' HD21 ' A' ' 116' ' ' LEU . 21.2 m -50.16 -24.0 2.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.086 -1.009 . . . . 0.0 108.635 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.605 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -120.18 -39.17 2.83 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.443 -0.786 . . . . 0.0 109.025 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.463 ' HG3' HD22 ' A' ' 29' ' ' LEU . 13.7 ttp85 -63.6 -53.71 47.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 108.703 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -60.17 -36.13 76.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -0.774 . . . . 0.0 109.175 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.949 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 6.8 t80 -74.84 -19.12 60.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.384 -0.822 . . . . 0.0 109.515 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.455 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 14.4 tp -77.96 -19.59 54.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.099 -1.0 . . . . 0.0 108.744 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -70.59 -46.89 62.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 108.769 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -66.74 -53.71 30.48 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 0.0 108.986 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.949 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 5.7 m -92.72 34.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 109.086 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.455 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 117.944 -1.026 . . . . 0.0 109.587 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 2.1 tt0 68.12 34.53 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.834 . . . . 0.0 109.526 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.61 42.68 3.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 5' ' ' THR . 9.9 p -75.16 162.84 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 1.098 HG22 ' HA ' ' A' ' 38' ' ' ASN . 65.8 p -74.68 108.82 7.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.661 ' CB ' ' CH2' ' A' ' 39' ' ' TRP . 35.8 mttp -63.7 -168.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.9 -1.125 . . . . 0.0 108.993 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.575 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -145.99 107.28 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 109.834 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.726 HG12 ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -111.86 150.57 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.713 HD22 HG12 ' A' ' 88' ' ' ILE . 1.4 tt -149.83 104.17 3.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.139 -0.975 . . . . 0.0 109.555 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.483 ' HE1' HD12 ' A' ' 116' ' ' LEU . 2.8 m-85 -81.96 164.38 21.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.95 . . . . 0.0 109.379 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.783 HG11 HD11 ' A' ' 99' ' ' LEU . 58.5 t -150.31 161.87 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.133 -0.979 . . . . 0.0 109.936 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.526 ' N ' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -178.4 142.09 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.39 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.732 HD11 ' HH2' ' A' ' 49' ' ' TRP . 13.2 tp -43.58 -79.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.686 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 15' ' ' ASN . . . -46.99 -74.33 0.25 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.524 HD22 ' HB2' ' A' ' 45' ' ' ALA . 25.8 t30 76.61 20.47 1.42 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -1.124 . . . . 0.0 109.321 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 15' ' ' ASN . 1.2 pp -156.65 30.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.444 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.6 m -135.01 -84.84 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.585 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.543 ' HB2' ' CG2' ' A' ' 141' ' ' VAL . 0.0 OUTLIER -115.42 -7.84 12.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -75.06 -51.02 3.68 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.786 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 19' ' ' SER . 55.9 Cg_exo -49.66 -21.23 5.23 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.855 1.703 . . . . 0.0 110.674 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.982 HG21 ' HA ' ' A' ' 142' ' ' TYR . 7.9 mm -60.31 -48.6 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.315 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.576 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -64.72 -20.27 66.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.932 . . . . 0.0 109.738 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.513 ' OE1' ' CB ' ' A' ' 43' ' ' SER . 4.7 mt-10 -77.22 -81.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.12 -0.987 . . . . 0.0 109.521 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.686 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -45.21 -40.28 7.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.31 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.022 ' HA ' HD11 ' A' ' 68' ' ' ILE . 54.1 t -59.87 -51.34 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.22 -0.925 . . . . 0.0 109.402 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.919 ' CE1' HG12 ' A' ' 30' ' ' VAL . 1.2 t80 -46.41 -42.06 14.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.024 . . . . 0.0 108.698 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -55.12 -59.81 4.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 0.1 OUTLIER -76.73 2.88 13.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.823 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.691 HD11 HG13 ' A' ' 146' ' ' VAL . 3.2 mt -94.0 -29.89 15.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.149 -0.97 . . . . 0.0 108.733 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.919 HG12 ' CE1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -84.54 -42.51 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.569 ' CA ' ' HB3' ' A' ' 36' ' ' SER . 1.9 t -42.47 -28.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 30' ' ' VAL . 5.7 t70 -58.07 -55.34 36.15 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.474 -0.766 . . . . 0.0 108.992 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.548 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 4.9 tp60 -73.08 -2.79 22.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.91 . . . . 0.0 109.368 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.5 OUTLIER 79.91 54.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.395 -0.815 . . . . 0.0 109.589 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.664 HD11 HD21 ' A' ' 153' ' ' LEU . 5.7 pt -144.78 9.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.141 -0.974 . . . . 0.0 109.987 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.637 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 9.7 p -69.16 -22.88 63.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.85 -1.156 . . . . 0.0 109.124 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.74 -20.64 38.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.312 -0.868 . . . . 0.0 108.799 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 1.098 ' HA ' HG22 ' A' ' 5' ' ' THR . 3.0 m-80 -110.31 44.54 1.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -0.845 . . . . 0.0 109.283 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.726 ' CE3' HG12 ' A' ' 8' ' ' VAL . 10.9 m95 -150.66 129.46 12.42 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.611 -1.236 . . . . 0.0 110.746 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 40' ' ' VAL . 56.6 t -99.14 79.21 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.567 HG12 ' CD2' ' A' ' 26' ' ' PHE . 6.9 mt -89.9 128.2 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.934 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -137.24 -159.53 0.96 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.482 -0.761 . . . . 0.0 109.06 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.513 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 60.3 p -151.85 172.53 16.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.112 -0.992 . . . . 0.0 109.852 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 11' ' ' VAL . . . -146.8 163.45 28.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.524 ' HB2' HD22 ' A' ' 15' ' ' ASN . . . -128.92 -29.53 2.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -1.184 . . . . 0.0 109.878 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.501 HG23 ' CG1' ' A' ' 11' ' ' VAL . 15.8 t 67.23 9.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 109.332 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.593 ' HB3' ' CE2' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -125.43 141.19 52.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.905 . . . . 0.0 109.358 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -84.01 6.28 22.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.697 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.732 ' HH2' HD11 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -102.9 -33.56 9.28 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 109.409 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.435 ' HA ' ' CD ' ' A' ' 53' ' ' ARG . 3.2 m120 -91.98 12.65 21.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.086 -1.009 . . . . 0.0 109.397 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 75' ' ' ARG . 13.3 t -75.33 85.22 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.74 -5.38 9.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.438 ' HB2' HG21 ' A' ' 16' ' ' ILE . 18.5 mtp180 -79.64 104.16 10.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -1.188 . . . . 0.0 109.468 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -66.04 173.98 1.89 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.375 -0.828 . . . . 0.0 109.59 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 53.3 Cg_exo -50.75 137.96 41.78 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.066 1.844 . . . . 0.0 110.288 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -57.37 145.71 66.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.416 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.706 ' O ' HG12 ' A' ' 60' ' ' VAL . 52.5 Cg_exo -50.5 -22.38 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.969 1.78 . . . . 0.0 110.345 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -85.55 -37.71 19.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.534 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.88 -4.91 59.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 109.674 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -80.82 -28.37 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -81.98 -19.01 41.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.498 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.467 ' C ' HD23 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -74.05 -33.91 63.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.511 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.781 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.14 -56.16 3.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.135 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -22.62 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.417 -0.802 . . . . 0.0 109.744 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 61' ' ' SER . 52.2 t-20 -70.66 -50.89 31.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.67 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -83.48 -5.04 59.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.945 . . . . 0.0 109.696 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.66 102.3 0.26 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.022 HD11 ' HA ' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -126.23 -33.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -1.118 . . . . 0.0 109.56 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 10.3 m120 70.77 49.42 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.355 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.85 142.39 57.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.85 18.17 1.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.502 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -103.01 155.42 18.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' ALA . 11.9 tptt -124.75 26.77 7.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 73' ' ' LYS . . . 56.94 161.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.611 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.564 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -168.27 171.74 9.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.407 -0.808 . . . . 0.0 109.256 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.482 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 2.6 tt0 -93.19 21.2 6.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.321 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 78' ' ' THR . 0.8 OUTLIER 52.2 178.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 109.598 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER 176.0 162.86 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.654 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -44.11 -35.99 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 109.469 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 84' ' ' THR . 2.9 tp10 -59.61 -48.86 80.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.783 . . . . 0.0 109.555 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.441 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -65.3 -13.3 58.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.744 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 6.3 m-85 -80.64 -75.86 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.729 HG23 ' HG2' ' A' ' 110' ' ' ARG . 14.8 p -54.08 -38.05 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 108.81 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.512 ' N ' HG13 ' A' ' 83' ' ' VAL . 38.8 m -58.02 -65.34 0.66 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.657 -0.652 . . . . 0.0 109.451 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.587 ' CE2' ' HB2' ' A' ' 42' ' ' ASP . 79.2 m-85 -81.36 125.3 30.21 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.33 -0.856 . . . . 0.0 109.499 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -73.8 -17.08 61.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.312 -0.867 . . . . 0.0 109.406 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 7' ' ' SER . 4.4 m-85 -130.07 131.08 45.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 109.861 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.852 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 5.1 mt -135.48 88.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 108.754 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -104.74 165.48 11.03 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.856 -1.152 . . . . 0.0 109.968 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.657 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -143.43 166.77 23.85 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.657 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -68.47 139.88 55.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.325 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.495 ' HB2' HD12 ' A' ' 126' ' ' ILE . 52.9 t0 -43.88 126.02 4.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 1.2 tt0 176.21 161.31 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.294 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -75.76 -6.86 52.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -74.73 -7.87 54.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.913 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.646 ' HG ' ' SG ' ' A' ' 90' ' ' CYS . 0.6 OUTLIER -89.19 7.04 37.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.937 . . . . 0.0 109.645 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -14.73 58.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 99' ' ' LEU . 2.8 p30 -92.77 -33.64 14.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.553 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.785 ' HB3' HG21 ' A' ' 113' ' ' ILE . 20.3 mt -71.58 -37.33 71.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.57 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.07 -31.69 71.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.543 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -10.0 45.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -71.69 -24.03 61.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.95 . . . . 0.0 109.56 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.41 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 1.8 p -70.02 -11.31 60.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.6 -23.97 21.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.581 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -102.7 8.99 39.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.925 . . . . 0.0 109.499 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.654 HG13 ' HG2' ' A' ' 79' ' ' LYS . 24.4 t -101.85 143.37 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 109.345 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 108' ' ' ASN . 5.7 mtmt -75.31 121.75 22.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 109.298 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 107' ' ' LYS . 2.2 m120 43.78 41.45 3.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.172 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.518 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -42.92 142.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.349 -0.844 . . . . 0.0 110.138 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.729 ' HG2' HG23 ' A' ' 83' ' ' VAL . 24.5 mmm180 -123.39 -2.57 8.49 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.852 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -84.24 106.68 16.05 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.39 -0.819 . . . . 0.0 110.722 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.95 98.02 2.41 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.785 HG21 ' HB3' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -72.85 131.28 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -0.999 . . . . 0.0 110.483 -178.377 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.8 tt0 -172.8 148.54 1.86 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.602 ' HB3' HD12 ' A' ' 96' ' ' LEU . 1.6 pp -90.66 157.0 17.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.438 -1.414 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.905 HD11 ' O ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -40.13 -68.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.483 -0.761 . . . . 0.0 109.925 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.563 ' N ' HD12 ' A' ' 115' ' ' LEU . . . 66.43 168.82 3.07 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.1 m -69.15 88.91 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.513 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.495 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -63.05 -37.25 86.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.454 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.569 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 166.68 -63.14 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.581 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 45.3 Cg_endo -68.72 -18.19 42.22 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.804 1.669 . . . . 0.0 110.365 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.89 162.27 19.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.27 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 124' ' ' GLN . 12.5 ptpt -143.35 54.14 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.932 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.449 ' CB ' ' O ' ' A' ' 123' ' ' LYS . 0.6 OUTLIER 71.74 61.11 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -158.35 44.36 0.3 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.922 . . . . 0.0 109.437 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -89.62 130.84 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.957 . . . . 0.0 109.387 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 126' ' ' ILE . 5.4 mt -41.58 99.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.749 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.47 ' HG2' ' OD2' ' A' ' 92' ' ' ASP . 31.5 mt-10 -117.53 28.94 8.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 0.0 109.38 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.13 148.3 35.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.1 -37.06 5.07 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.013 1.808 . . . . 0.0 110.114 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -161.79 -53.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.238 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -132.85 98.86 4.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.389 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.21 -47.51 89.24 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.15 -164.24 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -1.134 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -104.31 150.76 24.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.925 . . . . 0.0 109.455 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 70.56 11.38 7.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.57 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 0.5 OUTLIER -97.51 10.45 39.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.452 ' O ' HG12 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -76.16 -16.12 59.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.476 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -90.06 -51.8 5.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.609 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.421 ' H ' HG22 ' A' ' 140' ' ' THR . 1.0 OUTLIER -67.73 -19.25 65.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.556 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 142' ' ' TYR . 5.2 p -75.34 -47.4 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.912 . . . . 0.0 109.227 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.982 ' HA ' HG21 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -60.27 -39.5 87.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -39.83 85.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 109.485 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -62.95 -33.76 76.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.87 . . . . 0.0 109.356 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.768 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.2 m -62.18 -21.51 65.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 109.498 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.691 HG13 HD11 ' A' ' 29' ' ' LEU . 86.6 t -56.47 -58.67 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 108.882 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -13.18 61.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.248 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.905 ' O ' HD11 ' A' ' 116' ' ' LEU . 99.6 m -62.77 -12.3 23.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.565 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -125.53 -37.33 2.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -59.35 -42.4 91.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 109.158 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.31 -23.36 67.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 109.091 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 1.137 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 1.5 t80 -89.17 -22.95 22.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.829 . . . . 0.0 109.528 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.664 HD21 HD11 ' A' ' 35' ' ' ILE . 21.4 tp -77.12 -18.03 58.22 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.919 -1.113 . . . . 0.0 108.9 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.86 -47.89 19.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.15 -0.969 . . . . 0.0 109.116 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -67.01 -52.74 38.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 108.977 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 1.137 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 31.4 m -95.19 31.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.367 -0.833 . . . . 0.0 109.078 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.536 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.595 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -104.6 115.76 30.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.513 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -76.38 151.63 36.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.326 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 5' ' ' THR . 7.2 t -133.67 167.06 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.81 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.893 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -78.12 77.93 4.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.427 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.649 ' CG ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -41.22 118.08 0.97 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.342 -0.849 . . . . 0.0 109.657 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -107.01 122.54 46.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.931 -1.105 . . . . 0.0 109.786 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.943 ' O ' HG23 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -125.92 122.39 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 0.0 109.543 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -122.11 145.24 48.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.27 -0.893 . . . . 0.0 108.89 179.437 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 4.0 m-85 -103.86 158.74 16.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.082 -1.011 . . . . 0.0 109.884 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.741 HG22 ' HA3' ' A' ' 44' ' ' GLY . 85.7 t -144.28 147.06 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.416 -0.803 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -160.38 141.46 12.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.534 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' CYS . 9.2 tp -44.49 -68.06 0.23 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.236 -0.915 . . . . 0.0 109.476 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.18 -79.95 0.08 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.479 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 2.0 t-20 65.85 39.19 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.125 -1.221 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 1.7 pp -143.75 13.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.601 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 40.9 t 177.21 -71.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.728 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 19' ' ' SER . 65.6 mtt85 -84.4 75.9 10.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.682 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.581 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 163.19 -50.99 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.697 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 19' ' ' SER . 51.3 Cg_exo -51.59 -19.63 7.71 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.865 1.71 . . . . 0.0 110.589 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.758 HG22 ' SG ' ' A' ' 145' ' ' CYS . 3.4 mt -75.64 -39.77 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.949 . . . . 0.0 109.81 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 1.253 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -62.99 -40.05 96.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.048 -1.033 . . . . 0.0 109.375 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -70.92 -59.22 2.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.908 . . . . 0.0 109.208 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.829 ' HB1' HG22 ' A' ' 68' ' ' ILE . . . -45.95 -34.38 3.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.9 . . . . 0.0 108.992 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.007 HG11 ' HA ' ' A' ' 146' ' ' VAL . 46.0 t -66.25 -47.52 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.35 -0.844 . . . . 0.0 109.284 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.706 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 1.9 t80 -47.98 -43.47 29.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.827 -1.171 . . . . 0.0 108.02 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.475 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -54.2 -62.86 1.38 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.067 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -79.92 10.76 3.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.271 -0.893 . . . . 0.0 110.221 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.832 HD22 ' SG ' ' A' ' 149' ' ' CYS . 48.7 tp -98.58 -34.68 10.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 108.911 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.749 HG23 HG12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -90.86 -44.44 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.247 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -49.35 -29.1 5.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -0.916 . . . . 0.0 109.138 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -80.68 -37.1 31.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 108.993 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.531 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.5 OUTLIER -73.21 -11.0 60.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.413 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 5.5 t-20 78.49 32.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.713 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.781 HD13 HD21 ' A' ' 153' ' ' LEU . 4.6 pt -123.21 3.77 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 109.431 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.593 ' CA ' ' CG2' ' A' ' 30' ' ' VAL . 60.7 p -62.87 -31.38 72.4 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.097 -1.002 . . . . 0.0 109.457 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -54.85 -25.17 26.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.45 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.893 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -126.66 40.21 3.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.751 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.738 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 21.9 m95 -146.92 104.78 3.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.968 -1.083 . . . . 0.0 110.33 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' SER . 45.0 t -97.74 106.77 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.943 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.6 mp -107.37 146.58 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.066 -1.021 . . . . 0.0 110.501 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.444 ' C ' ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -140.66 -164.93 1.83 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.792 . . . . 0.0 109.496 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.1 176.89 8.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.377 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.741 ' HA3' HG22 ' A' ' 11' ' ' VAL . . . -163.86 159.21 31.93 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.489 ' C ' HG23 ' A' ' 46' ' ' VAL . . . -129.78 -31.03 2.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -1.153 . . . . 0.0 109.72 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.646 HG23 ' CG1' ' A' ' 11' ' ' VAL . 3.8 t 74.76 6.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.462 ' HB2' ' CD2' ' A' ' 49' ' ' TRP . 5.5 p -126.5 126.63 44.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.433 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.5 2.59 15.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.577 ' N ' ' CD1' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -102.27 1.46 35.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -0.997 . . . . 0.0 109.362 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -122.05 8.82 9.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.311 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.676 HG13 ' HA ' ' A' ' 75' ' ' ARG . 7.0 t -71.51 92.3 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.301 -0.874 . . . . 0.0 109.436 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . 116.41 7.13 14.48 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -84.45 82.94 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -1.165 . . . . 0.0 109.45 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.469 ' HB3' ' HD2' ' A' ' 73' ' ' LYS . 86.1 p -43.63 153.28 0.4 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 0.0 109.482 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 54' ' ' SER . 54.1 Cg_exo -49.98 -176.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.979 1.786 . . . . 0.0 110.258 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.18 139.08 36.47 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.393 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.629 ' O ' HG12 ' A' ' 60' ' ' VAL . 52.3 Cg_exo -51.03 -21.1 8.31 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.879 1.719 . . . . 0.0 110.369 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -87.94 -39.55 14.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.661 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.49 6.3 34.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -85.39 -38.25 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.458 ' N ' HG13 ' A' ' 60' ' ' VAL . 4.2 m -76.55 -15.85 59.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.355 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.454 ' C ' HD23 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -70.25 -29.43 66.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.846 . . . . 0.0 109.433 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.811 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -87.8 -55.32 3.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 108.902 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 -64.09 -10.51 22.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 109.563 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -59.06 -84.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.811 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -74.53 -24.91 59.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 109.773 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.447 ' O ' HG12 ' A' ' 68' ' ' ILE . . . 131.32 109.94 1.28 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.829 HG22 ' HB1' ' A' ' 24' ' ' ALA . 14.3 mm -150.16 -38.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -1.1 . . . . 0.0 109.603 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 68' ' ' ILE . 4.8 p30 51.63 173.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.81 . . . . 0.0 109.627 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.464 HG23 ' C ' ' A' ' 69' ' ' ASN . 20.5 p -157.43 -54.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 57.81 34.6 24.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.364 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -149.23 124.63 10.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 1.1 tppm? -98.21 27.36 4.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.902 . . . . 0.0 109.575 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 73' ' ' LYS . . . 73.91 131.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.527 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.676 ' HA ' HG13 ' A' ' 51' ' ' VAL . 5.5 mmt180 -143.95 142.22 30.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.535 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 77' ' ' VAL . 2.2 tt0 -66.2 119.94 12.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 78' ' ' THR . 4.1 t -45.43 170.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.516 ' H ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -153.78 175.9 12.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.445 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HG2' HG13 ' A' ' 106' ' ' VAL . 2.5 tmtt? -68.05 -45.03 75.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.624 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' O ' ' OG1' ' A' ' 84' ' ' THR . 37.3 tt0 -57.98 -44.86 87.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.543 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 1.3 m-20 -64.5 -30.35 71.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.801 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 78' ' ' THR . 12.5 m-85 -64.24 -67.01 0.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 109.755 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 110' ' ' ARG . 6.0 p -64.08 -20.07 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 6.0 m -69.96 -32.68 71.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.367 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 81' ' ' ASP . 27.4 m-85 -106.37 158.45 16.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.488 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' C ' ' CD1' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -108.87 -2.57 18.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.631 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.649 ' CE1' ' CG ' ' A' ' 6' ' ' LYS . 5.8 m-85 -138.42 139.85 39.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.855 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -150.78 116.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.233 -0.917 . . . . 0.0 109.288 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.938 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -129.53 153.98 47.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.315 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -122.72 169.83 10.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.36 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.451 ' HB2' ' HB2' ' A' ' 12' ' ' CYS . 6.3 mmt -81.06 74.1 8.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.33 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 94' ' ' SER . 0.1 OUTLIER 39.68 -101.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.778 . . . . 0.0 109.853 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 92' ' ' ASP . 45.9 mt-10 42.64 -96.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.072 -1.017 . . . . 0.0 109.262 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 96' ' ' LEU . 1.3 m -88.2 87.31 7.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 108.601 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -39.14 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.081 0.467 . . . . 0.0 110.773 -179.12 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.074 HD21 ' CG2' ' A' ' 113' ' ' ILE . 0.8 OUTLIER 32.72 36.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.119 0.485 . . . . 0.0 110.394 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 95' ' ' ASN . 7.3 ttt180 -91.21 -17.39 26.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.013 -1.054 . . . . 0.0 110.024 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.7 -51.01 2.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 0.0 110.046 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.6 HD12 ' SG ' ' A' ' 90' ' ' CYS . 11.4 mt -65.73 -18.38 65.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 109.807 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.729 ' HB2' HD22 ' A' ' 96' ' ' LEU . 61.6 t30 -72.97 -22.91 60.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.969 . . . . 0.0 109.168 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -89.68 -23.41 21.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.285 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.858 ' O ' HG23 ' A' ' 106' ' ' VAL . 10.9 mmmt -66.37 -30.12 70.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.343 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.0 p -72.87 -21.77 60.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.337 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -71.83 -35.21 69.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.296 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 1.2 pt20 -89.06 2.8 53.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 109.487 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 102' ' ' LYS . 70.8 t -92.99 122.49 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.189 -0.944 . . . . 0.0 109.299 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -56.48 102.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.274 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 m120 52.48 59.22 4.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.146 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.549 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -54.25 156.96 2.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.4 -0.812 . . . . 0.0 109.803 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.549 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 3.1 mtt180 -123.94 -23.06 4.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.445 -0.785 . . . . 0.0 109.367 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.855 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -70.55 92.41 0.84 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.377 -0.827 . . . . 0.0 110.278 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 101.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 1.074 ' CG2' HD21 ' A' ' 96' ' ' LEU . 1.8 mm -62.65 160.15 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.217 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.576 ' HB3' HD23 ' A' ' 89' ' ' LEU . 1.7 mt-10 173.82 -169.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 118' ' ' SER . 0.7 OUTLIER -147.06 156.87 43.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.925 -1.109 . . . . 0.0 109.582 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.718 HD11 ' HA ' ' A' ' 148' ' ' CYS . 1.0 OUTLIER -59.09 -40.91 86.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -48.74 -28.62 7.21 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -50.79 -49.01 59.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -1.104 . . . . 0.0 109.503 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -86.32 -94.19 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.94 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.477 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 5.3 t70 67.13 67.4 0.61 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.497 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 51.9 Cg_exo -51.62 -173.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.962 1.775 . . . . 0.0 110.208 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 55.07 -92.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.379 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 121' ' ' PRO . 12.0 pttt -102.92 148.34 25.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.337 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -97.26 119.86 36.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -159.03 0.97 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.519 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 1.5 mm -127.92 -2.97 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.695 HG22 ' N ' ' A' ' 128' ' ' GLU . 39.9 mt 60.67 -89.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.145 -0.972 . . . . 0.0 109.265 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.695 ' N ' HG22 ' A' ' 127' ' ' ILE . 4.2 mt-10 45.62 68.52 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.547 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.83 119.54 51.07 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.224 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.46 178.1 5.36 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.773 1.649 . . . . 0.0 110.325 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.442 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 3.9 m-85 -74.16 -1.31 19.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.649 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -92.01 74.11 5.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.383 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 132' ' ' TYR . . . -57.11 -159.97 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.4 -53.7 5.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -1.167 . . . . 0.0 109.389 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -170.89 101.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.25 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 48.75 30.12 2.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.111 -0.993 . . . . 0.0 109.156 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.87 76.43 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.45 -16.75 17.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.37 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.69 -27.33 27.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' VAL . 54.9 m -56.09 -54.63 42.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.454 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 18' ' ' ARG . 10.0 t -43.56 -55.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.262 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -48.51 -46.53 38.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -58.21 8.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.876 . . . . 0.0 109.798 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -67.68 -7.18 24.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -0.95 . . . . 0.0 109.419 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.758 ' SG ' HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -83.19 -28.56 29.21 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.306 -0.871 . . . . 0.0 109.361 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 1.007 ' HA ' HG11 ' A' ' 25' ' ' VAL . 40.3 t -65.35 -50.73 71.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.259 -0.9 . . . . 0.0 109.309 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.41 -19.19 62.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.084 -1.01 . . . . 0.0 108.831 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 1.253 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -52.34 -25.03 8.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.285 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.832 ' SG ' HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -112.45 -33.29 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -0.835 . . . . 0.0 109.856 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.775 ' CA ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -70.65 -56.84 5.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 109.307 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 154' ' ' GLU . . . -54.37 -21.97 11.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.545 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.98 ' O ' HG22 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -90.32 -29.57 18.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 109.763 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.781 HD21 HD13 ' A' ' 35' ' ' ILE . 10.7 tp -75.48 -25.22 57.16 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.939 -1.101 . . . . 0.0 109.0 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -71.31 -32.66 68.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.907 . . . . 0.0 109.218 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.68 -43.45 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.184 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.98 HG22 ' O ' ' A' ' 152' ' ' PHE . 17.1 m -101.34 25.69 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.393 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.5 ' NE ' ' O ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.407 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 61.4 54.2 3.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -120.79 27.83 8.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 109.552 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.88 152.26 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.154 -0.966 . . . . 0.0 109.372 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.935 HG22 ' HA ' ' A' ' 38' ' ' ASN . 1.7 p -120.89 160.82 22.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.654 ' CB ' ' CZ3' ' A' ' 39' ' ' TRP . 11.2 mttm -108.48 -168.42 1.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.25 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.51 ' HB2' ' HA ' ' A' ' 85' ' ' PHE . 3.1 p -140.43 105.37 4.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 109.44 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.829 HG21 ' HE2' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -122.86 143.11 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.412 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.61 HD22 HG12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -140.6 115.34 9.58 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -92.04 157.59 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.076 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.984 HG11 HD11 ' A' ' 99' ' ' LEU . 16.8 t -140.35 142.16 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -0.785 . . . . 0.0 109.425 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' HA ' ' A' ' 15' ' ' ASN . 1.6 p -147.9 19.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 8.9 tp 63.64 -96.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 109.981 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 15' ' ' ASN . . . -47.33 -60.17 5.36 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.767 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . 56.9 t30 66.8 14.76 9.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -1.162 . . . . 0.0 109.302 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.886 HD12 ' N ' ' A' ' 17' ' ' CYS . 2.6 pp -135.71 -37.95 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.438 -0.789 . . . . 0.0 108.959 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.886 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -122.28 -24.05 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -56.84 -76.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 109.231 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.588 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 46.0 p 179.46 61.2 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.931 -1.106 . . . . 0.0 110.406 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 19' ' ' SER . 49.5 Cg_exo -56.12 -17.5 20.15 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.713 1.609 . . . . 0.0 110.052 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.977 ' O ' HG23 ' A' ' 25' ' ' VAL . 10.8 mm -41.6 -38.52 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.52 -0.737 . . . . 0.0 110.264 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.954 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -53.96 -51.39 64.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.042 . . . . 0.0 109.679 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -66.36 -56.77 9.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.011 . . . . 0.0 109.356 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 1.029 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -46.7 -25.08 0.65 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.958 . . . . 0.0 109.074 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.977 HG23 ' O ' ' A' ' 21' ' ' ILE . 84.6 t -78.36 -43.32 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.264 -0.898 . . . . 0.0 109.36 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.829 ' HE2' HG21 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -57.51 -21.44 37.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -58.57 3.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 28' ' ' LYS . 10.0 tmtt? -75.89 2.77 11.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.356 -0.84 . . . . 0.0 109.225 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.956 HD11 ' HG3' ' A' ' 150' ' ' ARG . 34.2 tp -102.78 -37.17 7.99 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.955 HG23 HG12 ' A' ' 35' ' ' ILE . 9.8 p -90.82 -4.87 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 31' ' ' THR . 8.6 m -106.2 11.46 31.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.728 -1.233 . . . . 0.0 109.401 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -127.6 53.83 1.73 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 109.138 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.564 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.6 OUTLIER 175.56 31.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.486 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 33' ' ' GLN . 36.7 t30 46.18 37.06 3.6 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.955 HG12 HG23 ' A' ' 30' ' ' VAL . 2.0 tt -121.17 -4.6 9.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.693 -177.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.927 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -73.49 -53.26 11.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.058 -1.026 . . . . 0.0 110.506 -178.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 25.7 p-10 -56.93 -14.47 3.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.198 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.935 ' HA ' HG22 ' A' ' 5' ' ' THR . 69.6 m-20 -109.12 36.62 2.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.924 -1.11 . . . . 0.0 110.464 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.654 ' CZ3' ' CB ' ' A' ' 6' ' ' LYS . 17.8 m95 -150.95 136.9 18.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.486 -1.384 . . . . 0.0 111.516 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.97 74.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.518 ' CG1' HG13 ' A' ' 8' ' ' VAL . 3.1 mt -90.11 144.5 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.456 -0.777 . . . . 0.0 109.934 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.7 OUTLIER -142.31 -173.97 3.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 109.22 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.5 p -126.26 160.92 28.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.765 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -141.43 137.45 8.08 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.51 ' HB1' ' OD1' ' A' ' 50' ' ' ASN . . . -118.01 -9.29 10.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -1.194 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.615 ' CG2' HG11 ' A' ' 11' ' ' VAL . 2.5 t 55.05 21.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.4 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 38.2 t -160.42 160.01 31.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.524 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.59 ' HA ' HG23 ' A' ' 51' ' ' VAL . 10.7 p-10 -105.5 11.68 32.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.536 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -88.04 11.13 16.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.543 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.539 HD22 ' HB1' ' A' ' 74' ' ' ALA . 3.4 p-10 -144.89 13.91 1.5 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 48' ' ' ASP . 67.2 t -65.16 112.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 109.249 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.37 22.53 58.54 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.538 ' O ' HG22 ' A' ' 16' ' ' ILE . 39.0 mtp180 -106.25 85.12 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.519 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' ARG . 2.5 p -46.36 162.22 0.26 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.281 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 56' ' ' ASP . 52.6 Cg_exo -50.51 140.65 35.34 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.897 1.731 . . . . 0.0 110.142 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 6.2 m-20 -43.75 166.08 0.11 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.466 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 56' ' ' ASP . 49.7 Cg_endo -70.91 -7.2 20.88 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.987 1.791 . . . . 0.0 110.193 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -90.19 -40.5 12.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.9 . . . . 0.0 109.365 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -89.6 -16.88 29.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.423 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 57' ' ' PRO . 7.0 p -57.25 -27.81 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.92 . . . . 0.0 109.548 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -79.97 -48.82 12.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.408 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.506 ' SG ' ' CD2' ' A' ' 142' ' ' TYR . 6.3 t -45.76 -30.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.801 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.23 -45.1 9.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.935 . . . . 0.0 109.104 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.63 19.94 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.67 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 61' ' ' SER . 15.1 t-20 -91.35 -53.54 4.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.361 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.525 ' CE1' ' OH ' ' A' ' 142' ' ' TYR . 9.5 p80 -102.98 -31.79 10.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.21 109.9 1.29 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.029 HG12 ' HB1' ' A' ' 24' ' ' ALA . 8.5 tp -120.98 -26.83 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -1.163 . . . . 0.0 109.428 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 3.0 m-20 76.13 41.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.413 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 70' ' ' THR . 5.2 t -63.38 110.64 1.99 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.88 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.0 -23.55 5.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -84.74 132.76 34.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.295 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -95.91 154.17 17.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 109.542 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.539 ' HB1' HD22 ' A' ' 50' ' ' ASN . . . -46.6 169.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 76' ' ' GLN . 0.6 OUTLIER -169.16 161.48 10.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 109.484 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.54 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -96.61 128.77 43.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.528 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 46' ' ' VAL . 55.9 t -65.74 135.85 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 109.357 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -138.62 165.28 27.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.873 . . . . 0.0 109.505 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -44.09 -39.1 4.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' O ' ' OG1' ' A' ' 84' ' ' THR . 28.3 tt0 -54.19 -53.28 55.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.885 . . . . 0.0 109.546 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 2.7 m-20 -50.92 -46.89 61.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.37 -0.831 . . . . 0.0 110.125 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.774 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 77.6 m-85 -51.05 -63.11 1.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 108' ' ' ASN . 2.3 p -73.62 -4.04 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -0.861 . . . . 0.0 110.021 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 14.3 m -81.3 -65.45 1.01 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.602 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 50.2 m-85 -87.11 173.68 9.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.892 . . . . 0.0 110.001 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.586 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -116.9 -15.22 10.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.724 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CE1' ' HB3' ' A' ' 86' ' ' ASP . 1.6 m-85 -123.0 74.56 1.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.068 -1.02 . . . . 0.0 109.659 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.891 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 2.6 mt -85.22 94.04 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -105.58 -179.82 4.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.958 -1.089 . . . . 0.0 109.467 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.739 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -142.94 172.69 12.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.74 ' HE2' ' HA ' ' A' ' 91' ' ' MET . 30.9 mmt -67.52 -7.77 28.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 109.669 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 115' ' ' LEU . 5.7 p30 174.05 -176.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.0 . . . . 0.0 109.406 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -83.44 -7.58 59.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.78 -49.97 70.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.578 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -83.68 9.98 10.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.501 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.957 HD21 HG22 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -100.17 16.49 24.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.0 ttt-85 -84.87 -22.63 29.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.503 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 102' ' ' LYS . 0.9 OUTLIER -107.07 -32.64 7.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.466 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.984 HD11 HG11 ' A' ' 11' ' ' VAL . 24.5 mt -73.57 -36.01 65.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.493 ' HB2' HD22 ' A' ' 96' ' ' LEU . 5.5 t30 -66.17 -35.09 79.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.324 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -89.84 0.09 57.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.374 -0.829 . . . . 0.0 109.457 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.73 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -92.18 -22.33 19.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.478 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m -70.42 -12.61 61.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 0.0 109.41 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -86.27 -30.83 22.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -92.44 -10.36 38.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 109.348 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 102' ' ' LYS . 39.0 t -71.76 140.13 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -75.13 117.1 16.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.231 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.6 m120 48.28 46.38 20.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.544 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.11 150.88 2.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.96 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 5.8 ptm180 -140.58 9.9 2.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.467 -0.771 . . . . 0.0 109.111 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.891 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -98.39 116.07 29.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 110.321 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -70.57 124.22 23.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.957 HG22 HD21 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -99.1 114.95 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.795 -1.191 . . . . 0.0 110.498 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 20.7 mt-10 -147.51 -177.5 5.73 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 1.064 HD12 HD11 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -126.07 153.7 44.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.97 -1.081 . . . . 0.0 109.746 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.903 HD21 ' HA ' ' A' ' 148' ' ' CYS . 0.3 OUTLIER -43.47 104.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.373 -0.83 . . . . 0.0 109.521 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.38 157.17 16.45 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 m -65.06 93.75 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -1.133 . . . . 0.0 109.375 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -77.14 -93.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.598 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 1.1 m-20 -71.81 -62.27 1.7 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.054 -1.029 . . . . 0.0 109.789 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 55.5 Cg_endo -72.05 126.16 11.58 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.795 1.663 . . . . 0.0 110.256 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -105.13 111.99 24.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -150.56 158.12 43.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.551 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -88.42 98.44 11.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 176.57 108.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 1.064 HD11 HD12 ' A' ' 115' ' ' LEU . 1.8 tt -121.23 28.16 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 126' ' ' ILE . 20.0 tt 41.28 41.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.402 -0.811 . . . . 0.0 109.838 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.519 ' HG3' HG23 ' A' ' 126' ' ' ILE . 1.3 mt-10 -87.48 51.23 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 109.423 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.56 104.34 55.35 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.928 . . . . 0.0 109.42 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -49.4 169.83 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.8 1.667 . . . . 0.0 110.228 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.412 ' C ' ' CD1' ' A' ' 131' ' ' TYR . 3.0 t80 -84.79 106.09 16.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.55 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -146.4 -64.71 0.3 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 135.56 114.74 1.41 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -154.5 -49.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -1.1 . . . . 0.0 109.518 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.72 -19.6 20.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 56.65 24.6 9.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.509 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -127.99 87.89 2.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.453 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 29.0 p90 -71.48 -10.36 59.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.5 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -62.88 -34.84 78.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.412 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 0.2 OUTLIER -63.54 -25.78 68.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.309 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.554 ' CG1' ' HB2' ' A' ' 19' ' ' SER . 27.7 t -79.1 -31.11 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.312 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.962 ' HA ' HG21 ' A' ' 21' ' ' ILE . 6.1 t80 -69.18 -50.92 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.567 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.2 mm-40 -65.41 -41.6 93.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.952 . . . . 0.0 109.514 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 140' ' ' THR . 0.8 OUTLIER -68.87 -14.37 62.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 4.6 m -89.94 -8.6 51.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.868 ' HA ' HG11 ' A' ' 25' ' ' VAL . 46.2 t -62.57 -68.73 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.713 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.8 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 0.7 OUTLIER -58.94 -15.61 13.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.824 -1.173 . . . . 0.0 109.157 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.954 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -44.26 -32.97 1.43 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.202 -0.936 . . . . 0.0 108.582 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.895 ' SG ' HG12 ' A' ' 25' ' ' VAL . 1.6 p -115.09 -24.38 8.58 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.956 ' HG3' HD11 ' A' ' 29' ' ' LEU . 9.5 ttt-85 -76.55 -60.98 2.11 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.8 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -49.67 -36.51 25.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.441 -0.787 . . . . 0.0 109.149 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.737 ' CE2' HG21 ' A' ' 156' ' ' VAL . 17.0 t80 -77.9 -31.64 51.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.532 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.482 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 11.7 tp -67.9 -13.18 61.95 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.166 -0.959 . . . . 0.0 108.815 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 1.8 mt-10 -76.9 -53.41 7.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.898 . . . . 0.0 109.122 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -47.61 84.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.962 . . . . 0.0 109.117 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.737 HG21 ' CE2' ' A' ' 152' ' ' PHE . 14.1 m -97.64 25.6 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 109.083 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.482 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.548 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.304 0.573 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.665 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -84.95 71.0 10.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.877 . . . . 0.0 109.442 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 9.3 ttmt -41.93 162.94 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.157 -0.964 . . . . 0.0 109.573 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 m -139.16 135.96 34.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 0.0 109.912 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.765 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -141.7 155.53 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 108.927 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.792 HD13 ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -150.11 115.98 5.61 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 109.064 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.0 m-85 -86.8 151.56 23.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.512 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.651 ' HB ' HD11 ' A' ' 99' ' ' LEU . 5.4 t -143.82 157.92 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.59 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER 173.08 128.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -44.91 150.09 0.4 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.181 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.03 88.27 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 15' ' ' ASN . 25.6 t-20 -85.5 15.19 4.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -1.14 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 2.0 pp -119.22 131.79 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.613 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.78 ' SG ' ' CZ ' ' A' ' 138' ' ' PHE . 34.8 t 66.8 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.71 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.659 ' HA ' HG11 ' A' ' 141' ' ' VAL . 0.3 OUTLIER 43.11 78.63 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.681 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER 163.63 -61.48 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 0.0 109.94 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 19' ' ' SER . 52.1 Cg_endo -71.16 -1.25 9.28 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.85 1.7 . . . . 0.0 110.848 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.007 HG21 ' HA ' ' A' ' 142' ' ' TYR . 3.8 mm -74.6 -48.12 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.985 -1.072 . . . . 0.0 109.575 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.632 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -57.35 -27.85 62.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.551 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -73.27 -71.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -0.954 . . . . 0.0 109.318 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.492 ' O ' HG13 ' A' ' 68' ' ' ILE . . . -44.89 -26.97 0.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 108.887 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.96 HG12 ' SG ' ' A' ' 149' ' ' CYS . 72.2 t -70.23 -54.36 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.404 -0.81 . . . . 0.0 109.214 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.682 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 2.1 t80 -45.57 -35.78 4.21 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -63.8 -57.66 9.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.425 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -55.97 -21.15 19.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.857 . . . . 0.0 109.652 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.859 HD22 ' HG3' ' A' ' 150' ' ' ARG . 39.7 mt -85.62 -30.79 22.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.212 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.929 HG22 ' HA ' ' A' ' 36' ' ' SER . 2.9 p -90.67 -6.23 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.407 -0.808 . . . . 0.0 109.348 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -105.14 5.91 32.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.033 -1.042 . . . . 0.0 109.848 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 4.4 t0 -128.02 59.74 1.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 109.133 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.501 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER 171.28 31.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.831 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.4 t-20 45.11 32.01 0.84 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.838 HG12 HG23 ' A' ' 30' ' ' VAL . 2.7 tt -112.79 -7.31 11.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.687 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.929 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -73.11 -25.06 60.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.658 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -84.47 16.26 3.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 0.0 109.778 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.665 ' HA ' HG22 ' A' ' 5' ' ' THR . 8.6 m-80 -144.46 36.13 1.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.481 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.765 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 22.1 m95 -150.18 150.39 31.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.986 -1.071 . . . . 0.0 111.029 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.493 ' O ' HG12 ' A' ' 40' ' ' VAL . 80.5 t -128.31 70.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 26' ' ' PHE . 2.4 mp -89.56 140.22 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.398 -0.814 . . . . 0.0 110.626 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.521 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -146.25 171.58 14.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.507 -0.745 . . . . 0.0 109.268 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.8 p -105.1 162.38 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.975 . . . . 0.0 109.614 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.559 ' CA ' ' CG2' ' A' ' 77' ' ' VAL . . . -143.05 122.76 1.97 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -87.08 -41.26 13.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.142 -1.21 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER 80.25 -5.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.795 . . . . 0.0 109.436 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 76' ' ' GLN . 0.4 OUTLIER -126.49 179.61 5.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 109.371 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.515 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 19.3 t70 -120.38 7.87 10.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -91.55 -32.98 15.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.327 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -101.85 31.16 3.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 73.9 t -76.31 96.79 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.19 57.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -79.37 86.64 5.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -1.161 . . . . 0.0 109.555 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 53' ' ' ARG . 4.0 m -45.42 159.6 0.28 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.873 . . . . 0.0 109.369 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.45 152.41 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.98 1.787 . . . . 0.0 110.255 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.19 152.36 96.55 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.587 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 51.6 Cg_exo -51.22 -19.97 7.16 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.021 1.814 . . . . 0.0 110.475 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -81.89 -47.78 12.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -0.961 . . . . 0.0 109.796 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.747 ' O ' HD22 ' A' ' 63' ' ' LEU . . . -89.86 4.58 49.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.946 . . . . 0.0 109.807 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.587 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 6.8 p -89.93 -43.92 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.043 -1.036 . . . . 0.0 109.628 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.525 ' N ' HG13 ' A' ' 60' ' ' VAL . 3.8 p -76.82 -17.85 58.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.95 . . . . 0.0 109.521 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.7 m -78.26 -62.29 1.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -60.69 -27.99 68.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.567 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.749 ' H ' HD23 ' A' ' 63' ' ' LEU . 7.2 ttp85 -96.94 33.37 1.91 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.649 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' SER . 9.1 t-20 -131.5 -43.07 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.345 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.86 -22.15 34.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.36 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.449 ' O ' ' HD3' ' A' ' 28' ' ' LYS . . . 113.16 83.33 1.22 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 25' ' ' VAL . 1.3 tp -122.22 -24.5 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -1.16 . . . . 0.0 109.656 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 9.3 m-80 63.52 98.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.557 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.23 91.39 3.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.77 53.55 1.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.58 ' CD2' ' N ' ' A' ' 73' ' ' LYS . 20.6 t60 -143.94 155.87 44.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.447 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.58 ' N ' ' CD2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -104.75 130.75 52.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 75' ' ' ARG . . . -43.99 -69.9 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.601 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.495 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 61.06 158.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.373 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 47' ' ' SER . 22.6 tt0 -88.39 123.78 33.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.442 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.559 ' CG2' ' CA ' ' A' ' 44' ' ' GLY . 21.3 t -47.56 151.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.86 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -141.09 165.17 28.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.663 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.631 ' CG ' HG13 ' A' ' 106' ' ' VAL . 3.2 tmtt? -43.18 -41.67 3.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 109.495 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 84' ' ' THR . 24.4 tp10 -56.08 -48.37 76.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 109.553 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.487 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 1.2 m-20 -62.32 -34.02 75.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.77 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.826 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 79.3 m-85 -65.65 -79.07 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 110.163 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.663 HG23 ' HB3' ' A' ' 110' ' ' ARG . 7.3 p -48.13 -46.94 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.07 -1.019 . . . . 0.0 109.256 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.603 ' N ' HG13 ' A' ' 83' ' ' VAL . 16.4 m -45.85 -82.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.335 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.792 ' CE2' HD13 ' A' ' 9' ' ' LEU . 21.0 m-85 -57.13 166.5 1.07 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.317 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.33 -25.62 5.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.618 ' CD2' HG11 ' A' ' 156' ' ' VAL . 6.3 m-30 -109.38 72.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.107 -0.996 . . . . 0.0 109.852 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.907 HG13 ' HB1' ' A' ' 111' ' ' ALA . 1.3 mt -82.82 96.57 3.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.428 -0.795 . . . . 0.0 109.62 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -109.85 179.97 3.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.019 -1.051 . . . . 0.0 108.91 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -147.58 172.49 13.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.13 -0.982 . . . . 0.0 109.689 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.51 ' CE ' HD13 ' A' ' 116' ' ' LEU . 31.5 mmt -85.46 46.59 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.362 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' SER . 10.1 t70 56.93 -93.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.568 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.506 ' HG2' ' N ' ' A' ' 94' ' ' SER . 27.4 tt0 43.53 -94.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.305 -0.872 . . . . 0.0 109.338 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.6 ' O ' ' N ' ' A' ' 96' ' ' LEU . 4.6 p -85.67 88.2 7.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.09 -1.006 . . . . 0.0 108.71 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 96' ' ' LEU . 25.5 p-10 -31.94 85.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.091 0.472 . . . . 0.0 111.195 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.964 HD13 ' OD1' ' A' ' 100' ' ' ASN . 4.1 mt 29.48 56.98 0.15 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.244 0.545 . . . . 0.0 110.747 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -91.35 -50.96 5.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.082 -1.011 . . . . 0.0 109.65 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -92.77 -64.13 1.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.928 . . . . 0.0 109.653 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.651 HD11 ' HB ' ' A' ' 11' ' ' VAL . 17.3 mt -44.02 -40.11 4.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.217 -0.927 . . . . 0.0 109.668 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.964 ' OD1' HD13 ' A' ' 96' ' ' LEU . 3.2 t30 -61.59 -49.31 77.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -0.98 . . . . 0.0 109.182 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.83 14.6 11.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 108.918 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.683 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.8 OUTLIER -86.25 -40.41 15.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.479 -0.763 . . . . 0.0 109.356 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.6 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 1.3 p -65.86 -11.79 49.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.42 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.4 -36.82 68.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -99.19 8.6 44.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.825 HG11 ' SG ' ' A' ' 109' ' ' CYS . 46.7 t -83.54 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.367 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 108' ' ' ASN . 12.1 tptp -62.53 88.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 108.832 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 107' ' ' LYS . 9.2 t30 73.99 71.06 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 108.932 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.825 ' SG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -85.01 143.72 28.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.315 -0.866 . . . . 0.0 109.901 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.663 ' HB3' HG23 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -143.82 13.58 1.7 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 108.985 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.907 ' HB1' HG13 ' A' ' 88' ' ' ILE . . . -89.85 97.22 11.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.965 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' ALA . 15.0 mttt -46.66 123.63 5.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.61 ' CG2' HD21 ' A' ' 96' ' ' LEU . 1.1 mm -99.36 139.59 20.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.875 -1.141 . . . . 0.0 110.372 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -167.11 -177.43 3.73 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.663 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -134.0 145.73 49.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.009 -1.057 . . . . 0.0 109.642 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.882 HD21 ' HA ' ' A' ' 148' ' ' CYS . 0.0 OUTLIER -43.24 152.54 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.328 -0.858 . . . . 0.0 109.448 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -158.43 -143.76 3.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 123' ' ' LYS . 2.0 p -87.24 109.19 19.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.166 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -112.27 -81.96 0.59 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.41 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.582 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -61.56 -61.47 7.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.654 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 52.3 Cg_endo -71.78 -161.68 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.77 1.647 . . . . 0.0 110.209 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -144.35 36.61 1.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 118' ' ' SER . 12.2 ptpt -111.49 159.07 18.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.242 -0.911 . . . . 0.0 109.566 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.7 81.87 7.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.49 112.79 25.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 109.386 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.5 ' CG2' ' CG ' ' A' ' 92' ' ' ASP . 6.6 mm -124.8 152.35 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.314 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.425 ' C ' ' OD2' ' A' ' 92' ' ' ASP . 2.9 mm -92.25 64.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.155 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.459 ' HA ' ' OD2' ' A' ' 92' ' ' ASP . 3.0 mt-10 -85.55 46.75 1.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.668 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -127.24 144.79 51.89 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.68 -42.9 1.52 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.876 1.717 . . . . 0.0 110.218 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.96 178.4 4.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.379 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -124.98 12.65 8.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 109.458 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 96.51 -115.7 5.27 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.74 -48.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -1.154 . . . . 0.0 109.335 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.9 OUTLIER -102.26 159.71 15.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 74.18 5.92 4.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.534 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -177.42 120.88 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.78 ' CZ ' ' SG ' ' A' ' 17' ' ' CYS . 2.0 t80 -170.85 -50.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.323 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 140' ' ' THR . 2.5 pt-20 -66.66 -28.61 68.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.411 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.419 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 32.4 m -62.18 -43.93 97.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.387 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 18' ' ' ARG . 39.2 t -61.59 -57.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.234 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 1.007 ' HA ' HG21 ' A' ' 21' ' ' ILE . 1.4 t80 -46.52 -38.22 9.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 0.0 109.131 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.86 -39.27 79.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.737 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -68.66 -13.13 62.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.693 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.3 m -88.15 -12.56 43.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.754 ' HA ' HG11 ' A' ' 25' ' ' VAL . 95.8 t -58.54 -60.41 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.299 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.813 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -74.4 -18.49 60.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.897 . . . . 0.0 109.377 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.882 ' HA ' HD21 ' A' ' 116' ' ' LEU . 1.2 m -46.72 -32.21 3.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.151 -0.968 . . . . 0.0 109.184 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.96 ' SG ' HG12 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -114.07 -30.01 6.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 109.175 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.859 ' HG3' HD22 ' A' ' 29' ' ' LEU . 18.2 ttt180 -75.22 -57.72 3.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 0.0 109.109 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.813 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -51.77 -31.53 27.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.349 -0.844 . . . . 0.0 109.199 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.743 ' CE1' HG21 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -83.39 -29.36 28.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.813 . . . . 0.0 109.343 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.98 -18.11 65.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.067 -1.021 . . . . 0.0 108.666 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 3.7 mm-40 -70.09 -45.43 66.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.024 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -46.38 81.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.284 -0.885 . . . . 0.0 108.953 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.743 HG21 ' CE1' ' A' ' 152' ' ' PHE . 6.4 m -95.3 25.17 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.084 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 1.1 tmm_? . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.557 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.944 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -149.43 71.94 1.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.611 ' HG2' ' CE2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -42.28 166.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.151 -0.968 . . . . 0.0 110.304 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 85' ' ' PHE . 33.4 t -143.75 127.22 16.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.512 -0.742 . . . . 0.0 109.147 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.971 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -131.09 153.25 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 108.904 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.623 HD22 ' CD1' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -146.21 123.52 11.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.445 -0.784 . . . . 0.0 108.997 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.2 m-85 -95.2 165.99 12.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.995 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.635 HG11 HD11 ' A' ' 99' ' ' LEU . 2.0 t -147.38 149.11 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.349 -0.844 . . . . 0.0 109.644 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.761 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER 177.13 114.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 tp -46.74 156.94 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.0 109.405 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.35 49.55 75.14 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.445 ' OD1' ' HG3' ' A' ' 20' ' ' PRO . 43.4 t30 -74.29 82.09 1.86 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.133 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.566 HD12 ' N ' ' A' ' 17' ' ' CYS . 1.2 pp -152.55 -52.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.712 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.692 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -134.61 34.73 3.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.641 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -171.37 60.07 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 109.372 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.761 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 163.59 -51.68 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 109.599 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 19' ' ' SER . 54.1 Cg_exo -49.29 -21.27 4.41 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.839 1.692 . . . . 0.0 110.455 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.001 HG21 ' HA ' ' A' ' 142' ' ' TYR . 18.5 mm -58.97 -51.28 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.165 -0.96 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.781 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . . . -59.99 -16.97 34.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.136 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.51 ' OE1' ' CA ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -81.92 -72.81 0.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.221 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -43.49 -39.18 3.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.001 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 21' ' ' ILE . 47.2 t -60.83 -58.34 7.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.448 -0.782 . . . . 0.0 108.97 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 2.6 t80 -43.3 -29.12 0.38 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.928 . . . . 0.0 108.615 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.62 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -65.93 -62.2 1.63 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.331 -0.855 . . . . 0.0 109.226 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.08 -43.33 63.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 0.0 109.71 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.791 HD22 ' HG3' ' A' ' 150' ' ' ARG . 25.3 mt -60.39 -36.8 78.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.93 HG22 ' HA ' ' A' ' 36' ' ' SER . 4.4 p -90.03 -4.52 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.504 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -107.21 12.51 28.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.848 -1.158 . . . . 0.0 109.689 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 6.9 t0 -131.84 56.14 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.132 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.552 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.7 OUTLIER 173.56 31.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 109.627 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.1 t30 45.71 36.88 2.93 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.889 HG12 HG23 ' A' ' 30' ' ' VAL . 2.1 tt -119.54 -7.37 11.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.959 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.93 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -74.64 -37.2 62.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 109.992 -179.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.02 1.01 11.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 110.027 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.944 ' HA ' HG22 ' A' ' 5' ' ' THR . 6.8 m-20 -127.18 42.14 3.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.096 -1.003 . . . . 0.0 109.838 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.971 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 9.4 m95 -150.23 157.3 42.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.899 -1.126 . . . . 0.0 110.819 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.552 HG12 ' CE1' ' A' ' 85' ' ' PHE . 96.5 t -133.06 71.9 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.578 ' CG1' HG13 ' A' ' 8' ' ' VAL . 2.7 mp -89.65 137.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.413 -0.804 . . . . 0.0 110.13 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 3.7 t70 -143.33 -177.21 5.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.449 -0.782 . . . . 0.0 109.312 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.5 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 95.6 p -119.54 163.6 17.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.164 -0.96 . . . . 0.0 109.688 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -142.15 134.43 6.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.562 ' HB1' HD21 ' A' ' 50' ' ' ASN . . . -116.42 -12.41 11.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -1.227 . . . . 0.0 109.557 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.616 ' HA ' HG12 ' A' ' 77' ' ' VAL . 1.8 t 56.24 17.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' ' CE2' ' A' ' 49' ' ' TRP . 1.1 p -151.24 169.82 20.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HA ' HG23 ' A' ' 51' ' ' VAL . 4.5 m-20 -116.8 22.19 12.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.437 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.589 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -95.23 -24.97 16.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 109.24 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.562 HD21 ' HB1' ' A' ' 45' ' ' ALA . 6.5 p30 -108.88 9.62 26.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.838 . . . . 0.0 109.516 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 48' ' ' ASP . 74.3 t -65.17 90.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.76 29.08 4.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -105.32 95.13 5.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -1.158 . . . . 0.0 109.472 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -43.99 162.49 0.19 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.462 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.64 148.86 54.08 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.958 1.772 . . . . 0.0 110.134 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 5.9 t70 -50.75 139.56 21.36 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.272 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.496 ' O ' HG12 ' A' ' 60' ' ' VAL . 50.4 Cg_exo -51.93 -18.86 7.42 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.845 1.696 . . . . 0.0 110.439 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.492 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . 8.9 mtm180 -81.96 -39.25 23.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.097 -1.002 . . . . 0.0 109.675 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.792 ' O ' HD22 ' A' ' 63' ' ' LEU . . . -90.38 -1.62 57.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.94 . . . . 0.0 109.842 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.517 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 5.7 p -89.6 -39.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.05 -1.032 . . . . 0.0 109.651 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.46 ' N ' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -88.46 -8.87 54.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -89.24 -64.44 1.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.646 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.792 HD22 ' O ' ' A' ' 59' ' ' ALA . 1.6 pt? -43.34 -30.64 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.671 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.729 ' H ' HD23 ' A' ' 63' ' ' LEU . 3.5 ptp180 -93.16 41.84 1.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.852 . . . . 0.0 109.468 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -133.48 -43.95 0.83 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.382 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -83.17 -34.17 26.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.18 95.29 0.2 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.484 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 17.3 mm -146.08 -75.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -1.152 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 65.53 99.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.05 166.48 20.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -155.04 54.05 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.49 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.561 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.5 p-80 -122.71 170.61 9.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.02 154.48 37.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.554 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.99 122.7 28.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.461 ' HD2' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -129.74 172.36 11.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.417 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' SER . 1.1 tt0 -92.13 122.32 34.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.616 HG12 ' HA ' ' A' ' 46' ' ' VAL . 8.9 p -48.9 145.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.407 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 p -132.83 168.3 18.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.215 -0.928 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.582 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -51.03 -41.37 59.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 109.255 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -59.41 -38.28 80.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.56 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.08 -41.09 87.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -0.919 . . . . 0.0 109.978 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.813 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 81.1 m-85 -64.47 -62.36 1.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.797 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.528 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 3.8 p -65.76 -10.35 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.687 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.637 HG22 ' N ' ' A' ' 85' ' ' PHE . 3.4 m -87.97 -85.09 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.368 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.637 ' N ' HG22 ' A' ' 84' ' ' THR . 59.1 m-85 -56.33 109.04 0.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.526 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.404 ' C ' ' CD1' ' A' ' 87' ' ' TYR . 1.3 t0 -58.29 -20.87 46.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.611 ' CE2' ' HG2' ' A' ' 6' ' ' LYS . 6.6 m-30 -113.31 137.42 51.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.933 HG13 ' HB1' ' A' ' 111' ' ' ALA . 1.0 OUTLIER -145.45 104.24 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 108.652 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.66 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -120.74 156.65 31.37 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.906 -1.121 . . . . 0.0 109.744 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 115' ' ' LEU . 2.4 p -121.26 166.15 14.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.517 -0.739 . . . . 0.0 109.424 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.499 ' HE3' HD23 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -75.62 -62.56 1.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.719 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 93' ' ' GLU . 11.5 p-10 -178.62 -138.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.398 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 74.4 mt-10 63.12 -88.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.058 -1.026 . . . . 0.0 109.487 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -85.01 85.75 7.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 0.0 109.069 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.47 ' O ' ' C ' ' A' ' 96' ' ' LEU . 0.7 OUTLIER -51.21 86.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.684 -0.635 . . . . 0.0 110.083 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.978 HD22 ' HB2' ' A' ' 100' ' ' ASN . 0.4 OUTLIER 37.33 40.3 0.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.729 -0.607 . . . . 0.0 110.196 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -90.51 -50.14 6.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.045 -1.035 . . . . 0.0 109.479 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.6 -45.03 12.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.496 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.635 HD11 HG11 ' A' ' 11' ' ' VAL . 13.4 mt -62.58 -34.75 77.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.575 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.978 ' HB2' HD22 ' A' ' 96' ' ' LEU . 21.8 t-20 -62.17 -31.63 72.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -89.69 -11.4 42.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 109.424 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.888 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -74.93 -27.13 60.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.33 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.639 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 0.9 OUTLIER -73.8 -20.62 60.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.892 . . . . 0.0 109.339 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.63 -49.9 42.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.256 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -70.48 -19.39 62.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 109.253 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 102' ' ' LYS . 54.6 t -67.08 125.03 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.376 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -66.47 100.55 0.67 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.333 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.87 50.35 1.99 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -53.62 150.9 6.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.263 -0.898 . . . . 0.0 109.838 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 12.0 ptt180 -138.53 7.22 2.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.339 -0.85 . . . . 0.0 109.153 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.933 ' HB1' HG13 ' A' ' 88' ' ' ILE . . . -88.03 120.38 29.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.178 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.47 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -70.51 132.68 45.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.84 ' HB ' HD11 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -109.16 133.09 55.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.777 -1.202 . . . . 0.0 110.402 -179.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.8 OUTLIER -178.47 139.21 0.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -84.72 167.34 16.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.594 -1.316 . . . . 0.0 109.95 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.956 HD11 ' HA ' ' A' ' 148' ' ' CYS . 3.1 mm? -40.59 -44.23 2.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.752 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 54.44 -123.4 27.94 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -131.07 122.68 27.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 109.341 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.533 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.7 m-85 -127.83 3.42 6.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 0.0 109.634 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.587 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 162.58 -51.26 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.3 Cg_exo -49.72 140.43 29.67 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.794 1.663 . . . . 0.0 110.111 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -108.14 112.89 25.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.67 149.37 2.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.356 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 52.29 2.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.364 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.97 131.71 4.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.381 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -105.3 41.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.972 . . . . 0.0 109.165 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 126' ' ' ILE . 14.7 mt 71.44 19.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.98 . . . . 0.0 109.51 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.685 ' HG3' HG22 ' A' ' 126' ' ' ILE . 30.5 mt-10 -62.18 90.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' HB3' ' NH2' ' A' ' 18' ' ' ARG . 9.8 t70 -145.32 102.39 4.36 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.195 -0.941 . . . . 0.0 109.401 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -49.26 139.86 27.18 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.868 1.712 . . . . 0.0 110.308 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER 51.91 -161.72 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.479 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 131' ' ' TYR . 8.4 p90 -94.88 30.24 2.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 132' ' ' TYR . . . 43.63 -131.97 6.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -179.71 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -1.187 . . . . 0.0 109.475 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -78.09 123.48 26.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 135' ' ' ASP . . . 44.35 29.51 0.38 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.09 35.18 3.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.877 . . . . 0.0 109.459 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.492 ' CE2' ' HB3' ' A' ' 58' ' ' ARG . 5.0 t80 -133.24 -55.56 0.91 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.12 -44.53 68.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.0 109.388 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.7 m -60.52 -36.8 79.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.37 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.87 -53.54 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.324 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 1.001 ' HA ' HG21 ' A' ' 21' ' ' ILE . 2.4 t80 -59.56 -24.27 63.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.553 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -85.02 -24.45 28.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 0.0 109.931 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -13.77 42.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.091 -1.006 . . . . 0.0 109.498 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.781 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -90.3 -7.28 53.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 109.665 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.873 ' HA ' HG11 ' A' ' 25' ' ' VAL . 73.9 t -62.04 -63.62 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.218 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.451 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 4.2 mpt_? -68.62 -22.36 64.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.107 -0.996 . . . . 0.0 109.095 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.956 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.6 m -44.4 -28.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 108.823 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.629 ' SG ' ' CD1' ' A' ' 29' ' ' LEU . 1.5 p -111.79 -33.7 6.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.49 -0.756 . . . . 0.0 109.036 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.791 ' HG3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.91 -61.18 2.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -51.94 -28.05 15.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.451 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -84.35 -31.63 24.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.311 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 157' ' ' ARG . 13.8 tp -62.81 -54.14 43.54 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.039 -1.038 . . . . 0.0 108.792 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.522 ' HA ' ' CB ' ' A' ' 157' ' ' ARG . 5.6 pt-20 -44.31 -40.23 5.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.193 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -57.66 -63.16 1.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 87' ' ' TYR . 27.8 m -93.28 33.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.335 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 1.078 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -97.16 2.66 51.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.773 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.677 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER 52.53 162.76 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.846 0.831 . . . . 0.0 110.392 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 85' ' ' PHE . 2.0 m -150.29 107.54 3.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.98 -1.075 . . . . 0.0 109.496 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.837 HG11 ' HE2' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -102.9 138.55 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -139.62 107.7 5.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.407 -0.808 . . . . 0.0 109.503 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.808 ' CE1' HD13 ' A' ' 89' ' ' LEU . 5.6 m-85 -93.79 156.79 16.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.418 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 t -148.36 155.84 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.717 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -176.84 134.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.66 HD21 ' CZ3' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -50.26 171.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.26 -0.9 . . . . 0.0 109.431 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' LEU . . . 44.06 41.05 5.98 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.686 ' O ' HG23 ' A' ' 16' ' ' ILE . 8.8 t30 -67.68 91.77 0.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.469 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -162.17 -39.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.132 -0.98 . . . . 0.0 109.723 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.51 ' SG ' HD12 ' A' ' 16' ' ' ILE . 1.8 p -150.84 81.18 1.33 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 109.73 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.789 ' HA ' HG11 ' A' ' 141' ' ' VAL . 0.0 OUTLIER 165.14 -76.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 109.188 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.762 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -67.63 -49.23 40.97 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.389 -0.819 . . . . 0.0 110.337 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 19' ' ' SER . 71.8 Cg_exo -48.06 -20.33 2.1 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.964 1.776 . . . . 0.0 111.19 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.748 HG21 ' HA ' ' A' ' 142' ' ' TYR . 9.3 mt -64.83 -48.04 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 120.94 -1.1 . . . . 0.0 109.382 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.776 ' HA ' ' SG ' ' A' ' 145' ' ' CYS . . . -57.8 -19.28 27.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 109.353 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 24' ' ' ALA . 8.9 tm-20 -76.7 -70.21 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.216 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HB1' HG23 ' A' ' 68' ' ' ILE . . . -44.22 -47.77 9.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.358 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.867 HG11 ' HA ' ' A' ' 146' ' ' VAL . 63.6 t -54.17 -49.95 58.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 109.297 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.837 ' HE2' HG11 ' A' ' 8' ' ' VAL . 1.1 t80 -50.49 -37.9 41.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.031 -1.043 . . . . 0.0 108.379 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -45.05 82.09 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.191 -0.943 . . . . 0.0 108.841 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -81.61 -8.92 59.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.83 . . . . 0.0 110.104 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.689 HD22 ' HB2' ' A' ' 150' ' ' ARG . 3.9 mt -86.43 -31.08 21.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 109.323 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.804 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -90.85 -56.65 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.504 ' N ' HG22 ' A' ' 30' ' ' VAL . 1.2 m -44.8 -32.05 1.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.106 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.32 -42.58 44.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.105 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.52 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 4.4 tp60 -72.62 -6.85 47.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.411 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 33.9 t30 76.65 48.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 109.699 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.804 ' CG1' HG23 ' A' ' 30' ' ' VAL . 3.8 pt -140.42 8.66 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 109.626 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.615 ' HA ' HG21 ' A' ' 30' ' ' VAL . 24.5 p -68.06 -41.59 81.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.488 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.98 -20.17 3.21 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.284 -0.885 . . . . 0.0 109.361 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 1.078 ' HA ' HG22 ' A' ' 5' ' ' THR . 2.2 m-20 -121.11 45.29 2.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.936 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.677 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 6.7 m95 -150.33 129.04 12.35 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.871 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.95 87.73 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.534 ' HA ' HG13 ' A' ' 8' ' ' VAL . 3.4 mt -94.27 142.32 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.343 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.573 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 t0 -164.31 178.3 7.62 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.0 p -179.74 169.85 1.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.06 -1.025 . . . . 0.0 109.739 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.12 -163.03 28.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 15' ' ' ASN . . . -107.5 171.82 7.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -1.164 . . . . 0.0 109.487 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.523 HG22 HD11 ' A' ' 99' ' ' LEU . 93.3 t -104.74 -8.08 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.555 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.04 174.36 6.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.485 ' OD1' HG21 ' A' ' 51' ' ' VAL . 29.6 t70 -110.2 30.45 6.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.51 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.66 ' CZ3' HD21 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -102.49 -49.28 3.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.444 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -90.22 38.23 0.92 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.867 . . . . 0.0 109.65 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.485 HG21 ' OD1' ' A' ' 48' ' ' ASP . 73.2 t -82.13 94.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.347 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.559 ' H ' ' HB3' ' A' ' 74' ' ' ALA . . . 105.38 -17.15 44.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.18 136.83 8.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -1.087 . . . . 0.0 109.451 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.35 159.34 50.63 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.462 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 56' ' ' ASP . 53.4 Cg_endo -71.59 -3.4 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.015 1.81 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' PRO . 72.0 m-20 61.57 140.97 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 109.443 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.814 ' O ' HG12 ' A' ' 60' ' ' VAL . 56.6 Cg_endo -73.49 -1.34 10.53 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.901 1.734 . . . . 0.0 110.395 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.433 ' O ' ' OG ' ' A' ' 61' ' ' SER . 67.6 mtt180 -72.95 -28.11 62.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.13 -0.981 . . . . 0.0 109.611 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 63' ' ' LEU . . . -88.94 -39.94 13.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.814 HG12 ' O ' ' A' ' 57' ' ' PRO . 10.8 p -44.45 -25.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.597 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 58' ' ' ARG . 0.2 OUTLIER -48.34 -89.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.295 -0.878 . . . . 0.0 109.846 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.675 ' SG ' ' OE2' ' A' ' 139' ' ' GLU . 3.7 t -73.54 -3.75 29.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.035 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.57 ' HG ' HG21 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -86.56 -74.35 0.43 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.023 -1.048 . . . . 0.0 108.953 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.448 ' CB ' HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -81.49 74.14 8.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.43 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -146.29 -53.83 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.643 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -80.72 -23.16 39.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.26 61.63 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.642 HG23 ' HB1' ' A' ' 24' ' ' ALA . 21.7 mm -113.29 156.08 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -1.174 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.42 ' N ' HG22 ' A' ' 68' ' ' ILE . 12.0 m-80 -147.55 96.67 2.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.371 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 70' ' ' THR . 9.6 t -113.73 72.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.88 54.94 3.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 0.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.564 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.5 p-80 -133.63 155.66 49.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -0.955 . . . . 0.0 109.453 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.61 170.43 8.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 0.0 109.451 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.559 ' HB3' ' H ' ' A' ' 52' ' ' GLY . . . -90.56 148.33 22.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 109.526 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' HA ' HG13 ' A' ' 51' ' ' VAL . 3.1 mmt-85 -151.75 152.26 32.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.409 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.401 ' OE1' ' O ' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -80.57 135.44 36.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.401 ' O ' ' OE1' ' A' ' 76' ' ' GLN . 8.7 p -56.89 146.94 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.87 165.47 26.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.445 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.759 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -46.01 -36.72 5.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' ' OG1' ' A' ' 84' ' ' THR . 7.8 tt0 -59.69 -56.78 17.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 109.655 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 9.3 m-20 -50.54 -40.67 52.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -0.884 . . . . 0.0 109.808 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.941 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 43.4 m-85 -53.53 -58.13 8.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.072 -1.017 . . . . 0.0 109.335 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.544 ' HA ' ' CG ' ' A' ' 110' ' ' ARG . 0.8 OUTLIER -78.81 -2.26 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.536 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 56.0 m -78.27 -60.28 2.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.168 -0.957 . . . . 0.0 109.863 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.771 ' CD1' HD13 ' A' ' 9' ' ' LEU . 28.3 m-85 -96.46 178.36 5.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.14 -0.975 . . . . 0.0 109.863 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.481 ' OD1' ' HD3' ' A' ' 110' ' ' ARG . 1.1 t70 -118.2 -22.46 7.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.348 -0.845 . . . . 0.0 109.756 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.537 ' OH ' ' CG ' ' A' ' 6' ' ' LYS . 5.4 m-85 -112.01 67.09 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.98 -1.075 . . . . 0.0 109.623 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.933 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.1 mt -79.15 91.06 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.286 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.827 HD21 ' CE2' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -112.04 167.14 10.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.972 -1.08 . . . . 0.0 109.478 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.692 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -139.49 166.23 25.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.86 . . . . 0.0 109.06 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.692 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -66.76 133.56 50.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.388 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.82 ' CG ' HG21 ' A' ' 126' ' ' ILE . 5.7 t70 -42.94 110.06 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.68 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.5 -177.35 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.332 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.8 m -89.54 15.58 9.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -82.31 -14.74 54.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.546 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.62 HD21 ' CG2' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -86.49 5.13 36.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.098 -1.002 . . . . 0.0 109.604 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -19.25 65.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -0.96 . . . . 0.0 109.165 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.55 -43.19 4.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.872 . . . . 0.0 109.315 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.56 HD23 ' HZ ' ' A' ' 82' ' ' PHE . 13.0 mt -57.61 -34.04 68.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.304 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -69.19 -32.39 71.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.61 0.98 50.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 109.563 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -81.35 -30.21 33.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 109.442 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 p -63.76 -16.69 61.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -84.38 -31.36 24.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.338 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -12.54 43.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.392 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.759 HG13 ' HG2' ' A' ' 79' ' ' LYS . 62.8 t -77.17 147.37 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.315 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -83.58 112.21 19.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.203 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.14 37.85 27.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.311 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -43.27 160.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.748 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.6 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 0.0 OUTLIER -150.1 36.36 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.446 -0.784 . . . . 0.0 109.002 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.941 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -119.36 88.75 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -0.811 . . . . 0.0 110.025 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 111' ' ' ALA . 34.9 mtpt -46.13 121.09 3.08 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.62 ' CG2' HD21 ' A' ' 96' ' ' LEU . 1.7 mm -95.96 132.25 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.001 -1.062 . . . . 0.0 110.108 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 31.7 tp10 -159.09 165.54 33.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.462 -0.774 . . . . 0.0 109.649 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.586 ' CD2' HD12 ' A' ' 96' ' ' LEU . 22.3 mt -99.13 158.9 15.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.098 -1.001 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.944 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.5 OUTLIER -68.75 123.79 21.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 109.337 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . 140.77 -179.66 19.04 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 0.7 OUTLIER 74.52 36.91 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -1.184 . . . . 0.0 109.421 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.437 ' HB2' ' HD2' ' A' ' 121' ' ' PRO . 26.7 m-85 -125.23 -140.0 0.29 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.164 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.59 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -71.33 -51.02 10.41 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.0 109.726 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.7 Cg_exo -49.99 96.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.761 1.64 . . . . 0.0 110.275 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 25.0 mt-30 -80.91 -152.67 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.43 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 124' ' ' GLN . 0.3 OUTLIER 65.78 116.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.491 ' O ' ' CB ' ' A' ' 125' ' ' LEU . 2.0 tt0 -60.28 -150.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.159 -0.963 . . . . 0.0 109.431 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 125' ' ' LEU . 0.2 OUTLIER 73.55 70.23 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.459 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.944 HD11 ' O ' ' A' ' 116' ' ' LEU . 3.7 tt -87.57 177.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.18 -0.95 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.48 HG21 HH12 ' A' ' 18' ' ' ARG . 16.0 mt -82.61 98.54 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 0.0 109.445 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.482 ' HG3' ' OD1' ' A' ' 92' ' ' ASP . 8.9 mt-10 -130.96 55.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.9 OUTLIER -103.06 164.52 15.35 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.462 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 129' ' ' ASP . 54.9 Cg_endo -72.1 -164.37 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.028 1.819 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -70.93 -25.56 62.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.331 -0.856 . . . . 0.0 109.479 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.05 -81.15 0.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.532 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 114.31 -145.39 18.53 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -71.32 -83.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -1.135 . . . . 0.0 109.541 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.78 -71.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.94 46.26 1.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 109.566 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.43 ' OD2' ' HB ' ' A' ' 140' ' ' THR . 4.5 t70 -119.05 57.73 0.87 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.469 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -98.63 -25.34 14.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.675 ' OE2' ' SG ' ' A' ' 62' ' ' CYS . 4.2 tp10 -72.72 -31.28 64.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.325 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 96.1 m -65.45 -19.42 65.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 109.494 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.789 HG11 ' HA ' ' A' ' 18' ' ' ARG . 73.1 t -70.37 -70.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 0.0 109.228 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.748 ' HA ' HG21 ' A' ' 21' ' ' ILE . 3.2 t80 -48.19 -48.69 34.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.389 -0.82 . . . . 0.0 109.34 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -65.93 0.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.321 -0.862 . . . . 0.0 109.836 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 140' ' ' THR . 3.2 mm-40 -53.93 -19.26 4.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.776 ' SG ' ' HA ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -69.95 -41.94 73.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.845 . . . . 0.0 109.389 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.867 ' HA ' HG11 ' A' ' 25' ' ' VAL . 15.2 t -52.87 -60.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.314 -0.866 . . . . 0.0 109.929 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -8.99 53.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.928 ' SG ' HD22 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -69.63 -11.59 60.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.345 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.632 ' SG ' ' CD1' ' A' ' 29' ' ' LEU . 30.2 p -126.26 -41.64 1.89 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.233 -0.917 . . . . 0.0 109.21 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.689 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -58.25 -49.87 75.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.002 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.96 -21.54 64.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.458 -0.776 . . . . 0.0 109.236 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.827 ' CE2' HD21 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -90.01 -19.01 24.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.408 -0.808 . . . . 0.0 109.642 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.655 HD13 ' HZ ' ' A' ' 26' ' ' PHE . 9.0 tp -83.07 -26.04 31.48 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.03 -1.044 . . . . 0.0 108.748 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 1.0 OUTLIER -69.94 -29.3 66.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 108.997 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.49 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 2.2 tptt -80.32 -54.72 5.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 108.807 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 152' ' ' PHE . 16.5 m -98.33 45.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 108.891 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.405 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.533 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.3 0.571 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.879 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -126.16 83.44 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.485 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.68 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -41.47 163.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.748 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.593 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 62.4 p -136.62 116.47 13.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.024 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.779 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -119.41 142.94 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 109.115 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.595 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -140.38 105.43 4.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 0.0 109.424 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -83.27 158.34 22.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.446 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 90' ' ' CYS . 1.9 t -145.63 142.2 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.441 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -162.15 131.89 4.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 13' ' ' LEU . 12.9 tp -43.34 -56.19 3.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.658 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . -87.35 85.06 1.53 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.564 ' ND2' ' HB2' ' A' ' 74' ' ' ALA . 10.4 t30 -89.19 2.77 53.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -1.128 . . . . 0.0 109.548 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.727 HD12 ' C ' ' A' ' 16' ' ' ILE . 2.5 pp -146.86 12.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 109.733 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.44 ' N ' HD12 ' A' ' 16' ' ' ILE . 11.2 t -150.28 -54.89 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.044 -1.035 . . . . 0.0 109.561 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.481 ' HB2' ' HA3' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -43.3 -80.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.429 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.692 ' HB2' HG11 ' A' ' 141' ' ' VAL . 0.3 OUTLIER 167.16 66.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.491 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.18 63.4 8.71 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.175 1.917 . . . . 0.0 110.594 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 25' ' ' VAL . 3.8 mp -90.56 -17.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.013 -1.054 . . . . 0.0 109.732 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.594 ' O ' ' SG ' ' A' ' 149' ' ' CYS . . . -65.27 -32.32 73.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 43' ' ' SER . 1.5 tt0 -77.22 -68.59 0.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.375 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.737 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -43.53 -40.54 3.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.193 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.037 HG11 ' HA ' ' A' ' 146' ' ' VAL . 50.0 t -61.29 -53.37 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.38 -0.825 . . . . 0.0 109.158 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.555 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -46.52 -39.68 11.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.106 -0.997 . . . . 0.0 108.453 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.456 ' O ' ' OG1' ' A' ' 31' ' ' THR . 11.0 tpt85 -54.9 -60.18 3.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.165 -0.959 . . . . 0.0 108.97 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -10.18 35.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.893 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.831 HD12 HG12 ' A' ' 25' ' ' VAL . 2.7 mt -83.02 -76.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.064 -1.023 . . . . 0.0 108.971 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.893 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -43.45 -46.1 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -60.25 -42.46 95.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.115 . . . . 0.0 109.433 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -69.38 -16.6 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.131 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 1.9 tp60 -98.2 -9.38 25.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.401 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 2.7 t-20 77.18 48.58 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 109.391 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.893 ' CG1' HG23 ' A' ' 30' ' ' VAL . 2.9 pt -140.82 9.63 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.349 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.622 ' HA ' HG21 ' A' ' 30' ' ' VAL . 6.2 p -69.93 -35.0 74.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.062 -1.024 . . . . 0.0 109.546 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -58.35 -20.35 42.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.646 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.879 ' HA ' HG22 ' A' ' 5' ' ' THR . 11.8 m-20 -124.36 42.98 3.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.695 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.779 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 10.2 m95 -150.04 133.64 16.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.046 -1.034 . . . . 0.0 109.994 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 t -117.85 85.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.841 . . . . 0.0 108.992 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.646 HD11 HG11 ' A' ' 30' ' ' VAL . 2.2 mp -90.24 139.24 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 5.3 m-20 -150.53 146.58 26.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.427 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 74.5 p -116.5 156.76 26.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.53 164.8 32.23 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.16 128.06 51.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -1.147 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.702 HG22 HD11 ' A' ' 99' ' ' LEU . 86.2 t -47.47 -34.45 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.64 -177.15 3.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.937 . . . . 0.0 109.623 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.506 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 8.0 p-10 -102.43 24.59 10.13 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.299 -0.876 . . . . 0.0 109.457 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 38.9 m0 -65.54 -43.09 91.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.5 ' HB3' HG12 ' A' ' 16' ' ' ILE . 2.2 m-80 -119.91 61.49 0.84 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.148 -0.97 . . . . 0.0 109.753 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 91.1 t -84.7 102.58 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.236 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.61 10.2 63.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.445 ' HB3' HG21 ' A' ' 16' ' ' ILE . 15.4 mtt85 -82.09 126.25 31.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -1.149 . . . . 0.0 109.449 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -72.22 150.44 92.1 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.515 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.546 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 53.8 Cg_exo -50.1 137.12 37.51 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.928 1.752 . . . . 0.0 110.31 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 60' ' ' VAL . 32.9 p-10 -75.11 127.66 86.23 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.177 -0.952 . . . . 0.0 109.246 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.854 ' HA ' HG23 ' A' ' 60' ' ' VAL . 72.1 Cg_exo -43.85 -23.21 0.57 Allowed 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 122.107 1.871 . . . . 0.0 110.618 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -60.27 -53.46 57.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.874 -1.141 . . . . 0.0 108.392 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 61' ' ' SER . . . -76.73 -64.1 1.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.854 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.25 -28.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.583 -0.698 . . . . 0.0 109.387 179.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 57' ' ' PRO . 1.7 t -52.7 -53.52 46.45 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.444 -0.785 . . . . 0.0 110.487 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.456 ' C ' HD23 ' A' ' 63' ' ' LEU . 35.0 t -70.29 -17.92 63.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.123 -0.985 . . . . 0.0 110.541 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.763 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -90.14 -75.34 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.96 -1.087 . . . . 0.0 109.418 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' LEU . 3.6 ttt85 -43.62 -26.53 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 109.624 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -46.23 -66.26 0.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.887 . . . . 0.0 109.406 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 63' ' ' LEU . 12.6 p80 -76.33 -36.82 58.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.03 74.4 0.1 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.757 HD11 ' HA ' ' A' ' 25' ' ' VAL . 6.4 tp -86.53 -12.08 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.214 -1.168 . . . . 0.0 109.237 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.47 ' ND2' ' C ' ' A' ' 68' ' ' ILE . 1.3 p30 40.98 44.88 2.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.518 -0.739 . . . . 0.0 109.811 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.655 HG23 ' H ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -57.02 -76.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 109.515 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.655 ' H ' HG23 ' A' ' 70' ' ' THR . . . 55.49 76.23 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.114 -0.991 . . . . 0.0 109.414 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.557 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.6 p-80 -150.36 157.15 42.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.553 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.27 134.21 54.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 109.406 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.564 ' HB2' ' ND2' ' A' ' 15' ' ' ASN . . . -75.4 163.99 26.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.5 ' HD2' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -178.56 128.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.327 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.456 ' H ' HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -50.98 142.74 11.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.877 . . . . 0.0 109.59 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.525 HG12 ' CE2' ' A' ' 82' ' ' PHE . 30.0 t -58.57 162.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.511 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.466 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -160.5 161.5 32.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 109.547 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -48.77 -32.27 8.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.313 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 84' ' ' THR . 0.9 OUTLIER -64.8 -49.46 70.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.796 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -66.61 -26.79 67.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 110.184 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.932 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 42.4 m-85 -68.37 -68.45 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 109.727 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 110' ' ' ARG . 9.2 p -64.21 -22.02 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 85' ' ' PHE . 2.5 m -65.42 -71.93 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.126 -0.984 . . . . 0.0 109.527 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.595 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 84.5 m-85 -73.36 163.8 27.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.415 ' OD1' ' HG3' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -112.55 -17.55 12.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -0.843 . . . . 0.0 109.461 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.2 m-85 -119.75 81.32 1.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 109.202 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.883 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 1.4 mt -90.59 112.82 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 0.0 109.074 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -133.34 169.22 17.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.998 -1.064 . . . . 0.0 109.286 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.64 ' SG ' HD12 ' A' ' 99' ' ' LEU . 21.3 m -127.8 177.27 6.94 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.341 -0.849 . . . . 0.0 109.165 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.675 ' HA ' ' HE2' ' A' ' 91' ' ' MET . 16.6 mmt -85.36 47.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.894 ' OD1' HD23 ' A' ' 116' ' ' LEU . 4.2 m-20 54.38 87.86 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 109.465 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.37 158.24 43.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 109.375 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.0 p -71.89 -15.68 62.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.908 . . . . 0.0 109.459 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -72.24 -10.82 60.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.52 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.914 HD23 ' HB2' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -68.14 -31.23 70.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -19.59 4.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.439 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -93.81 -31.33 14.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.482 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.914 ' HB2' HD23 ' A' ' 96' ' ' LEU . 15.8 mt -66.6 -34.19 77.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.574 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -64.54 -24.55 67.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -91.88 -10.34 39.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 109.418 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.941 ' O ' HG23 ' A' ' 106' ' ' VAL . 2.4 mmmm -70.89 -32.99 70.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.892 . . . . 0.0 109.345 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.776 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 14.6 p -62.15 -28.05 69.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -46.68 75.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.355 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -85.02 0.74 50.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.606 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 102' ' ' LYS . 40.4 t -87.73 121.9 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.314 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 106' ' ' VAL . 9.0 tptt -45.03 99.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 106' ' ' VAL . 24.4 m120 48.11 58.75 4.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 109.526 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.776 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -53.78 147.24 12.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 109.793 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.556 ' HB3' HG23 ' A' ' 83' ' ' VAL . 8.6 ptt180 -131.29 2.12 4.21 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.932 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -86.6 118.56 26.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 110.151 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' ILE . 5.5 mtpm? -69.49 106.05 2.85 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.803 HG21 ' HB3' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -83.23 137.24 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.994 -1.066 . . . . 0.0 110.084 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.909 ' O ' HD11 ' A' ' 96' ' ' LEU . 1.2 tt0 -176.27 -170.47 0.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.49 -0.756 . . . . 0.0 109.057 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.717 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -122.65 118.06 27.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 109.496 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.905 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER 59.15 -87.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.839 . . . . 0.0 109.504 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 119' ' ' TYR . . . 166.04 -175.28 41.62 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.9 p -109.65 64.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -1.174 . . . . 0.0 109.487 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.441 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.9 m-85 -120.16 -140.86 0.34 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.176 -0.952 . . . . 0.0 109.143 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 0.2 OUTLIER 169.03 63.07 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.071 -1.018 . . . . 0.0 109.43 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.411 ' HG3' ' HB2' ' A' ' 151' ' ' ALA . 55.2 Cg_endo -71.6 -4.98 16.09 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.048 1.832 . . . . 0.0 110.243 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -161.37 -149.75 0.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.4 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 150.35 49.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -76.6 123.59 26.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -166.61 138.1 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.497 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.575 HG23 ' HB3' ' A' ' 92' ' ' ASP . 10.2 mm -95.35 150.47 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.362 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 3.0 mp -106.23 81.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.507 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.469 ' HG3' HG22 ' A' ' 126' ' ' ILE . 66.2 mt-10 -121.71 81.85 1.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.431 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 1.4 p30 -158.58 85.35 2.46 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.559 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 132' ' ' TYR . 50.7 Cg_endo -71.08 171.75 15.28 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.959 1.773 . . . . 0.0 110.283 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -43.58 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -134.21 -47.11 0.77 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.362 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 114.8 84.87 1.25 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.63 -66.61 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -1.142 . . . . 0.0 109.487 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -179.9 89.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.475 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 50.84 34.74 10.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 109.455 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.94 79.05 9.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.1 -61.25 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.39 -45.95 88.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 m -47.23 -33.03 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.42 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 19' ' ' SER . 44.7 t -67.62 -45.86 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.422 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 142' ' ' TYR . 8.7 t80 -57.7 -46.68 84.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -58.54 -56.43 22.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.962 . . . . 0.0 109.344 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.755 ' O ' ' SG ' ' A' ' 148' ' ' CYS . 15.7 mt-30 -64.85 -13.05 54.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 109.417 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.571 ' HA ' ' SG ' ' A' ' 148' ' ' CYS . 3.5 m -83.85 -27.02 29.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.315 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 1.037 ' HA ' HG11 ' A' ' 25' ' ' VAL . 87.6 t -55.14 -53.92 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.279 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.408 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -81.41 -15.86 53.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.238 -0.914 . . . . 0.0 109.334 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.905 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.3 m -50.17 -23.44 2.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 0.0 108.713 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.594 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -122.01 -42.48 2.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.238 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.484 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . 55.2 ttt-85 -59.19 -49.55 77.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.041 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.411 ' HB2' ' HG3' ' A' ' 121' ' ' PRO . . . -59.24 -19.8 48.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.827 . . . . 0.0 109.07 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.682 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 1.7 t80 -89.44 -25.42 21.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -0.831 . . . . 0.0 109.372 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.728 HD21 HD13 ' A' ' 35' ' ' ILE . 10.1 tp -77.79 -26.72 49.89 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.037 -1.039 . . . . 0.0 108.911 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 2.5 pt-20 -67.8 -30.39 69.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -0.968 . . . . 0.0 109.105 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.506 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -79.93 -51.34 9.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.89 . . . . 0.0 109.043 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.682 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 15.4 m -99.2 42.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 108.995 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.459 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.452 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 12.2 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.328 0.585 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.957 HG22 ' HA ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -149.67 75.94 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 109.223 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.663 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 22.3 mttp -51.46 -178.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 0.0 109.695 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.499 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 48.8 m -147.17 116.76 7.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.4 -0.813 . . . . 0.0 109.158 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.695 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -124.03 150.99 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 109.075 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.697 HD22 HG12 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -149.16 108.65 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.156 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.51 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 1.9 m-85 -81.52 157.38 24.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.895 HG11 HD11 ' A' ' 99' ' ' LEU . 59.5 t -138.8 149.87 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.883 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -169.04 133.4 1.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.415 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.619 HD11 ' CH2' ' A' ' 49' ' ' TRP . 13.4 tp -44.74 -61.76 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.87 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 15' ' ' ASN . . . -49.58 -88.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.865 ' O ' HG23 ' A' ' 16' ' ' ILE . 20.6 t30 76.69 17.82 1.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -1.102 . . . . 0.0 109.6 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.865 HG23 ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER -169.1 -71.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 4.8 p -76.72 -26.84 55.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.449 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 19' ' ' SER . 25.8 ttm180 -62.18 -13.13 24.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.249 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 18' ' ' ARG . 7.3 m 68.48 60.72 0.68 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.293 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 19' ' ' SER . 40.9 Cg_endo -69.35 81.33 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.965 1.777 . . . . 0.0 110.458 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.992 ' O ' HG23 ' A' ' 25' ' ' VAL . 6.8 mm -83.44 -15.61 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.87 . . . . 0.0 109.34 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.769 ' HB1' ' HB3' ' A' ' 148' ' ' CYS . . . -63.99 -51.65 63.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.132 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -60.34 -58.71 7.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 108.933 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.871 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -44.57 -38.0 3.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -0.849 . . . . 0.0 108.884 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 21' ' ' ILE . 70.4 t -60.32 -56.51 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.247 -0.908 . . . . 0.0 108.831 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.636 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 0.4 OUTLIER -43.58 -32.19 0.89 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -62.82 -52.88 61.44 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 108.853 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.519 ' HG3' HD13 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -63.29 -58.28 7.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.21 -0.931 . . . . 0.0 109.663 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.636 HD12 ' SG ' ' A' ' 149' ' ' CYS . 29.9 mt -43.47 -66.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 109.761 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.967 HG22 ' HA ' ' A' ' 36' ' ' SER . 3.0 p -58.8 -24.78 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 109.995 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 31' ' ' THR . 14.4 m -99.8 30.7 3.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.553 -1.342 . . . . 0.0 109.262 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -149.69 46.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.62 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -179.24 32.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -0.812 . . . . 0.0 109.041 -179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 33' ' ' GLN . 9.8 m120 46.7 42.08 11.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.826 HG12 HG23 ' A' ' 30' ' ' VAL . 1.7 tt -130.64 -5.38 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.247 0.546 . . . . 0.0 109.779 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.967 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -74.26 -33.27 63.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.937 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -76.08 1.79 14.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.64 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.957 ' HA ' HG22 ' A' ' 5' ' ' THR . 23.7 m-20 -128.8 37.91 4.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 109.785 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.695 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 18.2 m95 -150.62 139.89 21.28 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.853 -1.154 . . . . 0.0 110.899 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.451 HG12 ' CE2' ' A' ' 85' ' ' PHE . 44.1 t -112.04 73.62 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.495 ' CG1' HG13 ' A' ' 8' ' ' VAL . 2.9 mt -89.91 140.42 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -0.819 . . . . 0.0 109.862 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 14.7 t0 -149.06 -168.27 3.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.477 -0.764 . . . . 0.0 109.175 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.411 ' OG ' ' OD1' ' A' ' 15' ' ' ASN . 29.6 t -134.48 169.96 16.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 109.691 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.78 153.85 25.55 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.13 -18.43 6.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -1.142 . . . . 0.0 109.714 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.673 ' O ' HG12 ' A' ' 46' ' ' VAL . 58.1 t 56.98 17.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.381 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.578 ' HB3' ' CZ2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -145.26 144.71 30.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.299 -0.875 . . . . 0.0 109.413 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.487 ' HA ' HG23 ' A' ' 51' ' ' VAL . 5.0 m-20 -91.65 32.63 1.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.619 ' CH2' HD11 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -97.19 -33.95 11.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 109.331 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 11.8 m-20 -125.43 46.78 2.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.639 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.843 HG13 ' HA ' ' A' ' 75' ' ' ARG . 89.8 t -71.95 85.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.353 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.47 ' HA2' ' CG ' ' A' ' 73' ' ' LYS . . . 115.96 -6.44 19.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.523 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 2.5 mtt85 -76.55 96.25 4.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -1.113 . . . . 0.0 109.599 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.804 ' O ' HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -50.91 -179.36 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.123 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 61.5 Cg_exo -49.59 133.8 32.45 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.833 1.689 . . . . 0.0 110.239 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.579 ' OD1' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -43.76 145.3 1.22 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.465 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' VAL . 53.9 Cg_exo -50.09 -21.1 6.08 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.941 1.76 . . . . 0.0 110.386 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.2 mtt-85 -83.04 -50.41 8.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.758 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 1.04 ' O ' HD12 ' A' ' 63' ' ' LEU . . . -90.25 11.98 19.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 110.077 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.598 HG13 ' N ' ' A' ' 61' ' ' SER . 7.3 p -90.01 -49.14 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.042 -1.036 . . . . 0.0 109.607 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.598 ' N ' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -91.53 -29.84 16.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.132 -0.98 . . . . 0.0 109.682 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.9 m -90.17 20.38 4.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.04 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -64.68 102.47 0.58 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.772 -1.205 . . . . 0.0 108.412 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.596 ' HG3' ' CE1' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 59.36 15.56 4.46 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.741 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 64' ' ' ARG . 5.1 p30 35.29 100.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.008 0.908 . . . . 0.0 111.086 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 57.91 24.44 10.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 0.0 109.902 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.518 ' HA3' ' NE ' ' A' ' 64' ' ' ARG . . . -128.09 -4.66 5.46 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.932 HG21 ' CD2' ' A' ' 63' ' ' LEU . 25.2 mm -148.0 156.94 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -1.19 . . . . 0.0 109.698 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' HG22 ' A' ' 68' ' ' ILE . 2.5 m-80 -141.51 83.52 1.87 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.244 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.59 HG21 HD13 ' A' ' 63' ' ' LEU . 26.1 p -70.3 159.88 33.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.62 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -169.1 28.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.247 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.535 ' CD2' ' N ' ' A' ' 73' ' ' LYS . 8.7 t60 -124.27 157.75 34.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.36 -0.838 . . . . 0.0 109.254 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.535 ' N ' ' CD2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -89.71 -147.24 0.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 109.532 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 75' ' ' ARG . . . -137.75 -81.78 0.34 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.544 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.843 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 75.08 113.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.953 . . . . 0.0 109.392 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.647 ' H ' HG22 ' A' ' 51' ' ' VAL . 2.3 tt0 -43.68 143.05 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.428 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.606 HG23 ' H ' ' A' ' 46' ' ' VAL . 5.0 t -57.68 164.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -169.19 165.9 10.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.353 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.595 ' CG ' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -43.61 -31.88 0.85 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' OG1' ' A' ' 84' ' ' THR . 36.4 tt0 -59.41 -57.22 13.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.293 -0.88 . . . . 0.0 109.616 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.516 ' HB3' HD13 ' A' ' 9' ' ' LEU . 6.6 m-20 -66.11 -17.71 64.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.87 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.764 ' CD2' HG21 ' A' ' 106' ' ' VAL . 10.5 m-85 -70.47 -74.78 0.13 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.047 -1.033 . . . . 0.0 109.308 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 7.4 p -61.49 -24.2 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.458 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 5.8 m -64.45 -73.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.97 . . . . 0.0 109.448 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.622 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 57.1 m-85 -75.98 154.83 35.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.681 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 63.3 m-20 -108.71 -16.62 14.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.421 -0.799 . . . . 0.0 109.485 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.563 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 22.9 m-85 -118.25 67.74 0.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.64 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.917 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.1 mt -79.61 93.91 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.316 -0.865 . . . . 0.0 109.077 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -106.04 178.88 4.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 109.502 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.691 ' SG ' ' HB ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -132.88 176.82 8.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.346 -0.846 . . . . 0.0 109.41 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.688 ' O ' HG23 ' A' ' 127' ' ' ILE . 1.5 mmt -85.35 45.08 1.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.915 . . . . 0.0 109.594 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.693 ' HB3' HG23 ' A' ' 126' ' ' ILE . 0.7 OUTLIER 54.71 106.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.602 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -177.24 155.2 1.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.492 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -7.95 36.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -66.61 -16.05 63.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.449 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.564 HD21 HG22 ' A' ' 113' ' ' ILE . 0.3 OUTLIER -64.51 -22.31 66.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 109.537 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -55.55 -24.22 31.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.13 -43.35 11.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.364 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.895 HD11 HG11 ' A' ' 11' ' ' VAL . 9.2 mt -67.92 -13.23 61.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.65 -32.39 23.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.39 16.28 18.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.961 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -104.0 -19.37 14.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.56 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 96.5 p -71.06 -45.96 62.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.524 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.476 ' OD1' ' HG2' ' A' ' 105' ' ' GLN . 19.1 p-10 -62.18 -29.38 70.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.476 ' HG2' ' OD1' ' A' ' 104' ' ' ASN . 1.4 mm-40 -87.72 -15.24 37.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.949 . . . . 0.0 109.379 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 102' ' ' LYS . 25.6 t -71.36 150.18 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.261 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 108' ' ' ASN . 3.2 tptt -71.92 87.16 1.01 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.271 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 107' ' ' LYS . 50.3 t30 68.28 45.42 1.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 109.485 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -56.76 149.69 17.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 0.0 109.817 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 1.9 ptm180 -138.75 9.73 2.63 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.917 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -86.34 91.79 8.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.432 -0.792 . . . . 0.0 110.404 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -47.95 122.31 4.96 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 111' ' ' ALA . 1.3 mm -95.54 140.6 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.817 -1.177 . . . . 0.0 110.281 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 1.2 tt0 -168.61 -177.74 3.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -125.31 156.73 38.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.065 -1.022 . . . . 0.0 109.634 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.684 ' CD2' ' SG ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER -43.69 -26.64 0.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . -63.2 89.26 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER 170.38 -35.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -1.117 . . . . 0.0 109.461 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.447 ' CD2' ' HA ' ' A' ' 152' ' ' PHE . 22.9 m-85 -105.91 76.04 1.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 109.433 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 123' ' ' LYS . 2.1 m-20 -143.18 84.12 10.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.897 . . . . 0.0 109.622 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.18 -36.13 45.13 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.996 1.797 . . . . 0.0 110.237 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 122' ' ' GLN . 8.5 pt20 -155.44 68.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.429 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB3' ' OD1' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -169.97 128.86 0.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.305 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.93 95.62 3.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.326 -0.859 . . . . 0.0 109.466 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.14 -43.3 0.56 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.568 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.716 HG22 ' HG3' ' A' ' 128' ' ' GLU . 28.1 mm 57.51 102.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 109.461 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 91' ' ' MET . 4.6 tt -77.05 96.57 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.517 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.716 ' HG3' HG22 ' A' ' 126' ' ' ILE . 21.4 mt-10 -119.17 39.04 3.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 109.425 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -72.93 146.94 88.19 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 109.478 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -72.14 -175.38 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.957 1.771 . . . . 0.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.535 ' O ' ' CD1' ' A' ' 131' ' ' TYR . 40.6 t80 -68.7 -13.23 62.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.398 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -92.15 -28.93 16.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.85 176.59 43.65 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -79.96 -56.46 4.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.42 -71.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.872 . . . . 0.0 109.487 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.56 42.59 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.873 . . . . 0.0 109.494 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -82.9 74.89 9.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.577 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.735 ' O ' HG12 ' A' ' 141' ' ' VAL . 3.9 t80 -130.54 -39.25 1.29 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 0.0 109.477 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -80.65 -47.32 14.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.21 -0.932 . . . . 0.0 109.383 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.3 m -64.84 -40.39 95.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.386 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.761 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 8.7 p -52.33 -27.22 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.596 ' CE1' ' HG3' ' A' ' 64' ' ' ARG . 3.1 t80 -83.52 -47.89 10.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.356 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -49.81 -53.63 24.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.74 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HG3' ' N ' ' A' ' 145' ' ' CYS . 0.9 OUTLIER -73.94 -23.27 59.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.812 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.761 ' SG ' ' O ' ' A' ' 141' ' ' VAL . 1.8 m -68.07 -20.35 64.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.572 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.68 ' HA ' HG11 ' A' ' 25' ' ' VAL . 55.5 t -64.38 -70.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.953 . . . . 0.0 109.354 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.722 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 2.1 mtt-85 -63.5 -16.71 61.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.948 . . . . 0.0 109.354 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.769 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -46.3 -31.07 2.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 0.0 109.094 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.771 ' SG ' HG12 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -116.85 -30.99 5.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -0.873 . . . . 0.0 109.144 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.523 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 67.8 ttt-85 -71.68 -56.25 6.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 108.964 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.722 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -50.83 -32.14 19.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.427 -0.796 . . . . 0.0 109.234 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.891 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 1.1 t80 -79.12 -33.21 44.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.419 -0.801 . . . . 0.0 109.384 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.7 tp -67.22 -18.29 65.17 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.148 -0.97 . . . . 0.0 108.755 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 49.2 mm-40 -68.67 -63.6 1.03 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 108.832 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -53.13 -47.59 68.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 108.826 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.891 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 18.5 m -98.12 51.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 108.838 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.358 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.583 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 6' ' ' LYS . 1.8 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.938 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -47.71 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 109.6 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.691 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -47.14 175.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.225 -0.922 . . . . 0.0 109.584 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.581 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 1.4 m -149.62 105.88 3.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.235 -0.916 . . . . 0.0 109.43 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.983 HG11 ' CE2' ' A' ' 26' ' ' PHE . 2.0 p -111.5 138.92 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.248 -0.908 . . . . 0.0 110.202 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.668 HD22 ' CD1' ' A' ' 88' ' ' ILE . 0.5 OUTLIER -133.76 129.37 36.54 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.56 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 1.3 m-85 -110.41 155.57 22.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 110.036 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.758 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 40.0 t -144.29 145.67 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.781 ' SG ' ' HG2' ' A' ' 91' ' ' MET . 2.9 m -163.74 48.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.097 -1.002 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.672 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.7 OUTLIER 42.47 -95.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.427 -0.795 . . . . 0.0 109.577 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -60.37 89.09 0.03 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 4.5 t-20 -90.28 26.97 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -1.114 . . . . 0.0 109.457 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 53' ' ' ARG . 1.2 pp -122.63 -8.34 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.39 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -161.09 151.32 17.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.455 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.611 ' HD3' HD11 ' A' ' 127' ' ' ILE . 0.0 OUTLIER 51.96 63.17 2.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 162.44 -51.1 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.86 . . . . 0.0 109.823 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 19' ' ' SER . 66.1 Cg_exo -48.61 -21.94 3.9 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.909 1.739 . . . . 0.0 110.529 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.962 HG21 ' HA ' ' A' ' 142' ' ' TYR . 3.6 mm -66.59 -49.15 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.061 -1.025 . . . . 0.0 109.21 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.568 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -62.14 -18.29 60.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.137 -0.977 . . . . 0.0 109.272 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ALA . 18.3 tt0 -81.07 -82.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 109.41 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -44.23 -33.2 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.993 . . . . 0.0 109.357 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.839 HG11 ' HA ' ' A' ' 146' ' ' VAL . 44.3 t -65.72 -49.72 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.858 . . . . 0.0 109.426 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.983 ' CE2' HG11 ' A' ' 8' ' ' VAL . 1.1 t80 -53.43 -39.96 64.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.946 -1.096 . . . . 0.0 108.346 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -51.53 -67.16 0.27 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.282 -0.887 . . . . 0.0 108.961 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HA ' ' OG1' ' A' ' 31' ' ' THR . 28.9 tttt -73.15 -0.32 13.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 110.009 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.953 HD21 ' HB2' ' A' ' 150' ' ' ARG . 46.3 tp -85.32 -33.33 22.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 109.011 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.884 HG12 ' CE1' ' A' ' 26' ' ' PHE . 2.0 m -90.34 -31.05 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.977 HG23 ' CB ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -66.19 -33.04 74.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.662 -0.649 . . . . 0.0 109.348 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -66.84 -19.91 65.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 108.99 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.516 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 6.6 mm-40 -100.53 -3.01 31.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.434 -0.791 . . . . 0.0 109.531 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.9 OUTLIER 76.74 45.78 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.701 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.738 ' CD1' HD21 ' A' ' 153' ' ' LEU . 4.1 pt -137.41 3.24 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 0.0 109.942 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.977 ' CB ' HG23 ' A' ' 31' ' ' THR . 4.3 p -72.04 -30.77 65.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.928 -1.108 . . . . 0.0 109.48 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -60.62 -13.99 17.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.855 . . . . 0.0 109.277 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.938 ' HA ' HG22 ' A' ' 5' ' ' THR . 6.2 m-20 -129.01 48.15 2.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.691 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 5.7 m95 -150.11 143.43 25.08 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.888 -1.133 . . . . 0.0 110.666 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 t -117.54 81.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.67 HD11 HG11 ' A' ' 30' ' ' VAL . 3.5 mt -89.91 137.79 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.724 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -164.89 117.38 1.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.428 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 1.3 p -82.76 -171.62 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.965 . . . . 0.0 109.377 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.521 ' HA3' ' CG2' ' A' ' 77' ' ' VAL . . . -178.87 166.5 36.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.811 ' HB1' ' ND2' ' A' ' 50' ' ' ASN . . . -97.21 -167.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -1.106 . . . . 0.0 109.289 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.672 HG23 ' H ' ' A' ' 13' ' ' LEU . 38.5 t -121.2 -12.75 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.113 -0.992 . . . . 0.0 109.346 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -125.8 -153.66 0.58 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.526 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.687 ' HA ' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -119.85 -21.93 7.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 109.438 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.503 ' HZ2' HD21 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -54.9 -18.35 4.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.564 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.811 ' ND2' ' HB1' ' A' ' 45' ' ' ALA . 13.0 p30 -115.26 42.11 2.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.896 HG13 ' HD3' ' A' ' 75' ' ' ARG . 70.4 t -101.72 114.79 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.0 -6.99 83.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 16' ' ' ILE . 6.6 mtt180 -72.43 103.32 3.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -1.135 . . . . 0.0 109.507 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.1 p -59.82 154.64 46.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.537 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.04 158.77 3.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.974 1.783 . . . . 0.0 110.323 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -74.26 157.83 86.15 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.513 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 53.4 Cg_endo -71.87 -3.14 12.62 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.949 1.766 . . . . 0.0 110.256 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -89.49 -47.63 7.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB1' HD11 ' A' ' 21' ' ' ILE . . . -84.61 -16.77 40.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.454 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.513 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 9.8 p -65.09 -32.8 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.522 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.41 -10.17 54.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.4 m -80.82 -21.93 40.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -90.21 -66.66 0.9 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.027 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.9 ttm180 -47.33 -24.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.39 -0.819 . . . . 0.0 109.539 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -71.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -66.93 -8.79 32.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 109.644 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.8 69.3 0.81 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.597 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 10.3 mm -109.42 160.8 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -1.104 . . . . 0.0 109.458 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.498 ' N ' HG22 ' A' ' 68' ' ' ILE . 3.4 m120 -129.51 102.44 6.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.395 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -116.24 147.22 41.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.59 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -150.58 36.73 0.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.206 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -119.03 125.4 49.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.341 -0.85 . . . . 0.0 109.541 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -93.21 38.05 1.04 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.412 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 73' ' ' LYS . . . 65.94 169.54 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.898 . . . . 0.0 109.5 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.896 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 168.06 152.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -82.35 129.85 34.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.521 ' CG2' ' HA3' ' A' ' 44' ' ' GLY . 42.8 t -71.0 103.15 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 65.9 p -72.12 -164.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 109.095 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.878 ' HB2' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -86.29 -23.87 26.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.042 -1.036 . . . . 0.0 109.257 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 84' ' ' THR . 20.1 tt0 -65.46 -33.08 75.11 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.407 -0.808 . . . . 0.0 108.845 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -68.16 -17.86 64.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.39 -0.818 . . . . 0.0 108.975 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.827 ' CA ' ' HB2' ' A' ' 111' ' ' ALA . 32.1 m-85 -82.49 -65.24 1.03 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.364 -0.835 . . . . 0.0 109.208 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 110' ' ' ARG . 9.5 p -62.76 -19.17 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' GLU . 14.1 m -78.66 -67.47 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.0 109.244 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.579 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 53.3 m-85 -68.81 135.42 51.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.219 -0.926 . . . . 0.0 109.452 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -78.17 -23.63 47.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 7' ' ' SER . 6.9 m-85 -115.6 147.58 40.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.898 . . . . 0.0 109.539 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.859 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -156.82 95.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.366 -0.834 . . . . 0.0 108.832 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -114.1 156.88 23.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 109.749 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.508 ' HB2' HD12 ' A' ' 99' ' ' LEU . 36.1 t -124.6 146.48 49.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.476 -0.765 . . . . 0.0 109.059 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.781 ' HG2' ' SG ' ' A' ' 12' ' ' CYS . 20.4 mmt -42.91 150.71 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.69 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.512 ' OD1' HD12 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -45.16 -24.68 0.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 128' ' ' GLU . 9.5 mt-10 -41.29 -89.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.336 -0.852 . . . . 0.0 109.589 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 96' ' ' LEU . 39.2 p -79.41 83.09 5.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.246 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.811 ' HB2' HD22 ' A' ' 115' ' ' LEU . 17.3 p-10 -52.3 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.569 -0.707 . . . . 0.0 109.605 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.992 HD21 HG21 ' A' ' 113' ' ' ILE . 0.3 OUTLIER 41.56 27.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.625 -0.672 . . . . 0.0 109.9 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -90.28 -29.71 17.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.547 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.48 -38.63 7.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.514 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 90' ' ' CYS . 8.9 mt -67.05 -37.06 83.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.645 ' HB2' HD22 ' A' ' 96' ' ' LEU . 29.7 t30 -57.18 -19.49 20.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -89.73 -32.74 16.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.439 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.717 ' O ' HG23 ' A' ' 106' ' ' VAL . 9.5 mmmt -59.02 -32.88 70.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.882 . . . . 0.0 109.353 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 t -68.31 -31.59 71.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.244 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.09 -32.05 71.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -90.93 -11.28 39.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 109.302 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.878 HG22 ' HB2' ' A' ' 79' ' ' LYS . 81.5 t -86.08 140.73 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 119.35 23.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.342 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 109' ' ' CYS . 1.5 m-20 50.99 40.0 24.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.142 -0.974 . . . . 0.0 109.179 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -42.77 138.71 1.86 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.365 -0.834 . . . . 0.0 109.92 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.567 ' CB ' ' CZ ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -125.13 -5.12 7.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.806 . . . . 0.0 109.063 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.859 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -62.86 93.1 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.85 . . . . 0.0 110.207 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 86' ' ' ASP . 11.7 ttmt -46.29 106.48 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.992 HG21 HD21 ' A' ' 96' ' ' LEU . 2.9 mm -83.29 164.74 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.046 -1.034 . . . . 0.0 110.956 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.564 ' HB3' HD23 ' A' ' 89' ' ' LEU . 4.1 mt-10 176.47 -176.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.811 HD22 ' HB2' ' A' ' 95' ' ' ASN . 1.2 pp -141.49 138.75 33.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 0.0 109.84 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.4 OUTLIER -53.37 119.96 5.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.0 109.449 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -157.2 -159.84 9.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.58 114.36 2.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.477 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.0 m-85 -112.45 -17.83 12.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.583 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 163.84 -51.68 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.605 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 58.3 Cg_exo -49.26 164.41 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.698 1.599 . . . . 0.0 110.2 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -96.2 143.33 27.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.69 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 125' ' ' LEU . 3.9 tp60 -104.64 12.96 32.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 109.594 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.492 ' C ' ' O ' ' A' ' 124' ' ' GLN . 14.6 tp 33.47 81.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.169 0.509 . . . . 0.0 110.514 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.512 HD12 ' OD1' ' A' ' 92' ' ' ASP . 13.4 mm -48.15 143.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 109.201 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.612 ' O ' HG23 ' A' ' 127' ' ' ILE . 2.1 tt -119.9 95.3 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 94.4 mt-10 -121.86 69.2 0.93 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.432 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -114.73 144.9 32.79 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.505 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.91 -91.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.034 1.823 . . . . 0.0 110.278 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.495 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 32.5 t80 -166.32 50.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.329 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.76 109.88 4.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.33 145.91 16.41 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -110.44 -28.7 8.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -1.065 . . . . 0.0 109.371 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.439 ' OD1' ' CB ' ' A' ' 137' ' ' ASP . 2.6 p30 -91.71 17.8 8.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 45.47 49.55 10.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.439 ' CB ' ' OD1' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -79.98 79.05 6.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.47 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.415 ' CZ ' ' N ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -113.93 -10.05 12.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.499 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.46 -45.57 21.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 7.7 m -57.52 -25.35 59.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 18' ' ' ARG . 45.3 t -76.96 -36.46 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.962 ' HA ' HG21 ' A' ' 21' ' ' ILE . 4.7 t80 -64.37 -43.81 93.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -71.06 -48.95 49.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.66 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 148' ' ' CYS . 0.0 OUTLIER -59.33 -21.41 59.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.627 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.76 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.5 m -72.14 -32.6 67.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.839 ' HA ' HG11 ' A' ' 25' ' ' VAL . 77.7 t -49.49 -51.73 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.938 . . . . 0.0 109.289 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.448 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -77.68 -27.59 50.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.424 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.749 ' SG ' ' HA ' ' A' ' 145' ' ' CYS . 67.6 m -44.21 -26.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.138 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.601 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -115.11 -28.75 6.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.226 -0.921 . . . . 0.0 109.452 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.953 ' HB2' HD21 ' A' ' 29' ' ' LEU . 30.9 ttt85 -71.04 -59.2 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 108.99 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -49.43 -22.22 1.12 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.388 -0.82 . . . . 0.0 109.611 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 89' ' ' LEU . 1.3 t80 -90.19 -34.98 15.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 110.061 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.738 HD21 ' CD1' ' A' ' 35' ' ' ILE . 11.2 tp -67.28 -46.47 73.51 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.807 -1.183 . . . . 0.0 109.16 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 11.4 pt-20 -49.87 -38.23 34.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 108.638 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -59.98 -60.53 3.68 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.493 HG11 ' CE1' ' A' ' 87' ' ' TYR . 31.8 m -92.17 31.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.363 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.415 ' C ' ' OD1' ' A' ' 38' ' ' ASN . 59.5 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.781 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -87.93 75.95 8.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.684 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -41.33 153.04 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.759 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.586 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -133.23 117.29 17.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.082 -1.012 . . . . 0.0 109.579 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.719 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.4 OUTLIER -121.41 154.99 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.927 . . . . 0.0 109.591 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -149.99 106.53 3.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.868 . . . . 0.0 109.184 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.918 ' CE1' HD13 ' A' ' 89' ' ' LEU . 1.9 m-85 -88.41 155.15 19.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.777 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 2.0 t -145.94 149.83 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.232 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -166.35 154.0 9.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.539 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.7 tp -55.63 -67.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.02 78.92 1.5 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.643 ' ND2' ' HB2' ' A' ' 45' ' ' ALA . 42.5 p-10 -92.2 43.46 1.13 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -1.159 . . . . 0.0 109.419 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.848 HD12 ' H ' ' A' ' 17' ' ' CYS . 1.1 pp -132.88 -31.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 109.949 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.848 ' H ' HD12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -148.46 12.5 0.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.913 -1.117 . . . . 0.0 110.257 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.497 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 7.5 ttt-85 -125.35 -52.33 1.62 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.0 109.472 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.653 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -80.0 -44.35 1.48 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 110.949 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 19' ' ' SER . 73.5 Cg_exo -46.72 -17.0 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.99 1.793 . . . . 0.0 112.313 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.004 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -74.74 -45.33 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.336 -1.478 . . . . 0.0 108.894 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 145' ' ' CYS . . . -67.8 -42.98 80.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.01 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.432 ' CD ' ' HB2' ' A' ' 43' ' ' SER . 4.3 tt0 -58.59 -58.57 7.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 108.764 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.72 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -46.02 -36.87 6.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.327 -0.858 . . . . 0.0 108.841 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 21' ' ' ILE . 16.5 t -63.03 -52.12 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.274 -0.891 . . . . 0.0 108.952 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -52.53 -21.47 3.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -56.06 7.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 28' ' ' LYS . 5.1 tttt -78.07 1.43 21.06 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.874 HD21 ' HG3' ' A' ' 150' ' ' ARG . 9.9 tp -94.22 -36.14 12.15 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.921 HG22 ' HA ' ' A' ' 36' ' ' SER . 4.1 p -91.07 -14.66 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -99.1 17.28 20.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.914 -1.116 . . . . 0.0 109.521 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.96 55.39 1.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 108.993 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.572 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 3.2 tp60 173.47 31.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.559 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 33' ' ' GLN . 0.3 OUTLIER 45.34 39.47 4.42 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -178.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.874 HG12 HG23 ' A' ' 30' ' ' VAL . 2.3 tt -124.68 -6.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.53 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.921 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -75.53 -22.23 57.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -0.892 . . . . 0.0 109.798 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -88.45 26.9 1.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.152 -0.968 . . . . 0.0 109.19 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.781 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.7 OUTLIER -159.06 40.19 0.22 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.323 -0.861 . . . . 0.0 109.396 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.719 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 14.4 m95 -150.14 156.62 41.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.956 -1.09 . . . . 0.0 111.121 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.38 72.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.551 HG13 ' CG1' ' A' ' 8' ' ' VAL . 2.8 mt -89.66 129.56 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.397 -0.814 . . . . 0.0 110.395 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.456 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . 5.6 t0 -144.95 147.74 33.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.446 -0.783 . . . . 0.0 108.955 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.432 ' HB2' ' CD ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -120.17 159.23 25.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.035 -1.041 . . . . 0.0 109.75 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.68 179.47 39.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.643 ' HB2' ' ND2' ' A' ' 15' ' ' ASN . . . -104.11 145.6 29.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -1.119 . . . . 0.0 109.401 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.451 HG22 ' CD1' ' A' ' 99' ' ' LEU . 70.8 t -57.1 -35.2 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.92 -164.11 1.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.436 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.495 ' HA ' HG23 ' A' ' 51' ' ' VAL . 1.6 m-20 -92.43 57.59 3.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.902 . . . . 0.0 109.474 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -89.03 -33.9 16.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.336 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -146.98 47.95 1.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.361 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 48' ' ' ASP . 76.2 t -58.86 112.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA2' ' HG3' ' A' ' 73' ' ' LYS . . . 51.43 51.36 37.63 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 54' ' ' SER . 7.8 mtt180 -95.98 18.47 13.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -1.192 . . . . 0.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER 58.53 151.93 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.62 -0.675 . . . . 0.0 109.631 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.17 128.22 13.62 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.98 1.787 . . . . 0.0 110.186 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 17' ' ' CYS . 55.5 m-20 -48.02 154.91 0.93 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.518 ' O ' HG12 ' A' ' 60' ' ' VAL . 55.5 Cg_endo -71.7 -4.77 15.71 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.024 1.816 . . . . 0.0 110.306 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -62.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.25 -18.38 65.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 109.4 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.594 HG22 ' HD2' ' A' ' 64' ' ' ARG . 9.8 p -63.96 -41.45 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.179 -0.951 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.515 ' N ' HG13 ' A' ' 60' ' ' VAL . 8.8 p -77.02 -3.31 38.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.665 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.485 ' C ' HD23 ' A' ' 63' ' ' LEU . 1.7 t -90.14 -33.02 16.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.41 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.798 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.38 -55.07 3.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.274 -0.892 . . . . 0.0 109.207 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.594 ' HD2' HG22 ' A' ' 60' ' ' VAL . 7.7 ptm180 -56.87 -16.54 6.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.386 -0.821 . . . . 0.0 109.642 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.501 ' OD1' ' CD2' ' A' ' 66' ' ' HIS . 12.6 t-20 -66.46 -81.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.501 ' CD2' ' OD1' ' A' ' 65' ' ' ASN . 1.0 OUTLIER -150.7 20.57 0.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.588 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.03 -97.19 2.39 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.72 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 2.6 mp -119.46 161.29 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -1.13 . . . . 0.0 109.413 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.486 ' N ' HG22 ' A' ' 68' ' ' ILE . 2.2 m-80 -118.25 54.61 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.116 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -58.37 151.18 20.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.571 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -144.55 14.38 1.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.264 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 18.7 t60 -78.45 146.78 34.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.569 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 4.0 tptm -93.67 131.54 38.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 73' ' ' LYS . . . -48.42 176.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.548 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.467 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 171.51 139.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.466 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.405 ' H ' HG22 ' A' ' 51' ' ' VAL . 2.1 tt0 -70.07 131.41 44.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 109.51 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.647 HG12 ' CE1' ' A' ' 82' ' ' PHE . 71.8 t -48.75 131.54 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 109.334 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 79' ' ' LYS . 20.5 p -111.86 160.35 17.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.636 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -43.17 -44.3 5.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.573 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' O ' ' OG1' ' A' ' 84' ' ' THR . 23.6 tt0 -57.7 -47.82 81.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.837 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 1.1 m-20 -53.94 -43.78 70.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 109.983 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.894 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 49.6 m-85 -54.53 -50.89 66.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.499 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.567 ' HA ' ' CG ' ' A' ' 110' ' ' ARG . 1.0 OUTLIER -87.05 0.59 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 109.767 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.48 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 13.5 m -77.79 -53.32 7.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 110.244 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.606 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 16.7 m-85 -100.85 174.58 5.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.064 -1.022 . . . . 0.0 110.412 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 19.5 t0 -112.41 -19.84 12.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.466 -0.771 . . . . 0.0 109.578 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 7' ' ' SER . 1.4 m-85 -116.89 86.97 2.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 0.0 109.23 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.882 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 1.5 mt -95.73 123.45 47.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.339 -0.851 . . . . 0.0 109.327 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.918 HD13 ' CE1' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -149.59 153.38 37.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 109.267 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.55 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 4.7 p -127.37 167.59 15.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.557 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.536 ' HE1' ' HB2' ' A' ' 116' ' ' LEU . 16.9 mmt -60.89 142.04 56.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.682 ' HB3' HG23 ' A' ' 126' ' ' ILE . 16.9 m-20 -43.52 116.29 0.92 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 128' ' ' GLU . 11.3 tt0 -176.34 163.01 2.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.493 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 t -83.31 8.74 12.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -75.91 -11.97 60.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.588 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.9 OUTLIER -74.19 -2.37 24.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 0.0 109.607 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 13.7 ttt85 -63.63 -25.19 68.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.169 -0.957 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 0.4 OUTLIER -95.54 -43.91 7.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.395 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.516 ' HB3' HG21 ' A' ' 113' ' ' ILE . 6.0 mt -53.65 -44.71 69.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.357 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.48 -29.53 70.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.228 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -89.89 -5.8 56.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.903 . . . . 0.0 109.461 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.984 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -81.63 -20.93 38.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -0.874 . . . . 0.0 109.32 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -63.57 -36.59 84.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.826 . . . . 0.0 109.591 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -32.45 73.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.424 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -92.66 9.73 33.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.244 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.984 HG23 ' O ' ' A' ' 102' ' ' LYS . 49.1 t -98.68 145.29 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.392 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -73.39 106.54 5.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.064 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 109' ' ' CYS . 8.2 t-20 47.73 46.68 18.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.002 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.522 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -41.76 145.6 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.561 -0.712 . . . . 0.0 109.704 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.567 ' CG ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -137.6 25.15 2.88 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.311 -0.868 . . . . 0.0 109.111 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.894 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -106.73 131.43 53.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.392 -0.817 . . . . 0.0 109.858 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 88' ' ' ILE . 7.2 mtpt -83.19 100.22 10.43 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.662 HD13 ' N ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -76.32 135.46 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.734 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.46 -177.97 5.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.419 -0.801 . . . . 0.0 109.36 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.508 ' CD2' HD12 ' A' ' 96' ' ' LEU . 60.8 mt -110.71 152.75 26.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.652 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.677 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -69.08 -9.92 55.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.475 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 92' ' ' ASP . . . -45.94 -29.18 3.14 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.3 168.88 19.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -1.085 . . . . 0.0 109.471 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 55.41 73.65 0.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.37 75.54 13.63 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.13 105.89 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.915 1.743 . . . . 0.0 110.294 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 57.49 178.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.96 42.76 22.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.63 120.26 11.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tp -168.28 101.33 0.43 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.524 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.943 HG21 ' OE2' ' A' ' 128' ' ' GLU . 15.1 mm -54.28 141.09 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 127' ' ' ILE . 14.8 mt -100.76 57.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.93 . . . . 0.0 109.351 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.943 ' OE2' HG21 ' A' ' 126' ' ' ILE . 21.0 mt-10 -88.07 132.42 34.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.449 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 1.1 p30 -158.05 158.7 30.22 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 129' ' ' ASP . 51.4 Cg_endo -71.27 -90.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.038 1.825 . . . . 0.0 110.226 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.1 -42.84 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.454 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.09 100.02 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.07 -116.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -160.27 -55.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -1.162 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.41 18.48 15.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.622 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 137' ' ' ASP . . . -55.92 -20.41 15.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.321 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 0.7 OUTLIER 74.79 126.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.731 ' O ' HG12 ' A' ' 141' ' ' VAL . 80.8 t80 -82.42 0.74 40.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.605 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -79.47 -34.2 41.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.146 -0.971 . . . . 0.0 109.461 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.541 HG23 ' N ' ' A' ' 141' ' ' VAL . 15.0 t -76.4 -42.23 45.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 138' ' ' PHE . 9.0 p -46.64 -29.22 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.749 ' CD1' HG22 ' A' ' 21' ' ' ILE . 1.4 t80 -90.18 -46.34 8.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.102 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.03 -64.56 0.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.682 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -55.76 -20.09 13.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.102 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -72.33 -39.08 68.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.331 -0.856 . . . . 0.0 109.344 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.83 ' HA ' HG11 ' A' ' 25' ' ' VAL . 90.1 t -53.21 -71.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.034 -1.041 . . . . 0.0 109.74 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.54 ' HA ' ' CB ' ' A' ' 150' ' ' ARG . 13.1 mtm180 -62.49 -21.18 65.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.088 -1.007 . . . . 0.0 109.606 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.677 ' HA ' HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -45.81 -27.44 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.985 -1.072 . . . . 0.0 108.18 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.607 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -111.62 -23.12 10.86 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.874 ' HG3' HD21 ' A' ' 29' ' ' LEU . 8.5 ttp180 -76.48 -64.49 1.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.389 -0.819 . . . . 0.0 109.257 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -45.72 -37.87 6.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.257 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.667 ' O ' HG22 ' A' ' 156' ' ' VAL . 1.9 t80 -74.71 -37.38 62.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.42 -0.8 . . . . 0.0 109.3 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . 13.3 tp -67.14 -16.96 64.64 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.211 -0.93 . . . . 0.0 108.718 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -72.37 -50.52 26.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.035 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -42.43 98.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 108.841 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 152' ' ' PHE . 17.0 m -103.84 42.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 109.056 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.466 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.703 HG22 ' H ' ' A' ' 5' ' ' THR . 4.1 p . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.358 0.599 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.957 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -151.48 83.59 1.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.248 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.652 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -41.53 162.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.868 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.585 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 2.5 m -142.8 114.7 8.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 108.999 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.716 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.6 OUTLIER -118.01 147.77 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.733 -179.256 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -149.99 116.4 5.77 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 89' ' ' LEU . 2.5 m-85 -91.87 160.33 15.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 0.0 109.858 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.069 HG11 HD11 ' A' ' 99' ' ' LEU . 4.2 t -145.98 149.48 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.546 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -174.13 121.91 0.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.445 HD11 ' CZ2' ' A' ' 49' ' ' TRP . 44.6 tp -43.46 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 109.582 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . 148.96 -73.75 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.7 14.33 8.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -1.096 . . . . 0.0 109.425 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.616 HG21 ' HD3' ' A' ' 53' ' ' ARG . 1.3 pp -131.41 12.73 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 18' ' ' ARG . 15.3 t 179.12 137.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.77 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 23.7 ttm-85 84.15 -52.22 0.13 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.75 -0.594 . . . . 0.0 109.664 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -79.56 -50.1 1.32 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 110.049 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 19' ' ' SER . 70.2 Cg_exo -48.37 -33.66 23.23 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.902 1.735 . . . . 0.0 110.876 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.022 HG21 ' HA ' ' A' ' 142' ' ' TYR . 5.4 mm -65.75 -61.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.961 -1.087 . . . . 0.0 109.655 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.444 ' N ' ' HB3' ' A' ' 145' ' ' CYS . . . -62.5 -12.77 24.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 109.539 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 2.4 tm-20 -77.98 -74.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.401 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -53.96 -33.96 58.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 108.841 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.085 HG11 ' HA ' ' A' ' 146' ' ' VAL . 49.6 t -56.29 -59.75 2.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.393 -0.817 . . . . 0.0 109.202 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.736 ' CD1' HG12 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -47.52 -41.26 20.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.974 -1.079 . . . . 0.0 108.506 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.505 ' O ' ' OG1' ' A' ' 31' ' ' THR . 5.8 ttt85 -45.7 -60.07 2.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.006 -1.059 . . . . 0.0 109.403 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.481 ' HA ' ' OG1' ' A' ' 31' ' ' THR . 0.3 OUTLIER -75.32 -13.03 60.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.41 -0.806 . . . . 0.0 111.003 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.943 ' CD1' HG12 ' A' ' 25' ' ' VAL . 42.1 mt -76.37 -30.85 57.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.846 -1.159 . . . . 0.0 109.433 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.763 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -90.76 -31.85 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -60.86 -31.81 71.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 109.076 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.46 -40.61 89.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.357 -0.839 . . . . 0.0 109.328 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.532 ' HB3' HG23 ' A' ' 35' ' ' ILE . 32.0 tp60 -80.67 -6.54 58.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.874 . . . . 0.0 109.515 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 1.5 m120 72.67 47.44 0.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.763 ' CG1' HG23 ' A' ' 30' ' ' VAL . 5.9 pt -129.72 -1.14 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.917 . . . . 0.0 109.656 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 30' ' ' VAL . 2.1 p -58.36 -44.46 88.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 109.657 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.12 -28.03 6.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.548 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.957 ' HA ' HG22 ' A' ' 5' ' ' THR . 5.3 m-20 -112.58 46.1 1.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.716 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 7.6 m95 -149.86 144.54 26.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.157 -0.964 . . . . 0.0 110.194 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.718 HG12 ' CE1' ' A' ' 85' ' ' PHE . 33.8 t -124.16 78.11 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.568 ' HA ' HG13 ' A' ' 8' ' ' VAL . 2.6 mt -90.02 139.11 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.869 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -150.75 -173.53 4.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.285 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.439 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 1.1 t -126.46 165.95 18.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.692 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.93 131.94 4.82 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.747 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -93.41 -39.24 11.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.301 -1.117 . . . . 0.0 109.583 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER 80.84 -6.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.695 . . . . 0.0 109.466 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.0 m -141.31 137.33 32.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.624 ' HA ' HG23 ' A' ' 51' ' ' VAL . 1.3 t70 -88.38 14.1 10.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.516 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -86.25 3.45 43.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.695 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 49' ' ' TRP . 3.9 m-20 -144.46 22.78 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.577 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.984 HG13 ' HA ' ' A' ' 75' ' ' ARG . 60.9 t -64.85 128.37 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.05 -18.15 42.16 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.616 ' HD3' HG21 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -62.86 113.17 2.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -1.116 . . . . 0.0 109.365 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.4 m -76.45 153.01 83.79 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 56' ' ' ASP . 53.7 Cg_exo -50.25 143.72 25.33 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.957 1.771 . . . . 0.0 110.266 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 55' ' ' PRO . 4.5 m-20 -44.79 151.92 0.58 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.9 -6.0 18.19 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 121.93 1.753 . . . . 0.0 110.31 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.746 ' O ' ' SG ' ' A' ' 62' ' ' CYS . 16.0 mtt180 -86.26 -33.85 20.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.366 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB2' ' HZ ' ' A' ' 138' ' ' PHE . . . -89.14 -25.07 22.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.319 -0.863 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.583 HG13 ' N ' ' A' ' 61' ' ' SER . 9.9 p -64.71 -44.78 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.456 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.583 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -69.64 -8.46 47.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.631 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.746 ' SG ' ' O ' ' A' ' 58' ' ' ARG . 13.1 m -89.89 -66.71 0.9 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.593 HD12 HG21 ' A' ' 68' ' ' ILE . 1.7 pt? -57.78 -25.31 60.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.368 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.483 ' H ' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -91.56 30.89 1.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.349 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -133.21 -46.0 0.84 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.574 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -83.59 -33.58 25.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.427 ' O ' HG12 ' A' ' 68' ' ' ILE . . . 136.22 98.5 0.54 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.593 HG21 HD12 ' A' ' 63' ' ' LEU . 15.6 mm -149.42 -68.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -1.127 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 21.4 m-80 68.65 116.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.391 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 t -105.01 167.69 9.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.537 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -161.71 39.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.456 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' A' ' 73' ' ' LYS . 8.6 t60 -155.16 144.66 21.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.508 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' CD2' ' A' ' 72' ' ' HIS . 0.9 OUTLIER -115.82 151.18 35.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' ARG . . . -44.11 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.984 ' HA ' HG13 ' A' ' 51' ' ' VAL . 1.5 tpp180 69.15 8.1 6.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER 61.32 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 78' ' ' THR . 11.6 p -53.85 165.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.564 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -143.85 161.96 37.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.677 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -50.63 -41.57 55.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.274 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 84' ' ' THR . 0.3 OUTLIER -54.0 -41.13 67.61 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.354 -0.841 . . . . 0.0 109.53 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.443 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 0.9 OUTLIER -62.15 -31.88 72.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 109.842 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.685 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 77.6 m-85 -66.23 -59.2 3.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.063 -1.023 . . . . 0.0 109.399 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.52 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 2.6 p -72.98 -9.14 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.506 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 85' ' ' PHE . 3.4 m -81.76 -78.06 0.2 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.222 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.718 ' CE1' HG12 ' A' ' 40' ' ' VAL . 37.2 m-85 -70.06 156.52 39.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.253 -0.905 . . . . 0.0 109.315 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -106.43 -12.68 15.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.654 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 7' ' ' SER . 2.2 m-85 -121.88 78.21 1.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 109.712 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.92 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 2.8 mt -89.3 91.66 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.306 -0.872 . . . . 0.0 108.964 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.687 HD21 ' CE1' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -107.45 168.26 9.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 0.0 109.352 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 11' ' ' VAL . 3.9 m -136.51 175.21 9.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.259 -0.9 . . . . 0.0 109.292 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 16.8 mmt -84.07 12.51 6.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.447 ' O ' ' CD2' ' A' ' 115' ' ' LEU . 1.3 p30 170.66 176.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.579 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.733 ' HB2' HD11 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -107.34 -14.69 14.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 93' ' ' GLU . 0.5 OUTLIER -44.26 -53.0 7.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.582 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -89.16 -24.34 22.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.916 . . . . 0.0 109.571 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.84 ' O ' HD23 ' A' ' 96' ' ' LEU . 2.6 tt -58.7 -21.19 54.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.95 -28.24 0.44 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -94.65 -33.24 13.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.069 HD11 HG11 ' A' ' 11' ' ' VAL . 15.4 mt -67.17 -14.48 62.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -85.5 -31.78 22.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.98 -11.93 40.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.447 ' HE2' ' CZ ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -67.86 -42.47 81.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.434 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.698 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 1.1 p -53.03 -22.66 6.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.397 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -72.02 -44.05 64.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.383 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -83.08 -9.93 58.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.554 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.677 HG13 ' HG2' ' A' ' 79' ' ' LYS . 41.1 t -76.8 135.49 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.448 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -68.65 108.41 3.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.482 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.1 t30 51.93 48.98 21.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.279 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -48.36 148.77 1.78 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.282 -0.886 . . . . 0.0 109.773 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.52 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -136.95 5.21 2.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.417 -0.802 . . . . 0.0 109.206 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.92 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -85.44 94.43 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 110.388 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -52.82 122.88 10.02 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -96.97 129.38 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.79 -1.194 . . . . 0.0 110.114 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -155.3 -171.98 4.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 0.0 109.224 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 93' ' ' GLU . 20.2 mt -117.49 162.66 17.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.969 . . . . 0.0 109.517 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.658 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -85.85 58.71 5.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -123.07 -2.22 9.29 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 15.62 24.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -1.187 . . . . 0.0 109.487 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.434 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 2.8 m-85 -135.76 70.57 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -166.63 133.83 2.05 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.164 -0.96 . . . . 0.0 109.382 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.65 -30.55 29.03 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.769 1.646 . . . . 0.0 110.168 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -128.3 132.44 48.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.39 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -64.65 140.44 58.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.182 -0.949 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 125' ' ' LEU . 1.1 mt-30 -108.76 16.82 22.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.253 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.723 ' O ' HD23 ' A' ' 125' ' ' LEU . 1.6 tt 39.66 61.07 1.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.756 -0.59 . . . . 0.0 109.842 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.515 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 7.2 mm 62.08 139.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 0.0 109.345 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 129' ' ' ASP . 2.8 mp -101.43 -55.21 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.84 . . . . 0.0 109.365 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.515 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 33.5 mt-10 48.0 -92.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER 51.44 92.55 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.489 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.1 157.11 3.1 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.901 1.734 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -98.92 87.3 3.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -138.6 -74.83 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.525 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -142.73 117.79 1.17 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 137' ' ' ASP . 2.4 p30 -105.8 148.06 27.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -1.149 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -80.92 74.48 7.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 66.03 33.14 7.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.443 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 134' ' ' ASN . 0.4 OUTLIER -105.89 56.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 109.564 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.481 ' HZ ' ' HB2' ' A' ' 59' ' ' ALA . 66.9 t80 -111.36 -42.04 3.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 109.355 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -70.42 -36.15 73.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 0.0 109.307 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 56.8 m -65.81 -17.66 64.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.226 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 18' ' ' ARG . 22.3 t -81.67 -43.89 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 1.022 ' HA ' HG21 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.54 -25.89 65.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.216 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -83.9 -46.76 11.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.91 . . . . 0.0 109.651 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' A' ' 141' ' ' VAL . 16.2 pt20 -67.23 -13.3 61.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.24 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.77 ' SG ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -79.09 -19.21 51.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 109.457 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 1.085 ' HA ' HG11 ' A' ' 25' ' ' VAL . 54.4 t -61.3 -56.27 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.926 . . . . 0.0 109.27 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.87 -12.29 60.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.288 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.658 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.2 m -56.12 -18.78 10.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.15 -0.969 . . . . 0.0 108.988 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.588 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -124.42 -40.71 2.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.418 -0.801 . . . . 0.0 109.229 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.609 ' HB2' HD13 ' A' ' 29' ' ' LEU . 1.7 ttp180 -59.15 -46.36 88.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 108.71 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.487 ' O ' ' CG ' ' A' ' 154' ' ' GLU . . . -65.68 -18.97 65.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.474 -0.766 . . . . 0.0 109.098 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.934 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 4.6 t80 -90.07 -19.35 24.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.416 -0.802 . . . . 0.0 109.489 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.613 HD13 ' HZ ' ' A' ' 26' ' ' PHE . 14.5 tp -78.7 -22.74 46.22 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.037 -1.04 . . . . 0.0 108.768 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 151' ' ' ALA . 4.4 pt-20 -72.0 -33.71 68.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.1 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.458 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 5.8 mmtp -76.19 -51.65 11.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.916 . . . . 0.0 108.864 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.934 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 17.8 m -103.56 58.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.393 -0.817 . . . . 0.0 108.935 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.559 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 38' ' ' ASN . 1.9 t . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.852 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -130.64 82.75 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.933 . . . . 0.0 109.803 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.662 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -43.12 156.8 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -136.38 113.74 10.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.377 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.676 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 1.0 OUTLIER -117.8 142.71 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.572 HD22 ' CD1' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -142.23 116.61 9.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.445 -0.784 . . . . 0.0 109.136 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.763 ' CZ ' ' SG ' ' A' ' 148' ' ' CYS . 2.0 m-85 -91.1 161.51 15.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.651 HG11 HD11 ' A' ' 99' ' ' LEU . 74.5 t -149.47 152.93 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.475 ' HB3' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -178.28 126.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.437 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.95 124.95 13.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.48 62.47 1.87 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -84.02 74.85 10.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.425 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.642 HD12 ' SG ' ' A' ' 17' ' ' CYS . 0.6 OUTLIER -144.19 12.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.627 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.642 ' SG ' HD12 ' A' ' 16' ' ' ILE . 0.8 OUTLIER 173.74 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.716 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.585 ' HA ' HG11 ' A' ' 141' ' ' VAL . 2.4 ttm105 -94.6 66.68 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 109.572 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.59 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 162.44 -51.08 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.644 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 19' ' ' SER . 57.2 Cg_exo -49.89 -20.83 5.31 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.882 1.721 . . . . 0.0 110.425 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.881 HG21 ' HA ' ' A' ' 142' ' ' TYR . 1.9 mm -64.89 -51.16 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.147 -0.97 . . . . 0.0 109.183 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.67 ' O ' ' SG ' ' A' ' 149' ' ' CYS . . . -63.33 -19.87 65.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.48 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -73.51 -74.67 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.273 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB2' ' HB ' ' A' ' 70' ' ' THR . . . -44.2 -28.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 108.91 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.981 HG11 ' HA ' ' A' ' 146' ' ' VAL . 97.3 t -68.23 -53.32 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.328 -0.858 . . . . 0.0 109.21 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.807 ' CE1' HD11 ' A' ' 41' ' ' ILE . 5.2 t80 -46.22 -39.58 10.05 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.534 ' HD3' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -58.02 -53.36 59.07 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.385 -0.822 . . . . 0.0 109.202 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -76.67 -1.37 27.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 0.0 109.792 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.922 ' CD1' HG12 ' A' ' 25' ' ' VAL . 81.4 mt -92.55 -32.85 14.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.013 -1.054 . . . . 0.0 109.316 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.923 ' HA ' HD11 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -90.71 -49.87 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -52.6 -22.17 4.72 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.272 -0.893 . . . . 0.0 109.167 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -90.67 -31.41 16.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.029 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -79.16 -79.71 0.13 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 109.224 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 4.0 m-20 161.92 42.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.398 -0.814 . . . . 0.0 109.955 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.923 HD11 ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -139.15 11.55 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.976 -1.078 . . . . 0.0 109.837 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.678 ' N ' HG23 ' A' ' 30' ' ' VAL . 4.3 p -62.57 -21.36 65.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.944 -1.097 . . . . 0.0 109.51 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 3.4 m-20 -93.11 34.23 1.13 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.317 -0.865 . . . . 0.0 108.753 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.852 ' HA ' HG22 ' A' ' 5' ' ' THR . 6.6 m-20 -177.06 48.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 109.684 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.676 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 9.8 m95 -149.99 144.19 25.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.89 -1.131 . . . . 0.0 110.383 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.65 81.59 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.807 HD11 ' CE1' ' A' ' 26' ' ' PHE . 2.7 mp -89.93 137.77 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.831 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.581 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 4.4 m-20 -148.44 173.52 13.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -122.76 161.33 24.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.458 ' HA3' ' CG2' ' A' ' 77' ' ' VAL . . . -143.89 147.75 19.19 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 46' ' ' VAL . . . -116.79 -19.73 9.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -1.17 . . . . 0.0 109.558 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.583 ' CG2' ' CG1' ' A' ' 11' ' ' VAL . 4.5 t 69.92 6.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.07 164.03 31.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.601 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.493 ' HA ' HG23 ' A' ' 51' ' ' VAL . 48.5 p30 -110.45 11.59 23.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.865 . . . . 0.0 109.424 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -89.93 6.67 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.745 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.485 ' OD1' ' CD ' ' A' ' 53' ' ' ARG . 4.3 m-80 -147.81 29.76 0.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.58 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 75' ' ' ARG . 26.0 t -78.55 78.51 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 109.283 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA2' ' HD3' ' A' ' 73' ' ' LYS . . . 134.79 -19.86 3.92 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -63.42 90.68 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.417 -1.049 . . . . 0.0 109.409 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 13.4 p -55.72 161.91 2.96 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.856 . . . . 0.0 109.448 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 54' ' ' SER . 53.5 Cg_exo -50.44 153.79 6.99 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.043 1.829 . . . . 0.0 110.199 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 18.5 m-20 -75.38 144.91 78.84 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.928 . . . . 0.0 109.486 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.878 ' O ' HG12 ' A' ' 60' ' ' VAL . 51.6 Cg_exo -51.07 -19.63 6.17 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.959 1.773 . . . . 0.0 110.496 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -79.56 -45.64 18.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.147 -0.971 . . . . 0.0 109.821 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.679 ' O ' HD23 ' A' ' 63' ' ' LEU . . . -71.3 -17.98 62.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 109.885 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.878 HG12 ' O ' ' A' ' 57' ' ' PRO . 8.8 p -72.38 -28.15 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.932 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 14.7 m -64.2 -20.18 65.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.812 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.29 -75.06 0.47 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.198 -0.939 . . . . 0.0 109.745 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -53.87 -18.47 3.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.726 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.551 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 4.3 ttt180 -112.72 51.63 0.81 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.09 -1.006 . . . . 0.0 109.633 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' SER . 4.6 t-20 -129.27 -78.46 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 109.245 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -54.62 -33.05 59.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.317 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.86 104.76 1.34 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.889 HD11 ' HA ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -133.63 -174.36 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -1.169 . . . . 0.0 109.324 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.534 ' CB ' ' HD3' ' A' ' 27' ' ' ARG . 67.0 m-80 -140.18 118.01 11.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.505 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -142.18 -87.32 0.15 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.451 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.518 ' H ' HG23 ' A' ' 70' ' ' THR . . . 60.18 20.49 9.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.333 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.544 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.5 p-80 -90.09 157.4 17.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.495 ' HD3' ' HA2' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -107.87 150.13 27.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.21 170.69 15.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.939 . . . . 0.0 109.551 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.649 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -174.83 153.27 1.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.442 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.431 ' N ' ' HG3' ' A' ' 75' ' ' ARG . 31.6 tt0 -77.04 138.78 39.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.458 ' CG2' ' HA3' ' A' ' 44' ' ' GLY . 77.8 t -67.33 141.98 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 2.7 p -127.95 164.75 21.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.556 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.91 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -51.1 -45.36 61.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.407 ' O ' ' OG1' ' A' ' 84' ' ' THR . 32.7 tt0 -53.9 -38.21 64.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.481 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 78' ' ' THR . 7.3 m-20 -59.11 -41.17 87.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.748 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.805 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 94.4 m-85 -61.84 -54.31 43.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.513 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 108' ' ' ASN . 1.2 p -75.9 -5.84 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 109.612 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 4.0 m -85.89 -71.7 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.314 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 42' ' ' ASP . 71.6 m-85 -74.3 161.62 29.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -109.16 -21.81 12.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.673 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.7 m-85 -116.06 73.32 0.84 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.076 -1.015 . . . . 0.0 109.58 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.901 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.0 mt -86.15 89.81 2.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -100.5 174.3 6.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.041 -1.037 . . . . 0.0 109.441 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.637 ' SG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -150.05 159.8 44.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.431 -0.793 . . . . 0.0 109.091 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.619 ' HE1' ' SG ' ' A' ' 148' ' ' CYS . 32.6 mmt -67.49 167.86 12.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -0.96 . . . . 0.0 109.201 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -59.52 -149.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.793 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 92' ' ' ASP . 0.1 OUTLIER 76.87 -179.04 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.345 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 m -89.01 36.01 0.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -89.94 -15.47 31.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -86.74 -16.31 36.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 109.466 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 21.1 ttt85 -65.91 -11.42 46.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.0 -1.063 . . . . 0.0 109.169 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 13.8 t70 -108.36 -35.09 6.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.259 -0.9 . . . . 0.0 109.183 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.673 ' HB2' HD23 ' A' ' 96' ' ' LEU . 8.9 mt -69.18 -50.6 46.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.362 -0.836 . . . . 0.0 109.41 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -54.52 -26.18 30.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.415 -0.803 . . . . 0.0 109.406 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.83 -24.24 19.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.907 . . . . 0.0 109.478 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -65.94 -39.5 90.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.722 ' HG ' ' HG ' ' A' ' 109' ' ' CYS . 45.1 t -59.72 -17.95 38.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 0.0 109.319 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.31 -40.17 31.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 5.4 pt20 -76.85 -18.16 58.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.91 HG13 ' HG2' ' A' ' 79' ' ' LYS . 92.9 t -69.22 147.9 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -89.41 108.49 19.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.274 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.549 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.4 OUTLIER 65.18 42.04 4.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.074 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.722 ' HG ' ' HG ' ' A' ' 103' ' ' SER . 0.0 OUTLIER -52.35 152.44 3.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 0.0 109.894 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 4.0 ptm180 -140.32 8.75 2.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.424 -0.797 . . . . 0.0 109.184 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.901 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -90.65 91.51 8.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 110.313 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 111' ' ' ALA . 13.7 mtpt -47.33 116.97 1.57 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 111' ' ' ALA . 1.7 mm -93.65 135.98 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.858 -1.151 . . . . 0.0 110.685 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.532 ' HB3' HD23 ' A' ' 89' ' ' LEU . 2.6 tt0 -160.89 -176.27 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.726 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.6 OUTLIER -134.82 151.59 51.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.017 -1.052 . . . . 0.0 109.495 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.071 HD21 ' SG ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -42.25 135.17 2.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.443 -0.785 . . . . 0.0 109.669 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.31 -120.01 1.67 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.6 p -148.65 117.64 6.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -1.185 . . . . 0.0 109.6 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.525 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 23.9 m-85 -115.47 31.35 6.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.35 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.575 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 162.89 -51.24 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.404 -0.81 . . . . 0.0 109.539 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.5 Cg_exo -49.92 146.89 15.61 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.845 1.697 . . . . 0.0 110.071 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.67 11.36 32.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.118 -0.989 . . . . 0.0 109.672 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.57 146.66 25.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -112.85 62.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.392 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.27 76.32 1.56 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.541 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -74.62 137.77 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.265 -0.897 . . . . 0.0 109.083 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.609 HD11 ' CB ' ' A' ' 144' ' ' GLN . 95.2 mt -39.56 106.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.515 -0.741 . . . . 0.0 109.941 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.494 ' HG3' HG23 ' A' ' 126' ' ' ILE . 15.1 mt-10 -142.26 79.74 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.458 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 130' ' ' PRO . 0.9 OUTLIER -150.73 104.45 3.05 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.456 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 129' ' ' ASP . 54.4 Cg_exo -49.68 -174.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.755 1.636 . . . . 0.0 110.29 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -100.12 14.02 32.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.595 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.96 26.44 9.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.42 -105.38 1.58 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -113.48 -159.72 0.7 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -1.191 . . . . 0.0 109.384 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -119.21 -23.78 6.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.39 10.75 9.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -97.74 61.33 1.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.27 -51.26 2.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.561 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -27.29 34.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 109.363 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 61.0 m -61.79 -49.03 77.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.337 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 18' ' ' ARG . 53.5 t -53.6 -40.72 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 0.0 109.377 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.881 ' HA ' HG21 ' A' ' 21' ' ' ILE . 2.2 t80 -61.28 -48.4 81.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -55.01 -65.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 109.951 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.609 ' CB ' HD11 ' A' ' 127' ' ' ILE . 21.0 mm100 -53.38 -19.03 3.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.868 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.709 ' SG ' HG22 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -77.7 -38.09 48.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.117 -0.989 . . . . 0.0 109.645 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.981 ' HA ' HG11 ' A' ' 25' ' ' VAL . 2.9 t -51.57 -53.55 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.087 -1.008 . . . . 0.0 109.218 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -12.54 60.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.861 . . . . 0.0 109.344 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 1.071 ' SG ' HD21 ' A' ' 116' ' ' LEU . 36.2 t -56.46 -40.4 74.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.224 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.67 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -103.06 -29.26 11.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.365 -0.834 . . . . 0.0 109.52 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.736 ' HG3' HD22 ' A' ' 29' ' ' LEU . 2.2 ttt180 -72.21 -59.65 2.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.19 -19.82 23.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.454 -0.779 . . . . 0.0 109.206 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.636 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 2.6 t80 -90.59 -26.86 19.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.51 -0.744 . . . . 0.0 109.833 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.63 HD13 ' CZ ' ' A' ' 26' ' ' PHE . 8.7 tp -75.16 -25.68 58.52 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.912 -1.117 . . . . 0.0 109.109 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -69.22 -46.82 66.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.36 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -63.3 -54.75 32.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.636 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 17.5 m -102.87 54.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.256 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.508 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.55 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 5' ' ' THR . 18.0 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -175.24 84.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.343 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.67 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -42.59 163.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.585 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 74.4 m -145.58 109.83 4.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.107 -0.996 . . . . 0.0 109.586 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.924 HG11 ' CE2' ' A' ' 26' ' ' PHE . 1.5 p -110.75 144.79 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.217 -0.927 . . . . 0.0 109.627 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.607 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -141.49 126.04 17.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.125 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.0 m-85 -105.53 156.42 18.25 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 109.569 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.726 HG11 HD11 ' A' ' 99' ' ' LEU . 25.2 t -139.13 154.86 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.77 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.558 ' SG ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -170.62 129.79 0.84 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.423 -0.798 . . . . 0.0 109.16 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 12' ' ' CYS . 1.0 OUTLIER -42.39 -65.28 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.558 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . -87.43 87.59 1.55 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.528 ' O ' HG23 ' A' ' 16' ' ' ILE . 3.0 t-20 -90.04 40.76 1.02 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -1.129 . . . . 0.0 109.353 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.551 HD12 ' N ' ' A' ' 17' ' ' CYS . 1.8 pp -157.24 -40.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.925 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.561 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 0.9 OUTLIER -102.65 -15.33 16.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.496 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 14' ' ' GLY . 3.0 mmm-85 -75.53 0.18 18.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.599 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.816 ' OG ' HG21 ' A' ' 141' ' ' VAL . 10.0 p 60.14 56.08 4.29 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 109.568 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 19' ' ' SER . 45.3 Cg_endo -70.05 83.05 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.999 1.799 . . . . 0.0 109.941 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.724 HG22 HG23 ' A' ' 25' ' ' VAL . 3.2 mm -88.68 -21.02 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.796 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.69 ' CB ' ' SG ' ' A' ' 148' ' ' CYS . . . -54.52 -24.57 21.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.05 -1.031 . . . . 0.0 109.873 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 8.0 tp10 -76.75 -83.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 0.0 110.021 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.604 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -41.71 -30.75 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 109.836 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.018 HG11 ' HA ' ' A' ' 146' ' ' VAL . 60.9 t -64.32 -58.04 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.359 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.924 ' CE2' HG11 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -46.9 -41.72 16.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.108 -0.995 . . . . 0.0 108.64 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.1 OUTLIER -50.23 -66.42 0.39 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.237 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -13.71 29.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 110.164 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.746 HD22 ' HG3' ' A' ' 150' ' ' ARG . 8.5 mt -77.18 -78.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.161 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.864 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -42.73 -47.66 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.39 -0.819 . . . . 0.0 109.653 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -51.14 -46.69 62.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.81 -1.181 . . . . 0.0 109.502 -179.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.42 -30.16 70.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.962 . . . . 0.0 109.03 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.559 ' HB3' HG23 ' A' ' 35' ' ' ILE . 1.1 tt0 -79.68 -10.13 59.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 8.7 t30 77.61 25.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.453 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.864 ' CG1' HG23 ' A' ' 30' ' ' VAL . 1.6 pt -117.63 11.56 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.315 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.604 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 89.3 p -73.5 -12.35 60.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.683 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -83.94 10.1 10.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 109.332 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.678 ' HA ' HG22 ' A' ' 5' ' ' THR . 3.1 m-20 -155.38 51.99 0.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.67 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 7.9 m95 -150.3 154.37 37.74 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.902 -1.123 . . . . 0.0 110.865 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG12 ' HE1' ' A' ' 85' ' ' PHE . 10.2 t -130.49 80.59 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.59 HG12 ' CD2' ' A' ' 26' ' ' PHE . 3.3 mt -90.64 138.99 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.255 -0.903 . . . . 0.0 109.87 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -145.73 -178.71 6.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.82 . . . . 0.0 109.154 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.7 t -170.27 135.91 1.33 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.682 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.8 -177.06 33.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.785 ' HB2' ' OD1' ' A' ' 50' ' ' ASN . . . -95.12 141.02 29.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -1.183 . . . . 0.0 109.461 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.505 ' CG2' ' HG ' ' A' ' 99' ' ' LEU . 8.4 p -58.0 -24.71 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.344 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.4 m -124.43 170.88 10.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.372 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.587 ' CG ' HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -81.07 75.61 8.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.366 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.57 -32.68 6.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.785 ' OD1' ' HB2' ' A' ' 45' ' ' ALA . 4.1 p-10 -132.08 34.56 3.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.597 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.587 HG21 ' CG ' ' A' ' 48' ' ' ASP . 77.7 t -65.87 110.19 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.55 16.03 41.3 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 8.7 mtt-85 -120.72 86.64 2.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -1.171 . . . . 0.0 109.44 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -47.08 172.46 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.316 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 54' ' ' SER . 52.2 Cg_exo -50.95 123.78 12.46 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.885 1.723 . . . . 0.0 110.037 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 1.8 m-20 -43.09 155.89 0.27 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.604 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 60' ' ' VAL . 53.7 Cg_endo -71.68 -6.87 20.03 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.873 1.715 . . . . 0.0 110.142 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -34.65 18.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.06 26.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.447 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 57' ' ' PRO . 11.1 p -65.57 -36.55 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.875 . . . . 0.0 109.389 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 79.2 p -60.74 -15.96 34.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.3 t -85.51 -52.5 5.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.578 ' HB3' HG23 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -88.26 6.42 37.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.584 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.477 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 12.9 tpt180 -112.7 -36.09 5.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.504 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 61' ' ' SER . 53.8 t30 -52.37 -47.14 66.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.474 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -74.45 -49.71 21.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.41 93.54 0.71 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.917 HD11 ' HA ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -118.22 -178.92 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -1.163 . . . . 0.0 109.407 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -120.64 104.45 9.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.171 -0.955 . . . . 0.0 109.505 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 t -137.93 123.1 19.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.439 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.89 69.58 0.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -0.926 . . . . 0.0 109.459 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.51 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.1 p-80 -156.18 178.43 10.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.401 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 139.42 52.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -60.56 153.34 23.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.933 . . . . 0.0 109.216 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 74' ' ' ALA . 2.2 mmt85 -149.95 125.6 10.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.557 ' H ' HG22 ' A' ' 51' ' ' VAL . 1.4 tt0 -51.11 140.03 16.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.584 HG12 ' N ' ' A' ' 78' ' ' THR . 54.5 t -56.68 165.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.584 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -163.96 164.25 23.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.503 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.611 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.01 -37.68 33.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.292 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.424 ' O ' ' OG1' ' A' ' 84' ' ' THR . 1.1 tp10 -59.98 -52.7 64.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.884 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 1.1 m-20 -54.28 -49.39 69.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.142 -0.973 . . . . 0.0 110.11 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.872 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 62.9 m-85 -48.85 -68.74 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.145 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.479 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 4.1 p -66.38 -10.86 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.233 -0.917 . . . . 0.0 109.994 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 85' ' ' PHE . 3.3 m -78.43 -85.14 0.07 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.639 ' N ' HG22 ' A' ' 84' ' ' THR . 51.9 m-85 -62.09 132.63 53.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.587 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -72.11 -15.17 61.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.857 . . . . 0.0 109.465 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.7 m-85 -124.89 136.35 53.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.32 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.933 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 2.0 mt -142.74 89.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 109.254 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.816 HD23 ' HB3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -112.79 148.18 35.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.872 -1.143 . . . . 0.0 109.547 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.533 ' SG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -99.22 -179.58 4.28 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.262 -0.899 . . . . 0.0 108.654 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.822 ' CE ' ' SG ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -76.01 1.54 15.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.088 -1.007 . . . . 0.0 109.604 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 20.3 p30 178.34 -165.36 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.126 -0.984 . . . . 0.0 109.382 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.504 ' CB ' HD22 ' A' ' 115' ' ' LEU . 1.9 tt0 -97.0 -31.11 12.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.714 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.4 p -45.37 -41.17 8.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.928 . . . . 0.0 109.79 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -90.01 -26.35 20.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.206 -0.934 . . . . 0.0 109.795 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.582 HD12 ' HB3' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -62.15 -28.92 69.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.105 -0.997 . . . . 0.0 109.717 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -49.97 -21.87 1.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.702 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -104.09 -33.33 8.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.726 HD11 HG11 ' A' ' 11' ' ' VAL . 11.2 mt -74.09 -7.69 53.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.854 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.525 ' HB2' HD22 ' A' ' 96' ' ' LEU . 54.2 t-20 -90.33 -23.06 21.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -96.67 -9.17 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 109.698 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.794 ' O ' HG23 ' A' ' 106' ' ' VAL . 1.8 mmmt -73.36 -26.79 61.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.602 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.41 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 1.1 p -52.89 -42.37 65.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.566 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.37 -61.28 2.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.478 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.28 -21.32 5.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.247 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 102' ' ' LYS . 97.6 t -79.68 130.21 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.511 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -76.47 117.84 18.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.272 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.4 42.7 27.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 109.233 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.14 144.65 6.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.825 . . . . 0.0 109.946 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -135.17 2.51 3.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 0.0 109.202 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.933 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -80.71 102.01 9.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.118 -0.989 . . . . 0.0 109.904 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.46 95.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.691 HD13 ' O ' ' A' ' 111' ' ' ALA . 2.1 mm -65.33 158.44 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.071 -1.018 . . . . 0.0 110.321 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.816 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER 177.31 -168.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -147.21 147.88 30.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.048 -1.032 . . . . 0.0 109.68 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.725 HD22 ' SG ' ' A' ' 148' ' ' CYS . 69.0 tp -53.1 99.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . -175.24 177.18 47.26 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 1.7 m 79.6 -73.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.969 . . . . 0.0 109.689 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -100.67 57.82 0.92 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.949 . . . . 0.0 109.395 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -116.78 144.05 32.63 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.387 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CB ' ' NH2' ' A' ' 147' ' ' ARG . 55.7 Cg_endo -72.9 -163.56 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.887 1.725 . . . . 0.0 110.214 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER 73.58 -151.66 0.05 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.599 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.439 ' O ' ' HE3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -126.05 77.67 1.7 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.459 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.91 43.94 26.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.48 143.85 26.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.857 . . . . 0.0 109.487 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.1 mm -138.12 130.29 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 127' ' ' ILE . 10.9 tt -84.42 71.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.259 -0.9 . . . . 0.0 109.017 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.481 ' HA ' ' OD2' ' A' ' 92' ' ' ASP . 2.4 mt-10 -72.06 -67.47 0.54 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.732 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.49 79.36 54.52 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.723 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.42 ' HG3' ' CG1' ' A' ' 127' ' ' ILE . 53.6 Cg_endo -72.43 -21.05 23.2 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.968 1.779 . . . . 0.0 110.078 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.561 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 10.1 t80 -59.5 -24.7 63.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -111.25 84.32 1.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.878 . . . . 0.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -130.68 -135.96 3.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -122.4 -157.32 0.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -1.101 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.08 -22.0 12.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.43 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.72 25.21 2.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.407 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 138' ' ' PHE . 10.1 t0 -122.84 -142.55 0.32 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.271 -0.893 . . . . 0.0 109.151 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.959 ' O ' HG12 ' A' ' 141' ' ' VAL . 1.3 t80 82.73 -42.98 0.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.554 -0.716 . . . . 0.0 109.793 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.07 -35.67 80.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.989 -1.069 . . . . 0.0 109.41 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.8 m -66.9 -28.66 68.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.275 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.959 HG12 ' O ' ' A' ' 138' ' ' PHE . 2.3 p -60.54 -30.84 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.274 -0.891 . . . . 0.0 109.366 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 146' ' ' VAL . 1.7 t80 -85.09 -53.13 5.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 0.0 109.271 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -28.27 10.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.14 -47.74 7.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.497 ' CB ' ' HB ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -53.57 -21.87 7.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.333 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 1.018 ' HA ' HG11 ' A' ' 25' ' ' VAL . 60.2 t -51.03 -55.18 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.228 -0.92 . . . . 0.0 109.286 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -79.13 -18.46 53.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.292 -0.88 . . . . 0.0 109.304 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.822 ' SG ' ' CE ' ' A' ' 91' ' ' MET . 36.1 t -46.41 -25.88 0.74 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.088 -1.007 . . . . 0.0 108.844 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.591 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 2.5 p -119.95 -40.68 2.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.421 -0.8 . . . . 0.0 109.274 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.746 ' HG3' HD22 ' A' ' 29' ' ' LEU . 7.0 ttm-85 -62.23 -52.29 64.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 108.876 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -58.73 -18.82 34.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.878 . . . . 0.0 108.985 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.744 ' CE2' HD11 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -90.23 -25.68 20.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.783 . . . . 0.0 109.6 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.624 HD11 ' CD1' ' A' ' 35' ' ' ILE . 11.5 tp -75.61 -21.93 57.34 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.048 -1.032 . . . . 0.0 108.688 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -68.31 -48.39 65.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.902 . . . . 0.0 109.223 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -64.56 -48.85 73.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.014 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 152' ' ' PHE . 16.2 m -101.41 51.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.112 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.487 -179.833 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.539 HG22 ' N ' ' A' ' 5' ' ' THR . 8.2 p . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.451 0.643 . . . . 0.0 109.803 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 1.014 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -63.9 101.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.408 -0.807 . . . . 0.0 109.543 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.718 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -44.21 166.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.83 179.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.605 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 15.5 p -136.39 112.86 9.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.931 -1.105 . . . . 0.0 109.275 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.79 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -115.71 134.22 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 109.64 -179.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.99 HD13 ' CD1' ' A' ' 85' ' ' PHE . 1.9 tp -124.73 118.17 25.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.26 102.34 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.021 -1.049 . . . . 0.0 109.755 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.795 HG13 ' O ' ' A' ' 44' ' ' GLY . 3.0 t -106.26 151.07 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 108.977 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.48 136.56 11.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.954 -1.091 . . . . 0.0 109.815 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -47.91 117.19 1.77 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 109.057 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.36 75.27 1.18 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.503 ' O ' ' CG ' ' A' ' 20' ' ' PRO . 5.3 t-20 -57.64 -14.99 6.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -1.11 . . . . 0.0 109.625 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.707 HD12 ' N ' ' A' ' 17' ' ' CYS . 1.1 pp -111.01 -158.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.999 -1.063 . . . . 0.0 109.301 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.707 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER 59.81 115.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.043 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER 77.9 -2.88 2.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.286 -179.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.893 ' O ' HD12 ' A' ' 21' ' ' ILE . 1.4 t 45.26 96.85 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 109.856 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 52.8 Cg_exo -48.08 88.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.562 1.508 . . . . 0.0 109.667 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 19' ' ' SER . 2.0 mp -78.21 -11.72 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -0.868 . . . . 0.0 109.946 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.851 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -67.52 -43.18 81.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.99 -1.069 . . . . 0.0 108.976 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ALA . 1.6 tm-20 -76.15 -57.12 4.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.255 -0.903 . . . . 0.0 109.052 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.623 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -44.76 -41.25 6.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.887 . . . . 0.0 108.982 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.056 HG11 ' HA ' ' A' ' 146' ' ' VAL . 53.0 t -62.85 -51.23 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.807 . . . . 0.0 109.23 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.653 ' CD1' HG12 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -46.28 -36.72 6.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 108.547 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.427 ' HD2' ' OD1' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -62.07 -52.83 62.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.058 -1.026 . . . . 0.0 108.395 179.066 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -84.18 11.03 8.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 108.955 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.82 HD21 ' CB ' ' A' ' 150' ' ' ARG . 45.5 tp -97.43 -46.97 5.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.401 -0.812 . . . . 0.0 109.107 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.732 HG11 HD11 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -91.09 -39.24 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.5 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 0.4 OUTLIER -69.54 -8.44 47.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.593 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 9.0 t70 -95.99 -15.46 22.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.013 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 4.6 tp60 -102.68 -82.0 0.49 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.488 -0.757 . . . . 0.0 109.245 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 26.0 t30 172.84 46.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.449 -0.782 . . . . 0.0 108.899 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.806 HD12 HD21 ' A' ' 153' ' ' LEU . 1.4 pt -143.64 17.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.793 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.617 ' HB3' HG22 ' A' ' 30' ' ' VAL . 79.3 p -85.39 -26.97 26.12 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.792 -1.192 . . . . 0.0 109.355 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -58.49 -27.05 64.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 1.014 ' HA ' HG22 ' A' ' 5' ' ' THR . 2.6 m-20 -118.96 42.69 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.576 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.79 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 11.6 m95 -150.0 119.8 7.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.994 -1.066 . . . . 0.0 110.563 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.62 91.63 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.732 HD11 HG11 ' A' ' 30' ' ' VAL . 3.2 mt -92.41 129.1 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.918 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -154.2 137.15 15.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.319 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -107.75 178.07 4.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 109.394 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.795 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -168.27 171.21 42.46 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.47 ' O ' ' OE1' ' A' ' 76' ' ' GLN . . . -92.85 151.91 19.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -1.138 . . . . 0.0 109.419 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 13' ' ' LEU . 6.9 p -99.58 -17.21 6.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.28 -0.888 . . . . 0.0 108.786 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.458 ' O ' ' OE1' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -101.14 -148.34 0.37 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.386 -0.822 . . . . 0.0 109.505 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -150.28 16.11 0.82 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.079 -1.013 . . . . 0.0 109.715 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -100.22 0.22 39.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.6 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.444 ' OD1' ' CB ' ' A' ' 45' ' ' ALA . 8.1 p30 -118.6 5.8 11.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.9 t -56.29 110.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.473 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.55 29.84 9.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.542 ' HB3' HG21 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -123.59 131.88 53.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 109.352 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 10.1 p -95.12 162.5 24.66 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 54' ' ' SER . 52.7 Cg_exo -50.99 144.42 27.92 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.974 1.783 . . . . 0.0 110.166 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.413 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 8.0 m-20 -53.54 153.04 8.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.457 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 60' ' ' VAL . 50.1 Cg_endo -71.14 -15.05 32.07 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.043 1.829 . . . . 0.0 110.116 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -37.46 16.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.548 ' CB ' ' HB2' ' A' ' 19' ' ' SER . . . -90.15 -11.57 40.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.504 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -74.63 -30.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.497 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.89 0.18 21.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.586 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.485 ' C ' HD23 ' A' ' 63' ' ' LEU . 57.9 m -90.0 -18.44 26.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.322 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.8 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.12 -52.79 4.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.175 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -64.87 -10.44 28.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.875 . . . . 0.0 109.62 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.65 -85.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.604 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.585 ' CD2' HG12 ' A' ' 68' ' ' ILE . 1.7 p-80 -60.55 -25.42 66.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 109.555 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.26 107.62 1.66 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.623 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 17.1 mm -148.54 154.33 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -1.157 . . . . 0.0 109.493 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.505 ' ND2' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -137.52 119.35 15.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.483 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 t -121.57 174.98 6.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.981 . . . . 0.0 109.453 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -167.9 75.27 0.13 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -169.33 134.01 1.45 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.2 tptt -95.34 59.23 2.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.206 -0.934 . . . . 0.0 109.495 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 53' ' ' ARG . . . 51.79 -92.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.682 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER 59.53 151.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 109.534 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' A' ' 76' ' ' GLN . 34.2 tp60 -90.27 133.52 34.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 78' ' ' THR . 47.5 t -45.32 161.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.494 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.504 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -126.14 170.55 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.727 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.909 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -58.11 -53.52 57.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.862 . . . . 0.0 109.534 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -50.59 -42.81 56.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 109.746 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.466 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 6.7 m-20 -58.56 -42.19 87.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.673 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 1.021 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 10.5 m-85 -57.22 -51.2 70.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 109.334 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -80.17 -5.35 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.988 -1.07 . . . . 0.0 109.68 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 16.2 m -81.27 -58.7 2.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -0.831 . . . . 0.0 110.236 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.99 ' CD1' HD13 ' A' ' 9' ' ' LEU . 38.8 m-85 -77.54 165.2 24.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 110.192 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -108.68 -36.69 6.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -0.807 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -109.44 78.77 1.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 108.651 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.953 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.2 mt -86.44 87.26 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.915 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.603 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -96.98 174.75 6.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.025 -1.047 . . . . 0.0 109.205 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 1.1 p -149.93 148.2 28.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.383 -0.823 . . . . 0.0 109.375 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.615 ' HE2' ' SG ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -49.27 147.71 2.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 109.295 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.995 ' OD2' HD12 ' A' ' 126' ' ' ILE . 0.7 OUTLIER -52.23 -20.31 2.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 109.794 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 92' ' ' ASP . 2.3 mt-10 -43.02 -69.04 0.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 96' ' ' LEU . 12.2 t -87.34 85.62 7.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.904 . . . . 0.0 108.83 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.498 ' O ' ' C ' ' A' ' 96' ' ' LEU . 20.2 t-20 -50.28 86.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.752 -0.592 . . . . 0.0 110.285 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.052 HD21 ' CG2' ' A' ' 113' ' ' ILE . 0.7 OUTLIER 29.93 51.7 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.185 0.517 . . . . 0.0 110.683 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 98' ' ' ASP . 3.0 ttt85 -88.08 -91.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 109.59 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -57.22 -50.71 72.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 109.619 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.664 HD23 ' CZ ' ' A' ' 82' ' ' PHE . 5.0 mt -48.89 -26.97 2.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 0.0 109.678 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.64 ' HB2' HD22 ' A' ' 96' ' ' LEU . 34.4 t-20 -79.85 -38.31 33.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.96 3.06 54.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.626 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.941 ' O ' HG23 ' A' ' 106' ' ' VAL . 23.8 mmmt -84.88 -25.77 27.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.331 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -29.16 68.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -68.32 -60.21 2.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -54.42 -23.55 16.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 109.136 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 102' ' ' LYS . 38.8 t -82.3 105.71 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.426 -0.796 . . . . 0.0 109.415 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -44.31 117.27 1.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.546 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 107' ' ' LYS . 5.4 m-20 42.83 58.26 3.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.649 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -47.76 164.26 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.33 -0.856 . . . . 0.0 110.333 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.649 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 1.8 tpt180 -150.54 61.1 0.95 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 1.021 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -147.15 89.72 1.82 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.253 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 111' ' ' ALA . 6.1 mtpp -44.0 110.17 0.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 1.052 ' CG2' HD21 ' A' ' 96' ' ' LEU . 2.1 mm -87.2 144.42 9.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.036 -1.04 . . . . 0.0 110.503 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.493 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -163.95 -179.64 6.39 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.472 ' CD1' ' OD2' ' A' ' 92' ' ' ASP . 1.0 OUTLIER -132.35 146.3 51.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.94 -1.1 . . . . 0.0 109.482 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.848 HD13 ' SG ' ' A' ' 148' ' ' CYS . 1.4 tp -43.97 120.21 2.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.36 157.98 23.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.48 100.7 0.38 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -1.123 . . . . 0.0 109.523 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -90.18 -87.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -0.873 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.58 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -67.01 -61.62 4.63 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.695 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 55.2 Cg_endo -71.9 162.45 41.9 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.765 1.643 . . . . 0.0 110.361 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -108.69 24.52 12.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.53 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.95 104.76 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.942 . . . . 0.0 109.633 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.98 60.85 6.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.475 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -109.12 -54.35 2.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 109.513 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.995 HD12 ' OD2' ' A' ' 92' ' ' ASP . 8.2 mm 61.8 145.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 77.3 mt -109.04 93.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.398 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.527 ' CG ' ' OD1' ' A' ' 92' ' ' ASP . 34.4 mt-10 -124.29 8.35 8.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.577 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -94.56 146.56 31.69 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.451 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.94 170.75 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.928 1.752 . . . . 0.0 110.232 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CD1' ' A' ' 131' ' ' TYR . 14.2 p90 -103.11 125.89 50.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.458 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -146.69 111.24 5.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.865 . . . . 0.0 109.467 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -45.91 95.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 132' ' ' TYR . 1.3 m-80 -135.35 6.73 3.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -1.187 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.652 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 1.3 m-20 70.54 164.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 73.77 5.29 4.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.492 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -135.4 105.48 6.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.555 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -174.86 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.541 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -86.31 -17.1 35.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.531 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 36.7 m -82.4 -25.0 34.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.75 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 74.2 t -76.55 -44.86 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.549 ' CD1' HG21 ' A' ' 21' ' ' ILE . 2.6 t80 -74.74 -38.32 62.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.572 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -61.66 -61.52 2.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 148' ' ' CYS . 4.0 mt-30 -61.74 -29.36 70.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 109.507 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.806 ' SG ' ' N ' ' A' ' 22' ' ' ALA . 4.7 m -58.88 -40.2 83.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 109.68 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 1.056 ' HA ' HG11 ' A' ' 25' ' ' VAL . 84.0 t -51.57 -72.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 109.53 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.416 ' HG2' ' HB2' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -65.24 -11.29 39.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.419 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.851 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 20.2 t -53.78 -26.2 22.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.102 -0.999 . . . . 0.0 108.797 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.597 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -119.11 -30.57 4.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.394 -0.816 . . . . 0.0 109.251 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.82 ' CB ' HD21 ' A' ' 29' ' ' LEU . 11.0 ttt180 -67.48 -52.42 39.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.937 . . . . 0.0 108.856 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.416 ' HB2' ' HG2' ' A' ' 147' ' ' ARG . . . -55.9 -21.38 20.0 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.449 -0.782 . . . . 0.0 109.023 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.848 ' O ' HG22 ' A' ' 156' ' ' VAL . 1.5 t80 -90.63 -27.44 19.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.517 -0.74 . . . . 0.0 109.815 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.806 HD21 HD12 ' A' ' 35' ' ' ILE . 7.5 tp -78.06 -25.2 47.61 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.992 -1.067 . . . . 0.0 108.741 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 150' ' ' ARG . 1.8 mt-10 -66.28 -51.15 60.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.922 . . . . 0.0 109.18 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -55.3 25.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.395 -0.816 . . . . 0.0 109.336 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 152' ' ' PHE . 18.6 m -95.4 43.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.262 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.455 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 1.8 tmm_? . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.567 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 6' ' ' LYS . 3.9 p . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 1.03 HG22 ' HA ' ' A' ' 38' ' ' ASN . 18.1 p -49.99 90.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 0.0 109.571 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.639 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.7 OUTLIER -45.19 170.14 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.035 -1.04 . . . . 0.0 109.396 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.55 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -142.39 146.91 35.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.029 -1.045 . . . . 0.0 109.811 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.876 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -150.78 146.08 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 109.037 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.639 HD13 ' CD1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -133.01 126.74 32.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.722 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.442 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -109.18 124.39 50.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 108.897 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.505 HG13 ' C ' ' A' ' 44' ' ' GLY . 2.1 t -125.35 158.19 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 91' ' ' MET . 0.6 OUTLIER -177.99 131.2 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.794 . . . . 0.0 109.185 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.502 ' HB2' ' ND2' ' A' ' 95' ' ' ASN . 0.7 OUTLIER -43.7 149.98 0.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 109.579 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 50' ' ' ASN . . . 46.76 66.57 1.74 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.495 ' ND2' ' HG3' ' A' ' 20' ' ' PRO . 2.7 t-20 -88.8 67.64 8.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -1.113 . . . . 0.0 109.695 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -138.71 6.46 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.154 -0.966 . . . . 0.0 109.731 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.647 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 1.7 p 179.75 138.21 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.017 . . . . 0.0 109.618 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.647 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 1.9 mtm180 83.6 -48.6 0.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.815 -0.553 . . . . 0.0 109.65 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.615 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -82.97 -48.53 0.79 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 110.175 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 19' ' ' SER . 63.4 Cg_exo -49.58 -19.4 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.957 1.771 . . . . 0.0 111.047 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.956 HG21 ' HA ' ' A' ' 142' ' ' TYR . 2.5 mp -64.29 -44.93 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.87 -1.144 . . . . 0.0 109.4 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.199 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . . . -61.36 -35.29 77.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.507 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.462 ' OE2' ' HB2' ' A' ' 43' ' ' SER . 2.4 tt0 -70.19 -69.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.317 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.832 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -43.64 -33.31 1.17 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.135 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.987 HG11 ' HA ' ' A' ' 146' ' ' VAL . 58.7 t -65.26 -49.62 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.864 . . . . 0.0 108.754 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.836 ' CE2' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -50.41 -29.85 11.09 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -68.48 -50.71 50.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 109.2 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -20.07 66.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.776 HD11 HG12 ' A' ' 25' ' ' VAL . 11.5 mt -86.97 -28.34 22.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.047 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 36' ' ' SER . 2.5 p -90.22 -8.85 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.96 0.95 22.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -115.01 45.93 1.52 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.004 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.574 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -178.7 29.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.5 t30 45.35 45.88 10.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.76 HG12 HG23 ' A' ' 30' ' ' VAL . 1.3 tt -127.39 -1.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.229 0.538 . . . . 0.0 109.795 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.814 ' HA ' HG22 ' A' ' 30' ' ' VAL . 45.8 t -74.08 -45.83 46.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.737 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.87 -12.67 8.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 110.225 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 1.03 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -116.02 37.28 3.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.986 -1.071 . . . . 0.0 109.993 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.876 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 12.8 m95 -150.48 157.76 43.38 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.854 -1.153 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.87 72.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.473 HG21 ' HB3' ' A' ' 26' ' ' PHE . 2.5 mp -89.47 141.13 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 110.248 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -148.23 -165.83 2.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.503 -0.748 . . . . 0.0 109.048 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.462 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -165.67 165.82 18.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.685 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.505 ' C ' HG13 ' A' ' 11' ' ' VAL . . . 178.39 -170.48 42.56 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.38 -176.67 3.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.199 . . . . 0.0 109.346 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.812 HG13 ' HG ' ' A' ' 99' ' ' LEU . 39.3 t -93.7 -0.37 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.823 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.56 -178.24 6.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.514 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 2.0 p-10 -84.3 69.36 10.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -99.26 -77.68 0.52 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.423 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 14' ' ' GLY . 30.5 m120 -96.0 37.67 1.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.357 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 80.1 t -64.33 106.84 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.458 ' HA2' ' HG2' ' A' ' 73' ' ' LYS . . . 106.69 -34.14 5.93 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.601 ' O ' HG22 ' A' ' 16' ' ' ILE . 1.5 mtt180 -61.59 96.91 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -1.174 . . . . 0.0 109.487 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.75 164.55 1.59 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 56' ' ' ASP . 53.4 Cg_exo -50.57 119.52 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.035 1.823 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -43.41 150.07 0.54 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.688 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.59 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 50.9 Cg_exo -52.13 -18.03 6.73 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.098 1.865 . . . . 0.0 110.613 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -78.76 -46.04 19.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.052 -1.03 . . . . 0.0 109.889 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . . . -90.04 1.91 55.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -0.937 . . . . 0.0 110.055 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.59 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 5.5 p -90.02 -44.61 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.048 -1.032 . . . . 0.0 109.681 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.535 ' N ' HG13 ' A' ' 60' ' ' VAL . 53.3 p -79.07 -15.56 58.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.599 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.446 ' C ' HD23 ' A' ' 63' ' ' LEU . 1.2 m -73.8 -27.6 61.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 109.349 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.806 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -89.44 -52.57 4.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 108.943 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -14.09 16.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.814 . . . . 0.0 109.554 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -68.23 -61.06 2.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.547 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -69.67 -35.21 74.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.155 -0.966 . . . . 0.0 109.598 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 68' ' ' ILE . . . 141.11 -10.11 2.77 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.832 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 17.0 mm -43.82 159.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -1.154 . . . . 0.0 109.626 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.494 ' N ' HG22 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -131.5 175.37 9.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.522 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -160.09 -86.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 70' ' ' THR . . . 65.62 16.76 10.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.574 ' CE1' ' OD1' ' A' ' 42' ' ' ASP . 24.8 t60 -126.4 149.35 49.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.953 . . . . 0.0 109.46 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 0.4 OUTLIER -101.58 140.99 35.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.491 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 75' ' ' ARG . . . -42.56 -66.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.822 . . . . 0.0 109.723 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 65.31 164.9 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.343 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.483 ' HG2' ' N ' ' A' ' 77' ' ' VAL . 47.8 tt0 -100.98 156.01 17.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.483 ' N ' ' HG2' ' A' ' 76' ' ' GLN . 91.7 t -81.22 146.96 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.925 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -142.61 161.1 38.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.521 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG2' HG13 ' A' ' 106' ' ' VAL . 2.4 tmtt? -42.87 -34.77 1.01 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.469 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' OG1' ' A' ' 84' ' ' THR . 1.0 OUTLIER -61.57 -53.25 58.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.879 . . . . 0.0 109.681 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.42 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 3.5 m-20 -66.93 -19.01 65.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 109.823 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.897 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 13.1 m-85 -68.88 -68.59 0.39 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 109.532 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.647 HG23 ' HB3' ' A' ' 110' ' ' ARG . 9.9 p -67.29 -23.25 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 4.6 m -60.65 -67.59 0.38 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.639 ' CD1' HD13 ' A' ' 9' ' ' LEU . 82.5 m-85 -74.83 156.21 36.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 0.0 109.532 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.447 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -90.32 -36.33 14.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.322 -0.861 . . . . 0.0 109.387 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 7' ' ' SER . 17.5 m-85 -109.77 151.91 26.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.575 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.93 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 1.7 mt -153.69 80.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 108.833 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.507 HD21 ' CE1' ' A' ' 152' ' ' PHE . 0.1 OUTLIER -91.58 -174.75 3.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 109.583 -179.436 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.736 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -148.31 172.15 14.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.303 -0.873 . . . . 0.0 109.212 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.736 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -84.54 45.4 1.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 109.704 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.463 ' OD2' ' CG2' ' A' ' 127' ' ' ILE . 2.6 m-20 65.15 -144.52 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.537 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 128' ' ' GLU . 27.6 mt-10 73.5 158.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.6 m -81.08 6.41 13.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.624 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 13' ' ' LEU . 2.9 m120 -71.8 -9.32 58.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 99' ' ' LEU . 4.4 mt -81.45 -10.16 59.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.414 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -61.28 -21.84 64.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.01 -39.58 8.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.833 . . . . 0.0 109.467 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.812 ' HG ' HG13 ' A' ' 46' ' ' VAL . 8.6 mt -66.94 -18.76 65.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.93 . . . . 0.0 109.39 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -77.89 -33.48 51.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.86 -19.92 24.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.74 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -57.3 -35.09 69.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 109.452 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.538 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 0.3 OUTLIER -50.2 -49.09 53.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.375 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -64.71 -36.23 83.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.136 -0.977 . . . . 0.0 109.436 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.59 -4.8 55.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.212 -0.93 . . . . 0.0 109.473 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.957 HG11 ' SG ' ' A' ' 109' ' ' CYS . 41.2 t -86.32 117.98 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 108' ' ' ASN . 0.1 OUTLIER -53.14 105.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 108.644 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.457 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 15.7 m120 60.52 70.68 0.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.033 -1.042 . . . . 0.0 108.576 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.957 ' SG ' HG11 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -88.57 136.44 32.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 110.364 -179.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.647 ' HB3' HG23 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -128.96 1.81 5.31 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.93 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -83.3 110.58 18.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.446 -0.784 . . . . 0.0 110.164 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.16 125.39 26.23 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -100.04 132.0 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.94 -1.1 . . . . 0.0 110.29 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 10.3 mt-10 -163.79 -174.04 3.49 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -125.24 165.87 17.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.99 HD21 ' SG ' ' A' ' 148' ' ' CYS . 3.5 tp -42.51 -74.4 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.701 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.88 -110.73 3.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.565 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 1.8 t -151.56 136.24 17.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.461 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 118' ' ' SER . 23.9 m-85 -136.76 32.14 2.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.929 . . . . 0.0 109.586 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 163.06 -51.53 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.0 Cg_exo -49.46 162.62 0.53 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.799 1.666 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.77 45.04 1.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.883 . . . . 0.0 109.43 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 166.43 33.24 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -0.971 . . . . 0.0 109.413 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.03 90.08 4.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.343 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tt -103.04 138.68 39.57 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -0.925 . . . . 0.0 109.614 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.494 HG22 ' HG3' ' A' ' 128' ' ' GLU . 12.0 mm -143.93 125.95 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.398 -0.813 . . . . 0.0 109.301 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 127' ' ' ILE . 1.5 tt -105.08 78.22 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 109.113 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.494 ' HG3' HG22 ' A' ' 126' ' ' ILE . 6.7 mt-10 -77.12 -95.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 128' ' ' GLU . 2.0 m-20 47.51 95.12 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.323 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 131' ' ' TYR . 69.4 Cg_exo -47.33 -67.84 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.774 1.65 . . . . 0.0 110.347 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 130' ' ' PRO . 20.9 t80 178.83 61.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.505 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' GLY . 87.9 m-85 -141.14 16.92 2.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.457 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 132' ' ' TYR . . . 59.23 154.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -120.96 -26.81 5.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -1.114 . . . . 0.0 109.471 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.84 -160.92 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.362 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.67 77.34 6.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.405 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.21 108.96 4.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.519 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 8.9 t80 -123.23 -51.28 1.88 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.497 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -69.62 -33.28 72.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.503 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.2 m -49.2 -43.87 42.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.464 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.7 t -65.9 -48.2 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.848 . . . . 0.0 109.493 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.956 ' HA ' HG21 ' A' ' 21' ' ' ILE . 2.8 t80 -53.0 -27.98 21.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.332 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -83.73 -38.29 21.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.82 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -75.54 -11.43 60.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.686 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 1.199 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -89.97 -10.35 45.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.987 ' HA ' HG11 ' A' ' 25' ' ' VAL . 53.5 t -62.01 -48.94 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 109.234 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 1.2 mtt180 -79.72 -15.0 58.34 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.178 -0.951 . . . . 0.0 109.376 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.99 ' SG ' HD21 ' A' ' 116' ' ' LEU . 21.2 m -50.16 -24.0 2.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.086 -1.009 . . . . 0.0 108.635 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.605 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -120.18 -39.17 2.83 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.443 -0.786 . . . . 0.0 109.025 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.463 ' HG3' HD22 ' A' ' 29' ' ' LEU . 13.7 ttp85 -63.6 -53.71 47.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 108.703 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -60.17 -36.13 76.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -0.774 . . . . 0.0 109.175 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.949 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 6.8 t80 -74.84 -19.12 60.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.384 -0.822 . . . . 0.0 109.515 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.455 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 14.4 tp -77.96 -19.59 54.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.099 -1.0 . . . . 0.0 108.744 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -70.59 -46.89 62.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 108.769 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -66.74 -53.71 30.48 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 0.0 108.986 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.949 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 5.7 m -92.72 34.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 109.086 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.455 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 117.944 -1.026 . . . . 0.0 109.587 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 5' ' ' THR . 9.9 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 1.098 HG22 ' HA ' ' A' ' 38' ' ' ASN . 65.8 p -74.68 108.82 7.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.661 ' CB ' ' CH2' ' A' ' 39' ' ' TRP . 35.8 mttp -63.7 -168.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.9 -1.125 . . . . 0.0 108.993 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.575 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -145.99 107.28 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 109.834 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.726 HG12 ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -111.86 150.57 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.713 HD22 HG12 ' A' ' 88' ' ' ILE . 1.4 tt -149.83 104.17 3.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.139 -0.975 . . . . 0.0 109.555 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.483 ' HE1' HD12 ' A' ' 116' ' ' LEU . 2.8 m-85 -81.96 164.38 21.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.95 . . . . 0.0 109.379 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.783 HG11 HD11 ' A' ' 99' ' ' LEU . 58.5 t -150.31 161.87 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.133 -0.979 . . . . 0.0 109.936 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.526 ' N ' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -178.4 142.09 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.39 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.732 HD11 ' HH2' ' A' ' 49' ' ' TRP . 13.2 tp -43.58 -79.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.686 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 15' ' ' ASN . . . -46.99 -74.33 0.25 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.524 HD22 ' HB2' ' A' ' 45' ' ' ALA . 25.8 t30 76.61 20.47 1.42 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -1.124 . . . . 0.0 109.321 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 15' ' ' ASN . 1.2 pp -156.65 30.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.444 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.6 m -135.01 -84.84 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.585 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.543 ' HB2' ' CG2' ' A' ' 141' ' ' VAL . 0.0 OUTLIER -115.42 -7.84 12.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -75.06 -51.02 3.68 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.786 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 19' ' ' SER . 55.9 Cg_exo -49.66 -21.23 5.23 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.855 1.703 . . . . 0.0 110.674 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.982 HG21 ' HA ' ' A' ' 142' ' ' TYR . 7.9 mm -60.31 -48.6 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.315 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.576 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -64.72 -20.27 66.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.932 . . . . 0.0 109.738 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.513 ' OE1' ' CB ' ' A' ' 43' ' ' SER . 4.7 mt-10 -77.22 -81.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.12 -0.987 . . . . 0.0 109.521 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.686 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -45.21 -40.28 7.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.31 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.022 ' HA ' HD11 ' A' ' 68' ' ' ILE . 54.1 t -59.87 -51.34 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.22 -0.925 . . . . 0.0 109.402 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.919 ' CE1' HG12 ' A' ' 30' ' ' VAL . 1.2 t80 -46.41 -42.06 14.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.024 . . . . 0.0 108.698 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -55.12 -59.81 4.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 0.1 OUTLIER -76.73 2.88 13.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.823 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.691 HD11 HG13 ' A' ' 146' ' ' VAL . 3.2 mt -94.0 -29.89 15.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.149 -0.97 . . . . 0.0 108.733 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.919 HG12 ' CE1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -84.54 -42.51 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.569 ' CA ' ' HB3' ' A' ' 36' ' ' SER . 1.9 t -42.47 -28.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 30' ' ' VAL . 5.7 t70 -58.07 -55.34 36.15 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.474 -0.766 . . . . 0.0 108.992 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.548 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -73.08 -2.79 22.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.91 . . . . 0.0 109.368 179.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.5 OUTLIER 79.91 54.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.395 -0.815 . . . . 0.0 109.589 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.664 HD11 HD21 ' A' ' 153' ' ' LEU . 5.7 pt -144.78 9.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.141 -0.974 . . . . 0.0 109.987 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.637 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 9.7 p -69.16 -22.88 63.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.85 -1.156 . . . . 0.0 109.124 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.74 -20.64 38.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.312 -0.868 . . . . 0.0 108.799 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 1.098 ' HA ' HG22 ' A' ' 5' ' ' THR . 3.0 m-80 -110.31 44.54 1.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -0.845 . . . . 0.0 109.283 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.726 ' CE3' HG12 ' A' ' 8' ' ' VAL . 10.9 m95 -150.66 129.46 12.42 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.611 -1.236 . . . . 0.0 110.746 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 40' ' ' VAL . 56.6 t -99.14 79.21 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.567 HG12 ' CD2' ' A' ' 26' ' ' PHE . 6.9 mt -89.9 128.2 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.934 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -137.24 -159.53 0.96 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.482 -0.761 . . . . 0.0 109.06 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.513 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 60.3 p -151.85 172.53 16.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.112 -0.992 . . . . 0.0 109.852 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 11' ' ' VAL . . . -146.8 163.45 28.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.524 ' HB2' HD22 ' A' ' 15' ' ' ASN . . . -128.92 -29.53 2.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -1.184 . . . . 0.0 109.878 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.501 HG23 ' CG1' ' A' ' 11' ' ' VAL . 15.8 t 67.23 9.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 109.332 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.593 ' HB3' ' CE2' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -125.43 141.19 52.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.905 . . . . 0.0 109.358 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -84.01 6.28 22.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.697 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.732 ' HH2' HD11 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -102.9 -33.56 9.28 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 109.409 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.435 ' HA ' ' CD ' ' A' ' 53' ' ' ARG . 3.2 m120 -91.98 12.65 21.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.086 -1.009 . . . . 0.0 109.397 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 75' ' ' ARG . 13.3 t -75.33 85.22 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.74 -5.38 9.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.438 ' HB2' HG21 ' A' ' 16' ' ' ILE . 18.5 mtp180 -79.64 104.16 10.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -1.188 . . . . 0.0 109.468 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -66.04 173.98 1.89 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.375 -0.828 . . . . 0.0 109.59 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 53.3 Cg_exo -50.75 137.96 41.78 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.066 1.844 . . . . 0.0 110.288 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -57.37 145.71 66.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.416 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.706 ' O ' HG12 ' A' ' 60' ' ' VAL . 52.5 Cg_exo -50.5 -22.38 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.969 1.78 . . . . 0.0 110.345 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -85.55 -37.71 19.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.534 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.88 -4.91 59.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 109.674 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -80.82 -28.37 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -81.98 -19.01 41.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.498 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.467 ' C ' HD23 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -74.05 -33.91 63.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.511 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.781 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.14 -56.16 3.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.135 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -22.62 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.417 -0.802 . . . . 0.0 109.744 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 61' ' ' SER . 52.2 t-20 -70.66 -50.89 31.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.67 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -83.48 -5.04 59.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.945 . . . . 0.0 109.696 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.66 102.3 0.26 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.022 HD11 ' HA ' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -126.23 -33.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -1.118 . . . . 0.0 109.56 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 13.0 m-80 70.77 49.42 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.355 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.85 142.39 57.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.85 18.17 1.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.502 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.547 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.4 p-80 -103.01 155.42 18.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' ALA . 11.9 tptt -124.75 26.77 7.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 73' ' ' LYS . . . 56.94 161.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.611 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.564 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -168.27 171.74 9.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.407 -0.808 . . . . 0.0 109.256 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.482 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 2.6 tt0 -93.19 21.2 6.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.321 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 78' ' ' THR . 0.8 OUTLIER 52.2 178.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 109.598 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER 176.0 162.86 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.654 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -44.11 -35.99 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 109.469 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 84' ' ' THR . 2.9 tp10 -59.61 -48.86 80.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.783 . . . . 0.0 109.555 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.441 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -65.3 -13.3 58.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.744 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 6.3 m-85 -80.64 -75.86 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.729 HG23 ' HG2' ' A' ' 110' ' ' ARG . 14.8 p -54.08 -38.05 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 108.81 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.512 ' N ' HG13 ' A' ' 83' ' ' VAL . 38.8 m -58.02 -65.34 0.66 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.657 -0.652 . . . . 0.0 109.451 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.587 ' CE2' ' HB2' ' A' ' 42' ' ' ASP . 79.2 m-85 -81.36 125.3 30.21 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.33 -0.856 . . . . 0.0 109.499 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -73.8 -17.08 61.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.312 -0.867 . . . . 0.0 109.406 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 7' ' ' SER . 4.4 m-85 -130.07 131.08 45.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 109.861 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.852 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 5.1 mt -135.48 88.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 108.754 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -104.74 165.48 11.03 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.856 -1.152 . . . . 0.0 109.968 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.657 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -143.43 166.77 23.85 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.657 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -68.47 139.88 55.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.325 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.495 ' HB2' HD12 ' A' ' 126' ' ' ILE . 52.9 t0 -43.88 126.02 4.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 1.2 tt0 176.21 161.31 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.294 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -75.76 -6.86 52.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -74.73 -7.87 54.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.913 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.646 ' HG ' ' SG ' ' A' ' 90' ' ' CYS . 0.6 OUTLIER -89.19 7.04 37.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.937 . . . . 0.0 109.645 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -14.73 58.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 99' ' ' LEU . 2.8 p30 -92.77 -33.64 14.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.553 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.785 ' HB3' HG21 ' A' ' 113' ' ' ILE . 20.3 mt -71.58 -37.33 71.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.57 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.07 -31.69 71.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.543 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -10.0 45.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -71.69 -24.03 61.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.95 . . . . 0.0 109.56 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.41 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 1.8 p -70.02 -11.31 60.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.6 -23.97 21.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.581 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -102.7 8.99 39.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.925 . . . . 0.0 109.499 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.654 HG13 ' HG2' ' A' ' 79' ' ' LYS . 24.4 t -101.85 143.37 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 109.345 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 108' ' ' ASN . 5.7 mtmt -75.31 121.75 22.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 109.298 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 107' ' ' LYS . 2.2 m120 43.78 41.45 3.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.172 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.518 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -42.92 142.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.349 -0.844 . . . . 0.0 110.138 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.729 ' HG2' HG23 ' A' ' 83' ' ' VAL . 24.5 mmm180 -123.39 -2.57 8.49 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.852 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -84.24 106.68 16.05 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.39 -0.819 . . . . 0.0 110.722 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.95 98.02 2.41 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.785 HG21 ' HB3' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -72.85 131.28 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -0.999 . . . . 0.0 110.483 -178.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.8 tt0 -172.8 148.54 1.86 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.602 ' HB3' HD12 ' A' ' 96' ' ' LEU . 1.6 pp -90.66 157.0 17.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.438 -1.414 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.905 HD11 ' O ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -40.13 -68.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.483 -0.761 . . . . 0.0 109.925 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.563 ' N ' HD12 ' A' ' 115' ' ' LEU . . . 66.43 168.82 3.07 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.1 m -69.15 88.91 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.513 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.495 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -63.05 -37.25 86.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.454 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.569 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 166.68 -63.14 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.581 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 45.3 Cg_endo -68.72 -18.19 42.22 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.804 1.669 . . . . 0.0 110.365 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.89 162.27 19.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.27 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 124' ' ' GLN . 12.5 ptpt -143.35 54.14 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.932 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.449 ' CB ' ' O ' ' A' ' 123' ' ' LYS . 0.6 OUTLIER 71.74 61.11 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -158.35 44.36 0.3 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.922 . . . . 0.0 109.437 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -89.62 130.84 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.957 . . . . 0.0 109.387 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 126' ' ' ILE . 5.4 mt -41.58 99.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.749 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.47 ' HG2' ' OD2' ' A' ' 92' ' ' ASP . 31.5 mt-10 -117.53 28.94 8.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 0.0 109.38 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.13 148.3 35.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.1 -37.06 5.07 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.013 1.808 . . . . 0.0 110.114 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -161.79 -53.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.238 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -132.85 98.86 4.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.389 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.21 -47.51 89.24 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.15 -164.24 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -1.134 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -104.31 150.76 24.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.925 . . . . 0.0 109.455 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 70.56 11.38 7.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.57 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 0.5 OUTLIER -97.51 10.45 39.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.452 ' O ' HG12 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -76.16 -16.12 59.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.476 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -90.06 -51.8 5.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.609 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 140' ' ' THR . 1.0 OUTLIER -67.73 -19.25 65.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.556 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 142' ' ' TYR . 5.2 p -75.34 -47.4 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.912 . . . . 0.0 109.227 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.982 ' HA ' HG21 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -60.27 -39.5 87.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -39.83 85.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 109.485 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.437 ' NE2' ' HB3' ' A' ' 125' ' ' LEU . 10.7 mm100 -62.95 -33.76 76.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.87 . . . . 0.0 109.356 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.768 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.2 m -62.18 -21.51 65.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 109.498 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.691 HG13 HD11 ' A' ' 29' ' ' LEU . 86.6 t -56.47 -58.67 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 108.882 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -13.18 61.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.248 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.905 ' O ' HD11 ' A' ' 116' ' ' LEU . 99.6 m -62.77 -12.3 23.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.565 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -125.53 -37.33 2.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -59.35 -42.4 91.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 109.158 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.31 -23.36 67.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 109.091 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 1.137 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 1.5 t80 -89.17 -22.95 22.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.829 . . . . 0.0 109.528 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.664 HD21 HD11 ' A' ' 35' ' ' ILE . 21.4 tp -77.12 -18.03 58.22 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.919 -1.113 . . . . 0.0 108.9 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.86 -47.89 19.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.15 -0.969 . . . . 0.0 109.116 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -67.01 -52.74 38.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 108.977 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 1.137 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 31.4 m -95.19 31.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.367 -0.833 . . . . 0.0 109.078 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.536 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.595 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 5' ' ' THR . 7.2 t . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.404 0.621 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.893 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -78.12 77.93 4.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.427 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.649 ' CG ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -41.22 118.08 0.97 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.342 -0.849 . . . . 0.0 109.657 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -107.01 122.54 46.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.931 -1.105 . . . . 0.0 109.786 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.943 ' O ' HG23 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -125.92 122.39 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 0.0 109.543 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -122.11 145.24 48.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.27 -0.893 . . . . 0.0 108.89 179.437 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 4.0 m-85 -103.86 158.74 16.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.082 -1.011 . . . . 0.0 109.884 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.741 HG22 ' HA3' ' A' ' 44' ' ' GLY . 85.7 t -144.28 147.06 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.416 -0.803 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -160.38 141.46 12.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.534 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' CYS . 9.2 tp -44.49 -68.06 0.23 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.236 -0.915 . . . . 0.0 109.476 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.18 -79.95 0.08 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.479 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 2.0 t-20 65.85 39.19 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.125 -1.221 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 1.7 pp -143.75 13.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.601 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 40.9 t 177.21 -71.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.728 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 19' ' ' SER . 65.6 mtt85 -84.4 75.9 10.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.682 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.581 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 163.19 -50.99 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.697 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 19' ' ' SER . 51.3 Cg_exo -51.59 -19.63 7.71 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.865 1.71 . . . . 0.0 110.589 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.758 HG22 ' SG ' ' A' ' 145' ' ' CYS . 3.4 mt -75.64 -39.77 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.949 . . . . 0.0 109.81 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 1.253 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -62.99 -40.05 96.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.048 -1.033 . . . . 0.0 109.375 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -70.92 -59.22 2.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.908 . . . . 0.0 109.208 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.829 ' HB1' HG22 ' A' ' 68' ' ' ILE . . . -45.95 -34.38 3.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.9 . . . . 0.0 108.992 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.007 HG11 ' HA ' ' A' ' 146' ' ' VAL . 46.0 t -66.25 -47.52 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.35 -0.844 . . . . 0.0 109.284 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.706 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 1.9 t80 -47.98 -43.47 29.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.827 -1.171 . . . . 0.0 108.02 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.475 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -54.2 -62.86 1.38 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.067 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -79.92 10.76 3.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.271 -0.893 . . . . 0.0 110.221 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.832 HD22 ' SG ' ' A' ' 149' ' ' CYS . 48.7 tp -98.58 -34.68 10.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 108.911 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.749 HG23 HG12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -90.86 -44.44 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.247 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -49.35 -29.1 5.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -0.916 . . . . 0.0 109.138 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -80.68 -37.1 31.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 108.993 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.531 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.5 OUTLIER -73.21 -11.0 60.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.413 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.2 OUTLIER 78.49 32.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.713 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.781 HD13 HD21 ' A' ' 153' ' ' LEU . 4.6 pt -123.21 3.77 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 109.431 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.593 ' CA ' ' CG2' ' A' ' 30' ' ' VAL . 60.7 p -62.87 -31.38 72.4 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.097 -1.002 . . . . 0.0 109.457 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -54.85 -25.17 26.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.45 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.893 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -126.66 40.21 3.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.751 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.738 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 21.9 m95 -146.92 104.78 3.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.968 -1.083 . . . . 0.0 110.33 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' SER . 45.0 t -97.74 106.77 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.943 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.6 mp -107.37 146.58 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.066 -1.021 . . . . 0.0 110.501 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.444 ' C ' ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -140.66 -164.93 1.83 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.792 . . . . 0.0 109.496 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.1 176.89 8.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.377 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.741 ' HA3' HG22 ' A' ' 11' ' ' VAL . . . -163.86 159.21 31.93 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.489 ' C ' HG23 ' A' ' 46' ' ' VAL . . . -129.78 -31.03 2.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -1.153 . . . . 0.0 109.72 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.646 HG23 ' CG1' ' A' ' 11' ' ' VAL . 3.8 t 74.76 6.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.462 ' HB2' ' CD2' ' A' ' 49' ' ' TRP . 5.5 p -126.5 126.63 44.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.433 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.5 2.59 15.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.577 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -102.27 1.46 35.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -0.997 . . . . 0.0 109.362 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -122.05 8.82 9.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.311 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.676 HG13 ' HA ' ' A' ' 75' ' ' ARG . 7.0 t -71.51 92.3 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.301 -0.874 . . . . 0.0 109.436 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . 116.41 7.13 14.48 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -84.45 82.94 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -1.165 . . . . 0.0 109.45 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.469 ' HB3' ' HD2' ' A' ' 73' ' ' LYS . 86.1 p -43.63 153.28 0.4 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 0.0 109.482 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 54' ' ' SER . 54.1 Cg_exo -49.98 -176.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.979 1.786 . . . . 0.0 110.258 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.18 139.08 36.47 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.393 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.629 ' O ' HG12 ' A' ' 60' ' ' VAL . 52.3 Cg_exo -51.03 -21.1 8.31 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.879 1.719 . . . . 0.0 110.369 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -87.94 -39.55 14.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.661 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.49 6.3 34.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -85.39 -38.25 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.458 ' N ' HG13 ' A' ' 60' ' ' VAL . 4.2 m -76.55 -15.85 59.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.355 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.454 ' C ' HD23 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -70.25 -29.43 66.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.846 . . . . 0.0 109.433 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.811 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -87.8 -55.32 3.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 108.902 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 -64.09 -10.51 22.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 109.563 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -59.06 -84.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.811 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.48 ' CD2' ' H ' ' A' ' 66' ' ' HIS . 8.0 p80 -74.53 -24.91 59.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 109.773 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.447 ' O ' HG12 ' A' ' 68' ' ' ILE . . . 131.32 109.94 1.28 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.829 HG22 ' HB1' ' A' ' 24' ' ' ALA . 14.3 mm -150.16 -38.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -1.1 . . . . 0.0 109.603 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 68' ' ' ILE . 4.8 p30 51.63 173.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.81 . . . . 0.0 109.627 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.464 HG23 ' C ' ' A' ' 69' ' ' ASN . 20.5 p -157.43 -54.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 57.81 34.6 24.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.364 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -149.23 124.63 10.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 1.1 tppm? -98.21 27.36 4.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.902 . . . . 0.0 109.575 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 73' ' ' LYS . . . 73.91 131.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.527 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.676 ' HA ' HG13 ' A' ' 51' ' ' VAL . 5.5 mmt180 -143.95 142.22 30.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.535 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 77' ' ' VAL . 2.2 tt0 -66.2 119.94 12.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 78' ' ' THR . 4.1 t -45.43 170.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.516 ' H ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -153.78 175.9 12.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.445 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HG2' HG13 ' A' ' 106' ' ' VAL . 2.5 tmtt? -68.05 -45.03 75.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.624 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' O ' ' OG1' ' A' ' 84' ' ' THR . 37.3 tt0 -57.98 -44.86 87.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.543 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 1.3 m-20 -64.5 -30.35 71.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.801 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 78' ' ' THR . 12.5 m-85 -64.24 -67.01 0.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 109.755 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 110' ' ' ARG . 6.0 p -64.08 -20.07 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 6.0 m -69.96 -32.68 71.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.367 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 81' ' ' ASP . 27.4 m-85 -106.37 158.45 16.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.488 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' C ' ' CD1' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -108.87 -2.57 18.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.631 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.649 ' CE1' ' CG ' ' A' ' 6' ' ' LYS . 5.8 m-85 -138.42 139.85 39.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.855 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -150.78 116.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.233 -0.917 . . . . 0.0 109.288 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.938 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -129.53 153.98 47.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.315 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -122.72 169.83 10.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.36 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.451 ' HB2' ' HB2' ' A' ' 12' ' ' CYS . 6.3 mmt -81.06 74.1 8.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.33 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 94' ' ' SER . 0.1 OUTLIER 39.68 -101.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.778 . . . . 0.0 109.853 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 92' ' ' ASP . 45.9 mt-10 42.64 -96.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.072 -1.017 . . . . 0.0 109.262 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 96' ' ' LEU . 1.3 m -88.2 87.31 7.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 108.601 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -39.14 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.081 0.467 . . . . 0.0 110.773 -179.12 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.074 HD21 ' CG2' ' A' ' 113' ' ' ILE . 0.8 OUTLIER 32.72 36.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.119 0.485 . . . . 0.0 110.394 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 95' ' ' ASN . 7.3 ttt180 -91.21 -17.39 26.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.013 -1.054 . . . . 0.0 110.024 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.7 -51.01 2.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 0.0 110.046 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.6 HD12 ' SG ' ' A' ' 90' ' ' CYS . 11.4 mt -65.73 -18.38 65.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 109.807 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.729 ' HB2' HD22 ' A' ' 96' ' ' LEU . 7.7 t-20 -72.97 -22.91 60.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.969 . . . . 0.0 109.168 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -89.68 -23.41 21.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.285 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.858 ' O ' HG23 ' A' ' 106' ' ' VAL . 10.9 mmmt -66.37 -30.12 70.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.343 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.0 p -72.87 -21.77 60.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.337 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -71.83 -35.21 69.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.296 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 1.2 pt20 -89.06 2.8 53.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 109.487 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 102' ' ' LYS . 70.8 t -92.99 122.49 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.189 -0.944 . . . . 0.0 109.299 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -56.48 102.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.274 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 m120 52.48 59.22 4.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.146 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.549 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -54.25 156.96 2.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.4 -0.812 . . . . 0.0 109.803 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.549 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 3.1 mtt180 -123.94 -23.06 4.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.445 -0.785 . . . . 0.0 109.367 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.855 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -70.55 92.41 0.84 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.377 -0.827 . . . . 0.0 110.278 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 101.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 1.074 ' CG2' HD21 ' A' ' 96' ' ' LEU . 1.8 mm -62.65 160.15 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.217 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.576 ' HB3' HD23 ' A' ' 89' ' ' LEU . 1.7 mt-10 173.82 -169.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 118' ' ' SER . 0.7 OUTLIER -147.06 156.87 43.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.925 -1.109 . . . . 0.0 109.582 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.718 HD11 ' HA ' ' A' ' 148' ' ' CYS . 1.0 OUTLIER -59.09 -40.91 86.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -48.74 -28.62 7.21 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -50.79 -49.01 59.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -1.104 . . . . 0.0 109.503 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -86.32 -94.19 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.94 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.477 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 5.3 t70 67.13 67.4 0.61 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.497 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 51.9 Cg_exo -51.62 -173.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.962 1.775 . . . . 0.0 110.208 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 55.07 -92.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.379 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 121' ' ' PRO . 12.0 pttt -102.92 148.34 25.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.337 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -97.26 119.86 36.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -159.03 0.97 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.519 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 1.5 mm -127.92 -2.97 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.695 HG22 ' N ' ' A' ' 128' ' ' GLU . 39.9 mt 60.67 -89.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.145 -0.972 . . . . 0.0 109.265 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.695 ' N ' HG22 ' A' ' 127' ' ' ILE . 4.2 mt-10 45.62 68.52 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.547 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.83 119.54 51.07 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.224 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.46 178.1 5.36 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.773 1.649 . . . . 0.0 110.325 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.442 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 3.9 m-85 -74.16 -1.31 19.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.649 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -92.01 74.11 5.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.383 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 132' ' ' TYR . . . -57.11 -159.97 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.4 -53.7 5.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -1.167 . . . . 0.0 109.389 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -170.89 101.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.25 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 48.75 30.12 2.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.111 -0.993 . . . . 0.0 109.156 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.87 76.43 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.45 -16.75 17.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.37 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.69 -27.33 27.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' VAL . 54.9 m -56.09 -54.63 42.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.454 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 18' ' ' ARG . 10.0 t -43.56 -55.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.262 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -48.51 -46.53 38.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -58.21 8.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.876 . . . . 0.0 109.798 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -67.68 -7.18 24.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -0.95 . . . . 0.0 109.419 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.758 ' SG ' HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -83.19 -28.56 29.21 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.306 -0.871 . . . . 0.0 109.361 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 1.007 ' HA ' HG11 ' A' ' 25' ' ' VAL . 40.3 t -65.35 -50.73 71.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.259 -0.9 . . . . 0.0 109.309 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.41 -19.19 62.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.084 -1.01 . . . . 0.0 108.831 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 1.253 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -52.34 -25.03 8.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.285 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.832 ' SG ' HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -112.45 -33.29 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -0.835 . . . . 0.0 109.856 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.775 ' CA ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -70.65 -56.84 5.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 109.307 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 154' ' ' GLU . . . -54.37 -21.97 11.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.545 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.98 ' O ' HG22 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -90.32 -29.57 18.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 109.763 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.781 HD21 HD13 ' A' ' 35' ' ' ILE . 10.7 tp -75.48 -25.22 57.16 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.939 -1.101 . . . . 0.0 109.0 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -71.31 -32.66 68.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.907 . . . . 0.0 109.218 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.68 -43.45 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.184 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.98 HG22 ' O ' ' A' ' 152' ' ' PHE . 17.1 m -101.34 25.69 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.393 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.5 ' O ' ' NE ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.407 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.935 HG22 ' HA ' ' A' ' 38' ' ' ASN . 1.7 p -120.89 160.82 22.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.654 ' CB ' ' CZ3' ' A' ' 39' ' ' TRP . 11.2 mttm -108.48 -168.42 1.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.25 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.51 ' HB2' ' HA ' ' A' ' 85' ' ' PHE . 3.1 p -140.43 105.37 4.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 109.44 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.829 HG21 ' HE2' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -122.86 143.11 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.412 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.61 HD22 HG12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -140.6 115.34 9.58 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -92.04 157.59 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.076 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.984 HG11 HD11 ' A' ' 99' ' ' LEU . 16.8 t -140.35 142.16 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -0.785 . . . . 0.0 109.425 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' HA ' ' A' ' 15' ' ' ASN . 1.6 p -147.9 19.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 8.9 tp 63.64 -96.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 109.981 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 15' ' ' ASN . . . -47.33 -60.17 5.36 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.767 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . 5.3 t-20 66.8 14.76 9.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -1.162 . . . . 0.0 109.302 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.886 HD12 ' N ' ' A' ' 17' ' ' CYS . 2.6 pp -135.71 -37.95 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.438 -0.789 . . . . 0.0 108.959 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.886 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -122.28 -24.05 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -56.84 -76.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 109.231 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.588 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 46.0 p 179.46 61.2 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.931 -1.106 . . . . 0.0 110.406 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 19' ' ' SER . 49.5 Cg_exo -56.12 -17.5 20.15 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.713 1.609 . . . . 0.0 110.052 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.977 ' O ' HG23 ' A' ' 25' ' ' VAL . 10.8 mm -41.6 -38.52 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.52 -0.737 . . . . 0.0 110.264 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.954 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -53.96 -51.39 64.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.042 . . . . 0.0 109.679 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -66.36 -56.77 9.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.011 . . . . 0.0 109.356 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 1.029 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -46.7 -25.08 0.65 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.958 . . . . 0.0 109.074 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.977 HG23 ' O ' ' A' ' 21' ' ' ILE . 84.6 t -78.36 -43.32 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.264 -0.898 . . . . 0.0 109.36 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.829 ' HE2' HG21 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -57.51 -21.44 37.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -58.57 3.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 28' ' ' LYS . 10.0 tmtt? -75.89 2.77 11.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.356 -0.84 . . . . 0.0 109.225 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.956 HD11 ' HG3' ' A' ' 150' ' ' ARG . 34.2 tp -102.78 -37.17 7.99 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.955 HG23 HG12 ' A' ' 35' ' ' ILE . 9.8 p -90.82 -4.87 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 31' ' ' THR . 8.6 m -106.2 11.46 31.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.728 -1.233 . . . . 0.0 109.401 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -127.6 53.83 1.73 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 109.138 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.564 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.6 OUTLIER 175.56 31.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.486 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 33' ' ' GLN . 2.8 t-20 46.18 37.06 3.6 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.955 HG12 HG23 ' A' ' 30' ' ' VAL . 2.0 tt -121.17 -4.6 9.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.693 -177.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.927 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -73.49 -53.26 11.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.058 -1.026 . . . . 0.0 110.506 -178.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 25.7 p-10 -56.93 -14.47 3.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.198 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.935 ' HA ' HG22 ' A' ' 5' ' ' THR . 69.6 m-20 -109.12 36.62 2.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.924 -1.11 . . . . 0.0 110.464 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.654 ' CZ3' ' CB ' ' A' ' 6' ' ' LYS . 17.8 m95 -150.95 136.9 18.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.486 -1.384 . . . . 0.0 111.516 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.97 74.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.518 ' CG1' HG13 ' A' ' 8' ' ' VAL . 3.1 mt -90.11 144.5 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.456 -0.777 . . . . 0.0 109.934 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.7 OUTLIER -142.31 -173.97 3.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 109.22 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.5 p -126.26 160.92 28.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.765 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -141.43 137.45 8.08 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.51 ' HB1' ' OD1' ' A' ' 50' ' ' ASN . . . -118.01 -9.29 10.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -1.194 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.615 ' CG2' HG11 ' A' ' 11' ' ' VAL . 2.5 t 55.05 21.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.4 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 38.2 t -160.42 160.01 31.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.524 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.59 ' HA ' HG23 ' A' ' 51' ' ' VAL . 10.7 p-10 -105.5 11.68 32.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.536 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -88.04 11.13 16.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.543 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.539 HD22 ' HB1' ' A' ' 74' ' ' ALA . 3.4 p-10 -144.89 13.91 1.5 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 48' ' ' ASP . 67.2 t -65.16 112.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 109.249 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.37 22.53 58.54 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.538 ' O ' HG22 ' A' ' 16' ' ' ILE . 39.0 mtp180 -106.25 85.12 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.519 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' ARG . 2.5 p -46.36 162.22 0.26 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.281 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 56' ' ' ASP . 52.6 Cg_exo -50.51 140.65 35.34 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.897 1.731 . . . . 0.0 110.142 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 6.2 m-20 -43.75 166.08 0.11 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.466 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 56' ' ' ASP . 49.7 Cg_endo -70.91 -7.2 20.88 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.987 1.791 . . . . 0.0 110.193 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -90.19 -40.5 12.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.9 . . . . 0.0 109.365 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -89.6 -16.88 29.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.423 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 57' ' ' PRO . 7.0 p -57.25 -27.81 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.92 . . . . 0.0 109.548 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -79.97 -48.82 12.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.408 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.506 ' SG ' ' CD2' ' A' ' 142' ' ' TYR . 6.3 t -45.76 -30.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.801 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.23 -45.1 9.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.935 . . . . 0.0 109.104 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.63 19.94 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.67 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 61' ' ' SER . 15.1 t-20 -91.35 -53.54 4.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.361 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.525 ' CE1' ' OH ' ' A' ' 142' ' ' TYR . 9.5 p80 -102.98 -31.79 10.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.21 109.9 1.29 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.029 HG12 ' HB1' ' A' ' 24' ' ' ALA . 8.5 tp -120.98 -26.83 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -1.163 . . . . 0.0 109.428 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 1.3 m120 76.13 41.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.413 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 70' ' ' THR . 5.2 t -63.38 110.64 1.99 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.88 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.0 -23.55 5.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.469 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 22.7 t60 -84.74 132.76 34.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.295 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.469 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -95.91 154.17 17.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 109.542 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.539 ' HB1' HD22 ' A' ' 50' ' ' ASN . . . -46.6 169.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 76' ' ' GLN . 0.6 OUTLIER -169.16 161.48 10.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 109.484 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.54 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -96.61 128.77 43.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.528 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 46' ' ' VAL . 55.9 t -65.74 135.85 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 109.357 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -138.62 165.28 27.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.873 . . . . 0.0 109.505 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -44.09 -39.1 4.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' O ' ' OG1' ' A' ' 84' ' ' THR . 28.3 tt0 -54.19 -53.28 55.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.885 . . . . 0.0 109.546 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 2.7 m-20 -50.92 -46.89 61.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.37 -0.831 . . . . 0.0 110.125 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.774 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 77.6 m-85 -51.05 -63.11 1.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 108' ' ' ASN . 2.3 p -73.62 -4.04 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -0.861 . . . . 0.0 110.021 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 14.3 m -81.3 -65.45 1.01 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.602 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 50.2 m-85 -87.11 173.68 9.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.892 . . . . 0.0 110.001 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.586 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -116.9 -15.22 10.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.724 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CE1' ' HB3' ' A' ' 86' ' ' ASP . 1.6 m-85 -123.0 74.56 1.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.068 -1.02 . . . . 0.0 109.659 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.891 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 2.6 mt -85.22 94.04 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -105.58 -179.82 4.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.958 -1.089 . . . . 0.0 109.467 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.739 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -142.94 172.69 12.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.74 ' HA ' ' HE2' ' A' ' 91' ' ' MET . 30.9 mmt -67.52 -7.77 28.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 109.669 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 115' ' ' LEU . 5.7 p30 174.05 -176.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.0 . . . . 0.0 109.406 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -83.44 -7.58 59.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.78 -49.97 70.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.578 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -83.68 9.98 10.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.501 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.957 HD21 HG22 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -100.17 16.49 24.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.0 ttt-85 -84.87 -22.63 29.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.503 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 102' ' ' LYS . 0.9 OUTLIER -107.07 -32.64 7.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.466 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.984 HD11 HG11 ' A' ' 11' ' ' VAL . 24.5 mt -73.57 -36.01 65.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.493 ' HB2' HD22 ' A' ' 96' ' ' LEU . 5.5 t30 -66.17 -35.09 79.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.324 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -89.84 0.09 57.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.374 -0.829 . . . . 0.0 109.457 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.73 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -92.18 -22.33 19.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.478 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m -70.42 -12.61 61.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 0.0 109.41 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -86.27 -30.83 22.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -92.44 -10.36 38.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 109.348 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 102' ' ' LYS . 39.0 t -71.76 140.13 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -75.13 117.1 16.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.231 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 83' ' ' VAL . 2.5 m-80 48.28 46.38 20.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.544 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.11 150.88 2.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.96 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 5.8 ptm180 -140.58 9.9 2.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.467 -0.771 . . . . 0.0 109.111 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.891 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -98.39 116.07 29.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 110.321 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -70.57 124.22 23.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.957 HG22 HD21 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -99.1 114.95 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.795 -1.191 . . . . 0.0 110.498 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 20.7 mt-10 -147.51 -177.5 5.73 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 1.064 HD12 HD11 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -126.07 153.7 44.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.97 -1.081 . . . . 0.0 109.746 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.903 HD21 ' HA ' ' A' ' 148' ' ' CYS . 0.3 OUTLIER -43.47 104.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.373 -0.83 . . . . 0.0 109.521 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.38 157.17 16.45 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 m -65.06 93.75 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -1.133 . . . . 0.0 109.375 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -77.14 -93.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.598 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 1.1 m-20 -71.81 -62.27 1.7 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.054 -1.029 . . . . 0.0 109.789 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 55.5 Cg_endo -72.05 126.16 11.58 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.795 1.663 . . . . 0.0 110.256 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -105.13 111.99 24.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -150.56 158.12 43.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.551 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -88.42 98.44 11.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 176.57 108.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 1.064 HD11 HD12 ' A' ' 115' ' ' LEU . 1.8 tt -121.23 28.16 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 126' ' ' ILE . 20.0 tt 41.28 41.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.402 -0.811 . . . . 0.0 109.838 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.519 ' HG3' HG23 ' A' ' 126' ' ' ILE . 1.3 mt-10 -87.48 51.23 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 109.423 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.56 104.34 55.35 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.928 . . . . 0.0 109.42 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -49.4 169.83 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.8 1.667 . . . . 0.0 110.228 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.412 ' C ' ' CD1' ' A' ' 131' ' ' TYR . 3.0 t80 -84.79 106.09 16.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.55 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -146.4 -64.71 0.3 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 135.56 114.74 1.41 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -154.5 -49.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -1.1 . . . . 0.0 109.518 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.72 -19.6 20.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 56.65 24.6 9.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.509 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -127.99 87.89 2.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.453 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 29.0 p90 -71.48 -10.36 59.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.5 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -62.88 -34.84 78.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.412 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 0.2 OUTLIER -63.54 -25.78 68.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.309 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.554 ' CG1' ' HB2' ' A' ' 19' ' ' SER . 27.7 t -79.1 -31.11 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.312 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.962 ' HA ' HG21 ' A' ' 21' ' ' ILE . 6.1 t80 -69.18 -50.92 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.567 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -65.41 -41.6 93.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.952 . . . . 0.0 109.514 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 140' ' ' THR . 0.8 OUTLIER -68.87 -14.37 62.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 4.6 m -89.94 -8.6 51.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.868 ' HA ' HG11 ' A' ' 25' ' ' VAL . 46.2 t -62.57 -68.73 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.713 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.8 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 0.7 OUTLIER -58.94 -15.61 13.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.824 -1.173 . . . . 0.0 109.157 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' CYS . . . . . 0.954 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -44.26 -32.97 1.43 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.202 -0.936 . . . . 0.0 108.582 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.895 ' SG ' HG12 ' A' ' 25' ' ' VAL . 1.6 p -115.09 -24.38 8.58 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.956 ' HG3' HD11 ' A' ' 29' ' ' LEU . 9.5 ttt-85 -76.55 -60.98 2.11 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.8 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -49.67 -36.51 25.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.441 -0.787 . . . . 0.0 109.149 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.737 ' CE2' HG21 ' A' ' 156' ' ' VAL . 17.0 t80 -77.9 -31.64 51.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.532 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.482 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 11.7 tp -67.9 -13.18 61.95 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.166 -0.959 . . . . 0.0 108.815 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 1.8 mt-10 -76.9 -53.41 7.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.898 . . . . 0.0 109.122 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -47.61 84.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.962 . . . . 0.0 109.117 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.737 HG21 ' CE2' ' A' ' 152' ' ' PHE . 14.1 m -97.64 25.6 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 109.083 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.482 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.548 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -98.7 113.55 25.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.941 . . . . 0.0 109.467 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -67.33 172.57 4.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.45 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -124.69 150.16 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.564 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.665 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -84.95 71.0 10.97 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.877 . . . . 0.0 109.442 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 9.3 ttmt -41.93 162.94 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.157 -0.964 . . . . 0.0 109.573 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 m -139.16 135.96 34.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 0.0 109.912 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.765 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -141.7 155.53 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 108.927 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.792 HD13 ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -150.11 115.98 5.61 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 109.064 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.0 m-85 -86.8 151.56 23.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 109.512 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.651 ' HB ' HD11 ' A' ' 99' ' ' LEU . 5.4 t -143.82 157.92 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.59 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.426 ' O ' ' C ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER 173.08 128.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.521 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -44.91 150.09 0.4 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.216 -0.927 . . . . 0.0 109.181 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.03 88.27 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 15' ' ' ASN . 25.6 t-20 -85.5 15.19 4.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -1.14 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 17' ' ' CYS . 2.0 pp -119.22 131.79 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.613 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.78 ' SG ' ' CZ ' ' A' ' 138' ' ' PHE . 34.8 t 66.8 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.71 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.659 ' HA ' HG11 ' A' ' 141' ' ' VAL . 0.3 OUTLIER 43.11 78.63 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 0.0 109.681 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER 163.63 -61.48 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.895 . . . . 0.0 109.94 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 19' ' ' SER . 52.1 Cg_endo -71.16 -1.25 9.28 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.85 1.7 . . . . 0.0 110.848 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.007 HG21 ' HA ' ' A' ' 142' ' ' TYR . 3.8 mm -74.6 -48.12 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.985 -1.072 . . . . 0.0 109.575 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.632 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -57.35 -27.85 62.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.551 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -73.27 -71.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -0.954 . . . . 0.0 109.318 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.492 ' O ' HG13 ' A' ' 68' ' ' ILE . . . -44.89 -26.97 0.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 108.887 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.96 HG12 ' SG ' ' A' ' 149' ' ' CYS . 72.2 t -70.23 -54.36 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.404 -0.81 . . . . 0.0 109.214 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.682 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 2.1 t80 -45.57 -35.78 4.21 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.442 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -63.8 -57.66 9.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.425 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -55.97 -21.15 19.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.857 . . . . 0.0 109.652 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.859 HD22 ' HG3' ' A' ' 150' ' ' ARG . 39.7 mt -85.62 -30.79 22.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.212 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.929 HG22 ' HA ' ' A' ' 36' ' ' SER . 2.9 p -90.67 -6.23 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.407 -0.808 . . . . 0.0 109.348 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -105.14 5.91 32.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.033 -1.042 . . . . 0.0 109.848 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 4.4 t0 -128.02 59.74 1.48 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 109.133 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.501 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER 171.28 31.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.831 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.456 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.4 t-20 45.11 32.01 0.84 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.838 HG12 HG23 ' A' ' 30' ' ' VAL . 2.7 tt -112.79 -7.31 11.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.687 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.929 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -73.11 -25.06 60.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.658 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -84.47 16.26 3.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.872 . . . . 0.0 109.778 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.665 ' HA ' HG22 ' A' ' 5' ' ' THR . 8.6 m-80 -144.46 36.13 1.2 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.223 -0.923 . . . . 0.0 109.481 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.765 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 22.1 m95 -150.18 150.39 31.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.986 -1.071 . . . . 0.0 111.029 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.493 ' O ' HG12 ' A' ' 40' ' ' VAL . 80.5 t -128.31 70.9 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 26' ' ' PHE . 2.4 mp -89.56 140.22 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.398 -0.814 . . . . 0.0 110.626 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -146.25 171.58 14.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.507 -0.745 . . . . 0.0 109.268 179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.8 p -105.1 162.38 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.139 -0.975 . . . . 0.0 109.614 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.559 ' CA ' ' CG2' ' A' ' 77' ' ' VAL . . . -143.05 122.76 1.97 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.731 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -87.08 -41.26 13.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.142 -1.21 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER 80.25 -5.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.795 . . . . 0.0 109.436 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 76' ' ' GLN . 0.4 OUTLIER -126.49 179.61 5.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 109.371 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.515 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 19.3 t70 -120.38 7.87 10.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -91.55 -32.98 15.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.0 109.327 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -101.85 31.16 3.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 73.9 t -76.31 96.79 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.459 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.19 57.33 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -79.37 86.64 5.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -1.161 . . . . 0.0 109.555 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 53' ' ' ARG . 4.0 m -45.42 159.6 0.28 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.873 . . . . 0.0 109.369 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -50.45 152.41 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 121.98 1.787 . . . . 0.0 110.255 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.19 152.36 96.55 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.486 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.587 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 51.6 Cg_exo -51.22 -19.97 7.16 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.021 1.814 . . . . 0.0 110.475 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -81.89 -47.78 12.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -0.961 . . . . 0.0 109.796 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.747 ' O ' HD22 ' A' ' 63' ' ' LEU . . . -89.86 4.58 49.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.187 -0.946 . . . . 0.0 109.807 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.587 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 6.8 p -89.93 -43.92 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.043 -1.036 . . . . 0.0 109.628 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.525 ' N ' HG13 ' A' ' 60' ' ' VAL . 3.8 p -76.82 -17.85 58.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.95 . . . . 0.0 109.521 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.7 m -78.26 -62.29 1.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.749 HD23 ' H ' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -60.69 -27.99 68.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.567 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.749 ' H ' HD23 ' A' ' 63' ' ' LEU . 7.2 ttp85 -96.94 33.37 1.91 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 109.649 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 61' ' ' SER . 9.1 t-20 -131.5 -43.07 1.03 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.345 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.86 -22.15 34.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.909 . . . . 0.0 109.36 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.449 ' O ' ' HD3' ' A' ' 28' ' ' LYS . . . 113.16 83.33 1.22 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 25' ' ' VAL . 1.3 tp -122.22 -24.5 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -1.16 . . . . 0.0 109.656 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 9.3 m-80 63.52 98.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.557 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.23 91.39 3.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -119.77 53.55 1.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.58 ' CD2' ' N ' ' A' ' 73' ' ' LYS . 20.6 t60 -143.94 155.87 44.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.447 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.58 ' N ' ' CD2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -104.75 130.75 52.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 75' ' ' ARG . . . -43.99 -69.9 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.601 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.495 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 61.06 158.96 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.928 . . . . 0.0 109.373 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 47' ' ' SER . 22.6 tt0 -88.39 123.78 33.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.442 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.559 ' CG2' ' CA ' ' A' ' 44' ' ' GLY . 21.3 t -47.56 151.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.86 . . . . 0.0 109.533 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -141.09 165.17 28.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.663 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.631 ' CG ' HG13 ' A' ' 106' ' ' VAL . 3.2 tmtt? -43.18 -41.67 3.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 109.495 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 84' ' ' THR . 24.4 tp10 -56.08 -48.37 76.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 0.0 109.553 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.487 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 1.2 m-20 -62.32 -34.02 75.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.77 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.826 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 79.3 m-85 -65.65 -79.07 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.953 . . . . 0.0 110.163 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.663 HG23 ' HB3' ' A' ' 110' ' ' ARG . 7.3 p -48.13 -46.94 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.07 -1.019 . . . . 0.0 109.256 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.603 ' N ' HG13 ' A' ' 83' ' ' VAL . 16.4 m -45.85 -82.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.335 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.792 ' CE2' HD13 ' A' ' 9' ' ' LEU . 21.0 m-85 -57.13 166.5 1.07 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.251 -0.906 . . . . 0.0 109.317 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.33 -25.62 5.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 109.852 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.618 ' CD2' HG11 ' A' ' 156' ' ' VAL . 6.3 m-30 -109.38 72.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.107 -0.996 . . . . 0.0 109.852 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.907 HG13 ' HB1' ' A' ' 111' ' ' ALA . 1.3 mt -82.82 96.57 3.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.428 -0.795 . . . . 0.0 109.62 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -109.85 179.97 3.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.019 -1.051 . . . . 0.0 108.91 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.5 OUTLIER -147.58 172.49 13.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.13 -0.982 . . . . 0.0 109.689 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.51 ' CE ' HD13 ' A' ' 116' ' ' LEU . 31.5 mmt -85.46 46.59 1.31 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.362 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' SER . 10.1 t70 56.93 -93.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.568 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.506 ' HG2' ' N ' ' A' ' 94' ' ' SER . 27.4 tt0 43.53 -94.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.305 -0.872 . . . . 0.0 109.338 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.6 ' O ' ' N ' ' A' ' 96' ' ' LEU . 4.6 p -85.67 88.2 7.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.09 -1.006 . . . . 0.0 108.71 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 96' ' ' LEU . 25.5 p-10 -31.94 85.87 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.091 0.472 . . . . 0.0 111.195 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.964 HD13 ' OD1' ' A' ' 100' ' ' ASN . 4.1 mt 29.48 56.98 0.15 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.244 0.545 . . . . 0.0 110.747 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -91.35 -50.96 5.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.082 -1.011 . . . . 0.0 109.65 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -92.77 -64.13 1.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.928 . . . . 0.0 109.653 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.651 HD11 ' HB ' ' A' ' 11' ' ' VAL . 17.3 mt -44.02 -40.11 4.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.217 -0.927 . . . . 0.0 109.668 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.964 ' OD1' HD13 ' A' ' 96' ' ' LEU . 3.2 t30 -61.59 -49.31 77.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -0.98 . . . . 0.0 109.182 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.83 14.6 11.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 108.918 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.683 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.8 OUTLIER -86.25 -40.41 15.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.479 -0.763 . . . . 0.0 109.356 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.6 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 1.3 p -65.86 -11.79 49.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.42 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.4 -36.82 68.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -99.19 8.6 44.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.825 HG11 ' SG ' ' A' ' 109' ' ' CYS . 46.7 t -83.54 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 0.0 109.367 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 108' ' ' ASN . 12.1 tptp -62.53 88.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.156 -0.965 . . . . 0.0 108.832 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 107' ' ' LYS . 9.2 t30 73.99 71.06 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.214 -0.929 . . . . 0.0 108.932 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.825 ' SG ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -85.01 143.72 28.74 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.315 -0.866 . . . . 0.0 109.901 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.663 ' HB3' HG23 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -143.82 13.58 1.7 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 108.985 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.907 ' HB1' HG13 ' A' ' 88' ' ' ILE . . . -89.85 97.22 11.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.965 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 111' ' ' ALA . 15.0 mttt -46.66 123.63 5.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.61 ' CG2' HD21 ' A' ' 96' ' ' LEU . 1.1 mm -99.36 139.59 20.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.875 -1.141 . . . . 0.0 110.372 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -167.11 -177.43 3.73 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.663 ' N ' HD23 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -134.0 145.73 49.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.009 -1.057 . . . . 0.0 109.642 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.882 HD21 ' HA ' ' A' ' 148' ' ' CYS . 0.0 OUTLIER -43.24 152.54 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.328 -0.858 . . . . 0.0 109.448 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -158.43 -143.76 3.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 123' ' ' LYS . 2.0 p -87.24 109.19 19.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.166 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -112.27 -81.96 0.59 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.41 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.582 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -61.56 -61.47 7.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.281 -0.887 . . . . 0.0 109.654 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 52.3 Cg_endo -71.78 -161.68 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.77 1.647 . . . . 0.0 110.209 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -144.35 36.61 1.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 118' ' ' SER . 12.2 ptpt -111.49 159.07 18.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.242 -0.911 . . . . 0.0 109.566 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.7 81.87 7.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.23 -0.919 . . . . 0.0 109.505 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.49 112.79 25.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.193 -0.942 . . . . 0.0 109.386 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.5 ' CG2' ' CG ' ' A' ' 92' ' ' ASP . 6.6 mm -124.8 152.35 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.314 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.425 ' C ' ' OD2' ' A' ' 92' ' ' ASP . 2.9 mm -92.25 64.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.155 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.459 ' HA ' ' OD2' ' A' ' 92' ' ' ASP . 3.0 mt-10 -85.55 46.75 1.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.668 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -127.24 144.79 51.89 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.68 -42.9 1.52 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.876 1.717 . . . . 0.0 110.218 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.96 178.4 4.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.379 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -124.98 12.65 8.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 109.458 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 96.51 -115.7 5.27 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.74 -48.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -1.154 . . . . 0.0 109.335 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.9 OUTLIER -102.26 159.71 15.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 74.18 5.92 4.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.534 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -177.42 120.88 0.11 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.487 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.78 ' CZ ' ' SG ' ' A' ' 17' ' ' CYS . 2.0 t80 -170.85 -50.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.323 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 140' ' ' THR . 2.5 pt-20 -66.66 -28.61 68.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 109.411 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.419 ' N ' ' HG3' ' A' ' 139' ' ' GLU . 32.4 m -62.18 -43.93 97.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.387 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 18' ' ' ARG . 39.2 t -61.59 -57.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 109.234 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 1.007 ' HA ' HG21 ' A' ' 21' ' ' ILE . 1.4 t80 -46.52 -38.22 9.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 0.0 109.131 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.86 -39.27 79.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.737 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -68.66 -13.13 62.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.693 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.3 m -88.15 -12.56 43.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.754 ' HA ' HG11 ' A' ' 25' ' ' VAL . 95.8 t -58.54 -60.41 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.299 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.813 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 0.0 OUTLIER -74.4 -18.49 60.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.897 . . . . 0.0 109.377 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.882 ' HA ' HD21 ' A' ' 116' ' ' LEU . 1.2 m -46.72 -32.21 3.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.151 -0.968 . . . . 0.0 109.184 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.96 ' SG ' HG12 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -114.07 -30.01 6.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -0.882 . . . . 0.0 109.175 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.859 ' HG3' HD22 ' A' ' 29' ' ' LEU . 18.2 ttt180 -75.22 -57.72 3.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 0.0 109.109 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.813 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -51.77 -31.53 27.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.349 -0.844 . . . . 0.0 109.199 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.743 ' CE1' HG21 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -83.39 -29.36 28.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.813 . . . . 0.0 109.343 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.98 -18.11 65.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.067 -1.021 . . . . 0.0 108.666 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 3.7 mm-40 -70.09 -45.43 66.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.024 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -46.38 81.91 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.284 -0.885 . . . . 0.0 108.953 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.743 HG21 ' CE1' ' A' ' 152' ' ' PHE . 6.4 m -95.3 25.17 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.4 -0.812 . . . . 0.0 109.084 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 1.1 tmm_? . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.557 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.91 30.31 5.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.421 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 67.18 170.8 0.26 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -88.21 143.55 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.361 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.944 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -149.43 71.94 1.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.611 ' HG2' ' CE2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -42.28 166.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.151 -0.968 . . . . 0.0 110.304 -179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 85' ' ' PHE . 33.4 t -143.75 127.22 16.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.512 -0.742 . . . . 0.0 109.147 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.971 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -131.09 153.25 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 108.904 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.623 HD22 ' CD1' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -146.21 123.52 11.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.445 -0.784 . . . . 0.0 108.997 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.2 m-85 -95.2 165.99 12.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.107 -0.995 . . . . 0.0 109.817 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.635 HG11 HD11 ' A' ' 99' ' ' LEU . 2.0 t -147.38 149.11 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.349 -0.844 . . . . 0.0 109.644 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.761 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER 177.13 114.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.55 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 tp -46.74 156.94 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.0 109.405 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.35 49.55 75.14 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.445 ' OD1' ' HG3' ' A' ' 20' ' ' PRO . 43.4 t30 -74.29 82.09 1.86 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.133 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.566 HD12 ' N ' ' A' ' 17' ' ' CYS . 1.2 pp -152.55 -52.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 109.712 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.692 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -134.61 34.73 3.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 109.641 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -171.37 60.07 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.264 -0.898 . . . . 0.0 109.372 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.761 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 163.59 -51.68 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 109.599 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 19' ' ' SER . 54.1 Cg_exo -49.29 -21.27 4.41 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.839 1.692 . . . . 0.0 110.455 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.001 HG21 ' HA ' ' A' ' 142' ' ' TYR . 18.5 mm -58.97 -51.28 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.165 -0.96 . . . . 0.0 109.647 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.781 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . . . -59.99 -16.97 34.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 109.136 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' OE1' ' CA ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -81.92 -72.81 0.42 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.221 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -43.49 -39.18 3.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.001 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 21' ' ' ILE . 47.2 t -60.83 -58.34 7.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.448 -0.782 . . . . 0.0 108.97 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 2.6 t80 -43.3 -29.12 0.38 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.216 -0.928 . . . . 0.0 108.615 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.62 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -65.93 -62.2 1.63 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.331 -0.855 . . . . 0.0 109.226 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.08 -43.33 63.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 0.0 109.71 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.791 HD22 ' HG3' ' A' ' 150' ' ' ARG . 25.3 mt -60.39 -36.8 78.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.93 HG22 ' HA ' ' A' ' 36' ' ' SER . 4.4 p -90.03 -4.52 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.504 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -107.21 12.51 28.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.848 -1.158 . . . . 0.0 109.689 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 33' ' ' GLN . 6.9 t0 -131.84 56.14 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.889 . . . . 0.0 109.132 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.552 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.7 OUTLIER 173.56 31.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -0.877 . . . . 0.0 109.627 -179.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.1 t30 45.71 36.88 2.93 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.889 HG12 HG23 ' A' ' 30' ' ' VAL . 2.1 tt -119.54 -7.37 11.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.959 -177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.93 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.5 OUTLIER -74.64 -37.2 62.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.893 . . . . 0.0 109.992 -179.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -74.02 1.01 11.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 110.027 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.944 ' HA ' HG22 ' A' ' 5' ' ' THR . 6.8 m-20 -127.18 42.14 3.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.096 -1.003 . . . . 0.0 109.838 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.971 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 9.4 m95 -150.23 157.3 42.94 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.899 -1.126 . . . . 0.0 110.819 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.552 HG12 ' CE1' ' A' ' 85' ' ' PHE . 96.5 t -133.06 71.9 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.578 ' CG1' HG13 ' A' ' 8' ' ' VAL . 2.7 mp -89.65 137.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.413 -0.804 . . . . 0.0 110.13 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 3.7 t70 -143.33 -177.21 5.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.449 -0.782 . . . . 0.0 109.312 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.5 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 95.6 p -119.54 163.6 17.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.164 -0.96 . . . . 0.0 109.688 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -142.15 134.43 6.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.562 ' HB1' HD21 ' A' ' 50' ' ' ASN . . . -116.42 -12.41 11.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.114 -1.227 . . . . 0.0 109.557 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.616 ' HA ' HG12 ' A' ' 77' ' ' VAL . 1.8 t 56.24 17.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' ' CE2' ' A' ' 49' ' ' TRP . 1.1 p -151.24 169.82 20.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.273 -0.892 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HA ' HG23 ' A' ' 51' ' ' VAL . 4.5 m-20 -116.8 22.19 12.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 109.437 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.589 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -95.23 -24.97 16.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.197 -0.939 . . . . 0.0 109.24 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.562 HD21 ' HB1' ' A' ' 45' ' ' ALA . 6.5 p30 -108.88 9.62 26.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.838 . . . . 0.0 109.516 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.628 HG23 ' HA ' ' A' ' 48' ' ' ASP . 74.3 t -65.17 90.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.894 . . . . 0.0 109.464 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.76 29.08 4.81 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.1 OUTLIER -105.32 95.13 5.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -1.158 . . . . 0.0 109.472 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -43.99 162.49 0.19 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.888 . . . . 0.0 109.462 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.64 148.86 54.08 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.958 1.772 . . . . 0.0 110.134 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 5.9 t70 -50.75 139.56 21.36 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.272 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.496 ' O ' HG12 ' A' ' 60' ' ' VAL . 50.4 Cg_exo -51.93 -18.86 7.42 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.845 1.696 . . . . 0.0 110.439 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.492 ' HB3' ' CE2' ' A' ' 138' ' ' PHE . 8.9 mtm180 -81.96 -39.25 23.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.097 -1.002 . . . . 0.0 109.675 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.792 ' O ' HD22 ' A' ' 63' ' ' LEU . . . -90.38 -1.62 57.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.94 . . . . 0.0 109.842 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.517 ' O ' ' CD2' ' A' ' 63' ' ' LEU . 5.7 p -89.6 -39.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.05 -1.032 . . . . 0.0 109.651 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.46 ' N ' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -88.46 -8.87 54.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -89.24 -64.44 1.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.646 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.792 HD22 ' O ' ' A' ' 59' ' ' ALA . 1.6 pt? -43.34 -30.64 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.671 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.729 ' H ' HD23 ' A' ' 63' ' ' LEU . 3.5 ptp180 -93.16 41.84 1.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.336 -0.852 . . . . 0.0 109.468 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -133.48 -43.95 0.83 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.262 -0.899 . . . . 0.0 109.382 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -83.17 -34.17 26.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.18 95.29 0.2 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.484 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 17.3 mm -146.08 -75.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -1.152 . . . . 0.0 109.453 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 65.53 99.65 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.05 166.48 20.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.484 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -155.04 54.05 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.49 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.561 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.5 p-80 -122.71 170.61 9.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.487 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.02 154.48 37.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.192 -0.942 . . . . 0.0 109.554 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.99 122.7 28.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.461 ' HD2' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -129.74 172.36 11.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.417 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 47' ' ' SER . 1.1 tt0 -92.13 122.32 34.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.616 HG12 ' HA ' ' A' ' 46' ' ' VAL . 8.9 p -48.9 145.91 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.407 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 p -132.83 168.3 18.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.215 -0.928 . . . . 0.0 109.466 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.582 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -51.03 -41.37 59.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 109.255 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -59.41 -38.28 80.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.56 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.08 -41.09 87.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.229 -0.919 . . . . 0.0 109.978 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.813 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 81.1 m-85 -64.47 -62.36 1.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.797 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.528 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 3.8 p -65.76 -10.35 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.687 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.637 HG22 ' N ' ' A' ' 85' ' ' PHE . 3.4 m -87.97 -85.09 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.319 -0.863 . . . . 0.0 109.368 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.637 ' N ' HG22 ' A' ' 84' ' ' THR . 59.1 m-85 -56.33 109.04 0.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.526 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.404 ' C ' ' CD1' ' A' ' 87' ' ' TYR . 1.3 t0 -58.29 -20.87 46.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.263 -0.898 . . . . 0.0 109.502 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.611 ' CE2' ' HG2' ' A' ' 6' ' ' LYS . 6.6 m-30 -113.31 137.42 51.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.933 HG13 ' HB1' ' A' ' 111' ' ' ALA . 1.0 OUTLIER -145.45 104.24 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 108.652 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.66 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -120.74 156.65 31.37 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.906 -1.121 . . . . 0.0 109.744 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 115' ' ' LEU . 2.4 p -121.26 166.15 14.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.517 -0.739 . . . . 0.0 109.424 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.499 ' HE3' HD23 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -75.62 -62.56 1.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.719 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 93' ' ' GLU . 11.5 p-10 -178.62 -138.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.398 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 74.4 mt-10 63.12 -88.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.058 -1.026 . . . . 0.0 109.487 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -85.01 85.75 7.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 0.0 109.069 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.47 ' O ' ' C ' ' A' ' 96' ' ' LEU . 0.7 OUTLIER -51.21 86.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.684 -0.635 . . . . 0.0 110.083 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.978 HD22 ' HB2' ' A' ' 100' ' ' ASN . 0.4 OUTLIER 37.33 40.3 0.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.729 -0.607 . . . . 0.0 110.196 179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -90.51 -50.14 6.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.045 -1.035 . . . . 0.0 109.479 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.6 -45.03 12.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 109.496 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.635 HD11 HG11 ' A' ' 11' ' ' VAL . 13.4 mt -62.58 -34.75 77.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 109.575 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.978 ' HB2' HD22 ' A' ' 96' ' ' LEU . 21.8 t-20 -62.17 -31.63 72.16 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 0.0 109.474 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -89.69 -11.4 42.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.938 . . . . 0.0 109.424 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.888 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -74.93 -27.13 60.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.33 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.639 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 0.9 OUTLIER -73.8 -20.62 60.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.892 . . . . 0.0 109.339 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.63 -49.9 42.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.256 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -70.48 -19.39 62.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.944 . . . . 0.0 109.253 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 102' ' ' LYS . 54.6 t -67.08 125.03 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.376 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -66.47 100.55 0.67 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.333 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.87 50.35 1.99 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -53.62 150.9 6.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.263 -0.898 . . . . 0.0 109.838 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.528 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 12.0 ptt180 -138.53 7.22 2.55 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.339 -0.85 . . . . 0.0 109.153 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.933 ' HB1' HG13 ' A' ' 88' ' ' ILE . . . -88.03 120.38 29.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 110.178 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.47 ' O ' ' HB ' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -70.51 132.68 45.9 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.84 ' HB ' HD11 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -109.16 133.09 55.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.777 -1.202 . . . . 0.0 110.402 -179.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.8 OUTLIER -178.47 139.21 0.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -84.72 167.34 16.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.594 -1.316 . . . . 0.0 109.95 -179.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.956 HD11 ' HA ' ' A' ' 148' ' ' CYS . 3.1 mm? -40.59 -44.23 2.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.582 -0.699 . . . . 0.0 109.752 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 54.44 -123.4 27.94 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -131.07 122.68 27.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 109.341 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.533 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.7 m-85 -127.83 3.42 6.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 0.0 109.634 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.587 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 162.58 -51.26 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.608 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.3 Cg_exo -49.72 140.43 29.67 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.794 1.663 . . . . 0.0 110.111 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -108.14 112.89 25.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -172.67 149.37 2.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.356 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.69 52.29 2.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.364 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.97 131.71 4.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.381 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -105.3 41.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.972 . . . . 0.0 109.165 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 126' ' ' ILE . 14.7 mt 71.44 19.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.133 -0.98 . . . . 0.0 109.51 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.685 ' HG3' HG22 ' A' ' 126' ' ' ILE . 30.5 mt-10 -62.18 90.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' HB3' ' NH2' ' A' ' 18' ' ' ARG . 9.8 t70 -145.32 102.39 4.36 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.195 -0.941 . . . . 0.0 109.401 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -49.26 139.86 27.18 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.868 1.712 . . . . 0.0 110.308 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 132' ' ' TYR . 0.0 OUTLIER 51.91 -161.72 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.479 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.565 ' CE2' ' CE2' ' A' ' 131' ' ' TYR . 8.4 p90 -94.88 30.24 2.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 132' ' ' TYR . . . 43.63 -131.97 6.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -179.71 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -1.187 . . . . 0.0 109.475 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -78.09 123.48 26.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 135' ' ' ASP . . . 44.35 29.51 0.38 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.09 35.18 3.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.877 . . . . 0.0 109.459 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.492 ' CE2' ' HB3' ' A' ' 58' ' ' ARG . 5.0 t80 -133.24 -55.56 0.91 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.12 -44.53 68.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.261 -0.9 . . . . 0.0 109.388 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 27.7 m -60.52 -36.8 79.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 109.37 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.3 t -62.87 -53.54 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.324 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 1.001 ' HA ' HG21 ' A' ' 21' ' ' ILE . 2.4 t80 -59.56 -24.27 63.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.553 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -85.02 -24.45 28.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 0.0 109.931 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.46 -13.77 42.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.091 -1.006 . . . . 0.0 109.498 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.781 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -90.3 -7.28 53.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.286 -0.884 . . . . 0.0 109.665 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.873 ' HA ' HG11 ' A' ' 25' ' ' VAL . 73.9 t -62.04 -63.62 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.145 -0.972 . . . . 0.0 109.218 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.451 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 4.2 mpt_? -68.62 -22.36 64.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.107 -0.996 . . . . 0.0 109.095 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.956 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.6 m -44.4 -28.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 0.0 108.823 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.629 ' SG ' ' CD1' ' A' ' 29' ' ' LEU . 1.5 p -111.79 -33.7 6.24 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.49 -0.756 . . . . 0.0 109.036 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.791 ' HG3' HD22 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.91 -61.18 2.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -51.94 -28.05 15.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.451 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -84.35 -31.63 24.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -0.826 . . . . 0.0 109.311 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' A' ' 157' ' ' ARG . 13.8 tp -62.81 -54.14 43.54 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.039 -1.038 . . . . 0.0 108.792 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.522 ' HA ' ' CB ' ' A' ' 157' ' ' ARG . 5.6 pt-20 -44.31 -40.23 5.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.192 -0.942 . . . . 0.0 109.193 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -57.66 -63.16 1.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.521 ' HB ' ' CE2' ' A' ' 87' ' ' TYR . 27.8 m -93.28 33.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.335 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -97.65 106.07 18.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.415 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -141.95 142.65 33.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.483 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 t -119.72 133.04 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.301 -0.875 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 1.078 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -97.16 2.66 51.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.773 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.677 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER 52.53 162.76 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.846 0.831 . . . . 0.0 110.392 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.52 ' HB3' ' HA ' ' A' ' 85' ' ' PHE . 2.0 m -150.29 107.54 3.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.98 -1.075 . . . . 0.0 109.496 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.837 HG11 ' HE2' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -102.9 138.55 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.274 -0.891 . . . . 0.0 109.097 179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.771 HD13 ' CD1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -139.62 107.7 5.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.407 -0.808 . . . . 0.0 109.503 -179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.808 ' CE1' HD13 ' A' ' 89' ' ' LEU . 5.6 m-85 -93.79 156.79 16.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.418 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.0 t -148.36 155.84 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.717 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -176.84 134.67 0.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.66 HD21 ' CZ3' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -50.26 171.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.26 -0.9 . . . . 0.0 109.431 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 13' ' ' LEU . . . 44.06 41.05 5.98 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.686 ' O ' HG23 ' A' ' 16' ' ' ILE . 8.8 t30 -67.68 91.77 0.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.469 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -162.17 -39.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.132 -0.98 . . . . 0.0 109.723 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.51 ' SG ' HD12 ' A' ' 16' ' ' ILE . 1.8 p -150.84 81.18 1.33 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.146 -0.971 . . . . 0.0 109.73 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.789 ' HA ' HG11 ' A' ' 141' ' ' VAL . 0.0 OUTLIER 165.14 -76.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.822 . . . . 0.0 109.188 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.762 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -67.63 -49.23 40.97 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.389 -0.819 . . . . 0.0 110.337 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 19' ' ' SER . 71.8 Cg_exo -48.06 -20.33 2.1 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.964 1.776 . . . . 0.0 111.19 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.748 HG21 ' HA ' ' A' ' 142' ' ' TYR . 9.3 mt -64.83 -48.04 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 120.94 -1.1 . . . . 0.0 109.382 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.776 ' HA ' ' SG ' ' A' ' 145' ' ' CYS . . . -57.8 -19.28 27.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 109.353 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' A' ' 24' ' ' ALA . 8.9 tm-20 -76.7 -70.21 0.47 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.216 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' HB1' HG23 ' A' ' 68' ' ' ILE . . . -44.22 -47.77 9.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.358 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.867 HG11 ' HA ' ' A' ' 146' ' ' VAL . 63.6 t -54.17 -49.95 58.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.182 -0.949 . . . . 0.0 109.297 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.837 ' HE2' HG11 ' A' ' 8' ' ' VAL . 1.1 t80 -50.49 -37.9 41.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.031 -1.043 . . . . 0.0 108.379 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -45.05 82.09 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.191 -0.943 . . . . 0.0 108.841 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -81.61 -8.92 59.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.83 . . . . 0.0 110.104 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.689 HD22 ' HB2' ' A' ' 150' ' ' ARG . 3.9 mt -86.43 -31.08 21.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.994 -1.066 . . . . 0.0 109.323 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.804 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -90.85 -56.65 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.504 ' N ' HG22 ' A' ' 30' ' ' VAL . 1.2 m -44.8 -32.05 1.42 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.106 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.32 -42.58 44.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.851 . . . . 0.0 109.105 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.52 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 4.4 tp60 -72.62 -6.85 47.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -0.854 . . . . 0.0 109.411 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 33.9 t30 76.65 48.57 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 0.0 109.699 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.804 ' CG1' HG23 ' A' ' 30' ' ' VAL . 3.8 pt -140.42 8.66 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 109.626 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.615 ' HA ' HG21 ' A' ' 30' ' ' VAL . 24.5 p -68.06 -41.59 81.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.012 -1.055 . . . . 0.0 109.488 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.98 -20.17 3.21 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.284 -0.885 . . . . 0.0 109.361 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 1.078 ' HA ' HG22 ' A' ' 5' ' ' THR . 2.2 m-20 -121.11 45.29 2.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.936 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.677 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 6.7 m95 -150.33 129.04 12.35 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.871 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.95 87.73 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.534 ' HA ' HG13 ' A' ' 8' ' ' VAL . 3.4 mt -94.27 142.32 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 0.0 110.343 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.573 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 t0 -164.31 178.3 7.62 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.0 p -179.74 169.85 1.29 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.06 -1.025 . . . . 0.0 109.739 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.12 -163.03 28.54 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' A' ' 15' ' ' ASN . . . -107.5 171.82 7.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -1.164 . . . . 0.0 109.487 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.523 HG22 HD11 ' A' ' 99' ' ' LEU . 93.3 t -104.74 -8.08 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.555 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.04 174.36 6.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.194 -0.941 . . . . 0.0 109.515 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.485 ' OD1' HG21 ' A' ' 51' ' ' VAL . 29.6 t70 -110.2 30.45 6.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.51 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.66 ' CZ3' HD21 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -102.49 -49.28 3.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.444 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -90.22 38.23 0.92 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.867 . . . . 0.0 109.65 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.485 HG21 ' OD1' ' A' ' 48' ' ' ASP . 73.2 t -82.13 94.65 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.347 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.559 ' H ' ' HB3' ' A' ' 74' ' ' ALA . . . 105.38 -17.15 44.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.18 136.83 8.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -1.087 . . . . 0.0 109.451 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.35 159.34 50.63 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.462 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 56' ' ' ASP . 53.4 Cg_endo -71.59 -3.4 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.015 1.81 . . . . 0.0 110.231 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' PRO . 72.0 m-20 61.57 140.97 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 109.443 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.814 ' O ' HG12 ' A' ' 60' ' ' VAL . 56.6 Cg_endo -73.49 -1.34 10.53 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.901 1.734 . . . . 0.0 110.395 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.433 ' O ' ' OG ' ' A' ' 61' ' ' SER . 67.6 mtt180 -72.95 -28.11 62.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.13 -0.981 . . . . 0.0 109.611 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 63' ' ' LEU . . . -88.94 -39.94 13.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.814 HG12 ' O ' ' A' ' 57' ' ' PRO . 10.8 p -44.45 -25.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.597 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 58' ' ' ARG . 0.2 OUTLIER -48.34 -89.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.295 -0.878 . . . . 0.0 109.846 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.675 ' SG ' ' OE2' ' A' ' 139' ' ' GLU . 3.7 t -73.54 -3.75 29.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 110.035 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.57 ' HG ' HG21 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -86.56 -74.35 0.43 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.023 -1.048 . . . . 0.0 108.953 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.448 ' CB ' HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -81.49 74.14 8.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 109.43 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -146.29 -53.83 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.198 -0.939 . . . . 0.0 109.643 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -80.72 -23.16 39.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -0.921 . . . . 0.0 109.66 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.26 61.63 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.642 HG23 ' HB1' ' A' ' 24' ' ' ALA . 21.7 mm -113.29 156.08 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -1.174 . . . . 0.0 109.498 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.42 ' N ' HG22 ' A' ' 68' ' ' ILE . 12.0 m-80 -147.55 96.67 2.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.371 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 70' ' ' THR . 9.6 t -113.73 72.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.88 54.94 3.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 0.0 109.499 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.564 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.5 p-80 -133.63 155.66 49.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -0.955 . . . . 0.0 109.453 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.61 170.43 8.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 0.0 109.451 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.559 ' HB3' ' H ' ' A' ' 52' ' ' GLY . . . -90.56 148.33 22.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 109.526 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' HA ' HG13 ' A' ' 51' ' ' VAL . 3.1 mmt-85 -151.75 152.26 32.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.409 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.401 ' OE1' ' O ' ' A' ' 77' ' ' VAL . 0.4 OUTLIER -80.57 135.44 36.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.541 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.401 ' O ' ' OE1' ' A' ' 76' ' ' GLN . 8.7 p -56.89 146.94 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.87 165.47 26.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 109.445 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.759 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -46.01 -36.72 5.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' O ' ' OG1' ' A' ' 84' ' ' THR . 7.8 tt0 -59.69 -56.78 17.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 109.655 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 9.3 m-20 -50.54 -40.67 52.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -0.884 . . . . 0.0 109.808 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.941 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 43.4 m-85 -53.53 -58.13 8.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.072 -1.017 . . . . 0.0 109.335 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.544 ' HA ' ' CG ' ' A' ' 110' ' ' ARG . 0.8 OUTLIER -78.81 -2.26 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.536 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 56.0 m -78.27 -60.28 2.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.168 -0.957 . . . . 0.0 109.863 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.771 ' CD1' HD13 ' A' ' 9' ' ' LEU . 28.3 m-85 -96.46 178.36 5.38 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.14 -0.975 . . . . 0.0 109.863 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.481 ' OD1' ' HD3' ' A' ' 110' ' ' ARG . 1.1 t70 -118.2 -22.46 7.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.348 -0.845 . . . . 0.0 109.756 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.537 ' OH ' ' CG ' ' A' ' 6' ' ' LYS . 5.4 m-85 -112.01 67.09 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.98 -1.075 . . . . 0.0 109.623 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.933 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.1 mt -79.15 91.06 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.286 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.827 HD21 ' CE2' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -112.04 167.14 10.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.972 -1.08 . . . . 0.0 109.478 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.692 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -139.49 166.23 25.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.86 . . . . 0.0 109.06 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.692 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -66.76 133.56 50.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.388 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.82 ' CG ' HG21 ' A' ' 126' ' ' ILE . 5.7 t70 -42.94 110.06 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.68 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.5 -177.35 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.332 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.8 m -89.54 15.58 9.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -82.31 -14.74 54.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.546 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.62 HD21 ' CG2' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -86.49 5.13 36.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.098 -1.002 . . . . 0.0 109.604 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -19.25 65.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -0.96 . . . . 0.0 109.165 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.55 -43.19 4.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.872 . . . . 0.0 109.315 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.56 HD23 ' HZ ' ' A' ' 82' ' ' PHE . 13.0 mt -57.61 -34.04 68.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.304 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -69.19 -32.39 71.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.23 -0.919 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.61 0.98 50.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 109.563 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -81.35 -30.21 33.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.129 -0.982 . . . . 0.0 109.442 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 p -63.76 -16.69 61.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.467 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -84.38 -31.36 24.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.338 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -12.54 43.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.898 . . . . 0.0 109.392 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.759 HG13 ' HG2' ' A' ' 79' ' ' LYS . 62.8 t -77.17 147.37 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.228 -0.92 . . . . 0.0 109.315 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -83.58 112.21 19.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.203 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.14 37.85 27.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 0.0 109.311 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.6 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -43.27 160.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.748 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.6 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 0.0 OUTLIER -150.1 36.36 0.68 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.446 -0.784 . . . . 0.0 109.002 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.941 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -119.36 88.75 2.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.402 -0.811 . . . . 0.0 110.025 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 111' ' ' ALA . 34.9 mtpt -46.13 121.09 3.08 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.62 ' CG2' HD21 ' A' ' 96' ' ' LEU . 1.7 mm -95.96 132.25 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.001 -1.062 . . . . 0.0 110.108 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 31.7 tp10 -159.09 165.54 33.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.462 -0.774 . . . . 0.0 109.649 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.586 ' CD2' HD12 ' A' ' 96' ' ' LEU . 22.3 mt -99.13 158.9 15.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.098 -1.001 . . . . 0.0 109.483 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.944 ' O ' HD11 ' A' ' 126' ' ' ILE . 0.5 OUTLIER -68.75 123.79 21.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 109.337 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.48 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . 140.77 -179.66 19.04 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 0.7 OUTLIER 74.52 36.91 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -1.184 . . . . 0.0 109.421 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.437 ' HB2' ' HD2' ' A' ' 121' ' ' PRO . 26.7 m-85 -125.23 -140.0 0.29 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.336 -0.852 . . . . 0.0 109.164 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.59 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -71.33 -51.02 10.41 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.0 109.726 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.7 Cg_exo -49.99 96.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.761 1.64 . . . . 0.0 110.275 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.418 ' O ' ' HB3' ' A' ' 123' ' ' LYS . 25.0 mt-30 -80.91 -152.67 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.878 . . . . 0.0 109.43 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 124' ' ' GLN . 0.3 OUTLIER 65.78 116.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.491 ' O ' ' CB ' ' A' ' 125' ' ' LEU . 2.0 tt0 -60.28 -150.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.159 -0.963 . . . . 0.0 109.431 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 125' ' ' LEU . 0.2 OUTLIER 73.55 70.23 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.459 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.944 HD11 ' O ' ' A' ' 116' ' ' LEU . 3.7 tt -87.57 177.84 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.18 -0.95 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.48 HG21 HH12 ' A' ' 18' ' ' ARG . 16.0 mt -82.61 98.54 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.933 . . . . 0.0 109.445 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.482 ' HG3' ' OD1' ' A' ' 92' ' ' ASP . 8.9 mt-10 -130.96 55.21 1.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.9 OUTLIER -103.06 164.52 15.35 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.462 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 129' ' ' ASP . 54.9 Cg_endo -72.1 -164.37 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.028 1.819 . . . . 0.0 110.256 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -70.93 -25.56 62.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.331 -0.856 . . . . 0.0 109.479 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.05 -81.15 0.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.532 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 114.31 -145.39 18.53 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -71.32 -83.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -1.135 . . . . 0.0 109.541 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -172.78 -71.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.597 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.94 46.26 1.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 109.566 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.43 ' OD2' ' HB ' ' A' ' 140' ' ' THR . 4.5 t70 -119.05 57.73 0.87 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.469 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -98.63 -25.34 14.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.489 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.675 ' OE2' ' SG ' ' A' ' 62' ' ' CYS . 4.2 tp10 -72.72 -31.28 64.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.325 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 96.1 m -65.45 -19.42 65.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.869 . . . . 0.0 109.494 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.789 HG11 ' HA ' ' A' ' 18' ' ' ARG . 73.1 t -70.37 -70.86 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 0.0 109.228 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.748 ' HA ' HG21 ' A' ' 21' ' ' ILE . 3.2 t80 -48.19 -48.69 34.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.389 -0.82 . . . . 0.0 109.34 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -65.93 0.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.321 -0.862 . . . . 0.0 109.836 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 140' ' ' THR . 3.2 mm-40 -53.93 -19.26 4.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.776 ' SG ' ' HA ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -69.95 -41.94 73.85 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.349 -0.845 . . . . 0.0 109.389 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.867 ' HA ' HG11 ' A' ' 25' ' ' VAL . 15.2 t -52.87 -60.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.314 -0.866 . . . . 0.0 109.929 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.95 -8.99 53.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.727 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.928 ' SG ' HD22 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -69.63 -11.59 60.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.345 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.632 ' SG ' ' CD1' ' A' ' 29' ' ' LEU . 30.2 p -126.26 -41.64 1.89 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.233 -0.917 . . . . 0.0 109.21 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.689 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -58.25 -49.87 75.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 109.002 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.96 -21.54 64.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.458 -0.776 . . . . 0.0 109.236 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.827 ' CE2' HD21 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -90.01 -19.01 24.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.408 -0.808 . . . . 0.0 109.642 -179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.655 HD13 ' HZ ' ' A' ' 26' ' ' PHE . 9.0 tp -83.07 -26.04 31.48 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.03 -1.044 . . . . 0.0 108.748 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 1.0 OUTLIER -69.94 -29.3 66.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 108.997 179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.49 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 2.2 tptt -80.32 -54.72 5.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 108.807 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 152' ' ' PHE . 16.5 m -98.33 45.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 108.891 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.405 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.533 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.295 0.569 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -157.86 53.77 0.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.387 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -142.8 108.76 5.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.453 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.74 147.85 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.549 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.879 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.6 OUTLIER -126.16 83.44 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.485 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.68 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -41.47 163.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.864 . . . . 0.0 109.748 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.593 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 62.4 p -136.62 116.47 13.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.024 . . . . 0.0 109.661 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.779 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -119.41 142.94 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 109.115 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.595 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -140.38 105.43 4.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.341 -0.85 . . . . 0.0 109.424 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -83.27 158.34 22.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.446 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 90' ' ' CYS . 1.9 t -145.63 142.2 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.441 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.658 ' SG ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -162.15 131.89 4.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 13' ' ' LEU . 12.9 tp -43.34 -56.19 3.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.658 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . -87.35 85.06 1.53 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.564 ' ND2' ' HB2' ' A' ' 74' ' ' ALA . 10.4 t30 -89.19 2.77 53.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -1.128 . . . . 0.0 109.548 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.727 HD12 ' C ' ' A' ' 16' ' ' ILE . 2.5 pp -146.86 12.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 109.733 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.44 ' N ' HD12 ' A' ' 16' ' ' ILE . 11.2 t -150.28 -54.89 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.044 -1.035 . . . . 0.0 109.561 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.481 ' HB2' ' HA3' ' A' ' 14' ' ' GLY . 1.0 OUTLIER -43.3 -80.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.429 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.692 ' HB2' HG11 ' A' ' 141' ' ' VAL . 0.3 OUTLIER 167.16 66.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.491 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.18 63.4 8.71 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.175 1.917 . . . . 0.0 110.594 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 25' ' ' VAL . 3.8 mp -90.56 -17.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.013 -1.054 . . . . 0.0 109.732 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.594 ' O ' ' SG ' ' A' ' 149' ' ' CYS . . . -65.27 -32.32 73.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 43' ' ' SER . 1.5 tt0 -77.22 -68.59 0.6 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.156 -0.965 . . . . 0.0 109.375 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.737 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -43.53 -40.54 3.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -0.889 . . . . 0.0 109.193 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.037 HG11 ' HA ' ' A' ' 146' ' ' VAL . 50.0 t -61.29 -53.37 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.38 -0.825 . . . . 0.0 109.158 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.555 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -46.52 -39.68 11.27 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.106 -0.997 . . . . 0.0 108.453 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.456 ' O ' ' OG1' ' A' ' 31' ' ' THR . 11.0 tpt85 -54.9 -60.18 3.71 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.165 -0.959 . . . . 0.0 108.97 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 -10.18 35.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.893 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.831 HD12 HG12 ' A' ' 25' ' ' VAL . 2.7 mt -83.02 -76.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.064 -1.023 . . . . 0.0 108.971 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.893 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -43.45 -46.1 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.34 -0.85 . . . . 0.0 109.298 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -60.25 -42.46 95.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.115 . . . . 0.0 109.433 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -69.38 -16.6 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.131 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 1.9 tp60 -98.2 -9.38 25.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.401 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 2.7 t-20 77.18 48.58 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 109.391 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.893 ' CG1' HG23 ' A' ' 30' ' ' VAL . 2.9 pt -140.82 9.63 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.349 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.622 ' HA ' HG21 ' A' ' 30' ' ' VAL . 6.2 p -69.93 -35.0 74.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.062 -1.024 . . . . 0.0 109.546 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -58.35 -20.35 42.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.646 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.879 ' HA ' HG22 ' A' ' 5' ' ' THR . 11.8 m-20 -124.36 42.98 3.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.695 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.779 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 10.2 m95 -150.04 133.64 16.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.046 -1.034 . . . . 0.0 109.994 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.0 t -117.85 85.71 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.841 . . . . 0.0 108.992 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.646 HD11 HG11 ' A' ' 30' ' ' VAL . 2.2 mp -90.24 139.24 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 5.3 m-20 -150.53 146.58 26.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.427 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.45 ' HB3' ' HG3' ' A' ' 23' ' ' GLU . 74.5 p -116.5 156.76 26.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.53 164.8 32.23 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -104.16 128.06 51.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -1.147 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.702 HG22 HD11 ' A' ' 99' ' ' LEU . 86.2 t -47.47 -34.45 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.64 -177.15 3.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.2 -0.937 . . . . 0.0 109.623 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.506 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 8.0 p-10 -102.43 24.59 10.13 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.299 -0.876 . . . . 0.0 109.457 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 38.9 m0 -65.54 -43.09 91.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.5 ' HB3' HG12 ' A' ' 16' ' ' ILE . 2.2 m-80 -119.91 61.49 0.84 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.148 -0.97 . . . . 0.0 109.753 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.506 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 91.1 t -84.7 102.58 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.236 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.61 10.2 63.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.445 ' HB3' HG21 ' A' ' 16' ' ' ILE . 15.4 mtt85 -82.09 126.25 31.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -1.149 . . . . 0.0 109.449 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -72.22 150.44 92.1 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.515 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.546 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 53.8 Cg_exo -50.1 137.12 37.51 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.928 1.752 . . . . 0.0 110.31 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 60' ' ' VAL . 32.9 p-10 -75.11 127.66 86.23 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.177 -0.952 . . . . 0.0 109.246 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.854 ' HA ' HG23 ' A' ' 60' ' ' VAL . 72.1 Cg_exo -43.85 -23.21 0.57 Allowed 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 122.107 1.871 . . . . 0.0 110.618 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 61' ' ' SER . 0.0 OUTLIER -60.27 -53.46 57.37 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.874 -1.141 . . . . 0.0 108.392 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 61' ' ' SER . . . -76.73 -64.1 1.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.854 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -41.25 -28.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.583 -0.698 . . . . 0.0 109.387 179.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 57' ' ' PRO . 1.7 t -52.7 -53.52 46.45 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.444 -0.785 . . . . 0.0 110.487 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.456 ' C ' HD23 ' A' ' 63' ' ' LEU . 35.0 t -70.29 -17.92 63.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.123 -0.985 . . . . 0.0 110.541 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.763 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -90.14 -75.34 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.96 -1.087 . . . . 0.0 109.418 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' LEU . 3.6 ttt85 -43.62 -26.53 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.324 -0.86 . . . . 0.0 109.624 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -46.23 -66.26 0.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.887 . . . . 0.0 109.406 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' A' ' 63' ' ' LEU . 12.6 p80 -76.33 -36.82 58.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -0.949 . . . . 0.0 109.298 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.03 74.4 0.1 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.757 HD11 ' HA ' ' A' ' 25' ' ' VAL . 6.4 tp -86.53 -12.08 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.214 -1.168 . . . . 0.0 109.237 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.47 ' ND2' ' C ' ' A' ' 68' ' ' ILE . 1.3 p30 40.98 44.88 2.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.518 -0.739 . . . . 0.0 109.811 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.655 HG23 ' H ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -57.02 -76.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 109.515 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.655 ' H ' HG23 ' A' ' 70' ' ' THR . . . 55.49 76.23 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.114 -0.991 . . . . 0.0 109.414 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.557 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.6 p-80 -150.36 157.15 42.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.553 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.27 134.21 54.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 109.406 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.564 ' HB2' ' ND2' ' A' ' 15' ' ' ASN . . . -75.4 163.99 26.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.507 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.5 ' HD2' ' CG1' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -178.56 128.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.327 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.456 ' H ' HG22 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -50.98 142.74 11.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.877 . . . . 0.0 109.59 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.525 HG12 ' CE2' ' A' ' 82' ' ' PHE . 30.0 t -58.57 162.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.511 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.466 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -160.5 161.5 32.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 109.547 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -48.77 -32.27 8.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.313 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 84' ' ' THR . 0.9 OUTLIER -64.8 -49.46 70.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.796 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -66.61 -26.79 67.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 0.0 110.184 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.932 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 42.4 m-85 -68.37 -68.45 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.134 -0.979 . . . . 0.0 109.727 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 110' ' ' ARG . 9.2 p -64.21 -22.02 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.301 -0.874 . . . . 0.0 109.864 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 85' ' ' PHE . 2.5 m -65.42 -71.93 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.126 -0.984 . . . . 0.0 109.527 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.595 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 84.5 m-85 -73.36 163.8 27.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.415 ' OD1' ' HG3' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -112.55 -17.55 12.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.352 -0.843 . . . . 0.0 109.461 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.2 m-85 -119.75 81.32 1.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 109.202 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.883 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 1.4 mt -90.59 112.82 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 0.0 109.074 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -133.34 169.22 17.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.998 -1.064 . . . . 0.0 109.286 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.64 ' SG ' HD12 ' A' ' 99' ' ' LEU . 21.3 m -127.8 177.27 6.94 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.341 -0.849 . . . . 0.0 109.165 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.675 ' HA ' ' HE2' ' A' ' 91' ' ' MET . 16.6 mmt -85.36 47.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.894 ' OD1' HD23 ' A' ' 116' ' ' LEU . 4.2 m-20 54.38 87.86 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 109.465 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.37 158.24 43.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 109.375 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.0 p -71.89 -15.68 62.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.908 . . . . 0.0 109.459 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -72.24 -10.82 60.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 109.52 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.914 HD23 ' HB2' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -68.14 -31.23 70.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.47 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -19.59 4.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 109.439 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -93.81 -31.33 14.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.482 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.914 ' HB2' HD23 ' A' ' 96' ' ' LEU . 15.8 mt -66.6 -34.19 77.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.574 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -64.54 -24.55 67.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.51 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -91.88 -10.34 39.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 109.418 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.941 ' O ' HG23 ' A' ' 106' ' ' VAL . 2.4 mmmm -70.89 -32.99 70.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.892 . . . . 0.0 109.345 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.776 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 14.6 p -62.15 -28.05 69.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -46.68 75.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.355 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -85.02 0.74 50.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.875 . . . . 0.0 109.606 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 102' ' ' LYS . 40.4 t -87.73 121.9 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.314 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 106' ' ' VAL . 9.0 tptt -45.03 99.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.364 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 106' ' ' VAL . 24.4 m120 48.11 58.75 4.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 109.526 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.776 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -53.78 147.24 12.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.327 -0.858 . . . . 0.0 109.793 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.556 ' HB3' HG23 ' A' ' 83' ' ' VAL . 8.6 ptt180 -131.29 2.12 4.21 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.932 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -86.6 118.56 26.09 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 110.151 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 88' ' ' ILE . 5.5 mtpm? -69.49 106.05 2.85 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.803 HG21 ' HB3' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -83.23 137.24 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.994 -1.066 . . . . 0.0 110.084 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.909 ' O ' HD11 ' A' ' 96' ' ' LEU . 1.2 tt0 -176.27 -170.47 0.36 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.49 -0.756 . . . . 0.0 109.057 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.717 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -122.65 118.06 27.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.087 -1.008 . . . . 0.0 109.496 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.905 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER 59.15 -87.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.839 . . . . 0.0 109.504 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' A' ' 119' ' ' TYR . . . 166.04 -175.28 41.62 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.9 p -109.65 64.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -1.174 . . . . 0.0 109.487 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.441 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.9 m-85 -120.16 -140.86 0.34 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.176 -0.952 . . . . 0.0 109.143 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 119' ' ' TYR . 0.2 OUTLIER 169.03 63.07 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.071 -1.018 . . . . 0.0 109.43 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.411 ' HG3' ' HB2' ' A' ' 151' ' ' ALA . 55.2 Cg_endo -71.6 -4.98 16.09 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.048 1.832 . . . . 0.0 110.243 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -161.37 -149.75 0.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.4 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.91 150.35 49.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -76.6 123.59 26.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -166.61 138.1 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.934 . . . . 0.0 109.497 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.575 HG23 ' HB3' ' A' ' 92' ' ' ASP . 10.2 mm -95.35 150.47 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.362 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 92' ' ' ASP . 3.0 mp -106.23 81.62 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.507 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.469 ' HG3' HG22 ' A' ' 126' ' ' ILE . 66.2 mt-10 -121.71 81.85 1.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.431 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 1.4 p30 -158.58 85.35 2.46 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.183 -0.948 . . . . 0.0 109.559 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 132' ' ' TYR . 50.7 Cg_endo -71.08 171.75 15.28 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.959 1.773 . . . . 0.0 110.283 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.424 ' C ' ' O ' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -43.58 96.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -134.21 -47.11 0.77 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.362 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 114.8 84.87 1.25 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.63 -66.61 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -1.142 . . . . 0.0 109.487 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -179.9 89.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.475 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 50.84 34.74 10.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.89 . . . . 0.0 109.455 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.94 79.05 9.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -135.1 -61.25 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -63.39 -45.95 88.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 m -47.23 -33.03 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.42 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 19' ' ' SER . 44.7 t -67.62 -45.86 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.422 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 142' ' ' TYR . 8.7 t80 -57.7 -46.68 84.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 0.0 109.46 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -58.54 -56.43 22.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.16 -0.962 . . . . 0.0 109.344 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.755 ' O ' ' SG ' ' A' ' 148' ' ' CYS . 15.7 mt-30 -64.85 -13.05 54.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 109.417 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.571 ' HA ' ' SG ' ' A' ' 148' ' ' CYS . 3.5 m -83.85 -27.02 29.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.315 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 1.037 ' HA ' HG11 ' A' ' 25' ' ' VAL . 87.6 t -55.14 -53.92 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.279 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.408 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -81.41 -15.86 53.89 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.238 -0.914 . . . . 0.0 109.334 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.905 ' HA ' HD11 ' A' ' 116' ' ' LEU . 5.3 m -50.17 -23.44 2.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 0.0 108.713 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.594 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -122.01 -42.48 2.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.78 . . . . 0.0 109.238 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.484 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . 55.2 ttt-85 -59.19 -49.55 77.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.222 -0.924 . . . . 0.0 109.041 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.411 ' HB2' ' HG3' ' A' ' 121' ' ' PRO . . . -59.24 -19.8 48.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.827 . . . . 0.0 109.07 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.682 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 1.7 t80 -89.44 -25.42 21.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -0.831 . . . . 0.0 109.372 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.728 HD21 HD13 ' A' ' 35' ' ' ILE . 10.1 tp -77.79 -26.72 49.89 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.037 -1.039 . . . . 0.0 108.911 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 2.5 pt-20 -67.8 -30.39 69.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -0.968 . . . . 0.0 109.105 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.506 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -79.93 -51.34 9.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.89 . . . . 0.0 109.043 179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.682 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 15.4 m -99.2 42.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.851 . . . . 0.0 108.995 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.459 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.452 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -81.36 -169.14 2.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.912 . . . . 0.0 109.409 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.96 87.75 2.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 38' ' ' ASN . 12.2 p -71.75 157.09 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.607 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.957 HG22 ' HA ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -149.67 75.94 1.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 109.223 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.663 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 22.3 mttp -51.46 -178.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 0.0 109.695 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.499 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 48.8 m -147.17 116.76 7.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.4 -0.813 . . . . 0.0 109.158 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.695 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -124.03 150.99 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -0.885 . . . . 0.0 109.075 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.697 HD22 HG12 ' A' ' 88' ' ' ILE . 1.0 OUTLIER -149.16 108.65 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.156 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.51 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 1.9 m-85 -81.52 157.38 24.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.895 HG11 HD11 ' A' ' 99' ' ' LEU . 59.5 t -138.8 149.87 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.883 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -169.04 133.4 1.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.415 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.619 HD11 ' CH2' ' A' ' 49' ' ' TRP . 13.4 tp -44.74 -61.76 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.87 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 15' ' ' ASN . . . -49.58 -88.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.865 ' O ' HG23 ' A' ' 16' ' ' ILE . 20.6 t30 76.69 17.82 1.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -1.102 . . . . 0.0 109.6 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.865 HG23 ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER -169.1 -71.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 4.8 p -76.72 -26.84 55.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.449 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 19' ' ' SER . 25.8 ttm180 -62.18 -13.13 24.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.249 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 18' ' ' ARG . 7.3 m 68.48 60.72 0.68 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.293 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 19' ' ' SER . 40.9 Cg_endo -69.35 81.33 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.965 1.777 . . . . 0.0 110.458 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.992 ' O ' HG23 ' A' ' 25' ' ' VAL . 6.8 mm -83.44 -15.61 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.87 . . . . 0.0 109.34 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.769 ' HB1' ' HB3' ' A' ' 148' ' ' CYS . . . -63.99 -51.65 63.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.132 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -60.34 -58.71 7.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 108.933 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.871 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -44.57 -38.0 3.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -0.849 . . . . 0.0 108.884 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.992 HG23 ' O ' ' A' ' 21' ' ' ILE . 70.4 t -60.32 -56.51 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.247 -0.908 . . . . 0.0 108.831 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.636 ' N ' ' SG ' ' A' ' 149' ' ' CYS . 0.4 OUTLIER -43.58 -32.19 0.89 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -62.82 -52.88 61.44 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.356 -0.84 . . . . 0.0 108.853 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' HG3' HD13 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -63.29 -58.28 7.67 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.21 -0.931 . . . . 0.0 109.663 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.636 HD12 ' SG ' ' A' ' 149' ' ' CYS . 29.9 mt -43.47 -66.91 0.32 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.291 -0.881 . . . . 0.0 109.761 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.967 HG22 ' HA ' ' A' ' 36' ' ' SER . 3.0 p -58.8 -24.78 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.355 -0.841 . . . . 0.0 109.995 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 31' ' ' THR . 14.4 m -99.8 30.7 3.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.553 -1.342 . . . . 0.0 109.262 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -149.69 46.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.62 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -179.24 32.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -0.812 . . . . 0.0 109.041 -179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 33' ' ' GLN . 9.8 m120 46.7 42.08 11.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.826 HG12 HG23 ' A' ' 30' ' ' VAL . 1.7 tt -130.64 -5.38 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.247 0.546 . . . . 0.0 109.779 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.967 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -74.26 -33.27 63.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.937 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -76.08 1.79 14.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.919 . . . . 0.0 109.64 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.957 ' HA ' HG22 ' A' ' 5' ' ' THR . 23.7 m-20 -128.8 37.91 4.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.156 -0.965 . . . . 0.0 109.785 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.695 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 18.2 m95 -150.62 139.89 21.28 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.853 -1.154 . . . . 0.0 110.899 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.451 HG12 ' CE2' ' A' ' 85' ' ' PHE . 44.1 t -112.04 73.62 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.495 ' CG1' HG13 ' A' ' 8' ' ' VAL . 2.9 mt -89.91 140.42 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.39 -0.819 . . . . 0.0 109.862 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 14.7 t0 -149.06 -168.27 3.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.477 -0.764 . . . . 0.0 109.175 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.411 ' OG ' ' OD1' ' A' ' 15' ' ' ASN . 29.6 t -134.48 169.96 16.49 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.155 -0.966 . . . . 0.0 109.691 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.78 153.85 25.55 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.13 -18.43 6.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -1.142 . . . . 0.0 109.714 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.673 ' O ' HG12 ' A' ' 46' ' ' VAL . 58.1 t 56.98 17.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.381 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.578 ' HB3' ' CZ2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -145.26 144.71 30.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.299 -0.875 . . . . 0.0 109.413 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.487 ' HA ' HG23 ' A' ' 51' ' ' VAL . 5.0 m-20 -91.65 32.63 1.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -0.879 . . . . 0.0 109.466 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.619 ' CH2' HD11 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -97.19 -33.95 11.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 109.331 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 11.8 m-20 -125.43 46.78 2.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.639 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.843 HG13 ' HA ' ' A' ' 75' ' ' ARG . 89.8 t -71.95 85.68 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.353 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.47 ' HA2' ' CG ' ' A' ' 73' ' ' LYS . . . 115.96 -6.44 19.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.523 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 2.5 mtt85 -76.55 96.25 4.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -1.113 . . . . 0.0 109.599 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.804 ' O ' HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -50.91 -179.36 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.123 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.575 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 61.5 Cg_exo -49.59 133.8 32.45 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.833 1.689 . . . . 0.0 110.239 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.579 ' OD1' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -43.76 145.3 1.22 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.465 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' VAL . 53.9 Cg_exo -50.09 -21.1 6.08 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.941 1.76 . . . . 0.0 110.386 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 34.2 mtt-85 -83.04 -50.41 8.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.758 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 1.04 ' O ' HD12 ' A' ' 63' ' ' LEU . . . -90.25 11.98 19.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.177 -0.952 . . . . 0.0 110.077 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.598 HG13 ' N ' ' A' ' 61' ' ' SER . 7.3 p -90.01 -49.14 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.042 -1.036 . . . . 0.0 109.607 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.598 ' N ' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -91.53 -29.84 16.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.132 -0.98 . . . . 0.0 109.682 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.9 m -90.17 20.38 4.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.04 HD12 ' O ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -64.68 102.47 0.58 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.772 -1.205 . . . . 0.0 108.412 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.596 ' HG3' ' CE1' ' A' ' 142' ' ' TYR . 0.2 OUTLIER 59.36 15.56 4.46 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.741 -178.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 64' ' ' ARG . 5.1 p30 35.29 100.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.008 0.908 . . . . 0.0 111.086 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 57.91 24.44 10.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 0.0 109.902 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.518 ' HA3' ' NE ' ' A' ' 64' ' ' ARG . . . -128.09 -4.66 5.46 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.932 HG21 ' CD2' ' A' ' 63' ' ' LEU . 25.2 mm -148.0 156.94 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.176 -1.19 . . . . 0.0 109.698 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.466 ' N ' HG22 ' A' ' 68' ' ' ILE . 2.5 m-80 -141.51 83.52 1.87 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.244 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.59 HG21 HD13 ' A' ' 63' ' ' LEU . 26.1 p -70.3 159.88 33.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.62 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -169.1 28.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.247 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.535 ' CD2' ' N ' ' A' ' 73' ' ' LYS . 8.7 t60 -124.27 157.75 34.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.36 -0.838 . . . . 0.0 109.254 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.535 ' N ' ' CD2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -89.71 -147.24 0.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -0.964 . . . . 0.0 109.532 -179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 75' ' ' ARG . . . -137.75 -81.78 0.34 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.544 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.843 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 75.08 113.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -0.953 . . . . 0.0 109.392 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.647 ' H ' HG22 ' A' ' 51' ' ' VAL . 2.3 tt0 -43.68 143.05 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.428 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.606 HG23 ' H ' ' A' ' 46' ' ' VAL . 5.0 t -57.68 164.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -169.19 165.9 10.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.353 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.595 ' CG ' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -43.61 -31.88 0.85 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.491 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' OG1' ' A' ' 84' ' ' THR . 36.4 tt0 -59.41 -57.22 13.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.293 -0.88 . . . . 0.0 109.616 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.516 ' HB3' HD13 ' A' ' 9' ' ' LEU . 6.6 m-20 -66.11 -17.71 64.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.185 -0.947 . . . . 0.0 109.87 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.764 ' CD2' HG21 ' A' ' 106' ' ' VAL . 10.5 m-85 -70.47 -74.78 0.13 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.047 -1.033 . . . . 0.0 109.308 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.525 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 7.4 p -61.49 -24.2 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.458 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 5.8 m -64.45 -73.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.97 . . . . 0.0 109.448 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.622 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 57.1 m-85 -75.98 154.83 35.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.681 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 112' ' ' LYS . 63.3 m-20 -108.71 -16.62 14.14 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.421 -0.799 . . . . 0.0 109.485 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.563 ' CE2' ' HD3' ' A' ' 6' ' ' LYS . 22.9 m-85 -118.25 67.74 0.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.903 . . . . 0.0 109.64 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.917 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.1 mt -79.61 93.91 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.316 -0.865 . . . . 0.0 109.077 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -106.04 178.88 4.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 109.502 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.691 ' SG ' ' HB ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -132.88 176.82 8.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.346 -0.846 . . . . 0.0 109.41 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.688 ' O ' HG23 ' A' ' 127' ' ' ILE . 1.5 mmt -85.35 45.08 1.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.915 . . . . 0.0 109.594 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.693 ' HB3' HG23 ' A' ' 126' ' ' ILE . 0.7 OUTLIER 54.71 106.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.279 -0.888 . . . . 0.0 109.602 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -177.24 155.2 1.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.492 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -7.95 36.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -66.61 -16.05 63.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.449 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.564 HD21 HG22 ' A' ' 113' ' ' ILE . 0.3 OUTLIER -64.51 -22.31 66.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.902 . . . . 0.0 109.537 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -55.55 -24.22 31.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -89.13 -43.35 11.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.364 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.895 HD11 HG11 ' A' ' 11' ' ' VAL . 9.2 mt -67.92 -13.23 61.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.65 -32.39 23.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -96.39 16.28 18.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.961 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -104.0 -19.37 14.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.472 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.56 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 96.5 p -71.06 -45.96 62.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.524 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.476 ' OD1' ' HG2' ' A' ' 105' ' ' GLN . 19.1 p-10 -62.18 -29.38 70.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.519 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.476 ' HG2' ' OD1' ' A' ' 104' ' ' ASN . 1.4 mm-40 -87.72 -15.24 37.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.949 . . . . 0.0 109.379 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 102' ' ' LYS . 25.6 t -71.36 150.18 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.261 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 108' ' ' ASN . 3.2 tptt -71.92 87.16 1.01 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.271 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 107' ' ' LYS . 50.3 t30 68.28 45.42 1.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.953 . . . . 0.0 109.485 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -56.76 149.69 17.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 0.0 109.817 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.525 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 1.9 ptm180 -138.75 9.73 2.63 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.917 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -86.34 91.79 8.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.432 -0.792 . . . . 0.0 110.404 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 0.6 OUTLIER -47.95 122.31 4.96 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.635 HD13 ' O ' ' A' ' 111' ' ' ALA . 1.3 mm -95.54 140.6 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.817 -1.177 . . . . 0.0 110.281 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 1.2 tt0 -168.61 -177.74 3.22 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -125.31 156.73 38.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.065 -1.022 . . . . 0.0 109.634 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.684 ' CD2' ' SG ' ' A' ' 148' ' ' CYS . 0.5 OUTLIER -43.69 -26.64 0.25 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . -63.2 89.26 0.06 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER 170.38 -35.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -1.117 . . . . 0.0 109.461 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.447 ' CD2' ' HA ' ' A' ' 152' ' ' PHE . 22.9 m-85 -105.91 76.04 1.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 109.433 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.462 ' OD1' ' HB3' ' A' ' 123' ' ' LYS . 2.1 m-20 -143.18 84.12 10.58 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.897 . . . . 0.0 109.622 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -50.18 -36.13 45.13 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.996 1.797 . . . . 0.0 110.237 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 122' ' ' GLN . 8.5 pt20 -155.44 68.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.429 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.462 ' HB3' ' OD1' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -169.97 128.86 0.92 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 109.305 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.93 95.62 3.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.326 -0.859 . . . . 0.0 109.466 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.14 -43.3 0.56 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.257 -0.902 . . . . 0.0 109.568 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.716 HG22 ' HG3' ' A' ' 128' ' ' GLU . 28.1 mm 57.51 102.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 109.461 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 91' ' ' MET . 4.6 tt -77.05 96.57 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.517 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.716 ' HG3' HG22 ' A' ' 126' ' ' ILE . 21.4 mt-10 -119.17 39.04 3.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 109.425 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -72.93 146.94 88.19 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 109.478 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -72.14 -175.38 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.957 1.771 . . . . 0.0 110.201 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.535 ' O ' ' CD1' ' A' ' 131' ' ' TYR . 40.6 t80 -68.7 -13.23 62.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.398 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -92.15 -28.93 16.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.85 176.59 43.65 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -79.96 -56.46 4.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -1.144 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.42 -71.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.872 . . . . 0.0 109.487 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.56 42.59 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.873 . . . . 0.0 109.494 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -82.9 74.89 9.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.577 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.735 ' O ' HG12 ' A' ' 141' ' ' VAL . 3.9 t80 -130.54 -39.25 1.29 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.89 . . . . 0.0 109.477 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -80.65 -47.32 14.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.21 -0.932 . . . . 0.0 109.383 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.3 m -64.84 -40.39 95.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.386 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.761 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 8.7 p -52.33 -27.22 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.596 ' CE1' ' HG3' ' A' ' 64' ' ' ARG . 3.1 t80 -83.52 -47.89 10.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 0.0 109.356 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -49.81 -53.63 24.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.74 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HG3' ' N ' ' A' ' 145' ' ' CYS . 0.9 OUTLIER -73.94 -23.27 59.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.812 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.761 ' SG ' ' O ' ' A' ' 141' ' ' VAL . 1.8 m -68.07 -20.35 64.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.572 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.68 ' HA ' HG11 ' A' ' 25' ' ' VAL . 55.5 t -64.38 -70.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -0.953 . . . . 0.0 109.354 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.722 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 2.1 mtt-85 -63.5 -16.71 61.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.184 -0.948 . . . . 0.0 109.354 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.769 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -46.3 -31.07 2.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.119 -0.988 . . . . 0.0 109.094 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.771 ' SG ' HG12 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -116.85 -30.99 5.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -0.873 . . . . 0.0 109.144 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.523 ' HB2' ' CD1' ' A' ' 29' ' ' LEU . 67.8 ttt-85 -71.68 -56.25 6.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 108.964 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.722 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -50.83 -32.14 19.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.427 -0.796 . . . . 0.0 109.234 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.891 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 1.1 t80 -79.12 -33.21 44.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.419 -0.801 . . . . 0.0 109.384 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.7 tp -67.22 -18.29 65.17 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.148 -0.97 . . . . 0.0 108.755 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 49.2 mm-40 -68.67 -63.6 1.03 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.363 -0.836 . . . . 0.0 108.832 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -53.13 -47.59 68.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 108.826 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.891 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 18.5 m -98.12 51.35 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 108.838 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 154' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.358 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.583 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 29.0 mt-10 60.09 92.52 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.473 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.71 119.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 6' ' ' LYS . 1.8 t -120.45 26.6 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.404 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.938 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -47.71 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.842 . . . . 0.0 109.6 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.691 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -47.14 175.01 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.225 -0.922 . . . . 0.0 109.584 179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.581 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 1.4 m -149.62 105.88 3.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.235 -0.916 . . . . 0.0 109.43 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.983 HG11 ' CE2' ' A' ' 26' ' ' PHE . 2.0 p -111.5 138.92 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.248 -0.908 . . . . 0.0 110.202 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.668 HD22 ' CD1' ' A' ' 88' ' ' ILE . 0.5 OUTLIER -133.76 129.37 36.54 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.56 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 1.3 m-85 -110.41 155.57 22.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 110.036 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.758 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 40.0 t -144.29 145.67 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.395 -0.816 . . . . 0.0 109.252 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.781 ' SG ' ' HG2' ' A' ' 91' ' ' MET . 2.9 m -163.74 48.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.097 -1.002 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.672 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.7 OUTLIER 42.47 -95.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.427 -0.795 . . . . 0.0 109.577 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . -60.37 89.09 0.03 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.422 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 4.5 t-20 -90.28 26.97 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -1.114 . . . . 0.0 109.457 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 53' ' ' ARG . 1.2 pp -122.63 -8.34 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.39 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -161.09 151.32 17.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.455 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.611 ' HD3' HD11 ' A' ' 127' ' ' ILE . 0.0 OUTLIER 51.96 63.17 2.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 162.44 -51.1 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.86 . . . . 0.0 109.823 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 19' ' ' SER . 66.1 Cg_exo -48.61 -21.94 3.9 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.909 1.739 . . . . 0.0 110.529 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.962 HG21 ' HA ' ' A' ' 142' ' ' TYR . 3.6 mm -66.59 -49.15 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.061 -1.025 . . . . 0.0 109.21 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.568 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -62.14 -18.29 60.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.137 -0.977 . . . . 0.0 109.272 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ALA . 18.3 tt0 -81.07 -82.08 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 109.41 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -44.23 -33.2 1.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.993 . . . . 0.0 109.357 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.839 HG11 ' HA ' ' A' ' 146' ' ' VAL . 44.3 t -65.72 -49.72 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.858 . . . . 0.0 109.426 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.983 ' CE2' HG11 ' A' ' 8' ' ' VAL . 1.1 t80 -53.43 -39.96 64.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.946 -1.096 . . . . 0.0 108.346 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -51.53 -67.16 0.27 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.282 -0.887 . . . . 0.0 108.961 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.496 ' HA ' ' OG1' ' A' ' 31' ' ' THR . 28.9 tttt -73.15 -0.32 13.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.54 -0.725 . . . . 0.0 110.009 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.953 HD21 ' HB2' ' A' ' 150' ' ' ARG . 46.3 tp -85.32 -33.33 22.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.121 -0.987 . . . . 0.0 109.011 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.884 HG12 ' CE1' ' A' ' 26' ' ' PHE . 2.0 m -90.34 -31.05 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.977 HG23 ' CB ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -66.19 -33.04 74.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.662 -0.649 . . . . 0.0 109.348 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -66.84 -19.91 65.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 108.99 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.516 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 6.6 mm-40 -100.53 -3.01 31.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.434 -0.791 . . . . 0.0 109.531 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.9 OUTLIER 76.74 45.78 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.701 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.738 ' CD1' HD21 ' A' ' 153' ' ' LEU . 4.1 pt -137.41 3.24 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 0.0 109.942 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.977 ' CB ' HG23 ' A' ' 31' ' ' THR . 4.3 p -72.04 -30.77 65.51 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.928 -1.108 . . . . 0.0 109.48 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -60.62 -13.99 17.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.331 -0.855 . . . . 0.0 109.277 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.938 ' HA ' HG22 ' A' ' 5' ' ' THR . 6.2 m-20 -129.01 48.15 2.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.671 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.691 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 5.7 m95 -150.11 143.43 25.08 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.888 -1.133 . . . . 0.0 110.666 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 t -117.54 81.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.67 HD11 HG11 ' A' ' 30' ' ' VAL . 3.5 mt -89.91 137.79 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 0.0 109.724 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -164.89 117.38 1.23 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.428 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' PHE . 1.3 p -82.76 -171.62 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.965 . . . . 0.0 109.377 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.521 ' HA3' ' CG2' ' A' ' 77' ' ' VAL . . . -178.87 166.5 36.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.811 ' HB1' ' ND2' ' A' ' 50' ' ' ASN . . . -97.21 -167.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.321 -1.106 . . . . 0.0 109.289 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.672 HG23 ' H ' ' A' ' 13' ' ' LEU . 38.5 t -121.2 -12.75 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.113 -0.992 . . . . 0.0 109.346 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 49' ' ' TRP . 0.1 OUTLIER -125.8 -153.66 0.58 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.267 -0.896 . . . . 0.0 109.526 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.687 ' HA ' HG23 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -119.85 -21.93 7.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.265 -0.897 . . . . 0.0 109.438 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.503 ' HZ2' HD21 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -54.9 -18.35 4.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.564 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.811 ' ND2' ' HB1' ' A' ' 45' ' ' ALA . 13.0 p30 -115.26 42.11 2.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.896 HG13 ' HD3' ' A' ' 75' ' ' ARG . 70.4 t -101.72 114.79 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -0.914 . . . . 0.0 109.523 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.0 -6.99 83.23 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 16' ' ' ILE . 6.6 mtt180 -72.43 103.32 3.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -1.135 . . . . 0.0 109.507 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.1 p -59.82 154.64 46.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.537 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -51.04 158.77 3.0 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.974 1.783 . . . . 0.0 110.323 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.545 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -74.26 157.83 86.15 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.419 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.513 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 53.4 Cg_endo -71.87 -3.14 12.62 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.949 1.766 . . . . 0.0 110.256 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -89.49 -47.63 7.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB1' HD11 ' A' ' 21' ' ' ILE . . . -84.61 -16.77 40.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.454 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.513 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 9.8 p -65.09 -32.8 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.522 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.41 -10.17 54.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.4 m -80.82 -21.93 40.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.679 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -90.21 -66.66 0.9 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.027 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.9 ttm180 -47.33 -24.27 0.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.39 -0.819 . . . . 0.0 109.539 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -71.93 0.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -66.93 -8.79 32.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 109.644 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.8 69.3 0.81 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.597 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 10.3 mm -109.42 160.8 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.323 -1.104 . . . . 0.0 109.458 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.498 ' N ' HG22 ' A' ' 68' ' ' ILE . 3.4 m120 -129.51 102.44 6.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.395 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.546 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -116.24 147.22 41.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.59 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -150.58 36.73 0.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.206 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -119.03 125.4 49.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.341 -0.85 . . . . 0.0 109.541 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -93.21 38.05 1.04 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.412 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 73' ' ' LYS . . . 65.94 169.54 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.898 . . . . 0.0 109.5 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.896 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 168.06 152.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -82.35 129.85 34.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.521 ' CG2' ' HA3' ' A' ' 44' ' ' GLY . 42.8 t -71.0 103.15 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 65.9 p -72.12 -164.68 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 0.0 109.095 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.878 ' HB2' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -86.29 -23.87 26.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.042 -1.036 . . . . 0.0 109.257 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 84' ' ' THR . 20.1 tt0 -65.46 -33.08 75.11 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.407 -0.808 . . . . 0.0 108.845 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -68.16 -17.86 64.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.39 -0.818 . . . . 0.0 108.975 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.827 ' CA ' ' HB2' ' A' ' 111' ' ' ALA . 32.1 m-85 -82.49 -65.24 1.03 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.364 -0.835 . . . . 0.0 109.208 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.528 HG23 ' HB3' ' A' ' 110' ' ' ARG . 9.5 p -62.76 -19.17 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.217 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' GLU . 14.1 m -78.66 -67.47 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.0 109.244 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.579 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 53.3 m-85 -68.81 135.42 51.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.219 -0.926 . . . . 0.0 109.452 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -78.17 -23.63 47.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.919 . . . . 0.0 109.295 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 7' ' ' SER . 6.9 m-85 -115.6 147.58 40.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.898 . . . . 0.0 109.539 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.859 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -156.82 95.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.366 -0.834 . . . . 0.0 108.832 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.658 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -114.1 156.88 23.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 109.749 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.508 ' HB2' HD12 ' A' ' 99' ' ' LEU . 36.1 t -124.6 146.48 49.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.476 -0.765 . . . . 0.0 109.059 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.781 ' HG2' ' SG ' ' A' ' 12' ' ' CYS . 20.4 mmt -42.91 150.71 0.15 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.69 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.512 ' OD1' HD12 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -45.16 -24.68 0.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 128' ' ' GLU . 9.5 mt-10 -41.29 -89.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.336 -0.852 . . . . 0.0 109.589 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 96' ' ' LEU . 39.2 p -79.41 83.09 5.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.246 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.811 ' HB2' HD22 ' A' ' 115' ' ' LEU . 17.3 p-10 -52.3 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.569 -0.707 . . . . 0.0 109.605 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.992 HD21 HG21 ' A' ' 113' ' ' ILE . 0.3 OUTLIER 41.56 27.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.625 -0.672 . . . . 0.0 109.9 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -90.28 -29.71 17.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.547 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.48 -38.63 7.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.514 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 90' ' ' CYS . 8.9 mt -67.05 -37.06 83.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.645 ' HB2' HD22 ' A' ' 96' ' ' LEU . 29.7 t30 -57.18 -19.49 20.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -89.73 -32.74 16.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.439 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.717 ' O ' HG23 ' A' ' 106' ' ' VAL . 9.5 mmmt -59.02 -32.88 70.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.882 . . . . 0.0 109.353 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 t -68.31 -31.59 71.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.284 -0.885 . . . . 0.0 109.244 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -61.09 -32.05 71.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -90.93 -11.28 39.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 109.302 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.878 HG22 ' HB2' ' A' ' 79' ' ' LYS . 81.5 t -86.08 140.73 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.548 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.75 119.35 23.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.342 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 109' ' ' CYS . 1.5 m-20 50.99 40.0 24.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.142 -0.974 . . . . 0.0 109.179 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -42.77 138.71 1.86 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.365 -0.834 . . . . 0.0 109.92 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.567 ' CB ' ' CZ ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -125.13 -5.12 7.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.806 . . . . 0.0 109.063 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.859 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -62.86 93.1 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.85 . . . . 0.0 110.207 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 86' ' ' ASP . 11.7 ttmt -46.29 106.48 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.992 HG21 HD21 ' A' ' 96' ' ' LEU . 2.9 mm -83.29 164.74 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.046 -1.034 . . . . 0.0 110.956 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.564 ' HB3' HD23 ' A' ' 89' ' ' LEU . 4.1 mt-10 176.47 -176.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.811 HD22 ' HB2' ' A' ' 95' ' ' ASN . 1.2 pp -141.49 138.75 33.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 0.0 109.84 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.739 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.4 OUTLIER -53.37 119.96 5.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.0 109.449 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -157.2 -159.84 9.76 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -58.58 114.36 2.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.477 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 2.0 m-85 -112.45 -17.83 12.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.583 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 163.84 -51.68 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.605 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 58.3 Cg_exo -49.26 164.41 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.698 1.599 . . . . 0.0 110.2 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -96.2 143.33 27.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 51.69 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.444 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.492 ' O ' ' C ' ' A' ' 125' ' ' LEU . 3.9 tp60 -104.64 12.96 32.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -0.937 . . . . 0.0 109.594 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.492 ' C ' ' O ' ' A' ' 124' ' ' GLN . 14.6 tp 33.47 81.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.169 0.509 . . . . 0.0 110.514 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.512 HD12 ' OD1' ' A' ' 92' ' ' ASP . 13.4 mm -48.15 143.61 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 109.201 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.612 ' O ' HG23 ' A' ' 127' ' ' ILE . 2.1 tt -119.9 95.3 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.565 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 92' ' ' ASP . 94.4 mt-10 -121.86 69.2 0.93 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.432 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -114.73 144.9 32.79 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.505 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.91 -91.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.034 1.823 . . . . 0.0 110.278 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.495 ' O ' ' CG ' ' A' ' 131' ' ' TYR . 32.5 t80 -166.32 50.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.329 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.76 109.88 4.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.33 145.91 16.41 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -110.44 -28.7 8.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.39 -1.065 . . . . 0.0 109.371 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.439 ' OD1' ' CB ' ' A' ' 137' ' ' ASP . 2.6 p30 -91.71 17.8 8.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 45.47 49.55 10.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.439 ' CB ' ' OD1' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -79.98 79.05 6.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.47 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.415 ' CZ ' ' N ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -113.93 -10.05 12.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.499 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.46 -45.57 21.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 7.7 m -57.52 -25.35 59.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.37 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 18' ' ' ARG . 45.3 t -76.96 -36.46 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.962 ' HA ' HG21 ' A' ' 21' ' ' ILE . 4.7 t80 -64.37 -43.81 93.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.422 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -71.06 -48.95 49.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.66 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 148' ' ' CYS . 0.0 OUTLIER -59.33 -21.41 59.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.627 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.76 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.5 m -72.14 -32.6 67.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.839 ' HA ' HG11 ' A' ' 25' ' ' VAL . 77.7 t -49.49 -51.73 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.938 . . . . 0.0 109.289 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.448 ' HA ' ' HB3' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -77.68 -27.59 50.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.424 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.749 ' SG ' ' HA ' ' A' ' 145' ' ' CYS . 67.6 m -44.21 -26.61 0.33 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.138 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.601 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -115.11 -28.75 6.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.226 -0.921 . . . . 0.0 109.452 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.953 ' HB2' HD21 ' A' ' 29' ' ' LEU . 30.9 ttt85 -71.04 -59.2 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 108.99 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -49.43 -22.22 1.12 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.388 -0.82 . . . . 0.0 109.611 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.658 ' CE2' HD11 ' A' ' 89' ' ' LEU . 1.3 t80 -90.19 -34.98 15.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 110.061 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.738 HD21 ' CD1' ' A' ' 35' ' ' ILE . 11.2 tp -67.28 -46.47 73.51 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.807 -1.183 . . . . 0.0 109.16 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 157' ' ' ARG . 11.4 pt-20 -49.87 -38.23 34.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.069 -1.019 . . . . 0.0 108.638 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 0.0 OUTLIER -59.98 -60.53 3.68 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.493 HG11 ' CE1' ' A' ' 87' ' ' TYR . 31.8 m -92.17 31.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.35 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.363 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.272 0.558 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -109.39 77.07 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -47.85 136.77 10.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.415 ' C ' ' OD1' ' A' ' 38' ' ' ASN . 59.5 t -117.01 148.77 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.478 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.781 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -87.93 75.95 8.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.684 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -41.33 153.04 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.759 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.586 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -133.23 117.29 17.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.082 -1.012 . . . . 0.0 109.579 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.719 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.4 OUTLIER -121.41 154.99 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.927 . . . . 0.0 109.591 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -149.99 106.53 3.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -0.868 . . . . 0.0 109.184 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.918 ' CE1' HD13 ' A' ' 89' ' ' LEU . 1.9 m-85 -88.41 155.15 19.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.777 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.518 ' O ' ' CB ' ' A' ' 90' ' ' CYS . 2.0 t -145.94 149.83 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.324 -0.86 . . . . 0.0 109.232 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -166.35 154.0 9.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.539 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.7 tp -55.63 -67.12 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.33 -0.856 . . . . 0.0 109.478 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.02 78.92 1.5 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.643 ' ND2' ' HB2' ' A' ' 45' ' ' ALA . 42.5 p-10 -92.2 43.46 1.13 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -1.159 . . . . 0.0 109.419 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.848 HD12 ' H ' ' A' ' 17' ' ' CYS . 1.1 pp -132.88 -31.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.233 -0.917 . . . . 0.0 109.949 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.848 ' H ' HD12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -148.46 12.5 0.92 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.913 -1.117 . . . . 0.0 110.257 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.497 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 7.5 ttt-85 -125.35 -52.33 1.62 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.057 -1.027 . . . . 0.0 109.472 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.653 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -80.0 -44.35 1.48 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 110.949 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 19' ' ' SER . 73.5 Cg_exo -46.72 -17.0 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.99 1.793 . . . . 0.0 112.313 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.004 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -74.74 -45.33 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 120.336 -1.478 . . . . 0.0 108.894 179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.681 ' HB2' ' HA ' ' A' ' 145' ' ' CYS . . . -67.8 -42.98 80.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.01 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.432 ' CD ' ' HB2' ' A' ' 43' ' ' SER . 4.3 tt0 -58.59 -58.57 7.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 108.764 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.72 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -46.02 -36.87 6.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.327 -0.858 . . . . 0.0 108.841 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 21' ' ' ILE . 16.5 t -63.03 -52.12 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.274 -0.891 . . . . 0.0 108.952 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.656 ' CE2' HG11 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -52.53 -21.47 3.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -56.06 7.09 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 28' ' ' LYS . 5.1 tttt -78.07 1.43 21.06 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.874 HD21 ' HG3' ' A' ' 150' ' ' ARG . 9.9 tp -94.22 -36.14 12.15 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.921 HG22 ' HA ' ' A' ' 36' ' ' SER . 4.1 p -91.07 -14.66 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.4 m -99.1 17.28 20.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.914 -1.116 . . . . 0.0 109.521 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.96 55.39 1.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -0.867 . . . . 0.0 108.993 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.572 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 3.2 tp60 173.47 31.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.559 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.468 ' C ' ' O ' ' A' ' 33' ' ' GLN . 0.3 OUTLIER 45.34 39.47 4.42 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -178.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.874 HG12 HG23 ' A' ' 30' ' ' VAL . 2.3 tt -124.68 -6.54 6.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.53 -177.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.921 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -75.53 -22.23 57.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -0.892 . . . . 0.0 109.798 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -88.45 26.9 1.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.152 -0.968 . . . . 0.0 109.19 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.781 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.7 OUTLIER -159.06 40.19 0.22 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.323 -0.861 . . . . 0.0 109.396 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.719 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 14.4 m95 -150.14 156.62 41.97 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.956 -1.09 . . . . 0.0 111.121 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.38 72.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.551 HG13 ' CG1' ' A' ' 8' ' ' VAL . 2.8 mt -89.66 129.56 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.397 -0.814 . . . . 0.0 110.395 -178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . 5.6 t0 -144.95 147.74 33.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.446 -0.783 . . . . 0.0 108.955 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.432 ' HB2' ' CD ' ' A' ' 23' ' ' GLU . 0.5 OUTLIER -120.17 159.23 25.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.035 -1.041 . . . . 0.0 109.75 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.68 179.47 39.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.643 ' HB2' ' ND2' ' A' ' 15' ' ' ASN . . . -104.11 145.6 29.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -1.119 . . . . 0.0 109.401 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.451 HG22 ' CD1' ' A' ' 99' ' ' LEU . 70.8 t -57.1 -35.2 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.92 -164.11 1.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.436 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.495 ' HA ' HG23 ' A' ' 51' ' ' VAL . 1.6 m-20 -92.43 57.59 3.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.902 . . . . 0.0 109.474 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -89.03 -33.9 16.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.338 -0.851 . . . . 0.0 109.336 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.466 ' HB2' ' OD1' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -146.98 47.95 1.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.361 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 48' ' ' ASP . 76.2 t -58.86 112.08 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA2' ' HG3' ' A' ' 73' ' ' LYS . . . 51.43 51.36 37.63 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 54' ' ' SER . 7.8 mtt180 -95.98 18.47 13.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -1.192 . . . . 0.0 109.389 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 53' ' ' ARG . 0.7 OUTLIER 58.53 151.93 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.62 -0.675 . . . . 0.0 109.631 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.17 128.22 13.62 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 121.98 1.787 . . . . 0.0 110.186 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 17' ' ' CYS . 55.5 m-20 -48.02 154.91 0.93 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.515 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.518 ' O ' HG12 ' A' ' 60' ' ' VAL . 55.5 Cg_endo -71.7 -4.77 15.71 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.024 1.816 . . . . 0.0 110.306 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -62.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.25 -18.38 65.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 109.4 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.594 HG22 ' HD2' ' A' ' 64' ' ' ARG . 9.8 p -63.96 -41.45 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.179 -0.951 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.515 ' N ' HG13 ' A' ' 60' ' ' VAL . 8.8 p -77.02 -3.31 38.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.665 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.485 ' C ' HD23 ' A' ' 63' ' ' LEU . 1.7 t -90.14 -33.02 16.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.41 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.798 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.38 -55.07 3.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.274 -0.892 . . . . 0.0 109.207 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.594 ' HD2' HG22 ' A' ' 60' ' ' VAL . 7.7 ptm180 -56.87 -16.54 6.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.386 -0.821 . . . . 0.0 109.642 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.501 ' OD1' ' CD2' ' A' ' 66' ' ' HIS . 12.6 t-20 -66.46 -81.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.558 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.501 ' CD2' ' OD1' ' A' ' 65' ' ' ASN . 1.0 OUTLIER -150.7 20.57 0.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.588 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -103.03 -97.19 2.39 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.72 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 2.6 mp -119.46 161.29 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -1.13 . . . . 0.0 109.413 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.486 ' N ' HG22 ' A' ' 68' ' ' ILE . 2.2 m-80 -118.25 54.61 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -0.907 . . . . 0.0 109.116 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -58.37 151.18 20.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.571 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -144.55 14.38 1.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.264 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 18.7 t60 -78.45 146.78 34.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.569 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 4.0 tptm -93.67 131.54 38.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 73' ' ' LYS . . . -48.42 176.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.106 -0.996 . . . . 0.0 109.548 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.467 ' HD3' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER 171.51 139.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.911 . . . . 0.0 109.466 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.405 ' H ' HG22 ' A' ' 51' ' ' VAL . 2.1 tt0 -70.07 131.41 44.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.883 . . . . 0.0 109.51 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.647 HG12 ' CE1' ' A' ' 82' ' ' PHE . 71.8 t -48.75 131.54 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.255 -0.903 . . . . 0.0 109.334 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 79' ' ' LYS . 20.5 p -111.86 160.35 17.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.636 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -43.17 -44.3 5.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.573 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' O ' ' OG1' ' A' ' 84' ' ' THR . 23.6 tt0 -57.7 -47.82 81.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 109.837 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.48 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 1.1 m-20 -53.94 -43.78 70.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 109.983 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.894 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 49.6 m-85 -54.53 -50.89 66.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.499 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.567 ' HA ' ' CG ' ' A' ' 110' ' ' ARG . 1.0 OUTLIER -87.05 0.59 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.388 -0.82 . . . . 0.0 109.767 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.48 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 13.5 m -77.79 -53.32 7.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 110.244 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.606 ' CG ' ' HB2' ' A' ' 9' ' ' LEU . 16.7 m-85 -100.85 174.58 5.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.064 -1.022 . . . . 0.0 110.412 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 19.5 t0 -112.41 -19.84 12.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.466 -0.771 . . . . 0.0 109.578 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 7' ' ' SER . 1.4 m-85 -116.89 86.97 2.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 0.0 109.23 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.882 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 1.5 mt -95.73 123.45 47.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.339 -0.851 . . . . 0.0 109.327 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.918 HD13 ' CE1' ' A' ' 10' ' ' PHE . 0.1 OUTLIER -149.59 153.38 37.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 109.267 -179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.55 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 4.7 p -127.37 167.59 15.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.557 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.536 ' HE1' ' HB2' ' A' ' 116' ' ' LEU . 16.9 mmt -60.89 142.04 56.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.682 ' HB3' HG23 ' A' ' 126' ' ' ILE . 16.9 m-20 -43.52 116.29 0.92 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.581 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 128' ' ' GLU . 11.3 tt0 -176.34 163.01 2.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 109.493 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 t -83.31 8.74 12.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -75.91 -11.97 60.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.588 ' O ' HD23 ' A' ' 96' ' ' LEU . 0.9 OUTLIER -74.19 -2.37 24.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 0.0 109.607 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 13.7 ttt85 -63.63 -25.19 68.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.169 -0.957 . . . . 0.0 109.41 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 0.4 OUTLIER -95.54 -43.91 7.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.395 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.516 ' HB3' HG21 ' A' ' 113' ' ' ILE . 6.0 mt -53.65 -44.71 69.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.357 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.48 -29.53 70.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.228 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -89.89 -5.8 56.43 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.903 . . . . 0.0 109.461 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.984 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -81.63 -20.93 38.67 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -0.874 . . . . 0.0 109.32 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -63.57 -36.59 84.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.826 . . . . 0.0 109.591 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -32.45 73.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.424 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -92.66 9.73 33.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.244 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.984 HG23 ' O ' ' A' ' 102' ' ' LYS . 49.1 t -98.68 145.29 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.392 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 107' ' ' LYS . 0.3 OUTLIER -73.39 106.54 5.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.064 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 109' ' ' CYS . 8.2 t-20 47.73 46.68 18.29 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.002 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.522 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -41.76 145.6 0.3 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.561 -0.712 . . . . 0.0 109.704 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.567 ' CG ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -137.6 25.15 2.88 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.311 -0.868 . . . . 0.0 109.111 179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.894 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -106.73 131.43 53.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.392 -0.817 . . . . 0.0 109.858 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 88' ' ' ILE . 7.2 mtpt -83.19 100.22 10.43 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.662 HD13 ' N ' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -76.32 135.46 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.734 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.46 -177.97 5.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.419 -0.801 . . . . 0.0 109.36 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.508 ' CD2' HD12 ' A' ' 96' ' ' LEU . 60.8 mt -110.71 152.75 26.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.652 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.677 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -69.08 -9.92 55.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.475 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.446 ' N ' ' OD1' ' A' ' 92' ' ' ASP . . . -45.94 -29.18 3.14 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.3 168.88 19.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -1.085 . . . . 0.0 109.471 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 55.41 73.65 0.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.37 75.54 13.63 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.903 . . . . 0.0 109.506 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -51.13 105.89 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.915 1.743 . . . . 0.0 110.294 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 57.49 178.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.96 42.76 22.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.63 120.26 11.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.495 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tp -168.28 101.33 0.43 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 109.524 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.943 HG21 ' OE2' ' A' ' 128' ' ' GLU . 15.1 mm -54.28 141.09 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 127' ' ' ILE . 14.8 mt -100.76 57.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.213 -0.93 . . . . 0.0 109.351 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.943 ' OE2' HG21 ' A' ' 126' ' ' ILE . 21.0 mt-10 -88.07 132.42 34.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.449 ' HB2' ' HD2' ' A' ' 130' ' ' PRO . 1.1 p30 -158.05 158.7 30.22 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 129' ' ' ASP . 51.4 Cg_endo -71.27 -90.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.038 1.825 . . . . 0.0 110.226 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.1 -42.84 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.454 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.09 100.02 2.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.07 -116.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -160.27 -55.35 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -1.162 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -115.41 18.48 15.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 109.622 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 137' ' ' ASP . . . -55.92 -20.41 15.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.321 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 0.7 OUTLIER 74.79 126.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.731 ' O ' HG12 ' A' ' 141' ' ' VAL . 80.8 t80 -82.42 0.74 40.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.605 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -79.47 -34.2 41.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.146 -0.971 . . . . 0.0 109.461 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.541 HG23 ' N ' ' A' ' 141' ' ' VAL . 15.0 t -76.4 -42.23 45.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 138' ' ' PHE . 9.0 p -46.64 -29.22 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.749 ' CD1' HG22 ' A' ' 21' ' ' ILE . 1.4 t80 -90.18 -46.34 8.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.334 -0.854 . . . . 0.0 109.102 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.03 -64.56 0.79 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.682 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -55.76 -20.09 13.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.102 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -72.33 -39.08 68.44 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.331 -0.856 . . . . 0.0 109.344 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.83 ' HA ' HG11 ' A' ' 25' ' ' VAL . 90.1 t -53.21 -71.25 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.034 -1.041 . . . . 0.0 109.74 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.54 ' HA ' ' CB ' ' A' ' 150' ' ' ARG . 13.1 mtm180 -62.49 -21.18 65.29 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.088 -1.007 . . . . 0.0 109.606 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.677 ' HA ' HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -45.81 -27.44 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.985 -1.072 . . . . 0.0 108.18 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.607 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.8 OUTLIER -111.62 -23.12 10.86 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.874 ' HG3' HD21 ' A' ' 29' ' ' LEU . 8.5 ttp180 -76.48 -64.49 1.1 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.389 -0.819 . . . . 0.0 109.257 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -45.72 -37.87 6.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.257 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.667 ' O ' HG22 ' A' ' 156' ' ' VAL . 1.9 t80 -74.71 -37.38 62.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.42 -0.8 . . . . 0.0 109.3 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . 13.3 tp -67.14 -16.96 64.64 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.211 -0.93 . . . . 0.0 108.718 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -72.37 -50.52 26.0 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.035 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -42.43 98.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 108.841 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 152' ' ' PHE . 17.0 m -103.84 42.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.385 -0.822 . . . . 0.0 109.056 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.466 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 3' ' ' GLN . 41.8 mt-10 -101.14 71.09 1.37 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.476 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.803 ' O ' HG12 ' A' ' 4' ' ' VAL . 39.2 mt-30 -152.15 157.28 41.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.95 . . . . 0.0 109.606 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.803 HG12 ' O ' ' A' ' 3' ' ' GLN . 4.1 p 48.31 178.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.607 -0.683 . . . . 0.0 109.887 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.957 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -151.48 83.59 1.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 109.248 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.652 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -41.53 162.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.868 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.585 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 2.5 m -142.8 114.7 8.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 108.999 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.716 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.6 OUTLIER -118.01 147.77 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.733 -179.256 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -149.99 116.4 5.77 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 89' ' ' LEU . 2.5 m-85 -91.87 160.33 15.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 0.0 109.858 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.069 HG11 HD11 ' A' ' 99' ' ' LEU . 4.2 t -145.98 149.48 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.546 ' O ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -174.13 121.91 0.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 109.46 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.445 HD11 ' CZ2' ' A' ' 49' ' ' TRP . 44.6 tp -43.46 96.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.0 109.582 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 12' ' ' CYS . . . 148.96 -73.75 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.7 14.33 8.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -1.096 . . . . 0.0 109.425 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.616 HG21 ' HD3' ' A' ' 53' ' ' ARG . 1.3 pp -131.41 12.73 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 18' ' ' ARG . 15.3 t 179.12 137.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.77 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 23.7 ttm-85 84.15 -52.22 0.13 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.75 -0.594 . . . . 0.0 109.664 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -79.56 -50.1 1.32 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 110.049 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 19' ' ' SER . 70.2 Cg_exo -48.37 -33.66 23.23 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.902 1.735 . . . . 0.0 110.876 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.022 HG21 ' HA ' ' A' ' 142' ' ' TYR . 5.4 mm -65.75 -61.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.961 -1.087 . . . . 0.0 109.655 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.444 ' N ' ' HB3' ' A' ' 145' ' ' CYS . . . -62.5 -12.77 24.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 109.539 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' HG3' ' HB2' ' A' ' 43' ' ' SER . 2.4 tm-20 -77.98 -74.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 109.401 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -53.96 -33.96 58.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 108.841 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.085 HG11 ' HA ' ' A' ' 146' ' ' VAL . 49.6 t -56.29 -59.75 2.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.393 -0.817 . . . . 0.0 109.202 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.736 ' CD1' HG12 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -47.52 -41.26 20.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.974 -1.079 . . . . 0.0 108.506 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.505 ' O ' ' OG1' ' A' ' 31' ' ' THR . 5.8 ttt85 -45.7 -60.07 2.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.006 -1.059 . . . . 0.0 109.403 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.481 ' HA ' ' OG1' ' A' ' 31' ' ' THR . 0.3 OUTLIER -75.32 -13.03 60.39 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.41 -0.806 . . . . 0.0 111.003 -179.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.943 ' CD1' HG12 ' A' ' 25' ' ' VAL . 42.1 mt -76.37 -30.85 57.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.846 -1.159 . . . . 0.0 109.433 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.763 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.5 OUTLIER -90.76 -31.85 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -60.86 -31.81 71.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 109.076 179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.46 -40.61 89.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.357 -0.839 . . . . 0.0 109.328 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.532 ' HB3' HG23 ' A' ' 35' ' ' ILE . 32.0 tp60 -80.67 -6.54 58.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.874 . . . . 0.0 109.515 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.464 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 1.5 m120 72.67 47.44 0.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.866 . . . . 0.0 109.514 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.763 ' CG1' HG23 ' A' ' 30' ' ' VAL . 5.9 pt -129.72 -1.14 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.232 -0.917 . . . . 0.0 109.656 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.59 ' N ' HG23 ' A' ' 30' ' ' VAL . 2.1 p -58.36 -44.46 88.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.935 . . . . 0.0 109.657 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.12 -28.03 6.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.548 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.957 ' HA ' HG22 ' A' ' 5' ' ' THR . 5.3 m-20 -112.58 46.1 1.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.455 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.716 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 7.6 m95 -149.86 144.54 26.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.157 -0.964 . . . . 0.0 110.194 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.718 HG12 ' CE1' ' A' ' 85' ' ' PHE . 33.8 t -124.16 78.11 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.568 ' HA ' HG13 ' A' ' 8' ' ' VAL . 2.6 mt -90.02 139.11 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.869 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -150.75 -173.53 4.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.285 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.439 ' HB2' ' HG3' ' A' ' 23' ' ' GLU . 1.1 t -126.46 165.95 18.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.692 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.93 131.94 4.82 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.747 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -93.41 -39.24 11.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.301 -1.117 . . . . 0.0 109.583 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.747 HG12 ' O ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER 80.84 -6.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.588 -0.695 . . . . 0.0 109.466 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.0 m -141.31 137.33 32.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.429 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.624 ' HA ' HG23 ' A' ' 51' ' ' VAL . 1.3 t70 -88.38 14.1 10.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.516 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -86.25 3.45 43.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.695 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 49' ' ' TRP . 3.9 m-20 -144.46 22.78 1.65 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.928 . . . . 0.0 109.577 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.984 HG13 ' HA ' ' A' ' 75' ' ' ARG . 60.9 t -64.85 128.37 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.364 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.05 -18.15 42.16 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.616 ' HD3' HG21 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -62.86 113.17 2.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -1.116 . . . . 0.0 109.365 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.4 m -76.45 153.01 83.79 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.515 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 56' ' ' ASP . 53.7 Cg_exo -50.25 143.72 25.33 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.957 1.771 . . . . 0.0 110.266 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 55' ' ' PRO . 4.5 m-20 -44.79 151.92 0.58 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.502 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.9 -6.0 18.19 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 121.93 1.753 . . . . 0.0 110.31 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.746 ' O ' ' SG ' ' A' ' 62' ' ' CYS . 16.0 mtt180 -86.26 -33.85 20.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.366 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB2' ' HZ ' ' A' ' 138' ' ' PHE . . . -89.14 -25.07 22.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.319 -0.863 . . . . 0.0 109.446 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.583 HG13 ' N ' ' A' ' 61' ' ' SER . 9.9 p -64.71 -44.78 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.456 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.583 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -69.64 -8.46 47.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.631 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.746 ' SG ' ' O ' ' A' ' 58' ' ' ARG . 13.1 m -89.89 -66.71 0.9 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.593 HD12 HG21 ' A' ' 68' ' ' ILE . 1.7 pt? -57.78 -25.31 60.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.368 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.483 ' H ' HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -91.56 30.89 1.24 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.349 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -133.21 -46.0 0.84 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.574 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -83.59 -33.58 25.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.427 ' O ' HG12 ' A' ' 68' ' ' ILE . . . 136.22 98.5 0.54 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.593 HG21 HD12 ' A' ' 63' ' ' LEU . 15.6 mm -149.42 -68.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -1.127 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 21.4 m-80 68.65 116.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.391 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 t -105.01 167.69 9.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.537 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -161.71 39.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.456 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' A' ' 73' ' ' LYS . 8.6 t60 -155.16 144.66 21.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.508 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' CD2' ' A' ' 72' ' ' HIS . 0.9 OUTLIER -115.82 151.18 35.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' ARG . . . -44.11 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.984 ' HA ' HG13 ' A' ' 51' ' ' VAL . 1.5 tpp180 69.15 8.1 6.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.277 -0.889 . . . . 0.0 109.512 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER 61.32 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 78' ' ' THR . 11.6 p -53.85 165.02 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.564 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -143.85 161.96 37.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.677 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -50.63 -41.57 55.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.274 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' A' ' 84' ' ' THR . 0.3 OUTLIER -54.0 -41.13 67.61 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.354 -0.841 . . . . 0.0 109.53 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.443 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 0.9 OUTLIER -62.15 -31.88 72.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.916 . . . . 0.0 109.842 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.685 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 77.6 m-85 -66.23 -59.2 3.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.063 -1.023 . . . . 0.0 109.399 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.52 ' O ' ' CD ' ' A' ' 110' ' ' ARG . 2.6 p -72.98 -9.14 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -0.936 . . . . 0.0 109.506 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.522 HG22 ' N ' ' A' ' 85' ' ' PHE . 3.4 m -81.76 -78.06 0.2 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.222 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.718 ' CE1' HG12 ' A' ' 40' ' ' VAL . 37.2 m-85 -70.06 156.52 39.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.253 -0.905 . . . . 0.0 109.315 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -106.43 -12.68 15.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.654 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 7' ' ' SER . 2.2 m-85 -121.88 78.21 1.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -0.946 . . . . 0.0 109.712 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.92 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 2.8 mt -89.3 91.66 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.306 -0.872 . . . . 0.0 108.964 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.687 HD21 ' CE1' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -107.45 168.26 9.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.235 -0.916 . . . . 0.0 109.352 -179.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 11' ' ' VAL . 3.9 m -136.51 175.21 9.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.259 -0.9 . . . . 0.0 109.292 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.406 ' O ' ' CB ' ' A' ' 92' ' ' ASP . 16.8 mmt -84.07 12.51 6.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 109.684 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.447 ' O ' ' CD2' ' A' ' 115' ' ' LEU . 1.3 p30 170.66 176.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.579 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.733 ' HB2' HD11 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -107.34 -14.69 14.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 93' ' ' GLU . 0.5 OUTLIER -44.26 -53.0 7.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.582 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -89.16 -24.34 22.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.916 . . . . 0.0 109.571 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.84 ' O ' HD23 ' A' ' 96' ' ' LEU . 2.6 tt -58.7 -21.19 54.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.522 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.95 -28.24 0.44 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -94.65 -33.24 13.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.435 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.069 HD11 HG11 ' A' ' 11' ' ' VAL . 15.4 mt -67.17 -14.48 62.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -85.5 -31.78 22.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.98 -11.93 40.18 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.956 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.447 ' HE2' ' CZ ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -67.86 -42.47 81.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.0 109.434 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.698 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 1.1 p -53.03 -22.66 6.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.397 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -72.02 -44.05 64.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.383 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 0.7 OUTLIER -83.08 -9.93 58.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.554 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.677 HG13 ' HG2' ' A' ' 79' ' ' LYS . 41.1 t -76.8 135.49 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 109.448 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -68.65 108.41 3.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.482 ' O ' HG23 ' A' ' 83' ' ' VAL . 6.1 t30 51.93 48.98 21.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.279 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 103' ' ' SER . 0.0 OUTLIER -48.36 148.77 1.78 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.282 -0.886 . . . . 0.0 109.773 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.52 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 0.3 OUTLIER -136.95 5.21 2.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.417 -0.802 . . . . 0.0 109.206 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.92 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -85.44 94.43 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 110.388 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -52.82 122.88 10.02 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -96.97 129.38 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.79 -1.194 . . . . 0.0 110.114 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -155.3 -171.98 4.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 0.0 109.224 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 93' ' ' GLU . 20.2 mt -117.49 162.66 17.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.149 -0.969 . . . . 0.0 109.517 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.658 HD11 ' HA ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -85.85 58.71 5.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -123.07 -2.22 9.29 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.72 15.62 24.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -1.187 . . . . 0.0 109.487 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.434 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 2.8 m-85 -135.76 70.57 1.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 119' ' ' TYR . 0.1 OUTLIER -166.63 133.83 2.05 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.164 -0.96 . . . . 0.0 109.382 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.65 -30.55 29.03 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.769 1.646 . . . . 0.0 110.168 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -128.3 132.44 48.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.39 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -64.65 140.44 58.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.182 -0.949 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 125' ' ' LEU . 1.1 mt-30 -108.76 16.82 22.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.253 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.723 ' O ' HD23 ' A' ' 125' ' ' LEU . 1.6 tt 39.66 61.07 1.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.756 -0.59 . . . . 0.0 109.842 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.515 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 7.2 mm 62.08 139.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.313 -0.867 . . . . 0.0 109.345 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 129' ' ' ASP . 2.8 mp -101.43 -55.21 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.84 . . . . 0.0 109.365 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.515 ' HG3' ' CG2' ' A' ' 126' ' ' ILE . 33.5 mt-10 48.0 -92.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 127' ' ' ILE . 0.3 OUTLIER 51.44 92.55 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.489 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -50.1 157.11 3.1 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.901 1.734 . . . . 0.0 110.254 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -98.92 87.3 3.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -138.6 -74.83 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.525 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -142.73 117.79 1.17 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.473 ' HB2' ' HB2' ' A' ' 137' ' ' ASP . 2.4 p30 -105.8 148.06 27.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -1.149 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -80.92 74.48 7.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.53 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 66.03 33.14 7.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.443 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 134' ' ' ASN . 0.4 OUTLIER -105.89 56.64 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.344 -0.847 . . . . 0.0 109.564 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.481 ' HZ ' ' HB2' ' A' ' 59' ' ' ALA . 66.9 t80 -111.36 -42.04 3.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.0 109.355 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -70.42 -36.15 73.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 0.0 109.307 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.421 ' O ' ' HG2' ' A' ' 144' ' ' GLN . 56.8 m -65.81 -17.66 64.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.226 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 18' ' ' ARG . 22.3 t -81.67 -43.89 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.13 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 1.022 ' HA ' HG21 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.54 -25.89 65.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.216 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -83.9 -46.76 11.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.91 . . . . 0.0 109.651 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' A' ' 141' ' ' VAL . 16.2 pt20 -67.23 -13.3 61.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.24 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.77 ' SG ' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -79.09 -19.21 51.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 109.457 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 1.085 ' HA ' HG11 ' A' ' 25' ' ' VAL . 54.4 t -61.3 -56.27 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.926 . . . . 0.0 109.27 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.87 -12.29 60.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.288 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.658 ' HA ' HD11 ' A' ' 116' ' ' LEU . 1.2 m -56.12 -18.78 10.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.15 -0.969 . . . . 0.0 108.988 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.588 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -124.42 -40.71 2.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.418 -0.801 . . . . 0.0 109.229 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.609 ' HB2' HD13 ' A' ' 29' ' ' LEU . 1.7 ttp180 -59.15 -46.36 88.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 108.71 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.487 ' O ' ' CG ' ' A' ' 154' ' ' GLU . . . -65.68 -18.97 65.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.474 -0.766 . . . . 0.0 109.098 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.934 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 4.6 t80 -90.07 -19.35 24.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.416 -0.802 . . . . 0.0 109.489 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.613 HD13 ' HZ ' ' A' ' 26' ' ' PHE . 14.5 tp -78.7 -22.74 46.22 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.037 -1.04 . . . . 0.0 108.768 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 151' ' ' ALA . 4.4 pt-20 -72.0 -33.71 68.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.1 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.458 ' N ' ' HG3' ' A' ' 154' ' ' GLU . 5.8 mmtp -76.19 -51.65 11.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -0.916 . . . . 0.0 108.864 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.934 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 17.8 m -103.56 58.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.393 -0.817 . . . . 0.0 108.935 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.559 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.29 0.567 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 179.44 132.03 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.354 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HG2' ' OD1' ' A' ' 38' ' ' ASN . 12.3 tt0 -137.51 82.2 1.91 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.705 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.426 ' O ' ' CG ' ' A' ' 38' ' ' ASN . 1.9 t -75.73 152.14 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 109.118 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.852 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.3 OUTLIER -130.64 82.75 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.933 . . . . 0.0 109.803 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.662 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -43.12 156.8 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -136.38 113.74 10.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.099 -1.001 . . . . 0.0 109.377 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.676 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 1.0 OUTLIER -117.8 142.71 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.572 HD22 ' CD1' ' A' ' 88' ' ' ILE . 0.4 OUTLIER -142.23 116.61 9.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.445 -0.784 . . . . 0.0 109.136 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.763 ' CZ ' ' SG ' ' A' ' 148' ' ' CYS . 2.0 m-85 -91.1 161.51 15.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.651 HG11 HD11 ' A' ' 99' ' ' LEU . 74.5 t -149.47 152.93 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.475 ' HB3' ' OG ' ' A' ' 19' ' ' SER . 0.0 OUTLIER -178.28 126.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.437 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.95 124.95 13.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.506 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.48 62.47 1.87 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -84.02 74.85 10.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.425 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.642 HD12 ' SG ' ' A' ' 17' ' ' CYS . 0.6 OUTLIER -144.19 12.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.627 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.642 ' SG ' HD12 ' A' ' 16' ' ' ILE . 0.8 OUTLIER 173.74 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.716 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.585 ' HA ' HG11 ' A' ' 141' ' ' VAL . 2.4 ttm105 -94.6 66.68 3.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 109.572 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.59 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 162.44 -51.08 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.644 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 19' ' ' SER . 57.2 Cg_exo -49.89 -20.83 5.31 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.882 1.721 . . . . 0.0 110.425 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.881 HG21 ' HA ' ' A' ' 142' ' ' TYR . 1.9 mm -64.89 -51.16 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.147 -0.97 . . . . 0.0 109.183 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.67 ' O ' ' SG ' ' A' ' 149' ' ' CYS . . . -63.33 -19.87 65.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.48 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -73.51 -74.67 0.17 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.273 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.625 ' HB2' ' HB ' ' A' ' 70' ' ' THR . . . -44.2 -28.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 108.91 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.981 HG11 ' HA ' ' A' ' 146' ' ' VAL . 97.3 t -68.23 -53.32 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.328 -0.858 . . . . 0.0 109.21 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.807 ' CE1' HD11 ' A' ' 41' ' ' ILE . 5.2 t80 -46.22 -39.58 10.05 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.534 ' HD3' ' CB ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -58.02 -53.36 59.07 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.385 -0.822 . . . . 0.0 109.202 179.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 68' ' ' ILE . 0.0 OUTLIER -76.67 -1.37 27.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 0.0 109.792 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.922 ' CD1' HG12 ' A' ' 25' ' ' VAL . 81.4 mt -92.55 -32.85 14.68 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.013 -1.054 . . . . 0.0 109.316 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.923 ' HA ' HD11 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -90.71 -49.87 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -52.6 -22.17 4.72 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.272 -0.893 . . . . 0.0 109.167 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -90.67 -31.41 16.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.029 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -79.16 -79.71 0.13 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.3 -0.875 . . . . 0.0 109.224 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.543 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 4.0 m-20 161.92 42.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.398 -0.814 . . . . 0.0 109.955 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.923 HD11 ' HA ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -139.15 11.55 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.976 -1.078 . . . . 0.0 109.837 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.678 ' N ' HG23 ' A' ' 30' ' ' VAL . 4.3 p -62.57 -21.36 65.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.944 -1.097 . . . . 0.0 109.51 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 3.4 m-20 -93.11 34.23 1.13 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.317 -0.865 . . . . 0.0 108.753 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.852 ' HA ' HG22 ' A' ' 5' ' ' THR . 6.6 m-20 -177.06 48.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.441 -0.787 . . . . 0.0 109.684 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.676 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 9.8 m95 -149.99 144.19 25.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.89 -1.131 . . . . 0.0 110.383 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.65 81.59 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.807 HD11 ' CE1' ' A' ' 26' ' ' PHE . 2.7 mp -89.93 137.77 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.831 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.581 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 4.4 m-20 -148.44 173.52 13.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -122.76 161.33 24.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.458 ' HA3' ' CG2' ' A' ' 77' ' ' VAL . . . -143.89 147.75 19.19 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 46' ' ' VAL . . . -116.79 -19.73 9.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -1.17 . . . . 0.0 109.558 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.583 ' CG2' ' CG1' ' A' ' 11' ' ' VAL . 4.5 t 69.92 6.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.07 164.03 31.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.601 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.493 ' HA ' HG23 ' A' ' 51' ' ' VAL . 48.5 p30 -110.45 11.59 23.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.865 . . . . 0.0 109.424 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -89.93 6.67 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.745 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.485 ' OD1' ' CD ' ' A' ' 53' ' ' ARG . 4.3 m-80 -147.81 29.76 0.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.58 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 75' ' ' ARG . 26.0 t -78.55 78.51 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 109.283 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA2' ' HD3' ' A' ' 73' ' ' LYS . . . 134.79 -19.86 3.92 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -63.42 90.68 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.417 -1.049 . . . . 0.0 109.409 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 13.4 p -55.72 161.91 2.96 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.331 -0.856 . . . . 0.0 109.448 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 54' ' ' SER . 53.5 Cg_exo -50.44 153.79 6.99 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.043 1.829 . . . . 0.0 110.199 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.465 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 18.5 m-20 -75.38 144.91 78.84 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.928 . . . . 0.0 109.486 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.878 ' O ' HG12 ' A' ' 60' ' ' VAL . 51.6 Cg_exo -51.07 -19.63 6.17 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.959 1.773 . . . . 0.0 110.496 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -79.56 -45.64 18.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.147 -0.971 . . . . 0.0 109.821 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.679 ' O ' HD23 ' A' ' 63' ' ' LEU . . . -71.3 -17.98 62.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.156 -0.965 . . . . 0.0 109.885 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.878 HG12 ' O ' ' A' ' 57' ' ' PRO . 8.8 p -72.38 -28.15 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.932 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 14.7 m -64.2 -20.18 65.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 109.812 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.29 -75.06 0.47 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.198 -0.939 . . . . 0.0 109.745 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -53.87 -18.47 3.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.726 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.551 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 4.3 ttt180 -112.72 51.63 0.81 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.09 -1.006 . . . . 0.0 109.633 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 61' ' ' SER . 4.6 t-20 -129.27 -78.46 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -0.956 . . . . 0.0 109.245 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -54.62 -33.05 59.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.317 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.86 104.76 1.34 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.889 HD11 ' HA ' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -133.63 -174.36 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -1.169 . . . . 0.0 109.324 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.534 ' CB ' ' HD3' ' A' ' 27' ' ' ARG . 67.0 m-80 -140.18 118.01 11.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.505 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -142.18 -87.32 0.15 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.297 -0.877 . . . . 0.0 109.451 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.518 ' H ' HG23 ' A' ' 70' ' ' THR . . . 60.18 20.49 9.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.333 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.544 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.5 p-80 -90.09 157.4 17.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.495 ' HD3' ' HA2' ' A' ' 52' ' ' GLY . 0.1 OUTLIER -107.87 150.13 27.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.21 170.69 15.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.197 -0.939 . . . . 0.0 109.551 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.649 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -174.83 153.27 1.69 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.442 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.431 ' N ' ' HG3' ' A' ' 75' ' ' ARG . 31.6 tt0 -77.04 138.78 39.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.458 ' CG2' ' HA3' ' A' ' 44' ' ' GLY . 77.8 t -67.33 141.98 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 2.7 p -127.95 164.75 21.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.194 -0.941 . . . . 0.0 109.556 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.91 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.6 OUTLIER -51.1 -45.36 61.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.396 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.407 ' O ' ' OG1' ' A' ' 84' ' ' THR . 32.7 tt0 -53.9 -38.21 64.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.481 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 78' ' ' THR . 7.3 m-20 -59.11 -41.17 87.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.748 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.805 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 94.4 m-85 -61.84 -54.31 43.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.513 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 108' ' ' ASN . 1.2 p -75.9 -5.84 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 109.612 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.417 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 4.0 m -85.89 -71.7 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.314 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 42' ' ' ASP . 71.6 m-85 -74.3 161.62 29.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -109.16 -21.81 12.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.673 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.7 m-85 -116.06 73.32 0.84 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.076 -1.015 . . . . 0.0 109.58 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.901 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.0 mt -86.15 89.81 2.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.324 -0.86 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -100.5 174.3 6.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.041 -1.037 . . . . 0.0 109.441 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.637 ' SG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -150.05 159.8 44.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.431 -0.793 . . . . 0.0 109.091 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.619 ' HE1' ' SG ' ' A' ' 148' ' ' CYS . 32.6 mmt -67.49 167.86 12.01 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.163 -0.96 . . . . 0.0 109.201 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 127' ' ' ILE . 0.4 OUTLIER -59.52 -149.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 109.793 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' A' ' 92' ' ' ASP . 0.1 OUTLIER 76.87 -179.04 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 109.345 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 m -89.01 36.01 0.8 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.473 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -89.94 -15.47 31.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -86.74 -16.31 36.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 109.466 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 21.1 ttt85 -65.91 -11.42 46.95 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.0 -1.063 . . . . 0.0 109.169 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 102' ' ' LYS . 13.8 t70 -108.36 -35.09 6.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.259 -0.9 . . . . 0.0 109.183 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.673 ' HB2' HD23 ' A' ' 96' ' ' LEU . 8.9 mt -69.18 -50.6 46.1 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.362 -0.836 . . . . 0.0 109.41 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -54.52 -26.18 30.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.415 -0.803 . . . . 0.0 109.406 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.83 -24.24 19.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.907 . . . . 0.0 109.478 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.569 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -65.94 -39.5 90.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.722 ' HG ' ' HG ' ' A' ' 109' ' ' CYS . 45.1 t -59.72 -17.95 38.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 0.0 109.319 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.31 -40.17 31.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 5.4 pt20 -76.85 -18.16 58.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.91 HG13 ' HG2' ' A' ' 79' ' ' LYS . 92.9 t -69.22 147.9 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.337 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -89.41 108.49 19.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.274 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.549 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.4 OUTLIER 65.18 42.04 4.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.074 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.722 ' HG ' ' HG ' ' A' ' 103' ' ' SER . 0.0 OUTLIER -52.35 152.44 3.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 0.0 109.894 -179.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 4.0 ptm180 -140.32 8.75 2.25 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.424 -0.797 . . . . 0.0 109.184 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.901 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -90.65 91.51 8.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 110.313 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 111' ' ' ALA . 13.7 mtpt -47.33 116.97 1.57 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 111' ' ' ALA . 1.7 mm -93.65 135.98 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.858 -1.151 . . . . 0.0 110.685 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.532 ' HB3' HD23 ' A' ' 89' ' ' LEU . 2.6 tt0 -160.89 -176.27 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.726 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.6 OUTLIER -134.82 151.59 51.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.017 -1.052 . . . . 0.0 109.495 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.071 HD21 ' SG ' ' A' ' 148' ' ' CYS . 0.8 OUTLIER -42.25 135.17 2.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.443 -0.785 . . . . 0.0 109.669 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.31 -120.01 1.67 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.6 p -148.65 117.64 6.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.185 -1.185 . . . . 0.0 109.6 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.525 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 23.9 m-85 -115.47 31.35 6.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.35 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.575 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 162.89 -51.24 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.404 -0.81 . . . . 0.0 109.539 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 54.5 Cg_exo -49.92 146.89 15.61 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.845 1.697 . . . . 0.0 110.071 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.67 11.36 32.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.118 -0.989 . . . . 0.0 109.672 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.57 146.66 25.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.2 -0.937 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -112.85 62.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.392 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.27 76.32 1.56 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.541 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -74.62 137.77 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.265 -0.897 . . . . 0.0 109.083 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.609 HD11 ' CB ' ' A' ' 144' ' ' GLN . 95.2 mt -39.56 106.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.515 -0.741 . . . . 0.0 109.941 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.494 ' HG3' HG23 ' A' ' 126' ' ' ILE . 15.1 mt-10 -142.26 79.74 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.458 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 130' ' ' PRO . 0.9 OUTLIER -150.73 104.45 3.05 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.0 109.456 -179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 129' ' ' ASP . 54.4 Cg_exo -49.68 -174.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.755 1.636 . . . . 0.0 110.29 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -100.12 14.02 32.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 109.595 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -115.96 26.44 9.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -92.42 -105.38 1.58 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -113.48 -159.72 0.7 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -1.191 . . . . 0.0 109.384 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -119.21 -23.78 6.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.501 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.39 10.75 9.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -97.74 61.33 1.58 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.27 -51.26 2.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.561 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -27.29 34.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 0.0 109.363 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 61.0 m -61.79 -49.03 77.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.337 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 18' ' ' ARG . 53.5 t -53.6 -40.72 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 0.0 109.377 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.881 ' HA ' HG21 ' A' ' 21' ' ' ILE . 2.2 t80 -61.28 -48.4 81.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -55.01 -65.19 0.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -0.897 . . . . 0.0 109.951 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.609 ' CB ' HD11 ' A' ' 127' ' ' ILE . 21.0 mm100 -53.38 -19.03 3.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.868 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.709 ' SG ' HG22 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -77.7 -38.09 48.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.117 -0.989 . . . . 0.0 109.645 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.981 ' HA ' HG11 ' A' ' 25' ' ' VAL . 2.9 t -51.57 -53.55 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.087 -1.008 . . . . 0.0 109.218 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -12.54 60.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.861 . . . . 0.0 109.344 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 1.071 ' SG ' HD21 ' A' ' 116' ' ' LEU . 36.2 t -56.46 -40.4 74.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.992 . . . . 0.0 109.224 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.67 ' SG ' ' O ' ' A' ' 22' ' ' ALA . 0.8 OUTLIER -103.06 -29.26 11.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.365 -0.834 . . . . 0.0 109.52 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.736 ' HG3' HD22 ' A' ' 29' ' ' LEU . 2.2 ttt180 -72.21 -59.65 2.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.19 -19.82 23.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.454 -0.779 . . . . 0.0 109.206 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.636 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 2.6 t80 -90.59 -26.86 19.46 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.51 -0.744 . . . . 0.0 109.833 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.63 HD13 ' CZ ' ' A' ' 26' ' ' PHE . 8.7 tp -75.16 -25.68 58.52 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.912 -1.117 . . . . 0.0 109.109 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -69.22 -46.82 66.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.36 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -63.3 -54.75 32.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.302 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.636 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 17.5 m -102.87 54.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.256 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.508 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.55 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.281 0.562 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' ' 2' ' ' GLU . 23.0 mm-40 -118.58 61.0 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 109.456 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 4' ' ' VAL . 1.8 tt0 -114.07 66.54 0.67 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.538 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 5' ' ' THR . 18.0 t -44.93 147.36 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.361 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.678 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -175.24 84.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.343 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.67 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -42.59 163.56 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.585 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 74.4 m -145.58 109.83 4.94 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.107 -0.996 . . . . 0.0 109.586 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.924 HG11 ' CE2' ' A' ' 26' ' ' PHE . 1.5 p -110.75 144.79 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.217 -0.927 . . . . 0.0 109.627 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.607 ' HB2' ' CG ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -141.49 126.04 17.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.125 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 2.0 m-85 -105.53 156.42 18.25 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.193 -0.942 . . . . 0.0 109.569 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.726 HG11 HD11 ' A' ' 99' ' ' LEU . 25.2 t -139.13 154.86 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.77 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.558 ' SG ' ' O ' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -170.62 129.79 0.84 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.423 -0.798 . . . . 0.0 109.16 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 12' ' ' CYS . 1.0 OUTLIER -42.39 -65.28 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 -179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.558 ' O ' ' SG ' ' A' ' 12' ' ' CYS . . . -87.43 87.59 1.55 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.528 ' O ' HG23 ' A' ' 16' ' ' ILE . 3.0 t-20 -90.04 40.76 1.02 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -1.129 . . . . 0.0 109.353 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.551 HD12 ' N ' ' A' ' 17' ' ' CYS . 1.8 pp -157.24 -40.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.925 . . . . 0.0 109.439 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.561 ' HB3' ' CE1' ' A' ' 131' ' ' TYR . 0.9 OUTLIER -102.65 -15.33 16.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.496 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.51 ' CG ' ' O ' ' A' ' 14' ' ' GLY . 3.0 mmm-85 -75.53 0.18 18.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.599 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.816 ' OG ' HG21 ' A' ' 141' ' ' VAL . 10.0 p 60.14 56.08 4.29 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 109.568 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 19' ' ' SER . 45.3 Cg_endo -70.05 83.05 0.77 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.999 1.799 . . . . 0.0 109.941 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.724 HG22 HG23 ' A' ' 25' ' ' VAL . 3.2 mm -88.68 -21.02 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.0 109.796 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.69 ' CB ' ' SG ' ' A' ' 148' ' ' CYS . . . -54.52 -24.57 21.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.05 -1.031 . . . . 0.0 109.873 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 8.0 tp10 -76.75 -83.6 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.102 -0.999 . . . . 0.0 110.021 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.604 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -41.71 -30.75 0.25 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 109.836 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.018 HG11 ' HA ' ' A' ' 146' ' ' VAL . 60.9 t -64.32 -58.04 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.359 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.924 ' CE2' HG11 ' A' ' 8' ' ' VAL . 0.9 OUTLIER -46.9 -41.72 16.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.108 -0.995 . . . . 0.0 108.64 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.479 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.1 OUTLIER -50.23 -66.42 0.39 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.237 179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -13.71 29.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 110.164 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.746 HD22 ' HG3' ' A' ' 150' ' ' ARG . 8.5 mt -77.18 -78.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.161 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.864 HG23 ' CG1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -42.73 -47.66 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.39 -0.819 . . . . 0.0 109.653 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -51.14 -46.69 62.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.81 -1.181 . . . . 0.0 109.502 -179.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -65.42 -30.16 70.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -0.962 . . . . 0.0 109.03 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.559 ' HB3' HG23 ' A' ' 35' ' ' ILE . 1.1 tt0 -79.68 -10.13 59.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 8.7 t30 77.61 25.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.453 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.864 ' CG1' HG23 ' A' ' 30' ' ' VAL . 1.6 pt -117.63 11.56 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.315 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.604 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 89.3 p -73.5 -12.35 60.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.683 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -83.94 10.1 10.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 109.332 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.678 ' HA ' HG22 ' A' ' 5' ' ' THR . 3.1 m-20 -155.38 51.99 0.59 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.67 ' CZ3' ' HB3' ' A' ' 6' ' ' LYS . 7.9 m95 -150.3 154.37 37.74 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.902 -1.123 . . . . 0.0 110.865 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG12 ' HE1' ' A' ' 85' ' ' PHE . 10.2 t -130.49 80.59 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.59 HG12 ' CD2' ' A' ' 26' ' ' PHE . 3.3 mt -90.64 138.99 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.255 -0.903 . . . . 0.0 109.87 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -145.73 -178.71 6.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.82 . . . . 0.0 109.154 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.7 t -170.27 135.91 1.33 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.159 -0.963 . . . . 0.0 109.682 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.8 -177.06 33.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.785 ' HB2' ' OD1' ' A' ' 50' ' ' ASN . . . -95.12 141.02 29.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -1.183 . . . . 0.0 109.461 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.505 ' CG2' ' HG ' ' A' ' 99' ' ' LEU . 8.4 p -58.0 -24.71 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.344 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.4 m -124.43 170.88 10.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.372 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.587 ' CG ' HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -81.07 75.61 8.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.366 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.57 -32.68 6.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.331 -0.856 . . . . 0.0 109.527 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.785 ' OD1' ' HB2' ' A' ' 45' ' ' ALA . 4.1 p-10 -132.08 34.56 3.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.597 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.587 HG21 ' CG ' ' A' ' 48' ' ' ASP . 77.7 t -65.87 110.19 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.55 16.03 41.3 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CG2' ' A' ' 16' ' ' ILE . 8.7 mtt-85 -120.72 86.64 2.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -1.171 . . . . 0.0 109.44 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -47.08 172.46 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.316 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 54' ' ' SER . 52.2 Cg_exo -50.95 123.78 12.46 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.885 1.723 . . . . 0.0 110.037 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 1.8 m-20 -43.09 155.89 0.27 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.604 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 60' ' ' VAL . 53.7 Cg_endo -71.68 -6.87 20.03 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.873 1.715 . . . . 0.0 110.142 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.96 -34.65 18.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.06 26.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 109.447 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 57' ' ' PRO . 11.1 p -65.57 -36.55 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.875 . . . . 0.0 109.389 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 79.2 p -60.74 -15.96 34.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.3 t -85.51 -52.5 5.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.578 ' HB3' HG23 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -88.26 6.42 37.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.584 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.477 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 12.9 tpt180 -112.7 -36.09 5.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.504 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 61' ' ' SER . 53.8 t30 -52.37 -47.14 66.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.474 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -74.45 -49.71 21.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.41 93.54 0.71 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.917 HD11 ' HA ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -118.22 -178.92 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.223 -1.163 . . . . 0.0 109.407 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -120.64 104.45 9.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.171 -0.955 . . . . 0.0 109.505 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.1 t -137.93 123.1 19.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.439 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.89 69.58 0.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.218 -0.926 . . . . 0.0 109.459 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.51 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.1 p-80 -156.18 178.43 10.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.401 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.51 139.42 52.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.271 -0.893 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 75' ' ' ARG . . . -60.56 153.34 23.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.206 -0.933 . . . . 0.0 109.216 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 74' ' ' ALA . 2.2 mmt85 -149.95 125.6 10.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.557 ' H ' HG22 ' A' ' 51' ' ' VAL . 1.4 tt0 -51.11 140.03 16.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.467 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.584 HG12 ' N ' ' A' ' 78' ' ' THR . 54.5 t -56.68 165.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.584 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -163.96 164.25 23.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.503 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.611 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.01 -37.68 33.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.292 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.424 ' O ' ' OG1' ' A' ' 84' ' ' THR . 1.1 tp10 -59.98 -52.7 64.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.884 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.478 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 1.1 m-20 -54.28 -49.39 69.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.142 -0.973 . . . . 0.0 110.11 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.872 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 62.9 m-85 -48.85 -68.74 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.145 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.479 ' HA ' ' HG2' ' A' ' 110' ' ' ARG . 4.1 p -66.38 -10.86 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.233 -0.917 . . . . 0.0 109.994 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 85' ' ' PHE . 3.3 m -78.43 -85.14 0.07 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.639 ' N ' HG22 ' A' ' 84' ' ' THR . 51.9 m-85 -62.09 132.63 53.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.339 -0.851 . . . . 0.0 109.587 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -72.11 -15.17 61.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.857 . . . . 0.0 109.465 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.585 ' CD2' ' O ' ' A' ' 7' ' ' SER . 3.7 m-85 -124.89 136.35 53.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.23 -0.919 . . . . 0.0 109.32 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.933 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 2.0 mt -142.74 89.9 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 109.254 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.816 HD23 ' HB3' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -112.79 148.18 35.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.872 -1.143 . . . . 0.0 109.547 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.533 ' SG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -99.22 -179.58 4.28 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.262 -0.899 . . . . 0.0 108.654 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.822 ' CE ' ' SG ' ' A' ' 148' ' ' CYS . 0.6 OUTLIER -76.01 1.54 15.15 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.088 -1.007 . . . . 0.0 109.604 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 20.3 p30 178.34 -165.36 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.126 -0.984 . . . . 0.0 109.382 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.504 ' CB ' HD22 ' A' ' 115' ' ' LEU . 1.9 tt0 -97.0 -31.11 12.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 0.0 109.714 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.4 p -45.37 -41.17 8.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.928 . . . . 0.0 109.79 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -90.01 -26.35 20.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.206 -0.934 . . . . 0.0 109.795 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.582 HD12 ' HB3' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -62.15 -28.92 69.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.105 -0.997 . . . . 0.0 109.717 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -49.97 -21.87 1.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 109.702 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -104.09 -33.33 8.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.726 HD11 HG11 ' A' ' 11' ' ' VAL . 11.2 mt -74.09 -7.69 53.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.16 -0.962 . . . . 0.0 109.854 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.525 ' HB2' HD22 ' A' ' 96' ' ' LEU . 54.2 t-20 -90.33 -23.06 21.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -96.67 -9.17 29.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.929 . . . . 0.0 109.698 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.794 ' O ' HG23 ' A' ' 106' ' ' VAL . 1.8 mmmt -73.36 -26.79 61.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.602 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.41 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 1.1 p -52.89 -42.37 65.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.566 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.37 -61.28 2.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.478 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.28 -21.32 5.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.247 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.794 HG23 ' O ' ' A' ' 102' ' ' LYS . 97.6 t -79.68 130.21 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.511 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -76.47 117.84 18.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.272 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.4 42.7 27.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.249 -0.907 . . . . 0.0 109.233 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.14 144.65 6.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.825 . . . . 0.0 109.946 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -135.17 2.51 3.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 0.0 109.202 179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.933 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -80.71 102.01 9.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.118 -0.989 . . . . 0.0 109.904 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.46 95.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.691 HD13 ' O ' ' A' ' 111' ' ' ALA . 2.1 mm -65.33 158.44 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.071 -1.018 . . . . 0.0 110.321 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.816 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER 177.31 -168.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -147.21 147.88 30.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.048 -1.032 . . . . 0.0 109.68 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.725 HD22 ' SG ' ' A' ' 148' ' ' CYS . 69.0 tp -53.1 99.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 0.0 109.393 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 118' ' ' SER . . . -175.24 177.18 47.26 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 117' ' ' GLY . 1.7 m 79.6 -73.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.553 -0.969 . . . . 0.0 109.689 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -100.67 57.82 0.92 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.949 . . . . 0.0 109.395 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -116.78 144.05 32.63 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.387 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CB ' ' NH2' ' A' ' 147' ' ' ARG . 55.7 Cg_endo -72.9 -163.56 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.887 1.725 . . . . 0.0 110.214 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER 73.58 -151.66 0.05 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.599 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.439 ' O ' ' HE3' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -126.05 77.67 1.7 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.459 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.91 43.94 26.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.954 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.48 143.85 26.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.857 . . . . 0.0 109.487 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.1 mm -138.12 130.29 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.162 -0.961 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 127' ' ' ILE . 10.9 tt -84.42 71.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.259 -0.9 . . . . 0.0 109.017 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.481 ' HA ' ' OD2' ' A' ' 92' ' ' ASP . 2.4 mt-10 -72.06 -67.47 0.54 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.732 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.49 79.36 54.52 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.723 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.42 ' HG3' ' CG1' ' A' ' 127' ' ' ILE . 53.6 Cg_endo -72.43 -21.05 23.2 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.968 1.779 . . . . 0.0 110.078 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.561 ' CE1' ' HB3' ' A' ' 17' ' ' CYS . 10.1 t80 -59.5 -24.7 63.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -111.25 84.32 1.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.878 . . . . 0.0 109.488 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -130.68 -135.96 3.89 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -122.4 -157.32 0.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -1.101 . . . . 0.0 109.44 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -109.08 -22.0 12.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.43 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.72 25.21 2.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.407 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.561 ' O ' ' CB ' ' A' ' 138' ' ' PHE . 10.1 t0 -122.84 -142.55 0.32 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.271 -0.893 . . . . 0.0 109.151 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.959 ' O ' HG12 ' A' ' 141' ' ' VAL . 1.3 t80 82.73 -42.98 0.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.554 -0.716 . . . . 0.0 109.793 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.07 -35.67 80.33 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.989 -1.069 . . . . 0.0 109.41 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.8 m -66.9 -28.66 68.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.275 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.959 HG12 ' O ' ' A' ' 138' ' ' PHE . 2.3 p -60.54 -30.84 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.274 -0.891 . . . . 0.0 109.366 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 146' ' ' VAL . 1.7 t80 -85.09 -53.13 5.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 0.0 109.271 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -28.27 10.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.14 -47.74 7.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.497 ' CB ' ' HB ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER -53.57 -21.87 7.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.333 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 1.018 ' HA ' HG11 ' A' ' 25' ' ' VAL . 60.2 t -51.03 -55.18 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.228 -0.92 . . . . 0.0 109.286 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -79.13 -18.46 53.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.292 -0.88 . . . . 0.0 109.304 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.822 ' SG ' ' CE ' ' A' ' 91' ' ' MET . 36.1 t -46.41 -25.88 0.74 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.088 -1.007 . . . . 0.0 108.844 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.591 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 2.5 p -119.95 -40.68 2.71 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.421 -0.8 . . . . 0.0 109.274 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.746 ' HG3' HD22 ' A' ' 29' ' ' LEU . 7.0 ttm-85 -62.23 -52.29 64.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 108.876 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -58.73 -18.82 34.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.878 . . . . 0.0 108.985 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.744 ' CE2' HD11 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -90.23 -25.68 20.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.783 . . . . 0.0 109.6 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.624 HD11 ' CD1' ' A' ' 35' ' ' ILE . 11.5 tp -75.61 -21.93 57.34 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.048 -1.032 . . . . 0.0 108.688 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -68.31 -48.39 65.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.902 . . . . 0.0 109.223 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -64.56 -48.85 73.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.014 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 152' ' ' PHE . 16.2 m -101.41 51.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -0.851 . . . . 0.0 109.112 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.487 -179.833 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.343 0.592 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 3' ' ' GLN . 5.2 tt0 -155.43 145.0 21.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.36 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER 43.88 69.37 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 0.0 109.218 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.539 HG22 ' N ' ' A' ' 5' ' ' THR . 8.2 p -85.23 161.71 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.853 . . . . 0.0 109.803 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 1.014 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.9 OUTLIER -63.9 101.01 0.34 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.408 -0.807 . . . . 0.0 109.543 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.718 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -44.21 166.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 108.83 179.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.605 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 15.5 p -136.39 112.86 9.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.931 -1.105 . . . . 0.0 109.275 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.79 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -115.71 134.22 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 109.64 -179.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.99 HD13 ' CD1' ' A' ' 85' ' ' PHE . 1.9 tp -124.73 118.17 25.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.26 102.34 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.021 -1.049 . . . . 0.0 109.755 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.795 HG13 ' O ' ' A' ' 44' ' ' GLY . 3.0 t -106.26 151.07 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 108.977 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -157.48 136.56 11.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.954 -1.091 . . . . 0.0 109.815 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.576 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -47.91 117.19 1.77 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.294 -0.879 . . . . 0.0 109.057 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.36 75.27 1.18 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.503 ' O ' ' CG ' ' A' ' 20' ' ' PRO . 5.3 t-20 -57.64 -14.99 6.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -1.11 . . . . 0.0 109.625 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.707 HD12 ' N ' ' A' ' 17' ' ' CYS . 1.1 pp -111.01 -158.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.999 -1.063 . . . . 0.0 109.301 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.707 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.1 OUTLIER 59.81 115.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.043 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 0.1 OUTLIER 77.9 -2.88 2.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.286 -179.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.893 ' O ' HD12 ' A' ' 21' ' ' ILE . 1.4 t 45.26 96.85 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.342 -0.849 . . . . 0.0 109.856 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 15' ' ' ASN . 52.8 Cg_exo -48.08 88.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.562 1.508 . . . . 0.0 109.667 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.893 HD12 ' O ' ' A' ' 19' ' ' SER . 2.0 mp -78.21 -11.72 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.312 -0.868 . . . . 0.0 109.946 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.851 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -67.52 -43.18 81.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.99 -1.069 . . . . 0.0 108.976 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' ALA . 1.6 tm-20 -76.15 -57.12 4.06 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.255 -0.903 . . . . 0.0 109.052 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.623 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -44.76 -41.25 6.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.887 . . . . 0.0 108.982 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.056 HG11 ' HA ' ' A' ' 146' ' ' VAL . 53.0 t -62.85 -51.23 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.807 . . . . 0.0 109.23 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.653 ' CD1' HG12 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -46.28 -36.72 6.48 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 108.547 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.427 ' HD2' ' OD1' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -62.07 -52.83 62.32 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.058 -1.026 . . . . 0.0 108.395 179.066 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 0.4 OUTLIER -84.18 11.03 8.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 108.955 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.82 HD21 ' CB ' ' A' ' 150' ' ' ARG . 45.5 tp -97.43 -46.97 5.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.401 -0.812 . . . . 0.0 109.107 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.732 HG11 HD11 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -91.09 -39.24 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.5 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 0.4 OUTLIER -69.54 -8.44 47.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.593 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 9.0 t70 -95.99 -15.46 22.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.013 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 4.6 tp60 -102.68 -82.0 0.49 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.488 -0.757 . . . . 0.0 109.245 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 26.0 t30 172.84 46.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.449 -0.782 . . . . 0.0 108.899 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.806 HD12 HD21 ' A' ' 153' ' ' LEU . 1.4 pt -143.64 17.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.793 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.617 ' HB3' HG22 ' A' ' 30' ' ' VAL . 79.3 p -85.39 -26.97 26.12 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.792 -1.192 . . . . 0.0 109.355 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -58.49 -27.05 64.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 0.0 109.271 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 1.014 ' HA ' HG22 ' A' ' 5' ' ' THR . 2.6 m-20 -118.96 42.69 2.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.576 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.79 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 11.6 m95 -150.0 119.8 7.08 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.994 -1.066 . . . . 0.0 110.563 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.62 91.63 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.732 HD11 HG11 ' A' ' 30' ' ' VAL . 3.2 mt -92.41 129.1 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.248 -0.907 . . . . 0.0 109.918 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -154.2 137.15 15.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.319 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -107.75 178.07 4.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.168 -0.957 . . . . 0.0 109.394 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.795 ' O ' HG13 ' A' ' 11' ' ' VAL . . . -168.27 171.21 42.46 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.47 ' O ' ' OE1' ' A' ' 76' ' ' GLN . . . -92.85 151.91 19.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -1.138 . . . . 0.0 109.419 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 13' ' ' LEU . 6.9 p -99.58 -17.21 6.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.28 -0.888 . . . . 0.0 108.786 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.458 ' O ' ' OE1' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -101.14 -148.34 0.37 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.386 -0.822 . . . . 0.0 109.505 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -150.28 16.11 0.82 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.079 -1.013 . . . . 0.0 109.715 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -100.22 0.22 39.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.6 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.444 ' OD1' ' CB ' ' A' ' 45' ' ' ALA . 8.1 p30 -118.6 5.8 11.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.9 t -56.29 110.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.473 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.55 29.84 9.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.542 ' HB3' HG21 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -123.59 131.88 53.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -1.146 . . . . 0.0 109.352 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 10.1 p -95.12 162.5 24.66 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 54' ' ' SER . 52.7 Cg_exo -50.99 144.42 27.92 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.974 1.783 . . . . 0.0 110.166 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.413 ' O ' ' HB ' ' A' ' 60' ' ' VAL . 8.0 m-20 -53.54 153.04 8.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.457 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 60' ' ' VAL . 50.1 Cg_endo -71.14 -15.05 32.07 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.043 1.829 . . . . 0.0 110.116 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -37.46 16.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.548 ' CB ' ' HB2' ' A' ' 19' ' ' SER . . . -90.15 -11.57 40.79 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.504 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -74.63 -30.3 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.497 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.89 0.18 21.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 0.0 109.586 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.485 ' C ' HD23 ' A' ' 63' ' ' LEU . 57.9 m -90.0 -18.44 26.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.322 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.8 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.12 -52.79 4.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.175 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -64.87 -10.44 28.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.875 . . . . 0.0 109.62 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.65 -85.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.604 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.585 ' CD2' HG12 ' A' ' 68' ' ' ILE . 1.7 p-80 -60.55 -25.42 66.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -0.936 . . . . 0.0 109.555 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.26 107.62 1.66 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.623 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 17.1 mm -148.54 154.33 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -1.157 . . . . 0.0 109.493 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.505 ' ND2' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -137.52 119.35 15.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.483 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.9 t -121.57 174.98 6.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.13 -0.981 . . . . 0.0 109.453 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -167.9 75.27 0.13 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.445 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -169.33 134.01 1.45 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.2 tptt -95.34 59.23 2.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.206 -0.934 . . . . 0.0 109.495 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 53' ' ' ARG . . . 51.79 -92.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.682 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER 59.53 151.9 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.17 -0.956 . . . . 0.0 109.534 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' A' ' 76' ' ' GLN . 34.2 tp60 -90.27 133.52 34.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 78' ' ' THR . 47.5 t -45.32 161.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.301 -0.874 . . . . 0.0 109.494 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.504 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -126.14 170.55 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.727 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.909 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -58.11 -53.52 57.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.862 . . . . 0.0 109.534 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -50.59 -42.81 56.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 109.746 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.466 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 6.7 m-20 -58.56 -42.19 87.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.673 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 1.021 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 10.5 m-85 -57.22 -51.2 70.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 109.334 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.569 ' CG2' ' HB3' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -80.17 -5.35 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.988 -1.07 . . . . 0.0 109.68 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 16.2 m -81.27 -58.7 2.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -0.831 . . . . 0.0 110.236 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.99 ' CD1' HD13 ' A' ' 9' ' ' LEU . 38.8 m-85 -77.54 165.2 24.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 0.0 110.192 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -108.68 -36.69 6.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -0.807 . . . . 0.0 109.386 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -109.44 78.77 1.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.172 -0.955 . . . . 0.0 108.651 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.953 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 3.2 mt -86.44 87.26 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.915 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.603 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -96.98 174.75 6.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.025 -1.047 . . . . 0.0 109.205 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 99' ' ' LEU . 1.1 p -149.93 148.2 28.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.383 -0.823 . . . . 0.0 109.375 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.615 ' HE2' ' SG ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -49.27 147.71 2.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 109.295 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.995 ' OD2' HD12 ' A' ' 126' ' ' ILE . 0.7 OUTLIER -52.23 -20.31 2.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.207 -0.933 . . . . 0.0 109.794 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 92' ' ' ASP . 2.3 mt-10 -43.02 -69.04 0.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 109.27 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 96' ' ' LEU . 12.2 t -87.34 85.62 7.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -0.904 . . . . 0.0 108.83 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.498 ' O ' ' C ' ' A' ' 96' ' ' LEU . 20.2 t-20 -50.28 86.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.752 -0.592 . . . . 0.0 110.285 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.052 HD21 ' CG2' ' A' ' 113' ' ' ILE . 0.7 OUTLIER 29.93 51.7 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.185 0.517 . . . . 0.0 110.683 179.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 98' ' ' ASP . 3.0 ttt85 -88.08 -91.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 109.59 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -57.22 -50.71 72.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.13 -0.981 . . . . 0.0 109.619 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.664 HD23 ' CZ ' ' A' ' 82' ' ' PHE . 5.0 mt -48.89 -26.97 2.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.201 -0.937 . . . . 0.0 109.678 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.64 ' HB2' HD22 ' A' ' 96' ' ' LEU . 34.4 t-20 -79.85 -38.31 33.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.96 3.06 54.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.626 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.941 ' O ' HG23 ' A' ' 106' ' ' VAL . 23.8 mmmt -84.88 -25.77 27.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.331 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -29.16 68.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.315 -0.866 . . . . 0.0 109.39 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -68.32 -60.21 2.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -54.42 -23.55 16.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.236 -0.915 . . . . 0.0 109.136 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 102' ' ' LYS . 38.8 t -82.3 105.71 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.426 -0.796 . . . . 0.0 109.415 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.522 ' O ' ' CD ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -44.31 117.27 1.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.546 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 107' ' ' LYS . 5.4 m-20 42.83 58.26 3.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.38 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.649 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -47.76 164.26 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.33 -0.856 . . . . 0.0 110.333 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.649 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 1.8 tpt180 -150.54 61.1 0.95 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 1.021 ' HB2' ' O ' ' A' ' 82' ' ' PHE . . . -147.15 89.72 1.82 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 110.253 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 111' ' ' ALA . 6.1 mtpp -44.0 110.17 0.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 1.052 ' CG2' HD21 ' A' ' 96' ' ' LEU . 2.1 mm -87.2 144.42 9.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.036 -1.04 . . . . 0.0 110.503 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.493 ' HB3' HD23 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -163.95 -179.64 6.39 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.472 ' CD1' ' OD2' ' A' ' 92' ' ' ASP . 1.0 OUTLIER -132.35 146.3 51.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.94 -1.1 . . . . 0.0 109.482 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.848 HD13 ' SG ' ' A' ' 148' ' ' CYS . 1.4 tp -43.97 120.21 2.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.36 157.98 23.17 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.48 100.7 0.38 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -1.123 . . . . 0.0 109.523 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -90.18 -87.62 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -0.873 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.58 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -67.01 -61.62 4.63 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.695 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 55.2 Cg_endo -71.9 162.45 41.9 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.765 1.643 . . . . 0.0 110.361 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -108.69 24.52 12.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.53 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.95 104.76 0.13 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.942 . . . . 0.0 109.633 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.98 60.85 6.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.353 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.475 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -109.12 -54.35 2.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.3 -0.875 . . . . 0.0 109.513 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.995 HD12 ' OD2' ' A' ' 92' ' ' ASP . 8.2 mm 61.8 145.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 92' ' ' ASP . 77.3 mt -109.04 93.43 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.398 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.527 ' CG ' ' OD1' ' A' ' 92' ' ' ASP . 34.4 mt-10 -124.29 8.35 8.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.577 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -94.56 146.56 31.69 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.451 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.94 170.75 18.12 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.928 1.752 . . . . 0.0 110.232 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.559 ' O ' ' CD1' ' A' ' 131' ' ' TYR . 14.2 p90 -103.11 125.89 50.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.458 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 134' ' ' ASN . 0.1 OUTLIER -146.69 111.24 5.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.865 . . . . 0.0 109.467 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -45.91 95.32 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 132' ' ' TYR . 1.3 m-80 -135.35 6.73 3.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -1.187 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.652 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 1.3 m-20 70.54 164.26 0.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.515 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 73.77 5.29 4.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.492 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -135.4 105.48 6.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.555 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -174.86 -33.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.541 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -86.31 -17.1 35.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.531 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 36.7 m -82.4 -25.0 34.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.75 ' O ' ' SG ' ' A' ' 145' ' ' CYS . 74.2 t -76.55 -44.86 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 109.529 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.549 ' CD1' HG21 ' A' ' 21' ' ' ILE . 2.6 t80 -74.74 -38.32 62.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 0.0 109.572 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -61.66 -61.52 2.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 148' ' ' CYS . 4.0 mt-30 -61.74 -29.36 70.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 109.507 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.806 ' SG ' ' N ' ' A' ' 22' ' ' ALA . 4.7 m -58.88 -40.2 83.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 109.68 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 1.056 ' HA ' HG11 ' A' ' 25' ' ' VAL . 84.0 t -51.57 -72.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 109.53 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.416 ' HG2' ' HB2' ' A' ' 151' ' ' ALA . 0.1 OUTLIER -65.24 -11.29 39.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.419 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.851 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 20.2 t -53.78 -26.2 22.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.102 -0.999 . . . . 0.0 108.797 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.597 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -119.11 -30.57 4.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.394 -0.816 . . . . 0.0 109.251 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.82 ' CB ' HD21 ' A' ' 29' ' ' LEU . 11.0 ttt180 -67.48 -52.42 39.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.937 . . . . 0.0 108.856 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.416 ' HB2' ' HG2' ' A' ' 147' ' ' ARG . . . -55.9 -21.38 20.0 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.449 -0.782 . . . . 0.0 109.023 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.848 ' O ' HG22 ' A' ' 156' ' ' VAL . 1.5 t80 -90.63 -27.44 19.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.517 -0.74 . . . . 0.0 109.815 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.806 HD21 HD12 ' A' ' 35' ' ' ILE . 7.5 tp -78.06 -25.2 47.61 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.992 -1.067 . . . . 0.0 108.741 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 150' ' ' ARG . 1.8 mt-10 -66.28 -51.15 60.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.922 . . . . 0.0 109.18 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -55.3 25.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.395 -0.816 . . . . 0.0 109.336 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 152' ' ' PHE . 18.6 m -95.4 43.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.262 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.455 ' HG2' ' HG ' ' A' ' 153' ' ' LEU . 1.8 tmm_? . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.567 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 54.72 175.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.31 -0.869 . . . . 0.0 109.502 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -102.33 -169.14 1.63 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.373 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 6' ' ' LYS . 3.9 p -64.71 151.23 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 1.03 HG22 ' HA ' ' A' ' 38' ' ' ASN . 18.1 p -49.99 90.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.329 -0.857 . . . . 0.0 109.571 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.639 ' HB3' ' CZ3' ' A' ' 39' ' ' TRP . 0.7 OUTLIER -45.19 170.14 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.035 -1.04 . . . . 0.0 109.396 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.55 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -142.39 146.91 35.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.029 -1.045 . . . . 0.0 109.811 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.876 HG12 ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -150.78 146.08 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -0.863 . . . . 0.0 109.037 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.639 HD13 ' CD1' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -133.01 126.74 32.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.722 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.442 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.6 OUTLIER -109.18 124.39 50.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 108.897 179.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.505 HG13 ' C ' ' A' ' 44' ' ' GLY . 2.1 t -125.35 158.19 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.149 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 91' ' ' MET . 0.6 OUTLIER -177.99 131.2 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.794 . . . . 0.0 109.185 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.502 ' HB2' ' ND2' ' A' ' 95' ' ' ASN . 0.7 OUTLIER -43.7 149.98 0.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 109.579 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.468 ' HA2' ' OD1' ' A' ' 50' ' ' ASN . . . 46.76 66.57 1.74 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.495 ' ND2' ' HG3' ' A' ' 20' ' ' PRO . 2.7 t-20 -88.8 67.64 8.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -1.113 . . . . 0.0 109.695 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -138.71 6.46 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.154 -0.966 . . . . 0.0 109.731 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.647 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 1.7 p 179.75 138.21 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.017 . . . . 0.0 109.618 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.647 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 1.9 mtm180 83.6 -48.6 0.13 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.815 -0.553 . . . . 0.0 109.65 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.615 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -82.97 -48.53 0.79 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 110.175 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 19' ' ' SER . 63.4 Cg_exo -49.58 -19.4 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 121.957 1.771 . . . . 0.0 111.047 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.956 HG21 ' HA ' ' A' ' 142' ' ' TYR . 2.5 mp -64.29 -44.93 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.87 -1.144 . . . . 0.0 109.4 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.199 ' HB2' ' SG ' ' A' ' 145' ' ' CYS . . . -61.36 -35.29 77.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.154 -0.966 . . . . 0.0 109.507 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' OE2' ' HB2' ' A' ' 43' ' ' SER . 2.4 tt0 -70.19 -69.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.236 -0.915 . . . . 0.0 109.317 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.832 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . -43.64 -33.31 1.17 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 109.135 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.987 HG11 ' HA ' ' A' ' 146' ' ' VAL . 58.7 t -65.26 -49.62 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -0.864 . . . . 0.0 108.754 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.836 ' CE2' HG11 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -50.41 -29.85 11.09 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.477 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -68.48 -50.71 50.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.262 -0.899 . . . . 0.0 109.2 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.0 -20.07 66.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.776 HD11 HG12 ' A' ' 25' ' ' VAL . 11.5 mt -86.97 -28.34 22.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.047 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 36' ' ' SER . 2.5 p -90.22 -8.85 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.96 0.95 22.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -115.01 45.93 1.52 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.004 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.574 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 1.0 OUTLIER -178.7 29.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' GLN . 1.5 t30 45.35 45.88 10.14 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.76 HG12 HG23 ' A' ' 30' ' ' VAL . 1.3 tt -127.39 -1.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.229 0.538 . . . . 0.0 109.795 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.814 ' HA ' HG22 ' A' ' 30' ' ' VAL . 45.8 t -74.08 -45.83 46.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.737 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.87 -12.67 8.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 110.225 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 1.03 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -116.02 37.28 3.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.986 -1.071 . . . . 0.0 109.993 -179.642 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.876 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 12.8 m95 -150.48 157.76 43.38 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.854 -1.153 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.87 72.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.473 HG21 ' HB3' ' A' ' 26' ' ' PHE . 2.5 mp -89.47 141.13 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 110.248 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -148.23 -165.83 2.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.503 -0.748 . . . . 0.0 109.048 179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.462 ' HB2' ' OE2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -165.67 165.82 18.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.142 -0.974 . . . . 0.0 109.685 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.505 ' C ' HG13 ' A' ' 11' ' ' VAL . . . 178.39 -170.48 42.56 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.38 -176.67 3.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.199 . . . . 0.0 109.346 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.812 HG13 ' HG ' ' A' ' 99' ' ' LEU . 39.3 t -93.7 -0.37 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.823 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.56 -178.24 6.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.514 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 2.0 p-10 -84.3 69.36 10.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 2.2 m95 -99.26 -77.68 0.52 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.294 -0.879 . . . . 0.0 109.423 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.468 ' OD1' ' HA2' ' A' ' 14' ' ' GLY . 30.5 m120 -96.0 37.67 1.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.357 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 48' ' ' ASP . 80.1 t -64.33 106.84 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.458 ' HA2' ' HG2' ' A' ' 73' ' ' LYS . . . 106.69 -34.14 5.93 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.601 ' O ' HG22 ' A' ' 16' ' ' ILE . 1.5 mtt180 -61.59 96.91 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -1.174 . . . . 0.0 109.487 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.75 164.55 1.59 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.483 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 56' ' ' ASP . 53.4 Cg_exo -50.57 119.52 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.035 1.823 . . . . 0.0 110.231 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -43.41 150.07 0.54 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.688 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.59 ' HA ' ' CG1' ' A' ' 60' ' ' VAL . 50.9 Cg_exo -52.13 -18.03 6.73 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.098 1.865 . . . . 0.0 110.613 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -78.76 -46.04 19.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.052 -1.03 . . . . 0.0 109.889 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . . . -90.04 1.91 55.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -0.937 . . . . 0.0 110.055 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.59 ' CG1' ' HA ' ' A' ' 57' ' ' PRO . 5.5 p -90.02 -44.61 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.048 -1.032 . . . . 0.0 109.681 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.535 ' N ' HG13 ' A' ' 60' ' ' VAL . 53.3 p -79.07 -15.56 58.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.599 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.446 ' C ' HD23 ' A' ' 63' ' ' LEU . 1.2 m -73.8 -27.6 61.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 109.349 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.806 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -89.44 -52.57 4.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 108.943 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -14.09 16.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.814 . . . . 0.0 109.554 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -68.23 -61.06 2.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.547 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -69.67 -35.21 74.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.155 -0.966 . . . . 0.0 109.598 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.419 ' O ' ' C ' ' A' ' 68' ' ' ILE . . . 141.11 -10.11 2.77 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.832 ' CG2' ' HB1' ' A' ' 24' ' ' ALA . 17.0 mm -43.82 159.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.239 -1.154 . . . . 0.0 109.626 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.494 ' N ' HG22 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -131.5 175.37 9.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.853 . . . . 0.0 109.456 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.522 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -160.09 -86.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 70' ' ' THR . . . 65.62 16.76 10.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.472 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.574 ' CE1' ' OD1' ' A' ' 42' ' ' ASP . 24.8 t60 -126.4 149.35 49.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.953 . . . . 0.0 109.46 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 0.4 OUTLIER -101.58 140.99 35.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.249 -0.907 . . . . 0.0 109.491 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 75' ' ' ARG . . . -42.56 -66.25 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.384 -0.822 . . . . 0.0 109.723 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER 65.31 164.9 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.343 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.483 ' HG2' ' N ' ' A' ' 77' ' ' VAL . 47.8 tt0 -100.98 156.01 17.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.483 ' N ' ' HG2' ' A' ' 76' ' ' GLN . 91.7 t -81.22 146.96 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.925 . . . . 0.0 109.467 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -142.61 161.1 38.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.521 -179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.55 ' HG2' HG13 ' A' ' 106' ' ' VAL . 2.4 tmtt? -42.87 -34.77 1.01 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.469 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' OG1' ' A' ' 84' ' ' THR . 1.0 OUTLIER -61.57 -53.25 58.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.293 -0.879 . . . . 0.0 109.681 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.42 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 3.5 m-20 -66.93 -19.01 65.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.904 . . . . 0.0 109.823 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.897 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 13.1 m-85 -68.88 -68.59 0.39 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 109.532 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.647 HG23 ' HB3' ' A' ' 110' ' ' ARG . 9.9 p -67.29 -23.25 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 4.6 m -60.65 -67.59 0.38 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.639 ' CD1' HD13 ' A' ' 9' ' ' LEU . 82.5 m-85 -74.83 156.21 36.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 0.0 109.532 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.447 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -90.32 -36.33 14.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.322 -0.861 . . . . 0.0 109.387 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 7' ' ' SER . 17.5 m-85 -109.77 151.91 26.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.575 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.93 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 1.7 mt -153.69 80.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 108.833 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.507 HD21 ' CE1' ' A' ' 152' ' ' PHE . 0.1 OUTLIER -91.58 -174.75 3.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 109.583 -179.436 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.736 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -148.31 172.15 14.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.303 -0.873 . . . . 0.0 109.212 179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.736 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.0 OUTLIER -84.54 45.4 1.13 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 109.704 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.463 ' OD2' ' CG2' ' A' ' 127' ' ' ILE . 2.6 m-20 65.15 -144.52 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.537 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 128' ' ' GLU . 27.6 mt-10 73.5 158.4 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.6 m -81.08 6.41 13.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.624 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 13' ' ' LEU . 2.9 m120 -71.8 -9.32 58.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 99' ' ' LEU . 4.4 mt -81.45 -10.16 59.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 109.414 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -61.28 -21.84 64.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.01 -39.58 8.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.833 . . . . 0.0 109.467 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.812 ' HG ' HG13 ' A' ' 46' ' ' VAL . 8.6 mt -66.94 -18.76 65.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.93 . . . . 0.0 109.39 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -77.89 -33.48 51.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.86 -19.92 24.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.225 -0.922 . . . . 0.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.74 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -57.3 -35.09 69.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.854 . . . . 0.0 109.452 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.538 ' HA ' ' SG ' ' A' ' 109' ' ' CYS . 0.3 OUTLIER -50.2 -49.09 53.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.375 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -64.71 -36.23 83.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.136 -0.977 . . . . 0.0 109.436 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.59 -4.8 55.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.212 -0.93 . . . . 0.0 109.473 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.957 HG11 ' SG ' ' A' ' 109' ' ' CYS . 41.2 t -86.32 117.98 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.397 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 108' ' ' ASN . 0.1 OUTLIER -53.14 105.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 0.0 108.644 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.457 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 15.7 m120 60.52 70.68 0.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.033 -1.042 . . . . 0.0 108.576 -179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.957 ' SG ' HG11 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -88.57 136.44 32.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 110.364 -179.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.647 ' HB3' HG23 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -128.96 1.81 5.31 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.93 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -83.3 110.58 18.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.446 -0.784 . . . . 0.0 110.164 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.16 125.39 26.23 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -100.04 132.0 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.94 -1.1 . . . . 0.0 110.29 -179.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 10.3 mt-10 -163.79 -174.04 3.49 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -125.24 165.87 17.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.99 HD21 ' SG ' ' A' ' 148' ' ' CYS . 3.5 tp -42.51 -74.4 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.701 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.88 -110.73 3.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.565 ' O ' ' CD1' ' A' ' 119' ' ' TYR . 1.8 t -151.56 136.24 17.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -1.165 . . . . 0.0 109.461 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 118' ' ' SER . 23.9 m-85 -136.76 32.14 2.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.929 . . . . 0.0 109.586 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.578 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 163.06 -51.53 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.0 Cg_exo -49.46 162.62 0.53 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.799 1.666 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.77 45.04 1.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.883 . . . . 0.0 109.43 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.37 166.43 33.24 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.147 -0.971 . . . . 0.0 109.413 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.03 90.08 4.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.343 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tt -103.04 138.68 39.57 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -0.925 . . . . 0.0 109.614 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.494 HG22 ' HG3' ' A' ' 128' ' ' GLU . 12.0 mm -143.93 125.95 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.398 -0.813 . . . . 0.0 109.301 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 127' ' ' ILE . 1.5 tt -105.08 78.22 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 109.113 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.494 ' HG3' HG22 ' A' ' 126' ' ' ILE . 6.7 mt-10 -77.12 -95.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.406 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 128' ' ' GLU . 2.0 m-20 47.51 95.12 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 109.323 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 131' ' ' TYR . 69.4 Cg_exo -47.33 -67.84 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.774 1.65 . . . . 0.0 110.347 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 130' ' ' PRO . 20.9 t80 178.83 61.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.505 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 133' ' ' GLY . 87.9 m-85 -141.14 16.92 2.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.887 . . . . 0.0 109.457 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 132' ' ' TYR . . . 59.23 154.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -120.96 -26.81 5.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -1.114 . . . . 0.0 109.471 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.84 -160.92 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.22 -0.925 . . . . 0.0 109.362 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.67 77.34 6.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.405 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.21 108.96 4.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -0.919 . . . . 0.0 109.519 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 8.9 t80 -123.23 -51.28 1.88 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -0.879 . . . . 0.0 109.497 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -69.62 -33.28 72.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.503 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.2 m -49.2 -43.87 42.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.464 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.7 t -65.9 -48.2 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.848 . . . . 0.0 109.493 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.956 ' HA ' HG21 ' A' ' 21' ' ' ILE . 2.8 t80 -53.0 -27.98 21.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.332 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -83.73 -38.29 21.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.167 -0.958 . . . . 0.0 109.82 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -75.54 -11.43 60.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.686 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 1.199 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -89.97 -10.35 45.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.987 ' HA ' HG11 ' A' ' 25' ' ' VAL . 53.5 t -62.01 -48.94 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 109.234 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 1.2 mtt180 -79.72 -15.0 58.34 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.178 -0.951 . . . . 0.0 109.376 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.99 ' SG ' HD21 ' A' ' 116' ' ' LEU . 21.2 m -50.16 -24.0 2.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.086 -1.009 . . . . 0.0 108.635 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.605 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.5 OUTLIER -120.18 -39.17 2.83 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.443 -0.786 . . . . 0.0 109.025 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.463 ' HG3' HD22 ' A' ' 29' ' ' LEU . 13.7 ttp85 -63.6 -53.71 47.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 108.703 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -60.17 -36.13 76.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.462 -0.774 . . . . 0.0 109.175 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.949 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 6.8 t80 -74.84 -19.12 60.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.384 -0.822 . . . . 0.0 109.515 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.455 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 14.4 tp -77.96 -19.59 54.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.099 -1.0 . . . . 0.0 108.744 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -70.59 -46.89 62.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.335 -0.853 . . . . 0.0 108.769 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -66.74 -53.71 30.48 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.859 . . . . 0.0 108.986 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.949 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 5.7 m -92.72 34.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 0.0 109.086 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.455 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 117.944 -1.026 . . . . 0.0 109.587 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' CB ' ' O ' ' A' ' 1' ' ' ALA . 2.1 tt0 68.12 34.53 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.834 . . . . 0.0 109.526 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.61 42.68 3.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 5' ' ' THR . 9.9 p -75.16 162.84 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 1.098 HG22 ' HA ' ' A' ' 38' ' ' ASN . 65.8 p -74.68 108.82 7.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.0 109.382 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.661 ' CB ' ' CH2' ' A' ' 39' ' ' TRP . 35.8 mttp -63.7 -168.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.9 -1.125 . . . . 0.0 108.993 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.575 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -145.99 107.28 4.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 109.834 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.726 HG12 ' CE3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -111.86 150.57 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.713 HD22 HG12 ' A' ' 88' ' ' ILE . 1.4 tt -149.83 104.17 3.29 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.139 -0.975 . . . . 0.0 109.555 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.483 ' HE1' HD12 ' A' ' 116' ' ' LEU . 2.8 m-85 -81.96 164.38 21.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.95 . . . . 0.0 109.379 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.783 HG11 HD11 ' A' ' 99' ' ' LEU . 58.5 t -150.31 161.87 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.133 -0.979 . . . . 0.0 109.936 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.526 ' N ' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -178.4 142.09 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.39 179.84 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.732 HD11 ' HH2' ' A' ' 49' ' ' TRP . 13.2 tp -43.58 -79.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.686 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 15' ' ' ASN . . . -46.99 -74.33 0.25 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.524 HD22 ' HB2' ' A' ' 45' ' ' ALA . 25.8 t30 76.61 20.47 1.42 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -1.124 . . . . 0.0 109.321 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 15' ' ' ASN . 1.2 pp -156.65 30.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.275 -0.89 . . . . 0.0 109.444 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.6 m -135.01 -84.84 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.585 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.543 ' HB2' ' CG2' ' A' ' 141' ' ' VAL . 0.0 OUTLIER -115.42 -7.84 12.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.58 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -75.06 -51.02 3.68 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.786 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 19' ' ' SER . 55.9 Cg_exo -49.66 -21.23 5.23 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.855 1.703 . . . . 0.0 110.674 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.982 HG21 ' HA ' ' A' ' 142' ' ' TYR . 7.9 mm -60.31 -48.6 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.315 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.576 ' N ' ' SG ' ' A' ' 145' ' ' CYS . . . -64.72 -20.27 66.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.932 . . . . 0.0 109.738 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.513 ' OE1' ' CB ' ' A' ' 43' ' ' SER . 4.7 mt-10 -77.22 -81.85 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.12 -0.987 . . . . 0.0 109.521 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.686 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -45.21 -40.28 7.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.31 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.022 ' HA ' HD11 ' A' ' 68' ' ' ILE . 54.1 t -59.87 -51.34 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.22 -0.925 . . . . 0.0 109.402 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.919 ' CE1' HG12 ' A' ' 30' ' ' VAL . 1.2 t80 -46.41 -42.06 14.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.024 . . . . 0.0 108.698 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -55.12 -59.81 4.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.538 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 0.1 OUTLIER -76.73 2.88 13.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.823 -179.718 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.691 HD11 HG13 ' A' ' 146' ' ' VAL . 3.2 mt -94.0 -29.89 15.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.149 -0.97 . . . . 0.0 108.733 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.919 HG12 ' CE1' ' A' ' 26' ' ' PHE . 1.0 OUTLIER -84.54 -42.51 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.569 ' CA ' ' HB3' ' A' ' 36' ' ' SER . 1.9 t -42.47 -28.32 0.21 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 30' ' ' VAL . 5.7 t70 -58.07 -55.34 36.15 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.474 -0.766 . . . . 0.0 108.992 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.548 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -73.08 -2.79 22.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.91 . . . . 0.0 109.368 179.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.5 OUTLIER 79.91 54.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.395 -0.815 . . . . 0.0 109.589 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.664 HD11 HD21 ' A' ' 153' ' ' LEU . 5.7 pt -144.78 9.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.141 -0.974 . . . . 0.0 109.987 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.637 ' HA ' ' CG2' ' A' ' 30' ' ' VAL . 9.7 p -69.16 -22.88 63.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.85 -1.156 . . . . 0.0 109.124 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -81.74 -20.64 38.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.312 -0.868 . . . . 0.0 108.799 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 1.098 ' HA ' HG22 ' A' ' 5' ' ' THR . 3.0 m-80 -110.31 44.54 1.22 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.349 -0.845 . . . . 0.0 109.283 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.726 ' CE3' HG12 ' A' ' 8' ' ' VAL . 10.9 m95 -150.66 129.46 12.42 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.611 -1.236 . . . . 0.0 110.746 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 40' ' ' VAL . 56.6 t -99.14 79.21 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.567 HG12 ' CD2' ' A' ' 26' ' ' PHE . 6.9 mt -89.9 128.2 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.266 -0.896 . . . . 0.0 109.934 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -137.24 -159.53 0.96 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.482 -0.761 . . . . 0.0 109.06 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.513 ' CB ' ' OE1' ' A' ' 23' ' ' GLU . 60.3 p -151.85 172.53 16.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.112 -0.992 . . . . 0.0 109.852 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.529 ' HA3' HG22 ' A' ' 11' ' ' VAL . . . -146.8 163.45 28.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.524 ' HB2' HD22 ' A' ' 15' ' ' ASN . . . -128.92 -29.53 2.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.187 -1.184 . . . . 0.0 109.878 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.501 HG23 ' CG1' ' A' ' 11' ' ' VAL . 15.8 t 67.23 9.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 109.332 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.593 ' HB3' ' CE2' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -125.43 141.19 52.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.905 . . . . 0.0 109.358 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' HA ' ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -84.01 6.28 22.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 109.697 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.732 ' HH2' HD11 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -102.9 -33.56 9.28 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.172 -0.955 . . . . 0.0 109.409 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.435 ' HA ' ' CD ' ' A' ' 53' ' ' ARG . 3.2 m120 -91.98 12.65 21.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.086 -1.009 . . . . 0.0 109.397 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 75' ' ' ARG . 13.3 t -75.33 85.22 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.74 -5.38 9.84 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.438 ' HB2' HG21 ' A' ' 16' ' ' ILE . 18.5 mtp180 -79.64 104.16 10.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -1.188 . . . . 0.0 109.468 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 0.6 OUTLIER -66.04 173.98 1.89 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.375 -0.828 . . . . 0.0 109.59 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 54' ' ' SER . 53.3 Cg_exo -50.75 137.96 41.78 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.066 1.844 . . . . 0.0 110.288 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.411 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -57.37 145.71 66.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.416 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.706 ' O ' HG12 ' A' ' 60' ' ' VAL . 52.5 Cg_exo -50.5 -22.38 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.969 1.78 . . . . 0.0 110.345 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -85.55 -37.71 19.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.534 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.88 -4.91 59.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 109.674 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -80.82 -28.37 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -81.98 -19.01 41.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 0.0 109.498 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.467 ' C ' HD23 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -74.05 -33.91 63.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.511 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.781 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.14 -56.16 3.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.135 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.98 -22.62 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.417 -0.802 . . . . 0.0 109.744 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 61' ' ' SER . 52.2 t-20 -70.66 -50.89 31.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.145 -0.972 . . . . 0.0 109.67 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -83.48 -5.04 59.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.945 . . . . 0.0 109.696 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.66 102.3 0.26 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.022 HD11 ' HA ' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -126.23 -33.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -1.118 . . . . 0.0 109.56 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 13.0 m-80 70.77 49.42 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.355 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.85 142.39 57.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.436 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.85 18.17 1.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.502 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.547 ' C ' ' CD2' ' A' ' 72' ' ' HIS . 2.4 p-80 -103.01 155.42 18.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' ALA . 11.9 tptt -124.75 26.77 7.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.51 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 73' ' ' LYS . . . 56.94 161.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.611 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.564 ' HA ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -168.27 171.74 9.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.407 -0.808 . . . . 0.0 109.256 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.482 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 2.6 tt0 -93.19 21.2 6.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.321 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 78' ' ' THR . 0.8 OUTLIER 52.2 178.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 109.598 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER 176.0 162.86 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.654 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -44.11 -35.99 2.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 109.469 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 84' ' ' THR . 2.9 tp10 -59.61 -48.86 80.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.783 . . . . 0.0 109.555 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.441 ' O ' HD11 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -65.3 -13.3 58.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.744 ' HA ' ' HB2' ' A' ' 111' ' ' ALA . 6.3 m-85 -80.64 -75.86 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.34 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.729 HG23 ' HG2' ' A' ' 110' ' ' ARG . 14.8 p -54.08 -38.05 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.888 . . . . 0.0 108.81 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.512 ' N ' HG13 ' A' ' 83' ' ' VAL . 38.8 m -58.02 -65.34 0.66 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.657 -0.652 . . . . 0.0 109.451 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.587 ' CE2' ' HB2' ' A' ' 42' ' ' ASP . 79.2 m-85 -81.36 125.3 30.21 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.33 -0.856 . . . . 0.0 109.499 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 110' ' ' ARG . 0.3 OUTLIER -73.8 -17.08 61.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.312 -0.867 . . . . 0.0 109.406 -179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 7' ' ' SER . 4.4 m-85 -130.07 131.08 45.63 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.187 -0.946 . . . . 0.0 109.861 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.852 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 5.1 mt -135.48 88.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 108.754 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -104.74 165.48 11.03 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.856 -1.152 . . . . 0.0 109.968 -179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.657 ' SG ' ' N ' ' A' ' 91' ' ' MET . 0.0 OUTLIER -143.43 166.77 23.85 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.657 ' N ' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -68.47 139.88 55.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 0.0 109.325 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.495 ' HB2' HD12 ' A' ' 126' ' ' ILE . 52.9 t0 -43.88 126.02 4.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 1.2 tt0 176.21 161.31 0.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.294 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -75.76 -6.86 52.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -74.73 -7.87 54.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.913 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.646 ' HG ' ' SG ' ' A' ' 90' ' ' CYS . 0.6 OUTLIER -89.19 7.04 37.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.937 . . . . 0.0 109.645 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -14.73 58.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 99' ' ' LEU . 2.8 p30 -92.77 -33.64 14.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.553 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.785 ' HB3' HG21 ' A' ' 113' ' ' ILE . 20.3 mt -71.58 -37.33 71.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.234 -0.916 . . . . 0.0 109.57 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.07 -31.69 71.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.543 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -10.0 45.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.547 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -71.69 -24.03 61.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -0.95 . . . . 0.0 109.56 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.41 ' HB2' ' SG ' ' A' ' 109' ' ' CYS . 1.8 p -70.02 -11.31 60.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -89.6 -23.97 21.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.581 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -102.7 8.99 39.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.219 -0.925 . . . . 0.0 109.499 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.654 HG13 ' HG2' ' A' ' 79' ' ' LYS . 24.4 t -101.85 143.37 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 109.345 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 108' ' ' ASN . 5.7 mtmt -75.31 121.75 22.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 109.298 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 107' ' ' LYS . 2.2 m120 43.78 41.45 3.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.172 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.518 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -42.92 142.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.349 -0.844 . . . . 0.0 110.138 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.729 ' HG2' HG23 ' A' ' 83' ' ' VAL . 24.5 mmm180 -123.39 -2.57 8.49 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.852 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -84.24 106.68 16.05 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.39 -0.819 . . . . 0.0 110.722 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.95 98.02 2.41 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.785 HG21 ' HB3' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -72.85 131.28 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -0.999 . . . . 0.0 110.483 -178.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 2.8 tt0 -172.8 148.54 1.86 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.602 ' HB3' HD12 ' A' ' 96' ' ' LEU . 1.6 pp -90.66 157.0 17.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.438 -1.414 . . . . 0.0 109.454 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.905 HD11 ' O ' ' A' ' 148' ' ' CYS . 0.1 OUTLIER -40.13 -68.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.483 -0.761 . . . . 0.0 109.925 -179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.563 ' N ' HD12 ' A' ' 115' ' ' LEU . . . 66.43 168.82 3.07 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.1 m -69.15 88.91 0.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.513 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.495 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -63.05 -37.25 86.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.454 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.569 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 166.68 -63.14 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.581 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 45.3 Cg_endo -68.72 -18.19 42.22 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.804 1.669 . . . . 0.0 110.365 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.89 162.27 19.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.265 -0.897 . . . . 0.0 109.27 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 124' ' ' GLN . 12.5 ptpt -143.35 54.14 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.932 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.449 ' CB ' ' O ' ' A' ' 123' ' ' LYS . 0.6 OUTLIER 71.74 61.11 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.479 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -158.35 44.36 0.3 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.922 . . . . 0.0 109.437 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -89.62 130.84 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.957 . . . . 0.0 109.387 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 126' ' ' ILE . 5.4 mt -41.58 99.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.376 -0.828 . . . . 0.0 109.749 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.47 ' HG2' ' OD2' ' A' ' 92' ' ' ASP . 31.5 mt-10 -117.53 28.94 8.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 0.0 109.38 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.13 148.3 35.69 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.326 -0.859 . . . . 0.0 109.517 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.1 -37.06 5.07 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.013 1.808 . . . . 0.0 110.114 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -161.79 -53.16 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.238 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.42 ' OH ' ' CD2' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -132.85 98.86 4.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.389 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.21 -47.51 89.24 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.15 -164.24 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -1.134 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.618 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -104.31 150.76 24.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.925 . . . . 0.0 109.455 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 135' ' ' ASP . . . 70.56 11.38 7.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.57 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 141' ' ' VAL . 0.5 OUTLIER -97.51 10.45 39.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.562 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.452 ' O ' HG12 ' A' ' 141' ' ' VAL . 0.1 OUTLIER -76.16 -16.12 59.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.476 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -90.06 -51.8 5.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.609 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 140' ' ' THR . 1.0 OUTLIER -67.73 -19.25 65.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.556 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.56 HG13 ' N ' ' A' ' 142' ' ' TYR . 5.2 p -75.34 -47.4 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.912 . . . . 0.0 109.227 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.982 ' HA ' HG21 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -60.27 -39.5 87.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.52 -39.83 85.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.412 -0.805 . . . . 0.0 109.485 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.437 ' NE2' ' HB3' ' A' ' 125' ' ' LEU . 10.7 mm100 -62.95 -33.76 76.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.307 -0.87 . . . . 0.0 109.356 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.768 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 1.2 m -62.18 -21.51 65.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.226 -0.921 . . . . 0.0 109.498 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.691 HG13 HD11 ' A' ' 29' ' ' LEU . 86.6 t -56.47 -58.67 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 108.882 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.14 -13.18 61.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.364 -0.835 . . . . 0.0 109.248 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.905 ' O ' HD11 ' A' ' 116' ' ' LEU . 99.6 m -62.77 -12.3 23.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.565 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . 0.1 OUTLIER -125.53 -37.33 2.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -59.35 -42.4 91.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.282 -0.886 . . . . 0.0 109.158 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.31 -23.36 67.38 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 109.091 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 1.137 ' CZ ' HG21 ' A' ' 156' ' ' VAL . 1.5 t80 -89.17 -22.95 22.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.829 . . . . 0.0 109.528 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.664 HD21 HD11 ' A' ' 35' ' ' ILE . 21.4 tp -77.12 -18.03 58.22 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.919 -1.113 . . . . 0.0 108.9 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.86 -47.89 19.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.15 -0.969 . . . . 0.0 109.116 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -67.01 -52.74 38.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 108.977 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 1.137 HG21 ' CZ ' ' A' ' 152' ' ' PHE . 31.4 m -95.19 31.86 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.367 -0.833 . . . . 0.0 109.078 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.536 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.595 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -104.6 115.76 30.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.513 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -76.38 151.63 36.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.326 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 5' ' ' THR . 7.2 t -133.67 167.06 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.81 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.893 HG22 ' HA ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -78.12 77.93 4.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.427 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.649 ' CG ' ' CE1' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -41.22 118.08 0.97 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.342 -0.849 . . . . 0.0 109.657 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -107.01 122.54 46.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.931 -1.105 . . . . 0.0 109.786 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.943 ' O ' HG23 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -125.92 122.39 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 0.0 109.543 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.561 HD21 HD11 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -122.11 145.24 48.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.27 -0.893 . . . . 0.0 108.89 179.437 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 4.0 m-85 -103.86 158.74 16.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.082 -1.011 . . . . 0.0 109.884 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.741 HG22 ' HA3' ' A' ' 44' ' ' GLY . 85.7 t -144.28 147.06 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.416 -0.803 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -160.38 141.46 12.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 109.534 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' CYS . 9.2 tp -44.49 -68.06 0.23 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.236 -0.915 . . . . 0.0 109.476 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.18 -79.95 0.08 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.479 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 2.0 t-20 65.85 39.19 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.125 -1.221 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 1.7 pp -143.75 13.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.601 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 40.9 t 177.21 -71.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.728 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 19' ' ' SER . 65.6 mtt85 -84.4 75.9 10.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.682 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.581 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.6 OUTLIER 163.19 -50.99 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.697 179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 19' ' ' SER . 51.3 Cg_exo -51.59 -19.63 7.71 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.865 1.71 . . . . 0.0 110.589 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.758 HG22 ' SG ' ' A' ' 145' ' ' CYS . 3.4 mt -75.64 -39.77 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.949 . . . . 0.0 109.81 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 1.253 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -62.99 -40.05 96.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.048 -1.033 . . . . 0.0 109.375 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -70.92 -59.22 2.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.908 . . . . 0.0 109.208 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.829 ' HB1' HG22 ' A' ' 68' ' ' ILE . . . -45.95 -34.38 3.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.9 . . . . 0.0 108.992 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.007 HG11 ' HA ' ' A' ' 146' ' ' VAL . 46.0 t -66.25 -47.52 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.35 -0.844 . . . . 0.0 109.284 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.706 ' CZ ' HG11 ' A' ' 8' ' ' VAL . 1.9 t80 -47.98 -43.47 29.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.827 -1.171 . . . . 0.0 108.02 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.475 ' O ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER -54.2 -62.86 1.38 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.067 179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -79.92 10.76 3.86 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.271 -0.893 . . . . 0.0 110.221 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.832 HD22 ' SG ' ' A' ' 149' ' ' CYS . 48.7 tp -98.58 -34.68 10.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 108.911 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.749 HG23 HG12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -90.86 -44.44 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.247 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -49.35 -29.1 5.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -0.916 . . . . 0.0 109.138 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -80.68 -37.1 31.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 108.993 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.531 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 0.5 OUTLIER -73.21 -11.0 60.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.413 179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 33' ' ' GLN . 0.2 OUTLIER 78.49 32.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.713 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.781 HD13 HD21 ' A' ' 153' ' ' LEU . 4.6 pt -123.21 3.77 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 109.431 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.593 ' CA ' ' CG2' ' A' ' 30' ' ' VAL . 60.7 p -62.87 -31.38 72.4 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.097 -1.002 . . . . 0.0 109.457 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -54.85 -25.17 26.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.45 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.893 ' HA ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -126.66 40.21 3.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -0.92 . . . . 0.0 109.751 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.738 ' CZ3' HG12 ' A' ' 8' ' ' VAL . 21.9 m95 -146.92 104.78 3.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.968 -1.083 . . . . 0.0 110.33 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' SER . 45.0 t -97.74 106.77 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.943 HG23 ' O ' ' A' ' 8' ' ' VAL . 3.6 mp -107.37 146.58 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.066 -1.021 . . . . 0.0 110.501 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.444 ' C ' ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -140.66 -164.93 1.83 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.792 . . . . 0.0 109.496 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.1 176.89 8.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.377 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.741 ' HA3' HG22 ' A' ' 11' ' ' VAL . . . -163.86 159.21 31.93 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.489 ' C ' HG23 ' A' ' 46' ' ' VAL . . . -129.78 -31.03 2.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -1.153 . . . . 0.0 109.72 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.646 HG23 ' CG1' ' A' ' 11' ' ' VAL . 3.8 t 74.76 6.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.172 -0.955 . . . . 0.0 109.498 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.462 ' HB2' ' CD2' ' A' ' 49' ' ' TRP . 5.5 p -126.5 126.63 44.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.931 . . . . 0.0 109.433 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.5 2.59 15.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.577 ' CD1' ' N ' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -102.27 1.46 35.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -0.997 . . . . 0.0 109.362 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -122.05 8.82 9.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.311 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.676 HG13 ' HA ' ' A' ' 75' ' ' ARG . 7.0 t -71.51 92.3 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.301 -0.874 . . . . 0.0 109.436 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . 116.41 7.13 14.48 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -84.45 82.94 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -1.165 . . . . 0.0 109.45 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.469 ' HB3' ' HD2' ' A' ' 73' ' ' LYS . 86.1 p -43.63 153.28 0.4 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.345 -0.847 . . . . 0.0 109.482 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 54' ' ' SER . 54.1 Cg_exo -49.98 -176.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.979 1.786 . . . . 0.0 110.258 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.18 139.08 36.47 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.393 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.629 ' O ' HG12 ' A' ' 60' ' ' VAL . 52.3 Cg_exo -51.03 -21.1 8.31 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.879 1.719 . . . . 0.0 110.369 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -87.94 -39.55 14.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.661 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.49 6.3 34.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.21 -0.931 . . . . 0.0 109.553 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 57' ' ' PRO . 9.9 p -85.39 -38.25 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.927 . . . . 0.0 109.513 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.458 ' N ' HG13 ' A' ' 60' ' ' VAL . 4.2 m -76.55 -15.85 59.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.355 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.454 ' C ' HD23 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -70.25 -29.43 66.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.846 . . . . 0.0 109.433 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.811 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -87.8 -55.32 3.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 108.902 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.5 ttp85 -64.09 -10.51 22.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 109.563 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -59.06 -84.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.811 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.48 ' CD2' ' H ' ' A' ' 66' ' ' HIS . 8.0 p80 -74.53 -24.91 59.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.173 -0.954 . . . . 0.0 109.773 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.447 ' O ' HG12 ' A' ' 68' ' ' ILE . . . 131.32 109.94 1.28 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.829 HG22 ' HB1' ' A' ' 24' ' ' ALA . 14.3 mm -150.16 -38.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -1.1 . . . . 0.0 109.603 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 68' ' ' ILE . 4.8 p30 51.63 173.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.405 -0.81 . . . . 0.0 109.627 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.464 HG23 ' C ' ' A' ' 69' ' ' ASN . 20.5 p -157.43 -54.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 57.81 34.6 24.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.364 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -149.23 124.63 10.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.544 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 1.1 tppm? -98.21 27.36 4.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.902 . . . . 0.0 109.575 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 73' ' ' LYS . . . 73.91 131.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.0 109.527 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.676 ' HA ' HG13 ' A' ' 51' ' ' VAL . 5.5 mmt180 -143.95 142.22 30.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.934 . . . . 0.0 109.535 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.458 ' O ' ' O ' ' A' ' 77' ' ' VAL . 2.2 tt0 -66.2 119.94 12.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 78' ' ' THR . 4.1 t -45.43 170.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.489 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.516 ' H ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -153.78 175.9 12.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.445 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HG2' HG13 ' A' ' 106' ' ' VAL . 2.5 tmtt? -68.05 -45.03 75.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 109.624 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' O ' ' OG1' ' A' ' 84' ' ' THR . 37.3 tt0 -57.98 -44.86 87.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.543 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 1.3 m-20 -64.5 -30.35 71.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.801 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 78' ' ' THR . 12.5 m-85 -64.24 -67.01 0.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.131 -0.98 . . . . 0.0 109.755 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 110' ' ' ARG . 6.0 p -64.08 -20.07 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 80' ' ' GLU . 6.0 m -69.96 -32.68 71.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.367 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 81' ' ' ASP . 27.4 m-85 -106.37 158.45 16.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.488 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' C ' ' CD1' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -108.87 -2.57 18.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.631 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.649 ' CE1' ' CG ' ' A' ' 6' ' ' LYS . 5.8 m-85 -138.42 139.85 39.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.855 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -150.78 116.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.233 -0.917 . . . . 0.0 109.288 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.938 HD11 ' CE2' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -129.53 153.98 47.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.315 179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -122.72 169.83 10.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.36 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.451 ' HB2' ' HB2' ' A' ' 12' ' ' CYS . 6.3 mmt -81.06 74.1 8.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.896 . . . . 0.0 109.33 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 94' ' ' SER . 0.1 OUTLIER 39.68 -101.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.456 -0.778 . . . . 0.0 109.853 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 92' ' ' ASP . 45.9 mt-10 42.64 -96.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.072 -1.017 . . . . 0.0 109.262 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 96' ' ' LEU . 1.3 m -88.2 87.31 7.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 108.601 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -39.14 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.081 0.467 . . . . 0.0 110.773 -179.12 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.074 HD21 ' CG2' ' A' ' 113' ' ' ILE . 0.8 OUTLIER 32.72 36.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.119 0.485 . . . . 0.0 110.394 179.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 95' ' ' ASN . 7.3 ttt180 -91.21 -17.39 26.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.013 -1.054 . . . . 0.0 110.024 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.7 -51.01 2.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.101 -1.0 . . . . 0.0 110.046 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.6 HD12 ' SG ' ' A' ' 90' ' ' CYS . 11.4 mt -65.73 -18.38 65.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 109.807 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.729 ' HB2' HD22 ' A' ' 96' ' ' LEU . 7.7 t-20 -72.97 -22.91 60.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.969 . . . . 0.0 109.168 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 10.3 ttt-85 -89.68 -23.41 21.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.285 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.858 ' O ' HG23 ' A' ' 106' ' ' VAL . 10.9 mmmt -66.37 -30.12 70.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.343 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.0 p -72.87 -21.77 60.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.337 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -71.83 -35.21 69.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.296 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 102' ' ' LYS . 1.2 pt20 -89.06 2.8 53.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 0.0 109.487 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 102' ' ' LYS . 70.8 t -92.99 122.49 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.189 -0.944 . . . . 0.0 109.299 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -56.48 102.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.274 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 m120 52.48 59.22 4.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.146 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.549 ' SG ' ' N ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -54.25 156.96 2.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.4 -0.812 . . . . 0.0 109.803 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.549 ' N ' ' SG ' ' A' ' 109' ' ' CYS . 3.1 mtt180 -123.94 -23.06 4.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.445 -0.785 . . . . 0.0 109.367 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.855 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -70.55 92.41 0.84 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.377 -0.827 . . . . 0.0 110.278 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 101.57 0.05 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 1.074 ' CG2' HD21 ' A' ' 96' ' ' LEU . 1.8 mm -62.65 160.15 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.31 -0.869 . . . . 0.0 110.217 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.576 ' HB3' HD23 ' A' ' 89' ' ' LEU . 1.7 mt-10 173.82 -169.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 118' ' ' SER . 0.7 OUTLIER -147.06 156.87 43.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.925 -1.109 . . . . 0.0 109.582 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.718 HD11 ' HA ' ' A' ' 148' ' ' CYS . 1.0 OUTLIER -59.09 -40.91 86.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -48.74 -28.62 7.21 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -50.79 -49.01 59.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -1.104 . . . . 0.0 109.503 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -86.32 -94.19 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.197 -0.94 . . . . 0.0 109.693 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.477 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 5.3 t70 67.13 67.4 0.61 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.497 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 51.9 Cg_exo -51.62 -173.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.962 1.775 . . . . 0.0 110.208 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 55.07 -92.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.379 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 121' ' ' PRO . 12.0 pttt -102.92 148.34 25.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.337 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -97.26 119.86 36.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.426 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.74 -159.03 0.97 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.266 -0.896 . . . . 0.0 109.492 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.519 ' CG2' ' HG3' ' A' ' 128' ' ' GLU . 1.5 mm -127.92 -2.97 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.695 HG22 ' N ' ' A' ' 128' ' ' GLU . 39.9 mt 60.67 -89.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.145 -0.972 . . . . 0.0 109.265 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.695 ' N ' HG22 ' A' ' 127' ' ' ILE . 4.2 mt-10 45.62 68.52 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.547 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.83 119.54 51.07 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.224 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.46 178.1 5.36 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.773 1.649 . . . . 0.0 110.325 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.442 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 3.9 m-85 -74.16 -1.31 19.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.649 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 132' ' ' TYR . 0.3 OUTLIER -92.01 74.11 5.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.383 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 132' ' ' TYR . . . -57.11 -159.97 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.4 -53.7 5.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -1.167 . . . . 0.0 109.389 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -170.89 101.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 109.25 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 48.75 30.12 2.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.111 -0.993 . . . . 0.0 109.156 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.87 76.43 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.538 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -100.45 -16.75 17.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.37 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.69 -27.33 27.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 141' ' ' VAL . 54.9 m -56.09 -54.63 42.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.454 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' A' ' 18' ' ' ARG . 10.0 t -43.56 -55.05 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.273 -0.892 . . . . 0.0 109.262 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -48.51 -46.53 38.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.129 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.33 -58.21 8.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.876 . . . . 0.0 109.798 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -67.68 -7.18 24.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.18 -0.95 . . . . 0.0 109.419 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.758 ' SG ' HG22 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -83.19 -28.56 29.21 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.306 -0.871 . . . . 0.0 109.361 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 1.007 ' HA ' HG11 ' A' ' 25' ' ' VAL . 40.3 t -65.35 -50.73 71.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.259 -0.9 . . . . 0.0 109.309 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.41 -19.19 62.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.084 -1.01 . . . . 0.0 108.831 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 1.253 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -52.34 -25.03 8.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.285 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.832 ' SG ' HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -112.45 -33.29 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -0.835 . . . . 0.0 109.856 -179.626 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.775 ' CA ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -70.65 -56.84 5.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.108 -0.995 . . . . 0.0 109.307 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 154' ' ' GLU . . . -54.37 -21.97 11.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.545 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.98 ' O ' HG22 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -90.32 -29.57 18.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 109.763 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.781 HD21 HD13 ' A' ' 35' ' ' ILE . 10.7 tp -75.48 -25.22 57.16 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.939 -1.101 . . . . 0.0 109.0 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -71.31 -32.66 68.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.248 -0.907 . . . . 0.0 109.218 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.68 -43.45 18.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.184 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.98 HG22 ' O ' ' A' ' 152' ' ' PHE . 17.1 m -101.34 25.69 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.393 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.5 ' O ' ' NE ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.407 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 61.4 54.2 3.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -120.79 27.83 8.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.322 -0.861 . . . . 0.0 109.552 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.88 152.26 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.154 -0.966 . . . . 0.0 109.372 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.935 HG22 ' HA ' ' A' ' 38' ' ' ASN . 1.7 p -120.89 160.82 22.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.917 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.654 ' CB ' ' CZ3' ' A' ' 39' ' ' TRP . 11.2 mttm -108.48 -168.42 1.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.25 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.51 ' HB2' ' HA ' ' A' ' 85' ' ' PHE . 3.1 p -140.43 105.37 4.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.213 -0.929 . . . . 0.0 109.44 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.829 HG21 ' HE2' ' A' ' 26' ' ' PHE . 0.2 OUTLIER -122.86 143.11 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.412 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.61 HD22 HG12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -140.6 115.34 9.58 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -92.04 157.59 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 110.076 -179.169 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.984 HG11 HD11 ' A' ' 99' ' ' LEU . 16.8 t -140.35 142.16 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -0.785 . . . . 0.0 109.425 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' HA ' ' A' ' 15' ' ' ASN . 1.6 p -147.9 19.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 8.9 tp 63.64 -96.45 0.05 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 109.981 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 15' ' ' ASN . . . -47.33 -60.17 5.36 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.767 ' HA ' ' SG ' ' A' ' 12' ' ' CYS . 5.3 t-20 66.8 14.76 9.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -1.162 . . . . 0.0 109.302 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.886 HD12 ' N ' ' A' ' 17' ' ' CYS . 2.6 pp -135.71 -37.95 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.438 -0.789 . . . . 0.0 108.959 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.886 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -122.28 -24.05 5.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -56.84 -76.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.0 109.231 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.588 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 46.0 p 179.46 61.2 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 120.931 -1.106 . . . . 0.0 110.406 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 19' ' ' SER . 49.5 Cg_exo -56.12 -17.5 20.15 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.713 1.609 . . . . 0.0 110.052 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.977 ' O ' HG23 ' A' ' 25' ' ' VAL . 10.8 mm -41.6 -38.52 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.52 -0.737 . . . . 0.0 110.264 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.954 ' HB1' ' SG ' ' A' ' 148' ' ' CYS . . . -53.96 -51.39 64.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.042 . . . . 0.0 109.679 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -66.36 -56.77 9.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.082 -1.011 . . . . 0.0 109.356 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 1.029 ' HB1' HG12 ' A' ' 68' ' ' ILE . . . -46.7 -25.08 0.65 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.168 -0.958 . . . . 0.0 109.074 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.977 HG23 ' O ' ' A' ' 21' ' ' ILE . 84.6 t -78.36 -43.32 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.264 -0.898 . . . . 0.0 109.36 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.829 ' HE2' HG21 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -57.51 -21.44 37.88 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -58.57 3.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 28' ' ' LYS . 10.0 tmtt? -75.89 2.77 11.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.356 -0.84 . . . . 0.0 109.225 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.956 HD11 ' HG3' ' A' ' 150' ' ' ARG . 34.2 tp -102.78 -37.17 7.99 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.955 HG23 HG12 ' A' ' 35' ' ' ILE . 9.8 p -90.82 -4.87 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 31' ' ' THR . 8.6 m -106.2 11.46 31.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.728 -1.233 . . . . 0.0 109.401 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -127.6 53.83 1.73 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 109.138 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.564 ' HB3' ' CG2' ' A' ' 35' ' ' ILE . 0.6 OUTLIER 175.56 31.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.486 -179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 33' ' ' GLN . 2.8 t-20 46.18 37.06 3.6 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.955 HG12 HG23 ' A' ' 30' ' ' VAL . 2.0 tt -121.17 -4.6 9.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.693 -177.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.927 ' HA ' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -73.49 -53.26 11.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.058 -1.026 . . . . 0.0 110.506 -178.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 25.7 p-10 -56.93 -14.47 3.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.198 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.935 ' HA ' HG22 ' A' ' 5' ' ' THR . 69.6 m-20 -109.12 36.62 2.83 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.924 -1.11 . . . . 0.0 110.464 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.654 ' CZ3' ' CB ' ' A' ' 6' ' ' LYS . 17.8 m95 -150.95 136.9 18.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.486 -1.384 . . . . 0.0 111.516 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.97 74.5 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.518 ' CG1' HG13 ' A' ' 8' ' ' VAL . 3.1 mt -90.11 144.5 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.456 -0.777 . . . . 0.0 109.934 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.7 OUTLIER -142.31 -173.97 3.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 109.22 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.5 p -126.26 160.92 28.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.765 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -141.43 137.45 8.08 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.51 ' HB1' ' OD1' ' A' ' 50' ' ' ASN . . . -118.01 -9.29 10.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -1.194 . . . . 0.0 109.562 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.615 ' CG2' HG11 ' A' ' 11' ' ' VAL . 2.5 t 55.05 21.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.19 -0.944 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.4 ' C ' ' HG3' ' A' ' 76' ' ' GLN . 38.2 t -160.42 160.01 31.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.168 -0.958 . . . . 0.0 109.524 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.59 ' HA ' HG23 ' A' ' 51' ' ' VAL . 10.7 p-10 -105.5 11.68 32.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.536 ' CD1' ' C ' ' A' ' 49' ' ' TRP . 0.4 OUTLIER -88.04 11.13 16.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.543 -179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.539 HD22 ' HB1' ' A' ' 74' ' ' ALA . 3.4 p-10 -144.89 13.91 1.5 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 109.465 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 48' ' ' ASP . 67.2 t -65.16 112.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 0.0 109.249 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.37 22.53 58.54 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.538 ' O ' HG22 ' A' ' 16' ' ' ILE . 39.0 mtp180 -106.25 85.12 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.519 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 53' ' ' ARG . 2.5 p -46.36 162.22 0.26 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.281 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 56' ' ' ASP . 52.6 Cg_exo -50.51 140.65 35.34 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.897 1.731 . . . . 0.0 110.142 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' CB ' ' HD2' ' A' ' 57' ' ' PRO . 6.2 m-20 -43.75 166.08 0.11 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.466 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 56' ' ' ASP . 49.7 Cg_endo -70.91 -7.2 20.88 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.987 1.791 . . . . 0.0 110.193 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -90.19 -40.5 12.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.9 . . . . 0.0 109.365 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -89.6 -16.88 29.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.423 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 57' ' ' PRO . 7.0 p -57.25 -27.81 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.92 . . . . 0.0 109.548 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.2 OUTLIER -79.97 -48.82 12.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.408 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.506 ' SG ' ' CD2' ' A' ' 142' ' ' TYR . 6.3 t -45.76 -30.63 1.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.801 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -90.23 -45.1 9.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.935 . . . . 0.0 109.104 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.63 19.94 3.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.67 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 61' ' ' SER . 15.1 t-20 -91.35 -53.54 4.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.361 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.525 ' CE1' ' OH ' ' A' ' 142' ' ' TYR . 9.5 p80 -102.98 -31.79 10.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.881 . . . . 0.0 109.412 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 131.21 109.9 1.29 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.029 HG12 ' HB1' ' A' ' 24' ' ' ALA . 8.5 tp -120.98 -26.83 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -1.163 . . . . 0.0 109.428 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 1.3 m120 76.13 41.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.893 . . . . 0.0 109.413 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 70' ' ' THR . 5.2 t -63.38 110.64 1.99 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -0.88 . . . . 0.0 109.487 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -122.0 -23.55 5.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.469 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 22.7 t60 -84.74 132.76 34.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.295 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.469 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -95.91 154.17 17.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.203 -0.936 . . . . 0.0 109.542 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.539 ' HB1' HD22 ' A' ' 50' ' ' ASN . . . -46.6 169.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.517 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 76' ' ' GLN . 0.6 OUTLIER -169.16 161.48 10.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 109.484 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.54 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -96.61 128.77 43.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.528 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 46' ' ' VAL . 55.9 t -65.74 135.85 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 109.357 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -138.62 165.28 27.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.873 . . . . 0.0 109.505 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HG2' HG13 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -44.09 -39.1 4.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' O ' ' OG1' ' A' ' 84' ' ' THR . 28.3 tt0 -54.19 -53.28 55.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.885 . . . . 0.0 109.546 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 84' ' ' THR . 2.7 m-20 -50.92 -46.89 61.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.37 -0.831 . . . . 0.0 110.125 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.774 ' O ' ' HB2' ' A' ' 111' ' ' ALA . 77.6 m-85 -51.05 -63.11 1.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 108' ' ' ASN . 2.3 p -73.62 -4.04 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -0.861 . . . . 0.0 110.021 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.501 ' HB ' ' HA ' ' A' ' 81' ' ' ASP . 14.3 m -81.3 -65.45 1.01 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.045 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.602 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 50.2 m-85 -87.11 173.68 9.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.892 . . . . 0.0 110.001 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.586 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -116.9 -15.22 10.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.724 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.586 ' CE1' ' HB3' ' A' ' 86' ' ' ASP . 1.6 m-85 -123.0 74.56 1.22 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.068 -1.02 . . . . 0.0 109.659 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.891 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 2.6 mt -85.22 94.04 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -105.58 -179.82 4.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.958 -1.089 . . . . 0.0 109.467 -179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.739 ' SG ' ' HG ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -142.94 172.69 12.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.74 ' HA ' ' HE2' ' A' ' 91' ' ' MET . 30.9 mmt -67.52 -7.77 28.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 0.0 109.669 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 115' ' ' LEU . 5.7 p30 174.05 -176.41 0.08 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.099 -1.0 . . . . 0.0 109.406 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 0.8 OUTLIER -83.44 -7.58 59.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.78 -49.97 70.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.578 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -83.68 9.98 10.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.201 -0.937 . . . . 0.0 109.501 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.957 HD21 HG22 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -100.17 16.49 24.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.0 ttt-85 -84.87 -22.63 29.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.503 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.5 ' O ' ' CG ' ' A' ' 102' ' ' LYS . 0.9 OUTLIER -107.07 -32.64 7.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.466 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.984 HD11 HG11 ' A' ' 11' ' ' VAL . 24.5 mt -73.57 -36.01 65.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.493 ' HB2' HD22 ' A' ' 96' ' ' LEU . 5.5 t30 -66.17 -35.09 79.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 109.324 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -89.84 0.09 57.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.374 -0.829 . . . . 0.0 109.457 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.73 ' O ' HG23 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -92.18 -22.33 19.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.478 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m -70.42 -12.61 61.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 0.0 109.41 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -86.27 -30.83 22.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -92.44 -10.36 38.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 109.348 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 102' ' ' LYS . 39.0 t -71.76 140.13 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -75.13 117.1 16.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.231 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 83' ' ' VAL . 2.5 m-80 48.28 46.38 20.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.544 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -50.11 150.88 2.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.96 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 83' ' ' VAL . 5.8 ptm180 -140.58 9.9 2.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.467 -0.771 . . . . 0.0 109.111 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.891 ' HB1' ' CG1' ' A' ' 88' ' ' ILE . . . -98.39 116.07 29.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 110.321 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -70.57 124.22 23.72 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.957 HG22 HD21 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -99.1 114.95 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.795 -1.191 . . . . 0.0 110.498 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 20.7 mt-10 -147.51 -177.5 5.73 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 1.064 HD12 HD11 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -126.07 153.7 44.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.97 -1.081 . . . . 0.0 109.746 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.903 HD21 ' HA ' ' A' ' 148' ' ' CYS . 0.3 OUTLIER -43.47 104.49 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.373 -0.83 . . . . 0.0 109.521 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.38 157.17 16.45 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 25.5 m -65.06 93.75 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -1.133 . . . . 0.0 109.375 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -77.14 -93.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.54 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.598 ' CB ' ' CD ' ' A' ' 121' ' ' PRO . 1.1 m-20 -71.81 -62.27 1.7 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.054 -1.029 . . . . 0.0 109.789 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 120' ' ' ASP . 55.5 Cg_endo -72.05 126.16 11.58 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.795 1.663 . . . . 0.0 110.256 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -105.13 111.99 24.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -150.56 158.12 43.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.551 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -88.42 98.44 11.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.438 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 176.57 108.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 1.064 HD11 HD12 ' A' ' 115' ' ' LEU . 1.8 tt -121.23 28.16 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.654 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 126' ' ' ILE . 20.0 tt 41.28 41.3 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.402 -0.811 . . . . 0.0 109.838 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.519 ' HG3' HG23 ' A' ' 126' ' ' ILE . 1.3 mt-10 -87.48 51.23 2.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 109.423 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.56 104.34 55.35 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.928 . . . . 0.0 109.42 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -49.4 169.83 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.8 1.667 . . . . 0.0 110.228 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.412 ' C ' ' CD1' ' A' ' 131' ' ' TYR . 3.0 t80 -84.79 106.09 16.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.55 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -146.4 -64.71 0.3 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 135.56 114.74 1.41 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -154.5 -49.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.33 -1.1 . . . . 0.0 109.518 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.72 -19.6 20.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . 56.65 24.6 9.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.509 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -127.99 87.89 2.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.429 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.453 ' C ' ' CD1' ' A' ' 138' ' ' PHE . 29.0 p90 -71.48 -10.36 59.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.5 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -62.88 -34.84 78.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.412 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 144' ' ' GLN . 0.2 OUTLIER -63.54 -25.78 68.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.309 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.554 ' CG1' ' HB2' ' A' ' 19' ' ' SER . 27.7 t -79.1 -31.11 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.312 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.962 ' HA ' HG21 ' A' ' 21' ' ' ILE . 6.1 t80 -69.18 -50.92 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.567 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -65.41 -41.6 93.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.178 -0.952 . . . . 0.0 109.514 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 140' ' ' THR . 0.8 OUTLIER -68.87 -14.37 62.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 0.0 109.391 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 21' ' ' ILE . 4.6 m -89.94 -8.6 51.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.868 ' HA ' HG11 ' A' ' 25' ' ' VAL . 46.2 t -62.57 -68.73 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.884 . . . . 0.0 109.713 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.8 ' HB3' ' HB2' ' A' ' 151' ' ' ALA . 0.7 OUTLIER -58.94 -15.61 13.77 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.824 -1.173 . . . . 0.0 109.157 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.954 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 0.5 OUTLIER -44.26 -32.97 1.43 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.202 -0.936 . . . . 0.0 108.582 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.895 ' SG ' HG12 ' A' ' 25' ' ' VAL . 1.6 p -115.09 -24.38 8.58 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.956 ' HG3' HD11 ' A' ' 29' ' ' LEU . 9.5 ttt-85 -76.55 -60.98 2.11 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.8 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . . . -49.67 -36.51 25.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.441 -0.787 . . . . 0.0 109.149 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.737 ' CE2' HG21 ' A' ' 156' ' ' VAL . 17.0 t80 -77.9 -31.64 51.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.532 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.482 ' O ' ' CA ' ' A' ' 157' ' ' ARG . 11.7 tp -67.9 -13.18 61.95 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.166 -0.959 . . . . 0.0 108.815 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 157' ' ' ARG . 1.8 mt-10 -76.9 -53.41 7.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.262 -0.898 . . . . 0.0 109.122 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -47.61 84.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.962 . . . . 0.0 109.117 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.737 HG21 ' CE2' ' A' ' 152' ' ' PHE . 14.1 m -97.64 25.6 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 109.083 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.482 ' CA ' ' O ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.548 -179.829 . . . . . . . . 2 2 . 1 stop_ save_